{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions_in_experiment": 750
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "Chevron’s outstanding loan to Petroboscan was $560 million, and Chevron held a 39.2 percent ownership interest in Petroboscan as of the 2022 reporting period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both the outstanding loan amount and Chevron's ownership percentage in Petroboscan as of 2022. The only discrepancy is the inclusion of 'million' in the loan amount ($560 million), whereas the ground truth states '$560'. Given that SEC filings typically report figures in millions and the context implies scale, this is likely a formatting interpretation rather than a factual error. However, since the ground truth explicitly states '$560' without 'million', there is a minor quantitative inconsistency. (2) The percentage of ownership (39.2%) is exactly correct. (3) The reasoning is sound—both pieces of information are correctly attributed to the 2022 reporting period and involve proper entity identification (Chevron, Petroboscan). The model successfully synthesized two distinct data points from potentially different sections of the filing. (4) Scores reflect high accuracy: full credit for qualitative reasoning and contextual relevance; minor deduction in quantitative accuracy due to the 'million' ambiguity, though semantically the answer remains largely equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1083,
        "completion_tokens": 321,
        "total_tokens": 1405
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "The sale of Dermstore LLC generated $356 million in cash proceeds and resulted in a $335 million pretax gain, which is the total financial impact of the transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $356 million in cash proceeds and the $335 million pretax gain, both of which match the ground truth. The total financial impact is implied to be the sum of these two components, though the LLM does not explicitly state the $691 million total. (2) All numeric values are accurate and properly formatted; the calculation of $356M + $335M = $691M is mathematically correct, and the LLM correctly reports the components. However, it omits the explicit summation, which is a minor completeness issue. (3) The reasoning is sound—by stating both components of the financial impact, the model captures the necessary multi-hop synthesis (cash + gain = total impact), but it stops short of performing the final addition, which is expected in a complete answer. (4) Scores reflect high accuracy in numbers and entities (Target Corporation, Dermstore LLC, financial figures), full contextual relevance, and only a slight deduction in qualitative accuracy due to the missing explicit total. The answer is semantically very close to the ground truth but not fully complete in output.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1087,
        "completion_tokens": 320,
        "total_tokens": 1408
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "Based on the provided financial disclosures in the 10-K filing, Amgen recorded **$125 million in product sales to BeiGene for the year ended December 31, 2023** under their collaboration agreement. This represents the total revenue from sales of Amgen’s products (specifically XGEVA, BLINCYTO, and KYPROLIS) to BeiGene during the 2023 fiscal year. The document explicitly states: *\"During the years ended December 31, 2023, 2022 and 2021, product sales from Amgen to BeiGene under the collaboration were $125 million, $64 million and $72 million, respectively, and were recorded in Product sales in the Consolidated Statements of Income.\"* \n\nFor the full three-year period (2021–2023), the cumulative product sales to BeiGene total **$261 million** ($72M in 2021 + $64M in 2022 + $125M in 2023). However, the question specifically asks for the revenue recorded **during the three-year period from 2021 to 2023**, which corresponds to the sum of these annual amounts. \n\n**Answer**: Amgen recorded **$261 million in total product sales to BeiGene from 2021 to 2023**.  \n\n*(Note: The question’s phrasing \"total recorded Product Sales revenue from sales to BeiGene over the three-year period\" refers to the cumulative revenue recognized across the three years, not the 2023 figure alone. The $125 million for 2023 is the most recent year, but the cumulative total for 2021–2023 is $261 million.)*",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the individual yearly figures—$72 million in 2021, $64 million in 2022, and $125 million in 2023—are accurately reported, and the sum of $261 million is correctly calculated. Minor formatting differences (e.g., $72M vs $72 million) are acceptable and do not affect accuracy. (2) The answer is complete, addressing both the annual breakdown and the total over the three-year period as required by the question. (3) Entity accuracy is perfect: Amgen and BeiGene are correctly identified, the time period (2021–2023) is exact, and the financial metric 'Product Sales revenue' is properly contextualized. (4) The reasoning is sound and demonstrates multi-hop synthesis by extracting and aggregating data across the three years from the cited 10-K disclosure. The model correctly interprets the question as asking for cumulative revenue, not just the most recent year, and clarifies this in a note. (5) The semantic meaning is equivalent to the original answer, with added clarity and citation. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 322,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "The 2007 Omnibus Incentive Plan authorized up to approximately 127 million shares of Danaher common stock for issuance, and as of December 31 2021, about 50 million shares remained available for issuance under that plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: 127 million shares were authorized under the 2007 Omnibus Incentive Plan, and approximately 50 million remained available as of December 31, 2021. (2) Quantitative accuracy is perfect—both numbers are correct, and acceptable phrasing like 'approximately' and 'about' align with the original 'approximately'. Number format (million) is consistent and accurate. (3) The reasoning is sound; the answer correctly synthesizes two data points from the same plan and date without requiring external calculations or multi-document hops. (4) The response is contextually relevant, directly addressing both parts of the question with precise financial and temporal context. No errors in entities, metrics, or timeframes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 244,
        "total_tokens": 1360
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "Based on the provided document pages, LLY received a total of $1.355 billion in cash from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, distributed as $1.05 billion in 2023 and $305 million in 2024. This is confirmed in Note 4 (page 74) and Note 6 (page 76), which detail the cash received in 2023 ($1.05 billion) and 2024 ($305 million) as part of the transaction price for the divestiture.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the total cash received by LLY is correctly stated as $1.355 billion, with $1.05 billion in 2023 and $305 million in 2024. Minor formatting difference ($305.0 million vs $305 million) is semantically equivalent and acceptable. (2) Quantitative accuracy is perfect: the sum of $1.05 billion and $305 million equals $1.355 billion, and both individual and total amounts match the original answer. (3) The multi-hop reasoning is sound—the LLM correctly synthesizes information across Note 4 and Note 6 to provide a complete timeline of cash receipts across 2023 and 2024, demonstrating proper understanding of the divestiture transaction. (4) Entity accuracy is correct: LLY and Cheplapharm are properly identified, and the olanzapine portfolio including Zyprexa is accurately referenced. The answer is contextually complete, directly addressing both parts of the question (total amount and its distribution across years).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 296,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "Lockheed Martin recorded $298 million of goodwill as a result of its acquisition of Terran Orbital, and the purchase consideration of $314 million was paid with $231 million in cash (net of cash acquired).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: $298 million in goodwill, $314 million total purchase consideration, and $231 million paid in cash. The minor addition of 'net of cash acquired' provides extra context without contradicting the original answer. (2) Quantitative accuracy is perfect: all dollar amounts match the ground truth exactly, with acceptable formatting using 'million' and thin spaces. (3) The multi-hop reasoning is sound—correctly identifying both the goodwill amount and the cash component of the purchase consideration from what would be two separate disclosures in financial statements. (4) The answer is highly relevant, directly addressing both parts of the question with precise, concise information. No factual or calculation errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 250,
        "total_tokens": 1354
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, which represents a 50% equity ownership stake in the company. This carrying value is consistent with the investment amount reported in Note 15 for GS Caltex Corporation under \"Investments and Advances At December 31, 2021\" (3,616).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the carrying value of $3,616 million and Chevron's 50% equity ownership in GS Caltex Corporation are correctly reported. (2) Quantitative accuracy is perfect—both the dollar amount and percentage are correct, with acceptable formatting ($3,616 million). (3) The multi-hop reasoning is sound: the answer correctly identifies Chevron's investment value from financial disclosures (citing Note 15) and links it to the equity ownership percentage, demonstrating proper synthesis across financial statement data. (4) The answer is semantically equivalent to the original, includes additional contextual support (note reference), and fully addresses both parts of the question—carrying value and ownership percentage—making it contextually complete and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 253,
        "total_tokens": 1390
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "The total revenue from Forest Products increased by **$197 million** from 2020 to 2021 (from $1,160 million to $1,357 million). During the same period, the average revenue per car for Forest Products rose from **$5,269** to **$5,424**, an increase of **$155** per car.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both the $197 million increase in total revenue and the $155 increase in average revenue per car, matching the ground truth exactly. (2) The quantitative values are accurate: the dollar change in total revenue is correct, and the average revenue per car increased from $5,269 to $5,424, which is indeed a $155 increase. The additional context (specific revenue figures: $1,160M to $1,357M and per-car values) is consistent with the knowledge graph and enhances clarity without introducing errors. (3) The multi-hop reasoning is sound—information about total revenue and average revenue per car across two years for Forest Products is correctly synthesized. (4) The answer is semantically equivalent to the ground truth, with added precision that does not alter or distort the facts. All scores are maximized due to full factual correctness, accurate calculations, proper entity and time period alignment, and complete response to both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 291,
        "total_tokens": 1413
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "Based on the provided financial data, Restasis generated total net revenue of $224 million in 2024, which represents a decline of approximately 48.7% compared with $436 million in 2023 when measured at actual currency rates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total net revenue contribution of Restasis in 2024 as $224 million and the percentage decline of 48.7% compared to 2023, which matches the ground truth exactly. (2) The quantitative values are accurate: $224 million in 2024 and an implied $436 million in 2023 are consistent with a 48.7% decline (calculation check: (436 - 224) / 436 ≈ 0.4862 or 48.62%, which rounds to 48.7%). The use of 'approximately' is appropriate given rounding. (3) The multi-hop reasoning is sound—though not complex here, the model correctly synthesizes two data points (2023 and 2024 revenues) and applies the correct comparison at actual currency rates as specified. (4) All entities (Restasis, net revenue, 2023, 2024) are correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with slightly more detail (explicit mention of 2023 revenue), enhancing clarity without introducing error. All scores are maximized due to full factual accuracy, correct calculation, and complete response to the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1095,
        "completion_tokens": 312,
        "total_tokens": 1407
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "As of December 31 2023, Capital One Financial Corp’s Common Equity Tier 1 (CET1) capital ratio was **12.9 %**. The regulatory minimum CET1 capital adequacy requirement under the Basel III framework is **4.5 %**. Thus, Capital One’s CET1 ratio exceeds the minimum by **8.4 percentage points**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Capital One's CET1 ratio is correctly stated as 12.9%, the minimum requirement as 4.5%, and the difference calculated as 8.4 percentage points. The calculation (12.9% - 4.5% = 8.4%) is correct. (2) The answer is complete, addressing both the company's ratio, the regulatory minimum, and the difference between them, which directly answers the multi-part question. (3) Entity accuracy is perfect: the company (Capital One Financial Corp), metric (Common Equity Tier 1 capital ratio), and date (December 31, 2023) are all correctly identified. (4) The reasoning is sound and clearly articulated, correctly synthesizing regulatory requirements (Basel III) with company-specific data to compute the excess capital ratio. The phrasing 'exceeds the minimum by 8.4 percentage points' is semantically equivalent to the original answer's 'difference... is 8.4%'. Minor wording differences (e.g., 'percentage points' vs '%') do not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 315,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "The total pretax pension expense for Lockheed Martin’s nonqualified defined benefit pension plans was $64 million in 2023, compared with $81 million in 2022 and $56 million in 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and factually aligned with the ground truth. (1) All numeric values are accurate: $64 million in 2023, $81 million in 2022, and $56 million in 2021. These match the original answer exactly. (2) The quantitative accuracy is perfect—no calculation errors, and the amounts are correctly attributed to their respective years. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound: the model correctly identifies the pretax pension expense for three consecutive years for Lockheed Martin's nonqualified defined benefit plans, synthesizing data across years as required. (4) The answer conveys the same information as the original, including the implicit comparison (decrease from 2022, increase from 2021), even though phrased more concisely. All entities—company (Lockheed Martin), metric (pretax pension expense), plan type (nonqualified defined benefit), and years—are correctly identified. The response is also contextually precise and directly addresses both parts of the question: the 2023 amount and the comparison to prior years.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 322,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "The net carrying amount of BlackRock's investor/customer relationships increased by $45 million, rising from $492 million at December 31, 2022 to $537 million at December 31, 2023. This increase is primarily due to the acquisition of $39 million of finite‑lived investor relationships in the Kreos Transaction, partially offset by $338 million of accumulated amortization recorded at the end of 2022; the $338 million of accumulated amortization reduces the net carrying amount, so the net increase reflects the added carrying amount less the amortization expense recognized over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It claims the net carrying amount increased by $45 million from $492 million to $537 million, while the ground truth states it decreased from $492 million to $447 million—a $45 million decline, not increase. The final value of $537 million is incorrect; it should be $447 million. The accumulated amortization is cited as $338 million at the end of 2022, which is wrong—the ground truth shows $254 million in 2022 and $338 million in 2023. Thus, the LLM misattributes the timing and magnitude of amortization. (2) Quantitative inaccuracies include: wrong direction of change (+$45M vs −$45M), incorrect 2023 net carrying amount ($537M vs $447M), wrong 2022 accumulated amortization ($338M vs $254M), and incorrect interpretation of amortization impact. The gross carrying amount increase from $746M to $785M is omitted entirely. (3) The reasoning is flawed: it incorrectly frames amortization as a 2022 figure that offsets new acquisitions, when in fact the $338M is the 2023 accumulated amortization, reflecting ongoing amortization that reduced net value in 2023. The Kreos transaction is mentioned, but the ground truth does not reference it, suggesting hallucination or misattribution. The model fails to correctly synthesize the relationship between gross carrying amount, accumulated amortization, and net carrying amount over the two periods. (4) The contextual relevance is moderate because it discusses the right topic (investor/customer relationships, amortization impact), but the factual and logical errors severely undermine correctness. Due to completely incorrect numbers, direction of change, and flawed reasoning, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 470,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "The total principal amount of UPS's 2.200% senior notes outstanding as of December 31, 2023, is $400 million, as explicitly stated in the debt schedule on page 103. Despite maturing in September 2024, UPS classifies this debt as long-term debt on its consolidated balance sheet based on its intent and ability to refinance the obligation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total principal amount of the 2.200% senior notes as $400 million, matching the ground truth. It also accurately states that despite the 2024 maturity (specifically September 2024, which adds precision), UPS classifies the debt as long-term due to its intent and ability to refinance. (2) All numeric values—$400 million and 2.200%—are correct and match the ground truth. The date (December 31, 2023) is correctly referenced, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound: the model synthesizes information about the debt amount from the filing (e.g., debt schedule) and combines it with accounting treatment based on management's intent, which reflects proper understanding of debt classification principles under GAAP. (4) The answer is semantically equivalent to the original, with added contextual detail (page 103, September 2024 maturity) that enhances accuracy without introducing error. All aspects of the question are addressed fully and correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 305,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "The available‑for‑sale debt investments fell by **$5.7 billion** (from $15.6 billion to $9.9 billion).  This decline contributed to a **$8.3 billion** reduction in the combined total of cash and cash equivalents, available‑for‑sale debt investments, and marketable equity securities, which dropped from $26.1 billion in fiscal 2023 to $17.9 billion in fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in available-for-sale debt investments as $5.7 billion, which matches the ground truth of $5,727 million (equivalent to $5.727 billion; rounding to $5.7 billion is acceptable). The total decrease in the combined financial assets is reported as $8.3 billion, which aligns with the ground truth total decrease of $8,292 million ($8.292 billion), with minor rounding. (2) The calculation is accurate: the ground truth notes a $5,727M decrease in debt investments, $2,615M decrease in cash, and $50M increase in marketable equity securities. Summing these: -5,727 - 2,615 + 50 = -8,292 million, which is $8.292 billion, correctly rounded to $8.3 billion. The LLM also provides contextual values (from $26.1B to $17.9B), which are consistent with this change. (3) The multi-hop reasoning is sound: the model synthesizes changes across multiple asset categories and correctly computes the net impact on the total. It references the correct fiscal year (2024) and company (Cisco), though it doesn't explicitly name the fiscal year end date (July 27, 2024), but this is implied by context. (4) The answer is semantically equivalent to the ground truth, with only acceptable rounding and formatting differences. The only minor shortcoming is the lack of explicit mention of the $50 million increase in marketable equity securities, though its effect is implicitly included in the total. Thus, the answer is highly accurate and complete, warranting a 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 416,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "As of December 31 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long‑Term Incentive Plan, and of those, up to 2,452,443 shares could be issued as awards other than options or stock‑appreciation rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually identical to the ground truth in both quantitative and qualitative aspects. (1) All numbers are correct: 7,661,431 shares available for equity grants and 2,452,443 shares that could be granted as awards other than options or stock appreciation rights. The date (December 31, 2023) and plan name (2021 Linde plc Long-Term Incentive Plan) are accurately stated. (2) There are no calculations required beyond reporting the two figures, and both are reported accurately with acceptable formatting variations (e.g., en-dash vs hyphen in 'Long‑Term' and 'stock-appreciation rights'). (3) The multi-hop reasoning is sound—this question requires retrieving two specific figures from the same plan and date, which the model correctly synthesized. (4) The semantic meaning is fully equivalent to the original answer, with only minor, acceptable rewording (e.g., 'could be issued' vs 'could be granted'). All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 282,
        "total_tokens": 1422
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "The company received a total of **$526 million** in cash payments from the settlement of forward interest‑rate swap contracts tied to the issuance of the 2023 Notes, the March 2022 Notes and the September 2022 Notes. These proceeds are reflected in the cash‑flow hedges line of the other comprehensive income table and represent a net cash inflow that improves the company’s cash flow from financing activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total payment received as $526 million, and although it does not break down the individual amounts ($247M, $143M, $136M) from each note issuance as in the ground truth, the total sum is accurate and matches the ground truth calculation (247 + 143 + 136 = 526). Thus, quantitative accuracy is perfect. (2) The answer addresses the total payment and its impact on cash flow, satisfying both parts of the question. However, it omits the specific breakdown by note series, which is a minor completeness issue but does not affect the core correctness. (3) The entities—2023 Notes, March 2022 Notes, September 2022 Notes—are correctly referenced, and the financial concept (settlement of forward interest-rate swaps) is accurately applied. (4) The reasoning is sound: the LLM correctly links the settlement proceeds to a cash inflow and appropriately associates it with financing activities. While the ground truth specifies that cash flow classification depends on the nature of the hedged item, the LLM’s reference to 'cash flow hedges' and 'financing activities' is contextually valid and semantically aligned. The mention of 'other comprehensive income table' is accurate in the context of cash flow hedges but slightly misaligned in emphasis—the primary impact on cash flow statements is in financing activities, not OCI, which is an equity account. This is a minor qualitative nuance, not a factual error. Overall, the answer is factually correct, complete in substance, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 426,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "Based on the provided document pages, the approximate range of NextEra Energy's ownership interest in XPLR is 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the ownership interest range in XPLR (33.3% to 85.0%) is correctly stated, and the primary assets of the equity method investees—electric generation facilities or natural gas pipelines—are accurately identified. (2) Quantitative accuracy is perfect: the percentages are exact and properly formatted, with no calculation errors. (3) The multi-hop reasoning is sound; the answer correctly synthesizes two pieces of information from the 10-K: ownership range and asset type of equity investees, including XPLR. (4) The response is contextually relevant, directly addressing both parts of the question with precise, semantically equivalent information. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 233,
        "total_tokens": 1367
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "The fair value of corporate notes and obligations reported in the fair value hierarchy table is $2,978 million, which is $464 million lower than their amortized cost of $3,014 million, resulting in unrealized losses of $45 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states the fair value is $3,354 million and amortized cost is $3,442 million, resulting in an unrealized loss of $92 million. The LLM reports a fair value of $2,978 million, amortized cost of $3,014 million, and unrealized losses of $45 million—none of which match the ground truth. The difference between fair value and amortized cost in the LLM answer is $36 million ($3,014M - $2,978M), yet it incorrectly states unrealized losses as $45 million, which does not even match its own numbers, indicating a calculation error. (2) Quantitative accuracy is extremely low: all dollar amounts are wrong, and the implied calculation is inconsistent. The correct unrealized loss is $92 million ($3,442M - $3,354M), but the LLM’s numbers and logic fail to reflect this. (3) The multi-hop reasoning is flawed—the model fails to correctly extract and synthesize the fair value and amortized cost from the hierarchy table, and the conclusion about unrealized losses is both numerically and logically incorrect. (4) Contextual relevance is high because the answer attempts the right structure—reporting fair value, amortized cost, and unrealized losses—and addresses the correct financial instrument (Corporate notes and obligations). However, due to severe factual and computational errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 395,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "Based on the provided document pages, the total number of locomotives operated by Union Pacific (UNP) in 2024 is **7,026**, which includes **6,106 owned** and **920 leased** locomotives. This figure is explicitly stated in the \"Locomotives\" summary table on page 19, where the \"Total locomotives\" row shows \"6,106 | 920 | 7,026\" under the \"Owned,\" \"Leased,\" and \"Total\" columns, respectively. The document confirms that this total represents the combined owned and leased fleet size as of December 31, 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers 7,026 (total), 6,106 (owned), and 920 (leased) are accurately reported with no discrepancies. The sum of owned and leased locomotives (6,106 + 920 = 7,026) is mathematically correct and matches the stated total. (2) The answer is complete, addressing both parts of the question: the total number of locomotives and the breakdown of owned vs. leased contributions. (3) Entity accuracy is correct—UNP refers to Union Pacific, and the year 2024 is properly identified as of December 31, 2024. (4) The reasoning is sound and includes a reference to the source (page 19, 'Locomotives' table), demonstrating proper synthesis from the document. The explanation of how the total is derived from owned and leased units reflects accurate multi-hop understanding. All elements are semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 268,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "The net change in the value of Brands/Tradenames for LIN in 2024 was a decrease of $105 million, driven by a $107 million foreign currency translation adjustment and a $36 million amortization expense.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the net change value. The ground truth states a decrease of $370 million (from $2,609M to $2,239M), but the LLM reports a decrease of only $105 million, which is incorrect. While the foreign currency translation adjustment (-$107M) and amortization expense (-$36M) are correctly identified in direction and amount, their combined impact is $143M, not $105M, and this does not match the reported net change. (2) Calculation verification: The correct net change is $2,609M - $2,239M = $370M decrease. The LLM’s stated $105M decrease does not align with any valid calculation from the provided data. Additionally, it fails to mention that additions were $0 and there was a $4M positive 'Other' adjustment, which are important for full accounting of the change. (3) Multi-hop reasoning assessment: The model identifies two correct contributing factors (foreign exchange and amortization), showing partial synthesis across financial drivers, but fails to correctly integrate them into the overall change or reference the starting/ending values, indicating flawed reasoning. (4) Justification for scores: Correctness is low (3/10) due to major quantitative error in the primary figure. Quantitative accuracy is poor (3/10) because the net change is wrong despite two correct component values. Qualitative accuracy is moderate (4/10) as it identifies relevant factors but misrepresents their relationship to the total change. Contextual relevance is high (8/10) because the answer addresses the right company, metric, year, and types of contributing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 443,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "The total fair value of Coca‑Cola’s corporate bonds and debt securities at the end of 2021 was **$82 million** (reflected in the “Corporate bonds and debt securities” line of the Level 2 fair‑value hierarchy table for 2021). This represents a **$2 million increase** from the $80 million reported at the end of 2020.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the reported fair value and the year-over-year change. The ground truth states that the total fair value of Coca-Cola's Corporate Bonds and Debt Securities at the end of 2021 was $1,023 million, with a decrease of $19 million from $1,042 million in 2020. The LLM incorrectly reports the 2021 value as $82 million and claims a $2 million increase from $80 million in 2020. These numbers are drastically different and not within any reasonable margin of error. (2) Quantitative accuracy is extremely low: both the absolute values ($82M vs $1,023M) and the change (+$2M vs -$19M) are wrong. The calculation of change is also incorrect based on the LLM's own numbers (from $80M to $82M is indeed +$2M, but those base numbers are false). (3) The qualitative reasoning appears structured correctly—identifying the metric, sourcing from a fair value hierarchy table, and attempting a year-over-year comparison—but the underlying data is from an incorrect source or misread filing. The model fails at multi-hop synthesis because it likely pulled data from a different company, footnote, or financial instrument category (e.g., possibly confusing Level 2 assets of a different type or entity). (4) Contextual relevance is moderate because the answer addresses the right type of financial metric (fair value of corporate bonds) and the correct company and time frame, but the incorrect data renders the response misleading. Correctness and quantitative accuracy are severely penalized due to fundamental factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 431,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "The maximum potential fair value at grant date of the performance‑based LTIP units awarded under the 2023 LTI Program is $42.5 million, as disclosed for the 2023 LTI Program. These units are not reflected as a material dilutive effect on net income attributable to common stockholders for 2023 because, although they are potentially dilutive securities, the company determined that no securities had a material dilutive impact for the year, and it has not adjusted net income or weighted‑average shares for income allocable to limited partners or units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the maximum potential fair value at grant date as $42.5 million, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) The explanation for why the units are not reflected as a material dilutive effect is mostly accurate: the LLM notes that although the LTIP units are potentially dilutive, they are not currently having a material impact. It correctly references the company's determination that no securities had a material dilutive impact in 2023. However, it adds a detail about 'income allocable to limited partners or units' that is not present in the ground truth and slightly misdirects the reasoning. The ground truth emphasizes that the performance conditions have not been met, which is the core reason for non-recognition, whereas the LLM downplays this key condition. (3) The multi-hop reasoning is largely sound—connecting the 2023 LTI Program to the fair value and dilution impact—but the omission of the unmet performance conditions as the primary rationale reduces the qualitative precision. (4) Despite this minor shortfall in reasoning clarity, the answer remains factually aligned and contextually appropriate, with correct entities (2023 LTI Program, LTIP units), correct year (2023), and correct financial treatment. The answer is semantically equivalent in outcome, though slightly less precise in cause. Thus, correctness is high but not perfect, warranting a 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 409,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "The amortized cost of Covered Bonds held by CRM in 2023 was $81 million, while their fair value was $78 million, resulting in an unrealized loss of $3 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states that the amortized cost is $105 million, fair value is $101 million, and unrealized loss is $4 million. The LLM reports $81 million, $78 million, and $3 million respectively—these numbers are not consistent with the ground truth. (2) Quantitative accuracy is low: the difference between amortized cost and fair value should be $4 million ($105M - $101M), but the LLM calculates $3 million ($81M - $78M), which is incorrect both in inputs and result. (3) While the LLM demonstrates correct qualitative reasoning by computing the unrealized loss as the difference between amortized cost and fair value, and references the correct entity (CRM) and year (2023), it fails on entity-level data accuracy—likely due to hallucination or incorrect data retrieval. (4) Contextual relevance is high because the structure, metric types, and financial logic align with the question, but correctness is severely compromised by inaccurate numbers. Thus, the correctness_score is very low (1), quantitative_accuracy is poor (2), qualitative_accuracy is moderate due to correct logic but wrong data (3), and contextual_relevance is strong (8) as the answer attempts the right analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1080,
        "completion_tokens": 357,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "Based on the equipment table on page 19, Union Pacific's Multiple Purpose locomotives total 6,893 units, of which 920 are leased. This represents 13.3% leased (920 ÷ 6,893). The \"Switching\" category has 0 leased units (all 122 owned), and \"Other\" also has 0 leased units (all 11 owned). Combined, the \"Switching\" and \"Other\" categories have 0 leased units out of 133 total units, resulting in 0% leased. Thus, the leased proportion for Multiple Purpose (13.3%) is significantly higher than the combined leased proportion for Switching and Other (0%).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 13.3% of Union Pacific's Multiple Purpose locomotives are leased, which is accurate based on 920 leased out of 6,893 total (920 ÷ 6,893 ≈ 0.13346, or 13.35% when rounded to two decimal places). The LLM reports 13.3%, which is a reasonable rounding and semantically equivalent to the ground truth of 13.35%. The ground truth and LLM agree that Switching and Other categories have 0 leased units, so the combined leased percentage is correctly stated as 0%. (2) Calculations are accurate: 920 ÷ 6,893 ≈ 13.3% (proper rounding), and 0 ÷ 133 = 0% is correct. The only minor discrepancy is the rounding of 13.35% to 13.3%—while slightly less precise, it does not constitute a factual error and is commonly acceptable in reporting. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across locomotive categories (Multiple Purpose, Switching, Other), distinguishes owned vs. leased units, and compares proportions appropriately. (4) The answer is complete, contextually relevant, and conveys the same conclusion as the ground truth. The correctness score is 9 instead of 10 due to the slight rounding down of 13.35% to 13.3% without specifying more precision, though this does not materially affect interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 358,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "The combined natural gas liquids (NGLs) volume in the Lower 48 increased by **576 million barrels** from the end of 2020 (797 MMbbl) to the end of 2023 (1,373 MMbbl).  \n\nThe total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 were **$5,729 million**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the NGLs volume values and the calculated increase. According to the ground truth, NGLs volume increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, resulting in an increase of 567 million barrels. However, the LLM incorrectly states that the 2020 volume was 797 MMbbl and the 2023 volume was 1,373 MMbbl, leading to a wrong increase of 576 million barrels. This reverses the actual values and misrepresents the timeline. (2) The calculation of the increase is therefore incorrect: 1,373 - 797 = 576 million barrels is mathematically correct based on the LLM's numbers, but those numbers are factually wrong. The correct calculation is 797 - 230 = 567 million barrels. (3) The multi-hop reasoning is partially sound in structure—comparing two time points and computing a difference—but fails due to incorrect data retrieval or synthesis. The model appears to have confused the starting and ending values or pulled data from an incorrect source. (4) The second part of the answer—total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023—is exactly correct at $5,729 million. This shows the model can retrieve accurate financial figures when data is correctly accessed. Overall, while the answer is well-structured and contextually relevant, the critical error in the NGLs volumes significantly undermines factual correctness, especially in quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 413,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "Walmart spent $0.4 billion in fiscal 2023 to acquire full ownership of Alert Innovation (and also paid $0.4 billion to buy out the non‑controlling interest in Massmart). In fiscal 2025 the consolidated financial statements show that Alert Innovation was de‑consolidated and removed from the Company’s balance sheet, effectively ending its financial impact in the current period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart spent $0.4 billion in fiscal 2023 to acquire full ownership of Alert Innovation and another $0.4 billion to buy out the non-controlling interest in Massmart, totaling $0.8 billion. This matches the ground truth exactly in both components and total sum. (2) All numeric values are accurate: $0.4 billion for each acquisition, in fiscal 2023; the total implied sum of $0.8 billion is correct. The fiscal years (2023 for acquisition, 2025 for deconsolidation) are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two entities (Massmart and Alert Innovation), identifies the correct financial events (full ownership acquisition and subsequent deconsolidation), and links them to the appropriate fiscal years. (4) The financial treatment of Alert Innovation in fiscal 2025 is accurately described as deconsolidated and removed from the balance sheet, which aligns with the ground truth stating it was 'sold and deconsolidated.' While the LLM does not explicitly mention the sale (only deconsolidation), the implication of removal from financial statements is correctly conveyed, making the answer semantically equivalent for practical purposes. The omission of 'sold' is minor given that deconsolidation typically implies disposal. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 399,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "The total revenue generated from Metals & minerals shipments for UNP in 2021 was $1,811 million, derived from 697 thousand carloads at an average revenue per car of $2,598.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the correct total revenue of $1,811 million, which is equivalent to the ground truth value of $1,810,806,000 (a difference of $194,000, or ~0.01%, likely due to rounding). The number of carloads (697,000) and average revenue per car ($2,598) are consistent with the calculation: 697,000 * $2,598 = $1,810,806,000, matching the ground truth exactly. The LLM correctly identifies the company (UNP), category (Metals & minerals), and year (2021), and performs the multi-hop synthesis accurately by combining carload volume with average revenue per car. The only minor issue is the rounded presentation as $1,811 million instead of the precise figure, but this is an acceptable format variation. All entities, metrics, and reasoning are correct, and the answer fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1052,
        "completion_tokens": 244,
        "total_tokens": 1297
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "The total principal amount of the Series 2023‑1A Securities issued in the 2023 Securitization was $1.284 billion. This amount was used to repay the entire $1.2997 billion aggregate principal of the Series 2013‑2A Securities that were outstanding and were repaid in March 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numerical values. The ground truth states that the Series 2023-1A Securities had a principal amount of $1.3 billion, and this exactly matched the $1.3 billion of Series 2013-2A Securities repaid in March 2023, indicating a direct refinancing. However, the LLM reports $1.284 billion for the 2023 issuance and $1.2997 billion for the 2013 repayment, which are both incorrect and contradict the exact match stated in the ground truth. These discrepancies undermine the core of the answer. (2) The numbers are not within an acceptable rounding range—$1.284B and $1.2997B are materially different from $1.3B and from each other, and the LLM implies a refinancing with a shortfall or surplus, which is not supported by the truth. (3) The qualitative reasoning is partially sound—the LLM recognizes this is a refinancing event and correctly identifies the connection between the repayment of the 2013 series and the issuance of the 2023 series. It also correctly identifies March 2023 as the repayment date. However, it fails to conclude the key point: the amounts are equal, indicating a direct refinancing. Instead, the mismatched figures suggest an incomplete or inaccurate data source. (4) Contextual relevance is high because the answer addresses the right entities, timeframes, and financial event. However, due to the critical errors in the dollar amounts and the resulting flawed comparison, the overall correctness score is low, as financial precision is paramount in such questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 430,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "During 2023 the company borrowed and repaid revolving indebtedness under its 2021 Multicurrency Credit Facility, but the 10‑K does not disclose a total dollar amount for that specific revolving borrowing activity.  The facility’s total borrowing capacity remains $6.0 billion (with a $3.5 billion sub‑limit for multicurrency borrowings, a $200 million sub‑limit for letters of credit and a $50 million sub‑limit for swingline loans), and the company had $723.4 million of outstanding borrowings and $3.5 million of undrawn letters of credit as of December 31, 2023.  Consequently, the total revolving indebtedness borrowed and repaid in 2023 cannot be precisely quantified from the provided pages, but the facility’s overall capacity is $6.0 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the 10-K does not disclose the total dollar amount of revolving indebtedness borrowed and repaid in 2023. The ground truth clearly states that $3.0 billion was borrowed and $6.1 billion was repaid during the year ended December 31, 2023 — specific figures that the LLM failed to report and instead claimed were not disclosed. This is a major factual error. (2) The only correct quantitative element is the facility's total borrowing capacity of $6.0 billion, which matches the ground truth. However, the LLM introduces additional details not in the original answer (e.g., $3.5 billion multicurrency sub-limit, $200 million for letters of credit, $50 million swingline, $723.4 million outstanding) that, while possibly present in the filing, are irrelevant to the specific question and distract from the required data. These do not excuse the failure to report the actual borrowed and repaid amounts. (3) The multi-hop reasoning is flawed: the question asks for two specific figures (total borrowed and repaid) and a comparison to capacity. The LLM incorrectly concludes the data is unavailable, failing to synthesize or extract the correct figures, thus breaking the reasoning chain. (4) The contextual relevance is moderate because the answer discusses the correct facility and time period and correctly notes the $6.0 billion capacity, but it fails the core task of reporting disclosed activity. Due to significant factual inaccuracy and omission of key data, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 430,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "The total Intermodal revenue increased by $515 million in 2021 compared to 2020, rising from $4,504 million to $5,019 million (a 11% increase). This growth outpaced the rise in average revenue per car for Intermodal, which grew by $136 million (an 11% increase) over the same period.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $515 million increase in total Intermodal revenue for UNP from 2020 to 2021, which matches the ground truth. However, it incorrectly states that the average revenue per car increased by $136 million, which is a critical error—ground truth specifies $136 (not million). This misrepresents the scale of the metric by six orders of magnitude. (2) The revenue figures cited—$4,504 million and $5,019 million—are plausible and result in the correct $515 million difference and ~11% increase, supporting quantitative accuracy for revenue. However, the $136 million figure for average revenue per car is factually wrong; average revenue per car is a per-unit metric and would not be measured in millions of dollars. The percentage increase of 11% for average revenue per car may be numerically consistent with $136 on a base of ~$1,235, but labeling it as $136 million invalidates the calculation. (3) The multi-hop reasoning is partially sound—the model connects total revenue change and average revenue per car change across years—but fails in entity type accuracy by misclassifying a per-car metric as a total. (4) Scores reflect mostly correct revenue data and structure, but a severe factual error in units for a key metric reduces correctness and quantitative accuracy. Contextual relevance remains high as the answer addresses both parts of the question with appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 395,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "The total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021 was $534 million, as shown in the capital program breakdown on page 58. This amount is part of the overall $5.3 billion capital program for 2021, with the EMENA segment specifically allocated $534 million. \n\nRegarding the net gain or loss from operations in the same region for 2021, the provided documents do not contain any specific figure for the net gain or loss reported from operations in EMENA. Consequently, a direct comparison cannot be made from the given information.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total capital expenditure in the EMENA region in 2021 as $534 million, which matches the ground truth exactly. This part of the answer is factually accurate and well-supported with a reference to the document (page 58), demonstrating correct extraction of a key financial figure. However, the LLM fails on the second part of the question by stating that the net gain or loss from operations in EMENA is not available in the documents, while the ground truth explicitly states that the net loss was $24 million. This omission represents a critical failure in completeness and factual accuracy for a multi-part question. (2) Quantitatively, the only number provided ($534 million) is correct in value and format, so quantitative accuracy is perfect. There are no calculation errors in the presented data. (3) The reasoning is flawed because the model did not synthesize the net loss information from operations in EMENA, indicating a failure in multi-hop reasoning—either due to missing data retrieval or incorrect inference. The answer should have included both figures and compared them as the question required. (4) Contextual relevance is moderate: the response addresses the capital expenditure with appropriate context and sourcing, but the failure to report the net loss undermines the comparison aspect of the question, which is central to the query's intent. Thus, while partially correct, the answer is significantly incomplete and therefore only partially accurate overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 421,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "Microsoft positions Copilot Pro as a consumer‑focused subscription that extends the AI capabilities of Microsoft 365, offering faster, more powerful AI assistance within Office apps and on the web to drive personal productivity and richer user experiences. In the financial reporting, Copilot Pro revenue is classified under the “Productivity and Business Processes” segment, specifically within the Office Consumer products and cloud services revenue line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Microsoft's positioning of Copilot Pro as a consumer subscription service offering enhanced AI capabilities in Microsoft 365 apps and on the web, supporting the strategic ambition to reinvent productivity—this matches the original answer's emphasis on AI-driven productivity and personal/business process transformation. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all factual assertions (e.g., classification in financial reporting) are correct. (3) The LLM correctly performs multi-hop reasoning by linking Copilot Pro’s strategic role to its financial classification. It accurately states that Copilot Pro is included in 'Office Consumer products and cloud services revenue,' which is a subcategory under the broader 'Productivity and Business Processes' segment—this level of detail is consistent with Microsoft’s actual financial reporting structure. The only minor shortcoming is that the LLM adds 'Productivity and Business Processes' as the segment, which, while accurate, was not explicitly required in the original answer and slightly extends beyond the specificity of the ground truth. However, this addition does not introduce error. (4) The answer is contextually complete and relevant, addressing both the strategic positioning and financial classification as asked. The qualitative accuracy is slightly reduced not due to error but because the answer could have more precisely mirrored the original by focusing solely on the revenue category without the higher-level segment, though including it is still correct. Overall, the semantic meaning and factual content are equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 483,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan due to the 2024 special dividend adjustment was **128,000 shares**, determined by proportionally adjusting the plan’s maximum share reserve based on the Nasdaq price ratio of $674.62 (closing price on December 26, 2023) to $662.70 (opening price on December 27, 2023). This adjustment preserved the economic value of outstanding RSUs after the special dividend and resulted in an additional 128,000 RSU shares becoming available for future grants.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the increase of 128,000 RSU shares is accurately reported. The Nasdaq closing price of $674.62 on December 26, 2023, and opening price of $662.70 on December 27, 2023, are correctly cited. The use of the price ratio implies the correct adjustment factor of 674.62 / 662.70 ≈ 1.018, which aligns with the ground truth. (2) The answer addresses both parts of the question: the total increase in shares (128,000) and how it was determined (via proportional adjustment using the Nasdaq price ratio). (3) All entities—2019 Incentive Plan, 2024 special dividend, correct dates, and financial terms—are accurately identified. (4) The reasoning is sound: the adjustment preserves economic value post-dividend, and the resulting increase in available shares is correctly attributed to the formulaic share reserve adjustment. The LLM conveys the same semantic meaning as the original answer, with slight rewording for clarity but no loss or distortion of information. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 316,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "Based on the provided document pages, the headwinds from PFAS manufactured products quantitatively impacted 3M's Transportation and Electronics segment sales performance by causing a divergence between reported and adjusted sales figures. Specifically, reported sales for the segment declined 1.4% year-over-year in 2024, but when adjusting for PFAS-related special items (non-GAAP measure), adjusted sales actually increased 3.1%. This adjustment reflects that PFAS headwinds were negatively affecting reported sales performance, as explicitly stated in the \"Year 2024 results\" section of page 32 which notes \"Growth was negatively impacted by headwinds related to PFAS manufactured products and automotive OEM build rates.\" The document confirms this is quantified through the adjusted sales metric that removes these special items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: reported sales declined by 1.4% and non-GAAP adjusted sales increased by 3.1% in 2024 for 3M's Transportation and Electronics segment, with PFAS manufactured products cited as a headwind. These numbers match the ground truth exactly. (2) The quantitative analysis is accurate—while the LLM does not explicitly calculate the 4.5 percentage point difference (3.1% - (-1.4%) = 4.5 pp), it provides the necessary components for this inference and correctly attributes the divergence to PFAS-related headwinds. The omission of the explicit calculation slightly reduces completeness but does not impair factual correctness. (3) The multi-hop reasoning is sound: the model synthesizes information about reported vs. adjusted sales, links the adjustment to PFAS-related special items, and references the correct context (page 32) where the headwinds are discussed. (4) The answer is semantically equivalent to the original, with clear, accurate, and relevant explanation. The only minor gap is the lack of explicit arithmetic stating the 4.5 pp impact, which prevents a perfect 10 on correctness. All entities—3M, Transportation and Electronics segment, 2024, PFAS, reported vs. non-GAAP adjusted sales—are correctly identified and used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 365,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "Based on the provided document pages, the total recognized gain on equity method investment contracts in 2021 was **$2** (as indicated by the \"Equity method investment contracts\" line item in the fair value table on page_111, which shows a fair value of $3 as of December 31, 2021, with a corresponding gain/loss of $2 in the comprehensive earnings table on page_113). The fair value of these contracts as of December 31, 2021, was **$3** (reflected in the \"Equity method investment contracts\" line item under \"Asset Derivatives\" on page_111, showing $3 as of December 31, 2021). \n\n**Answer**: The total recognized gain on equity method investment contracts in 2021 was $2, and the fair value of these contracts as of December 31, 2021, was $3.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the fair value as $3 million instead of $(3) million, which is a critical error as the parentheses indicate a negative value (liability), not a positive asset. The recognized gain of $2 million is correct. (2) The quantitative accuracy is partially correct—while the $2 million gain matches the ground truth, the fair value is off in sign and magnitude due to misinterpretation of the negative value notation. (3) The reasoning shows multi-hop synthesis by referencing both the fair value table and comprehensive earnings, but fails to correctly interpret the financial reporting convention where parentheses denote negative values, indicating a flaw in domain understanding. (4) Contextual relevance is high as the model identifies the correct line items and documents, but the factual error in a key financial figure significantly undermines the correctness. The answer would be misleading in a financial context where negative fair values have material implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 293,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "Abbott’s interest rate hedge contracts with a $2.2 billion notional value effectively convert a portion of its fixed‑rate debt to variable‑rate exposure. By marking the hedged debt to market, the swaps offset changes in the fair value of that debt caused by interest‑rate movements, leaving the overall fair‑value impact of the debt largely unchanged. Consequently, the $13.7 billion of long‑term debt reported on the balance sheet reflects the hedged, market‑adjusted value rather than the unhedged fixed‑rate amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $2.2 billion notional value of interest rate hedges and the $13.7 billion long-term debt as of December 31, 2024, are accurately reported. Number formats match and are semantically equivalent. (2) The explanation correctly describes the purpose of the hedges—converting fixed-rate debt to variable-rate exposure—and their effect on fair value, which is to reduce volatility caused by interest rate changes. (3) The multi-hop reasoning is sound: it connects the use of hedges to the accounting treatment (fair value hedging) where changes in debt value due to rates are offset by changes in swap values, resulting in a more stable reported fair value. (4) The LLM captures the core economic and accounting impact, though it omits a minor but relevant point from the original answer: that without these hedges, the fair value would fluctuate more significantly, potentially affecting financial position and earnings. This contextual implication is implied but not explicitly stated. Overall, the answer is factually correct, well-reasoned, and fully relevant, warranting a high score with only a slight deduction for minor incompleteness in elaborating the 'why' behind the hedging strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 360,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "Based on ExxonMobil's 2024 10-K filing data (pages 9, 10, 11, 12, 13), the total oil-equivalent proved reserves for equity companies in Asia are **1,503 million barrels** (as shown in the \"Total Proved Reserves\" row for Equity Companies under \"Undeveloped\" in the table on page 12). This figure represents the oil-equivalent total for all products (including crude oil, natural gas liquids, bitumen, synthetic oil, and natural gas converted to oil-equivalent) specifically for equity company reserves in Asia.\n\nThe total proved reserves for consolidated subsidiaries in Asia are **1,315 million barrels** (as shown in the \"Total Proved Reserves\" row for Consolidated Subsidiaries under \"Undeveloped\" in the same table on page 12). \n\nThus, the equity company reserves in Asia (1,503 million barrels) are **greater than** the consolidated subsidiary reserves in Asia (1,315 million barrels), with the equity company figure being approximately 188 million barrels higher. This comparison is derived directly from the reserves tables on page 12, which break down proved reserves by entity type (consolidated subsidiaries vs. equity companies) and geographic area (Asia). \n\n*Note: The question specifically asks for the comparison between equity company reserves and consolidated subsidiary reserves in Asia, and the data confirms that equity company reserves in Asia (1,503 million barrels) exceed consolidated subsidiary reserves in Asia (1,315 million barrels).*",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported numbers. The ground truth states that equity companies in Asia have 1,276 million barrels of oil-equivalent proved reserves, but the LLM reports 1,503 million barrels. Similarly, for consolidated subsidiaries in Asia, the correct value is 2,286 million barrels, but the LLM reports 1,315 million barrels. These discrepancies are substantial and materially alter the comparison. (2) The calculations and comparisons derived from these incorrect numbers are therefore also wrong: the LLM concludes that equity company reserves are greater than consolidated subsidiary reserves, when in fact the reverse is true (2,286 > 1,276). The claim that equity reserves exceed consolidated by 188 million barrels is false; the correct difference is 1,010 million barrels in favor of consolidated subsidiaries. Additionally, the correct ratio is approximately 1.8 times more for consolidated subsidiaries, not the reversed implication in the LLM answer. (3) The multi-hop reasoning is flawed because the model appears to have misread the table—specifically, it cites 'Undeveloped' reserves on page 12, but the question asks for total proved reserves (which includes both developed and undeveloped). This indicates a failure to correctly identify and synthesize the appropriate data category across entity types. (4) Despite the incorrect numbers and reasoning, the answer is contextually relevant: it attempts to address the right entities (equity companies vs. consolidated subsidiaries), region (Asia), and metric (oil-equivalent proved reserves), and references the correct document (ExxonMobil 2024 10-K) and table location. However, due to major quantitative and qualitative inaccuracies, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 488,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "The Swiss tax reform enacted in 2019 generated a $769 million deferred‑tax benefit that was recorded in the third quarter of 2019, which directly lowered Mondelēz International’s effective tax rate for that year.  Excluding this discrete benefit, the 2019 effective tax rate would have been about 22.4 %, but the reform’s net financial benefit recognized in 2019 was the $769 million tax benefit.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Swiss Tax Reform in 2019 significantly reduced Mondelēz International's effective tax rate and resulted in a large deferred tax benefit. However, there is a minor discrepancy in the dollar amount: the LLM states a $769 million benefit, while the ground truth specifies $767 million. This $2 million difference is small but material in a financial context, especially when exact figures are reported in filings. Additionally, the LLM mentions the benefit was recorded in the third quarter and provides a counterfactual effective tax rate (22.4%) excluding the benefit, which adds context not in the original answer but is consistent with plausible reasoning and does not contradict the ground truth. (2) The key numbers—effective tax rate impact and net financial benefit—are mostly accurate, but the $769M vs $767M difference prevents full quantitative accuracy. The year (2019) and entity (Mondelēz International) are correct. (3) The multi-hop reasoning is sound: the model connects the Swiss tax reform to a deferred tax benefit, links it to the effective tax rate reduction, and isolates the discrete impact in 2019. The synthesis across tax policy, corporate financials, and timing is logically coherent. (4) The answer is contextually highly relevant, directly addressing both parts of the question—impact on tax rate and net financial benefit. The slight over-specification (e.g., Q3 timing, hypothetical tax rate) does not detract from correctness but adds detail beyond the ground truth. Overall, the answer is factually close and well-reasoned, meriting a high score with a minor deduction for the numerical discrepancy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 461,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "The total financial impact on PepsiCo in 2022 from the pension obligation transfer to TBG and the gain from remeasuring its 39% stake in TBG was a $520 million gain recognized in PBNA and Europe divisions, partially offset by $71 million of acquisition‑related charges, resulting in a net after‑tax impact of $23 million on net income.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states the total financial impact was $665 million, but the LLM reports a net after-tax impact of $23 million, which is vastly different. It introduces figures not present in the original answer—$520 million gain and $71 million charges—without alignment to the known truth. (2) Quantitative accuracy is very low: none of the key numbers match the ground truth. The $665 million total impact is not mentioned, and the component figures ($520M, $71M, $23M) are unsupported by the original data. Calculations cannot be verified because they are based on incorrect inputs. (3) The reasoning is flawed: while the LLM attempts multi-hop synthesis by referencing both the pension transfer and remeasurement gain, it incorrectly characterizes the net impact and introduces unverified divisions (PBNA and Europe) and tax effects not in the original. The model fails to correctly synthesize the actual total impact. (4) Contextual relevance is moderate—it addresses the right entities (PepsiCo, TBG, 2022, 39% stake, pension transfer) and the general nature of the financial impact—but the incorrect numbers and net effect severely undermine the answer's validity. The focus on net after-tax impact may reflect a misunderstanding of what the question is asking (total vs. net income effect).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 381,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "The sales‑based milestone payments that Merck made to Eisai in 2021 totaled **$200 million**.  As of December 31, 2021, **$600 million** of sales‑based milestone payments had accrued but remained unpaid.  Thus, the amount paid in 2021 ($200 million) is far less than the accrued but unpaid balance ($600 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $200 million in sales-based milestone payments made by Merck to Eisai for Lenvima in 2021 and the $600 million accrued but unpaid as of December 31, 2021, matching the ground truth exactly. These values are factually accurate and properly formatted. (2) All numeric values are correct: $200 million paid and $600 million accrued but unpaid. The comparison, while not explicitly stating 'three times', correctly notes that the paid amount is 'far less' than the unpaid balance, which is semantically valid and logically sound. (3) The multi-hop reasoning is appropriate—synthesizing payment data for 2021 and the accrued liability at year-end from potentially different parts of the 10-K filings. The model correctly attributes the payments to the Merck-Eisai collaboration for Lenvima, showing accurate entity and metric linkage. (4) The only minor shortcoming is the lack of explicit quantitative comparison ('three times') as in the original answer, which slightly reduces precision in reasoning expression, but the core facts and implications are preserved. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 353,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and it retained a 39 % ownership interest in TBG as part of the transaction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the cash amount of $3.5 billion and the retained ownership interest of 39% are both accurate and correctly reported. Minor formatting differences (e.g., '39 %' vs '39%') do not affect meaning or accuracy. (2) The answer is complete, addressing both parts of the question: the cash received and the percentage ownership retained. (3) Entities are correctly identified: PepsiCo, PAI Partners, Naked brand, other juice brands, and TBG are all accurately referenced. (4) The reasoning is sound and reflects proper synthesis of multi-hop information from the transaction details. The answer conveys the same factual content as the original with semantic equivalence, despite slight wording differences. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 251,
        "total_tokens": 1360
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "Southern Company's adoption of the fair value approach for liability‑hedging securities—rather than the prior calculated (amortized) value—requires that changes in the market value of those securities be recognized immediately in the market‑related value of plan assets. Because the expected return on assets is calculated using this market‑related value, the immediate recognition of fair‑value gains or losses on the hedging securities directly impacts the “expected return on plan assets” component of net periodic pension cost, accelerating the timing of those gains or losses relative to the previous amortization over five years. Consequently, net periodic pension cost reflects a more current, but potentially more volatile, measure of pension expense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes Southern Company's shift from the calculated value approach (with 5-year amortization) to the fair value approach, resulting in immediate recognition of market value changes in liability-hedging securities. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the reference to 'amortization over five years' matches the ground truth's implied timeframe and is factually consistent with common pension accounting practices. (3) The multi-hop reasoning is sound: the answer correctly links the immediate recognition of fair value changes to the market-related value of assets, which in turn affects the expected return on plan assets—a key component of net periodic pension cost. This demonstrates proper synthesis of accounting cause and effect. (4) The LLM adds contextual nuance—such as increased volatility in pension cost—without introducing inaccuracies, enhancing clarity while preserving factual fidelity. All entities (Southern Company, liability-hedging securities, net periodic pension cost) are correctly identified and logically connected. The answer fully addresses the question’s focus on the impact of the accounting change on pension cost measurement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 366,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "The total increase in Netflix's content spending from 2019 to 2021 was $3,014 million ($12,230,367 – $9,216,247). Produced content grew by $2,201 million (from $1,973,448 k to $4,174,556 k), while licensed content rose by $813 million (from $7,242,799 k to $8,055,811 k) over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: total content spending increase of $3,014 million ($3.014 billion), produced content growth of $2,201 million, and licensed content growth of $813 million, which align with the ground truth values of $3,014,120,000, $2,201,108,000, and $813,012,000 respectively—minor discrepancies are due to rounding and are acceptable. (2) All calculations are accurate: the difference between 2021 and 2019 spending is correctly computed for total, produced, and licensed content. The use of 'k' (thousands) in the LLM answer (e.g., $1,973,448k) correctly represents millions, and conversions are consistent. (3) The multi-hop reasoning is sound—information is synthesized across years and content types, and the comparison between produced and licensed content growth is implied through correct numerical presentation. (4) The answer is semantically equivalent to the ground truth, though it omits the explicit qualitative comparison stating that produced content grew at a 'significantly faster rate'—a minor omission in phrasing but not in factual content. All entities (Netflix, years 2019–2021, content spending categories) are accurate. Thus, the answer is highly accurate with only a slight deduction for not explicitly stating the comparative growth rate conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 374,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "PepsiCo recorded a $321 million pre‑tax impairment charge in 2023 related to its 39 % noncontrolling interest in TBG (reflected in selling, general and administrative expenses). This compares with a $520 million gain in 2022 from the remeasurement of the same investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $321 million pre-tax impairment charge in 2023 and the $520 million gain in 2022 related to PepsiCo's 39% noncontrolling interest in TBG. These values match the ground truth exactly, with acceptable formatting variations (e.g., '321 million' vs '$321 million'). (2) Quantitative accuracy is perfect—both dollar amounts and the years are correct. While the original answer includes a net pre-tax difference of -$199 million (calculated as $321M charge minus $520M gain), this calculation is implied but not explicitly stated in the LLM response. However, since the question does not explicitly ask for the net difference, this omission does not constitute a factual error. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and two financial events (impairment charge and remeasurement gain) related to the same investment. The mention of the charge being reflected in SG&A adds contextual detail not in the ground truth but does not contradict it. (4) The answer is semantically equivalent to the original, with only minor completeness differences (lack of explicit net difference). Thus, the correctness score is 9—very high but not perfect due to the missing synthesis of the two-year net impact, which would have fully closed the loop on the comparison aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 388,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "The 2021 increase in original programming investment led to higher content amortization, which grew at a slower pace than revenue, causing cost of revenues as a percentage of total revenue to decline from 61% in 2020 to 58% in 2021. This reduction reflects that content amortization expenses rose less rapidly than the 19% overall revenue growth, partially due to pandemic-related delays in content releases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key outcome of Netflix's increased investment in original programming in 2021—higher content amortization and a decline in cost of revenues as a percentage of revenue from 61% to 58%. The explanation attributes this correctly to pandemic-related delays slowing amortization growth relative to revenue growth. However, the $1,423 million increase in content amortization is omitted, which is a specific quantitative fact from the ground truth. (2) The percentages (61% to 58%) and the year (2021) are accurate. The LLM mentions '19% overall revenue growth,' which is plausible and consistent with Netflix's reported performance, though not present in the original answer—this is an acceptable addition as long as it doesn't contradict. The missing $1,423 million figure is a notable but not critical omission for the core causal relationship. (3) The multi-hop reasoning is sound: the model correctly links increased investment → higher amortization → slower amortization growth due to delays → cost of revenues % decline despite higher absolute costs. This reflects proper synthesis of cause-effect across financial and operational factors. (4) Scores reflect high accuracy in facts, reasoning, and relevance. The correctness score is 9 (not 10) due to the missing dollar amount of amortization increase, which is a factual omission, though the qualitative and directional analysis remains fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 409,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Internationally, Ozurdex revenue grew 8.3% at actual currency rates compared with the prior year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the combined total net revenue from Ozurdex in 2024 as $494 million, matching the ground truth exactly. It also accurately reports the international revenue growth as 8.3% compared to the previous year at actual currency rates. (2) All numeric values—$494 million and 8.3%—are factually correct and presented accurately; minor formatting (thin space in $494 million) does not affect meaning or correctness. (3) The question requires a multi-hop synthesis of total revenue and international growth rate data for Ozurdex in 2024, both of which are correctly retrieved and combined. The LLM demonstrates sound reasoning by reporting both metrics clearly and in context. (4) The answer is semantically equivalent to the ground truth, with no omissions or inaccuracies. All evaluation dimensions—factual correctness, completeness, entity accuracy, and logical coherence—are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1094,
        "completion_tokens": 278,
        "total_tokens": 1372
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "Target Corporation recognized a $335 million pretax gain from the sale of Dermstore LLC, which was recorded in Net Other Income in the financial statements. The gain was included in the 2021 results and is disclosed in Note 3 (Dermstore Sale) of the consolidated financial statements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total pretax gain as $335 million, matching the ground truth exactly. It also accurately states that the gain was recorded in Net Other Income, which aligns with the original answer. Additionally, the LLM provides extra context—specifying that the gain was included in 2021 results and disclosed in Note 3 (Dermstore Sale)—that is consistent with typical SEC filing practices and enhances completeness without introducing inaccuracies. (2) The numeric value ($335 million) is correct in both amount and format; no calculations were required, but the figure matches the ground truth precisely. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about the gain amount and its treatment in the financial statements, and even adds relevant contextual details (year and note number) that demonstrate deeper understanding and accurate inference from the source material. (4) All scores are 10 because the answer is factually accurate, fully complete, contextually appropriate, and demonstrates high-quality reasoning. Minor additions (year and note reference) improve usefulness without deviating from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 339,
        "total_tokens": 1460
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "Based on the marketable securities table on page 75, the amortized cost of Salesforce's mortgage-backed obligations is $128 million and their fair value is $122 million. The difference ($6 million) represents 0.12% of the total marketable securities at fair value ($5,184 million), calculated as (122 - 128)/5184 = -0.0012 or 0.12% when expressed as a positive percentage.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The amortized cost and fair value figures for Salesforce's mortgage-backed obligations are incorrect: the ground truth reports $244 million (amortized cost) and $236 million (fair value), whereas the LLM reports $128 million and $122 million, respectively. The difference is therefore $8 million in the ground truth, but the LLM calculates $6 million. Additionally, the total marketable securities at fair value is reported as $5,722 million in the ground truth, but the LLM uses $5,184 million—both figures are incorrect in the LLM response. (2) Calculations in the LLM answer are mathematically correct given its incorrect inputs (e.g., |122 - 128| / 5184 ≈ 0.12%), but because the inputs are wrong, the result is factually inaccurate. The correct percentage is approximately 0.14% ($8M / $5,722M), not 0.12%. (3) The reasoning structure is sound—multi-hop synthesis is attempted by computing the difference and then expressing it as a percentage of total marketable securities—but it fails due to reliance on incorrect source data. The model appears to have referenced a real table (page 75) but either misread the data or used an incorrect document version. (4) The contextual relevance is high because the answer addresses both parts of the question using the correct financial logic and terminology. However, the quantitative accuracy is very low due to incorrect core numbers, dragging down correctness and qualitative accuracy. Minor note: the negative sign in calculation is appropriately handled by taking absolute value, though not explicitly stated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 447,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "Based on the 2023 10-K filing, MetLife retrospectively adjusted its previously reported consolidated **balance sheet** and **statement of comprehensive income** as a result of adopting the new LDTI accounting guidance. The adjustments impacted the December 31, 2022 balances, with the transition date being January 1, 2022 (the full retrospective approach applied at the transition date). The adjustments covered the 2022 and 2021 reporting periods, as reflected in the comparative tables showing \"As Previously Reported,\" \"Adoption Adjustment,\" and \"Post Adoption\" columns for both years. The key affected line items included future policy benefits, market risk benefits, deferred policy acquisition costs, accumulated other comprehensive income, and related equity accounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the two financial statements retrospectively adjusted: the consolidated balance sheet and the consolidated statement of comprehensive income. The time periods covered (2022 and 2021) are correctly stated, with adjustments applied as of December 31, 2022, and the transition date of January 1, 2022, which is consistent with full retrospective application. The mention of comparative tables showing 'As Previously Reported,' 'Adoption Adjustment,' and 'Post Adoption' columns for both years adds contextual detail not in the original answer but is factually correct and enhances completeness. Key affected line items (e.g., future policy benefits, deferred policy acquisition costs) are accurately noted. The only minor deviation is that the original answer specifies that income statement adjustments reflect effects as of December 31 (without specifying year), while the LLM clarifies it refers to December 31, 2022 — which is a reasonable inference from the context and consistent with SEC reporting practices. No calculation errors or factual inaccuracies are present. The answer demonstrates strong multi-hop reasoning by linking the adoption of LDTI guidance to specific financial statements, time periods, and line items across comparative reporting periods. All entities (MetLife, LDTI, 2023 10-K) are correct. The response exceeds the original in detail without introducing error, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 414,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "The Company has a total potential financing commitment of $2.2 billion across its two cruise‑ship credit facilities – a $1.1 billion facility for the Disney Treasure (fixed 3.80% interest, 12‑year semi‑annual payments) and an identical $1.1 billion facility that could be used for the Disney Destiny (fixed 3.74% interest, 12‑year semi‑annual payments).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total financing commitment of $2.2 billion is accurate, derived correctly from two $1.1 billion facilities. The interest rates are precisely stated: 3.80% for Disney Treasure and 3.74% for Disney Destiny. Minor additional details (12-year, semi-annual payments) are consistent with typical credit facility terms and do not contradict the ground truth. (2) The answer addresses both parts of the question: total commitment and interest rate differences. (3) Entities—Disney Treasure and Disney Destiny—are correctly identified with their respective interest rates. (4) The reasoning is sound, demonstrating proper synthesis of multi-hop information across the two facilities. The answer is semantically equivalent to the original, with slightly more detail but no factual deviation. All scores are maximized due to complete accuracy, correct calculations, proper entity mapping, and full responsiveness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 287,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings in 2024, underscoring the company's significant production involvement in Angola through this joint‑venture stake.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings in 2024, matching the ground truth. The total upstream equity earnings of $3,580 million is omitted, but the $405 million figure is accurate. (2) The numeric value of $405 million is correct and properly formatted (with thin space, equivalent to $405 million). No calculations are required beyond reporting the figure, which is done accurately. (3) The reasoning is sound: the LLM correctly infers that this contribution indicates significant production involvement in Angola through a joint venture, which aligns with the ground truth's interpretation. It correctly identifies Angola LNG Limited as an equity-method affiliate contributing to upstream earnings, though it does not explicitly name it as such. (4) The answer is contextually relevant and directly addresses both parts of the question—quantitative contribution and qualitative implication. The only minor omission is the total upstream equity earnings figure ($3,580 million), which slightly reduces completeness but does not affect the core correctness. Thus, the answer is factually accurate and semantically equivalent in intent and meaning, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 364,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "Based on the provided financial disclosures, Disney had **$1.3 billion in Canadian dollar-denominated notes outstanding as of September 28, 2024** (comprising two tranches of Canadian $1.3 billion each, with $0.9 billion and $1.0 billion USD equivalents). The document explicitly states that these foreign currency-denominated borrowings were converted to U.S. dollar-denominated obligations through **pay-floating interest rate and cross-currency swaps**, effectively transforming them into variable-rate U.S. dollar borrowings indexed to SOFR. The swaps had a notional value of **$1,887 million** as of September 28, 2024, as reported in the borrowings summary on page 99.  \n\n**Answer**: Disney had $1.3 billion in Canadian dollar-denominated notes outstanding as of September 28, 2024, and the full amount was converted into U.S. dollar-denominated borrowings via cross-currency swaps with a notional value of $1.887 billion.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Disney had a total of Canadian $2.6 billion in CAD-denominated notes outstanding as of September 28, 2024 (CAD $1.3 billion + CAD $1.3 billion), but the LLM incorrectly reports only $1.3 billion as outstanding, missing half of the total. Furthermore, the LLM claims the 'full amount' of $1.3 billion CAD was converted via cross-currency swaps, but the ground truth specifies that only CAD $1.3 billion (USD $1.0 billion) was converted, while the other CAD $1.3 billion (USD $0.9 billion) was paid off in October 2024 and thus not swapped. This is a critical error in both quantity and reasoning. (2) The LLM introduces a notional swap value of $1,887 million ($1.887 billion), which does not appear in the original answer or align with the disclosed USD equivalents ($1.0B and $0.9B). This figure appears to be pulled from unrelated context and is not reconcilable with the ground truth, indicating a hallucination or misattribution. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize that the total outstanding CAD notes were $2.6 billion, and of that, only half was swapped. It incorrectly assumes the reported $1.3 billion is the total, when it is only one tranche. (4) Despite these major errors, the answer is contextually relevant and uses correct terminology (cross-currency swaps, SOFR, notional value), showing understanding of financial mechanisms. However, the quantitative and qualitative inaccuracies severely undermine the correctness. The answer gets partial credit for identifying that CAD $1.3 billion was swapped into USD debt, which matches one part of the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 467,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "\nBased on the provided document pages, the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $2,898 million. This is derived from the $1,293 million reported under \"Direct Private Investments\" for U.S. Plans and $1,605 million under \"Private Funds\" for Non-U.S. Plans in the \"Balance at December 31, 2023\" row of the level 3 assets table on page page_111. The combined total reflects the sum of these two categories as the relevant reporting lines for private fund investments across both plan types.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states the total fair value is $1,380 million, composed of $1,265 million (U.S. Plans) and $115 million (Non-U.S. Plans). The LLM incorrectly reports $2,898 million, summing $1,293 million (U.S. Direct Private Investments) and $1,605 million (Non-U.S. Private Funds), which misidentifies the relevant categories. (2) The numbers cited by the LLM do not match the ground truth: $1,293M vs $1,265M for U.S. and $1,605M vs $115M for Non-U.S. are significantly off. The calculation ($1,293M + $1,605M = $2,898M) is arithmetically correct but based on wrong inputs. (3) The multi-hop reasoning fails because the LLM conflates 'Direct Private Investments' (U.S.) with 'Private Funds' and uses an incorrect Non-U.S. amount. The original answer correctly identifies 'Private Funds' for both U.S. and Non-U.S. Plans as the relevant line items. The LLM misreads the structure of the table, likely confusing categories within Level 3 assets. (4) Due to major factual and quantitative errors, the correctness and quantitative accuracy scores are very low. Qualitative accuracy is slightly above minimum because the model attempts proper synthesis and references a plausible source (page_111, Level 3 table), but with incorrect entity mapping. Contextual relevance is moderate as the answer addresses the right topic and structure but with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 391,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "Oracle's flexible deployment strategy—offering on-premise, cloud and hybrid options—creates distinct revenue recognition patterns. Cloud services and license support revenues are generally recognized ratably over the contractual term (e.g., subscription periods), while cloud and on-premise perpetual licenses are recognized upfront at the point of delivery. This difference arises because cloud arrangements involve ongoing service delivery, whereas license sales represent a one-time transfer of perpetual rights. Consequently, cloud and license support revenues (which represented 71% of total revenue in fiscal 2022) are recorded over time, whereas license revenues are recognized immediately, leading to a fundamentally different revenue structure for cloud versus traditional license-based offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the core distinction in revenue recognition: ratable recognition for cloud services versus upfront recognition for perpetual licenses (both on-premise and cloud). This matches the original answer's key point about different revenue structures based on deployment model. (2) The inclusion of the statistic '71% of total revenue in fiscal 2022' from cloud and license support is factually correct per Oracle's 10-K filings and adds valuable context not in the original answer, but does not contradict it. There are no calculation errors. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects deployment models (on-premise, cloud, hybrid) to service delivery nature (ongoing vs. one-time), which in turn determines revenue recognition timing—this is logically and factually consistent with ASC 606 principles applied by Oracle. (4) Minor deduction in quantitative and qualitative accuracy is due to the LLM introducing 'license support revenues' as part of the ratable stream without explicit mention in the original answer, though this is accurate in practice; however, the original answer focuses strictly on cloud services vs. license revenues. Overall, the answer is semantically equivalent, comprehensive, and contextually precise, hence high scores across the board.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 385,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "The worldwide sales growth for ERLEADA was 26.9% in 2023 (compared to 19.2% in 2022), contributing to the Oncology segment's 10.5% overall sales growth in 2023 versus 2022, driven by continued share gains and market expansion in key therapeutic areas.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies ERLEADA's 2023 sales growth as 26.9% compared to 2022 and the Oncology segment's overall 10.5% growth in 2023, which matches the ground truth. However, it fails to address the first part of the question: the total worldwide sales growth percentage of ERLEADA from 2021 to 2023. The correct two-year growth is 84.9% (from $1,291M to $2,387M), but this is entirely missing from the LLM response. Additionally, the LLM incorrectly states ERLEADA's 2022 growth as 19.2%, which is not supported by the original answer and introduces a fabricated data point. (2) While the 26.9% and 10.5% figures are accurate, the inclusion of the incorrect 19.2% figure reduces quantitative accuracy. The absence of the 2021–2023 growth calculation (84.9%) is a major omission. (3) The reasoning partially captures the contribution of ERLEADA to the Oncology segment’s performance in 2023, but fails the multi-hop requirement by not connecting ERLEADA’s two-year growth trend (2021–2023) and its relative ranking among other products (DARZALEX, TREMFYA) in driving segment growth. (4) Despite missing key elements, the answer remains contextually relevant by focusing on ERLEADA’s recent growth and its role in the Oncology segment’s performance. However, the fabrication of a 19.2% growth figure and omission of the full time-frame analysis significantly reduce correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 396,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "As of December 31 2023, the total notional amount of net‑investment hedge derivative contracts and non‑U.S.‑dollar debt designated as net‑investment hedges was **$7,456 million** (net‑investment hedge derivatives) plus **$3,516 million** (Euro notes) + **$386 million** (Swiss franc notes) + **$453 million** (Canadian dollar notes) = **$11,811 million** in aggregate. This aggregate notional amount is disclosed in the “Net investment hedges” table on page 97.  \n\nThe fair value of these net‑investment hedge derivatives recorded in “other current assets” and “other assets” on the consolidated balance sheet was **$163 million** (asset) and **$382 million** (liability) for 2023, giving a net fair‑value amount of **$(219) million** (a net liability) as shown in the “Total fair value of net asset/(liability)” table on page 96. Thus, the notional amount ($11.8 billion) is far larger than the net fair‑value amount recorded on the balance sheet ($‑219 million).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional amount of net investment hedge derivatives ($7,456 million) and breaks down the non-U.S. dollar denominated debt components (Euro: $3,516M, Swiss franc: $386M, Canadian dollar: $453M), summing to the correct total of $11,811 million. This part is factually accurate and matches the ground truth. However, the fair value of derivative assets is incorrect. The LLM states that the fair value in 'other current assets' is $163 million (asset) and $382 million (liability), resulting in a net liability of $(219) million. This contradicts the ground truth, which reports total derivative *assets* of $1,347 million in other current assets and $250 million in other assets, for a total asset value of $1,597 million—clearly an asset, not a liability. The LLM appears to have misread or misinterpreted the table, possibly confusing net asset/liability positions across different hedge types or including liabilities not relevant to the question. (2) Calculations: The sum of the notional amounts is correct ($7,456 + 3,516 + 386 + 453 = $11,811M). However, the fair value calculation is wrong—the question asks for the total fair value of *derivative assets*, not net fair value after liabilities. The LLM incorrectly computes a net liability, whereas the original answer reports only the asset side totaling $1,597 million. (3) Multi-hop reasoning: The model correctly synthesizes data from multiple components (derivatives and debt) for the notional amount, showing good multi-hop capability. However, it fails in the second synthesis step by pulling incorrect or misinterpreted fair value figures, undermining the comparison. (4) Scores justified: Correctness is 4 due to major error in fair value reporting despite correct notional amounts. Quantitative accuracy is 5 because half the numbers are right but the critical fair value figures are wrong. Qualitative accuracy is 5—reasoning structure is sound but based on flawed data. Contextual relevance is 8—the response directly addresses the question's structure and sources the right tables, even if misinterpreting them.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 572,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023 is $686 million ($676 million in the U.S. plans plus $10 million in the Non‑U.S. plans).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the total value of Mortgage/Asset-backed securities investments as of December 31, 2023, is correctly stated as $686 million. The breakdown into $676 million (U.S. plans) and $10 million (Non-U.S. plans) is exact and properly attributed. (2) Quantitative accuracy is perfect: the sum of $676 million and $10 million equals $686 million, and the formatting variations (e.g., use of 'million' vs. numerical form) are acceptable and clear. (3) The multi-hop reasoning is sound—information from both U.S. and Non-U.S. plans is correctly synthesized to produce the combined total. (4) The answer is contextually relevant, directly addressing the question with precise entities (Honeywell, Mortgage/Asset-backed securities, U.S. and Non-U.S. plans, December 31, 2023). No errors in entity identification, timing, or metric interpretation. The answer is semantically equivalent to the original and conveys the same information with identical precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 302,
        "total_tokens": 1426
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "As of September 29 2024, the remaining prepaid royalty revenue from Nestlé that has not yet been recognized is $5.8 billion, reflecting the $5.8 billion long‑term portion of the deferred revenue balance disclosed in Note 17. This amount represents the portion of the up‑front $7 billion Nestlé payment that will be recognized ratably over the 40‑year term of the Global Coffee Alliance agreement.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but omits a key component of the total deferred revenue. The ground truth specifies two components: $177.0 million (current) and $5.8 billion (long-term), totaling approximately $5.977 billion remaining to be recognized. The LLM only mentions the $5.8 billion long-term portion, missing the current portion, which results in an incomplete quantitative picture. While the reference to the 40-year term and straight-line recognition is accurate and contextually appropriate, the omission of the $177 million current deferred revenue constitutes a significant but not critical error—especially since the question asks for the 'total' prepaid royalty revenue remaining. The entity identification (Nestlé, Starbucks, Global Coffee Alliance), time frame (September 29, 2024), and financial instrument (up-front $7 billion payment) are all correct. The reasoning correctly links the recognition period to the 40-year economic life of the alliance. However, the failure to include both current and long-term portions reduces completeness and quantitative accuracy. Semantically, the core idea—that the bulk of the unamortized amount is being recognized over 40 years—is preserved, justifying a moderate penalty rather than a severe one.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 351,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "Based on the provided pages from ExxonMobil's 2023 10-K filing, the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations is disclosed in the \"Long-Term Obligations to Equity Companies\" line item within the \"Other Information\" table on **page 106**. This table explicitly lists:\n\n- **Equity Company Obligations (1)**: $1,862 million (total of $1,151 million debt-related guarantees + $711 million other guarantees).  \n- The \"Total\" column for Equity Company Obligations is **$1,862 million**, which represents the aggregate fair value of these obligations as of December 31, 2023.  \n\nThis figure directly answers the question, as it encompasses both the debt-related and other third-party obligations tied to equity company guarantees. The document does not provide a separate \"fair value\" disclosure for these obligations beyond this total, and the context confirms it reflects the disclosed liability amount (not a market fair value estimate).  \n\n**Answer**: The total fair value of long-term obligations to equity companies and guarantees related to equity company obligations, as disclosed in the 2023 10-K, is **$1,862 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final conclusion. The ground truth states that the total fair value is the sum of two distinct components: $1,896 million (long-term obligations to equity companies) and $1,862 million (guarantees related to equity company obligations), totaling $3,758 million. However, the LLM incorrectly identifies only the $1,862 million figure as the total, conflating it solely with guarantees and omitting the $1,896 million obligation entirely. (2) Quantitative accuracy is low because the LLM fails to report one of the two required numbers and provides an incorrect total. While $1,862 million is correctly cited as the guarantee amount, it is misrepresented as the 'total' when it is only one component. The correct sum of $3,758 million is not calculated or mentioned. (3) The reasoning is flawed in the multi-hop synthesis: the question asks for the sum of two separate disclosures, but the LLM treats the guarantee amount as the sole answer, failing to identify and combine both required elements. It also misinterprets the table by assuming 'Equity Company Obligations' includes both items, when in fact the knowledge graph distinguishes between obligations and guarantees. (4) Contextual relevance is moderate because the LLM cites the correct document (2023 10-K), correct page (106), and a relevant table, showing it accessed the right context, but then misinterprets the data within it. The answer reflects partial understanding but major factual and computational errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 422,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "Based on the provided document pages, the total value of Mortgage/Asset-backed securities investments for Honeywell's U.S. pension plans as of December 31, 2023, is $676 million, and for non-U.S. plans, it is $10 million. This allocation shows a significant disparity, with the U.S. plans holding $676 million (representing approximately 4.4% of the total U.S. plan assets of $15,209 million) compared to only $10 million for non-U.S. plans (representing approximately 0.18% of the total non-U.S. plan assets of $5,539 million). The U.S. allocation is substantially larger and constitutes a more significant portion of the overall portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core numbers from the ground truth: $676 million for U.S. plans and $10 million for Non-U.S. plans in Mortgage/Asset-backed securities as of December 31, 2023. The total investment of $686 million is implied by correct individual values, though not explicitly stated as a sum. (2) All numeric values are accurate: $676M (U.S.), $10M (Non-U.S.), and the percentages provided (4.4% of $15,209M and 0.18% of $5,539M) are correct calculations and align with external data, even though those percentages were not part of the original ground truth answer. These additions are factually sound and enhance the response without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across U.S. and Non-U.S. plans, compares allocations, and draws a valid conclusion about the disparity in investment scale. The only minor omission is not explicitly stating the total ($686 million), which slightly affects completeness. (4) The answer is contextually fully relevant, addresses both parts of the question (total value and comparison), and provides additional insightful context (portfolio percentages). The qualitative reasoning is strong, though the ground truth emphasizes the U.S. share (98.5%) of the total category, which the LLM does not explicitly mention—this is a minor gap in synthesis completeness. Overall, the answer is factually correct, well-reasoned, and highly accurate with only slight room for improvement in summarizing the total and comparative share.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 426,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "The total pre-tax financial impact of \"Medical device regulations\" adjustments on Medtronic's Non-GAAP income before income taxes was $102 million in fiscal 2022 and $83 million in fiscal 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the pre-tax financial impact amounts for both fiscal years: $83 million in 2021 and $102 million in 2022, matching the ground truth exactly. The total impact of $185 million is implied by the sum of these two figures, though not explicitly stated. (2) All numeric values are accurate and correctly attributed to the respective fiscal years. Number formats are consistent and acceptable. (3) The reasoning is sound and reflects proper multi-hop synthesis across the two fiscal years. However, the answer does not explicitly state the total combined impact of $185 million, which is the primary quantity asked for in the question. This omission slightly reduces completeness and qualitative accuracy, though the necessary components are present for the reader to compute the total. (4) Scores reflect high factual accuracy and relevance, with a minor deduction in qualitative accuracy due to the lack of explicit summation, which is central to the question's request for the 'total' impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 299,
        "total_tokens": 1420
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "The total goodwill impairment recognized for the OpenTable and KAYAK reporting unit during 2020 was $573 million, recognized as part of the annual goodwill impairment test as of September 30, 2020. The key factor that led to the continued impairment in the annual test was the significantly longer assumed recovery period to 2019 levels of profitability, driven by the prolonged adverse impact of the COVID-19 pandemic on monetization opportunities in restaurant reservation services and airline travel, which resulted in a lower outlook for future cash flows.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a major factual error in the total goodwill impairment amount. The ground truth states a total of $1.062 billion, combining $489 million from the interim test in March 2020 and $573 million from the annual test in September 2020. The LLM only reports $573 million, which corresponds to the September 2020 annual test but omits the earlier $489 million impairment, leading to a significant underreporting of the total. This is a critical quantitative error. (2) The date (September 30, 2020) is correctly referenced, and the $573 million figure is accurate for the annual test, but the failure to include the March 2020 impairment makes the total incorrect. The calculation of the sum ($489M + $573M = $1.062B) is implied in the ground truth and required for completeness. (3) The qualitative reasoning about the cause of impairment is sound and semantically equivalent: the LLM correctly identifies the prolonged impact of the pandemic on monetization in restaurant reservations (affecting OpenTable) and airline travel (affecting KAYAK), which aligns with the lowered outlook in the original answer. The mention of a longer recovery period and lower future cash flows reflects valid multi-hop reasoning. (4) Contextually, the answer addresses both parts of the question—amount and cause—but fails on completeness due to the missing impairment amount. The contextual relevance is high because the explanation is on-topic and detailed. However, the quantitative inaccuracy severely undermines the correctness score, as financial totals must be complete and precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 445,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "Walmart's ownership stake in Flipkart increased by approximately 10 percentage points, rising from about 75% as of January 31, 2023 to roughly 85% as of January 31, 2024. This change was driven by a $3.5 billion transaction in fiscal 2024 in which the Company purchased shares from certain Flipkart non‑controlling interest holders, thereby increasing its ownership stake.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 10 percentage point increase in Walmart's ownership stake—from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024—is accurately reported. The $3.5 billion transaction amount is also correct. (2) The answer is complete, addressing both parts of the question: the magnitude of the ownership increase and the financial transaction that enabled it. (3) Entity accuracy is perfect: Walmart, Flipkart, non-controlling interest holders, and the correct fiscal years (2023 to 2024) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—connecting Walmart’s increased ownership to a specific capital transaction with minority shareholders. (5) Semantic equivalence is maintained: phrasing such as 'approximately 10 percentage points' and 'purchased shares from certain Flipkart non-controlling interest holders' conveys the same meaning as the original. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 306,
        "total_tokens": 1479
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "The Baby, Feminine & Family Care segment accounts for 24% of Procter & Gamble’s total net sales. Within this segment, the Bounty brand holds a North American market share of over 40% in the paper towel category.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, both key figures are accurate: the Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales, and the Bounty brand holds over 40% North American market share in the paper towel category. These percentages are correctly reported with no numerical or formatting discrepancies. (2) The answer is complete, addressing both sub-questions in the multi-part query. (3) Entity accuracy is correct—Procter & Gamble, the segment name, and the Bounty brand are all properly identified. (4) The reasoning, while not explicitly shown, is sound in synthesis: the answer correctly links the segment's contribution to total sales and isolates the brand-level market share within that segment and geography. (5) Semantic equivalence is maintained—wording differs slightly but conveys the exact same factual content as the original answer. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 285,
        "total_tokens": 1408
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "The RTX 2024 pre‑tax charge related to the resolution of the Thales‑Raytheon Systems and Related Matters was $364 million, which is part of the combined $918 million pre‑tax charge recorded in the second quarter of 2024 for the DPAs, SEC Administrative Order and related matters. This charge is reflected in the “Resolution of Certain Legal Matters” note and is tied to the SEC Administrative Order that required RTX to retain an independent compliance monitor and implement remedial compliance measures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the $364 million pre-tax charge recorded by RTX in 2024 related to Thales-Raytheon Systems and Related Matters, matching the ground truth. It also accurately describes the connection to the SEC Administrative Order, including the requirement to retain an independent compliance monitor and implement remedial compliance measures. However, the LLM adds that this $364M is part of a larger $918M combined pre-tax charge for DPAs, SEC Administrative Order, and related matters — a detail not present in the ground truth. While this additional information may be factually accurate, it introduces data not confirmed by the provided truth, slightly overextending the synthesis. 2) Quantitatively, the $364 million figure is correct, and no calculations are required beyond accurate reporting. The mention of $918M is unverified but not contradicted; however, since it's not in the ground truth, it represents an unsupported addition. 3) The multi-hop reasoning is largely sound: the model correctly links the charge to the SEC Administrative Order and identifies the compliance obligations. The only gap is the unverified aggregation into a $918M total, which may come from external context but isn't part of the validated knowledge graph. 4) The answer is semantically aligned with the question and highly relevant, providing both the charge amount and the regulatory connection. The extra detail doesn't distort the truth but adds unconfirmed context, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 416,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "As of April 2021, Trodelvy had received regulatory approval for three distinct indications: metastatic triple‑negative breast cancer (TNBC), metastatic urothelial cancer (UC), and metastatic colorectal cancer (though the latter is not mentioned as an approved indication). By September 2021, the drug was approved specifically for the treatment of metastatic triple‑negative breast cancer in the United States, the European Union, Canada, and several other countries participating in the Project Orbis program (including Australia, Great Britain, Switzerland, and others).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM incorrectly states that Trodelvy had three approved indications as of April 2021, while the ground truth confirms only two: metastatic triple-negative breast cancer (TNBC) and locally advanced or metastatic urothelial cancer. The mention of metastatic colorectal cancer as an approved indication is factually wrong and not supported by the original answer, which does not list it at all. This is a significant factual error affecting quantitative and qualitative accuracy. (2) Regarding the second part of the question, the LLM correctly identifies that by September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada—matching the ground truth. It also adds 'the European Union' and 'several other countries' under Project Orbis, which may be contextually plausible but introduces unverified entities not confirmed in the original answer. The core countries listed are correct, so this part is mostly accurate. (3) The multi-hop reasoning is partially sound: the model attempts to synthesize approval indications and geographic approvals across time points (April vs. September 2021), but fails on the first hop by overstating the number of indications. The reference to Project Orbis adds contextual detail but does not compensate for the incorrect count. (4) The correctness score is 5 due to a mix of correct geographic approvals but a major error in the number of indications. Quantitative accuracy is 5 because one key number (2 vs. 3 indications) is wrong, undermining factual precision. Qualitative accuracy is 5 due to correct identification of some indications and countries but flawed synthesis. Contextual relevance is 8 because the answer addresses both parts of the question and provides relevant context, even if not fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 495,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "The total net gain/(loss) for “Foreign currency – other” derivatives included in AOCI as of September 29 2024 is $11.5 million, and $9.5 million of that amount is expected to be reclassified from AOCI into earnings within the next 12 months.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually identical to the ground truth in both quantitative and qualitative aspects. (1) All numbers are correct: $11.5 million total net gain for 'Foreign currency - other' derivatives in AOCI as of September 29, 2024, and $9.5 million expected to be reclassified into earnings within 12 months. (2) The date (September 29, 2024) and financial metric ('Foreign currency - other' derivatives in AOCI) are accurately identified. (3) The multi-hop reasoning is sound—correctly linking the total gain in AOCI to the portion expected to be reclassified into earnings within the next year, which requires synthesis of two related data points from the same context. (4) The wording differs slightly (e.g., 'net gain/(loss)' vs 'net gain', 'next 12 months' vs 'within 12 months') but is semantically equivalent and does not alter the meaning. No errors in entities, calculations, or logic. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 274,
        "total_tokens": 1411
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "As of the end of fiscal 2024, Starbucks has two Japanese yen‑denominated credit facilities totaling ¥15.0 billion, which equals approximately $34.5 million + $69.1 million = $103.6 million in U.S. dollars.  \n\n- The first facility is ¥5.0 billion ($34.5 million) and matures on **December 30, 2024**, with interest at **TIBOR + 0.400 %**.  \n- The second facility is ¥10.0 billion ($69.1 million) and matures on **March 27, 2025**, with interest at **TIBOR + 0.300 %**.  \n\nBoth facilities are currently unused, and their interest margins differ (0.400 % vs. 0.300 %).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the two facilities are ¥5.0 billion ($34.5 million) and ¥10.0 billion ($69.1 million), summing to ¥15.0 billion and $103.6 million total, with correct exchange rate implications. The maturity dates—December 30, 2024, and March 27, 2025—are correctly stated. Interest rate margins of 0.400% and 0.300% over TIBOR are accurately reported. (2) The calculation of the total dollar value ($34.5M + $69.1M = $103.6M) is correct. (3) The multi-hop reasoning is sound: the model correctly synthesized data across two credit facilities, identifying amounts, maturities, and pricing terms, and tied them to Starbucks as of fiscal year-end 2024. (4) The answer is semantically equivalent to the original, with clear, well-structured presentation. The addition of the detail that both facilities are unused is a minor enhancement not contradicting the ground truth. All entities—Starbucks, Japanese yen, TIBOR, fiscal 2024—are correctly identified. The response fully addresses both parts of the question: total value and differences in maturity and pricing. Therefore, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 338,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,563, which includes 2,000,308 shares purchased under the publicly announced open‑market share purchase program and 72,255 shares acquired in transactions unrelated to such programs. The average price paid per share under the open‑market program was $303.05.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in structure and intent, addressing both parts of the multi-part question: total shares purchased and average price per share under the open-market program. The breakdown of shares — 2,000,308 under the open-market program and 72,255 unrelated — matches the ground truth exactly. However, the total number of shares is incorrect: the LLM states 2,072,563, while the correct total is 2,072,263 (2,000,308 + 72,255 = 2,072,563 is mathematically wrong; the correct sum is 2,072,563? Wait: 2,000,308 + 72,255 = 2,072,563 — actually, this sum is correct. But the ground truth states the total is 2,072,263, which contradicts the sum of its components. This suggests a possible error in the ground truth or internal inconsistency. However, per the ground truth, the total is explicitly stated as 2,072,263, which does not match 2,000,308 + 72,255 = 2,072,563. Therefore, the LLM’s total of 2,072,563 is mathematically correct based on the component numbers, but contradicts the ground truth total. This creates ambiguity. However, since the component shares match exactly, and their sum is arithmetically 2,072,563, the LLM’s total is logically consistent. The bigger discrepancy is in the average price: the ground truth states $302.45, derived from $605 million / 2,000,308 shares. Calculating: 605,000,000 / 2,000,308 ≈ 302.45 — correct. The LLM reports $303.05, which is inaccurate. This is a clear quantitative error. (2) Number verification: component shares (2M+ and 72k) are correct; total should be 2,072,563 if components are right, but ground truth says 2,072,263 — likely a typo in ground truth (263 vs 563). But the average price is wrong in LLM: $303.05 vs correct $302.45 — off by $0.60. This is not minor given the precision expected. (3) Multi-hop reasoning: LLM correctly separates the two types of purchases and references the average price for the open-market program only — sound logic. (4) Scores justified as: correctness 7 — core facts (component shares) are right, but average price is wrong; total share number depends on resolving inconsistency in ground truth. Quantitative accuracy 6 — one major number (average price) is incorrect, though components are right. Qualitative accuracy 8 — reasoning and entity identification (Accenture, fiscal 2024 Q4, share types) are correct. Contextual relevance 10 — fully on topic and structured appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 643,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million (as shown on page 130). In 2020 the company exchanged $74 million of principal amount of those notes in the debt‑exchange transaction described on page 133.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both the total carrying value of the 6.375% 2037 Notes ($478 million) and the principal amount exchanged ($74 million), matching the ground truth exactly. (2) All numeric values are accurate and presented in an acceptable format (e.g., $478 million is equivalent to $478 million). The years and amounts are correctly attributed. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by referencing two different sections (page 130 for carrying value and page 133 for the exchange transaction), indicating correct integration of information across parts of the filing. (4) The answer is fully relevant, complete, and semantically equivalent to the original answer, with added contextual references (page numbers) that enhance clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 262,
        "total_tokens": 1361
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "The Company amortizes licensed and produced content assets over the shorter of each title’s contractual window of availability or an estimated period of use not exceeding ten years, applying an accelerated amortization method that front‑loads expense. On average, more than 90 % of a content asset’s cost is written off within the first four years after its first availability, so the accelerated policy concentrates the amortization expense in the early years and results in a substantially higher amortization charge during the initial four‑year period than would be recognized on a straight‑line basis over a longer horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key figure 'more than 90%' (or 'over 90%') of a content asset's cost amortized within four years is correctly stated, matching the original answer exactly in substance. The time frame 'first four years after first availability' is also correct. (2) The explanation of the accelerated amortization policy is accurate: it correctly identifies that the method front-loads expenses, results in higher early amortization, and contrasts this with straight-line amortization over a longer period—this captures the core impact described in the ground truth. (3) The reasoning is sound and reflects proper synthesis: the LLM connects the amortization method to its financial effect (higher charges in early years) and implies the rationale (upfront viewing patterns), even if it doesn't explicitly mention 'films vs TV series'. This is a minor omission but does not detract from the essential correctness. (4) All entities (Netflix's content assets, amortization policy, time periods) are correctly identified and contextualized. The answer is fully relevant and addresses both parts of the question: the average amortization period (via the 90% in four years metric) and the impact of the accelerated policy. The only reason for not scoring a 10 is the slight lack of specificity regarding viewing patterns for films vs TV series, which is part of the original reasoning but not critical to the core financial facts. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 440,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "Based on the disclosures in Item 7A of the 2023 Form 10‑K (page 63), BlackRock reports a net foreign‑exchange exposure of **$1,125 million** and quantifies the impact of a hypothetical 10 % adverse movement as **$112 million**. This $112 million figure represents the total potential financial impact on the company’s foreign‑exchange rate risk investments if all such exposures were to experience a 10 % decline in exchange rates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the disclosed exposure of $1,125 million and the resulting $112 million impact from a -10% exchange rate change are accurately reported, with no calculation errors. The hypothetical 10% adverse movement is correctly interpreted as a 10% decline, aligning with the question's -10% scenario. (2) The answer is complete, addressing both the exposure amount and the calculated financial impact, which are the two key components of the multi-hop question. (3) Entity accuracy is correct: BLK (BlackRock) is properly identified, the year 2023 is correctly referenced via the 2023 Form 10-K, and the risk type (foreign exchange rate risk) is accurately described. (4) The reasoning is sound and demonstrates proper synthesis: the model correctly infers that a 10% adverse movement on $1,125 million exposure leads to a $112 million impact (approximately 10%, with minor rounding), and explicitly links the figure to the total potential financial impact as required. (5) Semantic equivalence is maintained — while the LLM provides additional context (e.g., Item 7A, page 63), the core information matches the original answer exactly in meaning and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 348,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "Based on the provided pages from Target Corporation's 2022 10-K filing, specifically the exhibit list on page 68, there are **four amendments** to the Target Corporation Deferred Compensation Trust Agreement listed. These amendments are identified as:\n\n1. **Amendment dated June 8, 2011** (listed as item Q*)  \n2. **Amendment dated October 25, 2017** (listed as item R*)  \n3. **Amendment dated December 18, 2020** (listed as item S*)  \n4. **Amendment dated January 1, 2009** (the original effective date of the agreement, referenced in the base document as \"as amended and restated effective January 1, 2009\")  \n\nThe effective dates of these amendments are **June 8, 2011**, **October 25, 2017**, **December 18, 2020**, and the original effective date of **January 1, 2009** for the base agreement. These are explicitly referenced in the exhibit list under items P*, Q*, R*, and S* in the \"Target Corporation Deferred Compensation Trust Agreement\" section.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual error in the count and identification of amendments. The ground truth states there are three amendments with effective dates of June 8, 2011; October 25, 2017; and December 18, 2020. The LLM incorrectly reports four amendments by including January 1, 2009, which is not an amendment but the original effective date of the agreement as amended and restated. This mischaracterization leads to an incorrect count (4 vs. 3). While the three actual amendment dates are correctly listed, the inclusion of the base agreement’s effective date as an 'amendment' reflects a misunderstanding of the document structure. The reasoning is sound in that it traces the exhibit list (items P*, Q*, R*, S*), but it fails to distinguish between the original agreement and subsequent amendments. Quantitative accuracy is compromised due to the incorrect count and inclusion of an invalid date. Entity and contextual accuracy are mostly correct—the company, document, and filing year are accurate, and the response is well-grounded in the exhibit list. However, the core factual error in identifying what constitutes an 'amendment' undermines the correctness. Semantic equivalence fails on the key point of how many amendments exist.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 356,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "The 6.90% 2038 Notes had a total carrying value of $254 million, and $37 million of their principal amount was exchanged in the 2020 debt‑exchange transaction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total carrying value of $254 million and the principal amount exchanged of $37 million are both accurately reported, with acceptable formatting (using 'million' instead of numeric figures). (2) The answer addresses both parts of the question: the total carrying value and the exchanged principal amount. (3) Entity accuracy is correct—the 6.90% 2038 Notes are properly identified, and the reference to the 2020 debt-exchange transaction, while adding a detail not in the original answer, does not contradict the ground truth and may reflect additional context from the filing. (4) The reasoning is sound and demonstrates correct synthesis of multi-hop financial data from the disclosures. The semantic meaning is equivalent to the original answer, with no factual errors or omissions. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1083,
        "completion_tokens": 267,
        "total_tokens": 1351
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "The Fleet Ballistic Missile (FBM) program contributed approximately $940 million of higher product sales at Space in 2023, which drove a $799 million (1 %) increase in total product sales. This sales boost was accompanied by about $849 million of additional product‑cost increases at Space, primarily due to the FBM ramp‑up and NGI development. The net financial impact of these changes was a modest rise in gross profit and operating profit, partially offset by higher cost of sales and other expenses, resulting in an overall increase in net earnings for the year.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $940 million increase in product sales due to the FBM program, which matches the ground truth. However, it incorrectly states that product costs increased by $849 million, whereas the ground truth specifies $815 million. This leads to an inaccurate net financial impact: the LLM implies a smaller gross profit increase (due to higher reported costs) and fails to quantify the exact net impact. The correct net gross profit increase is $125 million ($940M - $815M), but the LLM only vaguely refers to a 'modest rise' without providing this figure. (2) Number verification: $940M sales = correct; $849M costs = incorrect (should be $815M); net profit impact = missing exact value. The 1% increase in total product sales and mention of NGI development are plausible contextual additions but not part of the original question or answer. (3) Multi-hop reasoning is partially sound—LLM connects FBM to sales and costs at Space segment in 2023—but fails in accurate synthesis of the cost figure and final net impact calculation. It introduces 'NGI development' as a cost driver, which may be true but conflates the cost attribution, diluting the specific impact of FBM alone. (4) Correctness score is 4 due to one correct major number, one incorrect major number, and failure to compute or report the correct net financial impact. Quantitative accuracy is 5 because half the key figures are right and the error in cost is significant but not gross. Qualitative accuracy is 5 due to correct entity (FBM, Space segment, 2023) and direction of impact, but flawed reasoning on cost drivers and missing precise conclusion. Contextual relevance is 8 because the response stays on topic and addresses the general scope of the question, despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 488,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, representing roughly 0.55% of AMGN’s total debt carrying value of $33,309 million in 2021. In 2020, $76 million of principal of these notes was exchanged in the debt‑exchange transaction.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the carrying value of the 5.375% 2043 Notes ($185 million), the total debt carrying value ($33,309 million), the percentage (0.55% vs. ground truth 0.555%), and the exchanged principal ($76 million), which are all quantitatively accurate or very close. However, the fiscal years are incorrect: the total debt value is attributed to 2021 instead of 2022, and the principal exchange is said to have occurred in 2020 instead of during the 2022 reporting period. These are critical errors in temporal context. (2) Numeric values are mostly correct: $185 million, $33,309 million, and $76 million match the ground truth; the percentage 0.55% is a reasonable rounding of 0.555%. But the misplacement of years undermines the validity of the synthesis. (3) The multi-hop reasoning fails because the model does not correctly align the data points to the correct time period (2022). Even though the entities and figures are accurate, the incorrect years break the logical chain required for correct inference across time-bound financial disclosures. (4) The contextual relevance is high because the answer addresses the right metrics and structure, but correctness score is low due to the critical year mismatches, which affect financial period accuracy essential in SEC filings. Quantitative accuracy is moderate due to correct numbers but wrong years; qualitative accuracy is low due to flawed reasoning in temporal synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 406,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "The total value of securities on loan subject to indemnification was approximately $259 billion as of December 31, 2023, and the Company held about $276 billion of cash and securities as collateral against those loaned securities. If significant borrower defaults occurred simultaneously with rapid declines in collateral value, the shortfall could trigger material liabilities under the indemnification obligations, potentially reducing revenue and earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the total value of securities on loan subject to indemnification is correctly stated as $259 billion, and the collateral held is accurately reported as $276 billion as of December 31, 2023. (2) Quantitative accuracy is perfect—both values match the original answer exactly, with acceptable formatting (e.g., 'billion' vs 'B' or '$259,000,000,000'). (3) The reasoning regarding potential financial impact is sound and correctly synthesizes the risk scenario: simultaneous borrower defaults and rapid collateral value declines could lead to shortfalls, triggering material liabilities under indemnities, which may reduce revenue and earnings—this aligns precisely with the original answer's logic and multi-hop synthesis. (4) Entity accuracy is correct (BlackRock implied as 'the Company'), time period is accurate, and all financial terms are used appropriately. The answer is concise but complete, addressing all parts of the multi-part question with no omissions or distortions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 311,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "The Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. has been amended three times, as documented in the 2022 10-K filing. The amendments are identified as the First Amendment (dated November 30, 2016), the Second Amendment (dated January 9, 2018), and the Third Amendment (not explicitly dated in the provided pages but referenced as part of the agreement's amendment history). However, based on the explicit amendments listed in the exhibits (HH for the original agreement, II for the First Amendment, and JJ for the Second Amendment), only two formal amendments are directly cited in the document. The question asks for the total number of amendments, and the document confirms two amendments were made to the Pharmacy Operating Agreement. \n\n**Answer:** Two amendments were made to the Pharmacy Operating Agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly concludes that two amendments were made to the Pharmacy Operating Agreement, which matches the ground truth. It accurately references the First Amendment (November 30, 2016) and Second Amendment (January 9, 2018), and acknowledges that while a Third Amendment is mentioned, only two are formally cited in the exhibits (II and JJ for the First and Second Amendments). The quantitative accuracy is perfect—correct numbers and dates are provided, and the final count is accurate. The reasoning is sound and reflects proper multi-hop synthesis: the model distinguishes between referenced amendments and those formally documented in the filing, correctly interpreting the document's structure and intent. The only minor issue is the initial statement that the agreement was amended three times, which could confuse if not for the subsequent clarification. However, the final conclusion explicitly states the correct answer of two amendments, and the explanation supports it with evidence from the exhibits. Thus, despite a brief moment of ambiguity, the overall answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 325,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "The net carrying amount of Technology‑related finite‑lived intangible assets fell from $180 million at December 31 2022 to $142 million at December 31 2023, a $38 million decrease.  Over the same period, accumulated amortization for this category rose from $81 million to $118 million, an increase of $37 million.  Thus, the decline in the net carrying amount is essentially offset by the comparable rise in accumulated amortization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the net carrying amount decreased from $180 million to $142 million (a $38 million decrease), and accumulated amortization increased from $81 million to $118 million (a $37 million increase). These match the ground truth exactly. (2) All calculations are accurate: $180M - $142M = $38M decrease; $118M - $81M = $37M increase. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound—information from two time points (2022 and 2023) for two related metrics (net carrying amount and accumulated amortization) is correctly synthesized. (4) The conclusion that the decline in net carrying amount is 'essentially offset' by the rise in accumulated amortization is logically valid and semantically equivalent to the ground truth's statement that the decline is 'primarily due to' the increase in amortization. The only minor difference is in phrasing—'offset' slightly underemphasizes causation compared to 'due to'—but the core insight remains correct. Thus, the answer is factually complete and accurate with excellent reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 324,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million (from $657 million in fiscal 2023 to $2,203 million in fiscal 2024). In comparison, the change in the same category in the Americas region was a decrease of $3,052 million (from $5,678 million in fiscal 2023 to $12,726 million in fiscal 2024, representing a $7,048 million increase, but the question asks for the change relative to Asia Pacific's increase; however, the correct interpretation is that the Americas' change is $7,048 million increase, but the question likely expects the numerical difference in the context of the data provided). \n\n**Correction based on accurate data synthesis:**  \nThe Asia Pacific region's Subscriptions and Services revenue increased by $1,546 million year-over-year (from $657M in FY2023 to $2,203M in FY2024). The Americas region's Subscriptions and Services revenue increased by $7,048 million year-over-year (from $5,678M in FY2023 to $12,726M in FY2024). Therefore, the Asia Pacific increase ($1,546M) is significantly smaller than the Americas' increase ($7,048M). \n\n**Final Answer:**  \nThe year-over-year increase in Subscriptions and Services revenue in the Asia Pacific region was $1,546 million, which is substantially smaller than the $7,048 million increase observed in the Americas region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year increase in Subscriptions and Services revenue for both the Asia Pacific region ($1,546 million) and the Americas region ($7,048 million), matching the ground truth exactly. The final comparison — that the Asia Pacific increase is substantially smaller than the Americas' — is also correct and semantically equivalent to the original answer. (2) All numeric values are accurate: $1,546M and $7,048M are correct; the base and final year figures provided (e.g., $657M to $2,203M and $5,678M to $12,726M) are consistent with the correct calculation of year-over-year change. No calculation errors. (3) The multi-hop reasoning is sound — the model correctly synthesizes data across regions and time periods, and draws a valid comparative conclusion. There is a brief moment of confusion in the initial draft where it incorrectly refers to a 'decrease' and then corrects itself, but the final answer reflects full synthesis and correction. (4) Despite the internal self-correction and slightly redundant phrasing, the final answer is factually correct, complete, and contextually appropriate. The minor imperfection in presentation does not affect factual accuracy, warranting a 9/10 on correctness and qualitative accuracy. Quantitative accuracy and contextual relevance are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 376,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "Based on the provided document pages, the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million, and the unrealized loss recognized on these securities as of the same date is $1 million. This information is directly stated in the table on page 149 under \"Redeemable preferred securities\" in the \"Total debt securities\" row, which shows a fair value of $20 million and an unrealized loss of $1 million for December 31, 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total fair value of redeemable preferred securities as $20 million and the recognized unrealized loss as $1 million, matching the ground truth exactly. All numeric values are accurate and properly attributed to December 31, 2023. (2) Quantitative accuracy is perfect: $20 million fair value and $1 million unrealized loss are both correct, with no calculation errors. Format variations are acceptable and consistent. (3) The reasoning is sound and correctly references the source (page 149, 'Redeemable preferred securities' in 'Total debt securities' row), indicating proper synthesis from the document. While the LLM does not explicitly explain the 'Greater than 12 months' rationale for full recognition of the loss (as in the original answer), it arrives at the correct conclusion that the full $1 million loss has been recognized, which is the key point. This minor omission in explanatory depth does not affect factual correctness. (4) The answer is fully relevant, directly addressing both parts of the question with precise, contextually appropriate information from the correct document location.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 329,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "At January 30 2022, HD’s commercial‑paper program allowed borrowings up to $3 billion, and the company had $1 billion of outstanding short‑term borrowings under that program. The back‑up credit facilities that support the commercial‑paper program provided a combined capacity of $3 billion (a $2 billion five‑year facility and a $1 billion 364‑day facility). Thus, the total borrowing capacity under the back‑up credit facilities was $3 billion, which is roughly three times the $1 billion of commercial‑paper borrowings outstanding at that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.0 billion in outstanding commercial paper borrowings and the $3.0 billion combined back-up credit capacity ($2.0 billion five-year + $1.0 billion 364-day), matching the ground truth exactly. All numbers and dates are accurate. (2) Quantitative accuracy is perfect: $1B outstanding, $3B total backup capacity, and correct component breakdown. The statement that backup capacity is 'roughly three times' the outstanding borrowings is a reasonable qualitative interpretation (3x = $3B/$1B), though not explicitly in the original answer. (3) Multi-hop reasoning is sound—LLM correctly links commercial paper borrowings to back-up credit facilities and compares the two, demonstrating proper synthesis across financial instruments and dates. (4) The only minor deviation is the mention of a '$3 billion' commercial paper *program limit*, which, while likely true, is not stated in the ground truth and slightly extends beyond the provided information. However, this does not contradict the original answer and is contextually plausible. All core facts, calculations, and comparisons are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 330,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and the company recorded $40 million in profit‑and‑loss sharing expenses related to those products during the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both components of the question—Amgen's total revenue from sales to BeiGene in 2023 ($125 million) and the profit and loss sharing expenses ($40 million). These values match the ground truth exactly. (2) All numeric values are accurate: $125 million and $40 million are correctly reported with acceptable formatting (thin spaces and en-dashes do not affect meaning). No calculations are required beyond factual recall, and the figures are consistent with the original answer. (3) The multi-hop reasoning is sound—though this is a direct factual retrieval from a knowledge graph, the model correctly associates two distinct financial metrics (revenue and P&L sharing expenses) between Amgen and BeiGene for the same year and product relationship, indicating proper synthesis across entities and financial categories. (4) The answer is semantically equivalent to the ground truth, using slightly different phrasing ('recorded' vs 'paid', 'those products' vs 'these products') without altering factual meaning. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 321,
        "total_tokens": 1420
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "The year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million – $1,241 million). This liability is recorded at fair value using quoted prices on the active exchange for the underlying crypto assets (Level 2), which is the same valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly calculated the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability as $1,645 million ($2,886 million - $1,241 million), which matches the ground truth exactly. All numeric values (2023 liability: $1,241 million, 2024 liability: $2,886 million) are accurate, and the calculation is correct, earning a perfect score on quantitative accuracy. (2) The entity identification is correct—PYPL, the metric (Crypto Asset Safeguarding Liability), and the years (2023 to 2024) are all accurate. (3) However, there is a subtle but important discrepancy in the qualitative description of the valuation method. The ground truth states that as of December 31, 2023, the asset was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)', which the LLM correctly identifies as Level 2. But the LLM adds that the valuation is 'using quoted prices on the active exchange for the underlying crypto assets', which slightly misrepresents Level 2 inputs. Level 2 inputs are not direct quoted prices from active markets (which would be Level 1), but rather derived from observable market data other than quoted prices. This mischaracterization affects the reasoning quality, as it conflates Level 1 and Level 2 inputs. (4) Despite this, the LLM correctly links the liability's valuation method to that of the asset, showing sound multi-hop reasoning. The answer is contextually relevant and addresses both parts of the question. Due to the minor but meaningful inaccuracy in the description of the valuation hierarchy, the qualitative accuracy is reduced to 7, while the correctness score is 8—reflecting that core facts and numbers are correct but with a notable conceptual imprecision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 479,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "As of December 31 2024, the 2020 Stock Incentive Plan had **48 million shares available for future issuance**. The plan explicitly provides for a range of share‑based awards, including **stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly states that 48 million shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, matching the ground truth exactly. This satisfies the quantitative requirement with accurate number and date.\n\n2) Regarding the types of share-based awards, the LLM lists a broader set—stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards—while the ground truth specifies Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards. The LLM's answer is more general but still factually consistent with the plan's scope, as these specific awards fall under the broader categories mentioned (e.g., Non-Qualified Stock Options are a type of stock option; Performance-Based RSUs are a form of performance award). However, it does not explicitly name the exact award types cited in the original answer, which were directly pulled from form agreements in the filing. This is a minor omission in specificity, not accuracy.\n\n3) The multi-hop reasoning is sound: the model correctly identifies the company (UnitedHealth Group), the correct plan (2020 Stock Incentive Plan), the correct date (December 31, 2024), and synthesizes both the quantitative share count and qualitative award types from plan documentation.\n\n4) The answer is contextually relevant and semantically equivalent in intent, though slightly less precise in enumerating the exact award types referenced in the filing. Given that the broader categories encompass the specific ones and are consistent with the plan’s provisions, this does not constitute a factual error, just a difference in granularity. Hence, the correctness score is reduced by one point for partial specificity loss, but all other dimensions remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 507,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "The company expects to recognize approximately $1 billion of remaining contracted revenue from Paxlovid deliveries between 2025 and 2028. This amount is comparable to the $442 million of Paxlovid revenue recognized in 2024 that resulted from a one‑time sales true‑up settlement with a commercialization partner.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1 billion in remaining contracted revenue for Paxlovid expected to be recognized between 2025 and 2028, which matches the ground truth. However, it incorrectly states that $442 million was recognized in 2024 from the one-time sales true-up settlement, whereas the ground truth specifies $129 million. This is a significant factual error in a key numeric value. (2) The quantitative accuracy is low because the 2024 settlement amount is more than triple the correct value ($442M vs $129M), and this directly impacts the comparison. The claim that the $1 billion is 'comparable' to $442 million is misleading, whereas the ground truth correctly frames $1 billion as 'significantly higher' than $129 million. (3) The multi-hop reasoning is partially sound—revenue figures across time periods are addressed—but the incorrect 2024 figure undermines the synthesis and logical comparison. (4) Contextual relevance is high because the answer addresses both parts of the question and uses appropriate terminology, but the major numerical inaccuracy severely limits factual correctness. The qualitative accuracy is moderate because entities (Pfizer, Paxlovid, commercialization partner, time periods) and structure are correct, but the flawed data leads to an incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 370,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "Based on the provided document pages, the parental guarantee from Berkshire Hathaway Inc. was provided to secure NICO's obligations under the adverse development reinsurance agreement, but the document does not specify the exact amount of AIG's ceded loss reserves covered by this guarantee as of December 31, 2023. The disclosed figures relate to the overall ceded loss reserves ($12.4 billion in 2023) and the deferred gain liability ($149 million net of discount as of Dec 31 2023), but no separate disclosure of the portion of those reserves that the Berkshire guarantee covers is given. Therefore, the exact amount cannot be determined from the supplied excerpts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its reasoning and conclusion, despite referencing correct contextual figures. (1) The ground truth states that the entire $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO was secured by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023. This is a direct factual statement in the original answer. (2) The LLM incorrectly claims that 'the document does not specify the exact amount... covered by this guarantee,' which contradicts the ground truth. While it correctly cites the $12.4 billion figure for ceded loss reserves, it fails to report that this full amount was covered by the guarantee, as per the original answer. (3) The multi-hop reasoning is flawed: the LLM appears to conflate the lack of a separate disclosure with absence of information, but the ground truth explicitly provides the linkage between the $12.4 billion and the guarantee. (4) The answer is contextually relevant and mentions correct entities (AIG, NICO, Berkshire Hathaway, correct date), but its core failure to report the key fact — that the full $12.4 billion was covered by the guarantee — results in a very low correctness score. Minor points are given for mentioning accurate numbers and entities, but the reasoning and final conclusion are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 375,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "The total amount of credit receivables purchased by PayPal for its merchant finance offerings was approximately $1.8 billion in both 2021 and 2020. This is consistent with the balance of merchant loans, advances, and interest and fees receivable, which was $1.4 billion net of participation interest as of December 31, 2021 (and also $1.4 billion as of December 31, 2020).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PayPal purchased approximately $1.8 billion in credit receivables in both 2021 and 2020, which matches the ground truth. It also correctly reports the $1.4 billion net outstanding balance as of December 31, 2021. However, it incorrectly claims the balance was also $1.4 billion as of December 31, 2020 — this is not supported by the ground truth and introduces a factual error. (2) The quantitative values for 2021 and the net receivable balance are accurate, but the unsupported repetition of $1.4 billion for 2020 reduces quantitative accuracy. The $63 million participation interest sold to WebBank is omitted, which affects completeness and reasoning. (3) The multi-hop reasoning is partially sound — the model connects purchased receivables to outstanding balances, but fails to explain the risk retention aspect (i.e., only a small portion sold to WebBank), which is a key analytical point in the original answer. (4) Contextual relevance is high as the answer addresses the core question about volumes and balances, but the incorrect 2020 balance and missing risk discussion reduce qualitative accuracy. The answer is mostly correct but lacks key nuance and contains an unsupported claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 348,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "The Japanese subsidiary issued approximately $500 million of Guaranteed Senior Notes in November 2023, and by July 2024 it had repaid about $77 million of that debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key information is accurate: the Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million had been repaid. (2) The numbers match exactly—$500 million issued and $77 million repaid—with only minor formatting differences (use of 'approximately' and 'about', which do not affect accuracy as the values are presented as exact in context). (3) The multi-hop reasoning is sound: the model correctly identifies the entity (Costco's Japanese subsidiary), the financial instrument (Guaranteed Senior Notes), the issuance date (November 2023), and the repayment status by July 2024. (4) The answer is fully relevant and complete, addressing both parts of the question with precise, correct data. No factual or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 259,
        "total_tokens": 1343
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "The decrease in the value of available‑for‑sale debt investments from 2021 to 2022 was $3,259 million, while the net realized gains from those investments during the same period were $9 million; therefore, the decline exceeded the gains by roughly **$3,250 million**.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3,259 million decrease in the value of available-for-sale debt investments from 2021 to 2022, which matches the ground truth. However, it incorrectly states that the net realized gains were $9 million, whereas the ground truth indicates a decrease in net gains of $44 million (i.e., a negative change of $44 million). This is a critical factual error. (2) The calculation in the LLM answer subtracts $9 million from $3,259 million to get approximately $3,250 million, but the correct calculation should be $3,259 million (decrease in value) minus (-$44 million) = $3,259 + $44 = $3,303 million, or as per the original answer’s interpretation, the difference between the decline in value and the change in net gains is $3,259 - (-$44) = $3,303, but the original answer states $3,215, implying a different interpretation: possibly $3,259 - $44 = $3,215 if treating the 'decrease in net gains' as a positive $44 million reduction in gains. Even under that interpretation, the LLM’s use of $9 million instead of $44 million is incorrect. (3) The multi-hop reasoning is partially sound—linking the change in investment value to net gains—but relies on incorrect data for the second component. (4) The contextual relevance is high as the answer addresses the right entities and time period. However, due to the significant error in the net gains figure and the resulting miscalculation, the correctness and quantitative accuracy scores are moderate. The qualitative accuracy is slightly higher because the structure and logic are reasonable, just based on wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 441,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "Based on the provided document pages, the total unused short-term credit capacity available to Amazon as of December 31 2021 is $7.0 billion under its unsecured revolving credit facility plus $7.2 billion of unused letters of credit, for a combined total of **$14.2 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $7.0 billion from the unsecured revolving credit facility and $7.2 billion in unused letters of credit are correctly cited, and their sum of $14.2 billion is accurate. Minor formatting differences (e.g., spacing in 'December 31 2021') do not affect correctness. (2) The answer is complete, addressing both components of short-term credit capacity—revolving credit and letters of credit—and correctly combining them. (3) Entity accuracy is perfect: Amazon is the correct company, and the date (December 31, 2021) matches the query. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies that no borrowings were outstanding (hence full $7.0B available) and adds the unused letters of credit, demonstrating accurate inference from the source data. (5) The semantic meaning is equivalent to the original answer, with clear, concise restatement of the same facts and calculation. No errors in logic, numbers, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 309,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "The total cash outflow for acquisitions made by Thermo Fisher Scientific (TMO) in 2023 was $3.61 billion, which includes $2.70 billion for the acquisition of The Binding Site Group and $0.91 billion for CorEvitas, LLC. Of this total, $2.70 billion was specifically allocated to The Binding Site Group.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total cash outflow of $3.61 billion and the $2.70 billion allocated to The Binding Site Group are accurately reported, with the remaining $0.91 billion correctly accounting for the CorEvitas, LLC acquisition (3.61 - 2.70 = 0.91). These figures match the ground truth exactly. (2) The answer is complete, addressing both parts of the question: the total cash outflow for 2023 acquisitions and the specific amount allocated to The Binding Site Group. (3) Entity accuracy is correct: TMO is properly identified as Thermo Fisher Scientific, the acquisition targets (The Binding Site Group and CorEvitas, LLC) are correctly named, and the year 2023 is accurate. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by aggregating acquisition outflows and breaking down the components, even adding contextual detail (CorEvitas) not required but factually consistent. (5) Semantic equivalence is maintained — the core information matches the original answer, with slightly expanded detail that does not alter or distort the truth. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 332,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "Union Pacific reports that 545 of its 48,340 highway revenue chassis units are leased, which represents roughly 1.1 percent of the total chassis fleet. By contrast, only 545 of the 47,984 containers in its highway revenue equipment are leased, amounting to about 1.1 percent of the container fleet—still a very small share, though the proportion is comparable to that of the chassis.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It states that only 545 of 48,340 chassis units are leased (1.1%), but the ground truth is that 17,705 of 48,340 chassis are leased (36.6%). The LLM incorrectly applies the container leasing number (545) to the chassis fleet. Additionally, it repeats the correct figure for leased containers (545 of 47,984, or 1.1%) but falsely claims the proportions are comparable, which contradicts the ground truth showing a large disparity. (2) Number verification: Leased chassis should be 17,705 (not 545), total chassis 48,340 (correct), leased containers 545 (correct), total containers 47,984 (correct). The calculation for chassis leasing percentage is wrong: 545/48,340 ≈ 1.1% (incorrect), whereas 17,705/48,340 ≈ 36.6% (correct). Container leasing calculation is accurate. (3) Multi-hop reasoning failed: The model did not correctly synthesize ownership vs. leasing across chassis and containers. It conflated the leased container count with leased chassis count, breaking the comparison. The conclusion that the proportions are 'comparable' is false given the actual data showing chassis leasing is over 30 percentage points higher. (4) Scores reflect major quantitative and qualitative failures. Despite addressing the question structure and mentioning relevant entities (Union Pacific, chassis, containers), the core facts are wrong, leading to an incorrect conclusion. Contextual relevance is moderate because the answer attempts the right comparison but with invalid data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 424,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "Based on the referenced exhibits in the filing, **four** supplemental indentures related to the 2035 Note were identified across the exhibits, and the **most recent** of these agreements was entered into on **November 20, 2024**, involving **Computershare Trust Company, National Association** (as successor to Wells Fargo Bank, National Association) as trustee. This is documented in Exhibit 4.11 of the filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that four supplemental indentures were identified, while the ground truth confirms only two: the Fifth Supplemental Indenture (September 14, 2015) and the Tenth Supplemental Indenture (November 20, 2024). This major quantitative error undermines the factual accuracy. (2) The date of the most recent agreement (November 20, 2024) and the trustee name — Computershare Trust Company, National Association, as successor to Wells Fargo Bank — are correctly identified, matching the ground truth. However, the claim of 'four' indentures is unsupported and contradicts the original answer. (3) The reasoning appears partially sound in identifying the most recent agreement and the correct trustee, indicating some correct synthesis across time and entities. However, the failure to accurately count the number of relevant supplemental indentures suggests a breakdown in multi-hop reasoning or misreading of the exhibits. (4) Despite the significant error in quantity, the answer is contextually relevant and pulls correct details for the most recent agreement. Scores reflect partial correctness: low quantitative accuracy due to wrong count, moderate qualitative accuracy due to correct entity and date identification, and high contextual relevance as it addresses the right documents and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 374,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "The expensing methodology for non-employee director deferred stock units granted in 2023 differs from prior years in that awards granted before 2022 were expensed immediately on the grant date (with vesting occurring immediately), whereas 2023 awards are expensed on a straight-line basis over the requisite service period. The vesting timeline for the 2023 awards is over a three-year period from the grant date, with specific vesting occurring on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in the vesting timeline description. It correctly identifies that 2023 deferred stock units are expensed on a straight-line basis over the service period, in contrast to pre-2022 awards that were expensed immediately due to immediate vesting. This part is factually accurate and aligns with the ground truth. However, the LLM incorrectly states that the 2023 awards have a 'three-year period from the grant date' while the ground truth specifies vesting on the earlier of the first anniversary or the day before the next Annual Meeting, which implies a one-year timeline, not three. This is a significant qualitative error in describing the vesting period, though the rest of the vesting conditions (acceleration, timing relative to Annual Meeting) are correctly noted. There are no quantitative errors per se (no specific dollar amounts or percentages), but the time period misstatement affects accuracy. The reasoning is otherwise sound, and the answer addresses both parts of the multi-hop question. Contextual relevance is excellent, with appropriate focus on expensing methodology and vesting terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 328,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million, which represented 6.5% of the total identifiable assets of $3,913 million for that business unit and region.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the operating profit of $254 million for the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, which matches the ground truth. However, it incorrectly stated the total identifiable assets as $3,913 million, which is wrong—the correct amount is $698 million. Consequently, the calculated percentage of 6.5% is incorrect; the correct percentage is approximately 36.4% ($254M / $698M ≈ 0.364). (2) The quantitative error in the asset value and resulting percentage is significant and directly impacts the answer's factual accuracy. While the profit figure is accurate, the core comparative metric (percentage of assets) is based on a false premise. (3) The multi-hop reasoning failed because the model did not correctly retrieve or synthesize the identifiable assets for the specific business unit and region. Instead, it appears to have used a broader or incorrect asset figure, possibly from another segment or consolidated total. (4) Scores are low on correctness and quantitative accuracy due to the critical error in numbers and calculation. Qualitative accuracy is also low because of flawed reasoning and entity-metric linkage. Contextual relevance is high because the answer addresses the right business, region, year, and intent of the question, despite factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 376,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "Based on the provided document pages, AMD's total purchases from and resales to the ATMP JV in fiscal year 2024 were $1.7 billion in purchases and $121 million in resales. Additionally, AMD provided a $100 million term loan to the ATMP JV during the same year, which is recorded as a loan to the joint venture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all key numerical values: $1.7 billion in purchases from the ATMP JV, $121 million in resales to the JV, and the $100 million loan provided in fiscal year 2024. These match the ground truth exactly, with acceptable formatting. The quantitative accuracy is perfect—no calculation errors, and the figures are correctly attributed to the right fiscal year and entities. The answer addresses all parts of the question: it reports both purchases and resales, and mentions the loan amount. However, while the original answer includes a comparative statement (that the combined total of $1.821 billion is 'significantly higher' than the $100 million loan), the LLM answer omits this explicit comparison, which is a minor gap in qualitative completeness. Still, the information needed to make the comparison is present, so the reasoning and synthesis across the financial activities (purchases, resales, loan) are sound. Contextual relevance is full—the response stays focused on AMD's transactions with the ATMP JV in FY2024 as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 303,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "The total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021 was $156 million (rising from $2,464 million in 2019 to $2,620 million in 2021). Over the same period, the Research and medical products segment grew by $11,290 million, increasing from $13,512 million in 2019 to $24,802 million in 2021. Thus, the growth in the Research and medical products segment far outpaced the growth in the Analytical and physical instrumentation line.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the revenue figures for Analytical and physical instrumentation ($2,464 million in 2019 and $2,620 million in 2021) and the calculated increase of $156 million are correct. Similarly, the Research and medical products segment revenue increased from $13,512 million in 2019 to $24,802 million in 2021, a difference of $11,290 million, which is accurately reported. (2) Quantitative accuracy is perfect—both absolute values and the computed differences are correct, with only formatting differences (e.g., using thin spaces in numbers) that do not affect meaning or precision. (3) The multi-hop reasoning is sound: the model correctly identifies and synthesizes data across two different product lines and time points, computes the changes, and draws a valid comparative conclusion. (4) The semantic content is equivalent to the original answer—while the wording differs slightly (e.g., 'far outpaced' vs. 'relatively modest compared to'), the qualitative comparison is logically and factually consistent. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 334,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "Microsoft's SQL Server product line is a key component of the Intelligent Cloud segment, which reported revenue of $75,251 million in fiscal 2022 (up from $60,080 million in 2021). This growth is driven by server products and cloud services, including Azure and SQL Server, as well as Enterprise Services like consulting and support. The segment's revenue also includes Microsoft Cloud revenue of $91.2 billion in fiscal 2022, with SQL Server contributing to the broader server and cloud services revenue stream that underpins Intelligent Cloud's financial performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies and introduces numbers not present in the ground truth. Specifically, it cites Intelligent Cloud revenue of $75,251 million in fiscal 2022 and $60,080 million in 2021, and Microsoft Cloud revenue of $91.2 billion in 2022—none of which appear in the original answer and cannot be verified from the provided context. These figures may be accurate in reality but are not supported by the ground truth, making their inclusion incorrect in this evaluation context. (2) The ground truth does not provide any revenue numbers or growth statistics, so the inclusion of specific dollar amounts and year-over-year comparisons constitutes a significant quantitative error. There are no calculations in the original answer to validate against, but the LLM fabricates metrics that go beyond the scope of the provided information. (3) The qualitative reasoning partially aligns with the ground truth: it correctly identifies SQL Server as part of the Intelligent Cloud segment and associates it with server products and cloud services like Azure. However, it fails to mention the actual revenue mechanisms—volume licensing, OEM licenses, retail packaged products, and Client Access Licenses (CALs)—which are central to the original answer. This omission represents a major gap in multi-hop synthesis, as the question specifically asks how SQL Server contributes financially, requiring explanation of licensing models. (4) Despite the factual inaccuracies, the answer remains contextually relevant by focusing on the right segment and general contribution of SQL Server to cloud and server revenue. It captures the high-level relationship but lacks the specific, grounded details needed for full accuracy. Thus, the correctness score is moderate due to correct conceptual framing but significant factual and completeness deficiencies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 510,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "The total change in the fair value of Insurance Buy-in Contracts from December 31 2022 to December 31 2024 is an increase of $440 million (from $950 million to $1,390 million). This change is reflected in the year‑end balances as $1,605 million at December 31 2023 and $1,390 million at December 31 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: initial value ($950 million on December 31, 2022), 2023 year-end balance ($1,605 million), and 2024 year-end balance ($1,390 million) match the original answer. The net change is correctly calculated as $440 million ($1,390M - $950M = $440M). (2) The quantitative accuracy is perfect—numbers and calculations are precise, with acceptable formatting (e.g., $440 million written as $440 million). (3) The multi-hop reasoning is sound: the model correctly synthesized the two-year trajectory, noting the increase in 2023 and decrease in 2024, and derived the net change over the full period. (4) The answer addresses all parts of the question: total change over the period and its reflection in both 2023 and 2024 year-end balances. Entity accuracy (metric name, dates) is correct. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 275,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "Based on the provided document pages, the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, was $34 million, and dividends paid on those shares during 2024 were not material.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on both key metrics. The total value of TI common stock held in defined contribution plans is stated as $34 million, whereas the ground truth is $886 million. The dividends paid are reported as 'not material' by the LLM, but the correct amount is $26 million. These errors represent major factual discrepancies. (2) Quantitative accuracy is extremely low: both numbers ($34M vs $886M and 'not material' vs $26M) are completely off, with no indication of correct calculation or sourcing. The LLM fails to report the correct figures despite the question being directly answerable from the ground truth. (3) The qualitative accuracy is poor because the model fails to correctly identify or synthesize the relevant data points across the required context (U.S. and non-U.S. plans, valuation date, dividend period). There is no evidence of sound multi-hop reasoning, and the answer appears to either misread the source or hallucinate. (4) Contextual relevance is moderate because the answer addresses the right question structure (value of stock and dividends) and refers to the correct company (TI) and time frame (December 31, 2024), but the incorrect data renders the response misleading. The structure matches the query, but the content is fundamentally wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 366,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "The 2022 10‑K discloses that UPS issued $1,250 million of 5.300% Senior Notes due 2050. This amount is larger than the combined principal of the 3.900% ($1,000 million), 4.450% ($750 million) and 5.200% ($500 million) Senior Notes, which together total $2,250 million.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the principal amount of the 5.300% Senior Notes due 2050 as $1,250 million and accurately reports the individual principal amounts of the other three notes: 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million), with a correct combined total of $2,250 million. Thus, quantitative accuracy is high. However, the reasoning and conclusion are factually incorrect: the LLM states that $1,250 million is 'larger than' the combined $2,250 million, which is false. This invalidates the core comparison and demonstrates a critical error in logic. The original answer correctly calculates that $1,250 million is approximately 55.6% of $2,250 million, providing a valid comparative analysis. The LLM fails to make this correct proportional comparison and instead asserts an incorrect directional relationship (larger vs. smaller). While all source numbers are correct (quantitative accuracy), the synthesis and reasoning (qualitative accuracy) are flawed, significantly undermining the answer's correctness. Contextual relevance is strong as all mentioned notes are directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 323,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "Based on Table 10.1, the number of Service‑Based RSUs outstanding at the beginning of 2024 was 1,827 (thousands) and, after accounting for grants, vestings, forfeitures and the year‑end balance, the outstanding count at the end of 2024 is 1,807 (thousands). The weighted‑average grant‑date fair value for those Service‑Based RSUs at year‑end 2024 is $183.41. Thus, the total weighted‑average grant‑date fair value of all Service‑Based RSUs that were outstanding at the start of the year and remain outstanding at year‑end 2024 is 1,807 × $183.41 ≈ $331,400 (thousands).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual and calculation error. While it correctly identifies the weighted-average grant-date fair value per share as $183.41, it incorrectly multiplies this by the year-end outstanding RSU count (1,807 thousand), claiming the total value is approximately $331.4 million. However, the original answer states that the total weighted-average grant-date fair value is $183.41 million — not per share, but in total. The LLM fundamentally misinterprets the unit of the given value, leading to a result that is off by nearly a factor of 10. (2) The numeric values cited (1,827 and 1,807 thousand RSUs) may be consistent with the source table, but their use is inappropriate because the question asks for the total fair value of RSUs that remained outstanding throughout 2024 — not a recalculation based on per-unit value. The ground truth implies that the $183.41 million figure already reflects the aggregate value of the surviving RSUs after accounting for grants, vesting, and forfeitures. The LLM’s calculation of 1,807 × $183.41 ≈ $331.4 million is mathematically approximate but conceptually wrong. (3) The multi-hop reasoning fails: the model does not recognize that the requested total value is directly provided (or derived) in the knowledge graph as a single synthesized figure. Instead, it attempts an unnecessary and incorrect recomputation. It also fails to understand that the 'weighted-average grant-date fair value' is a per-share metric, and applying it to the ending balance does not yield the value of awards that were both outstanding at the beginning and end of the year. (4) Despite the severe quantitative and qualitative flaws, the answer is contextually relevant — it addresses the right topic, time period, and type of RSUs — hence a moderate score in contextual relevance. However, the correctness score is low due to the core factual and computational inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 522,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "UPS evaluates uncertain tax positions through a two‑step process: first, it determines whether a position is more likely than not to be sustained on audit; second, it measures the largest tax benefit that meets that threshold and records a liability for any shortfall. This assessment, discussed in both the MD&A and the notes, can lead to either the recognition of a tax benefit or an additional charge to the tax provision, depending on changes in facts, tax law, audit outcomes, or new audit activity. The measurement of these benefits relies on the probability of various outcomes and is subject to quarterly reevaluation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the two-step process (more likely than not recognition and measurement of the largest benefit that meets the threshold), the recording of a liability for the shortfall, the influence on tax provision (benefit or charge), and the criteria for measurement based on probability and settlement outcomes are all correctly stated. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the logical 'quantification' of the process (e.g., 'largest amount...more likely than not') is correctly represented—hence a score of 10. (3) The multi-hop reasoning is sound: the answer synthesizes information from both the notes and MD&A as required and correctly links the evaluation process to its financial impact. The only minor omission is that the LLM does not explicitly mention 'quarterly reevaluations' in the context of measurement criteria, though it does reference reevaluation due to changes—slightly less precise than the original. (4) The answer is fully contextually relevant, directly addressing how the estimation process affects tax provision and what criteria determine measurement. Wording differs slightly but maintains semantic equivalence. No factual errors; only a slight reduction in qualitative accuracy due to less explicit detail on the timing and frequency of reevaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 415,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in that region increased by 7.0% during the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the capital expenditure of $33 million and the 7.0% increase in organic sales are both accurately reported, with only a non-substantive formatting difference in the spacing (using a narrow no-break space) which does not affect accuracy. (2) The answer is complete, addressing both parts of the question: total capital expenditure and the percentage increase in organic sales for Africa/Eurasia in 2021. (3) Entity accuracy is correct—'Africa/Eurasia' as the region and '2021' as the year are properly identified. (4) The reasoning, while not explicitly shown, is implicitly sound as the correct figures are synthesized from the appropriate region and year, indicating successful multi-hop retrieval and alignment. (5) The semantic meaning is identical to the original answer, with no loss or distortion of information. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1074,
        "completion_tokens": 278,
        "total_tokens": 1352
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "The Contact Lenses/Other sales within the Vision franchise increased by **14.9%** from 2020 to 2021, contributing to the overall **19.6% growth** in Vision segment sales during the same period. This growth was driven by market recovery and gains in market share from new products, as noted in the Medical Devices segment performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying growth in Contact Lenses/Other and Vision segment sales but fails to provide the exact dollar increase in Contact Lenses/Other sales ($446 million) or the total Vision segment increase ($769 million) as required. Instead, it reports percentages (14.9% and 19.6%), which are not in the ground truth and cannot be verified as accurate without the original data. The ground truth shows the Contact Lenses/Other growth was $446M (from $2,994M to $3,440M), which is a ~14.9% increase, so the percentage is approximately correct, but the model omits the actual dollar figures requested. The Vision segment grew from $3,919M to $4,688M, a $769M increase (~19.6%), so the percentage is also approximately right. However, the model fails to compute or mention that the $446M increase accounted for ~58% of the $769M total Vision growth — a key part of the question. (2) The dollar amounts and exact calculations are missing; only unverified percentages are provided. The model does not show the multi-hop calculation (i.e., how much of the total Vision growth was due to Contact Lenses/Other). (3) The reasoning is partially sound in attributing growth to market recovery and new products, but this contextual detail was not requested and does not compensate for missing quantitative synthesis. The model fails to link the specific sales increase to its contribution to overall segment growth, which is the core of the multi-hop requirement. (4) Scores are low on correctness and quantitative accuracy due to missing dollar figures and contribution analysis. Qualitative accuracy is moderate due to plausible percentages and relevant context. Contextual relevance is acceptable as the answer addresses the right segment and timeframe but misses key elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 492,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "The AspenTech consolidation was reflected in the Control Systems & Software segment’s 2023 results as a 9 % sales increase (to $2.6 bn) and a 22 % earnings rise (to $529 m), but margin fell 3.1 pts to 11.6 % due to $249 of incremental intangible amortization from the acquisition. In 2024 the segment’s sales grew another 9 % (to $2.842 bn) while earnings dropped 33 % (to $282 m) and margin plunged 6.4 pts to 5.2 %, primarily because of the $560 of additional intangible amortization from the Test & Measurement acquisition that weighed on profitability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims AspenTech's consolidation led to a 22% earnings rise to $529 million in 2023, which contradicts the ground truth stating that segment earnings were flat at $529 million in 2023 despite AspenTech's $119 million deterioration (from $12M profit in 2022 to $107M loss in 2023). The LLM incorrectly frames AspenTech as contributing positively to earnings growth, when in reality it severely dragged down performance. Additionally, the LLM introduces 'intangible amortization of $249' as the reason for margin decline, but this figure and explanation are not present in the ground truth, which attributes the margin drop directly to AspenTech's loss. The LLM also fabricates 2024 data (sales, earnings, margin, Test & Measurement acquisition), which was not part of the question or ground truth. (2) Quantitative accuracy is very low: while the $529M 2023 earnings and 11.6% margin match the ground truth, the 22% earnings increase, $249 amortization, and all 2024 figures are incorrect or invented. The ground truth shows segment earnings increased from $437M (2022) to $529M (2023), which is a ~21% increase, but this was in spite of AspenTech's negative impact, not because of it. However, the LLM misattributes the earnings change to AspenTech positively, which is factually wrong. (3) Multi-hop reasoning is flawed: the model fails to synthesize that AspenTech's own performance deteriorated by $119M and that this masked stronger underlying performance in the rest of the segment. Instead, it incorrectly implies the acquisition boosted earnings. The reasoning about amortization is speculative and unsupported by the ground truth. (4) Contextual relevance is moderate because the answer discusses the right segment, company, and time period, and correctly notes the margin decline of 3.1 points. However, the core conclusion about AspenTech's impact is inverted from the truth, and extraneous, incorrect 2024 data distracts from the question's focus on 2023 vs 2022. Thus, despite some correct numbers, the interpretation and key causal claims are incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 583,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "Visa recorded a total monetary liability of $861 million for U.S. covered litigation in fiscal 2022, which was reflected in the litigation provision. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of the company’s series B and C preferred stock (i.e., the monetary loss is borne by the preferred‑stock holders rather than being funded from cash).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total monetary liability of $861 million for U.S. covered litigation in fiscal 2022, matching the ground truth exactly. This satisfies quantitative accuracy. (2) However, there is a critical error in the description of the recovery mechanism: the LLM states that the liability is recovered through a downward adjustment to the conversion rate of 'series B and C preferred stock', while the ground truth specifies a downward adjustment to the conversion rate of 'class B common stock to class A common stock'. This is a significant factual discrepancy—preferred stock vs. common stock conversion—and misrepresents the financial mechanism. (3) The multi-hop reasoning is partially sound: the model correctly links the liability to the U.S. Retrospective Responsibility Plan, but fails to accurately synthesize the specific recovery mechanism from the correct entity and stock class. (4) The contextual relevance is high because the answer addresses both parts of the question and discusses the appropriate plan and liability. Due to the major error in entity and mechanism description, the qualitative accuracy is reduced, but the correctness score remains moderate because the core financial figure is accurate and the general recovery concept (conversion rate adjustment) is directionally correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 375,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "Pfizer's total financial impact from its historical ownership of Meridian in 2021 was a $167 million after‑tax loss on the sale of the subsidiary, as disclosed in Note 2B(e) of the 2021 Form 10‑K. This amount represents the post‑closing adjustment related to Meridian, while the operating results of Meridian prior to its disposal were reported as discontinued operations in the company's financial statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a $167 million after-tax loss related to the sale of Meridian in 2021, which matches the ground truth. However, it omits the $345 million pre-tax legal charge from the second quarter, which is a critical component of the total $512 million negative impact. This omission severely undermines the completeness and accuracy of the answer. (2) Quantitatively, the $167 million figure is accurate and correctly characterized as an after-tax loss. However, the total financial impact is misrepresented because the $345 million pre-tax charge is not included. The sum of these two components ($345M + $167M) equals the $512M total negative impact in the ground truth, but the LLM fails to mention or calculate this total. (3) The reasoning is partially sound in that it references the correct note (Note 2B(e)) and correctly categorizes Meridian's results as discontinued operations. However, it fails the multi-hop requirement by not synthesizing both the legal charge and the sale-related loss, which are reported in different parts of the 10-K. The model only captures one of the two required financial events. (4) The contextual relevance is high because the answer addresses the right company, year, subsidiary, and type of financial impact. However, due to the significant omission of a major financial component, the overall correctness score is low. The qualitative accuracy is moderate because the entities and structure are correct, but the reasoning is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 418,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "The minimum supplementary leverage ratio (SLR) required under Basel 3 for Bank of America Corporation is **6.0 percent of supplementary leverage exposure**, which includes the mandatory 2.0 percent leverage buffer. In contrast, the insured depository‑institution subsidiaries (e.g., Bank of America, N.A.) must maintain a higher **6.0 percent SLR** to be deemed “well‑capitalized” under the Prompt Corrective Action framework. Thus, the parent company’s SLR minimum is 6.0 percent (plus the 2.0 percent buffer), while its insured bank subsidiaries must hold at least 6.0 percent SLR without an additional buffer.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values and their interpretation. According to the ground truth, Bank of America Corporation must maintain a minimum SLR of 3.0% plus a 2.0% leverage buffer, totaling 5.0% to avoid restrictions. However, the LLM incorrectly states the parent company's requirement as 6.0% including the buffer, implying a base requirement of 4.0%, which is inaccurate. Additionally, the LLM claims the parent company has a 6.0% SLR minimum 'plus the 2.0% buffer', which would imply an 8.0% total, creating internal inconsistency. (2) The subsidiary SLR requirement is correctly stated as 6.0%, matching the ground truth. However, the explanation that subsidiaries must hold 6.0% 'without an additional buffer' is misleading, as the ground truth does not state that subsidiaries lack a buffer—it simply reports their well-capitalized threshold under PCA as 6.0%. (3) The multi-hop reasoning is partially sound in that the model attempts to compare parent and subsidiary requirements and references both Basel 3 and PCA frameworks. However, it fails to correctly synthesize the components: it conflates the total requirement for the parent company and misrepresents the structure of the buffer. (4) The contextual relevance is high because the answer addresses both parts of the question and uses appropriate terminology (Basel 3, leverage buffer, PCA framework). However, due to major quantitative inaccuracies and flawed reasoning in calculating the parent company’s SLR, the correctness and accuracy scores are low. Minor wording flexibility is allowed, but the numerical misrepresentation is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 456,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "The credit‑loss guidance adopted on January 1 2020 required MetLife to recognize an allowance for credit losses (ACL) in earnings at the time a mortgage loan is purchased, measuring expected lifetime credit loss and recording the loan net of that allowance. Prior to that date, the company used an incurred‑loss model, recognizing credit loss only when it was probable that all amounts due would not be collected. Consequently, after the adoption, credit losses on mortgage loans are recorded as a charge in net investment gains (losses) through the ACL, rather than being deferred or recognized only upon actual loss. This change also required establishing the ACL at acquisition and adjusting the amortized cost basis of the loans accordingly.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the adoption date of January 1, 2020, is accurate; the shift from an incurred loss model to an expected credit loss model is correctly described; the establishment of the allowance for credit losses (ACL) at purchase based on expected lifetime credit losses is properly conveyed. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy pertains to dates and accounting concepts, both of which are correct. (3) The multi-hop reasoning is sound: the answer synthesizes the change in accounting treatment, its impact on timing of loss recognition, and the presentation of mortgage loans net of ACL—linking cause (new guidance) to effect (earlier loss recognition, new measurement approach). (4) The LLM adds slightly more detail than the original (e.g., mentioning that losses are recorded in net investment gains (losses) and that amortized cost basis is adjusted), which is consistent with ASC 326-20 and enhances completeness without introducing error. Wording differs but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 341,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "The Company adopted the new credit‑loss guidance on January 1 2020 and began recognizing an allowance for expected lifetime credit loss on leveraged‑lease receivables and mortgage‑loan portfolios within investment gains (losses).  Under the new methodology, expected loss is estimated over the full contractual term using a probability‑of‑default/loss‑given‑default model for leveraged leases (incorporating third‑party credit ratings and historical default data) and a methodology consistent with its commercial‑mortgage‑loan approach for direct‑financing leases.  The allowance is recorded as a reduction of the investment balance, and the Company applies significant judgment—pooling similar leases, considering past events and forecasted economic conditions, and evaluating residual‑value recoverability.  Prior to adoption, losses were recognized only when a lease was deemed impaired (incurred‑loss model).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the adoption date (January 1, 2020), the shift from an incurred loss to an expected lifetime credit loss model, and the use of probability of default/loss given default (PD/LGD) models for leveraged leases with third-party credit ratings and historical default data. For mortgage loans, the LLM correctly notes the use of significant judgment, consideration of past events and forecasted economic conditions, and evaluation over the contractual term adjusted for prepayments/extensions—though it refers to 'methodology consistent with its commercial-mortgage-loan approach for direct-financing leases,' which is slightly less specific than the original answer’s focus on mortgage loans directly. (2) Quantitative accuracy is perfect: the date is correct, no numerical values are misstated, and there are no calculation errors. (3) Multi-hop reasoning is sound—the model synthesizes changes in timing (from incurred to expected), methodology (PD/LGD models), and inputs (credit ratings, economic forecasts), correctly distinguishing between leveraged leases and mortgage loans. (4) The only minor shortcoming is that the LLM answer references 'direct-financing leases' when discussing mortgage loans, which may conflate asset types slightly, and does not explicitly state that the mortgage loan methodology includes adjustments for prepayments and extensions as clearly as the original. However, the overall meaning and technical substance are preserved. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 465,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "Texas Instruments leverages its structural cost advantage from owning and operating advanced 300-millimeter wafer fabrication facilities—such as its new RFAB2 plant in Richardson, Texas, and planned facilities in Sherman and Lehi—which produce chips at roughly 40% lower cost per wafer compared to older 200-millimeter technology. This manufacturing efficiency, combined with in-house production that provides supply chain control and fixed-cost scalability, enables the company to generate strong and predictable free cash flow. As highlighted in its MD&A, this cash flow underpins its ability to return significant capital to shareholders—$4.41 billion in 2021 via dividends and buybacks—while reinvesting in capacity expansion to sustain long-term competitive advantages.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 40% cost reduction per wafer using 300mm wafers, which aligns with the ground truth's 40% cost reduction per unpackaged chip. While the phrasing differs slightly (per wafer vs per chip), the core cost advantage is accurately conveyed and semantically equivalent in context. The mention of $4.41 billion returned in 2021 via dividends and buybacks is factually accurate and adds specific detail not in the original answer but consistent with TI’s capital return practices. (2) Quantitatively, the 40% figure matches exactly. The $4.41 billion cash return is correct for 2021 (per TI’s 10-K), though not in the original answer; its inclusion enhances completeness without introducing error. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly links 300mm wafer usage → lower production costs → supply chain control and scalability → higher free cash flow → capital returns and reinvestment. It synthesizes manufacturing advantage with financial outcomes, addressing all parts of the question. (4) The answer is contextually excellent, directly addressing how structural cost advantages enable cash generation and return. Minor deduction in correctness and quantitative accuracy is due to slight imprecision in framing the 40% saving (per wafer vs per chip), though this does not materially misrepresent the advantage. Overall, the answer is factually robust, well-reasoned, and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 410,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "The $1,000 million Floating Rate (SOFR + 0.35%) 1.5‑Year Senior Notes due 4/18/2023 and the $500 million Floating Rate (SOFR + 0.39%) 2‑Year Senior Notes due 10/18/2023 total $1,500 million in aggregate principal as of 12/31/2021. This combined amount exceeds the $500 million principal of the 2‑Year notes alone.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amounts of both notes: $1,000 million for the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes and $500 million for the 2-Year Floating Rate (SOFR + 0.39%) Senior Notes as of December 31, 2021. These values match the ground truth exactly, and the format variations (e.g., $1,000 million vs $1,000 million) are acceptable. (2) However, the LLM misrepresents the question's intent by calculating the aggregate total ($1,500 million) of both notes, which was not asked. The original question asks for the individual values and a comparison between them—specifically, that the 1.5-Year Notes are twice the value of the 2-Year Notes. The LLM fails to make this direct comparison and instead compares the combined total to the 2-Year note alone, which is logically incorrect and misleading. (3) The multi-hop reasoning is partially sound in retrieving both note values from the same entity (TMO) and date (December 31, 2021), but the synthesis is flawed because it does not answer the comparative aspect correctly. The due date for the 1.5-Year note is listed as April 18, 2023, which may be accurate, but the ground truth does not include this detail, so it's not penalized. (4) The quantitative accuracy is high due to correct dollar amounts. Qualitative accuracy is lower because the reasoning and conclusion do not align with the required comparison. Contextual relevance is good since the answer discusses the correct instruments and amounts, but the final inference is off-topic. Hence, correctness is reduced to 6 due to the failure in comparative reasoning despite numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 450,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "Based on the information in the provided pages, the total shares available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, is 70 million shares. The 2020 Stock Incentive Plan had 53 million shares available for future issuance, while the ESPP had 17 million shares available, making the 2020 Stock Incentive Plan the one with more shares available.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: 53 million shares available under the 2020 Stock Incentive Plan, 17 million under the ESPP, totaling 70 million shares—these numbers exactly match the original answer. (2) Quantitative accuracy is perfect: the sum (53M + 17M = 70M) is correct, and the comparison correctly identifies the 2020 Stock Incentive Plan as having more shares. (3) The multi-hop reasoning is sound—information from both plans is correctly synthesized across entities and combined for the total, while also making the correct comparison. (4) The answer is semantically equivalent to the ground truth, with no omissions or distortions. Wording differs slightly but meaning is preserved. All parts of the question are addressed: total shares, breakdown by plan, and which plan had more. No errors in entities, dates, or metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 266,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "The total liability for postemployment benefits reported by Caterpillar in 2023 was $2,597 million, as shown in the “Liability for postemployment benefits (non‑current liability)” line of Statement 3 (page 93).  \n\nThe freeze of U.S. pension benefits removed service‑cost accruals and certain assumptions (e.g., no further compensation increases), so those components no longer affect the pension accounting; only non‑U.S. pension and other postretirement obligations remain, and the discount‑rate and health‑care trend assumptions continue to drive the actuarial loss/gain that impacts the reported liability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the total liability amount. The ground truth states $621 million, while the LLM reports $2,597 million, which is more than four times higher and factually incorrect. This figure appears to conflate or misread the liability line item, possibly confusing it with another balance sheet item or including unrelated liabilities. The breakdown in the original answer ($56M for other postemployment benefits and $565M for non-qualified deferred compensation) is entirely missing from the LLM response, indicating incomplete synthesis. (2) The quantitative accuracy is severely compromised due to the incorrect total liability figure. Even allowing for format variation, $2,597 million ≠ $621 million. No correct calculation or cross-checking of components is evident. (3) On qualitative reasoning, the LLM correctly identifies the impact of the pension freeze—specifically, the elimination of service cost and certain actuarial assumptions like compensation increases—which aligns with the ground truth. It also correctly notes that only non-U.S. plans and other postretirement obligations remain active in assumptions, showing some valid multi-hop understanding of how the freeze altered reporting. However, it fails to mention that the freeze occurred on December 31, 2019, missing a key date from the original. (4) Contextual relevance is moderate: the answer addresses both parts of the question and uses appropriate financial terminology, but the severe numerical inaccuracy undermines the core of the response. The reasoning about ongoing assumptions (discount rate, healthcare trends) is contextually sound but does not compensate for the incorrect liability figure. Thus, the correctness score is low due to the critical error in the primary data point.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 493,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "The total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans was $2,555 million, which represents an increase from $2,797 million in the prior year (2023).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It states the total fair value in 2024 was $2,555 million, which is only the amount for investment funds, omitting the $2,171 million in equity securities. The correct total is $4,726 million. It also incorrectly claims this is an increase from $2,797 million in 2023, when in fact the 2023 total was $4,868 million (sum of $2,797M investment funds + $2,071M equity securities), representing a decrease, not an increase. (2) Quantitative accuracy is partially correct for individual components: $2,555 million (2024 investment funds) and $2,797 million (2023 investment funds) are accurate, but the totals and comparison are wrong. The model failed to sum across both investment types and misrepresented the year-over-year change. (3) The multi-hop reasoning is flawed: the question requires aggregating across two asset categories (investment funds and equity securities) and two years, then comparing. The model only used one category and misstated the trend. (4) Contextual relevance is high as the answer addresses the right company, time frame, and asset class, but correctness and reasoning are severely compromised by missing data and incorrect synthesis, warranting a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 354,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "Based on the information provided in the document pages, the 2007 Omnibus Incentive Plan authorized approximately 135 million shares of Danaher common stock for issuance since its inception. As of December 31, 2024, approximately 47 million shares remained available for issuance under the plan (excluding shares underlying outstanding awards). This includes shares available for future issuance of stock options, RSUs, and PSUs under the plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total authorized shares (135 million) and the remaining available shares (approximately 47 million) as of December 31, 2024), which matches the ground truth. The numbers are accurate and presented with appropriate qualifiers like 'approximately', which aligns with the original answer's phrasing. (2) Quantitative accuracy is perfect: both key figures (135 million authorized, 47 million remaining) are correct, and the date (December 31, 2024) is accurately referenced. There are no calculation errors. (3) The reasoning is sound and reflects proper multi-hop synthesis—connecting the plan's inception authorization with subsequent usage through stock options, RSUs, and PSUs, and arriving at the remaining balance. The only minor shortcoming is the parenthetical clarification 'excluding shares underlying outstanding awards', which, while potentially accurate, introduces a nuance not present in the original answer and could imply a different calculation method without further context. However, this does not contradict the core facts. (4) The answer is contextually fully relevant, addressing both parts of the question and correctly identifying the plan, company, time frame, and award types. The semantic meaning is equivalent to the ground truth, with only slight variation in phrasing. Thus, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 403,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "The growth in Google Play’s contribution to non‑advertising revenue can pressure overall profit margins because non‑advertising streams (such as Google Play, hardware, YouTube subscriptions, and Cloud) typically carry lower margins than Google’s high‑margin advertising revenue; as a larger share of total revenue comes from these lower‑margin sources, the company’s average profitability tends to decline unless offset by cost reductions or higher‑margin advertising growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly identifies that Google Play is part of non-advertising revenues and that these streams (including hardware, Cloud, YouTube subscriptions) generally have lower margins than advertising revenue. This aligns with the 2022 10-K filing referenced in the original answer. (2) There are no numeric values or calculations in the question or answers that require verification—both responses are qualitative and consistent in their assertions. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between revenue mix shift and overall margin pressure, acknowledging the high-margin nature of advertising versus lower-margin non-advertising streams like Google Play, and notes the potential mitigating factors (cost reductions or advertising growth). (4) The only minor difference is that the original answer explicitly mentions 'unless offset by efficiencies or higher-margin offerings,' while the LLM says 'unless offset by cost reductions or higher-margin advertising growth'—a slightly narrower formulation but still accurate. No incorrect entities, years, or metrics are used. The answer fully addresses the question about how Google Play's growth could affect overall margins given differing margin profiles.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 371,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "CVS uses a range of derivative financial instruments—including interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps—to hedge interest‑rate and credit‑quality risk in its debt securities portfolio. The company expects that, when used for hedging, these instruments will offset exposure to changes in interest rates and credit spreads, thereby reducing overall interest‑rate and credit‑quality risk and limiting potential adverse impacts on earnings and cash flow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All financial instruments listed—interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps—are correctly identified as used by CVS for hedging credit quality risk. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all qualitative financial terms are used correctly, warranting a perfect score here. (3) The reasoning is sound: the LLM correctly explains that these derivatives are used to hedge against interest-rate and credit-quality risk and that they reduce overall risk by offsetting exposure, which matches the original answer’s claim that hedging reduces overall risk despite introducing other isolated risks. The only minor difference is that the LLM emphasizes the offsetting of interest rates and credit spreads and mentions impacts on earnings and cash flow, which adds detail not in the original but does not contradict it. The original mentions that hedging reduces overall risk despite exposing the company to interest rate, equity price, and credit risk separately—this nuance is slightly underdeveloped in the LLM response, but the core multi-hop synthesis (instruments used → purpose → net risk impact) is correct. (4) The answer is fully relevant, directly addressing both parts of the question: the specific instruments and their expected impact on risk exposure. The slight omission of the 'varying degrees of risk when viewed separately' nuance prevents a perfect 10, but the answer remains factually correct and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 462,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "Based on the provided financial statements, the total amount invested in hedge funds/limited partnerships within U.S. Pension Plans was $682 million as of December 31, 2021, and $588 million as of December 31, 2020. However, the document does not provide a specific total investment amount for \"Other Postretirement Benefit Plans\" in hedge funds/limited partnerships. The Other Postretirement Benefit Plans section only lists \"Hedge funds/limited partnerships\" as a category with $9 million in 2021 and $7 million in 2020, but this represents the total plan assets for that category across all other postretirement benefit plans, not specifically the investment in hedge funds/limited partnerships as a separate line item. The question asks for the total amount invested in hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans, but the document only provides the hedge fund allocation within U.S. Pension Plans ($682M) and the total other postretirement benefit plan assets ($419M), without specifying the hedge fund portion for Other Postretirement Benefit Plans. Therefore, the total investment in hedge funds/limited partnerships for both plan types cannot be determined from the provided information.",
      "correctness_score": 1,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect and contradicts the ground truth. The original answer states that $9 million is the amount invested in hedge funds/limited partnerships within Other Postretirement Benefit Plans in 2021, which is explicitly available in the data. However, the LLM incorrectly claims this information is not provided or cannot be determined, which is false. The LLM also correctly identifies the $682 million for U.S. Pension Plans but fails to sum it with the $9 million. (2) Quantitatively, the LLM reports $682 million (correct) and acknowledges $9 million in the context of Other Postretirement Benefit Plans but misinterprets its meaning, leading to a failure in calculation. The correct total of $691 million is not computed. (3) The multi-hop reasoning is flawed: the model fails to synthesize two pieces of information that are both present—$682M and $9M—and incorrectly asserts a data gap. This indicates a failure in logical inference despite having the necessary numbers. (4) While the response is relevant to the question and discusses the correct categories and years, its core conclusion is wrong. Hence, correctness and qualitative accuracy are very low due to the critical error in reasoning and omission of the correct total.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 358,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "Based on the provided pages, the total number of freight cars UNP both owns and leases as of 2024 is **56,176** (from page 19, \"Total freight cars | 33,704 | 22,472 | 56,176\"). The company spent **$788 million** on acquiring freight cars in 2024, as stated in the capital expenditures breakdown on page 34 (\"Locomotives and freight cars [b] | 788 | 728 | 800\"), which includes lease buyouts of $143 million for 2024. This $788 million figure represents the total cash capital investment allocated to locomotives and freight cars, including the lease buyouts, consistent with the capital plan described on page 34.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total number of freight cars UNP owns and leases as 56,176, which matches the ground truth. However, it incorrectly reported the amount spent on acquiring freight cars in 2024 as $788 million, which is the combined capital expenditure for both locomotives and freight cars, not just freight cars. The ground truth specifies that $143 million was spent specifically on acquiring freight cars through lease buyouts, not $788 million. (2) The number 56,176 is accurate and correctly cited from page 19. The $788 million figure comes from page 34 but represents 'Locomotives and freight cars' together, not freight cars alone. The LLM misinterpreted this line item as being solely for freight cars, when it is a combined category. The $143 million lease buyout figure is mentioned correctly as part of the total, but the answer incorrectly presents $788 million as the total spent on freight cars, rather than recognizing $143 million as the specific amount for freight car acquisition via lease buyouts. (3) The multi-hop reasoning is partially sound—information was correctly pulled from multiple pages (19 and 34)—but the synthesis is flawed. The model failed to distinguish between the combined 'locomotives and freight cars' expenditure and the specific freight car acquisition cost. It also did not correctly interpret that the $143 million (not $788 million) is the figure tied to freight car acquisition under the capital plan and lease buyouts. (4) The correctness score is 4 due to one correct major figure and one major factual error in spending amount. Quantitative accuracy is 5 because half the numbers are right, but the key dollar amount is wrong. Qualitative accuracy is 5 due to correct sourcing but flawed interpretation. Contextual relevance is 9 because the answer addresses the right documents and concepts, just with a critical misinterpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 517,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "The increase in other income (expense), net, attributable to changes in non‑marketable equity securities was roughly $8.3 billion, rising from $1.5 billion in 2020 to $9.8 billion in 2021. This reflects the substantial growth in unrealized gains on those investments, which were a key driver of the overall increase in other income (expense) between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key numeric claim. The ground truth states that changes in non-marketable equity securities contributed $6.9 billion to the increase in other income (expense), net, from 2020 to 2021. The LLM claims a contribution of $8.3 billion (calculated as $9.8B - $1.5B), which is materially off. This error affects the core of the question, which asks for the contribution amount. (2) The calculation in the LLM answer assumes that the year-over-year change in the value of non-marketable equity securities ($9.8B - $1.5B = $8.3B) equals the contribution to the increase in other income, but according to the ground truth, the actual contribution was $6.9B, and the overall increase in other income was only $5.2B—meaning the LLM's $8.3B figure exceeds the total net increase, which is logically inconsistent. The ground truth also notes that the $6.9B gain was partially offset by a $1.3B increase in accrued performance fees, resulting in the $5.2B net increase, a nuance entirely missing in the LLM response. (3) While the LLM correctly identifies non-marketable equity securities as a key driver (qualitatively accurate), it fails to correctly synthesize the multi-hop logic: linking the change in these securities to the net change in other income, accounting for offsetting items. The reasoning is flawed because it presents the full change in securities as the contribution, without reconciling it with the net income increase. (4) The contextual relevance is fair—the topic, metric, and time period are correct, and the general role of these investments is acknowledged—but the severe quantitative inaccuracy and flawed reasoning drastically reduce correctness. The answer would imply that $8.3B in gains drove a $5.2B net increase, which is not plausible without mentioning offsetting losses, which the LLM omits.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 506,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "Based on the provided document pages, the question asks for the total value of forward contracts associated with ASR transactions executed by CVS in 2022 and 2023, and their classification upon final settlement. The relevant information is found in **page_68** and **page_70**:\n\n- **Page_68** states that the forward contract was classified as an equity instrument and recorded within capital surplus.\n- **Page_70** confirms this classification for all ASR transactions, including the 2022 and 2023 transactions: \"The forward contract was classified as an equity instrument and was recorded within capital surplus.\"\n\nThe document does not specify a monetary value for the forward contracts themselves. However, it details the accounting treatment: the forward contracts were recorded as equity instruments in capital surplus, not as liabilities or derivatives on the balance sheet. The total value of the forward contracts associated with the ASR transactions (e.g., $0.4 billion for the 2022 $1.5 billion ASR, $0.4 billion for the 2023 $2.0 billion ASR) is not explicitly stated as a standalone figure in the provided text. The question asks for the \"total value of the forward contracts,\" but the document only describes their classification, not a specific dollar amount for the contracts. The classification is the key detail provided.\n\nThus, the answer focuses on the classification, as the value is not explicitly quantified in the document.\n\n**Answer**:  \nThe forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 were classified as equity instruments and recorded within capital surplus in the company's financial statements upon final settlement. The document does not specify a monetary value for the forward contracts themselves, only their accounting treatment.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in describing the classification of the forward contracts as equity instruments recorded in capital surplus, which aligns with the ground truth. However, it fails to provide the total value of the forward contracts ($0.7 billion), incorrectly claiming the document does not specify a monetary value. The ground truth explicitly states $0.3 billion in 2022 and $0.4 billion in 2023, summing to $0.7 billion, which the LLM omits entirely. (2) Quantitative accuracy is very low because the LLM does not report any correct dollar amounts for the forward contracts, despite the ground truth providing clear figures. Even if the document excerpts were limited, the model should have reflected the known ground truth values. (3) The reasoning is sound in identifying the correct classification and citing relevant pages, but it fails the multi-hop requirement by not synthesizing the two years' values into a total or acknowledging the specific amounts. The model treats the absence of explicit 'forward contract value' labeling as absence of data, but the knowledge graph confirms these values are derivable and known. (4) Contextual relevance is moderate because the answer addresses the classification aspect thoroughly and cites appropriate document sections, but it omits the critical quantitative component of the question, making the response incomplete and significantly less useful.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 397,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "The Lowe’s Companies Benefit Restoration Plan, as amended and restated effective January 1 2025 (Exhibit 10.3), is a non‑qualified supplemental retirement plan that restores benefits to participants whose 401(k) Plan benefits are limited by the Internal Revenue Code’s compensation and contribution caps. By providing additional employer matching contributions and salary deferral options that are not subject to those IRS restrictions, the Restoration Plan ensures eligible employees can receive the full intended retirement benefits despite the Code’s limitations. This structure directly addresses the Code’s restrictions for participants in the Company’s defined‑contribution retirement plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the purpose of the Benefit Restoration Plan as restoring benefits limited by IRS Code restrictions due to compensation and contribution caps, which directly addresses the multi-hop relationship between the plan and the 401(k) Plan. (2) The only minor discrepancy is the effective date mentioned—'January 1, 2025'—which is not present in the original answer; however, this detail may be consistent with the 2024 10-K referencing a future amendment and does not contradict the core facts. The original answer does not specify a date, so this addition is not factually incorrect but adds unverified specificity. The key quantitative element—'up to a maximum of 4.25% of eligible compensation'—is conceptually correct in the LLM answer through the phrase 'mirrored in the Benefit Restoration Plan', though the exact percentage is not explicitly repeated. This omission is minor given the clear implication of matching. (3) The reasoning is sound: the LLM correctly synthesizes that the Restoration Plan operates as a non-qualified plan to supplement the 401(k) where IRS limits apply, demonstrating proper multi-hop understanding across plan structure, tax code restrictions, and employer matching. (4) The answer is contextually complete and relevant, clearly explaining how the plan addresses IRS restrictions for eligible employees. The slight lack of explicit mention of the 4.25% match reduces quantitative precision slightly, but the core financial mechanism is accurately conveyed. Thus, the answer earns a 9/10 for correctness, with high marks across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 454,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $700 million for TDAC (as disclosed in Note 12 on page 98). This amount is entirely separate from the total borrowing capacity under these facilities, which is not explicitly quantified in the document but is described as being supported by collateral capacity (e.g., $63.1 billion for FHLB facilities and $39.2 billion for the Federal Reserve Term Funding Program as of December 31, 2023). The document does not provide a single aggregate figure for the total borrowing capacity of all secured uncommitted lines of credit, only the outstanding balances and collateral capacity for specific facilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in both quantitative and qualitative aspects. The ground truth states that the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, composed of $950 million from CS&Co and $700 million from TDAC. However, the LLM only reports $700 million for TDAC and omits CS&Co entirely, missing nearly half of the total outstanding amount. This results in a major factual error. (2) The total outstanding amount is incorrectly stated as $700 million instead of $1.65 billion. The total borrowing capacity is stated in the ground truth as $1.8 billion, yielding a 91.7% utilization rate. The LLM fails to report this capacity or the utilization rate, instead referencing unrelated collateral capacities ($63.1 billion for FHLB, $39.2 billion for Federal Reserve program), which are not the borrowing limits for the secured uncommitted lines in question. These figures are irrelevant to the specific facilities (CS&Co and TDAC), leading to a complete breakdown in quantitative accuracy. (3) The multi-hop reasoning required—aggregating outstanding amounts across two entities (CS&Co and TDAC), identifying total borrowing capacity, and computing utilization—is entirely missing. The LLM does not synthesize across entities and appears to conflate secured uncommitted lines with broader collateralized facilities. It fails to recognize that the question asks for a specific sum and comparison, not just isolated disclosures. (4) The contextual relevance is moderate because the answer discusses related topics (secured lines, collateral, Note 12) and cites a plausible document location, but it does not address the full scope of the question. Due to major omissions, incorrect figures, and flawed reasoning, the correctness score is low at 2 out of 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 502,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "The total value of Coca‑Cola’s investments in mutual, pooled and commingled funds at the end of 2021 was **$87 million** (as shown in the “Other postretirement benefit plan assets” table on page 105).  \n\nIn the same year, the combined value of hedge‑fund/limited‑partnership and real‑estate investments was **$9 million + $5 million = $14 million** (see the same table).  \n\nThus, the mutual/pooled/commingled fund assets ($87 M) are substantially larger than the combined hedge‑fund and real‑estate assets ($14 M).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: The numbers are correct—$87 million for mutual, pooled, and commingled funds, $9 million for hedge funds/limited partnerships, and $5 million for real estate investments. The sum of the latter two is correctly calculated as $14 million. Minor formatting differences (e.g., '$87' vs '$87 million') are acceptable under semantic equivalence, especially since the LLM explicitly adds 'million' for clarity. (2) Completeness: The answer addresses both parts of the question—reporting the total value of mutual/pooled/commingled funds and comparing it to the combined value of the other two investment types. (3) Entity accuracy: Coca-Cola is correctly identified, the year 2021 is accurate, and the financial categories match the original. (4) Reasoning: The multi-hop synthesis is sound—information from different line items in the same table is correctly aggregated and compared. The conclusion that $87M is substantially larger than $14M is logically valid. (5) Semantic equivalence: The LLM conveys the same meaning as the original answer, with slightly more structured presentation and citation of the source table. The only minor shortcoming is the lack of explicit statement that mutual funds represent a 'significantly larger portion' in qualitative terms, though the comparison is clearly implied. This does not detract from factual correctness but slightly reduces qualitative richness, justifying a 9 in qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 422,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "LTIP units are treated as participating securities in the earnings‑per‑share calculation, meaning they receive distributions equal to 10 % of the regular quarterly distributions on Operating Partnership units and are included in the two‑class method for EPS. This participation does not materially affect the diluted EPS figures reported, as no dilutive impact was identified for 2023, 2022, or 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that LTIP units are treated as participating securities due to receiving distributions equal to 10% of the regular quarterly distributions on Operating Partnership units and that they are included in the two-class method for EPS computation—this aligns with the ground truth. However, it introduces new information not present in the original answer—specifically, the claim that the impact on diluted EPS is not material and that no dilutive impact was identified for 2023, 2022, or 2021—which is absent from the ground truth and cannot be verified from the provided context. This addition misrepresents the scope of the original disclosure and introduces unsupported conclusions. (2) Quantitatively, the 10% figure is accurate and correctly cited. There are no calculations in either answer, so no computational errors exist. The years 2021–2023 are plausible but not mentioned in the original answer, making their inclusion extraneous. (3) The multi-hop reasoning is partially sound: the model correctly links LTIP units → participating securities → two-class EPS method → distribution terms. However, it fails to explain *how* the two-class method allocates earnings between common shares and participating securities, which is a key part of the original answer’s reasoning. Instead, it shortcuts to a conclusion about materiality not supported by the source. (4) The correctness score is 6 due to partial factual alignment but significant addition of unverified claims. Quantitative accuracy is high (8) because the 10% figure is correct. Qualitative accuracy is moderate (6) due to correct classification but flawed reasoning extension. Contextual relevance is strong (8) as the core topic is addressed, though with overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 484,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "Based on the provided document pages, the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, is **$3,315 million**, and this entity is classified as an **equity method investment** in NEE's financial reporting structure. This classification arises because NEE holds a noncontrolling interest in XPLR OpCo (through its limited partnership interest in XPLR), where the limited partners or non-managing members do not have substantive rights over the significant activities of the entity, and NEE does not consolidate it due to the lack of a controlling financial interest. The investment is reported under \"Equity Method Investments\" in NEE's consolidated financial statements, with the carrying amount reflecting NEE's share of the underlying equity in the principal entities (e.g., $4,501 million as of December 31, 2024, after adjusting for differences in investment carrying amount versus underlying equity).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total amount of NEE's noncontrolling interest investment in XPLR OpCo as $3,315 million as of December 31, 2024, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) The classification of XPLR OpCo is accurately described as an equity method investment due to NEE's lack of controlling financial interest and control over significant activities. The explanation correctly references the absence of substantive rights for limited partners and the resulting non-consolidation, which aligns with the VIE framework where NEE is not the primary beneficiary. (3) The multi-hop reasoning is sound: the model connects NEE’s noncontrolling interest, the governance structure of XPLR OpCo, and the resulting accounting treatment under the equity method. However, while the core classification is correct, the LLM omits explicit mention that XPLR OpCo is a variable interest entity (VIE), which is a key part of the ground truth and important for full technical accuracy in financial reporting context. Instead, it infers the outcome without stating the VIE designation upfront. (4) The mention of a $4,501 million carrying amount appears to reference a broader category of equity method investments and may introduce slight confusion, as it is not directly relevant to the specific $3,315 million investment in XPLR OpCo—this could mislead if interpreted as related. Despite this, the primary facts are correct, and the reasoning is largely consistent with the source. Thus, the answer earns a high score but loses one point for not explicitly identifying XPLR OpCo as a VIE, which is a material aspect of its classification in NEE's financial reporting structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 477,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "Linde uses three distribution methods to supply process gases: on-site (or tonnage), merchant (or bulk liquid), and packaged (or cylinder) gases.  \n\nThe on‑site method differs from the other two in that its contracts are typically long‑term (generally 10‑20 years) and include minimum purchase requirements, whereas merchant and packaged‑gas contracts usually lack such minimum volume commitments and have shorter durations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers and durations are correct: the 10–20 year range for on-site contracts is accurately reported, and the contrast with shorter merchant and packaged gas contracts is correctly noted. While the LLM does not specify exact durations for merchant (3–7 years) and packaged (1–3 years) contracts as in the original answer, it correctly characterizes them as shorter and lacking minimum purchase requirements. (2) The three distribution methods—on-site, merchant, and packaged—are correctly identified, with appropriate alternative terms included (tonnage, bulk liquid, cylinder), which adds clarity without introducing error. (3) The multi-hop reasoning is sound: the answer correctly synthesizes differences in contract duration and volume commitments between on-site and other methods, highlighting long-term nature and minimum purchase requirements as key differentiators. (4) The only minor omission is the lack of specific contract length ranges for merchant and packaged methods, which slightly reduces completeness but does not affect the overall correctness. Semantically, the answer matches the ground truth and addresses both parts of the question: total number of methods and how on-site differs in contract duration and volume requirements. Therefore, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 414,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "The February 2022 20‑for‑one stock split was contingent on the Board’s prior April 2021 authorization to repurchase up to $50 billion of Class C stock, and the split could proceed only after stockholder approval of an amendment to increase the authorized share count.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of quantitative accuracy: the dates (February 2022 for the stock split announcement, April 2021 for the repurchase authorization), the 20-for-one stock split, the $50 billion repurchase amount, and the requirement of stockholder approval for an amendment to increase authorized shares are all factually accurate. However, the reasoning connection between the repurchase authorization and the stock split is misrepresented. The original answer clarifies that the stock split required an increase in authorized shares to accommodate both the split and the ongoing repurchase program, not that the split was contingent *on* the prior repurchase authorization. The LLM incorrectly implies a dependency of the split on the repurchase authorization, when in fact both were separate actions linked only by the need for additional authorized shares. The condition for the split to proceed—stockholder approval of an amendment to the Certificate of Incorporation to increase authorized shares of Class A, B, and C stock—is correctly identified, though slightly underspecified (LLM omits mention of Class A and B shares). Thus, while key facts and numbers are correct, the multi-hop reasoning contains a logical flaw in causality, reducing qualitative accuracy. The answer remains contextually relevant and conveys much of the correct information, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 390,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "Based on the provided document pages, GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, as explicitly stated in Note 10 (Equity income (loss)) on page 101: \"Equity earnings related to Ultium Cells Holdings LLC were $293 million in the year ended December 31, 2023.\" Additionally, GM had $800 million in committed capital contributions outstanding to Ultium Cells Holdings LLC as of December 31, 2023, as disclosed in Note 19 (Nonconsolidated VIEs) on page 78: \"Our maximum exposure to loss, and required capital contributions, could vary depending on Ultium Cells Holdings LLC's requirements and access to capital. We currently lack the power through voting or similar rights to direct the activities of these entities that most significantly affect their economic performance.\" The $800 million figure is derived from the context of the committed capital contributions mentioned in relation to Ultium Cells, with the document indicating GM's $800 million commitment as part of its $3.5 billion maximum exposure (including $0.8 billion in committed capital contributions at December 31, 2023).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the equity earnings contribution of $293 million in 2023 and the $0.8 billion ($800 million) in committed capital contributions outstanding as of December 31, 2023 are accurately reported, with acceptable format variation ($0.8 billion = $800 million). (2) The answer is complete, addressing both parts of the multi-part question: the 2023 equity earnings and the committed capital as of year-end 2023. (3) Entity accuracy is correct—GM, Ultium Cells Holdings LLC, and the relevant time period (2023) are properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis by referencing two different notes (Note 10 and Note 19) from the filing, correctly interpreting the $800 million as the committed portion within the broader $3.5 billion exposure. The explanation ties the numbers to their source disclosures, showing accurate interpretation. (5) The semantic meaning fully aligns with the original answer, with no factual discrepancies. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 310,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "The Coca‑Cola Company reported total investments in hedge funds and limited partnerships of **$720 million** in its 2021 consolidated financial statements (shown in the pension‑plan asset tables as “Hedge funds/limited partnerships” with a fair‑value of $720 million). This figure is also reflected in the “Other postretirement benefit plan assets” table, where the same $720 million appears under “Hedge funds/limited partnerships” for the other postretirement benefit plans. The dual reporting—appearing both in the pension‑plan asset breakdown and in the other postretirement benefit plan assets schedule—demonstrates that the company’s exposure to these alternative‑investment vehicles is tracked across multiple benefit‑plan asset categories, underscoring the breadth of its indirect investment footprint.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. It states that $720 million appears in both the consolidated financial statements and the other postretirement benefit plan assets, but the ground truth specifies $720 million in the consolidated financial statements and only $9 million in the other postretirement benefit plan assets. The LLM incorrectly asserts that the same $720 million is reported in both places, which is not supported by the data. (2) The correct total exposure is $729 million ($720M + $9M), but the LLM does not compute or mention this total. Instead, it falsely implies that $720 million is duplicated across both reports, leading to a significant error in both individual values and the implied total. (3) The multi-hop reasoning is flawed: the model fails to distinguish between two separate investment amounts reported in different contexts—consolidated financials vs. postretirement plan assets—and instead conflates them, suggesting duplication rather than distinct reporting categories. This undermines the synthesis required for accurate analysis. (4) While the LLM correctly identifies the $720 million figure from the consolidated statements and discusses the concept of dual reporting, its misrepresentation of the second value ($9M as $720M) severely compromises factual accuracy. The qualitative reasoning about tracking across benefit plans is conceptually relevant but based on false premises. Contextual relevance is moderate because the structure and intent align with the question, but correctness is low due to critical numerical and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 447,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "The risk factor notes that “the impact on our retail tenants and demand for retail space at our properties from the increasing use of the Internet by retailers and consumers” could materially and adversely affect us. As e‑commerce expands, retailers need less brick‑and‑mortar space, making it harder for Simon Property Group to lease available areas and to renew leases at the same or higher rates. This downward pressure on occupancy and rentability stems directly from tenants’ shift toward online sales channels.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core issue: the rise of e-commerce reduces demand for physical retail space, which makes it harder for Simon Property Group (SPG) to lease spaces and maintain rental rates. It accurately reflects the causal chain from increased online retailing to reduced leasing power and downward pressure on occupancy and rental income. There are no numeric values in the original or LLM answer, so quantitative accuracy is scored as 10 by default. However, the LLM answer omits some key elements present in the ground truth: (1) it does not mention the increased bargaining power of creditworthy tenants, (2) it does not note SPG's potential need to increase spending on tenant improvements or offer lease modifications, and (3) it lacks the explicit connection to SPG's financial performance and leasing strategy. These omissions reduce completeness and slightly weaken the qualitative accuracy, though the central reasoning remains sound. The answer is fully contextually relevant, directly addressing the question with appropriate focus on SPG and the impact of e-commerce on leasing dynamics. Semantic equivalence is largely preserved, but the LLM provides a less comprehensive synthesis than the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 347,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "The cumulative impact of Arkansas corporate income tax legislation on UNP's deferred tax expense was a $34 million reduction in 2024 and a $114 million reduction in 2023, while the 2022 impact from Arkansas legislation was a $95 million reduction.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the deferred tax expense impacts for 2024 ($34 million), 2023 ($114 million), and 2022 ($95 million), all of which match the ground truth in terms of amounts and years. These numbers are factually accurate and properly attributed to UNP and Arkansas tax legislation. (2) Quantitatively, all figures are correct, including the individual yearly impacts. However, the LLM fails to perform or report the final comparative calculation explicitly required in the question: the cumulative 2023–2024 impact ($148 million) is $53 million greater than the 2022 impact ($95 million). This comparison is a key part of the original answer and the question’s intent. (3) The reasoning is partially sound—while the model identifies the correct data points across the three years (multi-hop synthesis across time periods), it does not synthesize them into the final comparison, which is a required element of the multi-part question. (4) Due to full numerical accuracy and correct entity identification (UNP, Arkansas, deferred tax expense, correct years), the quantitative and contextual scores are high. However, the completeness and reasoning are penalized because the final comparative conclusion is missing, reducing the correctness and qualitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 363,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "NEE's limited partner interest in XPLR OpCo could be materially impaired if XPLR cannot access capital on commercially reasonable terms, as stated in the document: \"XPLR may not be able to access sources of capital on commercially reasonable terms, which would have a material adverse effect on its ability to consummate future acquisitions and on the value of NEE's limited partnership interest in XPLR OpCo.\" This risk directly impacts NEE's financial obligations and liquidity, as the inability to obtain capital could affect XPLR's cash distributions to NEE and potentially require NEE to support its subsidiary's financing needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying the risk to NEE's liquidity and financial obligations due to XPLR's potential inability to access capital. It accurately quotes the source document, supporting the claim that limited partner interest value could be materially impaired. The impact on cash distributions to NEE is correctly noted, which aligns with the ground truth. However, the LLM answer omits a key element present in the original answer: the dilution risk from XPLR issuing additional common units or converting securities, which would reduce NEE's share of future distributions. This is a significant aspect of the financial impact on NEE’s cash flows and thus a partial omission in completeness. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are involved and no false calculations made), and the reasoning is sound where present. The answer synthesizes the core risk correctly but misses one multi-hop element (dilution via unit issuance), slightly weakening the qualitative accuracy. Contextual relevance is strong as it directly addresses the question’s focus on financial obligations and liquidity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 335,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "The fair value of mortgage‑backed obligations reported in the “Marketable securities” section is $236 million (shown as $236 in the Level‑2 fair‑value hierarchy table), while the “Fair Value” column of the marketable securities table lists the same amount as $236 million. Thus, the two figures are identical – there is no difference between them.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. According to the ground truth, the fair value in the 'Marketable securities' section is $178, and in the 'Fair Value' column it is $236, resulting in a difference of $58. The LLM incorrectly states both values are $236 million, claiming no difference. This contradicts the original answer and misrepresents the data. (2) The quantitative values are wrong: LLM reports $236 for both, but ground truth shows $178 and $236. The difference should be $58, not $0. Even allowing for format variations, the numbers themselves are factually inaccurate. (3) The reasoning is flawed: the model fails to recognize a multi-hop requirement—comparing two different reported values from two sections. Instead, it incorrectly asserts they are the same, showing a failure in synthesis. (4) Scores are low because the core of the question—a comparison between two figures—is completely incorrect. The answer is contextually relevant in structure (discussing the right sections and metric), hence a minimal score for contextual relevance, but fails on all factual and reasoning dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 319,
        "total_tokens": 1479
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "The 10‑K shows that Google’s non‑advertising revenues (from Google Play, hardware, YouTube subscriptions, Cloud, and Other Bets) are growing and are recorded on a net basis when Google acts as an agent for app sales and in‑app purchases. Because these revenues carry lower margins than Google’s advertising revenues, their rising share puts downward pressure on overall profitability. The filing notes that “the margins on these revenues vary significantly and may be lower than the margins on our advertising revenues,” and that the increasing proportion of non‑advertising revenue therefore adversely affects consolidated margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Google Play revenues are reported on a net basis due to Google's role as an agent, which reduces reported revenue—this matches the original answer's explanation. (2) There are no numeric values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is sound: it connects revenue recognition method (net reporting) to the impact on non-advertising revenues and explains how the lower margins of these growing revenue streams affect overall profitability. (4) The LLM adds contextual detail not in the original—specific examples of non-advertising revenue streams (hardware, YouTube subscriptions, Cloud, Other Bets)—which is factually consistent with Google’s 10-K disclosures and enhances completeness without introducing error. The only minor shortcoming is that it slightly expands beyond Google Play to broader non-advertising revenues without explicitly anchoring all statements back to Google Play as the question focuses on, but this does not detract significantly from correctness. Overall, the semantic meaning, factual content, and reasoning are equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 365,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, the total committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023 were $0.8 billion (as disclosed in Note 11 under \"Nonconsolidated VIEs\" on page 78, which states \"inclusive of $0.8 billion and $1.4 billion in committed capital contributions to Ultium Cells Holdings LLC at December 31, 2023 and 2022\"). This compares to $1.4 billion in 2022, indicating a decrease of $0.6 billion from the previous year. The document confirms these contributions were part of GM's maximum exposure to loss related to nonconsolidated VIEs, specifically tied to its involvement with Ultium Cells.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the committed capital contributions of $0.8 billion in 2023 and $1.4 billion in 2022 are accurately reported, and the year-over-year decrease of $0.6 billion is correctly calculated. Minor formatting such as '$0.8 billion' vs '$800 million' is semantically equivalent and acceptable. (2) The answer is complete, addressing both parts of the question: the 2023 commitment and the comparison to the previous year. (3) Entity accuracy is correct—General Motors, Ultium Cells Holdings LLC, and the relevant years (2023 and 2022) are properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis by extracting and comparing two data points from the same note (Note 11, page 78) to derive the year-over-year change. The additional context about VIEs and exposure to loss supports the answer without introducing inaccuracies. Overall, the LLM answer is factually precise, logically structured, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 300,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "Based on the provided 10-K filing pages, Mastercard paid a total cash consideration of **$2.8 billion** for all acquisitions in 2024, which includes the $2.7 billion cash outlay for the RF UlEmate Parent, Inc. (Recorded Future) acquisition. Of that $2.8 billion total, **$1.7 billion was recorded as goodwill** on the balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: total cash consideration of $2.8 billion in 2024 for all acquisitions, including RF UlEmate Parent, Inc., and $1.7 billion attributed to goodwill. (2) Quantitative accuracy is perfect: the numbers $2.8 billion and $1.7 billion match exactly, and the additional detail that $2.7 billion of the total was for RF UlEmate (Recorded Future) is consistent with the total when combined with other smaller acquisitions. (3) Multi-hop reasoning is sound—the model correctly synthesized that the total cash consideration includes the RF UlEmate acquisition and that goodwill is a portion of that total. (4) The answer is semantically equivalent to the original, with added contextual clarity (e.g., naming Recorded Future as a known alias) without introducing errors. All entities (Mastercard, RF UlEmate Parent, Inc., 2024, goodwill) are correctly identified and placed in the right context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 281,
        "total_tokens": 1425
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "The UNP 10‑K does not provide a specific dollar amount for freight‑car lease buyouts over the 2022‑2024 period; the only related figure disclosed is that lease‑buyout costs of $143 million were included in 2024 capital investments, $57 million in 2023 and $70 million in 2022.  The company’s 2025 capital plan calls for roughly $3.4 billion of total capital spending, which includes investments to acquire freight cars to replace older equipment and support growth, but it does not quantify how much of that $3.4 billion will be devoted specifically to lease buyouts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all dollar amounts for freight car lease buyouts: $70M in 2022, $57M in 2023, and $143M in 2024, matching the ground truth exactly. The total of $270M is implied by listing the individual yearly figures, though it is not explicitly summed—this is a minor omission but does not detract from factual accuracy. (2) All numbers are quantitatively accurate and correctly attributed to the right years. The $3.4 billion 2025 capital plan is correctly cited, and the LLM accurately notes that the plan includes freight car acquisitions for replacement and growth, aligning with the ground truth. It also correctly states that the specific allocation for lease buyouts in 2025 is not disclosed, which is consistent with the original answer. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and connects past spending behavior to future capital planning. It correctly infers alignment in strategic intent (asset replacement and growth) even without explicit 2025 lease buyout figures. (4) The answer is contextually complete and highly relevant. The only reason for not scoring a perfect 10 is the lack of an explicit sum ($70M + $57M + $143M = $270M), which was directly stated in the ground truth. However, since all components are present and no incorrect claims are made, the correctness score remains high at 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 387,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "Based on the disclosed forward contract amounts and initial treasury stock transactions under the 2021 Repurchase Program, the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation in 2022 and 2023 was $1.5 billion (2022) and $2.0 billion (2023), for a combined total of $3.5 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $1.5 billion ASR in 2022 and $2.0 billion ASR in 2023, with a combined total of $3.5 billion, matching the ground truth exactly. (2) All numeric values are accurate and properly formatted; the sum ($1.5B + $2.0B = $3.5B) is correct. (3) The multi-hop reasoning is sound—information from both 2022 and 2023 transactions is synthesized correctly under the 2021 Repurchase Program, demonstrating proper cross-year and cross-transaction understanding. (4) The answer is semantically equivalent to the original, conveys the same information clearly, and fully addresses the question with no omissions or inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 225,
        "total_tokens": 1425
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "GM’s near‑term profitability still depends heavily on high‑margin full‑size ICE trucks and SUVs, which generate the cash needed to fund its EV rollout. However, the forward‑looking risk disclosures warn that accelerating EV adoption, tightening emissions regulations, and the uncertain commercialization of autonomous‑vehicle technologies could erode demand for those ICE models and increase costs, creating a tension between the current cash engine and the long‑term strategic shift toward electric vehicles that could jeopardize financial stability if EV profitability and market adoption do not materialize as expected.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core dynamic described in the ground truth: GM's reliance on high-margin ICE trucks to fund its EV transition, and the risk that declining demand for these vehicles—due to market or regulatory shifts—could undermine both short-term profitability and long-term strategic goals. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, all qualitative facts are correct. (2) The LLM correctly identifies the key entities: GM, full-size ICE trucks/SUVs as cash generators, EV strategic shift, and forward-looking risks. (3) The multi-hop reasoning is sound: it connects current profitability sources to future investment needs and highlights the tension if ICE revenues decline before EVs become profitable. The only minor gap is that the original answer specifically mentions 'shift in consumer preferences toward smaller, more fuel-efficient vehicles' as a risk, while the LLM cites 'accelerating EV adoption' and 'emissions regulations'—which are valid but slightly different risk drivers. This does not invalidate the answer but represents a subtle shift in emphasis. (4) The LLM answer is contextually excellent, directly addressing the interaction between ICE dependency and EV strategy and its impact on long-term financial stability. Overall, the semantic meaning and factual content align closely with the ground truth, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 403,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "The uncertainty surrounding the pace of the energy transition—driven by volatile commodity prices and evolving regulatory frameworks—directly influences Chevron’s asset impairment assessments and upstream investment strategies. Management evaluates reserves, cash‑flow models, and projected commodity price outlooks that incorporate assumptions about the speed of decarbonization; any significant downward revision to reserves or price outlook can trigger impairment reviews and may curtail capital spending on upstream projects. Consequently, periods of low prices or heightened regulatory pressure can lead to write‑downs of proved properties and a more cautious approach to new upstream development.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) It correctly identifies that uncertainty in the energy transition—driven by commodity prices and regulation—affects Chevron's asset impairment assessments and upstream investment decisions, which aligns with the original answer. (2) There are no specific numeric values, dates, or financial figures in either response, so quantitative accuracy is not applicable; however, the absence of incorrect numbers supports a full score. (3) The multi-hop reasoning is sound: the LLM connects energy transition uncertainty to commodity price forecasting, cash flow modeling, reserve evaluations, and ultimately impairment reviews and capital spending decisions—mirroring the causal chain in the ground truth. It correctly emphasizes that downward revisions in price or reserves can trigger impairments and reduce upstream investment. (4) The only minor gap is that the LLM does not explicitly mention the impact on Chevron’s ability to invest in lower-carbon energy solutions, which is a secondary but relevant point in the original answer. Otherwise, all key elements—impairment triggers, upstream cash flows, regulatory pressure, and capital expenditure caution—are accurately conveyed. The response is fully contextually relevant and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 369,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "Mastercard's Consumer Engagement Services—encompassing security solutions, consumer acquisition and engagement, and data-driven insights—directly strengthen its global payments network by enhancing customer value and driving transaction volume. These services, integrated with its payment network and commercial payment flows (e.g., Mastercard Move), generate revenue through value-added offerings while supporting network growth, as evidenced by its strategic priorities of expanding consumer and commercial payment capabilities and leveraging data/AI to improve engagement and network effects. This integrated approach underpins its financial performance, contributing to net revenue growth and operational efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth. It correctly identifies that Mastercard's Consumer Engagement Services strengthen the global payments network by enhancing customer value, driving transaction volume, and leveraging data—consistent with the original answer's emphasis on secure data use, consumer/merchant retention, and network effects. The mention of integrated offerings like Mastercard Move and strategic priorities around data/AI aligns with the interdependent suite of services described in the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis: linking consumer engagement to network growth, transaction flows, and financial performance. The only minor gap is that the LLM answer introduces specific program names (e.g., Mastercard Move) and strategic initiatives not explicitly mentioned in the ground truth, which, while plausible and contextually appropriate, are not verifiable from the provided knowledge graph. This does not constitute an error but adds detail beyond the source, slightly affecting qualitative precision. Overall, the answer is comprehensive, relevant, and conveys the same core message: Consumer Engagement Services boost network utility and financial performance through data-driven value creation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 390,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025 is **$0.4 billion**. This represents the initial acquisition cost of $0.4 billion paid in fiscal 2023 to buy out the noncontrolling interest in Alert Innovation (as noted on page 44: \"During fiscal 2023, we completed a $0.4 billion buyout of the noncontrolling interest shareholders of our Massmart subsidiary and completed a $0.4 billion acquisition of Alert Innovation\"). The subsequent sale and deconsolidation of Alert Innovation in fiscal 2025 did not generate a cash inflow that offset this initial outflow in the context of the question's focus on the *net cash impact* of the acquisition and sale sequence. The document does not specify a cash inflow from the sale itself, but the acquisition cost is explicitly stated as $0.4 billion in fiscal 2023. Thus, the net cash outflow tied to this transaction over the two fiscal years (2023 acquisition and 2025 deconsolidation) is $0.4 billion. \n\n(Word count: 149)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key financial figure of $0.4 billion as the net cash outflow, matching the ground truth. The acquisition cost in fiscal 2023 is accurately cited from the document (page 44), and the absence of a cash inflow from the deconsolidation in fiscal 2025 is correctly inferred, leading to the conclusion that the net impact remains $0.4 billion. (2) Quantitatively, the $0.4 billion figure is correct and consistently used; no calculations are required beyond recognizing that no offsetting inflow occurred, which aligns with the ground truth. Format is consistent and accurate. (3) The multi-hop reasoning is sound: the model connects the acquisition in fiscal 2023 with the deconsolidation in fiscal 2025 and synthesizes the net effect across years. However, there is a minor error in the LLM's citation — it incorrectly references the $0.4 billion buyout of noncontrolling interest in Massmart as if it were part of the Alert Innovation acquisition, when in fact these are two separate $0.4 billion transactions mentioned consecutively in the filing. Despite this confusion in explanation, the correct amount is still attributed to Alert Innovation’s acquisition. This does not affect the final answer but slightly undermines the reasoning clarity. (4) The answer is contextually fully relevant, directly addressing the net cash outflow impact across the specified fiscal years and focusing on the correct entities and events. The conclusion is factually aligned with the ground truth, warranting a high correctness score despite the minor misstatement in supporting detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 443,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023 is 0 units, because the disclosure states that “no securities had a material dilutive effect” for 2023 (and prior years). Consequently, no adjustment was made to net income attributable to common stockholders since the potentially dilutive securities would not have altered earnings per share.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that no adjustment was made to net income attributable to common stockholders because the potentially dilutive securities had no material dilutive effect, which aligns with the ground truth. However, the LLM states the combined total is '0 units', which is not explicitly supported by the original answer — the ground truth does not specify a numerical total but rather describes the composition of potentially dilutive securities (LTIP Units and exchangeable units). While the implication of 'no material dilutive effect' may lead to exclusion from diluted EPS calculations, asserting the total as 0 units goes beyond the information provided and introduces a quantitative claim not present in the original. (2) There are no explicit numbers in the ground truth to verify calculations against, but the LLM fabricates a precise figure (0 units) that is not stated or implied in the original answer, which only discusses the lack of materiality. This affects quantitative accuracy despite the conceptual alignment. (3) The multi-hop reasoning is partially sound — the model connects LTIP Units and exchangeable units to dilutive securities and correctly infers no adjustment due to lack of materiality. However, it overreaches by quantifying the total as zero instead of acknowledging the absence of a disclosed quantity. (4) Scores reflect high contextual relevance and mostly accurate reasoning, but docking for introducing an unsupported specific number and slight misrepresentation of the original answer’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 429,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "The total value of investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ is $5 million. This amount is disclosed under “Investments measured at NAV” in the postretirement benefit plans table on page 93, and it is reported alongside total investments at fair value of $461 million (Level 1 $386 million, Level 2 $75 million, Level 3 $0 million). Thus, the NAV‑measured investments represent a small fraction of the overall fair‑value portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its quantitative claims. The total value of Investments measured at NAV is stated as $5 million, but the ground truth is $14 million ($9 million + $5 million from two categories). The LLM only reports the second category and omits the first entirely. Additionally, the total investments at fair value are reported as $461 million, which matches only the second category in the ground truth; however, the correct total is $902 million ($441 million + $461 million). The LLM fails to sum across both categories, missing half the data. (2) Calculations are therefore also incorrect: the LLM does not compute or mention the 3.1% ratio of NAV-measured investments to total fair value, which requires correct totals. Even if implied, the fraction would be wrong based on incorrect inputs. (3) The multi-hop reasoning is flawed—the question requires aggregating two disclosed asset categories, but the LLM only identifies one. It fails to synthesize information across both categories, indicating a failure in multi-hop logic. (4) Contextual relevance is moderate because the answer refers to the correct document (VZ 2023 10-K), correct section (postretirement benefit plans), and correct metric (NAV vs. fair value), but it uses incomplete data. While the terminology and structure are appropriate, the factual core is inaccurate, warranting low scores in correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 404,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "In 2023, GM reported $293 million of equity earnings from its investment in Ultium Cells Holdings LLC. These earnings were disclosed in the consolidated financial statements under “Equity in net assets of nonconsolidated affiliates” within the segment reporting tables, specifically in the notes summarizing equity income from non‑consolidated affiliates.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the equity earnings amount of $293 million from Ultium Cells Holdings LLC in 2023, matching the ground truth exactly. This satisfies the quantitative accuracy requirement. However, the financial statement category is incorrect. The ground truth states that these earnings were disclosed under 'Automotive and other cost of sales', whereas the LLM claims they were reported under 'Equity in net assets of nonconsolidated affiliates' in segment reporting notes. These are distinct line items with different meanings—'Equity in net assets' relates to balance sheet presentation or equity method accounting disclosures, while 'Automotive and other cost of sales' is an income statement category where GM actually netted the equity earnings as a reduction in cost of sales. (2) The number $293 million is accurate and correctly attributed to GM, Ultium Cells Holdings LLC, and the fiscal year 2023. No calculation errors. (3) The multi-hop reasoning is partially sound—the model correctly links GM to Ultium Cells and retrieves the correct equity earnings figure—but fails in the second hop by misidentifying the financial statement category. This suggests a failure to accurately extract or interpret the specific disclosure location from the 10-K. (4) The correctness score is 6 due to one major factual error in the disclosure category despite correct numerical data. Quantitative accuracy is 10 because all numbers are correct. Qualitative accuracy is 5 due to the significant mischaracterization of the financial statement treatment. Contextual relevance is 8 because the answer addresses the core entities and question intent, albeit with a key error in financial reporting classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 472,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "The equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) fell from **0.8 % in 2023 to 0.7 % in 2024**. This modest decline reflects a continued reduction in the share of Class B stock held by these customers, while the overall ownership structure remains dominated by public investors (≈ 89.9 % equity ownership) and the Mastercard Foundation (≈ 9.3 % equity ownership).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the change in equity ownership of Principal or Affiliate Customers (Class B stockholders) from 0.8% in 2023 to 0.7% in 2024, matching the ground truth exactly. The reduction of 0.1 percentage points is implied by the stated values and is factually accurate. (2) All numeric values—0.8%, 0.7%, and the implied 0.1 percentage point decrease—are correct. The additional context about public investors (~89.9%) and the Mastercard Foundation (~9.3%) is consistent with typical ownership structure disclosures and does not contradict the ground truth; it enhances the answer without introducing inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change over time (2023 to 2024) and interprets the trend as a 'continued reduction,' which is a reasonable qualitative inference. While the original answer does not include the breakdown of other ownership groups, the LLM’s inclusion of this context is relevant and accurate, improving completeness without distorting facts. (4) The answer is semantically equivalent and slightly more informative than the ground truth. The only reason for not scoring a 10 is that the original answer does not mention the 'continued reduction' phrasing or the broader ownership breakdown, so while plausible, those additions are interpretive. However, they do not detract from correctness. All core requirements of the question are met with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 404,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "The total financial impact on Walmart related to Alert Innovation during fiscal 2023 was a $0.4 billion cash outlay for the acquisition of the entity. In the following fiscal year (fiscal 2025), this entity was sold and de‑consolidated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion cash outflow for Walmart's acquisition of Alert Innovation in fiscal 2023, which matches the ground truth. It also accurately states that the entity was sold and de-consolidated in the following fiscal year, which is correctly identified as fiscal 2025. (2) Quantitatively, the $0.4 billion figure is accurate and properly formatted; no calculations are required beyond correct identification of the amount and years. (3) The multi-hop reasoning is sound: the model correctly links Walmart’s acquisition in fiscal 2023 to the subsequent divestiture in fiscal 2025, synthesizing events across two fiscal years and two transactions (acquisition and deconsolidation). (4) The only minor issue is the phrasing 'following fiscal year (fiscal 2025)'—while fiscal 2025 is indeed when the sale occurred, it is not the immediate 'following' year after 2023 (fiscal 2024 would be); however, given that the ground truth confirms the sale occurred in fiscal 2025, and the LLM correctly reports that without implying immediacy in time, this is a permissible interpretation. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to potential ambiguity in temporal phrasing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 370,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "The 2021 Multicurrency Credit Facility was used to repay $1.0 billion of the 5.00% senior notes on February 14 2024, and to repay $500 million of the 0.600% senior notes on January 12 2024. After these repayments, the facility’s remaining borrowing capacity as of December 31 2023 was approximately $723.4 million (the outstanding principal balance under the facility).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total principal repaid ($1.5 billion: $500 million from 0.600% Notes and $1.0 billion from 5.00% Notes) and the timing of the repayments (January 12 and February 14, 2024), which aligns with the ground truth. However, it incorrectly states the remaining borrowing capacity under the 2021 Multicurrency Credit Facility as of December 31, 2023. The LLM claims it was approximately $723.4 million, which appears to reflect an outstanding balance rather than the available capacity. In contrast, the ground truth states that the company still had the ability to borrow up to $6.0 billion, with specific sublimits. This is a major factual error. (2) Quantitative accuracy is partially correct on repayment amounts and dates but severely flawed on the remaining capacity figure. The $723.4 million figure contradicts the $6.0 billion available capacity and suggests a fundamental misunderstanding of facility capacity vs. drawn amounts. (3) The multi-hop reasoning fails at the synthesis step: while the model correctly links the facility to the repayment of both notes, it incorrectly infers the remaining borrowing capacity, possibly confusing 'outstanding balance' with 'remaining capacity.' The original answer clearly states the undrawn capacity, not the drawn amount. (4) Contextual relevance is high because the answer addresses both parts of the question and uses correct entities (facility name, note types, dates). However, the critical error in the borrowing capacity undermines the correctness. Correctness score is low due to this major factual inaccuracy, despite correct repayment details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 452,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "Intel’s roadmap advances from the EUV‑enabled Intel 4 node (used for Meteor Lake) to Intel 3, which adds further FinFET optimizations and more EUV to boost performance‑per‑watt and area efficiency. The next node, Intel 20A, introduces the Ribbon FET (gate‑all‑around) and PowerVia backside power delivery, and is followed by Intel 18A, which will incorporate High Numerical Aperture (High‑NA) EUV as part of the progression toward more advanced transistor architectures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Intel 4 uses EUV for Meteor Lake; Intel 3 builds on it with more EUV and FinFET optimizations; Intel 20A introduces RibbonFET and PowerVia; Intel 18A will incorporate High Numerical Aperture (High-NA) EUV. (2) There are no numeric values requiring calculation, but all process node names (Intel 4, Intel 3, Intel 20A, Intel 18A) are correctly identified and sequenced—these are critical identifiers and match the original. (3) The multi-hop reasoning is sound: the answer traces the progression from current EUV use in Intel 4/3 to future transistor architectures (RibbonFET, PowerVia) and correctly identifies Intel 18A as the node introducing High-NA EUV. (4) Minor wording differences exist (e.g., 'Ribbon FET' vs 'RibbonFET'), but this does not affect factual accuracy. The LLM omits the explicit mention of 'performance-per-watt' and 'area efficiency' improvements in Intel 3, but does reference them indirectly via 'boost performance-per-watt and area efficiency'. Overall, the answer is semantically equivalent and factually correct, warranting a 9/10 due to slight compression of detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 341,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "Based on the disclosed asset categories in the 2023 10-K filing (page 93), the total fair value of investments in U.S. Treasuries and agencies for the other postretirement benefit plans is **$138 million**. This amount is part of the $461 million total investments at fair value, and it is separate from the cash and cash equivalents balance of **$27 million** reported for those same plans. Consequently, the combined value of U.S. Treasuries and agencies ($138 million) is **significantly larger** than the cash and cash equivalents ($27 million) for the disclosed categories.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses a key component of the multi-hop synthesis required. It correctly identifies $138 million as the amount invested in U.S. Treasuries and agencies for the other postretirement benefit plans, but fails to include the additional $101 million from the other disclosed asset category (pension plans), which is necessary to compute the total combined value of $239 million. The cash and cash equivalents figure is partially correct at $27 million, but this only reflects the amount for the postretirement benefit plans and omits the $30 million from pension plans, which totals $57 million in the ground truth. (2) Quantitatively, the individual numbers cited ($138M and $27M) are accurate as reported in the filing, but the answer does not sum across both disclosed categories as required. The comparison conclusion that Treasuries/agencies exceed cash is directionally correct, but the magnitude is misrepresented due to incomplete aggregation. (3) The reasoning is flawed in terms of multi-hop synthesis: the question asks for totals 'across both disclosed asset categories' (pension and other postretirement), but the LLM only considers one category. This represents a failure to fully synthesize across all relevant disclosures. (4) Scores reflect partial factual accuracy (quantitative accuracy 5), incomplete reasoning (qualitative accuracy 5), and high relevance to the topic (contextual relevance 8), but the correctness score is low (4) because the core requirement—aggregating across both categories—was not met, leading to an incomplete and misleading answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 445,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "The total net cash consideration paid by Danaher for Aldevron and the other 11 businesses acquired in 2021 was $1.3 billion, as disclosed in the \"Net cash consideration\" row of the table summarizing the 2021 acquisitions ($1.3 billion). Of the total goodwill recorded for these acquisitions ($1.0 billion), approximately $6.1 billion was attributed specifically to the Aldevron acquisition, as shown in the \"Goodwill\" line of the same table ($6,149 million for Aldevron versus $1,038 million for the other 11 businesses combined).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains major factual and quantitative errors. (1) Total net cash consideration is severely understated: the LLM claims $1.3 billion total, but the ground truth is $10,901 million ($10.9 billion), with $9,561 million for Aldevron alone and $1,340 million for the other 11 businesses. The LLM incorrectly states the total net cash consideration as $1.3 billion, which appears to conflate the amount for the other 11 businesses (rounded) with the total. (2) Goodwill figures are partially correct but mischaracterized: the LLM correctly identifies $6,149 million attributed to Aldevron, but incorrectly states total goodwill as $1.0 billion when it should be $7,187 million. It also mentions $1,038 million for the other 11 businesses, which is plausible but not in the ground truth provided, suggesting potential hallucination or misattribution. (3) Multi-hop reasoning fails: the model does not correctly synthesize the total cash consideration across both Aldevron and the other 11 businesses, and misrepresents the scale of the transaction. (4) While the answer attempts to address both parts of the question and references a table (contextually appropriate), the core numbers are factually wrong, undermining the response. Minor credit is given for correctly identifying the $6,149 million goodwill attributed to Aldevron. Overall, the answer is mostly incorrect due to severe numerical inaccuracies and failed synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 396,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "As of December 31 2023, GM’s total committed capital contribution to Ultium Cells Holdings LLC was **$800 million**, while the carrying amount of GM’s investment in Ultium Cells Holdings LLC reported on its balance sheet was **$2.268 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies GM's committed capital contribution as $800 million and the carrying amount as $2.268 billion, both of which match the ground truth values ($0.8 billion = $800 million; $2,268 million = $2.268 billion). The formatting differs slightly but the numeric values are semantically equivalent. 2) Quantitatively, all numbers are accurate: $800 million committed and $2.268 billion carrying amount. The comparison is implied by stating both figures, allowing the reader to infer that the carrying amount exceeds the committed amount, which aligns with the ground truth interpretation. 3) The reasoning is sound—by presenting both figures, the model enables the correct inference that GM’s investment carrying amount exceeds its committed capital, suggesting prior funding beyond current commitments or valuation adjustments. However, the LLM does not explicitly state the conclusion that GM had not fully funded its commitment (or the inverse), which is a minor omission in qualitative reasoning. 4) Contextual relevance is perfect—the response directly answers both parts of the question with precise figures and correct entities (GM, Ultium Cells Holdings LLC, December 31, 2023). Only the lack of explicit comparative reasoning prevents a full 10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 366,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "The depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 totaled $5,729 million, which is lower than the net book value of proved and unproved properties in that region—$74,014 million as of December 31, 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2023 depreciation, depletion, amortization, and impairments amount as $5,729 million, which matches the ground truth. However, it incorrectly states the net book value of proved and unproved properties as $74,014 million, which is actually the original total property value, not the net book value. The correct net book value as of December 31, 2023, is $37,185 million. This is a significant factual error. (2) The quantitative accuracy is partially correct—only one of the two key numbers (the $5,729 million) is accurate; the second number ($74,014 million) is misattributed. The comparison 'lower than' is technically true since $5,729M < $74,014M, but it's based on a wrong interpretation of the net book value, making the comparison misleading. (3) The multi-hop reasoning is flawed: the model fails to incorporate the accumulated depreciation ($36,829 million) or explain how net book value is derived (original value minus accumulated depreciation). It also misses the synthesis that adding 2023's charge to prior accumulated DDA reaches $42,558 million, which is relevant context. (4) The contextual relevance is high because the answer addresses the core elements of the question—2023 DDA and net book value—but the qualitative accuracy suffers due to incorrect entity mapping (confusing original cost with net book value) and incomplete reasoning. Hence, partial credit is given.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 398,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "The company repaid a total of $6.1 billion of revolving indebtedness under the 2021 Multicurrency Credit Facility during 2023, which included €842.6 million ($919.1 million) of borrowings used to settle the facility. This repayment reduced the outstanding balance of the facility to $723.4 million as of December 31, 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the total repayment of $6.1 billion under the 2021 Multicurrency Credit Facility in 2023, including the EUR-denominated repayment of €842.6 million, converted to $919.1 million, which matches the ground truth exactly. All numeric values—$6.1 billion total repayment, €842.6 million, and $919.1 million—are factually accurate and properly contextualized. (2) Quantitative accuracy is perfect: the numbers align with the original answer, and the currency conversion is correctly represented. (3) The reasoning is mostly sound, but the LLM adds a detail not present in the ground truth: that the outstanding balance was reduced to $723.4 million as of December 31, 2023. While consistent with the idea of reduced indebtedness, this specific figure is not mentioned in the original answer and introduces unverified information. Additionally, the LLM frames the EUR repayment as 'borrowings used to settle the facility,' which slightly mischaracterizes the original answer’s intent—these were repayments of existing EUR-denominated borrowings, not new borrowings to settle. The core multi-hop synthesis—linking USD and EUR repayments into a total and connecting it to reduced revolving indebtedness—is correct. (4) The answer is highly relevant and factually strong, but the addition of an unsupported balance figure and slight miswording on the use of funds prevent a perfect score. Thus, correctness is 8 due to minor overprecision and minor misrepresentation, despite full quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 424,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 requires the company to develop and obtain regulatory approval for site-specific coal ash impoundment closure plans, which include excavating and moving coal ash to lined landfills or for beneficial reuse. This regulatory framework directly impacts operational costs and closure activities by necessitating significant capital expenditures for excavation, transportation, and disposal, while also influencing cost recovery through retail rate cases and wholesale rate adjustments approved by state utility commissions and FERC.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying the impact of the North Carolina Coal Ash Management Act of 2014 on Duke Energy's operational costs and closure activities. It accurately reflects that compliance involves site-specific closure plans, excavation, movement of coal ash to lined landfills or for reuse, and that these activities entail significant capital expenditures. It also correctly notes cost recovery mechanisms through retail rate cases and FERC-approved wholesale rate adjustments, aligning with the original answer's mention of FERC-approved amended wholesale contracts in 2017. All entities (Duke Energy, North Carolina Coal Ash Management Act of 2014, FERC) and regulatory processes are correctly identified. There are no numeric inaccuracies—while no specific dollar amounts or site counts are mentioned in the LLM response, the absence does not constitute an error because the original answer's quantitative elements (e.g., three of four high-priority sites completed) are not strictly necessary to convey the core regulatory and financial impact. However, the LLM omits specific progress details (completion at three of four high-priority sites) and does not reference the glossary's role in defining the Coal Ash Act, which was part of the multi-hop requirement (glossary + business section). This minor omission in completeness and synthesis across both referenced sections prevents a perfect score, but the overall reasoning, factual accuracy, and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 421,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "Intel’s Agilex FPGA family, built on the 10 nm SuperFin process, provides the programmable logic and high‑performance transceivers that power the company’s IPU platforms, allowing cloud and communications providers to off‑load infrastructure workloads from CPUs and achieve lower total cost of ownership. The Intel eASIC N5X structured‑ASIC device complements this by offering a lower‑cost, lower‑power alternative to Agilex FPGAs for 5G‑focused acceleration, enabling faster time‑to‑market and reduced engineering expense in the same IPU‑centric ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Agilex FPGAs are built on Intel's 10nm SuperFin technology (correctly stated as '10 nm SuperFin process'), used in IPU platforms to offload CPU workloads, and deployed with cloud providers. The role of eASIC N5X as a lower-cost, lower-power structured ASIC alternative is accurately described, including benefits like reduced NRE and faster time-to-market. (2) There are no numeric values requiring calculation, and all technical specifications (e.g., process node) match the original. (3) Multi-hop reasoning is sound—linking Agilex FPGAs to IPU platforms, then connecting eASIC N5X as a complementary technology in the same ecosystem for infrastructure acceleration, particularly in 5G and cloud contexts. (4) The only minor deviation is the specific mention of '5G-focused acceleration' for eASIC N5X, which is plausible but not explicitly stated in the ground truth; the original emphasizes general cloud and communications use. This adds slight specificity beyond the source but does not contradict it. Overall, the answer is semantically equivalent, technically precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 345,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "Danaher has approximately 16,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing about 6.7% of its total global workforce of roughly 63,000 employees.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Danaher has 3,000 employees in Other Developed Markets, but the LLM incorrectly states 16,000—a major discrepancy. The North America employee count (24,000) is correct. The total global workforce (63,000) is accurately cited, but the collective percentage is severely miscalculated: the LLM states 6.7%, while the correct value is approximately 42.86%. (2) Calculation verification: (3,000 + 24,000) / 63,000 = 27,000 / 63,000 ≈ 42.86%. The LLM’s 6.7% is inconsistent with both its own numbers (40,000 / 63,000 ≈ 63.5%, not 6.7%) and the truth, indicating a possible calculation or data retrieval error. (3) Multi-hop reasoning is partially present—regions and total workforce are referenced—but the synthesis fails due to incorrect input data. The model does not correctly retrieve or align the employee numbers across regions. (4) Scores reflect mostly incorrect quantitative data (2/10), poor reasoning due to wrong inputs (3/10), and moderate contextual relevance as the structure and intent align with the question despite factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 325,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "As of May 31 2023, the total fair value of Nike’s foreign‑exchange forwards and options was **$557 million** (shown as “Foreign exchange forwards and options (1)” in the derivative‑assets table). This $557 million is also the total amount reported as derivative assets on the balance sheet for that year, matching the “TOTAL DERIVATIVE ASSETS” figure of $557 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the value of $557 million is accurately reported for both the fair value of foreign exchange forwards and options and the total derivative assets as of May 31, 2023. The date and dollar amount are correct, with acceptable formatting (e.g., $557 million). (2) The answer is complete, addressing both parts of the question: the total fair value of the derivatives and how it compares to the total derivative assets. (3) Entity accuracy is correct—Nike, the correct fiscal date (May 31, 2023), and the proper financial instruments (foreign exchange forwards and options) are all correctly identified. (4) The reasoning is sound: the LLM correctly infers that the $557 million in foreign exchange derivatives equals the total derivative assets, implying these instruments constitute the entirety of the derivative assets, which aligns with the ground truth's conclusion. (5) The semantic meaning is equivalent to the original answer, with clear, precise, and relevant explanation. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 318,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region rose from $4,854 million in 2022 to $5,729 million in 2023, an increase of $875 million. Over the same period, the number of productive wells in the Lower 48 grew from 6,954 gross (5,786 net) in 2022 to 14,251 gross (7,864 net) in 2023, reflecting an increase of 7,297 gross wells (2,078 net wells).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively: The ground truth states that the depreciation, depletion, amortization, and impairments (DD&A + impairments) expense in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, a correct increase of $1,662 million. The LLM incorrectly reports the starting point as $4,854 million in 2022 (not 2021), calculates an increase of only $875 million over a one-year period, and ignores the required 2021–2023 comparison. (2) The number of productive wells in the Lower 48 region decreased from 87 in 2021 to 38 in 2023 (a drop of 49), but the LLM claims a massive increase from 2022 to 2023 in both gross and net wells (from 6,954 to 14,251 gross), which contradicts the ground truth and uses implausible numbers (e.g., 87 wells in 2021 growing to over 14,000 in 2023 is inconsistent). (3) The reasoning fails on multiple levels: it uses the wrong years (2022–2023 instead of 2021–2023), reports incorrect values for both expenses and well counts, and does not perform the correct multi-hop synthesis across the required time frame and region. (4) The entities (Lower 48 region) and metric (DD&A + impairments, productive wells) are correctly identified, but all data is factually wrong. The answer is contextually relevant in topic but fails on factual accuracy, completeness, and correct temporal scope, warranting a very low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 391,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "The total combined fair value of U.S. Treasuries and agencies reported in the postretirement benefit plans is $138 million (2023) and $101 million (2022), which together represent the fixed‑income portion of the investments at fair value. Across the two categorizations—pension plans and other postretirement benefit plans—the allocation of these securities is essentially the same, with the securities classified under “Fixed income securities” (U.S. Treasuries and agencies) in both tables, showing comparable amounts and levels of valuation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to address the question properly. (1) Quantitatively, the numbers provided ($138 million and $101 million) are wrong and do not match the ground truth values of $1,412 million and $1,541 million from the two tables. The total combined value is stated as only $138 million in 2023, ignoring the second table entirely, whereas the correct sum is $2,953 million. (2) The LLM incorrectly frames the data as being from 'postretirement benefit plans' and mentions 2022, which is irrelevant to the question about the 2023 10-K and the combined value across both tables. (3) The reasoning is flawed: it fails to recognize that the two tables report overlapping or different categorizations of fair value investments, not pension vs. postretirement plans. It also misses the Level 1/Level 2 breakdowns entirely—stating only $138 million without context—while the ground truth specifies $1,274M/$138M and $1,312M/$229M across levels. (4) The answer misidentifies the entities and context, suggesting the values are split across benefit plans when the original answer refers to two fair value hierarchy tables. The comparison between categorizations is completely misrepresented. The LLM appears to have hallucinated a narrative around postretirement plans rather than analyzing the correct investment tables. Due to massive factual, numerical, and contextual errors, the scores are very low, with minimal credit for mentioning 'fixed income securities' and 'Level 1/Level 2' concepts, albeit incorrectly applied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 425,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "Based on the provided pages, Nike's timed deposits classified as cash and equivalents decreased by $160 million from fiscal year 2023 to 2024. This is calculated from the cash and equivalents figures in the fair value measurements table: $1,222 million as of May 31, 2024 (fiscal 2024) compared to $1,767 million as of May 31, 2023 (fiscal 2023), resulting in a $545 million decrease in total cash and equivalents. However, the specific \"timed deposits\" component within cash and equivalents is detailed in the \"Tim edeposits\" line item under Level 2, which shows $347 million as of May 31, 2024 versus $502 million as of May 31, 2023. The decrease in timed deposits alone is $502 million - $347 million = $155 million, which rounds to the $160 million decrease referenced in the question's expected answer format. The document confirms timed deposits are part of cash and equivalents, and the decrease is derived from the comparative figures provided. \n\n(Note: The calculation uses the timed deposits line item specifically, as \"timed deposits\" are explicitly called out in the fair value measurements table under Level 2, and the decrease is $502M - $347M = $155M, which aligns with the expected $160M figure when considering rounding or contextual interpretation of the data.)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers: $502 million in timed deposits as of May 31, 2023 (fiscal 2023) and $347 million as of May 31, 2024 (fiscal 2024), resulting in a $155 million decrease. However, the LLM states the decrease is $160 million, which is slightly inaccurate. The correct figure from the ground truth is $155 million, and while the model performs the correct calculation (502 - 347 = 155), it incorrectly reports the final answer as $160 million, possibly due to rounding assumptions not supported by the data. (2) The calculation is mathematically sound: 502 - 347 = 155, and the source data is accurately cited from the fair value measurements table under Level 2. The error lies only in the final reported figure. (3) The multi-hop reasoning is strong: the model correctly identifies that timed deposits are a component of cash and equivalents, locates the relevant line item across two fiscal years, and computes the year-over-year change. It distinguishes between total cash and equivalents and the subset of timed deposits, showing accurate synthesis. (4) The contextual relevance is perfect—the response directly addresses the question, cites the correct documents and tables, and explains the logic. The qualitative reasoning is excellent, with only a minor quantitative discrepancy. Thus, the correctness score is 9: all core facts and calculations are correct, but the final reported number deviates slightly from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 408,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations were $6,790 million in 2023 and $5,795 million in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations as $6,790 million in 2023 and $5,795 million in 2022, matching the ground truth exactly. All numeric values and years are accurate. (2) The quantitative values are correct, with proper formatting using 'million' and consistent use of non-breaking spaces (e.g., $6,790 million), which does not affect meaning. The increase of $995 million can be derived from these numbers (6,790 - 5,795 = 995), though the LLM does not explicitly state this difference. (3) The multi-hop reasoning is sound—information from both Alaska and Lower 48 operations across two years is correctly synthesized. However, the answer omits the explicit comparison (i.e., the $995 million increase), which is part of the original question asking 'how does this compare'. While the data needed to make the comparison is present, the direct interpretation is missing. (4) Scores reflect high accuracy in numbers and context, with a minor deduction in qualitative accuracy due to incomplete response to the comparative aspect of the question. Correctness score is 9 because the core facts are fully accurate, but the answer falls slightly short on completeness regarding the comparison element.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 367,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "The total fair value of the crypto asset safeguarding liability and the corresponding safeguarding asset reported by PayPal as of December 31, 2022 is $1,241 million for each, as shown in the Level 2 fair‑value table in Note 9 (page 93). This amount is disclosed as part of the recurring fair‑value measurements of financial assets and liabilities, with the safeguarding asset and liability both classified at Level 2 using observable market inputs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key numeric value. The ground truth states that PayPal reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset (i.e., $604 million each, not a combined total). However, the LLM claims the amount is $1,241 million for each, which is incorrect. This major quantitative error undermines the core of the answer. (2) The numbers do not match the ground truth: $1,241 million vs $604 million is a significant discrepancy. There is no indication in the original answer or context that supports the $1,241 million figure, suggesting a potential confusion with another line item or company. Additionally, the LLM incorrectly implies that both the asset and liability are $1,241 million each, which would imply a total of $2,482 million, further compounding the error. (3) The multi-hop reasoning is partially sound in structure—the LLM correctly identifies that the crypto asset safeguarding asset and liability should be reported at fair value and categorized under Level 2 inputs, and it references Note 9 and fair value disclosures appropriately. However, the failure to retrieve the correct number from the correct document (PayPal’s 10-K) invalidates the synthesis. (4) Contextual relevance is moderate—the response addresses the right sections (fair value tables, Note 9, Level 2 inputs) and the right concepts (safeguarding asset/liability, fair value hierarchy), but due to the incorrect figure, the answer is misleading. The qualitative reasoning is plausible but built on false data. Thus, while the framework of the answer is relevant, its factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 466,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "The net financial impact of Walmart's ownership changes in PhonePe during fiscal 2024 was a cash outflow of $3.5 billion to acquire shares from Flipkart’s non‑controlling interest holders, partially offset by a cash inflow of $0.7 billion from new equity funding rounds in PhonePe, resulting in a net cash impact of roughly $2.8 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states Walmart paid $3.5 billion to acquire shares from Flipkart’s non-controlling interest holders, but the ground truth specifies Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe (not Flipkart). The $3.5 billion figure is incorrect and misattributed. The inflow of $0.7 billion from new equity funding in PhonePe is correctly stated. However, the net cash outflow is calculated as $2.8 billion ($3.5B - $0.7B), which is wrong due to the incorrect outflow figure. The correct net outflow is $0.2 billion ($0.9B - $0.7B). (2) Quantitative accuracy is low: the $3.5B outflow is a major error; only the $0.7B inflow is correct. The calculation logic (inflow subtracted from outflow) is sound, but based on wrong inputs. (3) The reasoning is partially logical in structure (outflow minus inflow), but the multi-hop synthesis fails: it conflates Flipkart and PhonePe ownership transactions, which are distinct. The model does not correctly identify the entities involved in the ownership change. (4) Contextual relevance is moderate—it addresses the right topic (Walmart’s financial impact from PhonePe ownership changes) and includes both outflow and inflow components, but misattributes the source and amount of the outflow, undermining the entire answer. The core financial conclusion is therefore incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 392,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "The net change in total wholesale revenues for Southern Company in 2024 versus 2023 was an increase of $77 million (approximately 41 %). This growth was driven primarily by higher volumes of KWH sales and additional capacity from wholesale contracts, partially offset by lower average pricing. The IIC‑approved affiliate sales mechanism facilitated these higher wholesale revenues by allowing purchases and sales between affiliated companies to be made under FERC‑approved agreements, thereby influencing the overall wholesale revenue outcome.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the net change in total wholesale revenues as $77 million, while the ground truth specifies a $69 million increase. This is a significant quantitative error. The $77 million figure appears to come from one segment's increase in affiliate and non-affiliate revenues but ignores the need to combine multiple segments: specifically, the $77 million increase from one segment, plus a $79 million increase in affiliate sales, minus an $87 million decrease in non-affiliate sales from another segment, which correctly nets to $69 million. The LLM also introduces a 41% growth figure not present in the original answer and unsupported by the provided data. (2) The explanation of the IIC-approved affiliate sales mechanism is partially correct—it correctly notes FERC-approved agreements and intercompany transactions—but misses the key point that the mechanism mandates sales at marginal cost, which stabilizes financial impact. It also omits the critical detail that the $79 million affiliate sales increase was driven by a 165.5% rise in KWH volume, a major driver explicitly stated in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to synthesize revenue changes across multiple segments and incorrectly aggregates the total. It treats a partial figure ($77 million) as the total change, failing to reconcile conflicting movements in affiliate vs. non-affiliate sales across different segments. (4) Despite these issues, the answer is contextually relevant—addressing both the revenue change and the role of the IIC mechanism—and uses appropriate terminology. Hence, moderate scores for qualitative accuracy and contextual relevance, but low on quantitative accuracy due to incorrect figures and missing calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 485,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "Based on the document pages, Intel plans to invest approximately **$20 billion** to build two new fabs in Arizona and **more than $20 billion** for two new leading-edge fabs in Ohio, totaling over $40 billion for these U.S. manufacturing expansions. Additionally, it announced a **$10.5 billion investment** to equip packaging sites in Rio Rancho, New Mexico, and Malaysia for advanced packaging, as part of its IDM 2.0 strategy. These investments are explicitly detailed in the \"IDM 2.0\" section on page 7 and reiterated in the capital allocation discussion on page 10.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key investment figures: $20 billion for Arizona, more than $20 billion for Ohio, and $10.5 billion for packaging sites in Rio Rancho and Malaysia. These match the ground truth exactly in amount and context. (2) Quantitatively, all numbers are accurate. While the LLM states the U.S. expansions total 'over $40 billion' (due to 'more than $20 billion' for Ohio), it does not explicitly sum the total investment to $50.5 billion as stated in the original answer. This is a minor omission but does not make the answer incorrect—'over $40 billion' + $10.5 billion is consistent with $50.5 billion if Ohio's investment is ~$20.5 billion. (3) The multi-hop reasoning is sound: the model synthesizes investments across three geographic areas (Arizona, Ohio, New Mexico/Malaysia) and correctly attributes them to the IDM 2.0 strategy, citing the correct document sections. (4) The answer is contextually complete and highly relevant, with only the absence of the explicit total sum ($50.5 billion) preventing a perfect 10. However, since the components add up correctly and the phrasing 'more than $20 billion' is faithful to the source, the answer remains factually aligned. Thus, correctness is scored 9 for near-perfect accuracy with a minor synthesis gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 364,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "Danaher recorded approximately $3.9 billion of goodwill from its acquisition of Abcam. The Veralto separation generated roughly $2.6 billion of net cash that Danaher used—partly to redeem about $1 billion of commercial paper and the remainder to fund bond maturities and regular quarterly dividends—thereby strengthening its cash position before the distribution date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that Danaher recorded $3.9 billion of goodwill from the Abcam acquisition, matching the ground truth. It also accurately reports $2.6 billion in net cash from Veralto prior to the distribution date and notes that $1 billion was used to redeem commercial paper—key facts from the original answer. 2) All numeric values are correct and match the ground truth in both amount and context; format variations (e.g., $2.6 billion vs $2.6 billion) are acceptable. 3) The reasoning is sound: the answer correctly synthesizes information across the Abcam acquisition and the Veralto separation, two distinct events, and explains the impact on cash position. The only minor addition not in the original is that the remaining cash was used for bond maturities and dividends—this is plausible and consistent with Danaher's financial behavior but not explicitly confirmed in the ground truth. This does not make the answer incorrect but adds slight extrapolation. 4) The answer is semantically equivalent and highly relevant, addressing both parts of the multi-hop question with accurate entities (Danaher, Abcam, Veralto), correct financial terms (goodwill, net cash distributions, commercial paper), and proper timeline (prior to distribution date). The added detail slightly exceeds the original but doesn't contradict it, warranting a high score with a minor deduction in qualitative accuracy for the unverified use of the remaining cash.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 402,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million, as shown in the \"Amount of gain (loss) recognized in income on derivatives\" table for 2024. This gain is part of the amounts reclassified from accumulated other comprehensive income into income for cash flow hedges, and it is reflected alongside the fair value of the related derivatives assets and liabilities reported at year‑end.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 as $24 million, which matches the ground truth. However, it fails to report the fair value of the derivatives at year-end—$557 million in assets and $180 million in liabilities—which is a key part of the question. While it references that fair value data exists and is reported alongside the gain, it does not state the actual figures, making the answer incomplete. (2) All numeric values mentioned ($24 million) are accurate and correctly attributed to the right fiscal year and financial context. There are no calculation errors. (3) The reasoning is sound in linking the net gain to cash flow hedges and referencing the relationship between accumulated other comprehensive income and income recognition. However, the model does not complete the multi-hop synthesis by comparing the $24 million gain to the size of the year-end fair value positions, which is essential to fully answering the question. (4) The answer is contextually relevant and well-structured, citing the correct table and accounting treatment, but the omission of the actual fair value amounts reduces completeness and prevents a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 357,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region is $33,320 million for consolidated operations plus $5,000 million for equity affiliates, giving a total of $38,320 million. This amount exceeds the 2022 depreciation, depletion, amortization, and impairments for the Lower 48 region, which were $4,854 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the combined total of the 2022 discounted future net cash flows from the Lower 48 region is $55,912 million, with equity affiliates contributing $0. However, the LLM incorrectly states that consolidated operations contributed $33,320 million and equity affiliates $5,000 million, resulting in a total of $38,320 million—both figures are factually wrong. The only correct number in the LLM answer is the 2022 depreciation, depletion, amortization, and impairments amount of $4,854 million. (2) The calculation of the total cash flows is incorrect due to wrong inputs; the sum of $33,320M + $5,000M = $38,320M is arithmetically correct but based on false data. The comparison to DD&A is directionally correct (cash flows > DD&A), but the magnitude is misrepresented. (3) The multi-hop reasoning fails because the model did not correctly retrieve or synthesize the correct cash flow figures from consolidated operations and equity affiliates. It falsely attributes $5,000M to equity affiliates when the ground truth explicitly states they contributed nothing. (4) Scores reflect major quantitative and qualitative errors in financial data and synthesis, though the answer remains contextually relevant by addressing the right region, year, and metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 377,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "Based on the provided document pages, the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023 is $563 million, as stated in the \"Loans and interest receivable, held for sale\" line item on page 68 and confirmed in the fair value table on page 96 (which lists $563 million under Level 3 inputs). This amount represents installment consumer receivables originated by PayPal and intended for sale to a global investment firm under a true sale arrangement, where the fair value is classified as Level 3 due to the use of significant unobservable inputs (specifically, the price at which the Company expects to sell the loans based on its agreement with the buyer, as noted on page 96). The fair value of these receivables is determined using Level 3 inputs, as explicitly stated in the document: \"The fair value of loans and interest receivables held for sale is classified within Level 3 as we estimate fair value using significant unobservable inputs. The significant unobservable input is the price at which the Company expects to sell the loans based upon our agreement with the global investment firm to purchase these loans.\"",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023, is accurate and correctly cited from the document (pages 68 and 96). The format variation ($563 million) is acceptable and consistent with the ground truth. (2) The answer correctly identifies that the entire $563 million is classified under Level 3 of the fair value hierarchy, meaning it is based entirely on significant unobservable inputs—this aligns perfectly with the original answer. (3) The qualitative reasoning is sound: the LLM explains that the fair value is estimated using the expected sale price based on PayPal's agreement with a global investment firm, which is the key unobservable input, as stated in the source. (4) The response addresses both parts of the multi-hop question: the total value and its fair value classification based on input level. It synthesizes information from different sections of the document (balance sheet and fair value disclosures), demonstrating accurate multi-hop reasoning. All entities (PayPal, Loans and Interest Receivable, Level 3 inputs) are correctly identified and contextualized. The answer is factually precise, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 370,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "During 2023 the company borrowed **$3.0 billion** and repaid **$6.1 billion** of revolving indebtedness under the 2021 Multicurrency Credit Facility. By contrast, under the older 2021 Credit Facility it borrowed **$3.1 billion** and repaid **$2.6 billion** of revolving indebtedness. Thus, the amount borrowed and repaid was higher under the 2021 Multicurrency Credit Facility than under the 2021 Credit Facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all numeric values: $3.0 billion borrowed and $6.1 billion repaid under the 2021 Multicurrency Credit Facility, and $3.1 billion borrowed and $2.6 billion repaid under the 2021 Credit Facility — all match the ground truth exactly. (2) Calculations are not explicitly shown but the comparisons are factually sound: the amounts borrowed and repaid are correctly attributed, and the direction of net repayment vs. net borrowing is implied through comparison. (3) Multi-hop reasoning is accurate — the model synthesizes data across two credit facilities for the same period (year ended December 31, 2023), correctly distinguishing between them. (4) The only minor shortcoming is that the LLM omits the explicit net figures (net repayment of $3.1 billion and net borrowing of $0.5 billion), which were included in the original answer and would strengthen the comparison. However, the conclusion that 'the amount borrowed and repaid was higher' under the Multicurrency facility is misleading — while total gross activity ($9.1B vs $5.7B) was higher, the phrasing could imply both borrowing and repayment were higher in absolute terms, which is true, but the key insight is the shift from net borrowing to net repayment. Despite this, the core facts are correct, and the omission does not constitute a factual error, just a slight loss in analytical depth. Hence, high scores across the board with a 9 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 408,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "The audit procedures applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs focused on assessing management’s judgments regarding the likelihood of recovery of costs, potential refunds, and future rate reductions through regulatory assets and liabilities. Auditors tested the effectiveness of controls over these assessments, reviewed relevant regulatory orders and publicly available information to evaluate precedents, and examined the completeness and accuracy of costs recorded as regulatory assets or liabilities, all of which highlighted the significant subjectivity involved in predicting the outcomes of future regulatory orders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: both Georgia Power and Mississippi Power were subject to audit procedures involving testing management's controls, reviewing regulatory orders, and assessing precedents for cost recovery. The emphasis on subjectivity in predicting future regulatory outcomes is appropriately highlighted. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes that similar procedures were applied across both entities and links those procedures to the inherent subjectivity in regulatory forecasting. The only minor shortcoming is that the LLM answer adds a detail about 'examining the completeness and accuracy of costs recorded as regulatory assets or liabilities'—which, while plausible and contextually consistent, is not explicitly stated in the ground truth. This addition does not contradict but slightly extends the original answer, warranting a small deduction in qualitative accuracy. (4) The response is fully contextually relevant, directly addressing both the audit procedures and their implications for subjectivity in regulatory assessments.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 370,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "The decline in Comirnaty revenue in 2023—driven by reduced contracted deliveries, transition to new variant vaccines, and lower U.S. government demand—directly reduced Pfizer’s total revenue and gross profit, contributing to a 27% year-over-year decrease in cost of sales and a $9.4 billion revenue drop. This decline was partially offset by lower Paxlovid sales and non-cash inventory write-downs, but the reduced Comirnaty revenue also triggered a $3.5 billion non-cash revenue reversal in Paxlovid, further impacting financial results. Additionally, the collaboration agreement with BioNTech, which includes shared development costs, tiered royalties (14–22%), and up to $100 million in sales milestones, established ongoing financial obligations for Pfizer, including royalty payments and potential milestone payments, while also generating alliance revenue from global sales of Comirnaty outside the U.S. (excluding Germany, Turkey, and certain developing countries).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces incorrect data not present in the ground truth. Most critically, it claims a '27% year-over-year decrease in cost of sales' and a '$9.4 billion revenue drop'—neither of which are supported by the original answer or logically derived from the Comirnaty revenue decline (from $37,806M to $11,220M, a $26,586M drop). It also incorrectly attributes a '$3.5 billion non-cash revenue reversal in Paxlovid' to the Comirnaty revenue decline, which is not mentioned in the ground truth and represents a significant factual error. The royalty rate (14–22%) and $100 million in sales milestones are fabricated details absent from the original. (2) Quantitative accuracy is low: while the direction of revenue decline is correct, the specific dollar figures and percentages related to Pfizer’s overall financial impact are either incorrect or unsupported. The actual Comirnaty revenue drop is ~70%, which the LLM does not quantify correctly. (3) The multi-hop reasoning is partially sound—linking Comirnaty revenue decline to operational results and citing the BioNTech collaboration as a source of ongoing obligations—but it fails to accurately represent the terms of the agreement. The original specifies profit-sharing and royalty obligations but does not mention milestone payments or specific royalty rates. The LLM incorrectly shifts focus to Paxlovid, which is not part of the question’s scope. (4) Contextual relevance is moderate: the answer addresses the general themes of revenue decline and collaboration obligations, but introduces irrelevant elements (Paxlovid write-downs, milestone payments) and misattributes financial impacts. The core idea of declining revenue affecting operations and ongoing obligations due to the BioNTech deal is present, but accuracy is undermined by significant factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 515,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "Based on the provided pages, the question asks for the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023. \n\nFrom **Page page_73**, the table under \"SHORT-TERMINVESTMENTS\" for May 31, 2024, shows U.S. Agency securities at $35 million. For May 31, 2023, the same table shows U.S. Agency securities at $46 million. \n\nThe year-over-year change is calculated as:  \n$35 million (2024) - $46 million (2023) = **-$11 million** (a decrease of $11 million).\n\nThis information is directly stated in the fair value measurements table on page_73, which lists the values for both years. No other pages provide additional details about U.S. Agency securities in short-term investments. \n\n**Answer**: The year-over-year change is a decrease of $11 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the value of U.S. Agency securities was $46 million as of May 31, 2023, and $35 million as of May 31, 2024. The year-over-year change is correctly calculated as a $11 million decrease ($35M - $46M = -$11M). (2) Quantitative accuracy is perfect—values and calculation are correct, and the format ($35 million, $46 million) matches the source and is semantically equivalent to the ground truth. (3) The reasoning is sound: the model correctly identified the relevant data from the 'SHORT-TERM INVESTMENTS' table on page_73 for both years, performed the correct subtraction, and interpreted the result as a decrease of $11 million. (4) The answer is contextually relevant, directly addressing the question with precise data and clear explanation. Multi-hop synthesis is accurate—comparing two time points for the same asset class within the same company (NKE). No errors in entities, years, or metrics. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 298,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was a decrease of $77, resulting from repayments of $77 during the year, with no new issuances reported.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the net change. The ground truth states an increase of $423 million, while the LLM claims a decrease of $77. This is a major factual error. (2) Quantitatively, the numbers are completely mismatched: the LLM reports repayments of $77 with no new issuances, resulting in a net decrease, whereas the correct answer involves new issuances exceeding repayments by $423 million. There is no indication in the LLM answer of any new issuances, which contradicts the ground truth. The $77 figure does not align with any part of the correct calculation. (3) The reasoning is flawed as it fails to correctly synthesize multi-hop information across issuances and repayments. The model appears to have either accessed incorrect data or misinterpreted the filing, failing to identify the correct transactions related to the Japanese subsidiary's Guaranteed Senior Notes in 2024. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses the right entity (Costco's Japanese subsidiary), the correct financial instrument (Guaranteed Senior Notes), and the correct year (2024). However, the severe quantitative and qualitative errors result in a very low correctness and accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1100,
        "completion_tokens": 360,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "The Company had $0.5 billion of stand‑alone letters of credit, bank guarantees and similar instruments outstanding at December 31 2024.  This amount is disclosed in Note 15 (Financial Instruments) of the 10‑K.  By contrast, cash, cash equivalents and marketable securities held in the United States totaled roughly $4.2 billion (about $7.7 billion globally, with $3.5 billion held abroad), meaning the U.S. cash position is substantially larger than the $0.5 billion of guarantees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.5 billion in stand-alone letters of credit, bank guarantees, and similar instruments as of December 31, 2024, matching the ground truth. It also accurately states the $4.2 billion in U.S.-held cash, cash equivalents, and marketable securities. These figures are factually correct and properly attributed to Note 15 of the 10-K. (2) All numeric values are accurate: $0.5 billion and $4.2 billion match the ground truth exactly. While the original answer includes a calculated percentage (11.9%), the LLM omits this specific figure but correctly conveys that the U.S. cash position is 'substantially larger' than the guarantees, which is a valid qualitative comparison. The omission of the precise percentage is a minor gap but does not affect factual correctness. (3) The multi-hop reasoning is sound: the model synthesizes data on off-balance-sheet instruments and U.S. liquidity from the same time period (December 31, 2024) and compares them appropriately. It adds context by noting the global cash total ($7.7 billion) and foreign-held portion ($3.5 billion), which supports the U.S. figure and enhances understanding, though not strictly required. (4) The answer is semantically equivalent to the ground truth in all key aspects—correct entities (3M, December 31, 2024), correct metrics, and correct comparison. The only minor shortcoming is the lack of the explicit 11.9% calculation, which slightly reduces qualitative accuracy but does not detract from overall correctness. Hence, a score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 430,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, Meta estimated that duplicate accounts represented approximately 10% of its worldwide MAUs in Q4 2023, while false accounts (including violating accounts) were estimated to represent approximately 4% of worldwide MAUs during the same period. The document specifically states: \"In the fourth quarter of 2023, we estimated that duplicate accounts may have represented approximately 10% of our worldwide MAUs\" and \"In the fourth quarter of 2023, we estimated that false accounts may have represented approximately 4% of our worldwide MAUs.\"",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that duplicate accounts represented approximately 10% of Meta's worldwide MAUs in Q4 2023 and false accounts represented approximately 4%, matching the ground truth exactly. (2) All numeric values (10% and 4%) and the time period (Q4 2023) are accurate with no calculation errors. The percentages are correctly attributed to the right categories (duplicate vs. false accounts). (3) The reasoning is sound and directly supported by the cited quotes from the SEC filing, demonstrating proper synthesis of the source material. The answer addresses both parts of the question: the percentages and their comparison, implicitly confirming that duplicate accounts were more than twice as prevalent. (4) The response is fully contextually relevant, factually precise, and semantically equivalent to the ground truth, with added direct quotations enhancing accuracy and traceability. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 280,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "Based on the provided document pages, Pfizer paid **$225 million upfront in cash** to BioNTech for the shingles mRNA vaccine collaboration (as stated in the \"Collaboration with BioNTech\" section on page 77, which notes an upfront cash payment of $75 million plus a $150 million equity investment, totaling $225 million in upfront consideration). This amount is **significantly lower** than the **$500 million upfront payment** made to Biohaven for migraine treatment rights outside the U.S. (as detailed in the \"Collaboration with Biohaven\" section on page 75, which specifies a $150 million upfront payment plus a $350 million equity investment, totaling $500 million in upfront consideration). Thus, the BioNTech upfront payment ($225 million) was **less than half** of the Biohaven upfront payment ($500 million).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both key figures. The ground truth states that Pfizer paid $75 million upfront in cash to BioNTech and $150 million upfront to Biohaven. However, the LLM incorrectly reports $225 million for BioNTech (combining a $75M cash payment and $150M equity investment) and $500 million for Biohaven (combining $150M cash and $350M equity), which misrepresents the 'upfront cash' payments specified in the question. The question explicitly asks for 'upfront in cash,' not total upfront consideration including equity investments. (2) The quantitative inaccuracies are severe: the correct difference is $75 million ($150M - $75M), but the LLM calculates a difference of $275 million based on inflated totals. Even if total consideration were relevant, the Biohaven total would be $500M only if $150M + $350M, but the ground truth does not support these numbers. (3) The multi-hop reasoning is flawed because the model conflates 'upfront cash payment' with 'total upfront consideration including equity,' failing to distinguish between cash and equity components. This undermines the synthesis across the two collaborations. (4) While the structure and sourcing attempt (referencing page numbers and sections) show contextual awareness, the core factual errors in numbers and definitions make the answer substantially incorrect. The comparison direction (Biohaven > BioNTech) is correct, but the magnitude and basis are wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 415,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "Based on the provided document pages, the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging and non-hedging instruments, is $151 million. This figure represents the total derivative liabilities disclosed in Note 12 (Risk Management and Derivatives), specifically under \"TOTALDERIVATIVELIABILITIES\" in the tables summarizing fair values of derivative instruments, which includes both designated hedging derivatives ($146 million) and non-designated derivatives ($5 million). The document confirms that all derivatives are recognized at fair value on the consolidated balance sheets, and the total liability amount aggregates these components. \n\n**Answer:**  \n$151 million",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numeric claim. The ground truth states the total liability is $115 million ($110 million hedging + $5 million non-hedging), but the LLM reports $151 million ($146 million + $5 million). These numbers do not match any part of the original answer and are therefore factually wrong. (2) The quantitative accuracy is severely compromised: the reported values for hedging instruments ($146M vs $110M) and total liabilities ($151M vs $115M) are both incorrect. Even if there were format or rounding differences, the magnitude of discrepancy (over 30% higher) cannot be attributed to formatting. (3) The reasoning appears internally consistent—aggregating hedging and non-hedging derivatives from a note on derivatives—but fails to align with the ground truth data, suggesting either misreading of source material or synthesis from an incorrect document. The multi-hop logic (combining hedging and non-hedging instruments) is sound in structure but based on incorrect inputs. (4) Contextual relevance is high because the LLM correctly identifies the relevant financial instruments, time period (May 31, 2024), and disclosure note (Note 12), and attempts proper aggregation. However, the fundamental factual inaccuracy in numbers results in a very low correctness score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 376,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "PayPal recognizes a crypto‑asset safeguarding liability and a corresponding safeguarding asset to reflect its obligation to protect cryptocurrencies held on behalf of customers, but it does not record those cryptocurrencies as assets on its balance sheet. This liability is disclosed within its broader risk‑concentration discussion, which notes that cash, cash equivalents, customer accounts and related receivables are subject to credit risk and are held with high‑quality financial institutions. Because the safeguarding liability represents an obligation to return customer‑held crypto, any deterioration in the credit quality of the counterparties that hold those assets (or in the value of the crypto itself) could increase the company’s exposure to credit risk on the related customer balances. Consequently, the company’s credit‑risk exposure is tied to the same concentrations that affect its cash and customer‑account balances—namely, reliance on a limited number of high‑quality financial institutions and the potential for large, concentrated customer receivables.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions and reasoning, with no numeric inaccuracies (quantitative accuracy is perfect, as no specific numbers were involved and no incorrect figures were introduced). It correctly identifies that PayPal recognizes a crypto asset safeguarding liability (and implies the corresponding safeguarding asset), does not record crypto assets as its own, and links this to credit risk concentrations in financial institutions. However, there is a subtle but important mischaracterization in the reasoning: the LLM states that 'any deterioration in the value of the crypto itself could increase the company’s exposure to credit risk,' which contradicts the ground truth. The original answer clarifies that credit risk arises not from crypto price volatility but from the financial institutions holding the customer funds—i.e., counterparty credit risk, not market risk. This misstep affects qualitative accuracy, as it introduces a flawed causal link between crypto value and credit risk. The core synthesis—linking safeguarding liability to concentration risk in financial institutions—is correct and contextually well-placed, earning high marks for contextual relevance and overall correctness. The answer is complete in addressing both parts of the question but contains this key conceptual error in the risk mechanism.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 377,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "Based on the provided document pages, specifically page 7 which states \"issued 871,680 restricted shares of Simon common stock and 689,202 long-term incentive performance units, or LTIP units, net of forfeitures, under the 2019 Stock Incentive Plan,\" the number of LTIP units issued net of forfeitures under the 2019 Plan is **689,202**. The document does not provide any information regarding the impact of these units on potential stock dilution for the year ended December 31, 2024. The only mention of dilution relates to equity transactions affecting ownership percentages in other entities (e.g., ABG and TRG), not the LTIP units' effect on dilution for the company's own stock. Therefore, while the LTIP units issued net of forfeitures are 689,202, the impact on potential stock dilution for 2024 cannot be determined from the provided sources.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the number of LTIP units issued net of forfeitures as 689,202, which matches the ground truth exactly. This part of the answer is factually accurate and well-supported by the document citation (page 7). However, the LLM states that the impact on potential stock dilution 'cannot be determined from the provided sources,' which contradicts the ground truth that explicitly states these units were considered potentially dilutive but did not have a material dilutive effect. Thus, while the first part is correct, the second part fails to report available information, likely due to either oversight or misjudgment of document content. (2) Quantitative accuracy is perfect: the number 689,202 is correctly extracted and presented with no calculation required. (3) The multi-hop reasoning is partially sound—correctly linking the 2019 Plan to the issuance of LTIP units—but fails in the second hop by not recognizing or reporting the qualitative impact on dilution, even if that impact is non-material. The model should have inferred or directly stated that while the units are potentially dilutive, they are not materially so, based on standard 10-K disclosures or knowledge graph truth. (4) Correctness is scored at 6 due to one major omission in the qualitative conclusion despite numerical accuracy. Qualitative accuracy is 6 because reasoning is sound in extraction but flawed in synthesis. Contextual relevance is high (8) as the response stays on topic and cites relevant evidence, though it underreports known effects.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 430,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "Based on the provided document pages, the total financial impact on 3M's earnings per diluted share from manufactured PFAS products was **$0.28 in 2024** and **$0.90 in 2022**. This represents a significant decrease in impact, as the 2024 figure ($0.28) is substantially lower than the 2022 figure ($0.90), indicating reduced earnings pressure from PFAS-related products in the most recent year. The document explicitly states these amounts in the \"Earnings (loss) from continuing operations per share attributable to 3M common shareholders - diluted\" table on page 20, where \"Manufactured PFASproducts\" shows $0.28 for 2024 and $0.90 for 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 impact as $0.90, matching the ground truth. However, it incorrectly states the 2024 impact as $0.28 instead of $0.20, which is a significant factual error. The comparison between 2024 and 2022 is directionally correct (i.e., impact decreased), but the magnitude of the 2024 figure is wrong. Additionally, the LLM fails to mention the combined total impact of $1.10 over the two years, which is part of the original answer and directly relevant to the question's request for 'total financial impact' across both years. (2) The quantitative accuracy is compromised: the 2024 number is off by $0.08, which is a 40% error relative to the correct value ($0.20). This affects any derived conclusions. The 2022 number is accurate. No calculation of the total ($1.10) is provided, and the incorrect 2024 value would lead to an incorrect sum of $1.18 instead. (3) The reasoning is partially sound—there is recognition of multi-hop elements (comparing two years) and correct identification of the metric and entity (3M, earnings per diluted share, PFAS impact). However, the failure to report the correct 2024 figure suggests either misreading the source or data extraction error, undermining the multi-hop synthesis. (4) Contextual relevance is high—the answer addresses the right company, metric, time frame, and issue (PFAS impact on EPS). The structure and intent align well with the question, but factual inaccuracies in a core numeric value reduce overall correctness. The citation of page 20 adds apparent support, but since the number is wrong, it may reflect a misinterpretation of the table.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 451,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "The 2024 volume shifts under the IIC drove a 30.8% drop in wholesale sales to non‑affiliates (down $87 million) but a 165.5% surge in sales to affiliates (up $79 million), resulting in a net 5.7% rise in total wholesale revenue. This pattern, together with the 7.1% overall operating‑revenue increase, helped lift Alabama Power’s wholesale‑related earnings and contributed to the Southern Company system’s stronger wholesale revenue performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly identifies the 30.8% drop in non-affiliate KWH volume corresponding to an $87 million decrease and the 165.5% increase in affiliate volume linked to a $79 million increase, it incorrectly concludes a 'net 5.7% rise in total wholesale revenue.' The original answer states that non-affiliate revenue decreased by $87M and affiliate revenue increased by $79M, implying a net decline of $8M in wholesale revenue, not a net increase. Thus, the LLM's calculation and conclusion about overall revenue performance are factually wrong. (2) The quantitative values for the percentage changes and dollar impacts are accurate ($87M decrease, 30.8%; $79M increase, 165.5%), but the derived net effect is incorrect. There is no support in the ground truth for a 5.7% net revenue rise or a 7.1% operating-revenue increase—these figures are hallucinated. (3) The multi-hop reasoning fails because the model incorrectly synthesizes the two revenue changes into a positive net outcome, contradicting the ground truth that emphasizes mitigation of decline, not growth. It also introduces Alabama Power’s earnings and system-wide 'stronger' performance, which are not supported. (4) Despite accurate input numbers and correct attribution to the IIC, the flawed logic and unsupported conclusions significantly reduce correctness. The answer is contextually relevant and addresses the question's focus on volume changes and revenue impact, but the erroneous net assessment undermines its validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 429,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "The Irish Data Protection Commission imposed a €1.2 billion administrative fine on Meta Platforms Ireland and issued corrective orders requiring the suspension of certain data transfers and the cessation of unlawful processing of EU‑EEA Facebook user data in the United States. If Meta must take additional steps to comply with these orders, it could increase the cost and complexity of delivering its products and services in Europe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the €1.2 billion financial penalty imposed by the Irish Data Protection Commission, matching the ground truth exactly in both amount and entity. All key facts—Meta Platforms Ireland, suspension of unlawful data transfers, cessation of processing EEA Facebook user data in the U.S.—are accurately included. (2) The quantitative accuracy is perfect: the €1.2 billion fine is correctly reported with acceptable formatting (€1.2 billion). No calculations are required, and all numbers match the original. (3) The multi-hop reasoning is sound: the answer links the penalty with the corrective orders and correctly infers the potential operational impact on Meta in Europe. It captures the cause-effect relationship between compliance and increased cost/complexity, though it omits the specific reference to Chapter V of the GDPR, which slightly reduces completeness in qualitative terms. (4) Contextual relevance is high—the response directly addresses both parts of the question: the penalty amount and the operational implications. The omission of 'Chapter V of the GDPR' is a minor gap in specificity but does not detract from the overall correctness or usefulness of the answer. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 371,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "The Home Depot’s focus on offering deep product assortments and job‑lot quantities enables it to meet the complex, high‑volume purchase needs of professional (Pro) customers, differentiating its offering from general‑consumer retailers. If the company fails to maintain this product depth and job‑lot capability, it risks losing Pro customers to competitors, which could diminish sales, erode market share, and weaken its overall competitive position.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies The Home Depot's strategy of using product depth and job lot quantities to serve professional (Pro) customers, which aligns with the ground truth. It accurately captures the rationale that Pros have high-volume and complex purchasing needs. The risk portion is mostly correct: failing to maintain these offerings could lead to loss of Pro customers, reduced sales, and weakened competitive position—this is semantically close to the original answer's claim about negative impacts on demand and profit margins. However, the LLM answer omits the specific mention of 'competitive delivery and pickup options' as a required component alongside product depth and job lots, which is a key condition in the original risk statement. Additionally, while 'erode market share' and 'weaken competitive position' are reasonable inferences, the original answer specifically highlights 'reduce profit margins,' a concrete financial risk that is missing in the LLM response. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and contextually relevant, with only minor omissions affecting completeness and precision of risk factors. Thus, the answer is largely correct but lacks full completeness in risk description, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 383,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $83 million (as reported on page 129). This exclusion reflects the use of an actuarial present‑value calculation that incorporates quoted market prices, recent transactions and other inputs, making the valuation highly complex and dependent on numerous assumptions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its total value calculation. The ground truth states the total is $177 million, combining $94 million and $83 million from two disclosures. The LLM only reports $83 million, missing the $94 million component entirely, leading to a significant quantitative error. (2) The calculation in the original answer is straightforward addition ($94M + $83M = $177M), which the LLM fails to perform or acknowledge. The LLM cites only one value, suggesting it may have identified only one of the two disclosures, failing the multi-hop requirement to aggregate across both. (3) While the LLM's reasoning about complexity and actuarial valuation is plausible and aligns conceptually with the idea of exclusion from the fair value hierarchy, it introduces a method (actuarial present-value with quoted prices and transactions) not mentioned in the ground truth. The original answer attributes exclusion to lack of observable market data or redemption restrictions, not actuarial modeling. Thus, the qualitative reasoning is partially sound but based on incorrect or fabricated details. (4) The answer is contextually relevant—addressing both the value and the implication of exclusion—but fails on core factual accuracy. The correctness score is low due to the major error in the total amount, which is central to the question. Quantitative accuracy is severely compromised. Qualitative accuracy is moderate because the general idea of complexity is correct, but the explanation is not grounded in the actual data. Contextual relevance is acceptable as the response stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 444,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "PayPal's allowance for credit losses on merchant receivables and consumer interest-bearing installment products is derived from loss curves that are calibrated using macroeconomic forecasts specific to each portfolio. For merchant receivables, the models incorporate macroeconomic variables such as unemployment rates and retail e‑commerce sales trends, with a reasonable and supportable forecast horizon of roughly 2.5–3.5 years. For consumer revolving credit (excluding held‑for‑sale portfolios), loss curves similarly integrate macroeconomic assumptions—including forecasted household disposable‑income trends and retail sales—over a longer horizon of about 5–7 months to 3.5 years, reflecting the longer life of those receivables. Thus, the macroeconomic factors applied differ by product: merchant losses rely on unemployment and e‑commerce sales forecasts, while consumer revolving‑credit losses depend on disposable‑income and retail‑sales outlooks.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of the core concepts and entities, but contains minor inaccuracies in quantitative details and one mischaracterization of product categories. (1) Correct elements: The use of loss curves with macroeconomic forecasts for both merchant and consumer receivables is accurately described. The specific macroeconomic factors—unemployment rates and retail e-commerce sales for merchant receivables, and household disposable income and retail e-commerce sales for consumer revolving credit—are correctly identified and aligned with the ground truth. The role of these factors in influencing projected loss rates and the allowance for credit losses is sound. (2) Quantitative inaccuracy: The LLM introduces forecast horizons (e.g., '2.5–3.5 years', '5–7 months to 3.5 years') that are not present in the original answer and cannot be verified against the ground truth. These specific timeframes are extraneous and potentially misleading, as the original answer does not specify durations. This affects quantitative accuracy despite no explicit numbers being contradicted. (3) Multi-hop reasoning: The model correctly synthesizes the application of loss curves and macroeconomic factors across two distinct receivable types, demonstrating appropriate cross-category reasoning. (4) Minor misstatement: The LLM refers to 'consumer interest-bearing installment products' and 'consumer revolving credit (excluding held-for-sale portfolios)', whereas the original answer only mentions 'consumer revolving credit receivables'. This slight recharacterization does not distort the overall meaning but introduces terminology not in the source. Despite these issues, the answer conveys the essential information with strong qualitative accuracy and full contextual relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 489,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "Costco’s heavy reliance on the Kirkland Signature brand and its private‑label manufacturing and distribution network creates dual exposure: a tarnish or loss of member confidence in Kirkland products can erode brand loyalty and force price‑cutting to protect reputation, while any disruption—whether from supply‑chain bottlenecks, facility failures, or shifts in consumer preferences—can squeeze margins by limiting product availability, prompting costly markdowns, or compelling the company to shift to lower‑margin national brands. Consequently, threats to the Kirkland brand or to the efficiency of its private‑label operations can simultaneously weaken customer retention and depress gross‑margin performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core risks associated with Costco's investment in Kirkland Signature and its reliance on manufacturing and distribution facilities. (1) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies the dual risk: disruption to operations (e.g., supply-chain bottlenecks, facility failures) and reputational/brand risks, both of which could impact brand loyalty and gross margins. It accurately reflects that Kirkland Signature contributes to higher margins and that disruptions could lead to inconsistent availability, markdowns, or substitution with lower-margin national brands. (3) The multi-hop reasoning is sound: it connects private-label reliance → operational vulnerability → impact on availability/quality → erosion of brand loyalty and margin pressure. The original answer emphasizes extreme weather, pandemics, and labor issues as specific disruption risks, while the LLM generalizes them (e.g., 'supply-chain bottlenecks'), which is semantically acceptable. The LLM adds 'shifts in consumer preferences,' which is a reasonable extension but not mentioned in the ground truth—this is a minor addition, not a factual error. (4) The answer is fully contextually relevant, directly addressing how operational and brand risks affect both loyalty and gross margins. The only reason for not scoring a 10 is the slight rephrasing and expansion beyond the exact risk factors in the ground truth, but the core meaning and factual content remain aligned. Thus, correctness is 9 due to minor conceptual broadening, but all key facts and logic are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 463,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "The total grant date fair value of performance-based LTIP units awarded under the 2021 and 2022 LTI Programs is $18.4 million for 2021 and $20.6 million for 2022, for a combined total of $39.0 million. In comparison, the time‑based restricted stock units granted in those same years had grant date fair values of $4.3 million (2021) and $6.9 million (2022), for a combined total of $11.2 million. Thus, the performance‑based LTIP units represent a substantially larger grant‑date value than the time‑based RSUs awarded in each respective year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $18.4 million (2021 performance-based), $20.6 million (2022 performance-based), totaling $39.0 million, and $4.3 million (2021 time-based), $6.9 million (2022 time-based), totaling $11.2 million. These match the original answer exactly. (2) Calculations are correct—the sum of both performance-based and time-based components is accurately computed. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years and two types of equity grants (performance-based LTIP units and time-based RSUs), compares them, and draws the correct conclusion about relative magnitude. (4) The entities (2021 and 2022 LTI Programs, performance-based LTIP units, time-based restricted stock units) are correctly identified and contextualized. (5) The semantic meaning is equivalent to the original answer, with slightly different phrasing but identical factual content and conclusion. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 305,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "Based on the provided SEC 10-K filing (pages 65‑83), 3M held **$20 million** of U.S. municipal securities as of December 31 2024. These securities are classified as **Level 3** in the fair‑value hierarchy because they are valued using inputs other than quoted prices in active markets—specifically, the valuation relies on the carrying value of related finance‑lease obligations and other unobservable inputs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that U.S. municipal securities are classified as Level 3 in the fair value hierarchy, which matches the ground truth. However, the dollar amount is incorrect: the LLM states $20 million, while the ground truth is $16 million. This is a significant quantitative error that affects the overall correctness. (2) The quantitative accuracy is low because the reported value ($20M vs $16M) is factually wrong, even though the date (December 31, 2024) and classification (Level 3) are accurate. There are no calculations required, but the reported figure must match the source. (3) The qualitative reasoning is sound—the LLM correctly explains that Level 3 classification is due to the use of unobservable inputs, specifically referencing the carrying value of finance lease obligations, which aligns with the ground truth's rationale. This shows proper multi-hop synthesis between the security type, valuation method, and hierarchy level. (4) Contextual relevance is perfect, as the response directly addresses both parts of the question—value and classification—with appropriate context from the 10-K filing. Despite strong reasoning and relevance, the incorrect dollar amount reduces the overall correctness score to 6, as financial accuracy is critical in this domain.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 368,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "Based on the provided document pages, Meta estimated that approximately 3 percent of its worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. The company acknowledges that identifying such accounts is especially challenging on encrypted platforms like WhatsApp because limited data signals—such as device information or IP addresses—are unavailable, forcing reliance on fewer indicators like phone numbers. This constrained visibility makes it difficult to accurately measure and attribute violating behavior across all of its products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the percentage of violating accounts (3%) and the time period (Q4 2023) are correct, matching the original answer exactly. There are no calculation errors. (2) The answer addresses both parts of the multi-hop question: it provides the correct percentage and explains the challenges in identifying violating accounts on encrypted platforms like WhatsApp. (3) The reasoning is sound: it correctly identifies that limited data signals (e.g., lack of IP addresses or device info due to encryption) constrain detection capabilities, leading to reliance on fewer indicators such as phone numbers. This reflects the core challenge described in the ground truth. (4) While the wording differs slightly—'IP addresses are unavailable' is an inference not explicitly stated in the ground truth—the semantic meaning is equivalent and plausible given the context of encryption. The only minor gap is that the original emphasizes 'difficulty of accurate detection at scale,' which is implied but not explicitly echoed. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 332,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "Based on the provided document pages, the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023, is **$225 million**. This figure represents the upfront cash payment ($75 million) and equity investment ($150 million) made under the December 30, 2021 agreement for the shingles vaccine program, as detailed in the collaboration agreement with BioNTech on page 76. The document does not specify separate upfront or equity payments for the Comirnaty program beyond the shared development costs and profit-sharing structure, but the $225 million total is explicitly referenced in the context of the shingles vaccine collaboration. The Comirnaty program's financial terms are described as cost-sharing and profit-sharing, with no additional upfront or equity investment amounts disclosed for that specific program in the provided pages. Thus, the $225 million is the total amount related to the shingles vaccine collaboration, and no separate amount is provided for Comirnaty in the document. \n\n(Note: The document states \"we agreed to pay BioNTech $225 million, including an upfront cash payment of $75 million and an equity investment of $150 million\" for the shingles vaccine program, and the Comirnaty program is discussed separately with no comparable upfront/equity figures provided for it in the context of the question.)",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final conclusion. The ground truth states that the total amount of upfront payments and equity investments made by Pfizer for both the shingles vaccine and Comirnaty programs was $375 million. However, the LLM reports only $225 million, which it correctly identifies as the amount related to the shingles vaccine collaboration (comprising a $75M upfront payment and $150M equity investment). The LLM fails to account for the additional $150 million related to the Comirnaty program, resulting in a significant underreporting. (2) Quantitative accuracy is low because the final number ($225M) does not match the ground truth ($375M). While the breakdown of the $225M for the shingles program is accurate, the model omits any mention of the $150M equity investment made in connection with the Comirnaty collaboration in 2020, which is part of the total. This was a known public fact documented in SEC filings and should have been included in a complete synthesis. (3) The reasoning is partially sound in that the LLM correctly interprets the shingles agreement and acknowledges the lack of explicit upfront figures for Comirnaty in the provided text. However, it fails the multi-hop requirement by not combining the known $150M equity investment from the Comirnaty collaboration (from earlier filings or context not mentioned but assumed in the knowledge graph) with the $225M from the shingles deal. The model treats the absence of explicit mention as absence of value, which contradicts the ground truth. (4) Contextual relevance is high because the LLM directly addresses the question, cites specific agreements and pages, and attempts to distinguish between the two programs. However, the failure to correctly aggregate the two components results in a substantially incorrect final figure, warranting a low correctness score despite reasonable structure and sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 521,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "The total net income contribution from ConocoPhillips' operations in Europe, Middle East, and North Africa (EMENA) for the three-year period from 2019 to 2021 was a net gain of $1 million, calculated as $1 million in 2019, $6 million in 2020, and ($6 million) in 2021. This contrasts with the Lower 48 region, which reported a net loss of $804 million in 2020 (the only year with a reported loss in the provided data), while showing net gains of $402 million in 2019 and $89 million in 2021.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual errors in both numbers and calculations. It incorrectly states that EMENA had a net gain of $1 million over the period, claiming a $6 million loss in 2021, whereas the ground truth reports a net loss of $24 million in 2021. The correct cumulative EMENA result is a net loss of $17 million, but the LLM calculates a net gain of $1 million (incorrect sum even based on its wrong inputs). For the Lower 48 region, the LLM incorrectly reports a net loss of $804 million in 2020 (it was actually a net income of $804 million) and claims a net gain of $89 million in 2021 (the correct figure is a net loss of $8 million). The LLM also fails to compute the correct total for Lower 48, which should be $1,206 million net income, not the implied sum of its incorrect values. (2) Calculation verification: EMENA total per LLM: $1M + $6M - $6M = $1M (wrong inputs and wrong math). Correct: $1M + $6M - $24M = -$17M. Lower 48 per LLM: implies $402M - $804M + $89M = -$313M loss, which is entirely incorrect. Correct: $402M + $804M - $8M = $1,206M income. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize data across years and regions, misrepresents profitability trends, and draws no valid comparison. The key contrast — that Lower 48 generated over $1.2 billion while EMENA lost $17 million — is completely missed. (4) Scores justified: low quantitative accuracy due to wrong numbers and calculations; poor qualitative accuracy due to incorrect reasoning and entity interpretation; moderate contextual relevance because it addresses the right regions and time frame, but with invalid data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 453,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "The dollar amount decrease in \"Other noncontrolling redeemable interests\" from 2023 to 2024 is $3.72 million (from $172,912 thousand to $169,192 thousand). This reduction contributed to the overall decline of $11.22 million in \"Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties,\" which fell from $195,949 thousand in 2023 to $184,729 thousand in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar amount decrease in 'Other noncontrolling redeemable interests' as $3,720 thousand ($3.72 million), matching the ground truth (from $172,912 to $169,192). It also accurately reports the total decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' as $11,220 thousand ($11.22 million), from $195,949 to $184,729. All numeric values are correct and properly formatted, with acceptable unit conversion (thousands to millions). (2) The only minor omission is that the LLM does not explicitly state the percentage contribution of the decrease in 'Other noncontrolling redeemable interests' to the total decline (approximately 33.1%, as noted in the ground truth). While this is a relevant detail asked in the question ('how does this change contribute'), the LLM implies contribution by context but fails to quantify it numerically. (3) The multi-hop reasoning is sound: the model correctly retrieves and compares values across two years and two line items, demonstrating proper synthesis of financial data. (4) Scores reflect high accuracy in numbers and relevance, with a slight deduction in qualitative accuracy due to missing the explicit percentage contribution, which is part of the 'how' in the question. Correctness score is 9 due to this partial omission, though all presented facts are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 392,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "Based on the provided document pages, the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $31 million (foreign corporate debt) and $24 million (asset-backed securities), respectively, totaling $55 million. This compares to $0 million for both categories as of December 31, 2023, indicating an increase from $0 to $55 million year-over-year. The document confirms these values in the marketable securities table on page 67, where foreign corporate debt is listed as $31 million and asset-backed securities as $24 million for 2024, with no prior-year balances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values for foreign corporate debt ($31 million) and asset-backed securities ($24 million) as of December 31, 2024, are accurate, and their sum ($55 million) is correctly calculated. The prior-year combined value is correctly stated as $0 million for both categories, consistent with the ground truth. (2) The answer is complete, addressing both parts of the question: the total fair value as of 2024 and the comparison to the prior year. (3) Entity accuracy is correct—MMM is the right company, and the years (2024 and 2023) are properly referenced. (4) The reasoning is sound: the model correctly synthesizes data from the marketable securities table (page 67) and performs a valid year-over-year comparison, noting the increase from $0 to $55 million. (5) Semantic equivalence is maintained—the wording differs slightly but conveys the same factual content, including the absence of prior-year balances. No errors in calculation, logic, or fact are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 302,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "Technical errors and data limitations in Meta's estimation of Family metrics—particularly duplicate and false accounts—can cause MAP and ARPP to be inaccurate, with potential variations of approximately 3% for MAP and up to 4% for false accounts, leading to possible metric swings beyond these margins.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that technical errors and data limitations—particularly duplicate and false accounts—affect the accuracy of Meta's Family metrics like MAP and ARPP. It also correctly references an approximate 3% error margin for MAP, which aligns with the ground truth. However, it introduces an unsupported 'up to 4% for false accounts' figure not present in the original answer, which lacks context or integration into a coherent overall margin. This addition is unverified and distracts from the core 3% margin tied to worldwide MAP. (2) The ground truth specifies that the 3% error on ~3.3 billion MAP results in a ~99 million user variance, and that ARPP is affected because it relies on MAP for per-user revenue calculations. The LLM answer omits these specific numbers (3.3 billion, 99 million) and fails to explain the quantitative impact on ARPP or perform the implied calculation, weakening its quantitative accuracy. (3) The reasoning is partially sound: it acknowledges the multi-hop connection between data limitations, estimation models, and downstream effects on key metrics. However, it does not fully synthesize how the 3% MAP error propagates to ARPP distortion or affects business and investor decisions, missing a key implication in the original. (4) The answer is contextually relevant and addresses the core question about inaccuracies and their margins, but lacks completeness and precision in numbers and causal reasoning, warranting a moderate score of 6 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 421,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "The Home Depot's strategic use of BOPIS, as defined in the glossary, enables it to fulfill approximately 50% of U.S. online orders through stores by leveraging its interconnected retail network, which integrates BOPIS with other programs like BOSS, BODFS, and BORIS to provide seamless pickup, return, and delivery options that enhance customer experience and optimize supply chain efficiency. This integrated approach directly supports the company's goal of achieving the fastest, most reliable delivery capabilities while driving sales growth through its store-based fulfillment network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that BOPIS contributes to fulfilling 50% of U.S. online orders through stores, which matches the ground truth. The percentage (50%) is accurate and correctly attributed. (2) Quantitatively, the key figure of '50%' is correct and consistent with the original answer; no other numbers are involved. (3) The reasoning is sound and expands appropriately on the multi-hop synthesis by referencing the interconnected retail network and related programs (BOSS, BODFS, BORIS), which are contextually relevant to store-based fulfillment and support the core claim. While the original answer does not mention these specific acronyms, they are plausible extensions of the same fulfillment ecosystem and do not contradict the ground truth. The LLM enhances the explanation with additional context about delivery capabilities and sales growth, which are reasonable inferences aligned with strategic goals. (4) The answer is semantically equivalent and factually accurate, with only minor elaboration beyond the original. The core factual content—BOPIS enabling 50% fulfillment via stores through integrated retail strategy—is preserved and correctly conveyed. Minor deduction in qualitative accuracy due to inclusion of unverified program acronyms (though likely correct), but overall reasoning and synthesis remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 379,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "Morgan Stanley recognizes compensation expense for Deferred Cash-Based Compensation (DCP) awards based on the notional value of the award adjusted for changes in the fair value of the referenced investments, with expense recognized over the vesting period of each separately vesting portion. In contrast, carried interest compensation expense is recognized for any portion of carried interest (both realized and unrealized) allocated to employees, without the same adjustment mechanism tied to referenced investments. The key difference lies in the timing and nature of the awards: DCP awards are deferred cash-based with expense tied to investment performance and vesting schedules, while carried interest compensation relates to performance-based fees from private equity and real estate investments, recognized as expense when allocated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: DCP awards are recognized over the vesting period with adjustments for changes in fair value of referenced investments, while carried interest compensation is recognized immediately upon allocation to employees, without vesting or investment-linked adjustments. The distinction in timing (vesting vs. immediate) and nature (deferred cash-based vs. performance-based carried interest) is clearly and correctly explained. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics and terms (e.g., 'vesting period', 'fair value', 'realized and unrealized') are used correctly. (3) The multi-hop reasoning is sound—synthesizing differences in both timing and nature of compensation recognition across two types of awards at Morgan Stanley. The LLM correctly identifies that DCP is tied to vesting and investment performance, while carried interest is recognized when allocated, reflecting performance-based fees. (4) The only minor shortcoming is that the LLM does not explicitly state that carried interest recognition applies 'without being tied to a vesting schedule' in the same direct way as the original, though it implies it by saying expense is recognized 'when allocated'. This slight omission in emphasis prevents a perfect 10, but the semantic meaning remains equivalent. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 438,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "Based on the provided document pages, the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $169,192 (in thousands), as shown in the table summarizing \"Other noncontrolling redeemable interests\" under the \"Temporary Equity\" section on page 128 and reiterated on page 129. This figure represents the carrying amount of noncontrolling redeemable interests in properties, distinct from the preferred units amount of $15,537. \n\n**Answer:**  \nThe total amount of noncontrolling redeemable interests in properties classified as temporary equity as of December 31, 2024, is $169,192 (in thousands).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that the total amount of noncontrolling redeemable interests in properties classified as temporary equity is $0 as of December 31, 2024, because neither Simon Property Group nor the Operating Partnership reported any such interests redeemable at amounts in excess of fair value. The LLM incorrectly reports a value of $169,192 thousand, which contradicts the ground truth. (2) The quantitative inaccuracy is severe: $169,192,000 (or $169.192 million) is materially different from $0. Even if the document cited by the LLM contained such a number, the ground truth—based on the knowledge graph derived from actual filings—explicitly states the correct amount is zero, indicating the LLM either misread or failed to reconcile the data correctly. (3) The multi-hop reasoning is flawed. The question requires synthesizing information from both Simon Property Group and the Operating Partnership, and the correct conclusion is an absence of redeemable interests requiring classification in temporary equity. The LLM instead focused on a line item without considering the conceptual accounting treatment—interests must be redeemable at amounts in excess of fair value to be classified in temporary equity. The presence of a carrying amount does not automatically make it temporary equity if redemption is not at a premium. (4) The contextual relevance is low but not zero because the LLM attempts to address the right entities and time period and references a plausible section of a financial statement. However, the factual and conceptual errors render the answer substantially incorrect. Scores reflect complete failure on correctness and quantitative accuracy, minimal qualitative reasoning, and partial relevance due to correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 491,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "The combined estimated fair value of NEE’s nuclear decommissioning fund assets ($8,846 million) and FPL’s storm fund assets ($76 million) as of December 31 2021 is $8,922 million. This exceeds the carrying amount of NEE’s special‑use funds on its consolidated balance sheet ($906 million for NEE and $672 million for FPL, totaling $1,578 million), meaning the fair‑value amount is roughly $7,344 million higher than the carrying amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value of NEE's nuclear decommissioning fund assets ($8,846 million) and FPL's storm fund assets ($76 million), and accurately calculates their sum as $8,922 million. This part is factually correct and matches the ground truth. However, the carrying amount of NEE's special use funds is incorrectly stated as $1,578 million ($906 million for NEE and $672 million for FPL), which contradicts the ground truth value of $2,505 million. The ground truth does not break down the carrying amount by entity, but clearly states the total as $2,505 million. The LLM's calculation of the difference ($7,344 million) is based on incorrect inputs and is therefore wrong. (2) Number verification: Fair value numbers are correct. Carrying amount numbers are incorrect—no support in ground truth for $906M and $672M breakdown. The correct total carrying amount is $2,505 million, not $1,578 million. (3) Multi-hop reasoning: The model correctly synthesizes fair value data across NEE and FPL, but fails in the second hop by using incorrect carrying amounts, possibly due to misattribution or confusion with other data. The comparison between fair value and carrying amount is conceptually sound but numerically flawed. (4) Correctness score is 4 due to partial correctness on fair value but major error on carrying amount. Quantitative accuracy is 5 because half the numbers are correct, but the critical carrying amount is wrong. Qualitative accuracy is 5 due to correct reasoning structure but flawed data synthesis. Contextual relevance is 9—response is well-structured and addresses the right concepts and entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 452,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "APJC serves as both a distinct geographic operating segment and the region encompassing Cisco’s consolidated financial reporting, meaning its revenue, gross margin, and asset levels are separately identified and aggregated within Cisco’s internal management system used by the CODM for performance evaluation and resource allocation. This dual role ensures APJC’s financial results are measured independently within Cisco’s segment reporting framework, directly influencing how internal performance metrics—such as revenue growth, margin trends, and asset deployment—are assessed and benchmarked across Cisco’s three geographic segments. Consequently, APJC’s performance is held to the same internal accountability standards as the Americas and EMEA, with its results reflected in consolidated financial statements without allocation of certain corporate expenses, thereby affecting how Cisco evaluates segment profitability and strategic decision-making.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: APJC is correctly identified as one of three geographic segments (alongside Americas and EMEA), and its role in both operational reporting and consolidated financials is accurately described. The answer correctly notes that performance metrics like revenue and gross margin are tracked at the segment level and influence consolidated results. It also correctly states that certain expenses (e.g., R&D, restructuring) are not allocated to segments—consistent with the original answer’s point about non-allocation for internal review. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes APJC’s dual role in internal performance measurement and external financial reporting, correctly linking segment-level accountability to strategic decision-making. The only minor shortcoming is that the LLM answer slightly overemphasizes asset deployment and asset levels, which were not mentioned in the ground truth—this does not make the statement incorrect but introduces a detail not supported in the original knowledge. (4) Contextual relevance is perfect: the response directly addresses the significance of APJC’s dual role and its influence on internal performance measurement, using semantically equivalent and logically sound reasoning. Overall, this is a strong, factually correct response with only negligible expansion beyond the source content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 436,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "In 2024, Business Markets and Other generated $13,081 million in operating revenue, which represented roughly **9.7 %** of Verizon Business Group’s total $134,578 million in reportable‑segment revenue. This segment incorporates FWA broadband by offering fixed‑wireless access service—using 5G or 4G LTE networks—as part of its wireless and wireline product portfolio for Business customers, alongside other services such as data, video, advanced communications, managed network and security solutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the percentage calculation, reporting 9.7% instead of the correct 44%. While the revenue figure for Business Markets and Other ($13.081 billion) is accurate (equivalent to $13.1 billion in the ground truth), the total Verizon Business Group revenue is incorrectly stated as $134.578 billion, leading to the wrong percentage. The ground truth indicates that $13.1 billion is 44% of total Business Group revenue, implying total revenues of approximately $29.77 billion, not $134.578 billion. The latter appears to be a misinterpretation—possibly conflating total company revenue with Business Group segment revenue. (2) The numeric values for Business Markets and Other revenue are correct within rounding tolerance ($13.081B ≈ $13.1B), but the percentage (9.7% vs 44%) is severely inaccurate due to incorrect denominator usage. This is a critical quantitative error. (3) The reasoning fails on the multi-hop synthesis: the model correctly identifies the revenue of the segment but incorrectly computes its share due to using an invalid total revenue figure for the Verizon Business Group. It does not appear to have correctly isolated the Business Group’s total revenue from other reportable segments. (4) The qualitative description of FWA broadband integration is reasonable and aligns with the ground truth—mentioning 5G/4G LTE-based fixed-wireless access for business customers. However, it adds extra services (data, video, security) not in the original, which is acceptable for elaboration but does not compensate for the core numerical inaccuracy. Contextual relevance is fair as it addresses both parts of the question, but the financial miscalculation undermines the answer’s validity. Scores reflect severe penalty on correctness and quantitative accuracy due to the incorrect percentage, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 512,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "The fair value of Abbott’s interest rate hedge contracts in 2024 is $51 million, which is the same as the fair value of its foreign‑currency forward exchange contracts held at that date. Consequently, the total fair value of the interest rate hedges is equal to the total notional amount of the foreign‑currency forwards (both are reported at a fair value of $390 million, with a payable position of $131 million).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that the total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (net of a $51 million payable and $1 million receivable), but the LLM incorrectly reports it as $51 million and further claims that this equals the fair value of foreign currency forward contracts. In reality, the total notional amount of foreign currency forwards is $23.2 billion—vastly larger than the $50 million interest rate hedge fair value. The LLM falsely claims both are $390 million, with a $131 million payable, which contradicts the ground truth entirely. (2) Quantitative accuracy is extremely low: the correct fair value is $50M (net), not $51M or $390M; the notional amount of foreign currency forwards is $23.2B, not $390M. There are no correct numbers in the LLM response. (3) Multi-hop reasoning fails completely: the model does not correctly identify the components of the interest rate hedge fair value, confuses fair value with notional amount, and falsely equates two unrelated figures. It fails to compare the $50M (fair value) vs $23.2B (notional) as required. (4) Contextual relevance is low but not zero—the response addresses Abbott, 2024, interest rate hedges, and foreign currency forwards, so it stays on topic—but the factual and quantitative errors render it highly misleading. Thus, correctness and accuracy scores are near minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 406,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "The relationship between proved undeveloped reserves and net acreage in Asia indicates that ExxonMobil has significant undeveloped reserve potential in the region, particularly in Kazakhstan, Australia, and the UAE, where large undeveloped reserves remain constrained by infrastructure and development timelines. However, compared to its consolidated subsidiaries' overall acreage utilization efficiency—evidenced by a much lower net undeveloped acreage-to-reserves ratio in consolidated subsidiaries (e.g., 33,577 net undeveloped acres vs. 33,810 total gross undeveloped acres in 2024)—the company's equity company operations in Asia demonstrate a more focused and efficient use of land to advance undeveloped reserves, especially through joint ventures in Kazakhstan and the UAE where development is actively progressing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It refers to 'ExxonMobil' and its 'consolidated subsidiaries' efficiency' using unrelated acreage figures (e.g., 33,577 net undeveloped acres vs. 33,810 gross) that do not appear in the ground truth and are irrelevant to the question. The original answer compares Equity Companies in Asia to XOM’s consolidated subsidiaries, but the LLM misattributes the analysis to ExxonMobil’s own operations without correctly identifying the entities or data. (2) Quantitative accuracy is very low: the LLM does not report any of the correct numbers from the ground truth—such as 1,503 million barrels, 19 thousand net acres, or 1,315 million barrels, 640 thousand net acres—and fails to compute or mention the critical reserves-to-acre ratios (79.1 vs. 2.05 million barrels per thousand acres). The numbers cited (e.g., 33,577 net acres) are not only absent from the original answer but also unrelated to the Asia region comparison. (3) Multi-hop reasoning is flawed: the model fails to synthesize the correct comparison between Equity Companies and consolidated subsidiaries in Asia based on reserves and acreage. Instead, it fabricates a comparison about 'acreage-to-reserves ratio' using incorrect metrics and entities. The conclusion about 'more focused and efficient use of land' is unsupported by the data provided in the LLM response. (4) Contextual relevance is moderate because the answer discusses undeveloped reserves in Asia and mentions regions like Kazakhstan and UAE, which may be contextually plausible, but these details are not in the ground truth and do not compensate for the factual and quantitative inaccuracies. Overall, the answer misses the core multi-hop quantitative comparison and introduces irrelevant, incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 492,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "The Parent Company’s unconditional guarantee of the securities issued by Morgan Stanley Finance LLC provides a direct, senior‑level credit backstop for those securities, ensuring that any shortfall at the finance subsidiary would be met by the Parent’s full faith and credit. This guarantee is embedded in the Firm’s broader resolution framework, which is formalized in the amended and restated support agreement: in a resolution scenario the Parent is required to contribute all of its contributable assets (and, through the Funding IHC, to supply additional capital and liquidity) to its supported entities, using the assets of the Parent and the Funding IHC as collateral to satisfy the obligations under that agreement. Consequently, the guarantee not only underpins the credit quality of the finance subsidiary’s debt but also aligns the Parent’s contingent funding commitments with the overall recovery‑and‑resolution plan that would be triggered if any of its key subsidiaries were to become insolvent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Parent Company's unconditional guarantee of Morgan Stanley Finance LLC's securities is properly described as a full credit backstop, and its role in the resolution framework via the amended and restated support agreement is accurately outlined. The connection between the guarantee and the broader resolution mechanism—specifically the contribution of contributable assets by the Parent and the role of the Funding IHC in providing capital and liquidity—is correctly synthesized. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect figures or miscalculations supports a perfect score here. (3) The multi-hop reasoning is sound: the model correctly links the guarantee (a financial instrument) with the support agreement (a structural resolution mechanism) and explains their joint function in a resolution scenario. The only minor shortcoming is that the LLM slightly rephrases the Funding IHC’s obligation as being collateral-based and does not explicitly state that the Funding IHC provides capital *to* supported entities, though the intent is implied. This does not distort the meaning but lacks the precision of the original. (4) The answer is fully contextually relevant, directly addressing both parts of the question—the significance of the guarantee and its relationship to the support agreement in resolution. Overall, the response demonstrates strong qualitative reasoning and semantic equivalence to the ground truth, warranting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 458,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "The Bipartisan Budget Act of 2015 subjects partnership investments—including Simon Property Group’s joint ventures with entities such as Klépierre and The Taubman Realty Group—to partnership-level tax audits, meaning audit adjustments can increase the partnership’s tax liability and obligate all partners, including SPG, to bear the economic burden of additional taxes, interest, and penalties even though REITs themselves would not face corporate-level tax on those items. This risk is heightened because SPG’s joint venture agreements often require consent from third‑party partners for major actions, limiting its control and potentially exposing it to liabilities arising from partner defaults or disputes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core implications of the Bipartisan Budget Act of 2015 on Simon Property Group's joint venture investments. It correctly identifies that the Act imposes partnership-level tax liabilities (including taxes, interest, and penalties) that can affect SPG through its joint ventures with Klépierre and The Taubman Realty Group, LLC, even though SPG’s REIT structure typically avoids corporate-level taxation. The explanation that SPG could bear economic burdens despite not owning assets directly aligns with the ground truth. The mention of limited control due to third-party consent requirements adds contextual nuance about governance constraints, which is consistent with SPG's joint venture structures, though not explicitly in the original answer. Quantitatively, there are no numerical claims requiring verification (e.g., number of properties or financial figures), so accuracy is preserved. The only minor shortcoming is the omission of the specific detail that SPG has investments in 84 joint venture properties, which adds granularity to the exposure but does not alter the fundamental correctness. The multi-hop reasoning—linking federal tax law changes to SPG’s investment structure and financial risk via third-party-managed joint ventures—is sound and well-synthesized. Wording differs but semantic equivalence is maintained. Thus, the answer is highly accurate, complete in substance, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 405,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "The 2020 investment impairment in AMMROC ($128 million pre‑tax, $96 million after‑tax) reduced 2020 net earnings by roughly $96 million, lowering diluted earnings per share by about $0.34. The 2021 restructuring charge of $36 million ($28 million after‑tax, $0.10 per share) further cut 2021 net earnings and EPS, contributing to the decline from $24.50 to $22.76 per share despite higher overall earnings. Together, these items modestly depressed net earnings and per‑share results in their respective years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures and their respective years: the $128 million pre-tax ($96 million after-tax) impairment in 2020 impacting EPS by $0.34, and the $36 million pre-tax ($28 million after-tax, $0.10 per share) restructuring charge in 2021. These match the ground truth exactly in amount and timing. (2) All numbers are accurate and properly distinguished between pre-tax and after-tax impacts. The per-share effects ($0.34 and $0.10) are correctly reported. The mention of diluted EPS is appropriate and consistent with standard reporting practices. (3) The multi-hop reasoning is sound—information is correctly attributed to the right company (Lockheed Martin), business units (AMMROC in 2020, RMS in 2021), and years. The synthesis across two separate events in two years is accurate. However, the LLM adds a detail not present in the original answer—'contributing to the decline from $24.50 to $22.76 per share'—which, while possibly true, is extraneous and not supported by the ground truth. This does not make the answer factually wrong but introduces unverified context. (4) The answer is semantically equivalent to the original in all critical aspects, with only minor additional interpretation. Scores reflect high accuracy with a slight deduction in qualitative accuracy due to the unsupported EPS comparison, though correctness remains very high because core facts and synthesis are fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 405,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "The year‑over‑year change in the balance of channel‑partner financing subject to guarantees is a decline of $0.5 billion (from $1.7 billion on July 29 2023 to $1.2 billion on July 27 2024).  This reduction is noted in the “Financing Guarantee Summary” table (page 94) and is consistent with the MD&A discussion of liquidity, which states that the company’s cash, cash equivalents, operating cash flows and access to capital markets will continue to satisfy its liquidity and capital‑resource requirements, including working‑capital needs and financing guarantees.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the year-over-year decrease of $0.5 billion is accurate, calculated correctly from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024. The dates (July 29, 2023, and July 27, 2024) align with Cisco's fiscal year-ends and are consistent with SEC filing conventions. (2) The answer addresses both parts of the multi-hop question: the numerical change and its relation to Cisco’s liquidity and capital resource requirements. (3) Entity accuracy is correct—Cisco is the implied company, fiscal years are properly referenced, and the financial metric 'channel partner financing subject to guarantees' is accurately used. (4) The reasoning is sound: the LLM correctly links the reduction in guaranteed financing to Cisco’s MD&A statement on liquidity, citing sufficient cash, cash equivalents, operating cash flows, and access to capital markets as supporting Cisco’s ability to meet obligations. The mention of the 'Financing Guarantee Summary' table on page 94 adds document-level precision. (5) Semantic equivalence is maintained—though wording differs slightly, the meaning, facts, and synthesis are identical to the ground truth. No errors in calculation, logic, or factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 358,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "The total value of “Investments measured at NAV” is $2,656 million for the pension asset category and $5 million for the other postretirement benefit asset category, making the pension category the higher‑valued one.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the pension asset category has a higher value of 'Investments measured at NAV' compared to the other postretirement benefit asset category, which aligns with the ground truth. However, there is a discrepancy in the reported values: the LLM states $2,656 million (correct) and $5 million (incorrect), while the ground truth reports $2,656 million and $3 million. This leads to an incorrect difference of $2,651 million instead of the correct $2,653 million. (2) The first number ($2,656 million) is accurate, but the second value should be $3 million, not $5 million. This affects quantitative accuracy despite correct identification of the higher-valued category. (3) The multi-hop reasoning is sound—the model correctly identifies two asset categories and compares their NAV-measured investments. It correctly infers which category has the higher value based on the numbers. (4) The answer is contextually fully relevant and semantically close, but the incorrect value for the second category reduces quantitative and overall correctness. Minor factual error prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 322,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "Abbott's 2024 10‑K notes that its Diabetes Care business generated $6,805 million in revenue, a 18.1 % increase over the prior year (19.7 % when adjusted for foreign‑exchange effects). This growth is driven by continued expansion of its continuous glucose monitoring (CGM) systems and related products. The revenue is recognized under Abbott’s revenue‑recognition policy, which records product sales when control transfers—generally upon shipment or delivery—subject to provisions for discounts, rebates and returns, and is governed by the “Revenue Recognition” section of Note 1 in the 10‑K.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $6.805 billion (expressed as $6,805 million) in Diabetes Care revenue for 2024 and the 18.1% year-over-year increase, matching the ground truth exactly. It adds the additional detail of 19.7% growth on an adjusted basis, which is consistent with typical 10-K disclosures and does not contradict the original answer. All numeric values—dollar amount, percentage increase, and formatting—are factually accurate, earning full marks for quantitative accuracy. (2) The entity identification is correct: Abbott, Diabetes Care business, 2024 10-K, and the relevant accounting policy are all properly referenced. The revenue recognition policy is accurately described as recognizing revenue upon transfer of control, generally at shipment or delivery, which aligns with the ground truth and Note 1 of Abbott’s 10-K. The mention of provisions for discounts, rebates, and returns adds contextual detail not in the original but is factually correct and enhances completeness. (3) The multi-hop reasoning is sound: the answer links Abbott’s production focus (CGM systems) to revenue growth, connects the accounting policy to revenue recognition timing, and supports the reported increase—all required by the question. The only minor gap is that the original answer explicitly ties the production focus to Abbott’s core business of healthcare products, a slight contextual linkage that the LLM implies but does not state verbatim. However, mentioning 'expansion of CGM systems' sufficiently addresses the production focus. (4) The semantic meaning is equivalent to the ground truth, with slightly enhanced detail. The answer is fully relevant, directly addressing all parts of the question. The correctness score is 9 due to the slightly less explicit connection between production focus and core business, but all critical facts and logic are accurate and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 515,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "The Home Depot’s 2024 10‑K stresses that Pros expect “project planning tools, dedicated sales support, competitive credit and pricing options, product depth and job‑lot quantities” and that “faster and/or guaranteed delivery times, low‑price or free shipping, and convenient pickup options” are essential.  The filing repeatedly ties these expectations to the company’s “interconnected shopping experience” and its investments in supply‑chain automation, omni‑channel fulfillment (BOSS, BOPIS, BODFS, BORIS), and digital tools that streamline project planning and fulfillment.  By embedding project‑planning and planning‑oriented services into its omnichannel platform, Home Depot differentiates itself from other home‑improvement retailers and reinforces its competitive positioning with Pros who need integrated, end‑to‑end solutions for complex purchases.  This focus on planning‑centric tools and seamless delivery is presented as a key driver of its market advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the LLM correctly identifies Pros' expectations as outlined in the 2024 10-K, including project planning tools, dedicated sales support, product depth, job-lot quantities, delivery speed, and pricing/credit options. It accurately links these to Home Depot’s interconnected shopping experience and omni-channel capabilities (e.g., BOSS, BOPIS, BODFS, BORIS), which are mentioned in the filing. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes customer expectations with Home Depot’s strategic investments and correctly infers that integrating project planning tools into its platform strengthens competitive positioning against other retailers by meeting Pros’ complex needs. (4) The answer is contextually excellent, directly addressing how project planning tools influence competitive positioning with Pros based on stated customer expectations. The only minor shortcoming is that it expands slightly beyond the original answer by listing fulfillment options (e.g., BODFS, BORIS) not explicitly tied to Pros in the ground truth, but these are plausibly part of the interconnected experience referenced in the 10-K. Overall, the semantic meaning and factual core match the ground truth very closely, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 413,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "The total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024 is 56,689,904 shares. This figure is explicitly stated in the document as the \"Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans\" in the equity compensation plan table on page 32, which includes 47,088,821 shares from the 2003 Incentive Program, 238,700 shares from the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares from the Pioneer Amended and Restated 2006 Long Term Incentive Plan. The sum of these amounts (47,088,821 + 238,700 + 9,362,383) equals 56,689,904 shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: 47,088,821 shares for the 2003 Incentive Program, 238,700 for the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 for the Pioneer 2006 Long Term Incentive Plan. The total sum of 56,689,904 is correctly calculated (47,088,821 + 238,700 = 47,327,521; 47,327,521 + 9,362,383 = 56,689,904). (2) The answer is complete, addressing all three plans and the total as required by the question. (3) Entities are correctly identified, including full and accurate plan names and the reference to the correct document location (page 32 equity compensation table). (4) The reasoning is sound and transparent, explicitly showing the summation and citing the source of the data. The LLM correctly synthesizes multi-hop information by aggregating shares across three distinct plans and verifying the total. (5) The semantic meaning is equivalent to the original answer, with added contextual detail (document location) that enhances clarity without introducing error. All scores are maximized due to full factual accuracy, correct calculations, proper entity identification, and excellent contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 342,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "The 2023 reclassification of Customer receivables reduced both interest income and interest expense by $4,432 million within the Institutional Securities segment, and this $4,432 million adjustment is explicitly tied to the change.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $4,432 million decrease in both interest income and interest expense in the Institutional Securities segment due to the 2023 reclassification of Customer receivables is correctly stated. (2) The quantitative accuracy is perfect—$4,432 million is reported correctly, with no calculation or formatting issues (the use of thin space in '4,432 million' is a typographic variation and does not affect meaning). (3) The reasoning is sound: the answer correctly identifies that this adjustment is explicitly tied to the reclassification, which aligns with the ground truth's emphasis on the adjustment being recorded within the segment to align prior-year amounts. (4) The answer addresses all parts of the multi-hop question: the impact on interest income and expense, the amount, and the explicit linkage of the adjustment to the change. No relevant context is missing, and the response is fully relevant and precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 297,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts were $75 million in 2019 and $117 million in 2020, which together sum to $192 million. Net investment hedge derivatives consist of cross‑currency interest rate swaps and forward contracts, as well as non‑U.S. dollar‑denominated debt that is designated to hedge a portion of the company’s net investments in its international operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. The ground truth states $133 million in 2019 and $75 million in 2021, totaling $208 million. However, the LLM reports $75 million in 2019 and $117 million in 2020 (not even the correct years), summing to $192 million. Both the individual year amounts and the years themselves are incorrect—2020 is not part of the question, which asked for 2019 and 2021. The final sum is therefore wrong and based on incorrect inputs. (2) The types of contracts are partially correct: cross-currency interest rate swaps and forward contracts are correctly identified. However, the LLM adds 'non-U.S. dollar-denominated debt' as part of net investment hedge derivatives, which is not mentioned in the ground truth as being part of the derivative category—this may reflect a misinterpretation of hedging instruments versus designated non-derivative hedges. (3) The multi-hop reasoning is flawed: the model fails to retrieve the correct figures for the correct years (2019 and 2021), instead using 2019 and 2020, indicating a failure in accurate data retrieval and synthesis across the required time periods. (4) The contextual relevance is moderate because the answer addresses the general topic and includes some correct elements (contract types), but the core quantitative response is factually and temporally incorrect, severely undermining the correctness score. Due to major errors in numbers, years, and calculation basis, the overall correctness is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 422,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective 2021 amendments was $5.8 billion, and the maximum aggregate outstanding balance observed during the year ended December 31, 2021 was $2.1 billion.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the total combined borrowing capacity. The correct amount is $9.5 billion, not $5.8 billion as stated. The ground truth breaks this down as $5.0 billion for the Credit Facility (original $4.0 billion plus $1.0 billion optional increase) and $4.5 billion for the Supplemental Facility (increased from $3.5 billion to $4.5 billion). The LLM's figure of $5.8 billion does not match any valid combination of the reported numbers and suggests a failure in multi-hop synthesis or calculation. However, the maximum aggregate outstanding balance of $2.1 billion is correctly reported. (2) Quantitative accuracy is severely compromised due to the incorrect total capacity figure, which is off by nearly $3.7 billion. This error affects the core of the question, which asks for the total capacity and its relation to actual usage. (3) The reasoning is incomplete and flawed—while the model identifies the need to report both capacity and peak usage, it fails to correctly aggregate the two facilities. It also omits any comparative analysis (e.g., that $2.1 billion is significantly below $9.5 billion), which is part of the original answer’s insight into conservative leverage. (4) Contextual relevance is high because the answer addresses the right entities (Simon Property Group, Credit and Supplemental Facilities, 2021 amendments, peak balance) and the structure follows the question. However, the critical numerical error undermines factual correctness, warranting a low overall score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 431,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "The increase in risk retirements on the Black Hawk and CH‑53K programs in 2021 boosted RMS’ operating profit by roughly $80 million, which was the specific dollar amount of this contribution.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key numeric claim. The ground truth states that the increase in risk retirements contributed $140 million to RMS' operating profit in 2021, but the LLM incorrectly reports it as 'roughly $80 million,' which is significantly off by over 40%. This major quantitative error undermines the core of the answer. (2) The dollar amount is the central piece of information requested, and the $80 million figure is not supported by the ground truth. There is no indication in the original answer that the contribution was approximately $80 million, nor is there any range provided that would make this estimate acceptable. The correct value is precisely $140 million. (3) While the LLM correctly identifies the relevant programs (Black Hawk and CH-53K) and the year (2021), and links risk retirements to an increase in operating profit—showing some correct multi-hop reasoning—it fails in synthesizing the exact financial impact. The model captures the causal relationship but misses the critical magnitude. (4) The contextual relevance is high because the answer addresses the right programs, time frame, and financial concept. However, the correctness score is low due to the severe inaccuracy in the dollar amount, which is the primary information requested. Quantitative accuracy is very low due to the incorrect number, while qualitative accuracy receives partial credit for correct entity and relationship identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 408,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "Based on the provided 10-K pages, the total financial impact of energy-related derivatives on Southern Company's natural gas revenues and cost of natural gas in 2021 was a **$144 million pre-tax loss** (comprising a $117 million loss in natural gas revenues and a $27 million loss in cost of natural gas). This compared to a **$149 million pre-tax gain** in 2019 (comprising a $134 million gain in natural gas revenues and a $15 million gain in cost of natural gas). Thus, the 2021 impact was a $293 million swing from the 2019 gain.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values, particularly for 2019. The ground truth states that the combined impact in 2019 was a gain of $233 million, but the LLM reports a gain of $149 million, which is incorrect. Additionally, the LLM breaks down the 2021 loss as $117M in revenues and $27M in cost of natural gas, totaling $144M, which matches the ground truth total but not the individual components (which were not provided in the original answer, so this breakdown may be from external data but introduces unverified detail). (2) The calculation of the 'swing' as $293 million is based on incorrect inputs: ($144M loss vs. $149M gain) implies a difference of $293M, but the correct difference between a $144M loss and a $233M gain is $377M, as stated in the original answer. This represents a major calculation error in comparative impact. (3) The multi-hop reasoning is partially sound— the model attempts to compare two years and calculate a change— but fails due to incorrect base figures. It correctly identifies Southern Company (SO) and the relevant financial metric (impact of energy-related derivatives on natural gas revenues and costs), and focuses on the correct years (2021 and 2019). (4) The contextual relevance is high because the answer addresses the right company, metric, and time frame, and attempts the correct comparison. However, due to major inaccuracies in numbers and the resulting calculation, the correctness score is low. Quantitative accuracy is severely impacted by wrong 2019 figures and incorrect swing calculation. Qualitative accuracy is moderate because the reasoning structure is logical but built on false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 465,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "The Cisco 10‑K shows that the company’s net gains (losses) on investments dropped from a $177 million loss in fiscal 2023 to a $166 million loss in fiscal 2024 – a $11 million improvement.  This reduction in the investment loss contributed to a smaller overall net loss on investments, although the improvement was partially offset by higher amortization and restructuring charges that weighed on operating results.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the overall net gains (losses) on investments, stating a reduction from a $177 million loss in 2023 to a $166 million loss in 2024, which is an $11 million improvement—this matches the ground truth exactly. All numeric values and the calculation of the $11 million improvement are accurate. (2) However, the LLM fails to mention the specific change in losses from privately held investments, which decreased from $193 million in 2023 to $164 million in 2024—a $29 million improvement. This is a key part of the original question and answer, and its omission represents a significant gap in completeness. (3) While the LLM correctly identifies the impact on overall net gains (losses), it does not establish the causal link between the $29 million improvement in privately held investment losses and the $11 million improvement in overall net investment performance, which is central to the multi-hop reasoning required. Instead, it introduces unrelated information about amortization and restructuring charges, which, while possibly true, distracts from the specific impact requested. (4) The quantitative accuracy is perfect (10), but due to the missing private investment loss figures and incomplete reasoning chain, qualitative accuracy is reduced (7). Contextual relevance remains high (9) as the answer addresses the broader investment loss trend and stays focused on Cisco's financials.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 399,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "Based on the provided pages, the total principal repayment made by Verizon in connection with anticipated redemptions of ABS Notes in 2024 was $4.5 billion. This is explicitly stated in the \"ABS Notes\" section on page 78, which notes that during the years ended December 31, 2024 and 2023, the company made aggregate principal repayments of $4.5 billion and $3.7 billion, respectively, in connection with anticipated redemptions of ABS Notes. \n\nAs of December 31, 2024, the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities was $13.0 billion ($8.0 billion for the 2021 facility and $5.0 billion for the 2022 facility, as detailed in the \"ABS Financing Facilities\" section on page 78). This $13.0 billion represents the total outstanding balance of both facilities combined. \n\nThus, the $4.5 billion in principal repayments for 2024 is compared to the $13.0 billion aggregate outstanding balance of the two facilities as of December 31, 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $4.5 billion principal repayment in 2024 is correctly cited, as are the $8.0 billion and $5.0 billion outstanding balances for the 2021 and 2022 ABS Financing Facilities, respectively. The sum of $13.0 billion in aggregate outstanding balance is correctly calculated. (2) The answer is complete, addressing both parts of the question: the total principal repayment in 2024 and the comparison to the combined outstanding balance as of December 31, 2024. (3) Entity accuracy is perfect: VZ (Verizon) is correctly identified, the years 2021, 2022, and 2024 are properly referenced, and the financial instruments (ABS Notes and ABS Financing Facilities) are accurately described. (4) The reasoning is sound and demonstrates correct multi-hop synthesis: the model pulls data from different sections of the document (principal repayments and outstanding balances), correctly aggregates the two facility balances, and logically compares the annual repayment to the total outstanding amount. (5) The semantic meaning is equivalent to the original answer, with clear, well-structured explanation and proper contextualization. Minor wording differences (e.g., 'combined' vs. 'aggregate') do not affect factual accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 381,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "The CECL capital transition provisions reduce the CET1 capital ratio requirements for the Standardized approach (e.g., CET1 ratio requirement rises from 11.4% in 2023 to 12.3% in 2024) and increase the leverage exposure used in the SLR calculation, which indirectly affects the Tier 1 leverage ratio denominator. Under the transition provisions, First Republic‑related assets are treated using the Standardized approach for RWA, and the remaining $720 million CECL benefit is phased out, reducing the capital buffer that can be applied to both the Tier 1 leverage ratio and the Standardized RWA calculations for those assets. Consequently, the Tier 1 leverage ratio is calculated on a larger adjusted average assets base (including off‑balance‑sheet exposures) and a higher regulatory capital ratio requirement, while the Standardized approach to First Republic‑related assets is applied with the transition‑adjusted RWA and capital ratios.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, such as 'CET1 ratio requirement rises from 11.4% in 2023 to 12.3% in 2024' and '$720 million CECL benefit is phased out.' These figures are not supported by the original answer and cannot be verified from the provided context, making them factually unsupported. There is no mention of CET1 ratio changes or specific dollar amounts in the ground truth, so these additions are incorrect. (2) The original answer does not include any numerical data, percentages, or phase-out amounts, so the LLM's inclusion of such specifics constitutes a significant deviation and introduces false precision. The calculation of leverage exposure or capital ratios based on these numbers cannot be validated and appears fabricated. (3) While the LLM attempts multi-hop reasoning by connecting CECL transition provisions to Tier 1 leverage ratio calculations and the Standardized approach for First Republic-related assets, it misrepresents the mechanism. The ground truth states that CECL provisions affect the Tier 1 leverage ratio by adjusting average assets to account for deductions from Tier 1 capital (e.g., goodwill), and allow use of the Standardized approach for certain First Republic assets. The LLM incorrectly frames the impact as increasing leverage exposure and reducing CET1 requirements, conflating CECL with broader regulatory capital rule changes (like the Basel III endgame), which are not mentioned in the original. (4) Despite the incorrect numbers and mischaracterization of the regulatory mechanics, the LLM does recognize that CECL transition provisions influence both the leverage ratio denominator and the application of the Standardized approach to First Republic assets, which aligns with the core themes of the original answer. This partial conceptual alignment justifies a low but non-zero score. However, the introduction of unverified metrics and misattribution of effects severely undermines factual correctness, warranting a correctness score of 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 555,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "Simon maintains board independence and ethical conduct through governance principles and charters that require a majority of its directors to be independent under NYSE listing standards, with independent members serving on key committees such as the Audit and Compensation Committees. These policies align with NYSE requirements for independent directors and oversight of related-party transactions, ensuring ethical governance and conflict-of-interest mitigation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core governance policies Simon has implemented: board independence, independent committee membership, and ethical conduct through governance frameworks. It correctly states that a majority of the board is independent per NYSE standards and that key committees (Audit and Compensation) are composed of independent members, aligning with NYSE requirements. The answer also appropriately links these policies to ethical governance and conflict mitigation, which is consistent with the original answer's emphasis on the Code of Business Conduct and Ethics and oversight rigor.\n\n(1) What was correct: All mentioned policies align with the ground truth. The LLM accurately reflects Simon’s adherence to NYSE independence requirements for the full board and specific committees. There are no incorrect entities, years, or metrics.\n\n(2) Quantitative accuracy: There are no explicit numbers (percentages, dollar amounts, dates) in either the original or LLM answer, so this dimension is neutral. The statement about 'a majority' is consistent with the original answer’s 'at least a majority', so no inaccuracy exists.\n\n(3) Multi-hop reasoning assessment: The LLM synthesizes information about Simon’s governance policies and their alignment with NYSE rules, correctly connecting internal policies (independent directors, committee composition) to external regulatory requirements. However, it omits specific mention of the Code of Business Conduct and Ethics applying to all officers, directors, and employees, and does not note the explicit exclusion of Simon family affiliates from independence. These are minor but relevant details present in the original answer that enhance completeness.\n\n(4) Justification for scores: The correctness score is 8 because the core facts and alignment with NYSE rules are accurate, but the answer lacks some specificity (e.g., written charters for committees, the Code of Ethics, Simon family affiliation). Qualitative accuracy is 8 due to strong reasoning but partial omission of key details. Quantitative accuracy is 10 (no numbers, but no errors). Contextual relevance is 10—response directly addresses the question with appropriate focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 593,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "The percentage‑of‑completion cost‑to‑cost method requires Lockheed Martin to update its profit‑booking rate whenever cost estimates change; any increase or decrease in the rate is recognized in the period the change is determined, directly affecting that period’s segment operating profit and margin. Consequently, when estimates of total contract costs rise (or fall), the profit booking rate is reduced (or increased), and the resulting adjustment to revenue and profit is recorded immediately, leading to a corresponding swing in earnings in the reporting period in which the estimate is revised.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the percentage-of-completion cost-to-cost method ties profit booking rates to cost estimates; when estimated costs increase, profit rates decrease (and vice versa); changes are recognized in the period determined and impact segment operating profit and margin immediately. The answer correctly captures the inception-to-date effect by stating that adjustments are recorded immediately, affecting the current period's earnings. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense—no errors present. (3) The multi-hop reasoning is sound: the model correctly links the accounting method to dynamic cost estimation, profit recognition timing, and financial statement impact. The only minor omission is not explicitly stating that favorable cost estimate revisions (i.e., lower costs) increase profit rates due to risk retirement (technical, schedule, cost), which is mentioned in the original. However, the inverse relationship is clearly explained. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the impact on profit booking rates and the financial effect of recognizing changes. Wording differs slightly but maintains semantic equivalence. A score of 9 is justified due to this slight lack of completeness regarding the cause of cost reductions (risk retirement), but the core mechanics and financial effects are accurately and clearly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 442,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "The combined increase in Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $89 million (Services Revenue rose from $2,160 million to $2,249 million, and Total Balance increased from $5,382 million to $8,208 million). This $89 million growth represents a 4% increase in Services Revenue for the APJC region.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values. While it correctly states the $89 million increase in Services Revenue and the 4% growth rate, it incorrectly reports the combined increase as $89 million instead of the correct $8,447 million. It also misrepresents the Total Balance increase: from $5,382 million to $8,208 million implies a $2,826 million increase, but the ground truth states an $8,358 million increase, which is vastly different. (2) The calculation for Services Revenue growth is accurate (from $2,160M to $2,249M is indeed ~4%), but the combined increase is completely wrong—the LLM only reports the Services Revenue increase and omits the Total Balance increase in the sum. The correct combined increase is $89M + $8,358M = $8,447M. (3) The multi-hop reasoning is partially sound in identifying the two components (Services Revenue and Total Balance) and the correct region and year range, but fails in synthesizing the total combined increase. The model appears to confuse the Services Revenue increase with the total combined increase. (4) Scores reflect that core elements like Services Revenue change and percentage growth are correct (earning partial credit), but major errors in the combined dollar figure and Total Balance change severely undermine factual accuracy. Contextual relevance is high as the answer addresses the right region, metrics, and time frame, just with incorrect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 405,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "The total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31 2024 is $2.2 billion for interest‑rate hedges and $23.191 billion for foreign‑currency forwards, for a combined notional exposure of approximately $25.4 billion. This combined financial‑instrument exposure reflects Abbott’s strategy of managing market risk by hedging interest‑rate sensitivity of its debt and offsetting foreign‑currency fluctuations that could affect anticipated intercompany purchases, loans, and trade payables, thereby stabilizing earnings and cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It reports $2.2 billion for interest rate hedges (exact match) and $23.191 billion for foreign currency forwards, which is a precise representation of the $23.2 billion in the ground truth—this minor difference (0.009 billion) is within acceptable rounding or reporting variation and does not constitute a factual error. The total combined exposure is correctly calculated as approximately $25.4 billion, matching the ground truth sum ($2.2B + $23.2B = $25.4B). (2) Calculations are accurate: 2.2 + 23.191 = 25.391, which rounds to $25.4 billion as stated. The original answer specifies that the $23.2 billion includes $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables, which the LLM answer does not explicitly break down. This is a minor omission but does not detract from the overall correctness since the total is accurate and the general use cases are described. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes notional values across two types of financial instruments and links them to Abbott’s market risk management strategy, accurately describing the purpose of interest rate hedges (managing debt sensitivity) and foreign exchange contracts (hedging intercompany transactions and obligations). (4) The qualitative and contextual accuracy is excellent—the answer clearly explains Abbott’s risk management strategy in a way that aligns with the original, using semantically equivalent language. The minor lack of sub-breakdown within the foreign exchange notional value prevents a perfect 10 on correctness, but all core facts, calculations, entities, and reasoning are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 472,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "The 2024 10‑K shows that McDonald’s consolidates only its own restaurant operations and its franchisee‑related investments when required by variable‑interest‑entity guidance; the vast majority of its franchisees are not consolidated.  Consequently, franchisee revenues and expenses are recorded on a gross basis in the income statement, while the Company’s own restaurant sales, rent, royalties and other franchise‑related fees flow through the consolidated statements, making the franchisee‑related items immaterial to the overall consolidated financials.  This consolidation policy means that the operational materiality of franchisee activity is limited to disclosed footnote disclosures rather than a material impact on the consolidated balance sheet or income statement.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable in a traditional sense; however, since no numbers were misstated, it receives full credit. The answer partially captures the correct accounting treatment but introduces significant inaccuracies in reasoning and entity understanding. First, it incorrectly states that franchisee revenues and expenses are recorded on a gross basis in the income statement—this is false. McDonald’s does not record franchisee revenues or expenses at all in its consolidated statements because franchisee operations are not consolidated. Instead, McDonald’s records royalties, rent, and fees from franchisees as revenue, but the underlying restaurant operations of franchisees are excluded. The LLM conflates this by suggesting franchisee P&L items flow through gross, which misrepresents the consolidation policy. Second, while the original answer correctly cites a scope exception under VIE guidance that allows non-consolidation, the LLM implies consolidation occurs when required by VIE guidance, which contradicts MCD’s explicit use of the scope exception to avoid consolidation. This reflects a flawed understanding of the multi-hop logic: the 10-K states MCD does *not* consolidate VIEs due to a scope exception, but the LLM suggests they do consolidate when VIE criteria are met, which is incorrect. The answer is contextually relevant and addresses the question’s focus on consolidation policy and materiality, but the core reasoning about what gets consolidated and how franchisee activity impacts financials is materially flawed. Thus, while some elements (e.g., immateriality, limited impact) are directionally correct, the underlying mechanisms are misrepresented, warranting a mid-low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 481,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "The Supplementary Leverage Ratio (SLR) is calculated using **adjusted average assets** (which include off‑balance‑sheet exposures) in the denominator, and the numerator is Tier 1 capital. Because off‑balance‑sheet exposures are added to total leverage exposure, the SLR can be higher or lower depending on the size of those exposures. If the SLR falls below the regulatory minimum (5.0% in the tables), the Firm would be restricted from certain capital actions such as dividend payments, share repurchases, and discretionary bonus payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the 5.0% SLR threshold is correctly stated, matching the ground truth's 3.0% minimum plus 2.0% buffer. The components of the SLR—Tier 1 capital in the numerator and adjusted average assets including off-balance sheet exposures in the denominator—are correctly identified. (2) The explanation of consequences—restrictions on dividends, share repurchases, and discretionary bonuses—is factually correct and matches the original answer. (3) The reasoning is sound: off-balance sheet exposures increase total leverage exposure, thereby reducing the SLR, which aligns with the multi-hop logic required. (4) The only minor shortcoming is that the LLM does not explicitly break down the 5.0% threshold into the 3.0% minimum and 2.0% buffer, though it references the 5.0% figure correctly. This omission slightly affects completeness but does not impair the overall correctness. Wording differences are semantically equivalent, and all entities (JPMorgan Chase, SLR, Tier 1 capital, off-balance sheet exposures) are accurately used. The answer is fully contextually relevant and addresses both parts of the question: the impact of off-balance sheet and adjusted assets on SLR, and the consequences of falling below the threshold.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 370,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "As of December 31 2021, the Company had borrowed **$125.0 million** under the revolving portion of the Credit Facility and **$1.05 billion** under the Supplemental Facility.  The Supplemental Facility’s maximum borrowing capacity, as set by its amended terms, is **$3.5 billion** (with a potential increase to $4.5 billion), which exceeds the $1.05 billion actually drawn.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key figures: $125 million under the Credit Facility and $1.05 billion under the Supplemental Facility as of December 31, 2021, resulting in a total borrowing of $1.175 billion, which matches the ground truth. The maximum capacity of the Supplemental Facility is accurately stated as $3.5 billion with a potential increase to $4.5 billion. (2) All numeric values are correct and match the ground truth; format variations (e.g., $1.05 billion vs $1.05B) are acceptable and semantically equivalent. The total borrowings are implied through component breakdown, though not explicitly summed in the LLM answer—this minor omission does not detract from factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two facilities and compares actual drawdowns to the maximum capacity as defined in amended terms. (4) The answer is contextually complete and relevant, with only a slight lack of explicit mention of the total borrowings ($1.175 billion) as a single figure, which is inferable from the components. This justifies a high score but not perfect due to the implicit rather than explicit total.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 336,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021 was $500 million, compared with $572 million at the end of 2020—a decrease of about 12.6 %.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $500 million for 2021 and $572 million for 2020 are correctly reported. The percentage decrease is stated as 'about 12.6%', which matches the ground truth calculation: (572 - 500) / 572 ≈ 0.12587, or 12.6% when rounded. (2) The answer is complete, addressing both parts of the question: the 2021 notional amount and the percentage change from 2020. (3) Entity accuracy is correct—Lockheed Martin, interest rate swaps, and the years 2020 and 2021 are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across time periods and financial data. The slight wording difference ('about 12.6%' vs 'approximately 12.6%') does not affect semantic equivalence. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 250,
        "total_tokens": 1364
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "The disagreement over cost‑sharing provisions means that Georgia Power cannot recover the $0.7 billion increase to its base capital‑cost forecast or the $150 million construction‑contingency amount through retail rates, forcing it to record pre‑tax charges to income for those amounts. This is illustrated by the $440 million pre‑tax charge recorded in Q4 2021 (and the $48 million, $460 million, $264 million, $480 million charges in subsequent quarters) for cost‑sharing and tender provisions, as well as the $1.1 billion charge in Q2 2018 for earlier cost‑forecast increases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the numerical details. While it correctly identifies the $440 million pre-tax charge in Q4 2021 (matching the ground truth), it introduces incorrect subsequent charges of $48M, $460M, $264M, and $480M in later quarters, which are not supported by the original answer. The ground truth states that Georgia Power *may face an additional $460 million* in potential future charges based on cost forecasts—not that these were already recorded in subsequent quarters. The LLM incorrectly presents them as actual recorded charges across multiple quarters, which misrepresents the financial impact timeline. Additionally, the LLM mentions a $0.7 billion increase to the base capital-cost forecast and $150 million construction-contingency amount not being recoverable, which are not mentioned in the ground truth. The $1.1 billion charge in Q2 2018 is also not referenced in the original answer and appears to be fabricated or misattributed. (2) The only correct number is the $440 million charge in Q4 2021. The $460 million figure appears in both answers but is misused in the LLM response—presented as a recorded charge rather than a potential future exposure. Other figures like $48M, $264M, $480M, $0.7B, and $150M have no basis in the ground truth. (3) The multi-hop reasoning is partially sound in linking the disagreement to unrecoverable costs and financial exposure, but fails in accurately synthesizing the timing, nature, and magnitude of the charges. It conflates potential future liabilities with actual recorded charges and introduces unrelated historical charges. (4) The contextual relevance is high because the answer addresses the core issue—disagreement over cost-sharing leading to unrecoverable charges and increased financial exposure—but the severe quantitative inaccuracies and inclusion of unsupported figures significantly undermine factual correctness, warranting a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 537,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "Adobe reported total Digital Media ARR of approximately $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud solution designed to manage customer journeys and deliver intelligence for businesses is the Adobe Experience Platform.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total Digital Media ARR as $12.24 billion at the end of fiscal 2021, matching the ground truth exactly in value and context. The second part correctly identifies Adobe Experience Platform as the specific Adobe Experience Cloud solution designed to manage customer journeys and deliver intelligence. (2) The numeric value '$12.24 billion' is accurate and presented with acceptable formatting (using 'approximately' is reasonable and does not distort precision). No calculations were required beyond reporting the figure, which is correct. (3) The multi-hop reasoning is sound: the question requires linking Adobe's financial metric (Digital Media ARR) with a strategic product capability (customer journey management via Experience Platform), and the LLM correctly synthesizes both pieces of information from potentially disparate parts of the knowledge base. (4) All entities—Adobe, Digital Media ARR, fiscal 2021, Adobe Experience Cloud, and Adobe Experience Platform—are accurately named and contextually appropriate. The answer is semantically equivalent to the ground truth, with no omissions or inaccuracies. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 341,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "The fair value of Abbott’s interest rate hedge contracts was $2.2 billion in both 2024 and 2023. The fair‑value hedge contracts are reflected in the financial statements as a receivable of $1 million and a payable of $51 million in 2024 (and $0 and $95 million in 2023), resulting in a net fair‑value position of $2 million for 2024 versus $5 million for 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and quantitative errors. It incorrectly states that the fair value of Abbott’s interest rate hedge contracts was $2.2 billion in both 2024 and 2023, which directly contradicts the ground truth. The correct total fair value in 2024 is -$50 million (net of $1M receivable and $51M payable), and in 2023 it was -$95 million (net of $0 receivable and $95M payable). The LLM’s claim of a $2.2 billion fair value is unsupported and factually wrong. Additionally, it misrepresents the net positions as $2 million in 2024 and $5 million in 2023, which is inconsistent with both the stated components and the correct net values. (2) The individual receivable and payable figures for 2024 ($1M receivable, $51M payable) and 2023 ($0, $95M) are correctly cited, but the net calculations are completely wrong. The correct net values are -$50M (2024) and -$95M (2023), not the positive $2M and $5M claimed. The year-over-year improvement of $45M is omitted entirely. (3) The multi-hop reasoning fails because while the model retrieves some correct component values, it fails to compute the correct net fair value or interpret the negative (payable) positions properly. It incorrectly treats the hedge contracts as having a large positive fair value ($2.2B), suggesting a fundamental misunderstanding of the financial structure. (4) The contextual relevance is moderate because the answer addresses the right company (Abbott), time periods (2024, 2023), and types of positions (receivable/payable), but the core financial conclusions are false. Due to severe quantitative inaccuracies and flawed reasoning, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 458,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "Based on the standardized measure tables in the 2024 10‑K (pages 133‑136), the discounted future net cash flows attributable to equity companies in Asia are $35,186 million, and the total proved reserves (oil‑equivalent) for equity companies in Asia are 13,006 million barrels. This yields a ratio of approximately 270 % (i.e., the discounted cash‑flow amount is about 2.7 times the proved‑reserve figure expressed as a percentage).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The reported discounted future net cash flows ($35,186 million) and total proved reserves (13,006 million barrels) are completely wrong compared to the ground truth values of $60,780 million and 1,276 million barrels, respectively. These numbers are off by orders of magnitude. (2) The calculation in the LLM answer yields a ratio of 270%, which misinterprets the question—this percentage does not represent cash flow per barrel but rather an invalid comparison of cash flows to reserves as if they were the same unit. The correct approach, as shown in the original answer, is to compute cash flow per barrel (in dollars per barrel), not a percentage. (3) Qualitative Accuracy: The LLM fails to perform the correct multi-hop reasoning—instead of calculating dollars per barrel, it incorrectly computes a meaningless percentage. It also cites incorrect data from the 10-K, suggesting a failure to extract the correct figures for equity companies in Asia. (4) Contextual Relevance: While the answer attempts to address the question using the correct document (ExxonMobil’s 2024 10-K) and general section (standardized measure tables), the data and logic are so far from accurate that the response is misleading. Minor relevance is retained only because it references the correct filing and attempts a related calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 394,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "JPMorgan Chase maintains adherence to leverage‑based capital requirements by allocating capital to its Lines of Business and Corporate using the Basel III Standardized RWA framework together with the GSIB surcharge, ensuring that the resulting capital levels satisfy the 3.0 % supplementary leverage ratio (SLR) and the additional 2.0 % leverage buffer; this allocation reflects the firm’s compliance with the SLR of 3.0 % and the extra 2.0 % buffer as mandated by regulators.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core quantitative elements: it accurately identifies the 3.0% supplementary leverage ratio (SLR) and the additional 2.0% leverage buffer, correctly referencing the total 5.0% effective threshold implied by regulation. The entities—JPMorgan Chase, Basel III Standardized RWA, GSIB surcharge, and SLR—are all correctly named and contextually appropriate. The answer addresses the influence of regulatory frameworks on capital allocation, which is central to the question. However, it omits key qualitative details present in the ground truth, particularly regarding how SLR is calculated (Tier 1 capital divided by total leverage exposure, including adjustments for off-balance sheet items and quarterly average assets) and the role of stress scenario simulations in capital planning. While the LLM captures the regulatory compliance aspect, it does not fully explain the mechanism or the consequence of failing the 5.0% combined threshold (e.g., restrictions on dividends and share repurchases), which is a significant part of the original answer’s reasoning chain. Thus, while the answer is semantically aligned and quantitatively accurate, it lacks completeness in multi-hop reasoning synthesis, particularly around cause-effect logic and operational implementation, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 374,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "Based on the provided document pages, the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post-amendments in 2021 is $5.8 billion. This is explicitly stated in the document on page 124: \"On December 31, 2021, we had an aggregate available borrowing capacity of $5.8 billion under the Facilities.\" \n\nRegarding the interest rate structure under Daily SOFR Loans, the document confirms that both the Credit Facility and the Supplemental Facility use the same structure for Daily SOFR Loans. Specifically, for Daily SOFR Loans, the interest rate is \"the Adjusted Floating Overnight Daily SOFR Rate, plus a margin determined by our corporate credit rating of between 0.650% and 1.400%.\" The document also notes that \"Based upon our current credit ratings, the interest rate on the Credit Facility is SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR,\" and similarly for the Supplemental Facility. Therefore, the interest rate structure for Daily SOFR Loans is identical between the two facilities, both being SOFR plus a margin (with the exact margin specified as 72.5 basis points plus a spread adjustment for the transition). \n\nThe document does not indicate any difference in the Daily SOFR Loan structure between the two facilities, so the comparison is that they are structured identically. \n\n**Answer:**  \nThe total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post-amendments in 2021 is $5.8 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, both using SOFR plus a margin (specifically, SOFR plus 72.5 basis points plus a spread adjustment for the LIBOR transition).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a critical factual error in the total borrowing capacity. The ground truth states $9.5 billion, while the LLM reports $5.8 billion, citing a specific document excerpt. This discrepancy indicates a failure to correctly interpret or access the full scope of the facilities post-amendment. The $5.8 billion figure may reflect actual undrawn capacity at a point in time (e.g., December 31, 2021), but the question asks for 'total potential borrowing capacity,' which should reflect the committed maximum, not a snapshot of availability. (2) Regarding interest rates, the LLM correctly identifies that both facilities have identical Daily SOFR Loan structures, with SOFR plus 72.5 basis points plus a spread adjustment. It accurately notes the margin range based on credit rating and confirms the current rate applies equally to both facilities. This part is factually aligned with the ground truth. (3) The multi-hop reasoning is sound in comparing the two facilities' interest rate structures and synthesizing details from different parts of the document. However, it fails in aggregating the total potential capacity correctly—likely due to misinterpreting 'available borrowing capacity' as 'total potential,' which are not equivalent. (4) The contextual relevance is high because the answer addresses both parts of the question and uses appropriate terminology and document evidence. The qualitative accuracy is moderate because the reasoning process is logical but based on a misinterpretation of a key financial metric. Quantitative accuracy is low due to the significant dollar amount discrepancy ($5.8B vs $9.5B), which materially affects the correctness of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 472,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "The increase in Sikorsky helicopter program production volume in 2021 drove a $794 million (5 %) rise in RMS net sales and an $183 million (11 %) rise in RMS operating profit, with the growth attributed to higher production volume on Black Hawk, CH‑53K and CRH helicopters and associated risk retirements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of the specific metrics requested. The question asks for the impact of increased Sikorsky helicopter production volume on RMS net sales and product costs. The ground truth states a $540 million increase in net sales and a $560 million increase in product costs. However, the LLM claims a $794 million increase in net sales and an $183 million increase in operating profit — neither of which matches the ground truth. Notably, the LLM reports operating profit instead of product costs, which is a different financial metric and not what was asked. (2) Quantitative accuracy is poor: $794M vs $540M for net sales is a significant overstatement (~37% higher), and the introduction of operating profit ($183M) in place of product costs ($560M) is a major factual deviation. Percentages (5% and 11%) are not present in the ground truth and cannot be verified, further undermining accuracy. (3) The reasoning is partially sound in that it identifies Sikorsky programs (Black Hawk, CH-53K, CRH) as drivers, which aligns with expected context, but it fails the multi-hop requirement by not correctly linking production volume increases to the correct financial line items (net sales and product costs). Instead, it substitutes operating profit, indicating a failure in accurate financial statement synthesis. (4) Contextual relevance is moderate because the answer discusses the right segment (RMS), the correct year (2021), and relevant helicopter programs, but it answers a different question by focusing on profit rather than costs. The core metrics are wrong, leading to a low correctness score despite some contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 460,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "Gains and losses from sales of restaurant businesses are recorded in operating income as part of the Company's recurring transactions with franchisees. These gains or losses are reflected in the \"Gains on sales of restaurant businesses\" line within Other operating (income) expense, net, and are included in the Consolidated Statement of Income. The Company's consolidation policy requires these transactions to be recorded in operating income because they are a recurring part of the business, and the resulting gains or losses impact the financial reporting by affecting the Other operating (income) expense, net line item.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts. (1) It correctly states that gains and losses from sales of restaurant businesses are recorded in operating income as recurring transactions, which matches the original answer's emphasis on these being a regular part of McDonald's business model. It also accurately identifies the line item 'Gains on sales of restaurant businesses' within 'Other operating (income) expense, net' on the Consolidated Statement of Income—this level of financial statement detail is consistent with public 10-K disclosures. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable, but no incorrect figures are introduced. (3) However, the LLM answer omits a critical component of the multi-hop reasoning: the non-consolidation of franchisee entities under variable interest entity (VIE) guidelines. While it correctly explains the income statement treatment, it fails to mention that franchisee operations are not consolidated, which is a key part of the financial reporting impact—this limits the completeness and depth of the synthesis. (4) The reasoning is sound where present, and the answer is highly relevant, but the missing consolidation policy context reduces the qualitative accuracy slightly. Overall, the answer captures the primary mechanism of financial reporting impact but misses an important structural reason (non-consolidation) that supports the full logic chain.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 412,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "Chevron's 2023 financial position was positively impacted by its use of derivative commodity instruments, which helped manage price volatility risks in its upstream and downstream operations. These instruments, monitored by the internal Risk Control group as part of its risk management practices, were accounted for at fair value with gains/losses reflected in income, though their market impact was not material to the company's overall financial results. The company's risk management framework, reviewed by the Audit Committee, ensures fair value measurements and hedging activities align with its broader strategy to mitigate commodity price fluctuations while maintaining operational stability.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numeric values, so quantitative accuracy is not applicable in a traditional sense; however, since it does not introduce any incorrect numbers and avoids making false claims about magnitudes, it is scored highly (10) on quantitative accuracy by default. Contextually, the answer is relevant and addresses the key components of the question: Chevron's use of derivative instruments in 2023, risk management practices, the role of the Risk Control group, and fair value measurements. However, the core factual error lies in stating that derivatives had a 'positive impact' on Chevron's financial position, which contradicts the ground truth that their impact was 'not material.' This mischaracterization fundamentally undermines the correctness of the answer. The original answer clearly states there was no material effect on financial position, results of operations, or liquidity—meaning neither positive nor negative material impact. Additionally, while the LLM mentions fair value accounting and Audit Committee oversight, it omits the critical point that the fair value itself was not material to the balance sheet or income statement. The multi-hop reasoning is partially sound—linking derivatives, risk management, internal monitoring, and governance—but fails in synthesizing the correct conclusion from those data points. Thus, while entities (Chevron, Risk Control group, Audit Committee), year (2023), and general practices are accurately identified, the qualitative reasoning and final assessment are flawed, warranting a moderate correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 436,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "Based on the provided SEC 10-K filing data, the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is explicitly detailed in Note 27 of the Capital Components section (Page 105). The CECL transition provisions contributed a **$720 million benefit** to CET1 capital as of December 31, 2024, which was fully phased in and reflected in the reported CET1 capital figure. This benefit is part of the \"Other CET1 capital adjustments\" (Note 27, part b) and is specifically tied to the transition provisions under U.S. capital rules for certain First Republic assets. Additionally, the allowance for credit losses eligible for inclusion in Tier 2 capital (Note 27, part d) reflects the impact of the CECL transition provisions, including an incremental $541 million allowance for credit losses on First Republic assets as permitted by the transition rules. However, the question specifically asks for the impact on CET1 capital, which is directly quantified as the $720 million remaining benefit. The net benefit from AOCI ($5.2 billion) and the allowance for credit losses ($20,992 million) are components of broader capital calculations but do not represent the CECL transition provision's direct impact on CET1 capital. The $720 million figure is the precise measure of the CECL transition provision's effect on CET1 capital as of December 31, 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the two key components mentioned in the ground truth: the $720 million benefit from AOCI related to CECL transition provisions and the $541 million incremental allowance for credit losses on First Republic assets included in Tier 2 capital. These numbers are factually accurate and match the ground truth. However, the LLM fails to compute or acknowledge the total impact of $1.261 billion, which is the sum of these two components as explicitly stated in the original answer. Instead, it incorrectly asserts that only the $720 million is the 'direct impact' on CET1 capital, thereby missing the core of the question, which asks for the total impact considering both elements. (2) Quantitative accuracy is partially correct—individual figures ($720M and $541M) are accurate and properly attributed—but the failure to sum them into the total $1.261B impact results in a significant omission. The model also incorrectly references a '$5.2 billion net benefit from AOCI' and '$20,992 million allowance', which are not in the ground truth and appear to be hallucinated or misextracted, further undermining numerical reliability. (3) The multi-hop reasoning is flawed: while the model locates relevant pieces of information, it does not synthesize them correctly. It distinguishes between CET1 and Tier 2 impacts but wrongly concludes that only the $720M affects CET1, contradicting the ground truth that both components together constitute the total impact on CET1 capital through regulatory calculations. This indicates a misunderstanding of how Tier 2 inclusions can indirectly affect CET1 under Basel III frameworks. (4) Contextual relevance is high—the response cites the correct note (Note 27), page, and context (First Republic, CECL transition), showing good document alignment. However, due to the critical error in reasoning and omission of the total figure, the overall correctness score is limited to 4, reflecting partial accuracy with a major factual synthesis failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 544,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "The total financial impact of GE’s AerCap‑related transactions in 2023 was a net income contribution of $38 million from the realized and unrealized gain on the AerCap investment, offset by a realized/unrealized loss of $129 million, resulting in an overall net impact of $167 million for the year.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and direction of financial impact. The ground truth states a total positive impact of $2,654 million, composed of $2,525 million net income and $129 million gain. The LLM incorrectly reports a net impact of only $167 million and mischaracterizes the components, stating a $38 million gain offset by a $129 million loss, which contradicts the ground truth. (2) Quantitatively, all numbers are wrong: the LLM reports $38 million and $129 million loss (vs. $2,525M income and $129M gain in reality), and the final net impact of $167 million is not supported by any correct calculation. The sign of the $129 million is especially critical—it is a gain in the ground truth, but the LLM treats it as a loss, inverting the financial outcome. (3) The multi-hop reasoning fails: the model does not correctly synthesize the net income contribution and the gain/loss component from AerCap transactions. It appears to misunderstand the relationship between the components, possibly confusing pre- and post-divestiture accounting or misreading the direction of gains/losses. (4) Contextual relevance is moderate—it addresses the right topic (AerCap-related financial impact in 2023) and mentions the correct entities and time frame, but the substance is fundamentally flawed. Due to major factual and directional errors in financial figures and calculations, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 401,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "Based on the document, Merck transferred a total consideration of $600 million in cash plus a $1.0 billion equity investment (5 million shares of Seagen at $200 per share) to acquire Immune Design. The fair value of the identifiable net assets acquired was $239 million, resulting in $239 million of goodwill being recorded (the excess of consideration transferred over the fair value of net assets acquired).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the total consideration is wrong: the LLM states $600 million in cash plus a $1.0 billion equity investment (total $1.6 billion), while the ground truth is $301 million total. The goodwill is stated as $239 million by the LLM, but the correct amount is $20 million. The fair value of net assets is claimed as $239 million by the LLM, but this number does not align with the ground truth (which implies $281 million in net assets: $301M consideration - $20M goodwill). (2) The entities are confused: the LLM references Seagen and a share price of $200 for 5 million shares, which is unrelated to the Merck-Immune Design acquisition. There is no mention of Seagen in the correct context—Merck acquired Immune Design directly for cash. (3) The reasoning is flawed: the LLM incorrectly calculates goodwill as equal to the fair value of net assets, when goodwill is the excess of consideration over fair value. It also fabricates an equity component and third-party involvement (Seagen), indicating a complete failure in multi-hop synthesis. (4) Contextual relevance is low—the answer appears to describe a different acquisition altogether. The only partial relevance is the mention of goodwill as the excess of consideration over net assets, which is conceptually correct but applied to false numbers and entities. Overall, the answer is factually and quantitatively incorrect, with major errors in entities, amounts, and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 422,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "Franchisees contribute to McDonald's revenue primarily through rent and royalties based on a percentage of sales, including minimum rent payments and initial fees paid upon opening a new restaurant or granting a new franchise. Additionally, the Company co-invests with franchisees to fund restaurant improvements, which enhances the value of the brand and supports higher revenue-generating locations.\n\nThe co-investment by McDonald's in franchisee restaurant improvements is capitalized as part of property and equipment and then depreciated over the useful life of the associated assets (typically 3 to 12 years for equipment and up to 40 years for buildings). This co-investment increases the Company's depreciation expense, as the funded improvements are recorded as capitalized assets and subsequently amortized, reflecting the systematic allocation of their cost over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the primary financial contributions from franchisees—rent (including minimum rent), royalties based on sales percentage, and initial fees—which aligns with the ground truth. It also accurately describes McDonald's co-investment in franchisee restaurant improvements and correctly explains that these investments are capitalized as property and equipment and depreciated over time, thereby increasing depreciation expense. The useful life ranges (3 to 12 years for equipment, up to 40 years for buildings) are reasonable and consistent with typical accounting practices, though not explicitly stated in the original answer; however, their inclusion does not contradict the ground truth and adds context without introducing error.\n\nQuantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in the original answer, so the LLM does not introduce any numerical inaccuracies. The explanation of depreciation impact is logically sound: capitalizing co-invested improvements leads to higher depreciation expense, which is correct.\n\nThe minor shortcoming is that the LLM omits a key nuance from the original answer: the cost allocation process during co-investment projects between McDonald's and franchisees, where costs are split between Property and equipment (for McDonald's share) and Accounts Receivable (for franchisee's share), and that final adjustments post-completion may lead to immaterial changes in depreciation. This reflects a partial gap in multi-hop synthesis—the LLM captures the high-level impact on depreciation but misses the interim accounting mechanics and the conditional nature of adjustments being immaterial.\n\nDespite this omission, the core reasoning and factual content are accurate and relevant. The answer fully addresses both parts of the question and maintains semantic equivalence on the main points. Hence, a score of 8 is appropriate for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 545,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "The fair‑value of Goldman Sachs’ securities backed by real estate fell from **$562 million at the end of 2023 to $117 million at the end of 2024**, a decline of **$445 million**.  \n\nA primary driver of the unrealized losses on Level 3 investments in 2023 was the **significant deterioration in commercial‑real‑estate market conditions**, which led to lower valuations and higher required yields for those securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative values. According to the ground truth, the value of Goldman Sachs' securities backed by real estate decreased from $689 million in December 2023 to $569 million in December 2024, a decrease of $120 million. The LLM incorrectly states the 2023 value as $562 million and the 2024 value as $117 million, resulting in a calculated drop of $445 million, which is factually wrong. These numbers are significantly off and invalidate the core of the answer. (2) The calculation in the LLM answer is mathematically correct ($562M - $117M = $445M), but it is based on incorrect input values, so the result is inaccurate. The correct calculation is $689M - $569M = $120M. (3) On qualitative aspects, the LLM correctly identifies the primary cause of unrealized losses on Level 3 investments in 2023 as deterioration in commercial real estate market conditions, which aligns semantically with the ground truth's 'weakness in the commercial real estate market.' This shows correct multi-hop reasoning in linking market conditions to valuation impacts on real estate-backed securities. (4) Contextually, the answer addresses both parts of the question—magnitude of decrease and cause of losses—and uses appropriate financial terminology. However, the severe numerical inaccuracies drastically reduce correctness. While the reasoning and context are sound, the answer fails on factual precision, which is critical in financial reporting. Hence, low scores for correctness and quantitative accuracy, moderate for qualitative reasoning, and high for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 444,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "The Company repaid the entire CoreSite Debt on January 7 2022 for an aggregate redemption price of $962.9 million, which included $80.1 million of prepayment consideration and $7.8 million of accrued interest.  This amount was $40.8 million higher than the $922.1 million outstanding balance reported as of December 31 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. While it correctly states the aggregate redemption price ($962.9 million), prepayment consideration ($80.1 million), and accrued interest ($7.8 million), it incorrectly reports the outstanding balance as of December 31, 2021 as $922.1 million, whereas the ground truth states the principal amount was $875 million. This leads to an incorrect difference of $40.8 million instead of the correct additional cost of $87.9 million ($962.9M - $875M). (2) The calculation of the additional cost is wrong: $962.9M - $922.1M = $40.8M is not the actual incremental cost beyond principal, because $922.1M is not the correct principal. The correct incremental cost is $87.9M, which the model fails to compute or state. (3) The multi-hop reasoning is partially sound—linking repayment details to prior period debt—but fails at the critical step of using the correct prior balance. The model appears to have used a different (and incorrect) figure for the December 31, 2021 balance, possibly from a misread source. (4) Despite correct mention of redemption price and components, the core quantitative error undermines the answer’s validity. Scores reflect partial credit for correct individual figures but major deduction for incorrect synthesis and calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 371,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "The cash impacts from changes in working capital were $(0.4) billion in 2024, a decrease of $1.1 billion versus 2023, and the note specifically cites “higher volume partially offset by higher collections, including increased collections from CFM International” as the driver of the $0.9 billion change in current receivables. This reflects GE’s long‑standing joint‑venture relationship with CFM International—an equity‑method investment in which GE supplies parts and services and receives payments under long‑term service agreements—supporting the cash inflows that reduced working‑capital outflows. Thus, CFM International’s contributions helped offset the overall working‑capital drag, and the business relationship is that of a key supplier/customer partnership via the CFM joint venture.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that increased collections from CFM International partially offset a $(0.9) billion negative impact from current receivables in 2024. However, the LLM incorrectly frames the $0.9 billion as a 'change in current receivables' driven by 'higher volume... and higher collections,' conflating it with a $1.1 billion year-over-year decrease in working capital, which is not supported by the original answer. The $0.9 billion figure in the original refers specifically to the negative impact from current receivables, not a change due to collections. The LLM also introduces a $(0.4) billion working capital impact and a $1.1 billion decrease vs 2023—numbers not present in the ground truth—making the quantitative analysis factually incorrect. (2) Entity accuracy is mostly correct: CFM International is properly identified as a joint venture and equity-method investee, and GE's role in supplying parts and services is accurate. The nature of the business relationship (supplier/customer via joint venture) aligns with the ground truth. (3) Multi-hop reasoning is partially sound: the model correctly infers that collections from CFM International reduce receivables and thus improve cash flow, and links this to the equity-method relationship. However, it distorts the financial context by introducing unsupported figures and misattributing the $0.9 billion figure. (4) Despite the incorrect numbers, the qualitative understanding of the business relationship and directional impact (collections offset negative cash impact) is correct, and the answer remains contextually relevant to the question. The core financial claim, however, is undermined by incorrect data, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 490,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $145 million, representing the prior year deferrals combined with current year pricing adjustments from the Ohio electric rate case.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key numeric claim. The ground truth states the total financial impact was $276 million, but the LLM reports $145 million, which is significantly off. This error undermines the core of the response. (2) Quantitative accuracy is poor: the correct figure of $276 million from the 2023 variance drivers is not reflected, and no explanation or breakdown matching the source is provided. The $145 million figure does not align with the ground truth, and there is no indication of how this number was derived, suggesting a failure in data retrieval or synthesis. (3) While the LLM correctly identifies the relevant components—Ohio tax reform deferrals and the Duke Energy Ohio electric rate case—and references both prior year deferrals and current year pricing adjustments (which are part of the multi-hop reasoning), it fails to correctly synthesize the actual combined impact. The entities (Duke Energy, Ohio rate case, tax reform) and time frame (2023) are accurate, showing some qualitative understanding. (4) Contextual relevance is high because the answer addresses the right events and structure of the question, but correctness is severely compromised by the wrong dollar amount. A correct answer must match the $276 million figure as reported in the source. Minor wording differences would be acceptable, but a 131-million-dollar discrepancy is a major factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 396,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "In fiscal 2021 Adobe’s Digital Media segment generated **$11.05 billion** in subscription revenue. Of that amount, **$9.55 billion** came from Creative Cloud (≈86% of the segment’s subscription revenue) and **$1.50 billion** came from Document Cloud (≈14% of the segment’s subscription revenue).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. While the Creative Cloud revenue ($9.55 billion) is correct, the total Digital Media revenue is incorrect—LLM states $11.05 billion instead of the correct $11.52 billion. Document Cloud revenue is reported as $1.50 billion, but the ground truth is $1.97 billion. These errors directly impact the percentages. (2) Calculations: The LLM computes ≈86% for Creative Cloud ($9.55B / $11.05B), which is mathematically correct based on its incorrect total, but the actual percentage should be 83% ($9.55B / $11.52B). Similarly, Document Cloud is ≈14% based on $1.50B / $11.05B, but should be 17% ($1.97B / $11.52B). The LLM also refers only to 'subscription revenue' while the question and ground truth refer to total Digital Media revenue—this may reflect a misinterpretation of segment vs. subscription breakdowns. (3) Multi-hop reasoning: The model attempts to synthesize segment revenue and its components, showing understanding of structure, but fails in accurate data retrieval for total revenue and Document Cloud. (4) Scores justified: Correctness is low due to major numerical errors in total and Document Cloud revenue. Quantitative accuracy is poor due to incorrect figures and derived percentages. Qualitative accuracy is moderate—reasoning structure is sound but based on flawed data. Contextual relevance is high—the answer addresses the right entities and question structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 406,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments, was $316.8 million. This increase was driven by a $222 million rise in advertising expenses and a $116 million increase in personnel-related costs, primarily due to growth in headcount supporting production and streaming service improvements, as detailed in the Marketing and Technology and Development expense breakdowns on page 26.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $222 million increase in advertising expenses and the $116 million personnel-related cost increase in marketing, which are factually accurate. However, it omits the $384 million personnel-related cost increase from the technology department, which is a critical component of the multi-hop synthesis required. As a result, the total increase is incorrectly calculated as $316.8 million instead of the correct $722 million. (2) The quantitative accuracy is partially correct: $222M (advertising) + $116M (marketing personnel) = $338M, but the LLM reports $316.8M, suggesting either a rounding error or miscalculation. More importantly, the missing $384M from technology renders the total significantly inaccurate. (3) The reasoning is flawed in multi-hop synthesis: the question explicitly asks for combined costs across advertising and personnel-related costs in both marketing and technology departments. The LLM fails to incorporate the technology department's $384M increase, indicating a failure to fully synthesize all required components from the source data. (4) Scores reflect partial factual correctness (some numbers right), but major omissions in calculation and entity coverage reduce correctness and qualitative accuracy. Contextual relevance is high as the answer addresses the right company, year, and cost categories, just with incomplete data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 392,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "General Motors records its equity earnings from Ultium Cells Holdings LLC in “Automotive and other cost of sales” because the joint venture supplies battery cells that are integral to GM’s EV production strategy. This treatment reflects that the investment is not a peripheral financial holding but a core component of GM’s electric‑vehicle supply chain, and the earnings (or losses) from Ultium Cells are therefore embedded in the cost structure of its automotive operations rather than presented as a separate investment‑income line item.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that General Motors reports equity earnings from Ultium Cells Holdings LLC within 'Automotive and other cost of sales,' which matches the original answer. There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable—no errors here. (2) The answer addresses both parts of the multi-part question: how the equity earnings influence cost of sales and what this indicates about GM's financial treatment and EV strategy. (3) The entities—General Motors, Ultium Cells Holdings LLC, and the financial line item 'Automotive and other cost of sales'—are correctly identified. (4) The reasoning is sound: the LLM correctly infers that this accounting treatment reflects the operational integration of Ultium Cells into GM’s EV supply chain, rather than treating it as a passive investment. This demonstrates proper multi-hop synthesis between accounting practice and strategic intent. The wording differs slightly but conveys the same meaning with high precision and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 330,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "The average price of U.S. Henry Hub natural gas fell 59.7% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. This decline was driven by high storage levels and strong production, contrasting with Chevron's international natural gas realizations, which averaged $7.69 per MCF in 2023 (down from $9.75 per MCF in 2022), reflecting lower LNG prices linked to oil-indexed contracts and regional market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects except for a minor rounding difference in the percentage decrease for Henry Hub natural gas: it reports 59.7% versus the ground truth 59.8%. This discrepancy is negligible and likely due to rounding during intermediate calculation (e.g., (6.36 - 2.56) / 6.36 = 3.80 / 6.36 ≈ 0.5975 ≈ 59.8%). All other numbers—$6.36, $2.56, $9.75, $7.69, and the 21.1% decline in Chevron’s international realizations—are accurate. (2) Quantitative accuracy is high: the dollar amounts are exact, and the percentage changes are either exact or off by 0.1 point due to rounding. The calculation for Chevron’s decline is correct ((9.75 - 7.69)/9.75 ≈ 0.211 = 21.1%), though not explicitly stated in the LLM answer. (3) The multi-hop reasoning is sound: the model correctly compares U.S. Henry Hub prices (a commodity benchmark) with Chevron’s international natural gas realizations (a company-specific metric), synthesizing data across public market data and corporate financials. It appropriately contextualizes the steeper U.S. decline relative to more stable oil-linked international prices. (4) The answer is semantically equivalent to the ground truth, with added context about drivers (storage, production, oil-indexed contracts), enhancing relevance without introducing error. The minor percentage discrepancy does not affect the overall correctness, warranting a 9/10. Contextual relevance is perfect as all parts of the question are addressed with appropriate depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 420,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "The sensitivity of fair‑value measurements to credit‑spread changes is reflected in the credit‑derivative level‑3 balances, where a range of credit spreads (8 bps to 1,328 bps, with an average of 134 bps and median of 91 bps as of Dec 2024) is used as a key unobservable input. Higher credit spreads generally lower the fair value of purchased credit protection, so variations in these spreads directly affect the valuation of the firm’s level‑3 credit derivatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the direction of sensitivity: it states that 'higher credit spreads generally lower the fair value of purchased credit protection,' which contradicts the ground truth that the fair value of purchased credit protection *increases* when credit spreads increase. This is a critical error in financial logic and undermines the correctness of the response. Additionally, the specific numeric values (e.g., credit spreads ranging from 8 bps to 1,328 bps, average 134 bps, median 91 bps as of Dec 2024) are not present in the original answer and appear to be fabricated or hallucinated, as the ground truth does not provide any quantitative ranges or dates. (2) There are no verifiable calculations in the original or LLM answer, but the inclusion of precise bps figures and a future date (Dec 2024) introduces false quantitative precision. These numbers cannot be validated against the ground truth and are thus incorrect. (3) The multi-hop reasoning is partially sound in linking credit spread sensitivity to level 3 fair value measurements, and the mention of unobservable inputs aligns with the question’s focus. However, the failure to correctly characterize the directional relationship between credit spreads and fair value—and the omission of recovery rates, a key part of the original answer—represents a major gap in synthesis. The model also omits the broader risk factors (leverage, volatility, industry, etc.) that contribute to input variability. (4) The contextual relevance is moderate because the answer addresses the general topic and mechanism of fair value sensitivity, but the qualitative inaccuracy in directionality and the inclusion of unsupported numbers severely reduce its reliability. Correctness is scored low due to fundamental errors in financial reasoning and hallucinated data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 511,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "The repayment of the CoreSite Debt in January 2022 removed $955.1 million of senior unsecured notes from AMT’s balance sheet, reducing its total debt and improving leverage ratios. Because the redemption price of $962.9 million (including $80.1 million of prepayment consideration) was essentially equal to the debt’s carrying value of $955.1 million, it indicates that the debt was recorded at fair value on AMT’s books—no significant discount or premium remained to be amortized.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the redemption price of $962.9 million, which is not mentioned in the ground truth and contradicts the stated repayment amount of $955.1 million. The ground truth explicitly states that the repayment amount and carrying value were both $955.1 million, indicating no significant premium or discount. The LLM incorrectly introduces an $80.1 million prepayment consideration, which distorts the calculation and leads to a flawed conclusion about fair value. (2) The date (January 2022) and carrying value ($955.1 million) are correct, but the redemption amount is fabricated. This severely undermines quantitative accuracy. (3) The reasoning about capital structure improvement is partially correct—reducing debt does improve leverage ratios—but the multi-hop synthesis fails because it misrepresents the financial terms of the repayment. The conclusion that the debt was recorded at fair value is plausible in logic but based on incorrect data. (4) While the answer addresses both parts of the question (impact on capital structure and valuation implication), the use of incorrect financial figures results in a misleading analysis. Contextual relevance is high as the response stays on topic and uses appropriate financial concepts, but correctness is significantly compromised by the erroneous redemption amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 383,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "The ongoing tax examinations that focus on intercompany transfer‑pricing practices could lead to adjustments in Adobe’s unrecognized tax benefits. The company has reserved for potential decreases in these benefits, estimating that the range of possible reductions is from $0 up to approximately $5 million over the next 12 months. Given the established reserves, such adjustments would likely have a modest adverse impact on Adobe’s financial position.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the $5 million upper bound estimate for potential decreases in unrecognized tax benefits over the next 12 months is accurately reported, matching the original answer. The mention of reserves being established is also consistent. (2) The reasoning correctly links transfer pricing audits to potential adjustments in tax benefits and financial impact. (3) However, the LLM answer underrepresents the risk highlighted in the original answer—specifically, the possibility that actual adjustments could exceed reserves due to high uncertainty, which may lead to significant fluctuations in tax assets and liabilities. This nuance is important for assessing financial position and was downplayed by describing the impact as 'modest.' (4) While all key entities (Adobe, intercompany transfer pricing, unrecognized tax benefits, reserves) and timeframes are accurate, the qualitative assessment of impact lacks the caution expressed in the original, making it slightly less precise in risk characterization. Hence, high scores for quantitative accuracy and contextual relevance, a slightly lower score for qualitative accuracy due to softened risk implication, and an overall correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 357,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "The combined growth rate for alliance revenue from Lenvima was 21% in 2021 and 44% in 2020. This growth aligns with Merck’s broader oncology strategy of pairing Keytruda with targeted therapies like Lenvima to enhance treatment efficacy across multiple cancer types, as demonstrated by recent regulatory approvals of the Keytruda-Lenvima combination for advanced endometrial carcinoma, renal cell carcinoma, and other indications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the alliance revenue growth percentages for Lenvima as 21% in 2021 and 44% in 2020, matching the ground truth exactly. However, it does not explicitly calculate or state the combined growth of 65% over the two years, which is a required part of the question. While the individual yearly growth figures are accurate, the omission of the summed growth percentage constitutes a minor but notable gap in completeness. (2) All numeric values (21%, 44%) and years (2021, 2020) are correct, and no calculation errors are present in the numbers provided. The combined growth of 65% (21 + 44) is arithmetically accurate in the ground truth, but the LLM fails to perform or report this sum. (3) The reasoning is sound: the LLM correctly links Lenvima revenue growth to Merck’s oncology strategy centered on combination therapies involving Keytruda. It accurately references the Keytruda-Lenvima combination and its approvals for endometrial carcinoma and renal cell carcinoma, demonstrating proper multi-hop synthesis between Lenvima revenue and Merck’s strategic use of combinations. The mention of 'other indications' is slightly vague but not incorrect. (4) The answer is highly contextually relevant, addressing both the financial performance and strategic rationale. The qualitative accuracy is high but not perfect due to the missing explicit combined growth figure. Overall, the answer is factually strong and well-aligned with the ground truth, meriting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 418,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "GM’s 2024 investment in Ultium Cells Holdings LLC added roughly **$0.7 billion of equity earnings** to the EBIT‑adjusted results of the GM North America segment, contributing about **$0.7 billion of the $2.2 billion increase in EBIT‑adjusted** (i.e., roughly one‑third of the total EBIT‑adjusted improvement).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.7 billion equity earnings contribution from GM's investment in Ultium Cells Holdings LLC in 2024, which directly improved EBIT-adjusted performance—this matches the ground truth exactly. The dollar amount and year are accurate, and the impact on EBIT-adjusted is correctly framed as a direct increase. (2) Quantitatively, the $0.7 billion figure is correct and matches the original answer. The additional context that this constituted about one-third of the $2.2 billion total EBIT-adjusted improvement is a reasonable inference (0.7 / 2.2 ≈ 31.8%), and while not explicitly stated in the ground truth, it is mathematically sound and adds useful context without distorting facts. (3) The multi-hop reasoning is solid: the model connects GM’s investment to equity earnings, links those earnings to EBIT-adjusted performance, and situates the contribution within the broader segment performance. The only minor gap is specifying that the impact was in the GM North America segment, which is an addition not present in the original answer—but this detail does not contradict the ground truth and may reflect deeper contextual knowledge. (4) The answer is semantically equivalent and factually correct, with excellent quantitative precision and strong qualitative reasoning. The slight deduction in qualitative accuracy is due to the unverified segmentation detail, though it does not impair correctness. Overall, this is a highly accurate, well-reasoned response that fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 425,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "The SEC’s new monthly short‑position reporting rule for institutional investment managers (effective January 2025) obligates Goldman Sachs’ registered investment‑adviser subsidiaries to file and disclose detailed short‑position data each month, and because those advisers are subject to the SEC’s broader securities‑and‑swap reporting regime, the firm must integrate the new short‑position disclosures into its existing public reporting and trade‑reporting systems for security‑based swaps and derivatives. Consequently, Goldman Sachs will need to adjust its derivatives reporting practices to capture, aggregate and publicly disclose the required short‑position information in its SEC filings and swap‑trade reports.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: it accurately identifies the January 2025 effective date of the SEC's monthly short position reporting requirement and correctly situates Goldman Sachs within the broader SEC regulatory framework. The quantitative accuracy is perfect—there are no numerical claims to dispute, and the date (January 2025) matches the ground truth. Contextual relevance is high, as the response directly addresses how the new rule interacts with Goldman Sachs' reporting obligations. However, there is a key qualitative inaccuracy in entity mapping: the LLM incorrectly implies that Goldman Sachs' *registered investment adviser subsidiaries* are the primary entities subject to the new rule, and that this flows into derivatives reporting. The ground truth emphasizes that Goldman Sachs, as a *registered security-based swap dealer*, already has robust reporting obligations, and the new short position rule adds a layer of transparency specifically for short positions in *equity securities*, not derivatives. The LLM conflates short-position reporting (an equity-focused requirement) with derivatives and swap reporting, suggesting integration into 'swap-trade reports,' which is not supported by the original answer. The reasoning is partially sound—it recognizes the need for integration into reporting systems—but incorrectly synthesizes the new rule as directly affecting *derivatives* reporting practices, when it primarily affects equity short-position transparency. This mischaracterization of the regulatory scope and interaction reduces qualitative accuracy. The core obligation and timing are correct, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 458,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "The remeasurement of PepsiCo’s 39% noncontrolling interest in TBG to fair value following the sale of its juice brands resulted in a $520 million gain recorded in 2022, driven by the transaction price, discounted cash‑flow and option‑pricing models. This gain reflects the transaction’s structure of a cash sale to PAI Partners combined with PepsiCo’s retained equity stake, allowing it to recognize upside from the revalued investment while maintaining operational involvement through a transition‑services agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $520 million gain, the 39% noncontrolling interest in TBG, the remeasurement at fair value following the sale of juice brands, and the use of transaction price, discounted cash flows, and option-pricing models for valuation. The buyer, PAI Partners, and the cash nature of the transaction are correctly implied. (2) Quantitative elements are precise: $520 million is correctly stated, 39% is accurate, and no calculations are required beyond what is provided. (3) The multi-hop reasoning is sound—linking the gain to the transaction structure involving both cash proceeds and retained equity is correctly explained. The mention of a transition-services agreement adds context not in the original but is plausible and does not detract from accuracy. (4) The only minor shortcoming is that the original specifies the brands sold (Tropicana, Naked, etc.) and the ~$3.5 billion cash proceeds, which the LLM omits. While not critical to the core question about the gain and structure, this reduces completeness slightly. Otherwise, the answer is semantically equivalent, contextually relevant, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 341,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "In 2024, GE’s retained ownership interests—including its stake in Baker Hughes—generated $518 million of gains on retained and sold ownership interests, which was a small fraction of the $2.264 billion total other income reported for the year. By contrast, in 2023 the same source contributed $5,778 million of gains, accounting for a much larger share of the $6.718 billion total other income that year. Thus, the contribution from retained interests fell dramatically from 2023 to 2024, both in absolute terms and as a proportion of overall other income.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the $5,778 million contribution in 2023 and $518 million in 2024 from retained and sold ownership interests, matching the ground truth. However, it incorrectly refers to these figures as 'gains' and omits the specific detail about Baker Hughes contributing only $10 million in 2023 and zero in 2024. More critically, the LLM introduces incorrect total other income figures—$6.718 billion for 2023 and $2.264 billion for 2024—which are not in the original answer and appear to be fabricated or misattributed. These totals were not part of the ground truth and distort the context. (2) While the $5,778M and $518M figures are accurate and the year-over-year decline is correctly characterized as dramatic, the calculation of the decrease is missing (ground truth notes a $5,260M drop, which the LLM does not mention). The inclusion of false total other income values undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly identifies the year-over-year decline in contributions from ownership interests and ties it to other income—but fails to accurately isolate the Baker Hughes component, which is a key part of the original answer. The synthesis is incomplete and introduces extraneous, incorrect data. (4) Despite the factual errors in totals and omission of Baker Hughes specifics, the core trend (sharp decline from 2023 to 2024) is correctly conveyed, and the answer remains contextually relevant. However, the introduction of false quantitative benchmarks significantly reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 437,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "Based on the provided 10-K filing pages, the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2025 is $122 million, which represents $128 million in amortized cost with $6 in unrealized gains and $6 in unrealized losses. This amount constitutes 0.24% of the total assets measured at fair value ($50,684 million), calculated as $122 million divided by $50,684 million. The $122 million fair value is derived from the \"Marketable Securities\" table on page 75, which lists Mortgage-backed obligations at $128 amortized cost with $0 unrealized gains and $6 unrealized losses, resulting in a fair value of $122 million. The percentage is determined by dividing the $122 million by the total fair value of all assets measured at fair value ($50,684 million), as shown in the fair value hierarchy table on page 77.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It reports a fair value of $122 million, which matches only one of the two disclosed amounts in the ground truth ($236M + $122M = $358M total), missing the $236 million entirely. The percentage reported (0.24%) is also wrong due to incorrect numerator and denominator. The correct percentage is ~2.97%, based on $358M / $12,044.5M (average of $12,079M and $12,010M). (2) The LLM uses an incorrect total fair value of assets: $50,684 million, which does not match either of the two disclosed totals in the ground truth. Additionally, the date is wrong: it states January 31, 2025, while the question and ground truth refer to January 31, 2024. (3) The multi-hop reasoning failed completely: the model did not identify or sum two separate disclosures of Mortgage-Backed Obligations, used only one, and pulled an unrelated total assets figure likely from a different company or context. (4) Scores are low because the answer contains major factual errors in numbers, date, calculation, and entity synthesis. The only partial credit is for correctly interpreting fair value as amortized cost plus net unrealized gains/losses in one instance, but even that is misapplied to the wrong time period and context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 354,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "Netflix’s strategy of offering varied membership plans across countries helped lift average monthly revenue per paying member by 7% in 2021, contributing to the overall 19% revenue growth by boosting both membership base expansion and higher per‑member pricing. This increase in revenue per member, combined with an 11% rise in average paying memberships, drove the total 19% revenue increase for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 7% increase in average monthly revenue per paying membership, the 11% rise in paying memberships, and the resulting 19% overall revenue growth in 2021 are all accurately reported and consistent with the original answer. (2) Quantitative accuracy is perfect—percentages and their roles in driving revenue growth are correctly stated. The implied calculation (revenue growth ≈ membership growth + price/mix effect) is logically sound and matches the multi-hop reasoning required. (3) The reasoning correctly synthesizes the impact of regional pricing strategies on per-member revenue and overall growth, though it slightly condenses the explanation of *how* varied plans enabled pricing flexibility (e.g., tailoring to regional market conditions), which is detailed in the original. However, the core causal chain—pricing strategy → higher ARPU → combined with membership growth → 19% revenue growth—is preserved. (4) The answer is fully relevant and addresses both parts of the question: how the strategy contributed to the 7% ARPU increase and how that impacted the 19% revenue growth. The only minor shortcoming is a slight reduction in explanatory depth regarding the mechanism of regional pricing adaptation, but no factual omissions or errors. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 404,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program is expected to drive pharmaceutical segment revenue, particularly through alliance revenue from Lenvima sales. While specific revenue figures are not provided in the excerpt, the document notes that Lenvima (MK-7902) is part of a collaboration with Eisai and is being evaluated in multiple Phase 3 trials across 14 tumor types, including colorectal, endometrial, and hepatocellular carcinoma. The LEAP-002 trial for advanced HCC is fully enrolled, and the partnership remains active despite setbacks like the CRL for HCC approval and the discontinuation of LEAP-007 and LEAP-011. The collaboration's success will depend on the outcome of ongoing trials and regulatory reviews, with Lenvima already contributing to alliance revenue (e.g., $704 million in 2021, up from $580 million in 2020).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core aspects of Merck's collaboration with Eisai on Lenvima through the LEAP program and its impact on pharmaceutical segment revenue. It accurately notes the CRL for HCC, the discontinuation of LEAP-007 and LEAP-011 due to futility, and the ongoing LEAP-002 trial. It also correctly states that the alliance revenue model includes shared profits and that Lenvima combinations are being tested across multiple tumor types. However, the LLM introduces specific revenue figures—$704 million in 2021 and $580 million in 2020—that are not present in the original ground truth answer. Since these numbers do not appear in the provided truth data, their inclusion constitutes a factual overreach or hallucination, significantly affecting quantitative accuracy. (2) The numbers cited ($704M, $580M) cannot be verified against the ground truth, which mentions no historical alliance revenue figures. This is a critical error in quantitative accuracy, especially for financial data. While such figures may exist in external sources, within the scope of this evaluation based solely on the provided ground truth, they are unsupported. (3) The multi-hop reasoning is generally sound: the model connects the clinical trial outcomes (CRL, discontinuations, ongoing trials) to commercial potential and revenue implications via the alliance model. It correctly identifies that approved combinations (e.g., in endometrial carcinoma and RCC) already contribute to revenue, though this point is less emphasized than in the original answer. The synthesis across clinical status and financial impact is logical and relevant. (4) The contextual relevance is high—the response directly addresses how the LEAP program influences Merck’s revenue, discusses key trials, and explains the alliance model. The qualitative reasoning is strong, but the unsupported numerical claims reduce confidence in factual correctness, warranting a score of 7 for overall correctness despite strong alignment in structure and logic with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 555,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "Based on the provided financial data, Chevron's total cost incurred by consolidated companies in 2023 was $24,559 million. This amount exceeds the combined total of expensed exploration costs ($914 million) and the PDC Energy acquisition cost ($6,520 million) by $17,125 million ($24,559 - $914 - $6,520 = $17,125).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion, expensed exploration costs were $0.5 billion, and the PDC Energy, Inc. acquisition cost was $10.5 billion, resulting in a combined total of $11.0 billion and an excess of $13.6 billion. However, the LLM reports Chevron's total cost as $24,559 million ($24.559 billion), which is close but not exact, and uses incorrect values for expensed exploration costs ($914 million instead of $500 million) and PDC acquisition cost ($6,520 million instead of $10,500 million). These errors lead to a miscalculated difference of $17,125 million ($17.125 billion) instead of the correct $13.6 billion. (2) The calculations themselves are arithmetically correct based on the LLM's numbers, but the input values are factually wrong, undermining quantitative accuracy. (3) The reasoning structure is sound—multi-hop synthesis is attempted by identifying Chevron's total cost, subtracting two components—but the model fails to retrieve the correct values from the knowledge base, indicating a failure in entity-metric alignment. (4) Contextual relevance is moderate because the answer addresses the right question format and entities (Chevron, PDC Energy, cost components), but the incorrect data renders the conclusion invalid. The model appears to have used incorrect or hallucinated financial figures, leading to a mostly incorrect response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 417,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "American Tower determines the fair value of the market‑condition component of its 2024 performance‑based restricted stock units (PSUs) using a Monte Carlo simulation model. The model relies on key inputs such as the expected term (2.81 years), a risk‑free interest rate of 4.31 %, and annualized volatility of 26.75 % to calculate the probability of achieving the market‑condition requirement.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that American Tower uses a Monte Carlo simulation model to determine the fair value of its 2024 PSUs with a market condition component, which aligns with the ground truth. It also provides specific quantitative inputs used in the model (expected term: 2.81 years, risk-free rate: 4.31%, volatility: 26.75%), which are factually accurate and add detail not present in the original answer. However, the LLM fails to specify the key market metric used in the valuation — relative total shareholder return (RTSR) measured against the REIT constituents of the S&P 500 Index — which is a critical part of the question and missing from the response. (2) The numerical inputs provided (2.81 years, 4.31%, 26.75%) are precise and consistent with typical disclosures for such valuations, and no calculation errors are present. These numbers are plausible and enhance the answer, but they are supplemental rather than core to the question. (3) The reasoning is sound in describing how the Monte Carlo model works, but it does not complete the multi-hop synthesis by connecting the model to the specific performance metric (RTSR vs. S&P 500 REITs) that defines the market condition. This omission significantly reduces completeness. (4) The contextual relevance is high because the answer addresses the valuation method directly and includes advanced technical details. However, the absence of the specific market metric — the central element of the second part of the question — limits correctness despite strong supporting detail. Thus, while the answer is technically rich, it is incomplete on a key factual point, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 458,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "Based on the disclosed filings across the provided pages, **four amendments** to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented. The **fourth amendment** became effective on **July 1, 2022**, as explicitly stated in the filing for Exhibit 10.14 (Fourth Amendment to the Caterpillar Inc. Supplemental Employees' Investment Plan, effective as of July 1, 2022, referenced in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022). This amendment is distinct from earlier amendments (e.g., the Second Amendment effective December 14, 2018, and the Third Amendment effective January 1, 2022).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that there are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, which matches the ground truth. It also accurately states the effective date of the fourth amendment as July 1, 2022. (2) All quantitative elements—specifically the number of amendments (four) and the date (July 1, 2022)—are factually correct and match the original answer exactly. There are no calculation errors or date discrepancies. (3) The multi-hop reasoning is sound: the LLM references the specific exhibit (Exhibit 10.14) and the Form 10-Q filing for the quarter ended September 30, 2022, demonstrating synthesis across documents. It further distinguishes the fourth amendment from earlier ones, showing accurate entity and temporal differentiation. (4) The answer is semantically equivalent to the ground truth, with added contextual detail (e.g., filing type and exhibit number) that enhances accuracy without introducing error. All scores are maximized due to full factual correctness, precise dates, proper entity identification, and logical reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 320,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "The amortized cost of Corporate Notes and Obligations held by CRM in 2024 was $3,014 million, while their fair value was $2,978 million. This fair value is classified as Level 2 in the fair‑value hierarchy, meaning it is based on observable market inputs other than quoted prices for identical assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the amortized cost ($3,014 million) and fair value ($2,978 million) of Corporate Notes and Obligations held by CRM in 2024, which matches the ground truth. The implied $36 million unrealized loss is accurate, though not explicitly stated. However, the LLM incorrectly states that the entire fair value is classified as Level 2, which contradicts the ground truth: only $2,557 million of the $2,978 million fair value is categorized under Level 2 inputs in active markets. This is a critical omission and misrepresentation. (2) Quantitative accuracy is high for the numbers provided, but the model fails to report the $421 million difference between total fair value and Level 2 categorized value, and misassigns the Level 2 classification to the entire fair value. (3) The multi-hop reasoning is flawed: the question requires comparing the fair value to the Level 2 subset, but the LLM does not recognize that Level 2 is a partial categorization, not the whole. It fails to synthesize information across the two sources—specifically, the breakdown of fair value by valuation hierarchy level. (4) While the first part of the answer is factually sound, the mischaracterization of Level 2 classification significantly undermines the qualitative accuracy and overall correctness, warranting a mid-range score due to partial correctness but major conceptual error in the second part of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 398,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "Disney has secured financing for its two new cruise ships through two separate credit facilities, each initially sized at $1.1 billion. One facility, used to fund the Disney Treasure (delivered in October 2024), carries a fixed interest rate of 3.80% payable semi‑annually over 12 years. The second facility, intended for the upcoming Disney Destiny slated for fiscal 2026 delivery, would bear a fixed rate of 3.74% over the same 12‑year term if drawn. Early repayment is allowed subject to cancellation fees. These rates are comparable to the company’s broader borrowing costs, which include a weighted‑average effective interest rate of roughly 4.7% on its $40.5 billion of U.S. dollar‑denominated notes and a weighted‑average of about 5.47% on commercial paper.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total financing amount as $2.2 billion, composed of two $1.1 billion facilities for the Disney Treasure and Disney Destiny, with accurate interest rates of 3.80% and 3.74% respectively—matching the ground truth exactly. All numeric values (dollar amounts, percentages, and implied total) are correct. (2) Quantitative accuracy is perfect: $1.1B + $1.1B = $2.2B total, and both rates are reported with correct precision (3.80% and 3.74%). The mention of 12-year terms and semi-annual payments adds detail not in the original but does not contradict it. (3) The multi-hop reasoning is sound—correctly linking two separate financing facilities to two ships and comparing their rates. The addition of broader borrowing cost context (4.7% on notes, 5.47% on commercial paper) is accurate and enriches the answer, though not required. (4) The only minor deviation is that the original answer emphasizes the Destiny's facility is 'available' but not yet drawn, while the LLM says 'would bear...if drawn'—slightly more conditional phrasing than the original, but still factually appropriate. No factual errors; minor difference in emphasis does not affect correctness. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 359,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "Chevron's Tengizchevroil stake represents approximately 50% of its total equity method investments, amounting to $27,368 million of the $46,618 million total equity‑method investments at year‑end 2024. This 50% ownership translates into a significant share of production from the Kazakhstan joint venture, contributing roughly $3,375 million of Chevron’s equity‑method earnings and reflecting its substantial role in the country’s oil output.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in percentage calculation: it states that Tengizchevroil represents approximately 50% of Chevron's total equity method investments, but the correct percentage is approximately 58.7% ($27,368M / $46,618M). This is a significant quantitative inaccuracy despite correct input numbers. (2) The dollar amounts are accurate — $27,368 million and $46,618 million match the ground truth — but the derived percentage is wrong. The LLM also introduces a figure of $3,375 million in equity-method earnings, which is not present in the original answer and cannot be verified from the provided ground truth, making it potentially misleading. (3) The reasoning partially captures the multi-hop relationship: it correctly links Chevron’s investment stake to production contributions in Kazakhstan and identifies Tengizchevroil as a key asset. However, it fails to explicitly state that Tengizchevroil is an equity-method affiliate contributing to oil-equivalent production, and instead introduces unverified earnings data. (4) Contextual relevance is high because the answer addresses both parts of the question — percentage of investments and relation to production — and maintains focus on Chevron and Tengizchevroil. However, the incorrect percentage and unsupported earnings figure reduce factual reliability. Quantitative accuracy is penalized heavily due to the incorrect percentage derivation despite correct raw numbers. Qualitative accuracy is moderate due to sound structure but flawed synthesis. Correctness score reflects partial accuracy with major calculation error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 444,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "A change in credit spreads or upfront credit points directly impacts the fair value of Goldman Sachs’ level 3 credit derivatives, with wider spreads or higher upfront points generally decreasing the value of purchased credit protection (and increasing the value of written protection). The firm determines the fair value of these derivatives using valuation techniques that include option pricing models, correlation and discounted cash flow models, and significant unobservable inputs such as credit spreads, upfront credit points, and recovery rates, as detailed in Note 4 of the financial statements. These inputs are used in isolation to assess sensitivity, with fair value movements reflecting changes in these critical Level 3 inputs.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the direction of the impact on fair value. The original answer states that an increase in credit spreads or upfront credit points leads to an increase in the fair value of *purchased* credit protection. However, the LLM answer incorrectly states that wider spreads or higher upfront points 'generally decreasing the value of purchased credit protection,' which is the opposite of the ground truth. This misrepresents the economic relationship and undermines the core reasoning. The valuation techniques mentioned—option pricing, correlation, and discounted cash flow models—are correctly identified and align with the original answer. The mention of unobservable inputs (credit spreads, upfront points, recovery rates) and reference to Note 4 adds contextual detail not in the original but is plausible and relevant. There are no numerical values to verify, so quantitative accuracy is not applicable in a traditional sense, but the conceptual use of inputs is accurate. The reasoning is otherwise sound and the answer is contextually relevant, but the reversal of the fair value impact significantly affects correctness. Thus, while the answer demonstrates good structure and partial accuracy, the key directional relationship is wrong, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 372,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "The 2024 10‑K notes that the company’s ability to fund global communications‑site construction depends on maintaining compliance with debt covenants, including the Minimum Debt Service Coverage Ratio (DSCR). If the Minimum DSCR is not met, cash flow from the securitization trusts could be trapped, restricting excess cash that would otherwise be available for capital expenditures and REIT distributions, thereby limiting the company’s capacity to finance new tower builds worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core reasoning and captures the essential consequence of failing to meet the Minimum DSCR: restricted cash flow that limits funding for capital expenditures, including global communications site construction. It correctly identifies the link between DSCR compliance, cash trapping, and reduced capacity to finance new tower builds. However, it omits specific quantitative details present in the ground truth, such as the exact DSCR threshold (1.15x), the range of planned tower construction (1,950 to 2,550 sites), and the specific application of excess cash to the Series 2015-2 Notes or Loan. These omissions reduce completeness but do not invalidate the overall accuracy. All entities (AMT, DSCR, securitization trusts, capital expenditures) are correctly identified, and the reasoning chain—failure to meet DSCR leads to cash trapping, which limits funding for construction—is logically sound and semantically equivalent to the original. The answer is highly relevant to the question and synthesizes the multi-hop relationship between debt covenants and operational capacity. Quantitative accuracy is perfect as no incorrect numbers are stated (though none are specified).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 341,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "The critical audit matter identified by PwC relates to the product warranty liability, which Caterpillar estimates by applying historical claim rates to current field population and dealer inventory; auditors judged this estimate highly subjective and required specialized actuarial expertise to evaluate the reasonableness of the historical claim‑rate assumption.  Based on the disclosed figures, the product warranty liability recorded as of December 31 2024 is $1.7 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Caterpillar uses historical claim rates applied to current field population and dealer inventory to estimate its product warranty liability, which aligns with the ground truth. It accurately states that PricewaterhouseCoopers LLP (referred to as PwC) identified this as a critical audit matter due to the subjectivity and judgment involved, including the need for specialized actuarial expertise—this matches the original answer's emphasis on auditor judgment and effort. The financial estimate of $1.7 billion as of December 31, 2024, is numerically equivalent to $1,700 million in the ground truth, with acceptable format variation (billion vs million). (2) Quantitatively, the date (December 31, 2024) and dollar amount ($1.7 billion = $1,700 million) are correct. No calculations are required beyond recognition of unit equivalence, which is properly handled. (3) The multi-hop reasoning is sound: the answer connects Caterpillar’s accounting method → auditor’s identification of it as a critical audit matter → rationale (subjectivity, need for actuarial input) → resulting financial estimate, synthesizing information across entities and concepts correctly. (4) All entities (Caterpillar, PwC, product warranty liability, December 31, 2024) are accurate. The wording differs slightly but maintains full semantic equivalence. All scoring categories warrant top marks due to complete factual accuracy, correct synthesis, and precise numerical representation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 419,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "The document shows that Disney’s Asia Theme Parks borrowings carry a stated interest rate of 7.93% (page 99), while the effective interest rate on its senior unsecured notes is 4.71% (page 99). This spread reflects a higher cost of capital for the Asia Theme Parks debt relative to the company’s broader debt portfolio, indicating that financing for the parks is more expensive than the company’s overall borrowing cost.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the stated interest rate on Asia Theme Parks borrowings (7.93%) and the effective interest rate on Disney's senior unsecured notes (4.71%), matching the ground truth exactly. The difference of 3.22 percentage points is implied, though not explicitly calculated, but the direction and magnitude of the spread are accurately conveyed. (2) All numeric values are correct and properly attributed to page 99, aligning with the source. No calculation errors; the comparison is factually sound. (3) The reasoning correctly synthesizes the two interest rates to conclude that Asia Theme Parks debt has a higher cost of capital than senior unsecured notes, demonstrating valid multi-hop logic across debt categories. The answer could have slightly improved by explicitly quantifying the difference (3.22%) or mentioning potential reasons for the premium (e.g., risk, collateral), as in the original answer, but the core insight is preserved. (4) The response is contextually precise, directly addressing the question about relative cost of capital. Wording differs slightly but maintains semantic equivalence. Minor omission of explanatory factors prevents a perfect 10 on qualitative accuracy, but overall the answer is factually robust and well-aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 369,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ basin.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual components are accurate: the capitalized cost of $10,487 million and the 2.2 TCF contribution in the DJ Basin are correctly stated. (2) Quantitative accuracy is perfect—both dollar amount and volume (TCF) match the original answer exactly, with acceptable formatting (non-breaking spaces used in numbers). (3) The multi-hop reasoning is sound: the answer correctly links Chevron's 2023 PDC acquisition to both its financial cost and its operational impact in terms of reserves added in a specific U.S. basin. (4) The entity names (Chevron, PDC, DJ Basin), metric (capitalized cost), and year (2023) are all accurate. The only minor difference is 'DJ basin' vs 'DJ Basin'—a capitalization inconsistency that does not affect meaning or accuracy. The answer is complete, factually precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 265,
        "total_tokens": 1375
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "The adoption of the new LDTI accounting guidance required MetLife to retrospectively adjust its previously reported consolidated financial statements, primarily impacting the presentation of premiums, universal life policy fees, net investment and derivative gains/losses, and related expense and revenue categories. These adjustments, reflected in the \"Adoption Adjustment\" column across the income statement, balance sheet, equity, and comprehensive income tables, resulted in a $1.128 billion reduction in total revenues for 2022 and a $4.633 billion reduction in total expenses, leading to a significant increase in net income before tax from $2.859 billion to $6.364 billion. The retrospective application also materially changed the classification of certain liabilities (e.g., reclassifying $7.4 billion of future policy benefits to policyholder account balances) and adjusted retained earnings and accumulated other comprehensive income, as detailed in the balance sheet and equity statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides detailed quantitative information and discusses retrospective adjustments to multiple financial statements, which aligns with the question's focus. However, the ORIGINAL ANSWER (ground truth) only specifies that MetLife adjusted the consolidated statement of operations and consolidated statements of comprehensive income. The LLM answer goes beyond this by including balance sheet, equity, and specific dollar amounts such as a $1.128 billion reduction in revenues, $4.633 billion reduction in expenses, and reclassification of $7.4 billion in liabilities—none of which are present in the ground truth and cannot be verified as correct without external data. These specific figures and additional statements (e.g., balance sheet, equity) are not mentioned in the original answer, indicating potential hallucination or over-specification. While the general idea—that retrospective adjustments were made to income and comprehensive income statements due to LDTI’s material impact—is consistent, the inclusion of unsupported numerical details and expanded scope of adjusted statements reduces factual accuracy. The reasoning is logically structured and contextually relevant, showing understanding of retrospective application and its implications, but fails on quantitative fidelity and precise entity/metric alignment. Thus, the correctness score is reduced significantly due to unverified numbers and overreach beyond the known facts, despite correct identification of the core concept of retrospective adjustment to key income-related statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 429,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "The Solar Turbines Incorporated Managerial Retirement Objective Plan has been amended twice, with the most recent amendment becoming effective on January 1, 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that the Solar Turbines Incorporated Managerial Retirement Objective Plan has been amended twice, which matches the ground truth. It also accurately provides the effective date of the most recent amendment as January 1, 2022. All numeric and date information is correct, satisfying quantitative accuracy. The answer is semantically equivalent to the original answer, though it omits the specific name of the amendment ('Second Amendment'). This is a minor omission that does not affect the core factual correctness, as the count and date are accurate. The reasoning appears sound, correctly synthesizing information from the Caterpillar Inc. 2024 10-K filing regarding the plan amendments. The response is fully relevant to the question and conveys the necessary information. The only reason for not scoring a 10 is the lack of explicit mention of the 'Second Amendment' designation, which is part of the complete factual record in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 282,
        "total_tokens": 1398
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "The North Carolina Rate Case Order increased depreciation and amortization by $172 million (reflected in the $175 million rise in depreciation expense for Duke Energy Carolinas) and added $31 million of impairment and other charges, but the net effect on the consolidated statements of operations was a $13 million decrease in impairment of assets and other charges (from $44 million in 2023 to $31 million in 2024). Consequently, total operating expenses fell by $528 million in Duke Energy Florida and by $881 million in Duke Energy Carolinas, while the overall consolidated statement of operations showed a $45 million increase in net income, driven by the lower impairment charge and other favorable variances.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the ground truth states the total financial impact on Impairment of Assets and Other Charges was $68 million ($35M from Duke Energy Carolinas and $33M from Duke Energy Progress). The LLM instead claims a net decrease in impairment charges from $44M to $31M (a $13M decrease), with only $31M in total charges—this contradicts the ground truth both in magnitude and direction (increase vs. decrease). The $68M total is not mentioned or implied. (2) The LLM introduces unrelated figures such as a $172M increase in depreciation, $528M and $881M reductions in operating expenses in Duke Energy Florida and Carolinas, and a $45M increase in net income—none of which are part of the original answer or relevant to the specific question about impairment charges. (3) Entity accuracy fails: the answer references Duke Energy Florida, which was not involved in the North Carolina Rate Case impact on impairment charges according to the ground truth. (4) Reasoning is flawed: the LLM appears to conflate depreciation impacts with impairment charges and misrepresents the direction of the financial impact (decrease vs. actual increase of $68M). It also fails to synthesize the correct multi-hop information—aggregating the $35M and $33M charges into a total $68M—which is the core of the question. (5) The answer is not semantically equivalent; it describes a completely different financial outcome. Only minimal contextual relevance is retained as it discusses rate cases and impairment charges in a broad sense, but the specifics are entirely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 451,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "The 12% of total net revenues generated by licensed stores reflects a modest financial contribution compared to the dominant 82% from company-operated stores. Under the licensed model, Starbucks earns a margin on branded products and supplies sold to licensees, along with royalties and license fees, but these revenues carry lower gross margins and are offset by licensees bearing operating costs and capital investments. This structure allows Starbucks to expand its footprint with lower capital expenditure while leveraging local partners' market expertise, though it generates less direct revenue per store than company-operated locations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that licensed stores accounted for 12% of total net revenues, matching the ground truth. It accurately describes the structure of payments: margins on products and supplies, royalties, and license fees. It also correctly contrasts the lower per-store revenue with company-operated stores and notes the benefit of cost and capital shifting to licensees. The only minor omission is the explicit mention of 'fiscal 2024' as the time period, though the percentage is correctly attributed. 2) All numeric values (12%, 82%) are accurate and consistent with the ground truth. The 82% figure for company-operated stores is not in the original answer but is a reasonable inference (since 100% - 12% - ~6% from other segments ≈ 82%) and does not contradict known data. No calculations are required, and the percentages are correctly used. 3) The reasoning is sound: the model correctly synthesizes the financial model of licensed stores, explains the trade-off between lower direct revenue and improved margins via cost shifting, and contextualizes the strategic rationale. It demonstrates multi-hop understanding by linking revenue structure to operational and strategic outcomes. 4) The answer is semantically equivalent to the ground truth, with slightly more emphasis on strategic expansion and market expertise, which is a reasonable extension but not contradicted by the original. The core financial impact—revenue contribution and margin benefits via cost structure—is accurately conveyed. The absence of 'fiscal 2024' slightly reduces qualitative accuracy but does not materially mislead.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 442,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "Target’s owned and exclusive brands generate roughly one‑third of sales and carry higher margins than national brands, but they require longer lead times and involve greater responsible‑sourcing complexities. If Target fails to develop, source, and market these brands effectively, it could lose sales volume, erode the higher‑margin contribution, and expose the company to reputational damage and supply‑chain disruptions that would adversely affect its results of operations and financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial risk Target faces if it fails to develop, source, and market its owned and exclusive brands. (1) Quantitatively, the statement that these brands account for 'roughly one-third of sales' matches the ground truth exactly—no numerical discrepancies. (2) The answer correctly identifies that these brands carry higher margins than national brands and notes the longer lead times and responsible-sourcing risks, which are key qualitative elements. (3) The multi-hop reasoning is sound: it connects the importance of the brands to sales and margins, links operational challenges (lead times, sourcing) to financial and reputational risks, and concludes with a valid inference about adverse effects on operations and financial condition. (4) While the LLM omits explicit mention of 'longer-term forecasting of consumer demand' and 'exposure to supply chain disruptions due to earlier ownership in the supply chain'—details present in the original—it still captures the essence of those risks through 'supply-chain disruptions' and implications of sourcing complexities. The answer is semantically equivalent in intent and factual content, with only minor contextual omissions. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 378,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "Based on the provided pages from the 2024 10-K filing, **four amendments** to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated by reference from prior SEC filings. The most recent two amendments (the Third and Fourth Amendments, effective January 1, 2022, and July 1, 2022, respectively) were referenced in the following filings:  \n- **Third Amendment**: Incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021.  \n- **Fourth Amendment**: Incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of amendments (four), the effective dates (January 1, 2022, and July 1, 2022), and the exhibit references (Exhibit 10.28 and Exhibit 10.6) are all accurate. (2) The specific prior filings are correctly identified: the Third Amendment from the 2021 Form 10-K (year ended December 31, 2021) and the Fourth Amendment from the Q3 2022 Form 10-Q (quarter ended September 30, 2022). (3) The multi-hop reasoning is sound—information is synthesized across multiple filings (2024 10-K referencing prior 10-K and 10-Q), and the LLM correctly traces the incorporation by reference chain. (4) The answer is semantically equivalent to the original, with clear, well-structured presentation that preserves all factual content. No errors in entities, dates, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 252,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "Based on the provided pages from the 2024 10-K filing, the number of shares remaining available for future grant or issuance under the 2013 Equity Incentive Plan is **73 million shares**. Additionally, outstanding equity awards related to this plan include **8 million stock options outstanding** and **26 million restricted stock awards and units outstanding** (which includes performance-based stock units). These figures are derived from the \"Common Stock\" section on page 84, which details shares available for future grant (73 million) and the breakdown of outstanding awards.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is significantly incorrect in terms of quantitative accuracy. The original answer states that 73 shares (not 73 million) remain available for future grant under the 2013 Equity Incentive Plan. The LLM incorrectly reports this as 73 million shares, which is off by a factor of one million. Similarly, the LLM introduces specific numbers for outstanding awards—8 million stock options and 26 million restricted stock awards and units—that are not present in the original answer and are likely fabricated or misread from a source not in the ground truth. The original answer only states the types of equity awards outstanding (options, restricted stock awards and units, and performance-based stock units), not their quantities. Therefore, the inclusion of numerical values for outstanding awards is a factual overreach and incorrect. While the LLM correctly identifies the types of equity awards at a high level (options, restricted stock awards and units, which encompass performance-based units), it adds unsupported specifics. The reasoning appears to misinterpret the scale of the data (shares vs. millions of shares), indicating a failure in quantitative comprehension. The contextual relevance is moderate because the answer addresses the right plan and general categories of awards, but the massive numerical inaccuracies and invented figures severely undermine correctness. Multi-hop synthesis is not applicable here as the question relies on a single source, but the model fails to extract the correct magnitude of the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 422,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "Based on the provided financial data, **approximately 83% of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé**, as this segment generated $1,769.8 million in total revenue (with $1,476.5 million specifically attributed to Nestlé-related product sales and royalties, as indicated by the segment reporting and revenue mix details in the document). This aligns with the question's context that \"most of these revenues come from product sales and royalties through this partnership.\"",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The original answer (ground truth) explicitly states that while the majority of Starbucks' Channel Development revenues in fiscal 2024 come from the Global Coffee Alliance with Nestlé, no exact percentage is disclosed. The LLM fabricates a precise figure of 'approximately 83%' and cites specific dollar amounts ($1,769.8 million total, $1,476.5 million from Nestlé), which are not present in the ground truth and cannot be derived from the provided information. There is no quantitative basis in the original answer to support any percentage, let alone a calculated 83% (which would require dividing $1,476.5M by $1,769.8M ≈ 83.4%). This represents a serious hallucination of data. While the LLM correctly identifies the relevance of the Global Coffee Alliance and Nestlé to Channel Development revenues, it fails the core requirement of factual accuracy. The reasoning is not sound, as it invents numbers rather than acknowledging the absence of a disclosed percentage. Contextually, it addresses the right topic and entity relationship, but the inclusion of false precision severely undermines the answer's validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 326,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "The adoption of the new LDTI accounting guidance required MetLife to retrospectively adjust its previously reported consolidated financial statements, primarily impacting the presentation of future policy benefits, policyholder account balances, and related liabilities. These adjustments are illustrated in the tables presented as of December 31, 2022, in the 2023 10-K filing, which show the effects of the retrospective application on the consolidated statements of operations, comprehensive income, balance sheets, and cash flows. Specifically, the adjustments resulted in changes to net income, other comprehensive income, and equity balances, as reflected in the tables detailing the adoption adjustment impacts across multiple financial statement line items.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that deviate from the ground truth. While it correctly identifies that MetLife retrospectively adjusted its financial statements due to the LDTI guidance and mentions the December 31 tables in the 2023 10-K, it overstates the scope of the adjustments. The original answer specifies only the consolidated statement of operations and consolidated statements of cash flows were adjusted, but the LLM incorrectly includes consolidated balance sheets and statements of comprehensive income, which are not mentioned in the ground truth. Additionally, the LLM references adjustments to 'future policy benefits, policyholder account balances, and related liabilities' and changes to 'net income, other comprehensive income, and equity balances'—details not present in the original answer and unsupported by the provided truth. There are no numeric values to verify, so quantitative accuracy is based on correct mention of dates and statements; the reference to 'December 31, 2022' is plausible as a comparative date but the ground truth only specifies 'December 31' without a year, making this a minor over-specification rather than a clear error. The reasoning is partially sound in linking LDTI adoption to retrospective adjustments and referencing illustrative tables, but the failure to accurately limit the adjusted statements to only operations and cash flows constitutes a significant factual error. The answer is contextually relevant and addresses the general intent of the question, but lacks precision in entity and financial statement identification, reducing its correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 442,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "Based on the provided financial disclosures, the fair value of equity method investment contracts was $3 million in 2022, while total asset derivatives (including all derivative instruments) were $790 million. This indicates that equity method investment contracts represented a negligible portion of Mondelez International's derivative portfolio in 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3 million value for equity method investment contracts, which matches the ground truth. However, it states total asset derivatives as $790 million, which is incorrect—the ground truth reports $393 million. This is a significant quantitative error that affects the validity of the comparison. (2) The calculation of relative significance is not explicitly provided, but the conclusion that equity method investment contracts are 'negligible' is directionally correct. However, with the incorrect total, the implied percentage (~0.38%) is half of the actual (~0.76%), and the ground truth emphasizes 'less than 1%', which is accurate. The LLM’s qualitative interpretation is reasonable but based on flawed input. (3) The multi-hop reasoning is structurally sound—the model identifies the two relevant values and compares them to assess relative significance. However, the synthesis fails due to reliance on an incorrect total asset derivatives figure, undermining the factual basis of the conclusion. (4) Contextual relevance is high: the answer addresses both parts of the question (comparison and significance) and uses appropriate terminology. The company (MDLZ/Mondelez) and year (2022) are correct. The main failure is in quantitative accuracy, which drags down overall correctness. Thus, correctness_score is 5 due to partial factual accuracy with a major numerical error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 396,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "The freezing of U.S. pension benefits as of December 31 2019 eliminated the “expected rate of compensation increase” assumption for those plans, so CAT no longer incorporates compensation‑related growth in its pension obligation or cost calculations. This change reduces the sensitivity of pension expense and obligations to fluctuations in compensation assumptions and simplifies the actuarial modeling for the frozen U.S. plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately identifies that the freezing of U.S. pension benefits as of December 31, 2019, led to the elimination of the 'expected rate of compensation increase' assumption, which matches the original answer. (2) The date 'December 31, 2019' is correctly stated, and no other numerical values are required. (3) The reasoning is sound: since benefits were frozen, future compensation growth is no longer relevant, so the assumption is discontinued. The LLM adds contextually accurate implications—reduced sensitivity of pension obligations to compensation changes and simplified modeling—which are logical extensions consistent with accounting principles, though not explicitly stated in the ground truth. (4) The answer is semantically equivalent and highly relevant. The score is 9 instead of 10 because the original answer focuses strictly on the discontinuation of the assumption, while the LLM adds interpretive details (e.g., 'reduces sensitivity', 'simplifies modeling') that, while reasonable, go slightly beyond the verified ground truth. However, these additions do not introduce inaccuracies and are professionally sound, so high scores are warranted across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 352,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "Oracle’s heavy reliance on Oracle Engineered Systems—reflected in its hardware revenue structure—creates a concentrated exposure to supply‑chain constraints, component shortages, and manufacturing delays. Because these systems are a key driver of hardware sales, any disruption in the availability of critical components or in third‑party production capacity can depress hardware revenue, erode margins, and limit the company’s ability to sustain profitability in its hardware business. Consequently, managing supply‑chain risks is essential to preserving the profitability of Oracle’s engineered‑system portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth and captures the core causal relationship between Oracle's strategic focus on Oracle Engineered Systems and its vulnerability to supply chain disruptions. It correctly identifies that these systems are a major part of hardware revenue and that supply chain issues can lead to manufacturing delays, margin erosion, and profitability challenges. However, it omits specific details present in the original answer that reflect multi-hop synthesis from the 10-K filing, such as the increase in inventory purchases to secure capacity, the resulting risks of excess and obsolescence, and the negative impact on operating cash flows. While the LLM conveys the general risk and strategic exposure accurately (semantic equivalence on key points), it does not fully reflect the depth of cause-and-effect detailed in the ground truth, particularly around cost pass-through limitations and delayed revenue recognition. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers are introduced), and all entities (Oracle, Oracle Engineered Systems, hardware business) are correct. The reasoning is sound but less comprehensive than required for a top score. Contextual relevance is excellent—the response directly addresses the question's focus on strategic impact, supply chain, and profitability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 381,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area is $3,555 million, reflecting a 10.6 % increase from 2022. This growth outpaces the overall Pulmonary Hypertension category’s 11.6 % sales growth for the same period.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly reports the combined 2023 global sales revenue of $3,555 million for UPTRAVI and OPSUMIT, which matches the ground truth sum ($1,973M + $1,582M = $3,555M). This aspect is quantitatively accurate. However, the answer incorrectly states that the combined products had a 10.6% growth, which is inaccurate: 10.6% is the growth rate for OPSUMIT alone, while UPTRAVI grew at 19.7%. The LLM fails to report individual growth rates and instead misattributes OPSUMIT's growth to the combined total, which is a significant error in multi-hop reasoning. Additionally, the conclusion that the combined growth 'outpaces' the category’s 11.6% growth is incorrect — if the combined growth were actually 10.6% (which it isn’t), it would be slower, not faster. In reality, while UPTRAVI (19.7%) outpaces the category, OPSUMIT (10.6%) does not, and the combined growth rate would require a weighted average calculation not provided. The model also omits the breakdown of individual drug revenues and their respective growth rates, which are essential for completeness. While the context and entities (drug names, therapeutic area, year) are correct, the flawed synthesis and incorrect percentage attribution reduce both quantitative and qualitative accuracy. Contextual relevance is high as the answer addresses the general question framework and uses appropriate terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 381,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "The full‑year contribution from legacy PDC Energy assets added roughly **$2.2 billion** to Chevron’s U.S. upstream earnings in 2024, and it drove **net oil‑equivalent production up about 250,000 barrels per day (≈19 % higher)**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $2.2 billion increase in U.S. upstream earnings for CVX in 2024 from legacy PDC Energy assets is correctly stated. The impact on net oil-equivalent production is accurately conveyed as 250,000 barrels per day, with the ≈19% increase properly associated. (2) Quantitative accuracy is perfect: $2.2 billion, 250,000 barrels per day, and 19% are all correct and match the original answer exactly; format variations (e.g., '≈19%' vs '19%') are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound—the answer synthesizes the financial and production impacts of the PDC Energy acquisition on Chevron (CVX) in 2024, correctly attributing both earnings and production changes to the full-year contribution of the legacy assets. (4) Entity accuracy is strong: 'Chevron' is correctly used for CVX, '2024' is the right year, and 'net oil-equivalent production' is the correct metric. The answer is concise, relevant, and captures all components of the multi-part question without omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 320,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "The retrospective application of the new LDTI accounting guidance required adjustments to **all three core financial statements**: the consolidated statement of operations (including revenues, expenses, and net income), the consolidated statement of comprehensive income (reflecting changes to other comprehensive income components), and the consolidated balance sheet (modifying assets like market risk benefits and liabilities such as future policy benefits and policyholder account balances). This widespread impact indicates that the LDTI guidance fundamentally reshaped the company's financial reporting structure, affecting both the magnitude and presentation of key line items across the statements, with significant adjustments to retained earnings and accumulated other comprehensive income as well.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies regarding which financial statements were adjusted. The original answer states that MetLife adjusted the consolidated statements of equity and consolidated statements of comprehensive income. However, the LLM claims adjustments were made to all three core financial statements—including the statement of operations and balance sheet—which is not supported by the ground truth. While the implication about broad impact is reasonable, the LLM overstates the scope by incorrectly identifying the specific statements affected. There are no numeric values to verify in this case, so quantitative accuracy is based on correct reference to financial components; the mention of retained earnings and accumulated other comprehensive income is plausible but not confirmed in the original. The reasoning is logically structured but built on incorrect premises, failing the multi-hop synthesis requirement to accurately identify the precise statements adjusted. The contextual relevance is high because the answer addresses the question's intent about scope and implications, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 331,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "The total fair value of equity method investment contracts disclosed in the derivatives fair value table as of December 31, 2022 was **$3 million** (a negative amount of $(3) million). This is disclosed under “Equity method investment contracts” in the “Total derivatives” row of the fair‑value table on page 96 (and reiterated on page 94).  \n\nIn comparison, the total fair value of net investment hedge contracts (i.e., net investment hedge derivative contracts) was **$24 million** as of December 31, 2022, shown under “Net investment hedge contracts” in the same fair‑value table. Thus, the net investment hedge contracts had a substantially higher fair‑value amount than the equity method investment contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total fair value of equity method investment contracts as $(3) million and net investment hedge contracts as $24 million as of December 31, 2022, matching the ground truth. The negative value for equity method investment contracts is accurately represented as a $3 million liability (shown in parentheses), which the model correctly interprets as a negative amount. (2) All numeric values are correct and properly contextualized. The comparison between the two values is accurate: $24 million is substantially higher than $(3) million. There are no calculation errors. (3) The reasoning is sound and demonstrates multi-hop synthesis by correctly extracting and comparing two distinct line items from the same derivatives fair value table. The model references specific pages (96 and 94), indicating proper sourcing, though page numbers are not required for correctness. (4) The answer conveys the same information as the original answer with slightly more detail (e.g., page references), and the conclusion about the relative sizes is logically and semantically equivalent. The only minor shortcoming is that the original answer explicitly states that equity method investment contracts had a 'significantly smaller fair value,' while the LLM uses 'substantially higher' from the perspective of net investment hedges—this is semantically equivalent but slightly less direct in framing the comparison from the equity method side. This does not affect factual accuracy, hence a score of 9 instead of 10 on qualitative accuracy. All other aspects are fully correct and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 445,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "The net assets of Universal Beijing Resort increased from $62.5 billion at December 31 2023 to $62.5 billion at December 31 2024—reflecting essentially no change in the consolidated balance‑sheet figure for property and equipment net of depreciation, which remained $62.5 billion in both years. This stability is consistent with the cash‑flow disclosures that capital expenditures for the resort are presented separately in the consolidated statements of cash flows, indicating that the resort’s asset base was largely unchanged over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively, it claims Universal Beijing Resort's net assets were $62.5 billion in both 2023 and 2024, which is wildly off from the ground truth: net assets were $0.6 billion in 2023 and $0.3 billion in 2024 (a $0.5 billion decrease). The reported $62.5 billion figure appears to be a confusion with a line item like 'property and equipment' from Comcast's consolidated balance sheet, but even that is implausible and unsupported by context. (2) The calculation is completely wrong—there is no 'no change' in net assets; there is a 50% decrease. (3) The reasoning fails multi-hop synthesis: the question asks about Universal Beijing Resort’s net assets (derived from its assets minus liabilities as reported in Comcast’s consolidated statements), but the LLM incorrectly equates a single line item (property and equipment) with total net assets of the resort. It also misattributes stability in a consolidated line item to the resort’s financials without isolating the relevant data. (4) The answer is not semantically equivalent—it contradicts the ground truth in direction (increase vs. decrease), magnitude (62.5B vs. 0.6B), and conclusion. The contextual relevance is low because it discusses capital expenditures and cash flow disclosures not asked for and misapplies consolidated balance sheet line items to a specific joint venture. The answer reflects a fundamental misunderstanding of the financial structure and reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 407,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29 2024 is $103.6 million (comprising a ¥5 billion facility worth $34.5 million and a ¥10 billion facility worth $69.1 million). The 2021 Revolving Credit Agreement explicitly backs the commercial paper program by providing a $3 billion backstop commitment that can be drawn to fund any outstanding commercial paper issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the total value of Starbucks' Japanese yen-denominated credit facilities as $103.6 million, accurately breaking it down into the ¥5.0 billion ($34.5 million) and ¥10.0 billion ($69.1 million) components. All numerical values match the ground truth, including the USD equivalents and underlying yen amounts. (2) Quantitative accuracy is perfect: the sum $34.5M + $69.1M = $103.6M is correct, and the individual conversions from yen to USD are consistent with the original answer. Dates (maturities) are not mentioned in the LLM answer but were not explicitly required in the response to the question as posed. (3) The explanation of the 2021 Revolving Credit Agreement’s support for the commercial paper program is mostly accurate—it correctly identifies the $3.0 billion backstop commitment. However, it omits key details from the ground truth: that the commercial paper program allows issuance up to $3.0 billion and that proceeds are used for specific purposes (working capital, capex, dividends, etc.). While the core mechanism (backstop) is correctly described, the lack of detail on usage and program scope represents a minor gap in qualitative completeness. (4) Contextual relevance is high—the answer directly addresses both parts of the multi-hop question: the valuation of yen-denominated facilities and the relationship between the credit agreement and commercial paper program. The reasoning is sound and synthesizes information correctly across financial instruments and timeframes. The omission of the use of proceeds slightly reduces qualitative accuracy but does not impair the main factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 455,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "Oracle’s strategic focus on Oracle Engineered Systems—integrated hardware platforms such as Exadata, engineered systems, and Cloud@Customer—drives a significant share of its infrastructure‑technologies revenue, accounting for roughly 58‑60 % of total cloud services and license‑support revenue in recent fiscal years. At the same time, this hardware‑centric approach exposes Oracle to heightened supply‑chain risk, as it relies on single‑source component suppliers and external manufacturers; disruptions (e.g., pandemic‑related shortages, component constraints, or logistics delays) can delay product deliveries, increase production costs, and depress hardware margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle Engineered Systems (e.g., Exadata) as key contributors to infrastructure technologies revenue and links them to Oracle's broader hardware and cloud offerings. It accurately reflects the strategic importance of these systems and their impact on supply chain risks. However, the percentage cited (58–60%) is slightly imprecise—the ground truth specifies that infrastructure cloud services and license support revenues represented exactly 58% of total cloud services and license support revenues in fiscal 2022. The LLM generalizes this to 'recent fiscal years' and a range, which introduces minor inaccuracy. (2) The quantitative claim is mostly correct but lacks specificity: the original answer ties the 58% figure explicitly to fiscal 2022, while the LLM broadens it without specifying the year, risking misinterpretation. There are no calculation errors, but the lack of fiscal year precision reduces quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the connection between Oracle Engineered Systems, revenue contribution, and supply chain dependencies. It acknowledges reliance on single-source suppliers and external manufacturers and links disruptions to delivery delays and cost increases—consistent with the original. However, it omits specific consequences mentioned in the ground truth, such as increased inventory purchases, higher obsolescence risk, and negative impacts on operating cash flows. (4) Despite these omissions, the core facts and logic are correct, and the answer remains contextually relevant and well-aligned with the question. The score reflects high accuracy with minor gaps in specificity and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 472,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "The debt at Universal Beijing Resort decreased slightly from $3.5 billion in 2023 to $3.4 billion in 2024, reducing the total “Debt Not Guaranteed” category from $4.8 billion to $4.8 billion (the figure remains $4.8 billion, but the underlying amount fell by $0.1 billion). This modest decline contributed to a small reduction in the overall “Debt Not Guaranteed” balance shown in the table.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in Universal Beijing Resort's debt from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion, which matches the ground truth. However, it incorrectly states that the total 'Debt Not Guaranteed' category remained at $4.8 billion, implying no change, while the ground truth shows it decreased from $5.0 billion in 2023 to $4.8 billion in 2024—a $0.2 billion drop. The LLM acknowledges a 'small reduction' but inaccurately claims the total stayed at $4.8 billion, contradicting both the direction and magnitude of change. (2) The calculation of the $0.1 billion decrease in Universal Beijing Resort's debt is correct. However, the synthesis of how this affects the total 'Debt Not Guaranteed' category is flawed: the LLM fails to note the full $0.2 billion decline in the total and omits the contribution from the 'Other' debt decreasing from $1.5 billion to $1.4 billion. (3) The multi-hop reasoning is partially sound—linking Universal Beijing Resort's debt reduction to the broader category—but incomplete and misleading due to the incorrect presentation of the total category value as unchanged when it did change. (4) The correctness score is 5 due to partially correct numbers but significant error in the key outcome (total 'Debt Not Guaranteed' change). Quantitative accuracy is 5 because half the numbers are right but the total category misstatement is material. Qualitative accuracy is 5 due to flawed synthesis. Contextual relevance is 8 because the response addresses the right entities and question structure, despite factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 444,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts requires management to make significant judgments in estimating total contract costs and revenue recognition over time, which inherently involves high uncertainty and subjectivity. This complexity directly impacts audit procedures, as auditors must rigorously test the effectiveness of internal controls over cost estimates, evaluate the appropriateness of assumptions (e.g., inflation, technical risks, performance trends), and assess the potential for bias or error in revenue and cost recognition, particularly for contracts with long durations and significant gross margin variability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify or compare, and no calculations required. (2) The LLM correctly identifies the core issue: Honeywell's use of the cost-to-cost method introduces complexity due to management estimates of total contract costs and progress toward completion, which directly affects audit procedures. It accurately reflects that auditors must test internal controls, evaluate assumptions (e.g., inflation, technical risks), and focus on long-duration contracts with variable margins. (3) The multi-hop reasoning is sound: the model connects the accounting method (cost-to-cost) to estimation challenges, then to audit implications, synthesizing the causal chain correctly. (4) Minor difference: the original answer includes more specific detail about 'material adjustments if estimates change over time' and explicitly mentions 'subcontractor performance' and 'labor agreements' as cost influencers, which the LLM omits. However, these are contextual enhancements rather than critical omissions. The LLM captures the essential reasoning and audit impact, warranting a high score. Thus, correctness is 9 (not 10) due to slight incompleteness in detailing all risk factors and the potential for retrospective adjustments, but overall the answer is factually correct, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 406,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "The 2023 financial results show that NEER’s non‑qualifying hedge gains of $1,729 million were $1,429 million larger than the $300 million of gains recorded by FPL, highlighting that NEER reports gains from non‑qualifying hedges directly in net income, while FPL’s gains are modest and stem from its cost‑recovery clauses. This disparity reflects the different accounting treatment of derivative transactions: NEER marks its non‑qualifying hedges to market and includes the resulting gains in earnings, whereas FPL’s derivative gains are largely deferred as regulatory assets or liabilities and only recognized when realized through the cost‑recovery process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: NEER's $1,729 million in non-qualifying hedge gains, FPL's $300 million in gains, and the $1,429 million difference (calculated accurately as 1,729 - 300). These values match the ground truth exactly, with acceptable formatting ($1,729 million vs $1,729 million). (2) Quantitative accuracy is perfect—numbers, units, and the subtraction are correct. (3) The reasoning correctly captures the multi-hop synthesis: NEER recognizes non-qualifying hedge gains directly in net income, contributing to earnings volatility, while FPL defers most derivative gains due to its regulated cost-recovery framework. The LLM accurately reflects the regulatory deferral mechanism and links it to the smaller amount passed through to net income. (4) The only minor shortcoming is a slight omission in not explicitly stating that FPL’s $300 million represents gains that were *passed through* upon settlement, rather than being the result of cost-recovery clauses per se—the phrasing 'stem from its cost-recovery clauses' is somewhat imprecise compared to the ground truth’s clearer explanation of deferral until settlement. However, the core distinction in accounting treatment is correctly conveyed. Overall, the answer is factually sound, contextually appropriate, and semantically equivalent to the original answer with only minor wording nuance missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 390,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "Comcast consolidates Universal Beijing Resort (a 30%‑owned VIE) into its balance sheet, so the resort’s assets ($7.3 billion) and liabilities ($7.0 billion) are included in the consolidated totals, but the company’s own equity reflects only its 30% stake. Because the VIE’s debt is non‑recourse to Comcast, the maximum financial loss Comcast can incur is limited to its equity interest and any remaining capital commitment—approximately $1.4 billion of unfunded capital—representing roughly 2 % of the resort’s total debt financing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Comcast's 30% ownership and the consolidation of Universal Beijing Resort as a VIE, and it accurately reports the resort's assets ($7.3 billion) and liabilities ($7.0 billion) being included in the consolidated balance sheet. However, it incorrectly states that Comcast’s maximum risk of financial loss is approximately $1.4 billion of unfunded capital, representing roughly 2% of total debt, which contradicts the ground truth. The ground truth specifies that Comcast’s maximum risk is limited to its 30% equity interest in the $3.4 billion debt, equating to $1.02 billion (30% × $3.4B), not $1.4B or 2%. (2) The quantitative inaccuracies are significant: the $1.4 billion unfunded capital figure and 2% of total debt are unsupported by the original answer and factually incorrect. The correct proportion is 30% of $3.4 billion = $1.02 billion. (3) The reasoning is partially sound—correctly identifying VIE consolidation and non-recourse debt—but fails in the multi-hop synthesis by misrepresenting the nature of Comcast’s risk exposure. It introduces an unfunded capital commitment not mentioned in the ground truth and incorrectly ties it to the debt proportion. (4) Scores reflect major factual and calculation errors (correctness 4/10, quantitative 3/10), partially correct reasoning (qualitative 5/10), and high relevance to the question context (contextual 8/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 394,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "The cumulative goodwill impairment charges recognized for OpenTable in 2020 ($489 million) were substantially larger than the revenue contribution of OpenTable to Booking Holdings’ advertising and other segment in 2021, which was only $255 million (as disclosed in Note 5). Consequently, the 2020 impairment amount exceeded the 2021 advertising‑and‑other revenue generated by OpenTable.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. The cumulative goodwill impairment for OpenTable in 2020 was $1,062 million ($489M in Q1 + $573M in Q3), but the LLM incorrectly states it as only $489 million, omitting the Q3 charge. This is a critical error in quantitative accuracy. Additionally, the LLM claims OpenTable contributed only $255 million to the 'advertising and other' segment in 2021, which contradicts the ground truth of $1.1 billion. These numbers are not supported by the original data and appear fabricated or misread (e.g., possibly misinterpreting a line item in Note 5). (2) Calculations: The LLM incorrectly compares $489M (only part of the impairment) to $255M (an incorrect revenue figure), leading to a false conclusion. In reality, the $1,062M impairment was nearly equivalent to the $1.1B revenue, not 'substantially larger.' The direction and magnitude of the comparison are wrong. (3) Multi-hop reasoning: The model attempts to compare impairment charges to revenue contribution across years and segments, which aligns with the question’s intent. However, due to incorrect data retrieval from both the impairment and revenue sides, the synthesis fails. It does reference 'Note 5,' suggesting an attempt to ground in a source, but the numbers do not match the ground truth. (4) Scores justified: Correctness is low (2/10) due to fundamental errors in both key figures and the resulting comparison. Quantitative accuracy is poor (2/10) because both dollar amounts are wrong. Qualitative accuracy is slightly higher (3/10) because the model recognizes the relevant entities (OpenTable, Booking Holdings, goodwill impairment, advertising and other segment) and attempts a valid type of comparison. Contextual relevance is moderate (6/10) as the answer addresses the right topic and structure but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 503,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "ExxonMobil incorporates estimated greenhouse‑gas emission costs into its Corporate Plan by using those costs as part of the cash‑flow assumptions that drive its long‑term price, margin and capital‑allocation projections; the plan explicitly includes the cost of meeting its 2030 net‑zero Scope 1 and 2 emissions target for unconventional Permian Basin assets when estimating future cash flows for impairment testing. This forward‑looking emission‑cost assumption is embedded in the discounted‑cash‑flow models used to assess recoverability of asset groups and to determine any required impairment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in future cash flow assessments for asset recoverability, even in jurisdictions without current carbon pricing—this matches the original answer. (2) The specific future emission-reduction goal—achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin by 2030—is accurately identified, including the correct year (2030), scope (Scope 1 and 2), asset type (unconventional operated), and location (Permian Basin). (3) The multi-hop reasoning is sound: the model correctly links the emission costs to impairment testing via discounted cash flow models, showing understanding of how forward-looking environmental targets influence financial assessments. (4) All entities, timeframes, and financial concepts are used correctly. Minor wording differences (e.g., 'capital-allocation projections' or 'discounted-cash-flow models') enhance clarity without altering meaning. No factual errors, omissions, or calculation issues—full alignment with ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 343,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "Based on the provided SEC 10-K filing (Capital One Financial Corporation), the $2.4 billion regulatory capital addition under the CECL Transition Rule had 50 % phased in by December 31 2023, leaving $1.2 billion remaining. This remaining amount will be phased in at $600 million per year in 2024 and 2025. Consequently, for the capital‑conservation buffer period covering October 1 2023 through September 30 2024, the Company’s stress‑capital‑buffer requirement is 4.8 %, which translates to minimum CET1, Tier 1 and total capital ratios of 9.3 %, 10.8 % and 12.8 %, respectively. This buffer incorporates the phased‑in CECL impact, meaning the full $2.4 billion addition will be reflected in the capital ratios only after it is completely phased in.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor issue in the interpretation of capital conservation buffer requirements. (1) Quantitatively, all numbers are accurate: $1.2 billion remaining of the $2.4 billion CECL capital addition, $600 million phased in annually in 2024 and 2025, and the 4.8% stress capital buffer for the period October 1, 2023–September 30, 2024 are all correct. The statement that 50% was phased in by December 31, 2023, is consistent with $1.2 billion remaining. (2) The LLM correctly identifies the multi-hop elements: the remaining CECL phase-in and its impact on capital buffers. However, it introduces specific minimum CET1 (9.3%), Tier 1 (10.8%), and total capital (12.8%) ratios that are not present in the original answer and are not directly derivable from the provided ground truth without additional assumptions. While these figures may be accurate in context, they go beyond the information in the ground truth, which only states that Capital One exceeds requirements and maintains a 'well-capitalized' status. (3) The reasoning is sound in linking the phased-in CECL impact to capital ratios and noting that the full $2.4 billion will only be reflected after complete phase-in. However, the original answer clarifies that the 2.5% capital conservation buffer is separate from the 4.8% stress capital buffer, a distinction the LLM blurs by combining them into implied minimum ratios. (4) Despite this, the LLM answer remains highly relevant and factually grounded, with only a slight over-interpretation of buffer requirements. Hence, a score of 8 is justified for correctness—core facts and numbers are correct, but minor over-specification of ratios not in the ground truth prevents a 9–10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 478,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,711 million, calculated as $11,275 million (2022) minus $9,562 million (2023). This reduction was significantly larger than the change in Euro notes, which decreased by only $250 million (from $7,666 million in 2022 to $7,916 million in 2023, representing a $250 million increase, not a decrease). Thus, the U.S. dollar reduction was substantially greater in magnitude than the Euro notes' change.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total decrease in U.S. dollar notes and term loans as $1,711 million, which is very close to the ground truth value of $1,713 million (difference of $2 million, likely due to rounding). This minor discrepancy does not significantly affect the overall accuracy. The 2022 and 2023 values cited ($11,275M and $9,562M) are correct, and the subtraction is nearly accurate. (2) For Euro notes, the LLM correctly states the change involves $7,666 million in 2022 and $7,916 million in 2023, but incorrectly labels the $250 million increase as a 'decrease by only $250 million'—this is a clear contradiction in wording. However, it then correctly notes that it represents a $250 million increase in parentheses, showing awareness of the correct direction. Thus, the factual content is mostly accurate but expressed confusingly. (3) The multi-hop reasoning is sound: the model compares the reduction in USD-denominated debt to the change in Euro notes, synthesizing data across two financial instruments and two years. The conclusion that the U.S. dollar reduction was substantially greater in magnitude is correct and well-supported. (4) The correctness score is 8 due to the minor calculation discrepancy and the contradictory phrasing about Euro notes 'decreasing' despite correctly calculating an increase. Quantitative accuracy is 9 because numbers are nearly exact. Qualitative accuracy is 8 due to the reasoning being correct but expression flawed. Contextual relevance is 10 as all parts of the question are addressed with relevant data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 435,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "The Resideo subsidiary is obligated to make cash payments to Honeywell equal to 90% of Honeywell's annual net spending on environmental matters at certain sites, subject to a $140 million cap per year and continuing until the earlier of December 31, 2043, or the third consecutive year in which the annual payment falls below $25 million. Reimbursements collected from Resideo were $140 million in both 2023 and 2022, offsetting Honeywell's environmental cash outflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the $140 million annual cap and the 90% relationship to Honeywell's net spending on environmental matters at certain sites, which matches the original answer. (2) All numeric values—$140 million cap, 90%, $25 million threshold, and end date of December 31, 2043—are factually correct and consistent with the knowledge graph. The additional context about payment duration and reimbursement amounts in 2022 and 2023 is accurate and adds value without introducing errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes the indemnification terms, including the percentage, cap, and duration, linking Resideo’s obligation to Honeywell’s environmental spending. (4) While the original answer focuses only on the maximum payment and its relation to Honeywell’s spending, the LLM provides extra but correct contextual details (e.g., termination conditions, recent payments), which do not detract from correctness. The only minor difference is that the original emphasizes that the $140M *represents* 90% of Honeywell’s spending (i.e., implies the total spending is ~$155.6M), while the LLM frames it as a cap on a 90% payment—semantically very close and not factually contradictory. Thus, the answer is fully correct in substance, earning a 9 due to slight rephrasing that doesn’t affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 394,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "The changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses resulted in a $1,477 million decrease in fair value for Non-Qualifying Hedges and a $12 million increase for FPL Cost Recovery Clauses between December 31, 2022, and 2023, reflecting a net $1,489 million adverse shift in the FPL segment's hedge position. This contributed to NEE's total mark-to-market energy contract net liability of $232 million at December 31, 2023, as detailed in the fair value maturity analysis on page 53.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth in both quantitative and qualitative aspects. (1) Quantitatively, the LLM reports a $1,477 million decrease in fair value for Non-Qualifying Hedges and a $12 million increase for FPL Cost Recovery Clauses, which are completely inconsistent with the ground truth: FPL's total position decreased by only $1 million (from $3M to $2M), and NEER's decreased by $34 million (from $148M to $114M), for a combined $35 million decline. The LLM's figures are off by orders of magnitude. (2) The LLM introduces a 'net $1,489 million adverse shift' and references a 'mark-to-market energy contract net liability of $232 million' at year-end 2023, which are not supported by the original answer and appear to conflate different financial concepts or segments. (3) Qualitatively, the reasoning is flawed: the question asks about the impact on NEE's total financial position for FPL and NEER segments specifically related to Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses, but the LLM misrepresents the nature and scale of changes, fails to separate FPL and NEER impacts correctly, and does not report the actual obligation changes. (4) Contextually, while the LLM attempts to address hedge-related financial impacts, it does so with incorrect data and misaligned metrics, failing the multi-hop synthesis required—namely, comparing year-over-year changes across two segments and aggregating the effect on NEE. The answer cites a specific page (53) but contradicts the verified ground truth, suggesting hallucination or misinterpretation. Minor relevance is retained as it discusses hedges in the correct time frame and company context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 464,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "The Universal Beijing Resort’s net assets declined by $0.5 billion (from $7.8 billion in 2023 to $7.3 billion in 2024), while its debt obligations also fell by $0.1 billion (from $3.5 billion to $3.4 billion). Thus, the decrease in net assets is larger than the reduction in debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures, particularly regarding liabilities and net assets. While it correctly states that both net assets and debt decreased, the actual values and changes are incorrect. According to the ground truth, net assets decreased from $0.6 billion in 2023 to -$0.3 billion in 2024, a decline of $0.9 billion, not $0.5 billion as claimed. The LLM incorrectly equates total assets ($7.8B to $7.3B) with net assets, failing to account for liabilities in calculating net assets. Additionally, debt obligations (liabilities) decreased from $7.2 billion to $7.0 billion—a $0.2 billion reduction—not from $3.5B to $3.4B as stated. (2) Calculations are therefore flawed: the change in net assets is off by $0.4 billion, and the change in debt is understated by $0.1 billion. The comparison that 'the decrease in net assets is larger than the reduction in debt' is directionally correct but based on incorrect numbers. (3) Multi-hop reasoning is partially present—synthesizing asset and liability data across years to assess financial position—but fails at the critical step of computing net assets (assets minus liabilities). The model appears to misunderstand net assets as synonymous with total assets. (4) Despite these major quantitative errors, the answer is contextually relevant and attempts to address both parts of the question, earning moderate scores for qualitative reasoning and relevance. However, due to severe inaccuracies in core financial data and calculations, the correctness and quantitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 440,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) became eligible for a new pediatric patient population (aged 2–12 years) for the treatment of HIV, as indicated by its inclusion in the regulatory submissions and approvals listed in the document. The filing specifically targets regulatory filings in the United States (US Filing) and the European Union (EU Filing) for this pediatric indication, though the exact regions are noted as part of the broader regulatory strategy without explicit regional breakdowns beyond these submissions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the new patient population as pediatric patients aged 2–12 years for treatment with EDURANT (rilpivirine) for HIV, which matches the ground truth. It also accurately states that regulatory filings were targeted in the United States and European Union, aligning with the original answer. All entities (JNJ, EDURANT, rilpivirine, 2023 10-K, US, EU) are correct, and there are no numerical or date inaccuracies. The minor deduction in qualitative accuracy is due to the LLM's phrasing that regulatory regions were 'noted as part of the broader regulatory strategy without explicit regional breakdowns,' which slightly undercuts the clarity of the original filing's explicit mention of US and EU. However, the core information is correctly extracted and synthesized. The answer is contextually relevant, complete, and semantically equivalent to the ground truth, with only slight overcaution in interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 272,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "The merchant‑based transaction model expands Booking.com’s payment‑processing and fraud‑risk exposure, which raises operating costs and can compress margins despite generating incremental merchant revenue. At the same time, ongoing regulatory investigations in Switzerland and the EU—particularly antitrust and parity‑clause probes—could force commission reductions, new compliance obligations, or fines, all of which threaten Booking Holdings’ profitability and may require strategic adjustments to its pricing and contract practices.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, capturing the core financial and regulatory impacts on Booking Holdings as reported in 2022. (1) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies the merchant-based model's impact on operating costs (payment processing, fraud risk) and its margin-compressing effect despite incremental revenue, aligning with the ground truth. It also accurately notes regulatory pressures in Switzerland (commission reductions) and the EU (parity clauses, antitrust), which threaten profitability and necessitate strategic changes. (3) The multi-hop reasoning is sound: it synthesizes the financial model impact with cross-jurisdictional regulatory risks and links them to strategic implications. However, it omits specific details present in the original answer, such as the Swiss Price Surveillance Office by name, the Digital Markets Act's 'gatekeeper' designation, restrictions on data usage and service bundling, and the impact on long-term initiatives like Connected Trip. These omissions reduce completeness but do not invalidate the core message. (4) The answer is semantically equivalent in key aspects and highly contextually relevant, hence high scores in qualitative accuracy and contextual relevance. A score of 8 is justified due to minor but notable omissions in regulatory specifics and strategic constraints.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 407,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, comprising an initial five‑year term that can be extended twice for up to five years each (total extensions of up to 10 years), for a combined maximum of 15 years. This regulatory framework—allowing long‑term retention of gas resources with limited extensions—supports ExxonMobil’s long‑term LNG development strategy in the region, as highlighted in its 2022 10‑K filing where the company cites Papua New Guinea’s LNG projects as key growth drivers and emphasizes the stability of such long‑term licensing arrangements in its investment outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the maximum total duration of a petroleum retention license in Papua New Guinea as 15 years, with an initial 5-year term and up to two 5-year extensions (totaling 10 additional years), which aligns perfectly with the ground truth. All numeric values are accurate and properly formatted. (2) Quantitative accuracy is perfect: the 5-year initial term and two possible 5-year extensions (summing to 15 years total) are correctly calculated and presented. (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer connects the licensing duration framework to ExxonMobil’s long-term LNG strategy as outlined in its 2022 10-K, noting how long-term retention supports development of non-commercial-now-but-potentially-viable resources. While the LLM adds slight elaboration (e.g., 'key growth drivers', 'stability of long-term licensing'), these are reasonable inferences consistent with the original answer’s intent and do not introduce inaccuracies. (4) The answer is contextually fully relevant, addressing both the regulatory detail and its strategic implication for ExxonMobil. The only minor deviation is that the original answer explicitly mentions the Minister's discretion in granting extensions, which the LLM omits—this is a small but non-critical gap in completeness, hence the 9/10 on qualitative accuracy and correctness. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 414,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "The year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds (Level 2 assets) was a decrease of $21 million (from $257 million in 2022 to $236 million in 2023), while the change in its Hedge funds/limited partnerships investments was an increase of $121 million (from $0 million in 2022 to $121 million in 2023).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. According to the ground truth, Coca-Cola's investment in Mutual, pooled and commingled funds (Level 2) decreased from $83 million in 2022 to $37 million in 2023—a $46 million decrease. The LLM incorrectly reports this as a decrease from $257 million to $236 million ($21 million decrease). Similarly, for Hedge funds/limited partnerships, the ground truth shows a slight increase from $14 million to $18 million ($4 million increase), but the LLM claims an increase from $0 to $121 million—an entirely inaccurate representation. (2) These numerical inaccuracies invalidate all calculations and comparisons. The year-over-year changes are not only wrong in magnitude but also misrepresent the baseline (e.g., claiming zero investment in hedge funds in 2022 when it was $14 million). (3) While the LLM attempts the correct multi-hop reasoning—comparing YoY changes across two asset categories—the underlying data synthesis is completely flawed. It fails to retrieve or interpret the correct figures from the relevant financial disclosures, leading to false conclusions about capital reallocation. (4) Despite the incorrect numbers, the answer is contextually relevant: it addresses both parts of the question (YoY change in Level 2 pooled funds and comparison with hedge fund investments) and uses appropriate financial terminology. However, due to severe factual and quantitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 418,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was an $88 million pre‑tax charge recorded in \"estimated loss on regulatory disallowance,\" which directly reduced net income by that amount. This $88 million loss was partially offset by other favorable adjustments, resulting in a net increase of $43 million in net income for 2023 compared with 2022.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the ground truth states the total impact was a $53 million reduction in net income, composed of a $29 million decrease at gas distribution operations and a $24 million additional earnings adjustment. The LLM incorrectly reports an $88 million pre-tax charge and a net increase of $43 million in net income, which contradicts the actual reduction. The numbers do not match any part of the ground truth, and the calculation ($29M + $24M = $53M) is ignored. (2) The LLM introduces an 'estimated loss on regulatory disallowance' line item not mentioned in the original answer, and claims the $88M was 'partially offset by other favorable adjustments'—information absent from and unsupported by the ground truth. (3) Qualitatively, the reasoning is flawed: instead of synthesizing the two stated components of the financial impact, the model fabricates a different narrative involving offsets and pre-tax charges, failing the multi-hop synthesis required. (4) Contextually, while the answer addresses Nicor Gas and Southern Company Gas in 2023, it misrepresents the direction and magnitude of the financial impact, rendering it highly misleading. The answer suggests a net increase in income when the truth is a clear reduction. Thus, the correctness score is very low due to complete factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 387,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "AT&T classified WarnerMedia, Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift to streamline its portfolio and focus on core telecom businesses. This classification reflected AT&T's broader restructuring efforts to divest non-core assets, simplify operations, and redirect capital toward its core Communications segment, which accounted for nearly all of its 2023 operating revenue and income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all businesses classified as discontinued operations—WarnerMedia, Vrio, Xandr, and Playdemic—matching the ground truth. It accurately conveys the significance of the classification in the context of AT&T's strategic shift to focus on its core communications segment. While the original answer emphasizes that these divestitures were treated as a single strategic shift despite some not meeting materiality thresholds individually, the LLM captures the essence of this reasoning by framing it as part of a broader restructuring to divest non-core assets. The mention of the Communications segment accounting for nearly all 2023 operating revenue and income adds relevant context not in the original but does not contradict it; however, this specific performance detail is not part of the ground truth and slightly extends beyond the provided information. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities and years (e.g., 2023) are used appropriately. The reasoning is sound and reflects proper multi-hop synthesis across the divested units and their collective strategic purpose. The answer is semantically equivalent and highly relevant, warranting a high correctness score with only a minor deduction for slight over-enrichment beyond the source truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 368,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "The fair value of Medtronic's auction rate securities declined by $3 million from April 30 2021 to April 29 2022, and this decrease contributed to a $1 million reduction in the total unrealized loss position of the available‑for‑sale debt securities during the same period. Consequently, the overall fair‑value loss on the Company's available‑for‑sale debt securities grew modestly, reflecting the lower auction‑rate securities valuation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key aspects. The ground truth states that the fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the LLM claims a $3 million decline, which is false. Additionally, the LLM states that this decrease contributed to a $1 million reduction in the total unrealized loss position, which is not supported by the data. The actual total available-for-sale debt securities' fair value decreased by $364 million (from $7,257 million to $6,893 million), a significant decline not reflected in the LLM's characterization of a 'modest' growth in losses. (2) Quantitative inaccuracies include the incorrect change in auction rate securities (should be $0 change, not -$3M) and misrepresentation of the impact on total available-for-sale securities. The correct calculation for the total change is $7,257M - $6,893M = $364M decrease, which the LLM fails to mention or correctly interpret. (3) The multi-hop reasoning is flawed: the model incorrectly infers that auction rate securities declined and that this affected the total unrealized loss position, when in fact the stability of auction rate securities contrasts with the decline in other components of available-for-sale securities. The LLM fails to recognize that the overall decline was due to other securities, not auction rate securities. (4) Scores are low due to major factual and quantitative errors. The answer is partially relevant (contextual relevance 6) because it discusses the right entities and general topic, but the core facts and reasoning are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 451,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "The goodwill impairment charges recorded in 2020 for the OpenTable and KAYAK reporting units reduced the adjusted carrying value of goodwill to $1.0 billion as of September 30, 2020. The cumulative impact of these charges was a total impairment of $573 million for the year ended September 30, 2020.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the adjusted carrying value of goodwill was reduced to $1.0 billion by September 30, 2020, which matches the ground truth. However, it incorrectly states the cumulative impairment as $573 million, whereas the ground truth specifies two separate charges — $489 million in March 2020 and $573 million in September 2020 — totaling $1,062 million. The LLM appears to have reported only the September charge as the total, missing the earlier charge. (2) Quantitative accuracy is compromised due to this miscalculation: $573 million is a correct individual charge but not the cumulative total. The correct sum is $489M + $573M = $1,062M, which the LLM fails to report. Dates (September 30, 2020) and final carrying value ($1.0 billion) are accurate. (3) The reasoning is partially sound — the model correctly links the impairments to the reduction in carrying value and identifies the correct reporting unit (OpenTable and KAYAK). However, it fails in multi-hop synthesis by not aggregating both impairment charges across the two time periods, indicating a breakdown in full financial impact assessment. (4) Contextual relevance is high as the answer addresses the core question about carrying value and cumulative impact, but the factual error in the total impairment amount significantly undermines correctness. The qualitative accuracy is moderate because entities and timeline are correct, but the synthesis of financial events is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 412,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "Southern Company Gas's 2023 financial performance was negatively impacted by regulatory disallowances at Nicor Gas, which resulted in an $88 million estimated loss recorded in 2023 (compared to a $131 million pre-tax impairment charge in 2022). This regulatory disallowance, stemming from disallowed capital investments at Nicor Gas, contributed to a $29 million decrease in net income at gas distribution operations, partially offsetting other favorable factors like lower fuel costs. Consequently, while Southern Company Gas reported a $43 million increase in net income ($615 million in 2023 vs. $572 million in 2022), this growth was directly constrained by the $88 million regulatory disallowance charge, which reduced net income by that amount relative to what it would have been without the disallowance. Revenue also declined by $1.26 billion (21.1%) to $4.7 billion in 2023, with the document explicitly linking this decrease to \"lower volumes sold and regulatory disallowances at Nicor Gas\" alongside infrastructure program changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. While it correctly identifies the $29 million decrease in net income at gas distribution operations due to Nicor Gas's regulatory disallowances—matching the ground truth—it introduces an unsupported $88 million estimated loss in 2023, which is not mentioned in the original answer. The ground truth does not reference any $88 million charge or compare it to a $131 million pre-tax impairment in 2022, making these figures hallucinated or misattributed. Additionally, the LLM claims revenue declined by $1.26 billion (21.1%) to $4.7 billion, with specific percentage and dollar figures that are absent from the original answer. While the original confirms that revenue declined due to lower volumes and regulatory disallowances, it does not provide exact revenue figures or percentages, so including them reduces factual accuracy. (2) The only correct numeric element is the $29 million net income impact, which aligns with the ground truth. However, the $88 million charge and detailed revenue decline numbers lack support, and the comparison of net income growth from $572M to $615M is not in the original and cannot be verified from the provided truth. These additions suggest over-specificity beyond the source. (3) The reasoning is partially sound: the model correctly links Nicor Gas's disallowances to negative impacts on both net income and revenue at Southern Company Gas, demonstrating appropriate multi-hop synthesis between Nicor Gas and its parent. It also correctly infers a dual negative effect, which matches the original conclusion. However, the inclusion of unsupported financial figures undermines the validity of the reasoning chain. (4) Scores reflect that core qualitative elements (entities, direction of impact, causal relationship) are accurate, and the response is highly relevant to the question, but severe quantitative inaccuracies limit correctness. The answer goes beyond the available evidence with precise numbers not present in the ground truth, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 567,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "As of August 31 2022, the 2010 ESPP had authorized 90 million Class A shares, of which 73,808,772 had been issued, leaving **16,191,228 Class A ordinary shares still available for issuance**. This remaining amount represents **approximately 18 % of the total 90 million shares authorized** under the plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of shares remaining available for issuance (16,191,228) and the total authorized shares (90 million), which matches the ground truth. The percentage is reported as 'approximately 18%', while the exact value in the original answer is 17.99%. This minor rounding is acceptable under semantic equivalence, especially given the use of 'approximately'. (2) All numeric values are accurate: 90,000,000 authorized, 73,808,772 issued (90,000,000 - 16,191,228 = 73,808,772), and 16,191,228 remaining. The percentage calculation (16,191,228 / 90,000,000 = 0.1799 or 17.99%) is correct, and the LLM appropriately rounds to 'approximately 18%'. (3) The multi-hop reasoning is sound: the model correctly synthesizes the remaining shares and computes the percentage of the total authorized pool, demonstrating proper understanding of the relationship between issued, authorized, and available shares. (4) Scores are justified: full points for quantitative accuracy and contextual relevance; qualitative accuracy is 9 due to the slight imprecision in percentage (though 'approximately' mitigates this); overall correctness is 9 because the answer is factually and semantically equivalent to the ground truth with only negligible rounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 360,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "AT&T’s 2023 10‑K notes that it is partnering with Ericsson to accelerate commercial‑scale Open RAN deployments, aiming for roughly 70 % of its wireless traffic to run on open‑capable platforms by late 2026 and to have fully integrated Open RAN sites operating in 2024. This investment is expected to increase capital spending and depreciation in the short term, but the company says the software‑defined, virtualized network will lower long‑term network‑related expenses and improve operational efficiency as it scales fiber and 5G infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AT&T's collaboration with Ericsson on Open RAN deployment as outlined in the 2023 10-K, and accurately captures the short-term and long-term financial implications. (2) Quantitatively, the LLM introduces a specific target—'roughly 70% of its wireless traffic to run on open-capable platforms by late 2026' and 'fully integrated Open RAN sites operating in 2024'—which are not present in the original ground truth. However, these figures are plausible and consistent with public disclosures, and their inclusion does not contradict the original answer; they add detail without introducing inaccuracy. The absence of explicit mention of 'accelerated depreciation' in the LLM answer is a minor omission, but the reference to increased depreciation due to investment covers the core concept. (3) The reasoning is sound: it correctly synthesizes the multi-hop logic—collaboration leads to near-term spending pressure but long-term efficiency gains. The connection between Open RAN, software-defined networks, and lower network expenses is accurately conveyed. (4) The answer is contextually fully relevant, addressing both 2024 expense trends and longer-term operational efficiency goals. The slight addition of forward-looking metrics not in the original is not factually incorrect and enhances completeness. Thus, the answer earns a 9 for correctness, with high scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 408,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "Based on the provided financial data, ExxonMobil's consolidated subsidiaries had total proved developed bitumen reserves in Canada/Other Americas of **$3,844 million** as of December 31, 2021. This figure represents the capitalized cost of proved developed reserves in that region, which directly corresponds to the discounted future net cash flows from these reserves, as reported in the \"Results of Operations\" section for consolidated subsidiaries ($3,844 million). Thus, the total proved developed bitumen reserves value and the discounted future net cash flows from this region are both **$3,844 million** for 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers. The ground truth states that the total proved developed bitumen reserves were 2,635 million barrels (a volume measure), not $3,844 million (a monetary value). The LLM incorrectly reports reserves in dollars rather than barrels, conflating the concept of physical reserves with financial valuation. Additionally, the discounted future net cash flow in the ground truth is $28,710 million, not $3,844 million, making the LLM's cash flow figure incorrect as well. (2) The numbers are entirely inaccurate: reserves should be 2,635 million barrels (not $3,844 million), and discounted cash flows should be $28,710 million (not $3,844 million). The LLM appears to have misread or misinterpreted a capitalized cost figure as both the reserve volume and the cash flow, which is a critical error. (3) The reasoning is flawed—bitumen reserves are measured in barrels, not dollars, and must be distinguished from future cash flows. The LLM fails to perform the correct multi-hop synthesis, instead equating two unrelated financial figures incorrectly. It does not compare reserves to cash flows as required, because it misrepresents the nature of the reserve quantity. (4) The contextual relevance is moderate because the answer addresses the right company (XOM), region (Canada/Other Americas), and time frame (2021), and attempts to discuss both reserves and cash flows. However, due to fundamental factual and conceptual errors in both quantitative and qualitative dimensions, the answer is substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 434,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "The adoption of ASU No. 2022-02 replaced the troubled debt restructuring (TDR) accounting guidance with a new framework for \"financial difficulty modifications\" (FDMs), requiring Capital One to no longer classify modifications as TDRs when granted to borrowers experiencing financial difficulty. This change impacted allowance for credit losses reporting by altering how modifications are assessed and disclosed, particularly affecting the timing and methodology for estimating expected credit losses and related allowance balances as of December 31, 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the qualitative impact of ASU No. 2022-02 on Capital One's loan modification reporting practices, specifically the elimination of Troubled Debt Restructurings (TDRs) and the introduction of a new framework (referred to as 'financial difficulty modifications' or FDMs). This aligns with the ground truth's description of a new reporting framework for modified loans. However, the LLM answer fails to include any of the key quantitative impacts specified in the original answer. (2) The ground truth states that the adoption led to a $2.1 billion increase in the allowance for credit losses, resulting in a total of $15.3 billion as of December 31, 2023. These specific figures are entirely missing from the LLM response, representing a major omission in quantitative accuracy. There are no numbers mentioned at all, making the quantitative accuracy score low. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the change in accounting treatment and its effect on reporting and allowance estimation methodology. It captures the conceptual shift in how loan modifications are assessed under the new standard. However, it does not connect this change to the actual financial impact (i.e., the $2.1B increase), which is a critical component of the original answer and necessary for full correctness. (4) The contextual relevance and qualitative accuracy are high because the response addresses the right topic, uses correct terminology, and explains the nature of the change in accounting policy. But due to the absence of required numerical data, the overall correctness score is reduced to 6—partially correct but significantly incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 467,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could require additional loss estimates or capital contributions to its insurance subsidiaries, which may materially and adversely affect GE's financial position, cash flows, results of operations, or ability to provide financing to support its businesses. This risk is highlighted in the document as a factor that could impact GE's liquidity and financial condition.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general risk posed by Bank BPH's litigation to GE's financial position and liquidity, which aligns with the question's focus. However, it fails to include any of the specific quantitative data from the 2023 10-K filing that is central to the ground truth answer. (2) The original answer includes key figures: $17.0 billion in total cash, cash equivalents, and restricted cash, with $14.2 billion held outside the U.S. and $1.7 billion in countries with currency controls. The LLM answer omits all of these numbers, resulting in a significant deficit in quantitative accuracy. There are no calculations to verify, but the absence of factual financial data from GE’s filing undermines the answer’s precision. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies that contingent liabilities from Bank BPH could affect GE’s liquidity and financial condition. However, it does not connect the specific risk (litigation liabilities) to the constraint on accessing foreign cash due to repatriation costs or currency controls, which is a critical link in the original reasoning. The answer also incorrectly suggests the funds might be needed for 'insurance subsidiaries,' which is not mentioned in the ground truth and introduces a factual inaccuracy. (4) While the LLM answer is contextually relevant and identifies the correct entities (GE, Bank BPH, Poland, contingent liabilities), it lacks the depth and factual support needed for full accuracy. The correctness score is 5 due to partial factual alignment but major omissions in key financial data and flawed reasoning links.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 448,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "Based on the provided excerpt from the 2022 10-K filing (page 51, “Securities Authorized for Issuance under Equity Compensation Plans”), the Amended and Restated 2010 Share Incentive Plan had **14,830,623 shares subject to outstanding options, warrants, and rights** and **27,381,461 shares remaining available for future issuance** as of August 31 2022. Therefore, the total number of shares both issued upon exercise of outstanding options and still available for future issuance under that plan is **27,381,461**.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM correctly identifies the two key numbers from the ground truth: 14,830,623 shares subject to outstanding options and 27,381,461 shares available for future issuance. These values are quantitatively accurate and match the original answer. However, the LLM fails to correctly compute the total as requested in the question. The question asks for the total number of shares that were both issued upon exercise of outstanding options and still available for future issuance — which implies summing the two components (14,830,623 + 27,381,461 = 42,212,084). Instead, the LLM incorrectly states the total is only the 'shares remaining available for future issuance' (27,381,461), ignoring the issued portion. This is a critical error in reasoning and calculation. While the individual numbers are correct (hence high quantitative accuracy), the failure to perform the correct synthesis across both components results in a substantially incorrect final answer. The contextual relevance is high because the response cites the correct document, page, and plan, and addresses the right entities. However, the qualitative reasoning is flawed due to the incorrect interpretation of 'total' and failure to sum the two parts. Thus, the correctness score is moderate due to partial accuracy but major omission in required calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 367,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "The 2025 Term Loan was paid off on March 30 2023. The loan, a $2,500 term loan entered into in November 2022, was fully repaid and terminated on that date.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the $2,500 million 2025 Term Loan was paid off in full and terminated on March 30, 2023. The LLM correctly identifies the amount as $2,500 million (referred to as '$2,500 term loan', which in context clearly means $2,500 million, consistent with standard financial reporting conventions). (2) Quantitative accuracy is perfect: the dollar amount ($2,500 million) and date (March 30, 2023) match the ground truth exactly. Format variation ($2,500 vs $2,500 million) is acceptable and common in financial disclosures. (3) The reasoning is sound—though minimal, it correctly synthesizes that the loan was entered in November 2022 and fully repaid and terminated on the specified date, showing correct multi-hop understanding across time and events. (4) The answer addresses both parts of the question: the amount paid off and the termination date. No factual or contextual errors are present, and the response is fully relevant and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1062,
        "completion_tokens": 299,
        "total_tokens": 1361
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "The change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023 was a decrease of $47 million (from $86 million in 2022 to $39 million in 2023). Of the $39 million reported for 2023, $2 million was categorized under Level 2 valuation inputs.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $47 million decrease in KO's investment from 2022 to 2023 and the 2023 investment value of $39 million, which aligns with the ground truth. However, it incorrectly states that only $2 million of the 2023 investment was categorized under Level 2 valuation inputs, whereas the ground truth specifies $37 million (not $2 million) was under Level 2. This is a critical factual error. (2) The calculation of the change ($86M to $39M = -$47M) is accurate and consistent with the ground truth. However, the Level 2 amount is off by $35 million, indicating a major quantitative inaccuracy. (3) The multi-hop reasoning is partially sound—correctly identifying the change over time and sourcing the total 2023 investment—but fails in synthesizing the correct valuation input categorization, likely due to misreading or misrepresenting the data. (4) The contextual relevance is high as the answer addresses both parts of the question and uses appropriate financial terminology, but the severe error in the Level 2 amount drastically undermines factual correctness. Hence, low scores for correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 334,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31 2023 was $1,189 million, and net cash paid to AerCap for continuing involvement during the same period was $203 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, both values are accurate: $1,189 million for the pre-tax charge and $203 million in net cash paid to AerCap, with correct time period (year ended December 31, 2023). Minor formatting differences (use of thin spaces) do not affect accuracy. (2) The answer is complete, addressing both parts of the multi-part question. (3) Entities are correctly identified: GE (implied as the reporting entity), AerCap, and the two financial metrics (pre-tax charge for borrower litigation and net cash payment for continuing involvement). (4) The reasoning is sound, indicating proper synthesis of multi-hop information from the relevant SEC filings. The answer is semantically equivalent to the original, conveying the same facts with slightly different phrasing. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 263,
        "total_tokens": 1394
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "Accenture’s heavy investment in research and development—$1.1 billion in fiscal 2022 and a portfolio of over 8,300 patents—fuels its 360° value strategy, enabling it to deliver differentiated, sustainable technology solutions and accelerate enterprise‑wide transformation. This focus on innovation, combined with its global scale and industry expertise, positions Accenture uniquely against competitors who lack the same breadth of services, ecosystem partnerships, and talent‑driven capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states Accenture's $1.1 billion R&D investment in fiscal 2022, matching the ground truth. However, it introduces an additional fact—'over 8,300 patents'—which is not present in the original answer and cannot be verified from the provided knowledge graph, making it potentially inaccurate or unsupported. (2) All numeric values directly from the ground truth (i.e., $1.1 billion, fiscal 2022) are accurately reported with correct formatting. The added patent count lacks corroboration, but since it doesn’t contradict known data, it doesn’t fully invalidate the response. (3) The multi-hop reasoning is sound: the model correctly links R&D investment to the 360° value strategy and uses that to explain competitive differentiation. It captures the essence of Accenture’s unique positioning through innovation, scale, and ecosystem strengths. However, it omits specific components of 360° value mentioned in the original—such as financial business cases, inclusion and diversity, employee reskilling, and sustainability support—reducing completeness. (4) The answer is contextually excellent, directly addressing how R&D and 360° value enhance competitive positioning. While it synthesizes logically and maintains semantic alignment, the omission of key elements of 360° value and the addition of unverified data (patents) prevent a top score. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 393,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "AT&T classified WarnerMedia, Vrio, Xandr, and Playdemic as discontinued operations in 2023, as explicitly stated in Note 24. This classification required reclassifying their historical financial results and related cash flows to be presented separately as \"discontinued operations\" in the financial statements, ensuring these results do not affect the presentation of continuing operations' financial performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It correctly identifies all entities classified as discontinued operations by AT&T in 2023: WarnerMedia, Vrio, Xandr, and Playdemic—exactly matching the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts or percentages), so quantitative accuracy pertains to correct time period and entity classification, both of which are accurate (2023 is correctly cited). (3) The multi-hop reasoning is sound: the answer synthesizes the list of entities and correctly explains the accounting impact—namely, that financial results and cash flows are reclassified and reported separately as discontinued operations, which aligns with the conceptual treatment under GAAP and the original answer's explanation. (4) The answer is contextually relevant, directly addressing both parts of the question: the specific entities beyond WarnerMedia and the financial statement implications of the discontinued operations classification. Minor wording differences (e.g., 'ensuring these results do not affect the presentation of continuing operations') are semantically equivalent to the original answer's 'excluded from ongoing operations and reported separately.' No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 366,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29 2022 is $3 million. This loss is entirely classified as a loss in the “More than 12 months” maturity bucket, reflecting the securities’ placement in that category.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the total unrealized loss of $3 million is accurately reported, and the date (April 29, 2022) matches the original. (2) The distribution of the loss is correctly described as being entirely in the 'More than 12 months' maturity bucket, with no mention of losses in the 'less than 12 months' category, which aligns with the ground truth that no such loss is reported for shorter maturities. (3) The reasoning is sound and reflects proper synthesis from the 2022 10-K filing, correctly attributing the loss to the appropriate maturity period. (4) All entities—MDT, Auction Rate Securities, and the correct fiscal date—are accurately identified. The answer is concise, factually precise, and fully addresses both parts of the multi-hop question: total loss and its distribution by maturity. Minor wording differences (e.g., 'classified as a loss in the “More than 12 months” maturity bucket' vs. 'entirely associated with securities having maturity periods of more than 12 months') do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 314,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "During the May 2024 Class B‑1 common‑stock exchange offer, Visa accepted 241 million shares of Class B‑1 stock and issued approximately 120 million shares of Class B‑2 common stock. Thus, Class B‑2 shares represented roughly 33 % of the total shares issued in that exchange.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance of 120 million Class B-2 shares in May 2024, which matches the ground truth. However, it incorrectly states that Class B-2 shares represented 'roughly 33%' of the total shares issued, which is factually wrong. The correct percentage is approximately 71.4%, based on 120 million Class B-2 shares out of a total of 168 million shares (120M B-2 + 48M Class C). The LLM either miscalculates or misrepresents the total shares issued. (2) The number of Class B-2 shares (120 million) and the date (May 2024) are accurate. However, the percentage (33%) is significantly off—this suggests a major error in reasoning or data sourcing. The mention of Visa accepting 241 million shares of Class B-1 is not present in the ground truth and appears to be fabricated or misattributed. (3) The multi-hop reasoning fails: the model should have summed the Class B-2 and Class C shares to get the total issued (168M), then calculated 120/168 ≈ 71.4%. Instead, it arrives at 33%, implying it may have used an incorrect total or wrong numerator. The inclusion of an unsupported figure (241M shares accepted) further undermines the reasoning. (4) The contextual relevance is high as the answer addresses the exchange offer and the correct stock classes and time frame. However, due to the critical error in percentage calculation and the introduction of unsupported data, the overall correctness is significantly reduced. Quantitative accuracy is moderate due to one correct number but a major percentage error. Qualitative accuracy is low due to flawed logic and unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 443,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023 was 3.2 GW (11.7 GW in 2021 → 8.5 GW in 2023). This reduction in capacity corresponds to a decline in the number of wind turbines sold from 3,590 units in 2021 to 2,225 units in 2023, reflecting a 1,365-unit decrease.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the decrease in capacity from 11.7 GW in 2021 to 8.5 GW in 2023 is correctly calculated as 3.2 GW, and the reduction in units sold from 3,590 to 2,225 is correctly stated as a 1,365-unit decrease. (2) The answer addresses both parts of the multi-part question: the change in GW capacity and the corresponding change in number of turbines sold. (3) Entities are accurate—GE is correctly identified, and the years 2021 and 2023 are properly referenced with correct metrics (GW capacity and unit counts). (4) The reasoning is sound and reflects proper multi-hop synthesis: the answer links the decline in capacity to the decline in units sold, logically connecting two data points across time and metric types. The semantic meaning is equivalent to the original answer, with no omissions or inaccuracies. Minor wording differences do not affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 283,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "Based on the provided SEC 10-K pages, AT&T paid a total of **$23,406** for C-Band licenses (including $22,856 in cash payments in 2021 plus $550 upfront deposit), with additional **$955 in incentive payments** (Phase I clearing, December 2021) and **$2,112 in Phase II clearing payments** (2023), totaling **$26,473** in direct license-related costs. However, the question specifically asks for the amount \"including all incentive and relocation costs through 2023,\" and the document clarifies that **cash paid for spectrum deposits, capitalized interest, incentive payments, and relocation costs are classified as \"Acquisitions, net of cash acquired\" on the consolidated statements of cash flows** (page 64). \n\nThe total cash outflow for C-Band spectrum through 2023, as reported in the cash flow statement, is **$23,406** (the total purchase price for the licenses, excluding non-cash elements like capitalized interest). This amount is reflected in the **investing activities** section of the cash flow statement, not operating or financing activities, as it represents capital expenditures for acquiring spectrum licenses. The relocation costs ($650 in 2021, $98 in 2022, $109 in 2023) and incentive payments ($955 in 2021, $2,112 in 2023) are included within this $23,406 figure as part of the total cash paid for the spectrum acquisition. \n\n**Answer:** The total cash paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, was **$23,406 million**, classified as **investing cash outflows** in the company's consolidated statements of cash flows.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the total amount paid. The ground truth states that AT&T paid a total of $26,477 million, which includes $23,406 million in auction payments and $3,067 million in incentive and relocation costs. However, the LLM incorrectly calculates the total as $26,473 million (close but not exact), and then contradicts itself by stating the total cash paid was $23,406 million — which only includes auction deposits and excludes the separate incentive and relocation costs. This is a major error because the question explicitly asks for the total including all incentive and relocation costs through 2023. (2) The LLM misrepresents the composition of the $23,406 million, claiming that relocation and incentive payments are included within it, but the ground truth clearly separates $23,406 million (auction) and $3,067 million (incentive and relocation), summing to $26,477 million. The LLM also incorrectly implies that the $23,406 million figure in the cash flow statement includes all costs, when in fact the cash flow classification applies to the full spectrum-related outflows, including those separate incentive and relocation payments. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the total outflow by adding auction payments and separate incentive/relocation costs. It conflates classification in the cash flow statement with the total amount, incorrectly asserting that only $23,406 million was paid in cash for all purposes. (4) While the cash flow classification ('Acquisitions, net of cash acquired' under investing activities) is correctly identified and contextually relevant, the core quantitative answer is significantly off. The LLM gets partial credit for correctly citing individual components like $955 million for Phase I and $2,112 million for Phase II, and for identifying the correct years for relocation payments. However, the failure to sum these into the correct total and the misattribution of what is included in the $23,406 million severely undermines the answer's correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 565,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "Medtronic's discontinuation of the HVAD System in June 2021 reduced HVAD net sales from $141 million in fiscal 2021 to a negligible level in fiscal 2022, contributing to a modest overall sales dip in the Cardiovascular segment.  At the same time, growth drivers highlighted for fiscal 2022 included the expanding robotic‑assisted surgery platform (Hugo RAS), advanced energy and stapling technologies (LigaSure, Sonicision, Tri‑Staple), and the continued uptake of minimally invasive solutions such as the PillCam COLON capsule, Barrx 360 Express ablation system, and the Touch Surgery Enterprise video system.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the discontinuation of the HVAD System in June 2021 and accurately reports its $141 million in net sales during fiscal year 2021, which aligns with the ground truth. However, it incorrectly implies a 'modest overall sales dip in the Cardiovascular segment'—the ground truth states that Medical Surgical (not Cardiovascular) net sales increased to $9.1 billion in fiscal 2022, up 5%. This misattribution and incorrect conclusion about segment performance are significant factual errors. (2) Quantitatively, the $141 million figure is correct, and the timeline (fiscal 2021 to 2022) is accurate. However, the LLM fails to mention the $9.1 billion in Medical Surgical net sales and the 5% year-over-year growth, which are key financial metrics from the original answer. (3) The multi-hop reasoning is flawed: while the LLM correctly links HVAD discontinuation to revenue impact, it misidentifies the affected segment and incorrectly infers a negative overall impact. Additionally, the growth drivers listed—Hugo RAS, LigaSure, Sonicision, Tri-Staple, PillCam COLON, Barrx, and Touch Surgery—are not the ones highlighted in the ground truth. Instead, the correct growth drivers were Symplicity Spyral, Pulse Field Ablation, Aurora ICD, and transcatheter mitral/tricuspid therapies (Intrepid system). This represents a major failure in entity accuracy and synthesis. (4) The contextual relevance is moderate because the answer addresses the general theme of product discontinuation and growth drivers, but the specific facts and reasoning are largely incorrect. The qualitative accuracy is low due to incorrect product lines and flawed logic, despite some correct initial data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 469,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "Walmart paid $3.5 billion to acquire additional Flipkart shares from non‑controlling interest holders and settle the PhonePe liability, increasing its stake from roughly 75 % to about 85 % by the end of fiscal 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Walmart paid $3.5 billion during fiscal 2024 for two purposes—acquiring additional shares from Flipkart noncontrolling interest holders and settling the liability to former noncontrolling interest holders of PhonePe. The ownership increase from approximately 75% to 85% is correctly stated, with appropriate time context ('by the end of fiscal 2024') matching the ground truth's reference to January 31, 2024. (2) Quantitatively, the dollar amount ($3.5 billion) and percentage change (75% to 85%) are exact matches; minor formatting differences (e.g., 'about' vs 'approximately', spacing in '$3.5 billion') do not affect accuracy. (3) The multi-hop reasoning is sound—correctly linking Walmart’s cash outflow to two distinct transactions (Flipkart share acquisition and PhonePe liability settlement) and synthesizing the impact on ownership percentage across fiscal years. (4) Entities (Walmart, Flipkart, PhonePe, noncontrolling interest holders), fiscal period (2024), and financial actions are all correctly identified and contextualized. The answer is concise but complete, addressing both parts of the question with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 356,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "Microsoft's revenue recognition for volume licensing programs involves complex judgments around distinct performance obligations, timing of invoicing versus revenue recognition, and determining standalone selling prices (SSP) for bundled products and services. This complexity impacts financial statement presentation by requiring careful separation of revenue streams (e.g., recognizing unearned revenue ratably for multi-year agreements and cloud services) and necessitates extensive auditor scrutiny to validate SSP estimates, variable consideration (e.g., usage-based estimates), and contract term applications. The auditor’s focus on these areas ensures auditability, as evidenced by procedures testing control effectiveness, SSP reasonableness, and mathematical accuracy of revenue timing, particularly for arrangements where revenue recognition differs from invoicing (e.g., upfront billing for multi-year licenses).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Microsoft invoices annually at the beginning of contract periods and recognizes revenue ratably, creating unearned revenue or receivables; standalone selling prices (SSP) require judgment due to bundling (e.g., on-premises licenses with Software Assurance); and this complexity leads to auditor focus on revenue recognition, particularly around variable consideration and timing. (2) There are no numeric values in the question or answers requiring verification—both responses are qualitative and consistent in that regard, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM correctly links invoicing timing, revenue recognition patterns, SSP estimation challenges, and their combined impact on financial statement presentation and audit procedures. It accurately reflects that auditors test control effectiveness, SSP reasonableness, and mathematical accuracy—procedures aligned with critical audit matters. (4) Minor deduction in qualitative accuracy due to slightly less specificity on 'Software Assurance' and 'geographic/customer-size-based estimates' mentioned in the ground truth, though the essence is preserved. Overall, the answer is semantically equivalent, contextually precise, and fully addresses the question’s complexity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 388,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "Based on the provided document pages (specifically Note 13 - Benefit Plans on page 83), the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $126 million for 2022, $110 million for 2021, and $107 million for 2020. The question asks for the total over the three years, but the document only provides annual figures, not a cumulative total. However, the key part of the question is why no profit sharing contributions were included in this total. The document explicitly states: \"There were no profit sharing contributions made to the plan for the fiscal years ended May 31, 2022, 2021 and 2020.\" This is because the plan's terms allow for discretionary profit sharing contributions, but none were made during these fiscal years, as confirmed by the statement that \"the terms of the plan also allow for annual discretionary profit sharing contributions... to the accounts of eligible U.S. employees... There were no profit sharing contributions made to the plan for the fiscal years ended May 31, 2022, 2021 and 2020.\" Therefore, the total company contributions of $126 million (2022), $110 million (2021), and $107 million (2020) consist solely of matching contributions, with no profit sharing components included. \n\n(Note: The question asks for the total over three years, but the document only provides annual amounts. The answer focuses on the reason for no profit sharing contributions, as the annual figures are the only data provided for the contributions.)",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the annual company contributions for each of the three fiscal years—$126 million in 2022, $110 million in 2021, and $107 million in 2020—which match the ground truth. However, while the question explicitly asked for the total over the three years, the LLM stated that the document only provides annual figures and did not compute the sum, even though the total ($343 million) is a straightforward addition of the three amounts. This omission prevents a perfect score, though the component numbers are accurate. (2) The explanation for why no profit sharing contributions were included is fully correct and well-supported by the document: the plan allows for discretionary profit sharing contributions, but none were made in fiscal years 2022, 2021, or 2020. This matches the ground truth reasoning. (3) The multi-hop reasoning is sound—the LLM synthesized information about the plan structure, contribution types, and specific disclosures across years. It correctly distinguished between matching and profit sharing contributions. (4) The contextual relevance is high, as the response directly addresses both parts of the question using appropriate document evidence. The only deficiency is the failure to sum the annual contributions into a total, despite having all the necessary numbers. This is a minor but notable gap in completeness, warranting a 7 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 392,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "The total change in Chevron’s consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024 is an increase of 296 billion cubic feet (from 289 billion BCF at the end of 2023 to 468 billion BCF at the end of 2024).  \n\nIn Africa, reserves rose from 172 billion BCF at the end of 2023 to 457 billion BCF at the end of 2024, a change of +285 billion BCF.  \n\nThus, the Asia Pacific/Middle East region experienced a larger increase (+296 billion BCF) than Africa (+285 billion BCF) over the same period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the Asia Pacific/Middle East and Africa reserve changes. According to the ground truth, Chevron's natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet (from 312 to 296 BCF), but the LLM incorrectly states an increase of 296 BCF, using incorrect base values (289 to 468 BCF). For Africa, the ground truth shows an increase of 297 BCF (from 172 to 468 BCF), but the LLM reports an increase of 285 BCF (from 172 to 457 BCF), using an incorrect 2024 value. (2) The calculations are therefore fundamentally wrong: the LLM reports a +296 BCF change in Asia Pacific/Middle East when it should be -16 BCF, and +285 BCF for Africa instead of +297 BCF. These errors invalidate the conclusion that Asia Pacific/Middle East had a larger increase than Africa. (3) The multi-hop reasoning fails because the model misidentifies the reserve levels for both regions in both years, leading to incorrect comparisons. It also conflates the two regions' data, possibly due to confusing the values between them (e.g., using Africa’s 2024 value of 468 BCF for Asia Pacific/Middle East). (4) Despite the severe quantitative and qualitative inaccuracies, the answer is contextually relevant—it addresses the right company (Chevron), regions (Asia Pacific/Middle East and Africa), time frame (2023 to 2024), and metric (natural gas reserves change). However, the magnitude and direction of changes are incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 423,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "Walmart received $0.7 billion of equity funding related to PhonePe during fiscal 2024, and it paid $3.5 billion to acquire shares from PhonePe non‑controlling interest holders in the same fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Walmart received $0.7 billion from equity funding and paid $3.5 billion to acquire shares from noncontrolling interest holders in fiscal 2024, which matches the ground truth exactly. All numeric values are accurate and properly formatted. (2) Quantitative accuracy is perfect: both amounts are correct, and though the LLM does not explicitly calculate the net difference of $2.8 billion, the individual figures needed to derive this are present and accurate. (3) The reasoning is sound and the multi-hop synthesis between equity funding received and cash paid for share acquisition is correctly represented. However, the LLM answer omits the explicit comparison stated in the original answer (i.e., that Walmart spent $2.8 billion more than it received), which slightly reduces completeness and qualitative accuracy. (4) Despite this minor omission, the answer is factually correct, contextually relevant, and conveys the core information required. The absence of the net cash comparison prevents a perfect score, but the response is otherwise fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 322,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "RTX recorded a combined pre‑tax charge of $918 million in 2024 related to the resolution of the SEC Administrative Order and associated legal matters, and the compliance monitor appointed under those agreements will oversee RTX’s obligations for three years from the date the monitor is engaged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that RTX recorded a pre-tax charge of $918 million in 2024, which matches the ground truth in both amount and year. The second part accurately reflects that the compliance monitor will oversee RTX’s obligations for three years from the engagement date, consistent with the original answer. (2) The numeric value $918 million is correct and properly formatted; no calculations are required beyond accurate reporting, which is fulfilled. (3) The reasoning is sound and demonstrates correct synthesis of multi-hop information—linking the financial charge to the SEC Administrative Order and associated legal matters, and correctly identifying the duration of oversight by the compliance monitor. (4) All entities (RTX, SEC Administrative Order, compliance monitor) and timeframes (2024, three years) are accurately identified and contextually appropriate. The answer is semantically equivalent to the ground truth, with only minor rewording for clarity. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 300,
        "total_tokens": 1460
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "Microsoft’s fiscal 2023 Cloud revenue totaled **$137.4 billion**. This Cloud revenue is comprised of Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, **Dynamics 365**, and other commercial cloud properties.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the total Microsoft Cloud revenue for fiscal year 2023 as $137.4 billion, whereas the ground truth is $111.6 billion—a significant numerical discrepancy of over $25 billion. This major error undermines the factual accuracy of the response. However, the listed cloud offerings—Azure and other cloud services, Office 365 Commercial, commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties—are fully aligned with the original answer and correctly identify the components contributing to the revenue. (2) The quantitative inaccuracy is severe: $137.4B vs $111.6B is not a formatting or rounding difference but a clear factual error. No calculation is required in the question, but the reported figure must match the source. (3) The multi-hop reasoning aspect—identifying which services contribute to Microsoft Cloud revenue—is handled correctly. The model synthesizes the correct set of offerings across different product lines (Azure, Office 365, LinkedIn, Dynamics 365), demonstrating sound qualitative understanding of the revenue composition. (4) Due to the critical error in the revenue figure, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the reasoning and entity identification are correct, and contextual relevance is high as the answer directly addresses both parts of the question with appropriate structure and scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 403,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "Universal Beijing Resort's $3.5 billion debt as of December 31 2023 is reflected in Comcast’s consolidated balance sheet as part of the “Debt Subject to Cross‑Guarantees” line item, showing that the resort’s borrowing is fully guaranteed by Comcast and its subsidiaries. This debt appears alongside Comcast’s broader debt structure, which includes $94.4 billion of debt subject to cross‑guarantees and $3.5 billion of debt at Universal Beijing Resort that is secured by the resort’s assets and the equity interests of its investors.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and qualitative errors that undermine its correctness. (1) Quantitatively, while the $3.5 billion debt figure and December 31, 2023 date are correct, the claim that this debt is part of 'Debt Subject to Cross-Guarantees' is false. The ground truth explicitly states that Universal Beijing Resort's debt is categorized under 'Debt Not Guaranteed' and that Comcast provides no guarantees or liquidity support. The $94.4 billion figure for cross-guaranteed debt is not mentioned in the original answer and appears to be fabricated or misattributed. (2) The answer incorrectly asserts that Comcast fully guarantees the resort’s debt, directly contradicting the original statement that Comcast has no financial commitments or guarantees toward the resort. This is a critical error in both reasoning and fact. (3) Qualitatively, the model fails to recognize the VIE (Variable Interest Entity) consolidation structure and misrepresents the nature of Comcast’s exposure, which is limited to its 30% equity interest. It also omits the key detail that the debt is secured by a syndicate of Chinese financial institutions and the resort’s own assets, not backed by Comcast. (4) Contextually, the answer addresses the question’s surface topic—debt positioning—but fundamentally mischaracterizes the relationship between Universal Beijing Resort and Comcast’s consolidated debt structure, failing the multi-hop reasoning required to connect financing arrangements, consolidation accounting, and guarantee status. The answer conflates secured debt with guaranteed debt and misplaces the debt within Comcast’s segment disclosures. Due to these major inaccuracies, especially on liability structure and guarantees, the correctness score is low despite partial numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 487,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "Based on Note 6 (Fair Value Measurements), the Company’s short‑term investments consisted of $660 million of commercial paper and bonds as of May 31 2022, compared with $748 million as of May 31 2021. This decline reflects a reduction in the amount of commercial paper and bonds held, shifting the composition of short‑term investments toward a larger share of cash, Treasury securities, money‑market funds, time deposits and other Level 2 assets. Consequently, the proportion of short‑term investments allocated to commercial paper and bonds decreased from roughly 5.5 % of total short‑term investments in 2021 to about 4.5 % in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in Nike's investment in commercial paper and bonds from $748 million on May 31, 2021, to $660 million on May 31, 2022, matching the ground truth exactly. The $88 million decline is accurate (748 - 660 = 88). (2) The LLM adds specific contextual detail not in the original answer—namely, that the proportion of commercial paper and bonds in total short-term investments decreased from 5.5% to 4.5%. While this percentage shift is plausible and consistent with the trend, it is not present in the ground truth and cannot be verified from the provided data. This is a minor addition but does not contradict any facts. (3) The reasoning is sound: the model correctly infers a strategic shift in composition toward more liquid instruments like Treasury securities and money market funds, aligning with the ground truth’s mention of reallocation. The reference to Level 2 assets is consistent, though the ground truth specifies a drop in total Level 2 investments from $695M to $630M, which the LLM does not mention—this is a minor omission but does not invalidate the conclusion. (4) The answer is highly accurate, complete, and contextually appropriate. The only reason for not scoring a 10 is the unverified percentage figures and the omission of the exact Level 2 totals, which slightly affects completeness in multi-hop synthesis. However, core facts, numbers, and logic are correct, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 415,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "The introduction of Class B‑2 common stock does not affect the diluted earnings‑per‑share calculation for fiscal 2023 because no Class B‑2 shares were outstanding before the Class B‑1 exchange offer; consequently, there were no additional as‑converted shares to include in the diluted‑share denominator for that year.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly notes that no Class B-2 shares were outstanding prior to the exchange offer, it incorrectly states that this means there is no impact on diluted EPS. The ground truth correctly explains that the assumed conversion of Class B-2 shares into Class A stock in the as-converted structure does affect the diluted EPS denominator, increasing the weighted-average share count and potentially lowering diluted EPS. The LLM incorrectly assumes absence of actual shares means no dilutive effect, failing to understand that dilutive securities are considered 'as if converted' in diluted EPS calculations even if newly introduced. (2) There are no specific numbers or calculations in the question or answers, so quantitative accuracy is not heavily applicable—minor credit given for correctly referencing the absence of prior shares. (3) The multi-hop reasoning fails: the model does not correctly synthesize the accounting principle that potential dilution arises from convertible securities upon issuance, even in the same period, if they are dilutive and assumed converted. The introduction of Class B-2 stock creates a new class of as-converted shares that must be included in the diluted EPS calculation for fiscal 2023 if the exchange occurred during the year. (4) The correctness and qualitative accuracy scores are low due to this fundamental misunderstanding of diluted EPS mechanics. Contextual relevance is moderate because the answer addresses the right topic and entities (Class B-2 stock, diluted EPS, exchange offer) but draws the wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 450,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "The difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impacts Raytheon’s financial reporting by requiring a distinct FAS/CAS operating adjustment outside of segment results, reflecting the difference between U.S. GAAP (FAS) and CAS pension/Postretirement Benefit (PRB) expense recognition primarily tied to Raytheon. This adjustment, which is not applied to Collins or Pratt & Whitney (which generally use FAS basis), affects the segment’s reported operating profit and profit margins, as seen in the segment financial data where Raytheon’s operating profit is adjusted by this FAS/CAS item.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the FAS/CAS adjustment and correctly identifies that Raytheon is subject to CAS while Collins and Pratt & Whitney are not, which impacts Raytheon's operating profit. It accurately reflects that the adjustment is made outside segment results and affects reported profitability. There are no numeric values in the question or ground truth, so quantitative accuracy is scored as 10 by default. The answer is contextually relevant and addresses the core of the question. However, it omits a key element from the original answer: the expectation that Raytheon will recover these costs through pricing of its products and services to the U.S. government—a critical distinction in the financial reporting impact. This recovery mechanism is a significant part of why the CAS adjustment matters and is not mentioned at all, representing a meaningful omission in the multi-hop reasoning. While the LLM captures the mechanical impact on financial reporting, it misses the forward-looking economic recovery aspect that differentiates Raytheon’s situation. Thus, while the core facts are correct, the answer is incomplete in synthesizing the full financial implication, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 356,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "Based on the provided excerpts, **two separate Supplemental Indentures** specifically relate to the 1.850% Notes due 2020:  \n1. The **Ninth Supplemental Indenture** (dated February 12, 2015) involving **U.S. Bank National Association** as Trustee.  \n2. The **Twelfth Supplemental Indenture** (dated February 6, 2017) involving **The Bank of New York Mellon Trust Company, N.A.** as Trustee.  \n\nThese agreements are documented in the provided pages, with the Ninth Supplemental Indenture referenced in *page_105* and the Twelfth Supplemental Indenture referenced in *page_106*.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies that there are two Supplemental Indentures related to the 1.850% Notes due 2020, which aligns with the original answer. (2) The dates (February 12, 2015, and February 6, 2017), indenture numbers (Ninth and Twelfth), and trustee names (U.S. Bank National Association and The Bank of New York Mellon Trust Company, N.A.) are all factually correct and match the ground truth exactly. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across different excerpts (referencing page_105 and page_106) to identify both agreements and their respective trustees, demonstrating proper cross-document analysis. (4) The answer is semantically equivalent to the original, with clear, well-structured presentation and no factual or interpretive errors. All scoring categories warrant perfect marks due to complete accuracy, correct entity identification, precise dates and numbers, and appropriate contextual support.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 296,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal 2022 was $40 million, which is the amount recorded in “Other (income) expense, net” for the year ended May 31, 2022. This gain is part of the $130 million of gains reclassified from Accumulated other comprehensive income into income for cash‑flow hedges during the same period. As of May 31, 2021, the fair‑value of the foreign‑exchange forwards and options assets (recorded at fair value) was $92 million (gross derivative assets), which is substantially lower than the $875 million fair‑value of derivative assets reported as of May 31, 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 as $40 million, matching the ground truth. It also accurately states that the fair value of foreign exchange forwards and options assets as of May 31, 2021, was $92 million. These key figures are factually correct and properly attributed to the right fiscal periods and financial statements. (2) All numeric values are accurate: $40 million (net gain in FY2022) and $92 million (fair value as of May 31, 2021) match the ground truth exactly. The additional context about $130 million in gains reclassified from AOCI and the $875 million derivative assets as of May 31, 2022, while not part of the original answer, is consistent with broader financial disclosures and does not contradict the ground truth. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across fiscal years and distinguishes between income statement impacts (realized gains) and balance sheet fair values (assets). It appropriately compares the $40 million income effect in FY2022 to the $92 million asset value in FY2021, even though it adds extra context not in the original answer. (4) The answer is semantically equivalent and factually complete. The slight expansion with additional details (e.g., AOCI reclassifications, total derivative assets) enhances context without introducing inaccuracies, warranting a high score. Only a minor deduction in qualitative accuracy due to inclusion of non-essential information that slightly shifts focus, but does not impair correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 451,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "During 2021, AIG’s U.S. Personal Insurance segment recorded $412 million of favorable prior‑year development, while U.S. Property experienced $118 million of favorable prior‑year development. The favorable development in each segment stemmed from improved emergence of loss experience and subrogation recoveries, with the U.S. Personal Insurance benefit largely driven by catastrophe years 2017‑2018 and the U.S. Property benefit arising from favorable development across several specialty classes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claim about U.S. Property's prior year development. The ground truth states that no specific 2021 prior year development figure is provided for U.S. Property, but the LLM incorrectly asserts a $118 million favorable development. This is a major factual error. The $412 million favorable development for U.S. Personal Insurance is correct and matches the ground truth. (2) The quantitative accuracy is low because one of the two key numbers is fabricated or hallucinated. While $412 million is accurate, the $118 million for U.S. Property has no support in the original answer and contradicts it by asserting a figure that was explicitly not available. (3) The reasoning partially captures the idea that favorable development stemmed from improved loss emergence and subrogation, which aligns with the ground truth for U.S. Personal Insurance. However, it fails to address the actual differences in reserving approaches between the two segments—such as the use of frequency/severity methods in Personal Insurance versus IBNR factor and expected loss ratio methods in Property—which was a core part of the question. The LLM mentions outcomes but omits the methodological contrast entirely. (4) Contextual relevance is moderate because the answer discusses prior year developments and segments correctly, but misses the reserving methodology comparison, which is half of the question. The qualitative accuracy is medium because while some entities and trends are correctly identified, the reasoning lacks the required multi-hop synthesis of methodology differences and incorrectly invents a number. Correctness score is 4 due to one correct major fact but a critical error in both quantitative data and completeness of reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 496,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "Walmart's 2018 acquisition of a majority stake in Flipkart has exposed it to ongoing regulatory scrutiny in India, where the Directorate of Enforcement issued a show-cause notice in July 2021 alleging violations of foreign direct‑investment rules dating back to 2009‑2015; while Flipkart is responding and the matter remains at an early stage, the Company cannot predict whether a hearing or penalties will result, though it believes the issue is unlikely to have a material adverse effect on its overall business or financial statements. This exposure is highlighted in the 2023 10‑K (Item 5, “Certain Other Matters”) as part of its broader international investment strategy, which includes substantial investments in overseas markets such as India, and underscores the risk that foreign regulatory proceedings could affect Walmart’s global expansion and financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Walmart acquired a majority stake in Flipkart in 2018; the Directorate of Enforcement initiated proceedings over alleged FDI rule violations from 2009–2015; the show-cause notice was issued in July 2021 (specific date not in ground truth but factually correct and adds precision); Walmart cannot predict the outcome but does not believe it will have a material adverse effect. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2018 acquisition, 2009–2015 period, July 2021 notice) are correctly cited and consistent with public filings. Format is clear and precise. (3) Multi-hop reasoning is sound: the answer correctly links Walmart’s acquisition of Flipkart, the pre-acquisition regulatory issues, ongoing risk exposure, and how this fits into Walmart’s broader international investment strategy as disclosed in the 2023 10-K. It references Item 5, 'Certain Other Matters,' which is the correct section, demonstrating accurate sourcing. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the FDI violations occurred *prior to Walmart’s acquisition*, a nuance emphasized in the ground truth that helps clarify Walmart’s limited direct responsibility. However, the implication is present through the timeline. Wording differs but semantic meaning is equivalent. The answer is contextually excellent, directly addressing both the risk exposure and strategic implications as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 425,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "The total dollar value of Class A ordinary shares issued during the 2023 fiscal year was $1,342,773 million, as reflected in the “Issuances of Class A shares for employee share programs” line of the Consolidated Shareholders’ Equity Statement for the year ended August 31 2023. This issuance increased Accenture plc shareholders’ equity by $1,499,724 million, raising the total equity from $25,692,839 million (as of August 31 2023) to $27,192,563 million (as of August 31 2024).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and quantitative errors. The total dollar value of Class A ordinary shares issued in the 2023 fiscal year is stated as $1,342,773 million ($1.34 trillion), which is grossly incorrect compared to the ground truth of $7,970. This is off by more than 100 million percent. Similarly, the reported increase in shareholders' equity is $1,499,724 million ($1.5 trillion), whereas the actual increase is $2,595,807 — less than 0.3% of the LLM's figure. The ending equity balance is also wrong: LLM reports $27,192,563 million ($27.2 trillion), but the correct value is $28,288,646 (about $28.3 billion). The starting equity ($25,692,839 million) and ending equity values are inflated by a factor of 1,000 due to erroneous 'million' suffixes. (2) All calculations and numbers are incorrect. The difference between the LLM's stated beginning and ending equity is $1,499,724 million, which it incorrectly attributes to share issuance, but this number is fabricated and does not align with any actual data. The correct increase in total shareholders’ equity is $2,595,807 (from $25,692,839 to $28,288,646), which the LLM fails to compute or report accurately. (3) The multi-hop reasoning is flawed. While the LLM attempts to link share issuance to equity changes, it uses fabricated or misread numbers, likely due to misinterpreting financial statement units (e.g., treating thousands or actual dollars as millions). It also fails to correctly isolate the impact of share issuance within the broader equity changes. (4) The contextual structure of the answer is relevant — it addresses both parts of the question (issuance value and equity impact) and references the correct financial statement — but the complete collapse of numerical accuracy renders the answer factually useless. Hence, correctness and quantitative accuracy are near zero; qualitative accuracy is low due to reasoning based on false data; contextual relevance is moderate because the framework of the response matches the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 551,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "AIG applies loss development methods and expected loss ratio techniques to its excess casualty lines that attach above $10 million, segmenting non‑automobile claims by attachment‑point bands and using the results of capped $10 million losses to inform the reserve estimate for amounts above that threshold. Expected loss ratios—derived from projected ultimate loss ratios adjusted for rate changes, inflation and market trends—are employed especially for the most recent accident years, while loss development methods are used for older layers; the same expected loss ratios are also a key input in the reserving process for U.S. Property and aerospace exposures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core elements of the ground truth. (1) Quantitatively, all key figures are correct: the $10 million attachment point is accurately cited, and there are no numerical errors. The format '$10 million' is equivalent to '$10 million' in the original. (2) The answer correctly explains the layered reserving approach—using capped $10 million loss results to inform reserves above that threshold—which aligns with the ground truth's description of deriving expected loss estimates for higher layers based on lower-layer analysis. (3) It accurately identifies the use of both loss development methods and expected loss ratios in excess casualty, U.S. Property, and aerospace lines, particularly emphasizing expected loss ratios for recent accident years where data is sparse. (4) The role of adjustments for inflation, rate changes, and market trends in shaping expected loss ratios is correctly included. (5) The multi-hop reasoning is sound: the model connects AIG’s methodology across excess casualty and other lines (aviation, property), recognizing the shared reliance on expected loss ratios when loss data is immature. The only minor shortcoming is that the LLM answer does not explicitly mention that aviation reserving is driven by severity or that layer-specific development patterns guide ultimate loss estimation—details present in the original. However, the omission does not distort the meaning or reduce the factual accuracy significantly. Overall, the answer is semantically equivalent with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 439,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022 was $4,509,392. As of August 31, 2024, the remaining share purchase authorization was $6,694,281, which is higher than the $4.5 million repurchased in fiscal 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numeric values. The ground truth states that the total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266, but the LLM incorrectly reports it as $4,509,392—a material discrepancy. Additionally, the remaining share purchase authorization as of August 31, 2024, is reported in the ground truth as $2,694,281, whereas the LLM states $6,694,281, which is over double the correct amount. These errors severely undermine the factual correctness of the response. (2) The LLM also introduces a reference to 'fiscal 2024' repurchases of $4.5 million, which is not supported by the original answer and appears to be fabricated or misattributed. There is no mention in the ground truth of repurchases occurring in fiscal 2024, nor any comparison using that year’s repurchase data. This further invalidates the quantitative and temporal accuracy. (3) Regarding multi-hop reasoning, the model attempts to compare repurchase activity with remaining authorization, which aligns with the question's intent. However, because both input values are incorrect, the synthesis fails. The conclusion that the remaining authorization is 'higher' than repurchases is based on wrong numbers and does not reflect the ground truth, where $2.7M remaining is less than the $4.1M already repurchased—indicating substantial utilization of the authorization. (4) Despite these major errors, the answer is contextually relevant—it addresses the right company (Accenture plc), the correct share class (Class A ordinary shares), and the appropriate fiscal dates. The structure and intent of the response match the question, but the core data is factually unsound, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 490,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "The shift from “legitimate interests” to “consent” for behavioral advertising in Europe forces users to choose between a paid, ad‑free subscription or a free version that shows less‑personalized ads, which are expected to be less relevant and effective. This reduction in ad relevance and effectiveness is projected to lower both user engagement and advertising revenue, even as Meta continues to invest in AI‑driven targeting and new ad formats to mitigate the impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies the shift from 'legitimate interests' to 'consent' in Europe, the introduction of a paid ad-free subscription, and the reduced effectiveness of less-personalized ads. It accurately links these changes to lower user engagement and advertising revenue, aligning with the original answer. The only minor omission is the specific mention of high-monetization features like Feed and Stories, which are noted in the ground truth as being particularly affected. However, the broader impact on engagement and revenue is correctly conveyed. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are in dispute and no incorrect figures are presented), and the reasoning correctly synthesizes the causal chain from regulatory change to policy response to business impact. The answer is fully contextually relevant and captures the core multi-hop logic: regulatory change → policy shift → product changes → reduced ad effectiveness → lower engagement and revenue.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 311,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "The redemption policy for Accenture plc Class X ordinary shares requires that any redemption of those shares be matched by an equivalent redemption of the corresponding Accenture Canada Holdings Inc. exchangeable shares, ensuring that the total number of Class X shares outstanding never exceeds the number of exchangeable shares held. This mechanism maintains alignment between the two share classes by tying each Class X redemption to a proportional exchangeable‑share redemption. Consequently, the overall share count of Accenture plc is directly influenced by the volume of Class X share redemptions, which are constrained to the number of exchangeable shares available for redemption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. It accurately describes the one-to-one redemption mechanism between Accenture plc Class X ordinary shares and Accenture Canada Holdings Inc. exchangeable shares, ensuring the number of Class X shares never exceeds the exchangeable shares. The explanation correctly identifies that redemptions are tied on a one-for-one basis, maintaining alignment. The only minor deviation is in emphasis: the LLM frames the mechanism as redemptions being 'matched' rather than explicitly stating that the Class X shares are redeemed *upon* redemption or exchange of the exchangeable shares, which slightly weakens the causal direction implied in the original. However, this does not affect factual correctness. There are no numerical values to evaluate, so quantitative accuracy is scored as 10. The reasoning is sound, entities are correct, and the response is fully relevant to the question. Multi-hop synthesis is properly executed, linking the redemption policy to its impact on shares outstanding and the alignment mechanism across entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 318,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "The net milestone capitalization for Jardiance increased from $156.2 million as of 2020 to $136.1 million as of 2021, reflecting a $20.1 million decrease in the deferred amount. This decline shows that the previously capitalized milestone payments are being amortized to cost of sales over the collaboration term, consistent with the filing’s description of amortizing such intangible assets through the collaboration period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the net milestone capitalization 'increased' from $156.2 million in 2020 to $136.1 million in 2021, when in fact it decreased. This misstatement undermines the core of the answer despite correctly identifying the $20.1 million difference. The direction of change is essential to the question and was incorrectly conveyed. (2) Quantitatively, the dollar amounts ($156.2 million in 2020 and $136.1 million in 2021) and the calculated difference ($20.1 million) are accurate, and the years are correct. However, the interpretation of the change as an 'increase' when it is a decrease is a major error in quantitative reasoning. (3) The qualitative reasoning about amortization practices is partially sound — the model correctly links the decline to amortization of capitalized milestones and references amortization to cost of sales over the collaboration term, which aligns with the filing. However, it fails to mention key factors such as patent expiration or supplementary protection certificates that determine the amortization period, weakening the depth of the explanation. (4) The contextual relevance is high because the answer addresses both parts of the question — the change in capitalization and its relation to amortization practices — and uses appropriate financial terminology. However, due to the incorrect characterization of the trend (increase vs. decrease), the overall correctness is significantly reduced, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 422,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "The reserving approach differs by region: in the UK/Europe Property and Special Risks lines, where losses tend to be low‑frequency/high‑severity, the company relies on IBNR factor methods (applied to earned premium) to estimate ultimate expected losses, whereas in the U.S. Property line it also uses loss development and expected‑loss‑ratio methods alongside IBNR factors. Consequently, UK/Europe reserves are driven more by IBNR factor adjustments and stable development patterns, while U.S. Property reserves incorporate a broader mix of development and frequency/severity techniques to accommodate its higher‑frequency, varied‑severity exposures. This regional distinction shapes how each area refines and updates its loss reserves throughout the reserving process.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains key inaccuracies in reasoning and entity representation compared to the ground truth. (1) Correct elements: The answer correctly identifies that IBNR factor methods are used in both regions and acknowledges differences in claim frequency and severity. It correctly notes that UK/Europe Property uses IBNR factor methods due to low-frequency/high-severity losses and applies them to earned premium. The contextual relevance is high, as it addresses the core question about regional differences in reserving processes. (2) Quantitative accuracy is 10 because there are no specific numbers, dates, or financial figures in either the original or LLM answer, so no numeric inaccuracies exist. (3) However, the qualitative accuracy is lower due to significant reasoning errors: the LLM claims the U.S. Property line uses 'a broader mix' of methods including loss development and expected loss ratio techniques, which is not mentioned in the ground truth. Instead, the original answer emphasizes that both regions use IBNR factor methods, with the key difference being the shift toward non-admitted coverages in the U.S. altering the customer profile to be less severe—this critical point is entirely missing. Additionally, the LLM incorrectly characterizes U.S. Property as having 'higher-frequency, varied-severity exposures,' while the ground truth states the U.S. shift has led to *less severe* losses in aggregate. This misrepresents the nature of the regional difference. (4) The multi-hop synthesis is flawed because the model fails to connect the use of IBNR methods to the evolving customer base and reduced severity in the U.S., instead inventing methodological differences not present in the source. Thus, while the answer is well-structured and contextually relevant, it substitutes plausible but incorrect reasoning for the actual factual distinction, warranting a correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 522,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "Based on the document, Procter & Gamble holds a **global market share of more than 60% in blades and razors** (as stated in the Grooming segment description on page 18: \"Our global blades and razors market share is more than 60%, primarily behind our Gillette and Venus brands\"). This 60%+ share applies to the broader blades and razors category, which includes both manual razors and electric shavers. However, the document specifically states that P&G holds **over 25% of the male electric shavers market** (also on page 18), indicating that while it dominates the manual razor segment, its share in the electric shaver sub-category is significantly lower. Thus, the combined global market share for blades and razors (60%+) is substantially higher than its share in the male electric shavers segment (25%).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Procter & Gamble's global market share in blades and razors as 'more than 60%' and in male electric shavers as 'over 25%', which matches the ground truth. However, the question asks for the 'combined global market share' of the two segments, which the LLM does not compute or address directly. Instead, it compares them qualitatively, missing the explicit combination (60% + 25% = 85%+) and the comparative difference (>35 percentage points) highlighted in the original answer. (2) Quantitatively, the individual percentages are accurate and correctly attributed, but the lack of a combined total or difference calculation results in incomplete quantitative synthesis. The model avoids making a false calculation but fails to perform the implied comparison. (3) The reasoning is mostly sound—correctly distinguishing between manual blades/razors and electric shavers—but fails the multi-hop requirement to combine and compare the two shares numerically. The statement that '60%+ share applies to the broader blades and razors category, which includes both manual razors and electric shavers' is misleading, as the original answer treats blades/razors and male electric shavers as distinct categories, not subsets. This mischaracterization affects logical accuracy. (4) Despite this, the answer is highly relevant and conveys useful context, earning full marks for contextual relevance. The correctness score is 7 because core facts are accurate but the answer omits key synthesis required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 426,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "General Dynamics invested approximately $510 million in Aerospace segment product development in 2023, and it offsets a portion of these costs through cost‑sharing arrangements with suppliers that reimburse the company for development expenses, which are recorded as a reduction of R&D expense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the investment amount of $510 million in 2023 is accurately reported, with acceptable formatting (using 'approximately' is reasonable and does not distort the figure). (2) The mechanism—cost-sharing arrangements with suppliers that reimburse development costs and are recorded as a reduction of R&D expenses—is correctly described, matching the original answer's key elements: the purpose (reimbursement of development costs), the mechanism (cost-sharing), and the accounting treatment (reduction of R&D expense). (3) The reasoning is sound and reflects proper multi-hop synthesis: linking General Dynamics, the Aerospace segment, 2023, product development investment, and supplier cost-sharing mechanisms. (4) All entities (General Dynamics, Aerospace segment, suppliers), metric (R&D expense reduction), and time period (2023) are accurate. The answer is concise but complete, addressing both parts of the question with factual precision and appropriate context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 303,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "Accenture spent $4.509 billion on Class A ordinary‑share purchases during fiscal 2024.  After these purchases, the company held $4.505 billion of treasury shares (up from $4.107 billion in the prior year), reflecting the net increase in its treasury‑share balance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Accenture spent $4,111,266 on Class A Ordinary Share purchases in fiscal 2024, but the LLM claims $4.509 billion—a difference of over $4.5 billion, which is a major error. Similarly, the LLM reports treasury shares increased to $4.505 billion from $4.107 billion, implying an increase of approximately $398 million, which does not align with the ground truth increase of $4,111,266. These numbers are not even approximately correct and suggest confusion with unrelated data. (2) Quantitative accuracy is very low: the correct amount is ~$4.11 million, not $4.509 billion (off by three orders of magnitude). The prior and post treasury values are also incorrect. Even allowing for formatting variations (e.g., billion vs million), the values are not equivalent. (3) The qualitative reasoning appears structured—attempting to show the effect of share purchases on treasury stock—but fails on multi-hop synthesis because it uses entirely wrong figures. The logic flow (purchases increase treasury shares) is correct, but the data underpinning it is invalid. (4) Contextual relevance is high because the answer addresses the right entities (Accenture, Class A ordinary shares, treasury shares, fiscal 2024) and the causal relationship between share buybacks and treasury stock. However, due to gross numerical inaccuracies, the answer is substantially incorrect despite correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 409,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "The year‑over‑year dollar increase in the value of META’s Servers and Network Assets is $21.56 billion ( $68,397 million – $46,838 million = $21,559 million ≈ $21.56 billion ). This increase reflects assets that were placed in service and are subsequently depreciated on a straight‑line basis over their estimated useful lives (typically four to five years for servers and network equipment), consistent with the company’s depreciation policy described in the filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year dollar increase in META's Servers and Network Assets as $21.56 billion, which is a precise approximation of the exact $21.559 billion from the ground truth ($68,397 million - $46,838 million = $21,559 million). The formatting variation ($21.56 billion vs. $21.559 billion) is acceptable and common in financial reporting. (2) All numeric values are accurate and correctly calculated. The use of millions and billions is consistent and correctly converted. (3) The reasoning is sound: the LLM correctly links the increase in asset value to assets being placed in service and subject to depreciation over their useful lives (4–5 years), which aligns with META’s policy. However, it omits the specific mention that assets in construction in progress (CIP) are not depreciated until placed in service—a key nuance in the multi-hop logic that explains why a large increase in depreciable assets implies prior CIP assets were newly placed into service. This omission slightly weakens the qualitative depth but does not invalidate the core reasoning. (4) The answer is contextually excellent, directly addressing both parts of the question—quantitative change and relation to depreciation policy—with accurate synthesis of financial data and policy. The minor omission prevents a perfect 10 on qualitative accuracy, but quantitative and relevance scores remain high due to precision and alignment with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 408,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "Based on the provided document pages, Eli Lilly received FDA Breakthrough Therapy designation for several compounds in 2022, but the specific breakdown of \"submitted status versus discontinued development\" for **2022 designations** is not explicitly stated. However, from the pipeline data:\n\n- **Submitted status (as of 2022)**:  \n  - *Empagliflozin (Jardiance)* for **heart failure with preserved ejection fraction** was **submitted** (granted Breakthrough Therapy designation in 2021, with FDA priority review granted in 2022).  \n  - *Baricitinib (Olumiant)* for **alopecia areata** was **submitted** (granted Breakthrough Therapy designation in 2021, with submissions ongoing through 2022).  \n\n- **Discontinued development**:  \n  - *Baricitinib (Olumiant)* for **systemic lupus erythematosus** was **discontinued** in January 2022 (announced based on top-line Phase III results).  \n\nThus, **one indication** (systemic lupus erythematosus) was discontinued, while **two indications** (heart failure with preserved ejection fraction and alopecia areata) remained in submitted status. The specific compounds and therapeutic areas are:  \n- **Submitted**: Empagliflozin (heart failure), Baricitinib (alopecia areata).  \n- **Discontinued**: Baricitinib (systemic lupus erythematosus).  \n\n*Note: The document does not explicitly isolate \"2022 designations\" but references submissions and discontinuations occurring in 2022 based on the timeline provided.*",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but has significant errors in alignment with the ground truth. (1) Quantitatively, the LLM incorrectly states that one indication was discontinued in 2022 with FDA Breakthrough Therapy designation, while the ground truth explicitly states that *no indications with FDA Breakthrough Therapy designation were discontinued in 2022*. The discontinuation of Baricitinib for systemic lupus erythematosus in January 2022 is factually correct per external knowledge, but the key issue is whether that indication had received Breakthrough Therapy designation *in 2022* — the ground truth indicates no such designation in 2022 for discontinued programs. The LLM conflates events occurring in 2022 (discontinuation) with the year of designation, which is not supported by the ground truth. (2) The two submitted indications — Empagliflozin for heart failure with preserved ejection fraction and Baricitinib for alopecia areata — are correctly identified and match the ground truth in compound, therapeutic area, and status. However, the Breakthrough Therapy designation years cited (2021) contradict the question’s focus on *2022 designations*, making the answer misaligned with the query’s core requirement. (3) The multi-hop reasoning is partially sound — the model synthesizes pipeline status, compound, and indication — but fails to restrict the analysis to drugs that *received* the designation in 2022, instead including those with regulatory activity in 2022 regardless of designation year. (4) This leads to a major factual discrepancy: the ground truth states zero discontinued indications among 2022 designations, while the LLM reports one. Thus, despite correct identification of some pipeline events, the answer is factually incorrect on the central point. The contextual relevance is high as the answer addresses the right company and topic, and provides structured output, but the core correctness fails due to temporal and status misalignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 535,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "AIG applies loss development methods to its U.S. Other Casualty lines, which are long‑tail and subject to significant judicial and underwriting trends, whereas for U.S. Property it relies more on frequency/severity and expected loss ratio techniques due to the relatively shorter tail nature of those exposures. In 2021, U.S. Personal Insurance recorded $412 million of favorable prior‑year development, driven largely by subrogation recoveries on the 2017 and 2018 catastrophe years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $412 million favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years, matching the ground truth exactly in amount and cause. This satisfies the quantitative and entity accuracy for the second part of the question. (2) For the first part, the LLM correctly contrasts AIG's use of loss development methods for long-tail U.S. Other Casualty lines versus shorter-tail U.S. Property lines. However, it inaccurately states that AIG relies more on 'frequency/severity and expected loss ratio techniques' for Property lines. According to the ground truth, AIG primarily uses frequency/severity, loss development, and IBNR factor methods for Property lines, with IBNR factors applied to earned premiums for high-severity losses—this key detail about IBNR factor usage is missing. Additionally, the ground truth specifies that expected loss ratio methods are more heavily weighted in *recent accident years* for Casualty lines due to less credible loss data, a nuance not captured in the LLM response. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes reserving method differences and links 2021 adjustments to prior catastrophe recoveries. However, it omits specific methodological details (e.g., IBNR factors for Property, rationale for expected loss ratio use in Casualty) that are critical for full qualitative accuracy. (4) The contextual relevance is perfect—every part of the answer addresses the question directly. Quantitative accuracy is flawless (correct year, correct dollar amount, correct event linkage). Due to missing key methodological distinctions and nuances in reserving approaches, the answer is not fully complete or precise in qualitative terms, warranting a score of 8/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 504,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "The Baby, Feminine & Family Care segment contributed roughly 24 % of Procter & Gamble’s fiscal 2024 net sales. Within that segment, the Charmin brand accounts for the majority of the family‑care business in North America, representing about 40 % of the North American toilet‑paper market, which translates to roughly 10 % of total consolidated net sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the Baby, Feminine & Family Care segment contributed 24% of P&G's fiscal 2024 net sales, which matches the ground truth. However, it introduces incorrect quantitative claims about Charmin: stating Charmin holds 'about 40%' of the North American toilet paper market, whereas the ground truth reports approximately 25%. Additionally, the LLM asserts that this translates to 'roughly 10% of total consolidated net sales,' which is unsupported by the original answer and involves a flawed inference. The ground truth does not provide any estimate of Charmin's direct contribution to P&G's total net sales, only its market share within North American toilet paper. (2) The 24% figure is accurate, but the 40% market share and 10% sales contribution are factually incorrect and not derivable from the provided information. There is no calculation in the ground truth to support the 10% claim, making this a significant quantitative error. (3) The reasoning fails on the second hop: while it correctly identifies the segment contribution, it overreaches by combining an inflated market share with an unsupported extrapolation to total company sales. The multi-hop logic should have stopped at segment-level contribution and Charmin's role within a subcategory (toilet paper) of the family care business, not extended to a precise percentage of total net sales. (4) The answer is contextually relevant and addresses both parts of the question, but the factual inaccuracies in key percentages—especially the invented 10% of total sales—severely undermine correctness. The qualitative reasoning is partially sound but based on incorrect data, leading to a moderate score in that category.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 470,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "General Dynamics' $510 million R&D investment in 2023 is directed primarily toward modernizing its Combat Systems portfolio, most notably the Abrams main‑battle tank.  The company is delivering the SEPv3 upgrade package that adds next‑generation communications, power generation, fuel‑efficiency, optics and armor to the existing M1A2 fleet, and it is developing the more substantial M1E3 Abrams variant, which incorporates new systems‑architecture standards to enable faster technology upgrades, lower sustainment footprints and greater tactical mobility.  These upgrades, together with continued enhancements to the Stryker platform and related next‑generation capabilities (e.g., M‑SHORAD, high‑energy laser, microwave weapons), are intended to preserve market‑leading positions, secure export opportunities and drive future revenue growth from land‑combat vehicle sales and associated support services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $510 million R&D investment in 2023 is correctly stated, with no numerical or date inaccuracies. (2) The answer correctly identifies the Combat Systems segment’s focus on modernizing the Abrams tank, including both the SEPv3 upgrades to the M1A2 fleet and the development of the M1E3 variant. It accurately describes key features of the M1E3—such as faster technology upgrades, reduced sustainment footprint, and increased tactical mobility—mirroring the original answer. (3) The reasoning is sound and reflects proper multi-hop synthesis: linking R&D spending to specific platform developments (Abrams, Stryker), technical enhancements (communications, power, optics), and strategic outcomes (market leadership, export opportunities, revenue growth). (4) While the LLM omits explicit mention of 'advanced systems architecture' and 'fuel efficiency' in the context of M1E3 (though fuel-efficiency is mentioned under SEPv3), it captures the core strategic and financial outcomes—securing contracts, driving revenue, and maintaining market leadership—consistent with the original. The inclusion of M-SHORAD and directed-energy weapons adds context not in the ground truth but does not detract from accuracy. Overall, the answer is factually correct, well-reasoned, and fully relevant, warranting a 9/10 due to minor omission of specificity around M1E3’s technical scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 403,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "Based on the provided document pages, the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs, was $605 million for shares acquired under the program during the fourth quarter, plus $72.255 million for unrelated purchases (as noted in the table on page 39: \"During the fourth quarter of fiscal 2024, Accenture purchased 72,255 Accenture plc Class A ordinary shares in transactions unrelated to publicly announced share plans or programs\"). The total value of these purchases is $677.255 million. However, the document also states that the total dollar value of shares purchased under the publicly announced program for the entire fiscal year (including all quarters) was $4.5 billion (as referenced in the \"Purchases of Accenture plc Class A Ordinary Shares\" section on page 39 and confirmed by the $4.5 billion figure in the Key Metrics on page 40). The question asks for the total value combining both types of purchases, and the document explicitly states that the total dollar value of shares purchased under the program and unrelated to it during fiscal 2024 was $4.5 billion (as the $4.5 billion figure includes all share purchases, both under the program and unrelated to it, as per the context of the share purchase program description and the $4.5 billion cash returned to shareholders figure in the Key Metrics). Therefore, the total dollar value is $4.5 billion. \n\n(Note: The $4.5 billion figure is derived from the \"Cash returned to shareholders of $7.8 billion, including share purchases of $4.5 billion and dividends of $3.2 billion\" on page 40, and the share purchase details confirm this $4.5 billion represents the total value of Class A shares purchased during fiscal 2024, encompassing both program and unrelated transactions.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and reasoning errors. (1) The ground truth states the total dollar value of Class A Ordinary Shares purchased in fiscal 2024 was $609.1 million, with $605 million under the program and $4.1 million unrelated. The LLM incorrectly claims $4.5 billion as the total, which is a major factual error. The $4.5 billion figure cited refers to cumulative share purchases over multiple years or a misinterpretation of the 'cash returned to shareholders' context, not fiscal 2024 alone. (2) The LLM incorrectly calculates $605 million (fourth quarter only) + $72.255 million (unrelated, fourth quarter) = $677.255 million, but this conflates partial quarterly data with annual totals and misreads the time frame. The $72.255 million in unrelated purchases is only for Q4, not the full year, and cannot be summed with an annual program total. (3) The multi-hop reasoning fails: the model does not correctly synthesize that the $605 million and $4.1 million are annual figures from the ground truth, instead pulling disparate numbers from different contexts (e.g., Q4 data, cumulative program totals). (4) The LLM misinterprets the 'Cash returned to shareholders of $7.8 billion, including share purchases of $4.5 billion' as the total for fiscal 2024, but this contradicts the specific $609.1 million figure provided in the ground truth, indicating a failure to reconcile specific vs. aggregate data. The answer is contextually relevant in attempting to address the question but is factually and quantitatively unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 430,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "AT&T's 2021 cash payments to Crown Castle under the sublease arrangement ($253) are comparable to the initial $4,827 cash proceeds it received from Crown Castle in the 2013 tower transaction, though the 2013 payment was a one-time cash inflow from the sale of tower assets, while the 2021 payments represent ongoing sublease payments made under the continued tower leaseback arrangement.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the two key financial figures: $253 million in 2021 payments and $4,827 million ($4.827 billion) in initial 2013 proceeds, which matches the ground truth exactly in terms of numeric values and years. Thus, quantitative accuracy is perfect. (2) However, the qualitative reasoning is significantly flawed. The LLM states that the 2021 payment is 'comparable' to the 2013 proceeds, which is factually incorrect—the $253 million payment is only about 5.2% of the $4,827 million initial inflow and represents an annual outflow versus a one-time inflow. The ground truth emphasizes that the 2021 payment is 'a small fraction' of the original transaction, which the LLM fails to convey. Instead, it misleadingly suggests comparability. (3) The multi-hop reasoning is partially sound—linking the 2013 transaction to the 2021 sublease payment shows synthesis across time and arrangements—but the conclusion drawn from this comparison is illogical and contradicts the data. (4) Therefore, while numbers and entities are correct (AT&T, Crown Castle, 2013, 2021, sublease, tower transaction), and the context is relevant, the incorrect interpretation of the magnitude relationship severely undermines the answer's correctness, warranting a low correctness and qualitative accuracy score despite perfect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 375,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "Based on the disclosures in the 2021 10‑K (pages 50‑51, 64‑68), GM’s equity‑price risk analysis shows that a 10% adverse move in Stellantis stock would have had an **insignificant effect** on the fair value of its Stellantis warrant holdings ($1.5 bn at year‑end). Consequently, the potential financial impact of such a 10% stock‑price decline on GM’s equity investments in 2021 is considered negligible.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion fair value of GM's Stellantis warrants at year-end 2021 is accurately reported, and the 10% adverse change in Stellantis stock price is correctly linked to an 'insignificant effect' on financial statements. Format variations (e.g., $1.5 bn vs $1.5 billion) are acceptable. (2) The answer addresses all key parts of the question: it identifies GM’s valuation methodology (implied via sensitivity analysis), notes the sensitivity to equity price risk, and concludes that a 10% adverse movement would have a negligible financial impact. While the LLM does not explicitly name the Black-Scholes model or mention dividend yield (from the original answer), it correctly captures the outcome of the methodology—namely, that despite theoretical sensitivity, the financial impact is immaterial. (3) Entity accuracy is strong: 'General Motors', 'Stellantis', '2021', and 'equity investments' are correctly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: linking GM’s risk disclosure, the fair value of the warrants, and the conclusion about insensitivity to a 10% price move. The only minor omission is the lack of explicit mention of the Black-Scholes model, which slightly reduces qualitative accuracy but does not undermine the correctness of the conclusion. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 414,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "Based on the document, the Baby, Feminine & Family Care segment (which includes the adult incontinence sub-category) accounted for 24% of total net sales and 25% of total earnings, with the segment's major brands listed as Always, Always Discreet, Tampax, Bounty, and Charmin. The document specifically states that P&G competes in the adult incontinence sub-category behind Always Discreet with \"about 15% market share in the markets in which we compete.\" This 15% market share figure refers to the adult incontinence sub-category within the Baby, Feminine & Family Care segment, not the overall segment's market share. The document does not provide a specific percentage of the segment's total market share attributed to the adult incontinence sub-category via Always Discreet. Therefore, the exact percentage requested cannot be determined from the provided information.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in identifying that Always Discreet holds about 15% market share in the adult incontinence sub-category, but it fails to correctly interpret and convey the ground truth. The original answer states that the adult incontinence sub-category (via Always Discreet) contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment — not that Always Discreet has 15% within the adult incontinence sub-category. The LLM misattributes the 15% figure to the sub-category competition rather than recognizing it as the contribution to the overall segment's market share, which is the core of the question. Additionally, the LLM incorrectly concludes that the percentage 'cannot be determined,' which contradicts the provided ground truth. While the LLM correctly identifies relevant brands and segment context, it fails in multi-hop reasoning by not connecting the stated 15% contribution to the overall segment share. Quantitative accuracy is partially correct due to the presence of the 15% figure but misapplied. Qualitative reasoning is flawed in synthesis, though entities and general context are accurate. Contextual relevance is high as the response discusses the correct segment and brand.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 352,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024—including shares bought through the publicly announced open‑market program and those acquired in transactions unrelated to such plans (e.g., employee‑share‑plan withholdings)—was $303.05 per share. This figure is derived from the total cash outlay of $628 million for 2,072,563 shares purchased in the quarter, as reported in the “Purchases of Accenture plc Class A Ordinary Shares” table on page 39.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states an average price of $303.05 per share, which contradicts the ground truth of approximately $299.48. This is a significant factual error in the core numerical result. The LLM claims a total cash outlay of $628 million for 2,072,563 shares. However, verifying this calculation: $628,000,000 ÷ 2,072,563 ≈ $303.05, which matches the LLM's stated average price. Therefore, the internal calculation is consistent with its inputs, but the inputs themselves (total cash and number of shares) do not align with the ground truth data. (2) The quantitative accuracy is low because the key financial figures (cash outlay, number of shares, and resulting average price) are incorrect. Even though the format of numbers is acceptable, the values are factually wrong. (3) The qualitative accuracy is partially correct: the LLM correctly identifies the relevant components (publicly announced program and unrelated transactions) and the correct time period (Q4 fiscal 2024). It also references the appropriate table and page, suggesting correct entity and document identification. However, it fails in synthesizing the correct multi-hop data—either from misreading the source or using incorrect underlying data. (4) Contextual relevance is high because the structure, scope, and intent of the answer match the question, including inclusion of both share purchase types and a clear derivation path. The reasoning logic is sound but based on incorrect data, leading to an incorrect final answer. The discrepancy suggests a failure in data retrieval or interpretation from the source document.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 441,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "The net milestones capitalized for Jardiance increased from $156.2 million in 2020 to $136.1 million in 2021, a decrease of $20.1 million. This $20.1 million reduction is smaller than the $1,490.8 million of collaboration revenue reported for Jardiance in 2021.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that net milestones 'increased' when they actually decreased from $156.2 million in 2020 to $136.1 million in 2021—a $20.1 million decrease. While the magnitude of the difference ($20.1 million) is correctly calculated, the direction of change is reversed, which is a major error. (2) The collaboration revenue figure of $1,490.8 million is completely incorrect and does not match the ground truth of $175.0 million total collaboration and other revenue in 2021. This number appears fabricated or misattributed. (3) The multi-hop reasoning fails: the model should have recognized that the $136.1 million in net milestones capitalized in 2021 was part of the broader $175.0 million collaboration and other revenue, not compared to an inflated standalone collaboration revenue figure. The comparison logic is flawed. (4) Despite correct identification of the $156.2M and $136.1M figures and accurate calculation of the $20.1M difference, the reversal of trend direction and grossly incorrect collaboration revenue number severely undermine factual correctness. Contextual relevance is moderate because the structure and intent align with the question, but content is largely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 353,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "In 2021 GM recorded a $2.8 billion accrual for warranty recall campaigns, of which $2.0 billion related to the Chevrolet Bolt recall; the remaining $800 million covered other recall‑related expenses.  This accrual is partially offset by a $1.9 billion receivable from LG that GM recognized in the same period.  \n\nThe ongoing business relationship with Stellantis—through the Seller’s indemnification obligations under the 2017 sale agreement—requires GM to guarantee the Seller’s indemnity of Stellantis for certain losses arising from representations, warranties, emissions and product liabilities.  This indemnification and guarantee arrangement continues to affect GM’s post‑sale operations and exposure to litigation related to the former Opel/Vauxhall business.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The question asks for the gains GM recorded from its Stellantis warrants in 2021 and the ongoing business relationship affecting post-sale operations. The LLM instead discusses a $2.8 billion warranty accrual related to the Chevrolet Bolt recall and a receivable from LG, which is completely unrelated to Stellantis or warrant gains. The only partial relevance is the mention of an ongoing relationship with Stellantis, but even this is mischaracterized. (2) The ground truth states GM recorded $316 million in gains from Stellantis warrants in 2021. The LLM provides no such figure and instead invents unrelated financials ($2.8B accrual, $800M, $1.9B receivable), all of which are factually incorrect in this context. No correct numbers are present. (3) The multi-hop reasoning fails completely. The model does not connect GM’s warrant gains from Stellantis (a financial instrument outcome) with the continued operational relationship (supply/purchase of vehicles, parts, services). Instead, it fabricates a legal indemnity arrangement not mentioned in the ground truth and misrepresents the nature of the ongoing relationship. (4) The correctness score is 1 due to near-total factual inaccuracy. Quantitative accuracy is 1 because all numbers are wrong and unrelated. Qualitative accuracy is 2 because the model identifies Stellantis and a post-sale relationship, but misrepresents the nature. Contextual relevance is 3 because it at least addresses GM and Stellantis in a post-sale context, albeit incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 432,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "The deconsolidation of AIG Financial Products Corp. (AIGFP) resulted in a **pre-tax loss of $114 million** recognized in Net gain (loss) on divestitures and other, reflecting the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements. This loss was recorded as part of the reclassification of the $37.6 billion AIGFP loan receivable to a third-party asset with a full allowance for credit losses, and the deconsolidation was deemed immaterial to AIG's overall consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the pre-tax loss of $114 million, the correct line item 'Net gain (loss) on divestitures and other', and the $37.6 billion loan receivable reclassification with a full allowance for credit losses. All key facts from the ground truth are present and accurate. (2) Quantitative accuracy is perfect: $114 million and $37.6 billion match the original answer exactly; no calculations are required, but the values are correctly reported. (3) The multi-hop reasoning is sound—linking the Chapter 11 reorganization to deconsolidation, resulting loss recognition, and balance sheet impact is logically and accurately synthesized. The only minor omission is the specific date of the Chapter 11 filing (December 14, 2022), which is present in the ground truth but missing in the LLM answer. Additionally, the original answer explicitly states that AIG assessed no material impact on consolidated balance sheets or businesses, while the LLM version summarizes this as 'deemed immaterial'—semantically equivalent but slightly less detailed. (4) The answer is highly relevant, directly addressing both parts of the question: the amount of the loss and its reflection on AIG's financial statements. Due to the omission of the exact filing date and slightly reduced contextual detail on the 'no material impact' assessment, the qualitative accuracy is rated 9 rather than 10. Overall, the answer is factually correct and conveys the essential meaning of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 415,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "The total net value of Acquired Franchise Rights in 2024 is $1,858 million, which is lower than the reported gross value of $1,891 million in the prior year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively, it reports a net value of $1,858 million in 2024, which is drastically different from the ground truth of $598 million. It also claims the prior year's gross value was $1,891 million, whereas the correct 2023 gross value is $840 million. These numbers are not only wrong but more than double the actual figures. (2) The calculation or reasoning behind the LLM's numbers is unclear and unsupported by the ground truth. The correct net value is derived from $821 million (2024 gross) minus $223 million (accumulated amortization), which the LLM fails to mention or reflect. (3) The multi-hop reasoning is flawed: the question requires comparing 2024 net value to 2023 gross value, but the LLM incorrectly compares 2024 net to a fabricated prior gross value without showing proper synthesis across years or components. (4) The answer lacks key details such as accumulated amortization and the actual decrease of $19 million in gross value from 2023 to 2024. While the answer attempts to address the two-part question (net value in 2024 and comparison to prior gross), the severe factual inaccuracies in numbers and missing reasoning result in a very low correctness score. Minor credit is given for attempting the right structure and using appropriate financial terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 370,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "Based on the disclosed information in the 10-K filing (specifically pages 52, 54, 55, and 56), AT&T's total financial commitment for the C-Band licenses includes:\n\n1.  **Auction 110 Payment:** $9,079 total ($123 upfront deposit paid in Q3 2021 + $8,956 remaining payment due in Q1 2022).\n2.  **Future Costs:** $2,112 estimated for clearing Phase II spectrum (expected by end of 2023) + approximately $1,000 in compensable relocation costs (with $650 paid in Q4 2021, implying ~$350 remaining liability).\n\n**Therefore, the total financial commitment disclosed for the C-Band licenses, including both the auction payment and the estimated future costs for clearing and relocation, is $9,079 (auction payment) + $2,112 (Phase II clearing) + $1,000 (relocation) = $12,191.** (Note: The $9,079 is the total auction payment; the $2,112 and $1,000 are the estimated future costs for clearing and relocation, respectively, that are part of the overall commitment). The $9,079 is explicitly stated as the total payment for Auction 110, and the future clearing/relocation costs are separately disclosed as $2,112 (Phase II) and $1,000 (compensable relocation).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states AT&T's total financial commitment was $26,478 million (implied to be in millions based on context), with $23,406 for the auction, $2,112 for spectrum clearing, and $1,000 for relocation. However, the LLM incorrectly reports the auction payment as $9,079, which is less than half the correct amount. This leads to a total commitment of $12,191 instead of $26,478 — a major error. (2) The calculation in the LLM answer is internally consistent ($9,079 + $2,112 + $1,000 = $12,191), but all key inputs are wrong. The auction payment is severely understated. Additionally, the LLM references 'Auction 110' and specific quarterly payments not mentioned or verifiable in the ground truth, suggesting hallucination or misattribution. The $650 paid in Q4 2021 is not in the original answer and introduces unverified detail. (3) The multi-hop reasoning is partially sound in structure — the model attempts to sum auction, clearing, and relocation costs — but fails because it uses incorrect source data. It identifies the correct cost categories (auction, clearing, relocation), showing some understanding of the required synthesis. (4) The contextual relevance is high because the answer addresses the right components and cites document pages, indicating an attempt to ground in the filing. However, quantitative accuracy is very low due to incorrect figures. Qualitative accuracy is slightly higher because the framework of the answer (breaking down cost components) is reasonable, but entity and number accuracy is poor. Correctness score is low due to fundamental errors in core financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 461,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021. This reduction reflects the amortization of previously capitalized milestone amounts and is mirrored in Lilly’s diabetes portfolio performance: Jardiance net product revenue rose to $1,490.8 million in 2021 (up from $1,153.8 million in 2020), while the company’s share of collaboration revenue and royalty payments under the Boehringer Ingelheim partnership were adjusted, contributing to the overall growth and profitability of Lilly’s diabetes products.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM correctly reports the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), matching the ground truth exactly. The implied $20.1 million decrease is accurate, though not explicitly stated as a difference. However, the LLM introduces new financial data—Jardiance net product revenue rising from $1,153.8 million to $1,490.8 million in 2021 and collaboration adjustments with Boehringer Ingelheim—that are not present in the original answer and cannot be verified from the provided ground truth. These additions change the interpretation significantly.\n\n2) Quantitatively, all numbers are accurate and correctly formatted. The milestone amounts are correct, and the revenue figures, while unverifiable from the ground truth, are internally consistent. No calculation errors are present.\n\n3) The multi-hop reasoning is partially flawed. While the LLM correctly identifies the decrease in capitalized milestones, it incorrectly attributes the financial performance impact to revenue growth and partnership adjustments, which were not mentioned or implied in the original answer. The ground truth interprets the decline as a potential signal of slowed milestone achievements affecting financial performance, whereas the LLM portrays it as part of a positive growth narrative. This contradicts the original inference and introduces unsupported causal relationships.\n\n4) The contextual relevance is high because the answer addresses both parts of the question—change in capitalized milestones and impact on financial performance—but the qualitative inaccuracy in reasoning and introduction of unverified data reduces overall correctness. The answer is factually precise on the milestone amounts but diverges in interpretation, leading to a misleading conclusion about the implications for Lilly’s diabetes portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 502,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "In 2021 General Motors recognized a total financial benefit of **$1.1 billion** from its relationship with Stellantis, comprising **$0.9 billion of pension income** and **$0.2 billion of gains from Stellantis warrants**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numerical values provided. The ground truth states that General Motors recognized $1.0 billion in total financial benefit, composed of $0.8 billion in non-service pension income and $0.2 billion in warrant gains. However, the LLM reports $1.1 billion total, with $0.9 billion in pension income and $0.2 billion in warrant gains. This results in an incorrect total and misstated component amounts. (2) Quantitatively, both the pension income ($0.9B vs $0.8B) and the total benefit ($1.1B vs $1.0B) are overstated by $0.1 billion, even though the warrant gain amount is correct. The sum of $0.9B + $0.2B = $1.1B is internally consistent in the LLM answer, but the values themselves are factually wrong. (3) The multi-hop reasoning appears structurally sound—the model identifies the need to combine pension income and warrant gains from the Stellantis relationship—but fails in factual synthesis, likely due to incorrect data retrieval or misattribution. (4) Contextually, the answer is well-structured and addresses the right entities (General Motors, Stellantis, pension income, warrants) and the correct year (2021), so relevance is high. However, the quantitative inaccuracies severely undermine the correctness, warranting a low overall score despite proper framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 375,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "The deconsolidation of Corebridge resulted in a $4.8 billion pre‑tax loss, which included an $8.5 billion retained investment measured at fair value using Corebridge’s quoted stock price (a Level 1 input). Because the stock price is observable, the fair‑value measurement of AIG’s retained interest is classified as Level 1, and changes in that price directly affect the amount recorded in AIG’s equity‑method investment and, consequently, its net income from discontinued operations. This reflects AIG’s reduced ownership interest (down to 22.7 % by year‑end 2024) while still recognizing gains or losses from subsequent stock‑price movements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific quantitative figures such as a $4.8 billion pre-tax loss and an $8.5 billion retained investment, which are not present in the original answer (ground truth), making their accuracy unverifiable from the provided context. The ownership percentage of 22.7% by year-end 2024 is also not mentioned in the original answer, introducing potentially incorrect specifics. While the concept of fair value measurement using Corebridge’s stock price and its impact on AIG’s financial statements aligns with the ground truth, the exact numbers and dates are unsupported. (2) The original answer does not provide any dollar amounts, percentages, or specific fiscal years, so the inclusion of $4.8B, $8.5B, and 22.7% in the LLM response cannot be confirmed as accurate. These may be hallucinated or drawn from external data not in the knowledge graph used for the ground truth. (3) The reasoning is partially sound: the LLM correctly identifies that changes in Corebridge’s stock price affect AIG’s equity-method investment and that fair value changes impact income, which matches the multi-hop logic in the original answer. It connects stock price → fair value measurement → impact on financial statements → reflection of ownership interest. However, it adds a level of specificity (e.g., Level 1 inputs, exact percentages, deconsolidation loss) not present or required by the ground truth, suggesting overfitting or use of external knowledge. (4) The contextual relevance is high because the LLM addresses both parts of the question: the impact of stock price changes on financial statements and how this reflects ownership interest. The qualitative explanation of fair value, retained interest, and equity-method income is consistent with the original answer’s themes, even if the details exceed what is supported. Thus, while the direction and logic are correct, the unsupported numbers reduce factual accuracy, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 536,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "Based on the amortization data in Note 4 of the 2024 10-K (page 83), the net carrying value of **Other Identifiable Intangibles** for PepsiCo (PEP) in 2024 is **$144 million**. This represents a decrease of **$30 million** from the 2023 net balance of **$174 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total net value of Other Identifiable Intangibles for PEP in 2024 as $144 million, matching the ground truth value of $144 (with 'million' implied in the original answer). It also accurately states the decrease of $30 million from 2023 ($174 million) to 2024 ($144 million), which aligns with the ground truth calculation (174 - 144 = 30). (2) All numeric values are correct and consistent with the original answer; the inclusion of 'million' in the LLM answer is a valid and common clarification that does not alter the factual meaning. The calculation of the decrease is accurate. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies the relevant metric (Other Identifiable Intangibles), extracts values for two consecutive years (2023 and 2024), and computes the change due to amortization as implied by the context. (4) The answer is fully complete, addressing both parts of the question—2024 net value and the year-over-year decrease. Entity accuracy is perfect: PEP (PepsiCo), the correct financial metric, and correct years are all used. The answer is semantically equivalent to the ground truth and adds contextual clarity (e.g., referencing Note 4, page 83) without introducing errors. All scores are maximized due to full factual, quantitative, and logical alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 389,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "The total revenue generated from nuclear‑powered submarines in 2023 was $8,631 million, compared with $2,698 million from surface ships. This reflects the strategic emphasis on submarine programs such as the Columbia‑class and Virginia‑class, which together account for the majority of the Marine Systems segment’s revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue from nuclear-powered submarines ($8,631 million) and surface ships ($2,698 million) in 2023, matching the ground truth exactly. These figures are critical and accurately presented with acceptable formatting (e.g., $8,631 million). (2) All numeric values are correct, and while the LLM does not explicitly compute the 3.2:1 ratio, it correctly implies the dominance of submarine revenue by stating it reflects strategic emphasis. The absence of the explicit ratio calculation is a minor omission but does not detract from the core quantitative accuracy. (3) The reasoning is sound: the LLM correctly attributes the revenue disparity to the strategic importance of the Columbia-class and Virginia-class programs, aligning with the multi-hop logic in the ground truth that connects financial performance to defense priorities. It correctly identifies the Marine Systems segment as the source context, even if not explicitly named. (4) The answer is semantically equivalent to the original in all key aspects—revenue figures, strategic context, and program significance—making it highly contextually relevant and factually accurate. The only minor shortcoming is the lack of explicit ratio mention, which slightly affects completeness but not correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 396,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "The change in the fair value of GM's investment in Stellantis warrants between December 31, 2020 and December 31, 2021 was an increase of $0.3 billion (from $1.2 billion to $1.5 billion). Over the same period, the change in the fair value of marketable debt securities was essentially unchanged, with only a minimal potential decrease from a 50‑basis‑point interest‑rate increase that was deemed insignificant. Thus, the warrant fair‑value change was material, whereas the marketable‑debt‑security fair‑value change was negligible.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.3 billion increase in the fair value of GM's investment in Stellantis warrants from $1.2 billion to $1.5 billion, which matches the ground truth. However, it incorrectly states that the change in fair value of marketable debt securities was 'essentially unchanged' and 'negligible,' when in fact the ground truth shows a clear $0.4 billion decrease (from $9.0 billion to $8.6 billion). This is a significant factual error affecting the core comparison. (2) The quantitative values for the Stellantis warrants are accurate, but the marketable debt securities values and change amount are missing or misrepresented. The LLM fails to report the actual $0.4 billion decline, instead dismissing it as insignificant, which contradicts the documented decrease. (3) The multi-hop reasoning is partially sound in identifying both assets and the time frame, but fails in synthesizing the correct trend comparison: the ground truth emphasizes contrasting trends (equity up, debt down), while the LLM incorrectly suggests only the warrants changed materially. (4) The correctness score is 5 due to one major factual omission (the $0.4B debt decline), despite correct warrant data. Quantitative accuracy is 6 because half the numbers are right, but the other half are wrong or missing. Qualitative accuracy is 5 due to flawed reasoning in the comparison. Contextual relevance is 8 because the answer addresses the right entities and question structure, just with incorrect data on one key component.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 423,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "The net decrease in the value of Acquired Franchise Rights for PepsiCo from 2023 to 2024 was $33 million (from $1,891 million to $1,858 million). This reduction is reflected in the amortization expense, which remained essentially unchanged at $74 million for 2024 compared with $75 million in 2023, indicating that the smaller balance of acquired franchise rights is being amortized over the same remaining useful lives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, a $28 decrease. However, the LLM claims a decrease from $1,891 million to $1,858 million, which is a $33 million decrease—both the values and the magnitude of change are incorrect. These numbers do not match the ground truth, even allowing for format variations. (2) The amortization expense is partially correct: the LLM correctly states that amortization expense was $74 million in 2024, matching the ground truth. However, it adds that it was $75 million in 2023, which is not supported by the original answer and introduces unverified data. (3) The reasoning about amortization contributing to the reduction in net value is conceptually sound and aligns with accounting principles, and the LLM attempts to link amortization expense to the change in asset value, which reflects some correct multi-hop logic. However, because the underlying numbers are wrong, the synthesis fails. (4) The contextual relevance is moderate—the response addresses the right question structure (change in value and link to amortization), uses the correct company (PEP/PepsiCo), and correct metric (amortization expense), but the core financial data is incorrect, severely undermining factual accuracy. Thus, correctness and quantitative accuracy scores are low, qualitative accuracy is moderate due to correct conceptual reasoning, and contextual relevance is acceptable but not strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 429,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics contributed approximately $570 million of the $775 million (8%) rise in Aeronautics service costs in 2023, accounting for the majority of the service‑cost increase. This aligns with the $600 million boost in Aeronautics service sales driven by higher F‑35 sustainment volume, indicating that the sustainment‑cost growth was roughly in step with the service‑revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: $570 million in service cost increase related to F-35 sustainment, which is part of the $775 million (8%) overall service cost increase in 2023, and a corresponding $600 million increase in service sales at Aeronautics due to F-35 sustainment. These match the ground truth exactly. (2) Quantitative accuracy is perfect: all dollar amounts and percentages are correct, and the comparison between cost and sales increases is factually sound. The model does not make any calculation errors. (3) The multi-hop reasoning is mostly sound—linking F-35 sustainment costs to overall service cost growth and aligning it with sales growth in the same unit and year. However, the LLM omits the explicit conclusion from the ground truth that the $30 million difference (cost being $30M less than sales) suggests a potential margin improvement. This is a minor but relevant analytical point present in the original answer. (4) Despite this omission, the LLM captures the core facts, entities (Aeronautics, F-35 sustainment, 2023), and relationships accurately. Wording differs slightly (e.g., 'in step with' vs 'indicating potential improvement in margin'), but the semantic meaning is close. The answer is highly relevant and factually correct, warranting a 9/10 for overall correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 383,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "As of September 25 2024, Accenture’s board approved an additional $4 billion of share‑repurchase authority, bringing the company’s total remaining authorization for Class A ordinary share purchases to $6.694 billion. This expanded authority reflects Accenture’s strategy of returning cash to shareholders while maintaining flexibility to support growth initiatives and manage capital efficiently.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total share repurchase authority as $6.694 billion (equivalent to $6,694 million) as of September 25, 2024, matching the ground truth. It also accurately notes the additional $4 billion (i.e., $4,000 million) approved by the Board, which increased the prior $2,694 million to the new total. Number formats are acceptable variations (e.g., $4 billion = $4,000 million; $6.694 billion = $6,694 million).\n2) Quantitatively, all figures are correct and consistent with the original answer. The calculation of the increase ($2,694M + $4,000M = $6,694M) is implied and accurate.\n3) The reasoning is sound: the LLM correctly links the increased repurchase authority to Accenture’s financial strategy. While the original answer emphasizes 'actively managing its equity structure' and mentions both open-market and other purchase programs, the LLM captures the strategic intent by referencing 'returning cash to shareholders' and 'managing capital efficiently,' which are semantically aligned. However, the LLM omits explicit mention of the dual mechanisms (open-market and other programs), a minor but relevant detail in fully reflecting the strategy.\n4) Contextual relevance is high—the answer directly addresses both parts of the question: the total authority amount and its reflection on financial strategy. The synthesis across the two key data points (prior authority and new approval) is logically executed. The omission of specific program types slightly reduces qualitative accuracy but does not undermine the core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 429,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "A failure to meet membership growth expectations would directly pressure Netflix’s financial flexibility and profitability because its content costs are fixed and cannot be quickly reduced. If growth slows, the company would be unable to adjust expenditures or raise per‑membership revenue (e.g., via price hikes) fast enough to offset the shortfall, leading to tighter margins, reduced liquidity, and potentially lower profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately identifies that Netflix's content costs are fixed and non-adjustable in the short term, especially with the expansion into live programming. It correctly explains that failure to meet membership growth expectations limits the ability to increase per-member revenue or reduce costs, leading to pressure on margins, liquidity, and profitability. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis: (1) fixed costs from live programming expansion, (2) reliance on membership growth for revenue, (3) inability to adjust costs or prices quickly, (4) resulting financial impact. The only minor difference from the original answer is the omission of the explicit phrase 'non-adjustable regardless of membership growth rates,' but the meaning is preserved through 'cannot be quickly reduced' and 'unable to adjust expenditures.' Wording differs slightly (e.g., 'tighter margins' vs 'negatively impacting margins'), but the semantic meaning is identical. All entities (Netflix, content costs, membership growth, profitability, liquidity) are correctly identified and logically connected. The answer fully addresses the question’s focus on financial flexibility and profitability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 384,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "The 5.15% 2041 Notes had a carrying value of $729 million, which represented roughly 2.2 % of AMGN’s total debt carrying value of $33,309 million reported for 2021. According to the debt‑exchange table, $245 million of principal of the 5.15% 2041 Notes was exchanged in the 2020 private exchange offer.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the carrying value of the 5.15% 2041 Notes ($729 million), the total carrying value of all debt ($33,309 million), the percentage (2.2% ≈ 2.19%), and the exchanged principal amount ($245 million), which are all factually accurate. However, it incorrectly states that the total debt was reported for 2021 instead of 2022 as specified in the question and ground truth. This error affects entity accuracy and reasoning, particularly in the temporal context of the financial data. (2) All numeric values and calculations are correct: 729 / 33,309 ≈ 2.19%, which rounds to 2.2%, and $245 million in principal exchanged matches exactly. Number formats are acceptable with minor spacing (e.g., $729 million). (3) The multi-hop reasoning is mostly sound—synthesizing carrying values, computing percentages, and referencing the debt exchange table—but the incorrect year breaks the chain slightly by misattributing the reporting period. The model likely pulled correct figures but attached them to the wrong fiscal year, undermining full accuracy. (4) Scores reflect high quantitative and contextual accuracy, with a moderate deduction in qualitative and overall correctness due to the year mismatch, which is significant in financial reporting contexts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 361,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "The Company's goodwill accounting policy requires that if a Company‑operated restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition must be written off; if the sale occurs more than 24 months after acquisition, the goodw ill write‑off is based on the relative fair value of the business sold compared to the reporting unit. This is disclosed in the “Goodwill” footnote (page 43) and summarized in the goodwill activity table (page 45).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately describes McDonald's goodwill accounting policy: full write-off of goodwill if a restaurant is sold within 24 months of acquisition, and a relative fair value-based partial write-off if sold after 24 months. (2) There are no numerical values requiring calculation, but the 24-month threshold is correctly stated and matches the original answer. (3) The reasoning correctly captures the multi-hop logic: acquisition triggers goodwill recognition, and the timing of sale determines the treatment in financial reporting. The synthesis of accounting treatment based on time is sound. (4) The answer is contextually precise, directly addressing the impact on financial reporting of goodwill with correct entity (McDonald's), metric (goodwill), and time threshold (24 months). Minor formatting issues (e.g., 'goodw ill' typo) do not affect factual accuracy. The reference to footnote and page numbers adds contextual support without detracting from correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 301,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "Based on the provided document pages, AIG's equity method income from Corebridge after the deconsolidation date in 2024 was $601 million, calculated as the sum of dividends received and changes in Corebridge's stock price since the deconsolidation date (June 9, 2024), as reported in the table titled \"Corebridge pre-tax income\" on page 109. This equity method income reflects the post-deconsolidation period from August 2024 to November 2024, during which AIG sold approximately 43 million shares and later sold an additional 120 million shares in December 2024, resulting in a 22.7% ownership stake as of December 31, 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that equity method income is calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024, but does not specify a dollar amount. The LLM incorrectly asserts a precise figure of $601 million, which is not present in the ground truth and cannot be verified from the provided context. Additionally, the LLM claims the income was calculated over August to November 2024, which contradicts the ground truth's clearly defined post-deconsolidation period starting June 9, 2024. The ownership stake is also incorrect: the LLM states 22.7% as of December 31, 2024, while the ground truth specifies a retained 48.4% stake, a major discrepancy. (2) The quantitative inaccuracies include the unsupported $601 million figure, incorrect time period (August–November vs. June 9–December 31), and wrong ownership percentage (22.7% vs. 48.4%). These are critical financial and factual errors. (3) The reasoning is partially sound in that the LLM identifies the correct components of equity method income (dividends and stock price changes), showing some understanding of the accounting method. However, it fails in multi-hop synthesis by misaligning the timeline, inventing a specific dollar amount, and misstating ownership, suggesting confusion between different phases of AIG's divestment. (4) Contextual relevance is moderate—the answer addresses the right topic and attempts to explain the calculation method, but the inclusion of fabricated specifics and incorrect synthesis undermines its reliability. The mention of share sales (43M and 120M) adds detail not in the ground truth and distracts from the actual question about income calculation post-deconsolidation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 492,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "Based on the provided document pages, **franchisees do not contribute a specific percentage to McDonald's global workforce**. The document states that McDonald's has over 150,000 company employees worldwide, with approximately 70% based outside the U.S., and that \"over two million individuals who work in McDonald's franchised restaurants around the world\" are critical to the company's success. However, it does not provide a numerical percentage for franchisee contributions to the *total global workforce* (which would include both company employees and franchisee-operated restaurant staff). \n\nThe document also describes McDonald's recruitment initiative to increase franchisees from underrepresented groups by \"reducing upfront equity requirements for eligible franchisee candidates and providing ongoing learning and development.\" This initiative aims to diversify the franchisee demographic composition, aligning with the company's broader DEI (Diversity, Equity, and Inclusion) strategy to \"better represent the diverse communities in which McDonald's operates\" and \"accelerate cultures of inclusion and belonging.\" \n\n(Word count: 198)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that 'franchisees do not contribute a specific percentage to McDonald's global workforce,' which contradicts the ground truth and the data provided in the same response. The document clearly states that over two million individuals work in franchised restaurants and over 150,000 are company employees. From these numbers, the percentage can be calculated: 2,000,000 / (2,000,000 + 150,000) ≈ 93%, which matches the ground truth of 'over 93%.' The failure to compute or acknowledge this percentage is a significant quantitative error. (2) While the LLM correctly reports the two key figures (over 2 million in franchised restaurants, over 150,000 company employees), it fails to synthesize them into the required percentage, thus missing a core part of the question. This undermines the quantitative accuracy despite having correct input numbers. (3) The qualitative aspects of the answer are mostly sound: the description of the recruitment initiative—reducing upfront equity requirements and providing learning and development for underrepresented groups—is accurate and aligns with the ground truth. The mention of DEI strategy adds relevant context. (4) Contextual relevance is high because the answer addresses both parts of the question and uses appropriate terminology and framing, even if it draws an incorrect conclusion about the availability of percentage data. The reasoning failure lies in not performing a straightforward calculation from provided figures, which is critical in multi-hop financial reasoning. Thus, while the components are present, the synthesis is flawed, leading to a partially correct but ultimately misleading answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 464,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "The $100 million unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together shaved $41 million (≈2 %) off RMS’s 2023 operating profit, offsetting gains from favorable IWSS adjustments.  While RMS’s backlog grew in 2023 mainly from higher Sikorsky orders, the Sikorsky programs contributed only modestly to the backlog increase compared with the overall profit impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $100 million unfavorable adjustment and lower Black Hawk production as key factors reducing RMS's operating profit, and notes the net $41 million decrease in operating profit, which aligns with the ground truth. However, it incorrectly implies that the $41 million reduction is directly the sum or result of the $100 million adjustment and lower volume, without acknowledging the partial offset from IWSS gains (e.g., $65 million favorable adjustment and Aegis volume), which is a key part of the reasoning in the original answer. (2) The quantitative values are mostly accurate: $100 million and $41 million are correct. The ≈2% figure is not present in the ground truth and cannot be verified, introducing unverified information. The absence of the $65 million IWSS favorable adjustment in the explanation reduces completeness and accuracy in calculation context. (3) The multi-hop reasoning is partially sound—linking Sikorsky-related issues to profit decline and backlog growth—but misrepresents the comparative contribution of Sikorsky programs to backlog increase by stating they contributed 'only modestly' compared to the profit impact, which distorts the original point that despite profit decline, Sikorsky drove backlog growth due to higher orders. This mischaracterizes the relationship between profit and backlog. (4) Scores reflect mostly correct facts with key omissions in calculation logic and synthesis, but good contextual framing and relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 420,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "The total value of Broadcom's acquisition of VMware was approximately $53.4 billion, comprising about $30.8 billion in cash and 544 million shares of Broadcom common stock (on a split‑adjusted basis) that were issued to VMware shareholders. This acquisition aligns with Broadcom’s strategic focus on expanding its infrastructure‑software portfolio, adding VMware’s cloud‑foundation and multi‑cloud services capabilities to complement its existing enterprise‑software offerings and to drive growth in its infrastructure‑software segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the total acquisition value. The ground truth states $84,186 million (i.e., $84.186 billion), but the LLM reports approximately $53.4 billion, which matches only the stock component ($53,398 million) of the deal. This is a major factual inaccuracy. The cash portion is correctly reported as ~$30.8 billion (vs. $30,788 million in truth), and the mention of stock issuance (544 million shares) adds detail not in the original but is plausible and consistent with public disclosures. (2) The calculation of total value is incorrect: $30.8B + $53.4B should be ~$84.2B, but the LLM incorrectly presents $53.4B as the total, suggesting it conflated the stock component with the total consideration. This undermines quantitative accuracy. (3) Qualitatively, the reasoning is sound: the acquisition is correctly linked to Broadcom’s strategic focus on infrastructure software, specifically citing multi-cloud services and enterprise software growth, which aligns with the knowledge graph’s description of enhancing capabilities in multi-cloud and digital innovation. The synthesis of strategic intent across business segments is accurate and relevant. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: total value and strategic alignment. Despite the major numerical error, the explanation of strategic rationale is complete and accurate. Thus, correctness is reduced to 7 due to the critical miscalculation of total value, though core elements (cash amount, strategic logic) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 439,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "The $6.99 ad‑supported tier is being used to accelerate paid‑membership growth, which helped drive the 18% year‑over‑year increase in global paid subscribers reported in the 2024 filing; this expansion supports Netflix’s strategy of boosting overall market penetration while carefully managing ARPU.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All key elements are accurate: the $6.99 ad-supported tier, the 18% year-over-year increase in global paid memberships, and Netflix's strategy of balancing ARPU with market penetration are correctly identified. (2) Quantitative accuracy is perfect: the $6.99 price point and 18% growth figure match the original answer exactly; no calculations are required, but the reference to the 2024 filing is consistent with the timeline implied in the context. (3) The reasoning is sound and captures the multi-hop logic: the lower-priced tier drives subscriber growth (penetration) at a potential cost to ARPU, which reflects Netflix’s strategic tradeoff. The only minor omission is that the LLM does not explicitly state that lower ARPU is accepted 'at the expense of' per-user revenue, though the phrase 'carefully managing ARPU' implies this nuance. (4) The answer is highly relevant, directly addressing how the pricing tier relates to membership growth and strategic intent. Wording differs slightly but maintains semantic equivalence. No factual errors; deduction of 1 point due to slightly less explicit articulation of the tradeoff compared to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 345,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "McDonald's employs approximately 1.9 million people worldwide who work in both its company‑owned restaurants and its franchised locations. These employees are central to the company’s purpose of “feeding and fostering communities” and its mission to “make delicious feel‑good moments easy for everyone,” as reflected in its core values of Service, Inclusion, Integrity, Community and Family and reinforced through its people‑focused strategies, training programs and DEI commitments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer is partially correct in content but contains a significant error in the total workforce number. The ground truth states over 2,150,000 individuals, including over 150,000 Company employees and over 2 million in franchised restaurants. The LLM reports approximately 1.9 million total, which underestimates the actual figure by over 250,000. This quantitative inaccuracy is critical because the question specifically asks for the total number of individuals globally, a core part of the answer. 2) The numbers are not consistent with the ground truth: 150,000 (company) + 2,000,000 (franchise) = 2,150,000+, but the LLM states 1.9 million total, suggesting either incorrect data or flawed synthesis. No calculation is shown, but the total is factually wrong. 3) The qualitative aspects are strong: the LLM correctly identifies the company's purpose and mission—'feeding and fostering communities' and 'making delicious feel-good moments easy for everyone'—and links the workforce’s role in delivering service, aligning with core values and people-focused strategies. This shows sound reasoning and correct entity identification (McDonald's, mission, purpose). 4) Contextual relevance is high, as the answer addresses both parts of the question—workforce size and its contribution to mission—though the numerical error undermines completeness. The explanation of how employees support the mission is semantically equivalent and well-reasoned. Overall, the answer gets credit for correct framing and mission alignment but is penalized heavily for the incorrect headcount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 432,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "The total fair value of the VMware acquisition was $53.4 billion, representing the combined cash and stock consideration paid to acquire VMware. This acquisition significantly expands Broadcom’s infrastructure software capabilities by adding VMware’s leading multi‑cloud platform and associated technologies, thereby enhancing Broadcom’s ability to offer a comprehensive suite of infrastructure and security software solutions for complex private and hybrid cloud environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains a significant error in the total fair value: it states $53.4 billion, while the ground truth is $84,186 million ($84.186 billion). This is a major quantitative discrepancy. The ground truth breaks this down into $30,788 million in cash and $53,398 million in stock—interestingly, the LLM's figure of $53.4 billion closely matches only the stock component, suggesting confusion between total consideration and stock portion. 2) Despite this, the qualitative aspects are strong: the answer correctly identifies that the acquisition enhances Broadcom's infrastructure software capabilities through VMware's multi-cloud platform, and it accurately reflects the strategic benefit of strengthening Broadcom’s portfolio in infrastructure and security software, particularly for hybrid and private cloud environments. 3) The multi-hop reasoning is sound—linking the acquisition to enhanced software capabilities via VMware’s technology—but fails in synthesizing the correct total value from cash and stock components. 4) Contextual relevance is high as the response directly addresses both parts of the question and uses appropriate terminology. However, the severe numerical inaccuracy in the total fair value significantly undermines factual correctness, warranting a moderate overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 364,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "The 2024 10‑K shows that Netflix’s average monthly revenue per paying member fell 5% year‑over‑year (to $7.29 in 2024 versus $7.64 in 2023), even as it raised prices on many plans.  At the same time, the filing flags “adverse macro‑economic conditions, including inflation” as a risk that could force the company to adjust pricing or limit its ability to raise rates.  Thus, the need to retain members under rising cost and inflation pressures conflicts with the company’s pricing strategy of periodically increasing membership fees.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core conflict between Netflix's pricing strategy and macroeconomic pressures, which is contextually relevant and aligns with the original answer's intent. However, there are significant quantitative inaccuracies that undermine factual correctness. The claim that average monthly revenue per paying member fell 5% year-over-year to $7.29 in 2024 (from $7.64 in 2023) is not supported by the ground truth, which does not provide these specific figures or percentages. The original answer states that membership plans range from $1 to $32 per month as of December 31, 2024, but does not mention average revenue per user (ARPU) or any year-over-year change. This introduces fabricated metrics that misrepresent the data. While the LLM correctly identifies inflation and macroeconomic risks as cited in the 10-K and links them to potential pricing tension, it incorrectly frames recent price increases as a factual element of the 2024 filing—while plausible, this detail is not confirmed in the ground truth. The reasoning is logically sound in connecting pricing actions with retention risks under economic pressure, demonstrating adequate qualitative synthesis. However, the inclusion of unsupported numerical data reduces quantitative accuracy significantly. The answer addresses the multi-hop nature of the question (pricing strategy + macro risks + retention impact), but does so with incorrect figures, leading to a partially correct response with major factual flaws in numbers and metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 416,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "McDonald’s goodwill recorded from acquiring restaurants is tied to the franchisee’s performance and the valuation methodology used for those acquisitions. The company assigns goodwill to reporting units (often individual markets) based on the excess of purchase price over net tangible assets, typically using a discounted cash‑flow (Level 3) approach that relies on expected profitability and cash‑flow assumptions of the acquired unit. When a Company‑operated restaurant is sold, any associated goodwill is written off after 24 months (or proportionally thereafter), meaning that deteriorating franchisee performance or declining cash‑flow expectations can trigger goodwill impairments that reduce earnings. Thus, the financial exposure from franchisee performance directly influences the carrying value of goodwill and the potential for impairment charges.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core relationship between franchisee performance and goodwill accounting, noting that McDonald's uses discounted cash flow (Level 3) to assign goodwill and that deteriorating performance can trigger impairments. However, it misstates the timing and treatment of goodwill write-offs upon sale. The original answer specifies that if a restaurant is sold *within* 24 months of acquisition, the goodwill is written off *entirely*; if sold *after* 24 months, it is written off based on relative fair value. The LLM reverses the logic by stating write-offs occur 'after 24 months (or proportionally thereafter)', which inaccurately implies no write-off before 24 months and full write-off only after — contradicting the ground truth. (2) There are no explicit dollar amounts or percentages in either answer, so quantitative accuracy is high based on correct use of '24 months' and proper valuation methodology (discounted cash flow). The timing error is qualitative but impacts factual correctness. (3) The multi-hop reasoning is partially sound: the model connects franchisee performance → cash flow expectations → goodwill valuation → impairment risk. However, it fails to accurately synthesize the specific accounting rule tied to the 24-month threshold for acquisition and resale, a key multi-hop element in the original answer. (4) Contextual relevance is strong — the response stays focused on the question and uses appropriate financial terminology. The error in the write-off timing prevents a higher score, but the overall framework is correct, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 447,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "Lockheed Martin’s hypersonics programs are positioned as a key growth pillar within its Space segment, which focuses on advanced strike and defensive systems, satellite technologies, and next‑generation missile defense (e.g., NGI, Trident II D5, GPS III). The company expects several hypersonic programs with the U.S. Army and Navy to move into early production phases through 2026, feeding into its broader “Twenty‑First Century Security” strategy that emphasizes classified programs, current programs of record, and new awards. This aligns with Space’s strategic priorities of expanding resilient space‑based capabilities and leveraging differentiated technologies, thereby driving anticipated revenue growth and market share expansion through 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Lockheed Martin's hypersonics programs are correctly identified as part of the Space segment's strategic priorities, with specific mention of U.S. Army and Navy programs transitioning to early production through 2026. The reference to hypersonics as a key growth area alongside classified programs, current programs of record, and new awards matches the 2023 10-K filing. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (through 2026) are correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes that hypersonics contribute to Space segment priorities (advanced strike) and feed into broader corporate growth strategy, linking segment-level activities to company-wide strategic objectives. (4) Semantic equivalence is strong; the LLM adds contextual detail (e.g., NGI, Trident II D5, GPS III, 'Twenty-First Century Security') not in the original answer but consistent with public knowledge and supportive of the core claim. One minor point preventing a perfect 10 is that the original answer explicitly identifies hypersonics as one of four key growth areas, while the LLM implies this without stating the number 'four'—a slight omission in completeness, but not a factual error. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 407,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflects its projected financial contribution through the use of the multi-period excess earnings method under the income approach, which estimates the present value of projected cash flows generated by the technology less charges representing the contribution of other assets. This technique was applied to developed technology (valued at $90 million with an 11-year weighted-average amortization period) and customer contracts/relationships (valued at $410 million with an 11-year period), where the economic useful life was determined based on technology cycles, contract durations, and historical customer turnover, ensuring the estimated economic benefit over time aligns with the projected revenue streams from these intangible assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the multi-period excess earnings method under the income approach as the valuation technique used by Broadcom for VMware Cloud Foundation-related developed technology, which aligns with the ground truth. It also accurately describes how this method estimates present value of cash flows net of contributions from other assets, and links useful life to technology cycles and forecasts—key qualitative elements. However, the LLM introduces specific dollar amounts ($90 million for developed technology and $410 million for customer contracts) and an '11-year weighted-average amortization period' that are not present in the original answer and cannot be verified from the provided ground truth, making these additions factually unsupported. (2) Quantitative accuracy is compromised because while the numbers may be accurate in external context, they are not included in the ground truth statement, so their inclusion constitutes a factual overreach. There are no calculation errors per se, but the introduction of unverified figures reduces reliability. (3) The multi-hop reasoning is sound in linking valuation methodology to projected financial contribution and economic benefit over time. The explanation of how useful life determination ties into revenue projections shows good synthesis and understanding of the conceptual framework. (4) Scores reflect high qualitative and contextual accuracy—core methodology and rationale are correct—but reduced quantitative accuracy due to unsupported numeric additions. Correctness score is 7 because the central facts about the valuation method and its linkage to financial projections are correct, but the inclusion of unverified dollar amounts and amortization periods introduces significant extraneous information that affects factual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 497,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "The 2021 launch of Sky Glass added a new line of smart‑TV hardware to Comcast’s “Corporate and Other” segment, driving a $1.8 billion increase in operating costs and expenses for that segment (from $2.033 bn in 2020 to $1.819 bn in 2021 after the $1.8 bn rise).  Management explicitly warned that it expects to incur higher costs in 2022 related to the continued rollout of Sky Glass and the launch of XClass TV.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and calculations. It claims a '$1.8 billion increase in operating costs' and states Corporate and Other segment expenses rose from $2.033 billion in 2020 to $1.819 billion in 2021 — which is logically and mathematically incorrect (a rise to $1.819B from $2.033B is a decrease, not an increase). The ground truth does not provide specific dollar amounts for the cost impact of Sky Glass, only that costs increased due to Sky Glass and XClass TV partially offsetting prior savings. Thus, the precise $1.8B figure and the segment expense values are unsupported and incorrect. (2) The years 2021 and 2022 are correctly identified, and the mention of XClass TV aligns with the original answer, but the numerical data is fabricated or misstated. (3) The reasoning correctly identifies that Sky Glass launch increased costs in 2021 and that further costs were expected in 2022 due to continued rollout — this multi-hop synthesis (impact in 2021, forward-looking expectation in 2022) is accurate and shows proper understanding of strategic trajectory. (4) While the qualitative reasoning and contextual relevance are strong — correctly identifying the strategic expectation for 2022 and linking Sky Glass to increased segment costs — the severe quantitative errors undermine the answer’s reliability. The correctness score is reduced to 4 due to these major numerical inaccuracies, despite correct directional logic and entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 418,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "McDonald's acquisition valuation methodology for restaurants purchased from franchisees relies on a discounted cash flow approach (Level 3 inputs) to determine fair value, and it includes a specific goodwill write‑off policy: if a Company‑operated restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off; if sold after 24 months, the write‑off amount is based on the relative fair value of the sold business compared with its reporting unit. This policy can lead to significant goodwill write‑offs when restaurants are flipped quickly, as seen in the 2023 activity where net restaurant purchases and sales contributed to goodwill changes, and the company recorded $14.5 million of accumulated goodwill impairment losses. Consequently, any early‑sale of acquired locations can result in a full goodwill write‑off, directly reducing earnings and potentially affecting the consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key elements of the original answer. It correctly identifies McDonald's use of discounted cash flow (Level 3 inputs) for valuing acquired restaurants and accurately describes the goodwill write-off policy: full write-off if sold within 24 months, partial based on relative fair value if sold after. The reasoning and multi-hop synthesis are sound, correctly linking valuation methodology to goodwill treatment and financial implications. The only minor issue is the inclusion of specific quantitative details not present in the ground truth: the mention of $14.5 million in accumulated goodwill impairment losses and reference to 2023 activity. While these may be factually correct based on actual filings, they are not part of the provided ground truth and introduce unsupported specifics. This does not invalidate the answer but slightly reduces quantitative accuracy. The core financial implication—that early sales lead to larger, more immediate write-offs affecting earnings and the balance sheet—is semantically equivalent and well-explained. No entity errors; all terminology (e.g., reporting unit, fair value) is used correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 333,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "The concentration of financing in the 717 and 747‑8 aircraft, combined with the $1.8 billion of customer‑financing defaults tied to pandemic‑driven revenue and cash‑flow declines, amplifies Boeing’s vulnerability by limiting the ability to refinance or remarket those planes and by increasing exposure to defaults if the pandemic’s impact on airline solvency persists. This dual pressure heightens the risk that the company cannot recover cash from its financing portfolio, worsening liquidity stress and potentially forcing additional write‑downs or impairments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.8 billion portfolio default figure is correctly cited, with no other numerical discrepancies. Format is consistent and precise. (2) The entities—Boeing, 717 and 747-8 aircraft, customer financing portfolio, and the link to pandemic-related airline revenue and cash flow declines—are all correctly identified and contextually appropriate. (3) The reasoning is sound and captures the multi-hop logic: concentration risk in specific aircraft types limits remarketing options, which compounds default risk in a stressed market due to the pandemic, leading to liquidity stress and potential impairments. This mirrors the original answer’s causal chain. (4) While the LLM answer omits explicit mention of 'fewer customers' as a source of concentration risk (a minor detail in the ground truth), it effectively conveys the outcome—increased exposure and difficulty in recovery. The synthesis across pandemic impact, aircraft-specific concentration, and financial consequences is logically coherent and semantically equivalent. The answer is concise and directly relevant, with no extraneous or misleading content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 338,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "The launch of Sky Glass in Q4 2021 generated a modest revenue bump for the Corporate and Other segment – $461 million in 2021 versus $248 million in 2020 – driven by sales of the new smart‑TV hardware.  At the same time, the segment absorbed higher operating costs, reporting a $1,819 million expense in 2021 (down from $2,033 million in 2020) that the filing attributes in part to “costs related to Sky Glass and XClass TV” and to the incremental marketing and hardware‑supply expenses associated with the product’s debut.  In short, Sky Glass contributed additional revenue while also adding measurable cost pressures tied to its launch.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific financial figures ($461M revenue in 2021 vs $248M in 2020; $1,819M expenses in 2021 vs $2,033M in 2020) and attributes them to Sky Glass, but these numbers are not present in the original ground truth answer and cannot be verified as correct based on the provided knowledge. The ground truth does not include any quantitative data, only qualitative impacts (increased revenue, higher expenses). Therefore, the inclusion of precise dollar amounts and year-over-year comparisons introduces unverified, potentially hallucinated data. (2) The quantitative accuracy is low because the numbers cited (e.g., $461M revenue, $1,819M expenses) are not supported by the original answer and may be factually incorrect. There is no indication in the ground truth that expenses decreased from $2,033M to $1,819M or that revenue rose from $248M to $461M—these are specific numerical claims absent from the source. (3) The reasoning is partially sound: the LLM correctly identifies that Sky Glass contributed to both revenue and cost increases in the Corporate and Other segment, which aligns with the multi-hop synthesis required (product launch → segment impact → dual revenue/cost effect). However, the addition of unsupported figures undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the question directly—discussing both revenue and cost effects of Sky Glass on CMCSA’s Corporate and Other segment in 2021. Despite the hallucinated numbers, the structure and intent of the response are appropriate. Overall, the answer is partially correct in logic but significantly flawed due to invented quantitative details, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 473,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "As of December 31 2023, the fair value of commercial mortgage‑backed securities held by CVS is $975 million, and this category represents an unrealized loss of $100 million within the total debt‑securities portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the fair value of commercial mortgage-backed securities. The ground truth states $675 million, but the LLM reports $975 million, which is a material overstatement of $300 million. However, the unrealized loss amount of $100 million is correct. The answer omits the key comparative metric that this unrealized loss represents approximately 12% of the total unrealized losses across all debt securities, which totaled $836 million—a critical part of the original answer and the question's second component. (2) Quantitative accuracy is compromised due to the incorrect fair value figure and the missing percentage calculation that contextualizes the unrealized loss within the total debt securities portfolio. While $100 million in unrealized losses is accurate, the failure to include or correctly derive the 12% proportion (100/836 ≈ 12%) results in incomplete quantitative reporting. (3) The reasoning is partially sound in identifying the correct unrealized loss and linking it to the category, but it fails the multi-hop synthesis required to compare this loss to the total debt securities portfolio's unrealized losses. The model does not demonstrate integration of the total portfolio loss figure ($836 million) to compute or report the relative impact. (4) Contextual relevance is high because the answer addresses the two main elements—fair value and unrealized loss—using appropriate financial terminology and correct time reference (December 31, 2023). However, the incorrect fair value and missing comparative analysis reduce factual correctness significantly, warranting a moderate score of 4 out of 10 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 465,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "The growth in third‑party seller unit sales was a primary driver of the 12 % increase in overall net sales in 2023, contributing to higher product revenue and boosting advertising and subscription fees across North America and International segments. However, expanding third‑party seller activity introduces international risk: regulatory and legal constraints in markets such as China and India could restrict how Amazon structures its marketplace, potentially limiting future international expansion and exposing the company to fines, forced restructuring, or other adverse impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that third-party seller unit sales growth contributed to Amazon's 12% overall sales increase in 2023, matching the ground truth in both percentage and year. The role of third-party sellers in driving revenue across North America and International segments is accurately reflected. (2) Quantitatively, the 12% sales growth figure is correct and precisely matches the ground truth; no other numerical discrepancies exist. Format and units are consistent and accurate. (3) The reasoning is sound: the LLM correctly links third-party seller activity to broader sales and revenue streams (product, advertising, subscriptions), demonstrating multi-hop understanding. The international risk is also well-reasoned, citing regulatory constraints in key markets. However, while India is correctly cited in both answers, the LLM adds 'China' as an example not present in the ground truth. Though plausible, this introduces a minor factual deviation, as the knowledge graph specifically highlights India’s foreign ownership rules as the key risk. (4) Despite this small overgeneralization, the answer remains highly accurate, complete, and contextually appropriate, addressing both parts of the question with strong synthesis and correct core facts. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 397,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "The Deferred Compensation Plan has 1,853,363 shares remaining available for future issuance, while the Non-Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares remaining available for future issuance. This results in a difference of 1,712,810 shares (1,853,363 − 140,553).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Deferred Compensation Plan has 1,853,363 shares remaining, and the Non-Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares remaining. (2) The calculation of the difference (1,853,363 − 140,553 = 1,712,810) is correct and matches the ground truth exactly. (3) The multi-hop reasoning is sound—information from two different plans is correctly identified, extracted, and compared. (4) The entities (plan names, share counts, company context for Wells Fargo in 2023) are accurately referenced. The answer is semantically equivalent to the original and provides even more detail by breaking down the individual share counts, enhancing clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 238,
        "total_tokens": 1387
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "Based on the 2022 10‑K filing, PMI’s reduced‑risk product line includes heated‑tobacco units, heat‑not‑burn devices and related accessories, and other nicotine‑containing products such as e‑vapor and oral nicotine products. The filing specifically notes that “Net revenues related to reduced‑risk products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of our heated tobacco units, heat‑not‑burn devices and related accessories, and other nicotine‑containing products, which primarily include our e‑vapor and oral nicotine products.” Heated‑tobacco units (HTUs) such as HEETS, Marlboro HeatSticks, TEREA and other KT&G‑licensed brands are therefore a core component of the reduced‑risk category, contributing a substantial share of the $9.1 billion total reduced‑risk net revenue reported for 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the product categories in PMI's reduced-risk product line: heated tobacco units, heat-not-burn devices and accessories, and other nicotine-containing products like e-vapor and oral nicotine products. It appropriately emphasizes that heated tobacco units are a core component, citing specific examples (HEETS, Marlboro HeatSticks, etc.) and quoting directly from the 10-K to support this classification. The qualitative reasoning and entity identification are excellent, demonstrating proper multi-hop synthesis by linking product types to revenue reporting and strategic classification in the filing. However, there is a minor quantitative inaccuracy: the LLM references $9.1 billion in reduced-risk net revenue for 2021, but the question is about the 2022 10-K filing, and the revenue figure cited pertains to 2021, not 2022. While the 2021 figure may be factually correct in context, the answer would be stronger if it included 2022 data or clarified that the $9.1 billion was from the prior year. This does not invalidate the answer but introduces a slight misalignment in temporal context. Wording and semantic meaning remain equivalent to the ground truth, and all entities (product types, document type, company) are correct. The answer fully addresses both parts of the question: product categories and the role of heated tobacco units.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 396,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "Based on the provided 10-K filing pages, NVDA's revenue from DirectCustomerA was 12% of total revenue for fiscal year 2025 (Jan26,2025), compared to 0% for fiscal year 2024 (as indicated by the asterisk \"*\" meaning less than 10% and no data provided for 2024). The filing states \"No customer represented 10% or more of total revenue for fiscal year 2023,\" confirming DirectCustomerA was not a major customer in 2023 either. Thus, DirectCustomerA's revenue share increased from 0% in 2024 to 12% in 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that DirectCustomerA accounted for 12% of NVDA's revenue in fiscal year 2025, which matches the ground truth. However, it incorrectly states that the 2024 contribution was 0%, interpreting the asterisk (*) as meaning 'less than 10%' and equating it to 0%. The ground truth clarifies that the 2024 value was not disclosed (marked as '*'), and no numerical value—包括0%—can be assumed. This is a significant factual error. (2) The fiscal years are correctly identified (2025 and 2024), and the 12% figure is accurate. But the comparison claim that revenue share increased 'from 0% in 2024 to 12% in 2025' is unsupported by the data and factually incorrect per the original answer. The filing may state no customer was over 10% in 2023, but this does not confirm DirectCustomerA was 0% in 2024. (3) The multi-hop reasoning fails because the model assumes absence of disclosure implies zero contribution, which is not valid. The correct inference is that DirectCustomerA became a named top customer in 2025 after not being reported in 2024, not that it grew from 0%. (4) Scores reflect partial correctness: numbers for 2025 are right, but 2024 interpretation is wrong, leading to incorrect comparison. Contextual relevance is high as the answer addresses the right companies and time periods, but qualitative and quantitative accuracy suffer from the erroneous 0% claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 390,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "Based on the Exhibit listings in the 2023 10-K filing, Wells Fargo disclosed **two distinct versions of the Restricted Share Rights Award Agreement**—one for grants occurring on or after January 24, 2023, and a separate version for grants on or after January 23, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that there are two distinct versions of the Restricted Share Rights Award Agreement for the specified grant dates (January 24, 2023, and January 23, 2024), which matches the ground truth. All dates and the count of two versions are factually accurate, satisfying quantitative accuracy. The answer addresses both parts of the question—grants on or after the two dates—and correctly infers from the 10-K exhibit list that two versions exist. However, the LLM omits the specific filing status details (one 'incorporated by reference' and the other 'filed herewith') that are present in the original answer. While this does not affect the core numerical or entity accuracy, it represents a minor omission in completeness and qualitative depth, particularly regarding the multi-hop synthesis of how each version was included in the filing. Despite this, the semantic meaning and key facts are preserved, and the response is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 283,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "The FAA’s delayed approval to resume 787 deliveries kept Boeing unable to certify and hand over aircraft, which meant the company could not recognize revenue for those jets and had to carry forward a large “reach‑forward” loss.  Because the timing and value of any additional customer concessions were uncertain, Boeing’s cost‑of‑sales and margin forecasts for the 787 program were highly sensitive to the unknown approval date, leading to significant estimation risk and the need for extensive audit scrutiny of the revenue and loss calculations.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core issue: FAA approval delays for the 787 program created revenue recognition problems, led to a reach-forward loss, and introduced significant estimation uncertainty affecting cost of sales and margin forecasting. It accurately describes the mechanism—Boeing could not deliver or recognize revenue, had to carry forward losses, and faced uncertain customer concessions—leading to audit scrutiny. This reflects sound qualitative understanding and multi-hop reasoning linking regulatory delays to financial statement impacts. However, the LLM answer omits the key quantitative detail from the ground truth: the $4,574 million decrease in cost of sales in 2021 compared to 2020, which is a critical piece of evidence showing the financial impact. While the term 'reach-forward loss' is used correctly, the absence of this specific number significantly reduces quantitative accuracy. The years referenced (2022 in question, 2021 in answer) are adjacent but not fully aligned—the ground truth ties the cost of sales impact to 2021, while the question asks about 2022 implications. Still, the answer remains contextually relevant and semantically aligned in logic, even if missing precise numerical and temporal details. Thus, the correctness score is reduced primarily due to missing quantitative data, not flawed reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 376,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "Third‑party sellers drove the bulk of the sales increase in both North America and International markets in 2023, contributing to the 12% and 11% growth in those regions respectively.  Currency movements had a modest impact: foreign‑exchange rates reduced net sales by about $71 million overall, but they positively affected operating loss by $246 million in International and by $220 million in AWS, partially offsetting the currency‑related drag on revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that third-party sellers contributed to the 12% and 11% sales growth in North America and International segments respectively, which aligns with the ground truth. However, it incorrectly states that foreign exchange rates reduced net sales by $71 million overall, when in fact they reduced North America sales by $71 million but increased International sales by $88 million, resulting in a net positive impact of $17 million. The LLM misrepresents this as a net negative of $71 million, which is factually incorrect. Additionally, the LLM introduces irrelevant information about operating loss improvements in International (+$246 million) and AWS (+$220 million), which were not part of the original question or answer and are not supported by the ground truth. (2) Quantitative inaccuracies include the misstatement of the net FX impact: instead of a net positive $17 million ($88M gain - $71M loss), the model claims a $71M overall reduction, which is a major error. The introduction of $246M and $220M figures for operating loss is unsupported and incorrect. (3) The multi-hop reasoning is partially sound in linking third-party seller activity to regional sales growth, but fails in synthesizing the correct net effect of foreign exchange, and introduces extraneous, unverified data points, indicating flawed reasoning. (4) Scores reflect partial correctness on core growth drivers, severe quantitative errors on FX impact, moderate qualitative accuracy due to correct entity and year identification but flawed logic, and high contextual relevance as the response attempts to address the right topics despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 458,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "Wells Fargo’s deficiencies in its anti‑money‑laundering program could trigger regulatory restrictions that limit its ability to acquire other banks—because federal banking regulators evaluate a bank’s AML controls when reviewing any acquisition, and a weak AML framework can lead to enforcement actions or capital‑distribution constraints that impede future M&A activity. Such deficiencies would be assessed by the Federal Reserve Board (FRB), which reviews and approves bank‑holding‑company acquisitions and can impose conditions or prohibitions based on the applicant’s compliance with AML and other safety‑and‑soundness standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It correctly identifies that deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue bank acquisitions due to regulatory scrutiny during the approval process. The Federal Reserve Board (FRB) is accurately named as the regulatory body responsible for assessing these deficiencies—this matches the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model connects Wells Fargo’s AML obligations under the USA PATRIOT Act to regulatory review by the FRB during acquisition proposals, and correctly infers that weak AML controls could result in denial or restrictions. The only minor shortcoming is that the LLM does not explicitly mention the USA PATRIOT Act’s role in mandating AML evaluations or the national security rationale cited in the ground truth, which slightly reduces qualitative accuracy. (4) The answer remains highly contextually relevant, directly addressing both parts of the question—how AML deficiencies constrain acquisitions and which regulator assesses them. Overall, the response is semantically equivalent with only slight omission of legislative context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 394,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "The percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020 was 2.4%. Heated tobacco units fall under the \"Reduced-Risk Products\" category in PMI's financial reporting.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the 2.4% percentage increase in PMI's total international industry cigarette and heated tobacco unit volume from 2020 to 2021, matching the ground truth exactly. It also accurately identifies that heated tobacco units fall under the 'Reduced-Risk Products' category in PMI's financial reporting, with only a minor capitalization difference ('Reduced-Risk Products' vs 'reduced-risk products') that does not affect semantic meaning. (2) The numeric value (2.4%) is correct and precisely matches the ground truth; no calculations were required beyond what was reported, and the percentage is accurate. (3) The reasoning is sound and reflects proper synthesis of multi-hop information: the model correctly combines volume change data with product categorization from PMI's reporting structure. (4) All aspects of the question are addressed completely and accurately, with no omissions or errors. Therefore, full scores are justified across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 289,
        "total_tokens": 1423
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "Based on the provided information, Boeing's potential losses could increase by **$445 million** if every CCC‑rated receivable in the $1.8 billion financing portfolio defaults, calculated as $1.8 billion × 24.2 % default rate.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in reasoning and context but contains a significant quantitative error. The correct calculation is $1.8 billion × 24.2% = $435.6 million, but the LLM reports $445 million, which is inaccurate. This discrepancy affects the core factual correctness of the answer. (2) Number verification: $1.8 billion is correct, 24.2% is correct, but the resulting product is wrong. $1.8 billion × 0.242 = $435.6 million, not $445 million. The error is approximately $9.4 million, which is material in a financial context. (3) Multi-hop reasoning is sound—the model correctly identifies that applying the default rate to the portfolio size yields potential losses, and it references the correct entities (Boeing, CCC-rated receivables, customer financing portfolio). The logic chain is intact. (4) Despite correct entities and structure, the numerical inaccuracy reduces the correctness and quantitative accuracy scores significantly. However, the answer remains contextually relevant and qualitatively reasonable in approach, warranting moderate scores in those areas.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 314,
        "total_tokens": 1460
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "Based on the provided financial statements, DirectCustomerC accounted for 11% of NVIDIA's total revenue in the fiscal year ending January 26, 2025. This represents an increase from the previous fiscal year (January 28, 2024), where DirectCustomerC contributed 11% of revenue as well, but with a note indicating it was \"13%\" in the prior year's direct customer table (though the table explicitly states \"* Less than 10% of total revenue\" for the prior year, creating ambiguity). However, the document clearly states for fiscal year 2025: \"DirectCustomerC | 11% | *\", confirming it was exactly 11% of total revenue. The prior year's data for DirectCustomerC is listed as \"*\" (less than 10%), meaning it did not reach the 10% threshold in fiscal year 2024. Therefore, DirectCustomerC's revenue share remained at 11% year-over-year, but it was the only year in which it crossed the 10% threshold (fiscal 2025), while in fiscal 2024 it was below 10%. \n\n(Note: The document's table for fiscal 2024 lists DirectCustomerC as \"*\", confirming it was not material in that year, so the comparison shows DirectCustomerC moved from below 10% to exactly 11% of revenue.)",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the comparison between fiscal years. While it correctly states that DirectCustomerC accounted for 11% of NVDA's revenue in the fiscal year ending January 26, 2025, it incorrectly claims that in the prior year (ending January 28, 2024), the customer was below 10% (denoted by '*'). The ground truth explicitly states that DirectCustomerC represented 11% in both years. The LLM introduces confusion by referencing a '13%' figure and a 'direct customer table' not mentioned in the original answer, which contradicts the ground truth. (2) The quantitative accuracy is partially correct—11% for FY2025 is accurate, but the characterization of FY2024 as below 10% is wrong. There is no calculation involved, but the comparison is flawed. (3) The reasoning is unsound due to incorrect multi-hop synthesis: the model misinterprets the prior year's data despite the ground truth stating it was unchanged. The mention of ambiguity and conflicting internal document references (e.g., '13%' and '*') appears to be hallucinated or misread, as the original answer gives no such indication. (4) Contextual relevance is high because the answer addresses the right question, company, metric, and time frame, but the core factual claim about year-over-year change is incorrect. The answer suggests a change (from below 10% to 11%), while the truth is no change (11% both years). This significantly undermines correctness despite relevant structure and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 415,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "As of December 31, 2023, the fair value of the Company’s Commercial Mortgage‑Backed Securities (CMBS) was $675 million, and the associated unrealized losses on those securities totaled $100 million. This $100 million of unrealized loss is included in the overall $836 million of unrealized losses reported for all debt securities in an unrealized‑loss position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of CMBS as $675 million and the associated unrealized losses as $100 million, matching the ground truth exactly. These figures are presented with accurate formatting ($675 million, $100 million). (2) Quantitatively, all numbers are correct. The LLM adds contextual detail not in the original answer—specifically that the $100 million unrealized loss is part of a total $836 million in unrealized losses across all debt securities—which is factually consistent and enhances accuracy without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly isolates CMBS holdings and their unrealized losses for CVS Health as of December 31, 2023, and appropriately situates this within the broader portfolio context. While the original answer emphasizes that the $100 million represents ~14.8% of total unrealized losses (which the LLM omits), this percentage is implied by the $100M of $836M figure (100/836 ≈ 11.96%), though the exact percentage differs slightly. This minor discrepancy in implied proportion (due to rounding in the original) does not constitute an error. (4) The LLM answer is highly accurate, complete, and contextually relevant. The only reason for not scoring a 10 is the omission of the explicit '14.8%' characterization, which is a minor qualitative shortcoming in fully mirroring the original insight, though the numerical basis for it is present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 405,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "Based on the disclosed components of MetLife's financial statements, the treatment of changes in estimated fair value of Unit-linked securities differs between net investment income and net derivative gains (losses) as follows:\n\n- Changes in estimated fair value of Unit-linked securities are included in **net investment income** (as stated in Note 13, page 250: \"Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses)\" and Note 13, page 252: \"Amortization of premium/accretion of discount is included within net investment income. Impairments and changes in ACL charged to net income (loss) on certain securities are included in net investment gains (losses), while changes in estimated fair value of Unit-linked and FVO securities are included in net investment income\").\n\n- In contrast, changes in estimated fair value of embedded derivatives (including those related to Unit-linked features) are reported in **net derivative gains (losses)**, not in net investment income. This is explicitly confirmed in Note 13, page 252: \"Lapses associated with net embedded derivatives are included in net derivative gains (losses)\" and Note 13, page 250: \"Changes in estimated fair value are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions\" (referring to embedded derivatives within MRBs, which include Unit-linked features). \n\nThus, Unit-linked securities' fair value changes are treated as part of net investment income, while related embedded derivative components (e.g., guarantees in MRBs) are reported in net derivative gains (losses).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that changes in the estimated fair value of Unit-linked securities are included in net investment income, citing specific language from Note 13, page 252. This matches the original answer's core claim. (2) It accurately contrasts this with the treatment of lapses associated with net embedded derivatives, which are included in net derivative gains (losses), again citing Note 13, page 252. The reference to MRBs (Market Return-Based Contracts) and embedded derivatives related to Unit-linked features adds contextual precision. (3) The multi-hop reasoning is sound: it distinguishes between the accounting for the securities themselves (net investment income) versus the derivative components embedded within them (net derivative gains/losses), which reflects the correct synthesis across accounting concepts. (4) All entities (MetLife, Unit-linked securities, net investment income, net derivative gains/losses, embedded derivatives) are correctly identified and appropriately linked. There are no numerical inaccuracies—though no specific numbers (e.g., dollar amounts) are present, the qualitative financial reporting treatment is described with precise terminology and correct source references. The only minor shortcoming is that the LLM slightly expands on MRBs and U.S. dollar net asset positions, which, while not incorrect, are not essential to the core distinction highlighted in the ground truth. However, this does not detract from factual accuracy. Overall, the answer is semantically equivalent to the original, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 460,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "Boeing recorded a $3.5 billion loss on the 787 program in the fourth quarter of 2021, driven by rework‑related delivery delays and the associated customer considerations. Because the timing of FAA approval to resume deliveries—and therefore the amount of any additional customer compensation—remains uncertain, future revenue estimates for the program carry significant estimation risk; changes to the approval date or to the assumed delivery schedule could lower margins or trigger further reach‑forward losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.5 billion loss in Q4 2021, matching the ground truth exactly. All quantitative elements—dollar amount and time period—are accurate. (2) The explanation of how FAA approval uncertainty affects future revenue estimates is factually sound and aligns with the program accounting methodology described in the original answer. The LLM correctly links the uncertainty in FAA approval timing to risks in customer compensation, delivery schedules, margins, and potential reach-forward losses. (3) The multi-hop reasoning is strong: it connects the financial loss to delivery delays, ties FAA approval to contractual and revenue implications, and correctly references program accounting principles (implied through discussion of revenue estimation and margin impacts). (4) The only minor shortcoming is that the LLM does not explicitly name 'program accounting' as the methodology, though it accurately describes its effects. This omission slightly reduces qualitative accuracy but does not impair factual correctness. Overall, the answer is semantically equivalent and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 322,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "Based on the provided SEC 10-K filing (fiscal year ending January 26, 2025), **NVIDIA did not disclose the specific percentage of revenue derived from \"DirectCustomerA\"** in its financial statements. The document only states that DirectCustomerA accounted for **12% of total revenue** for fiscal year 2025 (and * for fiscal year 2024, indicating less than 10%). \n\nThe question asks for the *percentage of revenue* derived from DirectCustomerA in the fiscal year ending January 26, 2025, and how it compares to the prior fiscal year. The document confirms:\n- DirectCustomerA = **12%** of total revenue for FY2025 (January 26, 2025).\n- For FY2024 (January 28, 2024), DirectCustomerA is listed as \"*\" (less than 10% of total revenue), meaning it did not meet the 10% threshold in the prior year.\n\nThus, DirectCustomerA's revenue contribution **increased from less than 10% in FY2024 to 12% in FY2025**. However, the exact percentage for FY2024 is not provided (only that it was below 10%), so the comparison is that it was *not material* in FY2024 but became a 12% contributor in FY2025. \n\n**Answer**:  \nNVIDIA derived **12% of its revenue from DirectCustomerA** in the fiscal year ending January 26, 2025, compared to **less than 10%** in the prior fiscal year (FY2024), indicating an increase in revenue concentration from that customer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that NVDA derived 12% of revenue from DirectCustomerA in the fiscal year ending January 26, 2025, and notes the prior year (January 28, 2024) is marked with '*', which the model correctly interprets as 'less than 10%' — consistent with SEC disclosure conventions. Although the original answer states the prior year data is 'unavailable', the '*' notation typically means 'below the reporting threshold (usually 10%)', so interpreting it as '<10%' is standard and reasonable. (2) The comparison — that the customer was not a 10%+ customer in FY2024 but became one in FY2025 — is logically sound and adds useful context. (3) The multi-hop reasoning is correct: the model synthesizes data across two fiscal years and interprets disclosure symbols appropriately. (4) The only minor deviation from the original answer is the interpretation of '*' as 'less than 10%' rather than strictly 'unavailable'. However, in SEC filing context, this is not an error but a correct interpretation of disclosure practices. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score. The 9 (instead of 10) reflects a slight difference in framing — the original emphasizes unavailability, while the LLM infers magnitude — but this does not constitute a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 388,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "Based on the provided document pages, the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses, is **$109 million**. This figure represents the net cost recoveries from BeiGene for oncology product candidates during 2023, as disclosed in the collaboration details on page 132, which states: \"During the years ended December 31, 2023, 2022 and 2021, net costs recovered from BeiGene for oncology product candidates were $109 million, $199 million and $220 million, respectively, and were recorded as an offset to R&D expense.\" The document does not provide a separate line item for the fair value of the investment itself in this context, and the $109 million net cost recovery is the specific financial impact tied to the collaboration's cost-sharing mechanism for 2023. The fair value of the investment ($4.2 billion as of December 31, 2022, per page 148) is not directly combined with the $109 million cost recovery in the disclosed financial impact for the collaboration's operational expenses. Thus, the $109 million is the relevant total for the specified components in the question.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its final figure. The question asks for the total financial impact combining four components: fair value of the investment ($4.2B), net cost recoveries ($109M), product sales ($125M), and profit/loss sharing expenses ($40M), which sum to $4.374B as per the ground truth. The LLM incorrectly reports only the $109 million net cost recoveries as the 'total financial impact,' ignoring the other three major components. (2) Quantitatively, the $109 million figure is accurate and correctly cited from page 132, and the $4.2 billion fair value is also correctly referenced from page 148. However, the model fails to perform or even acknowledge the required summation across components. The absence of any mention of $125 million in product sales and $40 million in profit/loss sharing expenses—both critical to the total—is a major omission. (3) The reasoning is flawed in the multi-hop synthesis: while the model correctly identifies that multiple components are involved, it incorrectly concludes that only the $109 million is 'the relevant total,' dismissing the fair value and other collaboration revenues without justification. The statement that 'the document does not provide a separate line item for the fair value of the investment itself in this context' misinterprets the question, which explicitly asks to combine the fair value with collaboration-related cash flows. (4) The contextual relevance is moderate because the answer addresses the collaboration and cites correct document locations, but it fails the core requirement of aggregating all specified financial impacts. The model narrows the scope incorrectly to operational cost recoveries only, despite the question's clear directive to include the investment's fair value and other collaboration revenues.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 496,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "The document explains that estimated lifetime loss rates are applied over different forecast periods for each portfolio segment: commercial and agricultural mortgage loans use a two‑year forecast period, while residential mortgage loans use a two‑year forecast period as well but then revert to historical loss experience on a straight‑line basis over one year. After the applicable forecast period ends, the Company transitions to historical loss experience, applying it over the remaining period before the allowance is fully recognized. This differing duration of forecast‑based loss rates is what determines how long the estimated lifetime loss rates are applied before reverting to historical experience.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both commercial/agricultural and residential mortgage loans use a two-year forecast period for estimated lifetime loss rates, and that residential loans revert to historical loss experience over a one-year period. However, it fails to explicitly state the total duration before full reversion—4 years for commercial/agricultural (2-year forecast + 2-year reversion) and 3 years for residential (2-year forecast + 1-year reversion)—which is the core of the original answer. This omission affects completeness and reasoning. (2) Quantitatively, all mentioned periods (two-year forecast, one-year reversion for residential) are accurate and match the ground truth. There are no calculation errors, but the synthesis of total duration (e.g., 2+2=4 years vs 2+1=3 years) is missing, which is critical to the question about 'duration over which estimated lifetime loss rates are applied before reverting'. (3) The multi-hop reasoning is partially sound—information is drawn correctly from different segments, but the model does not fully synthesize the implication of differing reversion periods on total duration. The original answer makes a direct comparison of total timeframes (4 vs 3 years), which the LLM omits. (4) Scores reflect high factual accuracy and relevance, but deduction in correctness and qualitative accuracy due to missing synthesis of total duration, which is essential to fully answering the 'how does it affect' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 416,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "Costco’s self‑insurance program for employee health‑care benefits is funded through actuarial assumptions that estimate claim costs, but these estimates are highly uncertain and can be driven by unpredictable cost fluctuations and labor‑related risks such as rising health‑care expenses, wage pressures, union activity, and regulatory changes. If actual claims or benefit costs exceed the assumptions, the resulting under‑funding could strain cash flow and earnings, while unexpected labor cost increases could also pressure operating margins and overall financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: Costco uses actuarial assumptions (historical claims, demographics, severity) to estimate self-insurance liabilities, which are subject to uncertainty from healthcare cost fluctuations, regulatory changes, and labor-related risks. The LLM correctly identifies that if actual claims exceed estimates, this could lead to financial strain—specifically on cash flow, earnings, and operating margins—aligning with the original answer’s point about adverse impacts on financial condition and operations. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is 10 as no numbers were misstated. (3) The multi-hop reasoning is sound: the model connects self-insurance funding methodology → uncertainty in actuarial assumptions → exposure to cost volatility and labor risks → potential financial impact. It synthesizes the cause-effect chain correctly, though it adds 'wage pressures' and 'union activity' not explicitly mentioned in the original. These are reasonable inferences within labor-related risks but slightly extend beyond the source content. (4) Contextual relevance is perfect—the response directly addresses how actuarial estimation uncertainty in self-insurance could impact financial condition amid unpredictable costs and labor risks. Only a minor deduction in qualitative accuracy due to slight expansion beyond the original scope; otherwise, the answer is factually complete and well-aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 432,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "The pre-tax charges related to the CAE Settlement and restructuring activities in 2023 totaled $4.2 billion, reflecting the $5.3 billion present‑value contribution under the CAE Settlement net of the $1.1 billion existing accrual. As of December 31, 2023, the reconsolidation of the former deconsolidated Aearo Entities added a $0.7 billion equity‑investment asset and a $0.6 billion net liability for intercompany amounts to 3M’s balance sheet, while eliminating those balances from the prior‑year comparative figures.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that the total pre-tax charges were $4.2 billion, but this only accounts for the CAE Settlement. The ground truth specifies that the total pre-tax charges were $4.637 billion, combining the $4.2 billion CAE charge and $437 million in restructuring charges. The LLM omits the restructuring amount entirely, leading to a major quantitative error. (2) The explanation of the CAE charge as '$5.3 billion present-value contribution net of $1.1 billion existing accrual' ($5.3B - $1.1B = $4.2B) is consistent with possible underlying calculations and aligns with the $4.2B figure in the ground truth, so this part is plausible. However, the total charges are still misrepresented due to missing restructuring costs. (3) Regarding the reconsolidation impact, the LLM incorrectly states that the Aearo Entities 'added' a $0.7 billion equity investment asset and a $0.6 billion liability. The ground truth clarifies these items were 'removed' from the balance sheet upon reconsolidation, not added. This is a critical directional error in reasoning—reconsolidation eliminates separate accounting, so previously reported assets/liabilities are removed from the consolidated statements. The LLM reverses the effect. (4) While the entities (Aearo Entities, CAE Settlement) and year (2023) are correctly identified, and the response attempts multi-hop synthesis, the core financial figures and directional impacts are incorrect. The omission of restructuring charges and misstatement of balance sheet impact severely undermine correctness. Contextually, the answer is relevant and well-structured, hence a moderate contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 466,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "Google's integration of Gemini 2.0 into Vertex AI expands developers’ capabilities on Google Cloud by giving them direct access to the latest multimodal Gemini model for training, fine‑tuning, and deploying AI applications. Through Vertex AI, developers can leverage Gemini 2.0’s advanced text, code, audio, image and video understanding in conjunction with other first‑party and open models, as well as services such as vector search, grounding and distillation, enabling them to build more powerful, cost‑effective AI‑driven solutions across Google Cloud’s infrastructure, platform and cybersecurity offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Gemini 2.0 is integrated into Vertex AI, providing developers access to advanced generative models including multimodal capabilities. The mention of training, fine-tuning, and deploying AI applications matches the original answer's 'train, tune, augment, test, and deploy.' The inclusion of Gemini, Imagen, and Veo is implied through 'other first-party models,' which is reasonable. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes that the integration enhances developer capabilities on Google Cloud Platform by combining Gemini 2.0 with other AI services like vector search and grounding. The added detail about 'cost-effective' and 'cybersecurity offerings' extends slightly beyond the original but does not contradict it and adds contextual plausibility. (4) Semantic equivalence is strong—the core message about expanded developer tools for building sophisticated, multimodal applications is preserved. The only minor deduction is for slight over-elaboration on infrastructure and cybersecurity, which are not mentioned in the ground truth, but these do not impair factual correctness. Hence, a 9/10 on qualitative accuracy and 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 397,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "The inclusion of FVO securities in the fixed‑maturity yield calculation raises the reported investment income by adding the FVO securities’ earnings (e.g., $205 million in 2024) to the portfolio’s total income, while also increasing sensitivity to fair‑value movements because changes in the estimated fair value of those Level 3 FVO securities flow through net investment income (and AOCI) rather than being excluded. Consequently, any volatility in the fair‑value inputs used for those Level 3 securities directly amplifies fluctuations in reported investment income and the related sensitivity to fair‑value changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $205 million investment income contribution from FVO securities in 2024 is correctly stated, matching the original answer exactly. The year 2024 is also correctly identified. (2) The explanation of how FVO securities impact reported investment income and sensitivity to fair value changes is factually sound: FVO securities are included in yield calculations and their fair value changes—driven by Level 3 inputs like nonperformance risk and volatility assumptions—affect net investment income and AOCI, increasing income volatility. (3) The multi-hop reasoning is strong: the model correctly links the use of FVO securities in yield calculations (income impact) with their Level 3 valuation (fair value sensitivity), recognizing the dual role in both performance metrics and financial statement variability. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of 'unobservable inputs' and 'valuation techniques' compared to the original, though the concept is implied through 'volatility in fair-value inputs'. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 344,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "The total pre-tax financial impact of the initial deconsolidation of the Aearo Entities in 2022 and their subsequent reconsolidation in 2023 was $1.2 billion, recorded as a special item in Corporate and Unallocated (reflecting the $1.2 billion pre‑tax charge related to the Aearo bankruptcy and related litigation). These events are directly tied to the Combat Arms Earplugs litigation, as the deconsolidation and reconsolidation pertained to the Aearo entities that were involved in the earplug lawsuits, culminating in the $4.2 billion pre‑tax charge recorded in 2023 for the CAE Settlement of those earplug claims.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.2 billion pre-tax financial impact from the deconsolidation and reconsolidation events, which matches the ground truth. However, it incorrectly states that this $1.2 billion was recorded as a single pre-tax charge related to the Aearo bankruptcy and litigation, and further compounds the error by linking it to a '$4.2 billion pre-tax charge in 2023 for the CAE Settlement', which is factually incorrect and not part of the original answer. The ground truth specifies that the $1.2 billion consists of a $1.0 billion funding commitment plus $0.2 billion for projected case expenses, leading to a pre-tax charge in 2022; the 2023 reconsolidation had immaterial income statement impact. The $4.2 billion figure does not appear in the ground truth and is a significant factual error. (2) Quantitative accuracy is low because while $1.2 billion is correct, the introduction of the unsupported $4.2 billion figure and misattribution of timing and nature of charges severely undermines numerical correctness. (3) The reasoning is partially sound in linking the Aearo Entities' deconsolidation and reconsolidation to the Combat Arms Earplugs (CAE) litigation, which is accurate. However, the model fails the multi-hop synthesis by conflating separate events—specifically, the $1.2 billion charge with a later, much larger $4.2 billion settlement not mentioned in the ground truth—indicating a failure to correctly map financial events to their respective periods and causes. (4) Contextual relevance is high because the answer addresses the right companies, events, and litigation context, but correctness and qualitative accuracy are penalized due to major factual and quantitative errors that distort the financial narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 483,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "The integration of Adobe Firefly into Creative Cloud and Document Cloud directly fuels Adobe’s strategy of expanding its recurring revenue base and customer base by embedding generative AI capabilities into core workflows. Firefly’s AI-powered features—such as Generative Fill, Recolor, and Text-to-Image in Photoshop, and AI-driven tools in Express—enhance product value, driving higher subscription uptake, retention, and expansion among both novice and professional users. This aligns with Adobe’s focus on growing its Digital Media segment’s ARR (which reached $15.17 billion in fiscal 2023, up 14% YoY), while Document Cloud’s AI-enhanced document workflows (e.g., Acrobat’s Liquid Mode and AI-powered automation) attract new users across industries, further solidifying Adobe’s position as a platform for accessible, AI-driven creativity and document productivity.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic role of Adobe Firefly in driving recurring revenue and expanding the customer base through AI integration in Creative Cloud and Document Cloud, aligning with the ground truth. Key product integrations like Photoshop (Generative Fill, Text-to-Image) and Express are accurately mentioned, as well as Document Cloud enhancements like Liquid Mode and AI automation. However, the LLM introduces a specific quantitative claim—Digital Media segment ARR of $15.17 billion in fiscal 2023, up 14% YoY—that is not present in the original answer and cannot be verified from the provided ground truth. Since this number is not in the source, it risks inaccuracy even if it may be factually correct externally; thus, it affects quantitative accuracy. (2) The original answer does not include any financial figures or percentages, so the inclusion of ARR and YoY growth constitutes an unsupported addition. While such data might exist in Adobe’s public filings, the knowledge graph ground truth does not contain it, making this a hallucination or unsupported inference. (3) The multi-hop reasoning is strong: the LLM correctly links Firefly’s AI features to product value, subscription retention, user expansion (including novices), and long-term revenue—synthesizing across Creative Cloud, Document Cloud, and business strategy. It accurately reflects Firefly’s role within Adobe Sensei and broader AI efforts. (4) Despite the unsupported metric, the core qualitative reasoning and contextual relevance are excellent. The answer addresses all parts of the question, uses correct entities (Adobe Firefly, Creative Cloud, Document Cloud, Photoshop, Express, Acrobat), correct time context (fiscal 2023 implied by September 2023 launch), and correct strategic objectives. The score is reduced primarily due to the unverified numerical claim, but the overall answer remains largely accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 528,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31 2022 was $4,335 million, which represented the entire amount of its available‑for‑sale investments at that date. Consequently, this $4,335 million figure is the same as the total fair value of all available‑for‑sale investments reported for 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the total fair value of U.S. Treasury bills and money market mutual funds is correctly stated as $4,335 million, matching the sum of $1,676 million and $2,659 million from the ground truth. (2) The quantitative accuracy is perfect—both the total value and its equivalence to the total available-for-sale investments are correctly reported. Minor formatting differences (e.g., $4,335 million vs $4,335 million) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly infers that the sum of U.S. Treasury bills and money market mutual funds constitutes the entire available-for-sale investment portfolio, as confirmed by the knowledge graph. (4) The answer addresses both parts of the question: the total fair value of the specified securities and how that compares to all available-for-sale investments. Entity accuracy (Amgen, December 31, 2022, financial instruments) is correct. The response is concise, relevant, and fully aligned with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 318,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "The MetLife 2024 10‑K notes that the fair‑value of its unit‑linked securities is modeled using option‑pricing techniques that incorporate long‑term equity volatility and non‑performance risk spreads.  Sensitivity analysis in the Level‑3 tables shows that increases in long‑term equity volatility and decreases in non‑performance risk spreads each produce a measurable increase in the estimated fair value of those instruments.  Consequently, changes in those inputs directly affect the sensitivity of the fair‑value measurements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. It correctly identifies that MetLife uses long-term equity volatility and nonperformance risk spreads as key inputs in the valuation of unit-linked securities, consistent with the 2024 10-K. The LLM accurately notes that these are significant unobservable inputs affecting fair value, and that changes in them directly influence valuation sensitivity—this matches the core reasoning in the ground truth. It adds a specific detail from the Level-3 sensitivity analysis (increases in volatility and decreases in nonperformance risk spreads increase fair value), which is consistent with and enriches the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (MetLife, 2024 10-K, unit-linked securities, nonperformance risk spreads) are correct. The reasoning is sound and reflects proper multi-hop synthesis of how valuation techniques translate into sensitivity. The only minor limitation is that the LLM does not explicitly mention the application of nonperformance risk spreads to discount cash flows for market risk benefits (MRBs), which is a nuanced but important detail in the original. However, this omission does not undermine the overall correctness. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent as it directly addresses the question about valuation techniques and their impact on sensitivity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 408,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "Adobe's introduction of Generative Credits in Firefly directly supports its broader strategy to boost engagement and subscription revenue by embedding AI-powered content creation into Creative Cloud—offering creators and non-creative stakeholders (e.g., marketers, teams using Document Cloud) a tangible, value-driven reason to upgrade subscriptions. This aligns with Adobe’s focus on democratizing creativity through AI, expanding its addressable market beyond traditional creative professionals to include business users who leverage Firefly for tasks like social media content, document workflows, and collaboration, ultimately driving higher retention and recurring revenue through tiered access to generative capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. It correctly identifies the introduction of Generative Credits in Adobe Firefly as part of Creative Cloud and links it to Adobe's strategy of increasing customer engagement and subscription revenue. The answer accurately captures the multi-hop reasoning: (1) AI integration into core products enhances value, (2) tiered access (implied free and paid) supports upsell and expansion, and (3) expansion beyond creative professionals to marketers and business users broadens the customer base. It correctly references non-creative stakeholders and use cases like social media and document workflows, aligning with the ground truth's emphasis on communicators and collaboration. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor gap is that the LLM answer does not explicitly mention 'product-led growth' or 'conversion and retention' as directly as the original, and slightly less emphasis on the 'usage limit' triggering paid credits. However, the core logic and factual synthesis are sound, with excellent contextual relevance and entity accuracy (Adobe, Firefly, Creative Cloud, Document Cloud, generative AI). Thus, correctness is 9 due to slight omission of nuance, but not critical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 373,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "Google Cloud’s revenue growth is driven by AI‑optimized infrastructure and the Vertex AI platform, which give customers scalable compute (including TPUs) and easy access to Gemini and other generative‑AI models for building, deploying, and monetizing AI workloads across its cloud services. This AI‑centric stack enables Google Cloud to sell consumption‑based infrastructure and platform services to enterprises, developers, and cybersecurity customers, directly contributing to the company’s overall revenue from AI‑optimized offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Google Cloud's AI-driven revenue model and correctly identifies the role of Vertex AI and Gemini in enabling scalable, consumption-based services. It accurately reflects that Google Cloud monetizes AI-optimized infrastructure and developer services through usage and subscriptions, which aligns with the ground truth. There are no numeric inaccuracies (quantitative accuracy is perfect), as the answer avoids citing specific numbers that could conflict with the ground truth (e.g., 'billion-user products'). However, it omits a key multi-hop element: the integration of Gemini 2.0 into Google's seven two billion-user products (Android, Chrome, etc.) that drives ecosystem demand and indirectly boosts Google Cloud adoption. This omission reduces completeness and weakens the reasoning chain described in the original answer. While the LLM captures the direct revenue mechanism (AI infrastructure and platform services), it does not fully explain how consumer-side integration fuels enterprise demand—a core part of the causal logic. Thus, qualitative accuracy is reduced due to incomplete synthesis across the ecosystem and cloud business, though the content provided is relevant and correct. Contextual relevance remains high because the answer directly addresses the question's focus on revenue generation from AI infrastructure and developer services.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 389,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "Changes in prepayment and default rates affect the amortization of premium and accretion of discount on MetLife’s structured fixed‑maturity securities, thereby influencing the timing and amount of income recognized on those assets. Additionally, the valuation of FVO securities and other Level 3 investments incorporates unobservable inputs such as mortality, lapse, utilization, withdrawal, equity‑volatility and non‑performance risk spreads, which also materially affect fair‑value measurements and income recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that changes in prepayment and default rates impact income recognition on FVO securities—specifically through their effect on the amortization of premium and accretion of discount on structured fixed-maturity securities, which is a more detailed but factually consistent explanation than the original. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or figures; however, all referenced concepts are consistent and no incorrect data is introduced, warranting a full score. (3) The unobservable inputs listed in the LLM answer (equity volatility, non-performance risk spreads) match those in the ground truth. Additionally, the LLM includes other relevant unobservable inputs (mortality, lapse, utilization, withdrawal) that are not in the original answer but are contextually accurate for MetLife’s Level 3 valuations and consistent with SEC filings—this adds detail without introducing error. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects prepayment/default rates to income recognition mechanics and links unobservable inputs to fair value determination for FVO securities. The only minor deviation is the broader list of unobservables, which exceeds the original but is not incorrect—hence a 9 on qualitative accuracy. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 419,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "Costco's investment in Kirkland Signature products enhances gross margin performance by offering higher-margin private-label items that drive member loyalty through consistent quality and value, reinforcing the company's core business model. However, this strategy carries risks, including potential brand reputational damage and supply chain disruptions that could negatively impact sales and margins if product quality or availability falters.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Kirkland Signature products enhance gross margins due to higher-margin private-label items and their role in driving member loyalty through value and quality. It also accurately highlights the risks related to supply chain disruptions and reputational damage if quality or availability falters. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between private-label strategy, margin performance, member loyalty, and operational risks. The only minor omission is that the original answer explicitly mentions Kirkland's growing sales mix as a factor in margin performance, which strengthens the argument; the LLM answer implies this through 'driving member loyalty' but doesn't explicitly state the increasing sales contribution. (4) Despite this slight gap in completeness, the core facts, entities (Costco, Kirkland Signature), and causal logic are correct, and the response is fully relevant to the question. Thus, correctness is scored 9/10, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 358,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "The fair value of \"Other short-term interest-bearing securities\" was not disclosed in the provided pages, so its change from December 31 2022 to December 31 2023 cannot be determined. Consequently, the impact on the total available‑for‑sale investments for those years cannot be quantified from the given information.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect. The ground truth states that the fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023, and that total available-for-sale investments rose from $4,335 million to $10,404 million, a $6,069 million increase. The LLM falsely claims this information was not disclosed, which contradicts the provided ground truth. (2) No numeric values from the ground truth are present in the LLM response; all key figures ($0, $138 million, $4,335 million, $10,404 million, $6,069 million) are missing or denied. Calculations in the original answer are accurate and directly supported by the data, but the LLM fails to report any of them. (3) The question requires multi-hop reasoning: identifying the change in a specific investment category and linking it to the overall change in available-for-sale investments. The LLM did not perform this synthesis, instead asserting insufficient data, which reflects a failure in both retrieval and reasoning. (4) The correctness score is 1 due to complete factual inaccuracy despite clear ground truth. Quantitative and qualitative accuracy are both 1 because no correct numbers or reasoning are presented. Contextual relevance is 3 because the LLM at least addresses the right topic (fair value changes in securities and impact on total investments), though it denies the availability of data rather than answering.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 408,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "The Proposed Plan’s unresolved allocation of the CAD 32.5 billion settlement—exacerbated by RBH’s January 24, 2025 objection—signaled that PMI’s investment in RBH could be impaired. Accordingly, PMI performed a quantitative valuation of its RBH equity interest as of December 31, 2024 and recorded a non‑cash impairment charge of **$2,316 million** in the consolidated statement of earnings for 2024. This impairment reduced the carrying amount of the investment to an estimated fair value of **$714 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: RBH's objection on January 24, 2025, the CAD 32.5 billion settlement, the triggering of an impairment indicator, the quantitative valuation as of December 31, 2024, and the resulting non-cash impairment charge of $2,316 million. The fair value of PMI’s investment in RBH is correctly stated as $714 million. (2) Quantitative accuracy is perfect: both the impairment charge and the resulting fair value match the ground truth exactly, with acceptable formatting ($2,316 million). The carrying value can be inferred as $3,030 million ($714M + $2,316M), which aligns with the original answer’s implication. (3) Multi-hop reasoning is sound: the answer correctly links RBH’s objection to increased uncertainty resolution, which triggered an impairment review, leading to a DCF-based valuation and ultimately the impairment charge. Though the LLM omits specific details about the DCF assumptions (e.g., discount rate, tax deductibility), it captures the essential causal chain and outcome required by the question. (4) Contextual relevance is high—the response directly addresses both parts of the question: the influence of the Proposed Plan developments on the valuation and the resulting impairment charge. Minor omission of methodological details does not detract from factual correctness or completeness at the required level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 399,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "The filing indicates that TAC paid to Google Network partners is expected to increase as advertising revenues grow, with the TAC rate remaining constant at 22%. If advertising revenues from Google Network properties grew by $10 billion in 2023 versus 2022, the absolute dollar increase in TAC would be 22% of that growth, or $2.2 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative calculation is accurate: 22% of $10 billion is $2.2 billion, and the answer correctly reports this figure using consistent formatting ($2.2 billion). (2) The answer addresses all parts of the question: it acknowledges the constant TAC rate of 22%, the $10 billion revenue increase, and computes the resulting increase in TAC. (3) The reasoning is sound and reflects the multi-hop logic required: it correctly infers that if the TAC rate remains constant, the increase in TAC is simply the percentage of the revenue growth, which is a valid linear relationship as implied by the filing. (4) All entities—Google Network properties, TAC (Traffic Acquisition Costs), and the relevant financial relationship—are accurately referenced and synthesized. The answer is semantically equivalent to the ground truth, with clear, concise, and precise explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 270,
        "total_tokens": 1429
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "Based on the provided pages, the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, is an increase of $14,155 million (from $61,449 million to $75,604 million), while the change in fair value over the same period is an increase of $10,714 million (from $59,851 million to $70,565 million). The carrying value change ($14,155 million) is greater than the fair value change ($10,714 million), indicating that the increase in carrying value exceeded the increase in fair value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: the carrying value increased from $61,449 million to $75,604 million, a difference of $14,155 million, and the fair value increased from $59,851 million to $70,565 million, a difference of $10,714 million. These values match the original answer exactly. (2) All calculations are accurate: $75,604M - $61,449M = $14,155M and $70,565M - $59,851M = $10,714M. The comparison between the two changes is correctly stated — the carrying value increased more than the fair value. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two time points and two valuation methods (carrying value vs. fair value), then compares their changes over time. (4) The answer is semantically equivalent to the ground truth, with no omissions or distortions. Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 283,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com drove a $573 million increase in merchant transaction costs in 2022, which contributed to the overall rise in sales and other expenses. This growth in merchant‑related costs was reflected in a larger increase in total merchant revenues (up 94.6% YoY) compared with agency revenues, underscoring how the merchant expansion outpaced agency growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $573 million increase in merchant transaction costs due to the expansion of merchant accommodation reservation services at Booking.com in 2022, matching the ground truth exactly. This satisfies the quantitative requirement with accurate dollar amount and context. (2) The LLM adds a specific percentage (94.6% YoY growth in merchant revenues) not present in the original answer. While this figure may be factually accurate based on external data, it was not included in the ground truth, representing an addition rather than a contradiction. However, it does not distort the meaning and supports the same conclusion. (3) The reasoning is sound: the model correctly links increased transaction costs to higher merchant revenue growth versus agency revenues, demonstrating proper multi-hop synthesis between cost increases and revenue model performance. The conclusion that merchant expansion outpaced agency growth aligns with the ground truth’s assertion of stronger merchant revenue growth. (4) The answer is contextually complete and relevant, addressing both parts of the question—contribution to cost increase and relation to revenue growth. The only minor deviation is the inclusion of an unsourced percentage, which enhances but slightly extends beyond the provided truth. Thus, the answer is highly accurate with excellent quantitative fidelity and strong qualitative reasoning, warranting a 9/10 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 408,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs strengthens its Adaptive SoC portfolio by adding integrated high-performance RF data converters, directly addressing the growing demand for advanced RF data conversion in wireless, radar, and cable infrastructure markets. This move aligns with AMD's broader strategy to expand its presence in high-performance RF applications, leveraging its heterogeneous compute architecture to serve data center, industrial, and defense sectors where real-time signal processing and adaptable hardware are critical.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the introduction of Zynq UltraScale+ RFSoCs enhances AMD's Adaptive SoC portfolio, targets markets like wireless, radar, and cable infrastructure, and aligns with AMD's strategy to serve high-performance RF applications. The integration of RF data converters and focus on real-time processing and adaptable hardware are correctly emphasized. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links product introduction (RFSoCs) to technical capabilities (integrated RF data converters), target markets, and strategic alignment with AMD's broader goals in heterogeneous computing and domain-specific platforms. The only minor omission is that the LLM does not explicitly mention 'faster time-to-market' or 'sensor fusion and analytics'—phrases present in the ground truth that add slight contextual depth—but the essence of enabling rapid development and embedded real-time control is implied. (4) The answer is fully contextually relevant, directly addressing both the significance of the product launch and its alignment with AMD's strategy. Wording differs slightly but maintains semantic equivalence. No factual errors or entity inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 396,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity was $512 million as of December 31 2024 and $603 million as of December 31 2023, for a combined total of $1,115 million. The corresponding total fair values were $508 million for 2024 and $596 million for 2023, resulting in a combined fair‑value total of $1,104 million. Thus, the combined carrying value exceeds the combined fair value by $11 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $603 million (2023 carrying value), $512 million (2024 carrying value), $596 million (2023 fair value), and $508 million (2024 fair value) are correctly reported. The combined totals—$1,115 million for carrying value ($603M + $512M) and $1,104 million for fair value ($596M + $508M)—are correctly calculated. The $11 million difference (unrealized loss) is accurately derived. (2) The answer addresses both parts of the question: total carrying value for 2023 and 2024 combined, and comparison to total fair value. (3) Entities—UnitedHealth Group, debt securities - held-to-maturity, years 2023 and 2024—are correctly identified. (4) The multi-hop reasoning is sound: the model correctly aggregates data across two years and two financial metrics (carrying value and fair value), then synthesizes the comparison. Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 302,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com drove a **108.4% year-over-year increase in merchant gross bookings** in 2022, which directly contributed to a **94.6% increase in merchant revenues** and a **significant rise in sales and other expenses** (up 102.7% to $1,986 million). This growth in merchant-related costs, including transaction fees and third-party services, was explicitly tied to the expansion of merchant accommodation services, as noted in the document stating that \"merchant gross bookings increased more than agency gross bookings due to the expansion of merchant accommodation reservation services at Booking.com.\" Consequently, the increased sales and other expenses in 2022 were partially fueled by the higher transaction costs associated with this merchant growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific percentages (108.4% increase in merchant gross bookings, 94.6% increase in merchant revenues, 102.7% increase in expenses to $1,986 million) that are not present in the original answer and cannot be verified from the provided ground truth. The ground truth states only that the expansion contributed to a $573 million increase in merchant transaction costs, a key component of sales and other expenses, but does not provide overall percentage increases or total expense figures. These fabricated numbers severely undermine factual accuracy. (2) The quantitative inaccuracies are significant: the $573 million figure is entirely omitted and replaced with a $1,986 million expense total not mentioned in the original, and the percentages provided (108.4%, 94.6%, 102.7%) have no support in the ground truth. Even if formatting flexibility is allowed, the values themselves are incorrect or hallucinated. (3) The reasoning partially captures the multi-hop relationship: the model correctly infers that expansion in merchant services led to higher costs and that this is tied to greater growth in merchant gross bookings versus agency. It correctly identifies the causal chain from service expansion to increased bookings to higher expenses. However, it overreaches by quantifying overall sales and other expenses and their growth rates, which the original does not support. (4) The contextual relevance is moderate because the answer addresses the core theme—linking merchant service expansion to cost increases and booking growth—but fails on factual correctness due to unsupported numerical claims. The qualitative accuracy is low because while the logical structure is somewhat sound, it builds on incorrect data. The correctness score is low due to major quantitative errors and hallucination of key metrics not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 511,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "PayPal reports a crypto‑asset safeguarding asset of $1,241 million and a corresponding liability of $1,241 million as of December 31 2023 (the same amounts are shown on page 92). This reflects the company’s practice of holding crypto assets on behalf of users and recording both an asset (the safeguarded crypto) and a liability (the obligation to safeguard those assets), which it previously disclosed in Note 7 and later indicated it will discontinue recognizing upon adoption of SAB 122.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the crypto asset safeguarding asset and liability as $1,241 million each as of December 31, 2023, matching the ground truth exactly in both amount and date. Number formatting ($1,241 million) is acceptable and semantically equivalent. (2) All quantitative elements are accurate—no calculation errors or misstatements. (3) The reasoning is sound: the model correctly interprets that PayPal holds crypto assets on behalf of customers and records a corresponding liability, reflecting its involvement in crypto-related services. It adds contextual detail about disclosure in Note 7 and future discontinuation under SAB 122, which is factually consistent with filings and enhances accuracy without contradicting the ground truth. (4) The only reason for not scoring a 10 is the inclusion of forward-looking information about discontinuation under SAB 122, which, while accurate, slightly extends beyond the scope of the question’s focus on the 2023 position and its reflection of current involvement. However, this does not detract from correctness. All entities (PayPal, crypto asset safeguarding asset/liability, year 2023) are correctly identified. The answer fully addresses both parts of the question: the total value (implied sum is $2,482 million but correctly presented as two equal $1,241M components) and the implication for crypto involvement. Semantic equivalence is maintained with enhanced context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 403,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "The 2023 and 2024 aircraft impairment charges ($70 million and $157 million) reflect FedEx’s Network 2.0 strategy by documenting the non‑cash write‑downs tied to retiring older aircraft (MD‑11Fs, 757‑200s, A300s) to modernize its fleet and align capacity with the optimized, end‑to‑end network. Cumulatively, these impairment charges, together with the $582 million of 2024 business‑optimization costs and $273 million of 2023 optimization costs, represent the primary financial impact of the DRIVE transformation program through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the cumulative financial impact calculation. While it correctly identifies the 2023 and 2024 aircraft impairment charges ($70 million and $157 million), it introduces a $273 million '2023 optimization cost' that is not present in the ground truth. The original answer states only $582 million in business optimization costs in 2024, with no mention of 2023 optimization costs. This leads to an incorrect cumulative total. The ground truth reports total cumulative costs through 2024 as $839 million, which is the sum of $70M + $157M + $582M = $809M (note: $839M in original answer appears to be a minor error in the ground truth itself, but the LLM compounds this by adding unsupported $273M). (2) Quantitative accuracy is low because the LLM fabricates a $273 million cost not present in the source, severely undermining the financial analysis. The aircraft impairment figures are correct, but the additional number is not. (3) The reasoning is partially sound in linking impairment charges to fleet modernization and Network 2.0, and correctly identifying retired aircraft models. However, the multi-hop synthesis fails by introducing an unsupported cost figure, breaking the logical chain. The DRIVE program cost aggregation is therefore incorrect. (4) Contextual relevance is high—the answer addresses both parts of the question, discusses the strategic rationale, and attempts to quantify the financial impact. However, due to the critical error in financial data, the correctness score is low despite relevant structure and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 445,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "Based on the provided document pages, the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is **$4,327 million** (as reported in the fair value hierarchy table on page 55 and confirmed in the amortized cost/fair value table on page 52). The gross unrealized losses on these obligations increased from **$234 million** as of December 31, 2023, to **$274 million** as of December 31, 2024, representing an increase of **$40 million**. This is detailed in the \"Gross Unrealized Losses\" column of the debt securities table on page 52, which shows $234 million for 2023 and $274 million for 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the total fair value of U.S. government and agency obligations. The LLM reports $4,327 million, while the ground truth is $3,627 million. This discrepancy of $700 million is significant and incorrect. However, the LLM correctly identifies the gross unrealized losses increasing from $234 million in 2023 to $274 million in 2024, and correctly calculates the $40 million increase. (2) Quantitative accuracy is compromised due to the incorrect fair value figure, despite correct loss figures and correct calculation of the $40 million difference. The error in the primary number undermines the overall correctness. (3) The reasoning appears multi-hop and logical—citing specific tables and pages to support both the fair value and unrealized losses—but the synthesis is based on an incorrect source value for fair value, suggesting either a misreading of the document or a data extraction error. The structure and method of justification are sound, but the factual foundation for the first part is flawed. (4) Contextual relevance is high, as the LLM directly addresses both parts of the question, references appropriate tables, and provides accurate explanations for the unrealized losses. However, the major numerical error in the fair value figure reduces correctness and quantitative accuracy significantly, warranting a mid-low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 389,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "In 2023, Booking.com’s merchant‑basis transactions rose to 54% of gross bookings (up from 44% in 2022), which drove higher merchant‑related expenses—such as payment‑processing, personnel, and chargebacks—thereby pressuring operating margins despite generating incremental revenue. The increased merchant mix contributed to higher marketing spend (up 13% YoY to $6.8 bn) and amplified costs tied to alternative accommodations, ultimately dampening margin expansion relative to 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 and correctly links this shift to higher merchant-related expenses and margin pressure. However, it introduces a specific marketing spend figure—'up 13% YoY to $6.8 bn'—that is not present in the original answer and cannot be verified from the provided ground truth. This number may be factually incorrect or taken from an external source not in the knowledge graph, which undermines quantitative accuracy. Additionally, the original answer does not mention marketing spend or alternative accommodations as key cost components, so these are likely incorrect additions. (2) The percentages (44% to 54%) are accurate, but the $6.8 billion marketing figure and 13% YoY increase are unverified and not supported by the ground truth. No calculation errors are made with the provided numbers, but the introduction of unsupported figures reduces quantitative reliability. (3) The reasoning correctly follows the causal chain: higher merchant mix → higher costs → margin pressure. However, the key cost components cited in the ground truth—personnel expenses, payment processing fees, and chargebacks (recorded in 'Personnel' and 'Sales and other expenses')—are only partially reflected. The LLM mentions payment-processing and personnel but adds unverified elements like marketing and alternative accommodations. The multi-hop synthesis is partially sound but includes speculative or incorrect cost drivers. (4) The answer is contextually relevant and addresses the core question about margin impact and cost components, but it substitutes and adds unsupported details, reducing factual correctness. The omission of fraud-related chargebacks and misattribution of cost categories lowers the qualitative and quantitative accuracy. Correctness score is 6 due to partially correct facts with significant additions not grounded in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 527,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "The reclassification of eligible consumer installment receivables to “Loans and interest receivable, held for sale” and the shift to fair‑value measurement (now classified as Level 2) required the company to record these assets at their estimated fair value rather than at amortized cost. Consequently, any changes in fair value are recognized in “restructuring and other” expense, affecting income‑statement earnings, while the assets are presented on the balance sheet at the lower‑of‑cost-or‑fair‑value amount, leading to a more volatile asset valuation and a different pattern of income recognition compared with prior periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the reclassification of consumer installment receivables to 'Loans and interest receivable, held for sale' and the shift to fair value measurement using Level 2 of the fair value hierarchy, which aligns with the ground truth. It accurately notes that changes in fair value are recognized in 'restructuring and other' on the income statement, impacting income recognition, and that asset valuation becomes more volatile due to fair value presentation—this addresses the core of the question regarding asset valuation and income recognition impacts in 2024. However, the LLM omits two key factual elements from the original answer: (1) the reversal of the previously recorded allowance for credit losses, which decreased transaction and credit losses in 2023 (a direct financial statement impact related to the reclassification), and (2) the specific change in valuation methodology from an unobservable price-based model to one using observable inputs like executed prices from comparable loans sold to a global investment firm. These omissions reduce completeness and weaken the qualitative accuracy, particularly in explaining the full scope of the accounting change. While the LLM correctly infers that fair value changes affect earnings via 'restructuring and other,' it does not explicitly state that this treatment began in Q1 2024, though the context implies 2024 timing. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question. The reasoning is sound but incomplete in synthesizing all multi-hop elements (e.g., linking the methodological shift to improved transparency and the allowance reversal).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 464,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "As of December 31 2024, PMI’s total combined borrowing capacity from the newly‑established €1.5 billion (≈ $1.6 billion) revolving credit facility and its existing short‑term credit arrangements was approximately **$3.7 billion** (the €1.5 billion facility plus the $2.1 billion of uncommitted short‑term lines).  \n\nBy contrast, the borrowing capacity available under short‑term credit arrangements alone was about **$2.7 billion** at December 31 2023. Thus, the combined capacity in 2024 is roughly **$1 billion higher** than the short‑term capacity that existed a year earlier.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the €1.5 billion credit facility and converts it to approximately $1.6 billion, and correctly states the existing short-term credit arrangements as $2.1 billion in 2024, leading to a total combined capacity of $3.7 billion — this matches the ground truth. However, the comparison to the prior year is incorrect: the LLM states that the 2024 combined capacity is '$1 billion higher' than the 2023 short-term capacity of $2.7 billion, which is factually wrong. In reality, $3.7 billion is $1 billion *more*, but the ground truth explicitly states this represents a *decrease* compared to 2023, which contradicts the LLM's conclusion. This indicates a critical error in reasoning or data sourcing. (2) Numeric values are accurate: €1.5B ≈ $1.6B, $1.6B + $2.1B = $3.7B, and 2023 short-term capacity is correctly cited as $2.7B. However, the directional comparison (increase vs decrease) is incorrect, undermining the quantitative accuracy despite correct arithmetic. (3) The multi-hop reasoning fails in synthesis: the model correctly pulls data from two time points and two credit sources but draws the opposite conclusion from the ground truth regarding the year-over-year change. This suggests either a misinterpretation of the data or an error in the source knowledge. (4) Contextual relevance is high — the answer addresses both parts of the question, uses appropriate financial terminology, and structures the response clearly. However, the incorrect comparative conclusion significantly reduces factual correctness, warranting a score of 6 — partially correct with major errors in interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 449,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "Based on the provided financial data, NVIDIA's Compute & Networking segment contributed $47,405 million in revenue for fiscal year 2024. This is explicitly stated in the \"Revenue by Reportable Segments\" table on page 39, where Compute & Networking revenue is reported as $47,405 million for the year ended January 28, 2024. The document also confirms that one direct customer (Customer A) accounted for 13% of total revenue and one indirect customer accounted for 19% of total revenue, both attributable to this segment, with total company revenue being $27 billion (though this appears inconsistent with the reported $60,922 million total revenue in the same table). The $47,405 million figure represents the segment's revenue contribution.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that NVIDIA's Compute & Networking segment contributed $8.64 billion in fiscal year 2024. However, the LLM claims it contributed $47,405 million ($47.405 billion), which is vastly higher than both the ground truth and even the total company revenue of $27 billion stated in the question. This makes the core numeric claim impossible. (2) The LLM references a 'Revenue by Reportable Segments' table on page 39 with $47,405 million for Compute & Networking and total revenue of $60,922 million, but this contradicts the question's premise that total company revenue was $27 billion. The model fails to reconcile this discrepancy and instead highlights it without resolving it, suggesting it is relying on external data not aligned with the question's assumptions. The correct answer must be derived from the given data: 13% + 19% = 32% of $27 billion = $8.64 billion. (3) The multi-hop reasoning is flawed. The question implies that the direct and indirect customer percentages (13% and 19%) are tied to the Compute & Networking segment and that their combined contribution can be used to infer the segment's total revenue. The correct logic is that these two customers together account for 32% of total revenue, and if they are both attributed to Compute & Networking, then that segment’s revenue is at least $8.64 billion—matching the ground truth. The LLM instead pulls an unsupported number from a misaligned data source. (4) The model fails on quantitative accuracy due to grossly incorrect numbers, on qualitative accuracy due to flawed reasoning and source misuse, and on contextual relevance because it introduces conflicting data rather than solving within the question's framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 480,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "AIG's Internal Capital Framework quantifies aggregate economic risk at a given confidence level, incorporating diversification benefits across risk factors and business lines, and directly informs the capital resources needed to maintain consolidated target capitalization levels. This framework is integrated with the stress testing framework, which assesses exposure to significant financial and insurance risks, enabling AIG to evaluate and support the capital resources required at the Parent level to sustain its consolidated target capitalization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: AIG's Internal Capital Framework quantifies aggregate economic risk at a given confidence level, incorporates diversification benefits across risk factors and business lines, and informs capital resource assessments for maintaining consolidated target capitalization levels. The integration with the stress testing framework to evaluate exposure to significant financial and insurance risks is correctly described. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how the Internal Capital Framework and stress testing jointly support capital assessment and allocation, linking Parent-level capital needs to subsidiary support and overall financial resilience. The only minor omission is the explicit mention of 'guiding capital allocation decisions' and 'ensuring financial resilience' from the original, which are implied but not stated. (4) Contextual relevance is perfect—the response directly addresses all parts of the question, including the relationship between the Internal Capital Framework, diversification benefits, stress testing, and capital resource assessment. Thus, the correctness score is 9 due to slight compression of nuance, but all key facts and logic are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 407,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "Target’s owned and exclusive brands account for roughly one‑third of merchandise sales and generally carry higher margins, but they also require longer lead times, more complex forecasting, and greater exposure to supply‑chain disruptions. If a disruption prevents Target from accurately predicting demand or sourcing these products, it can lead to excess or insufficient inventory, forcing costly markdowns or stockouts. Such inventory imbalances erode margins and can diminish profitability, especially when higher‑margin owned‑brand items are affected. Consequently, effective inventory management is critical to preserving the financial performance associated with these brands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the statement that Target's owned brands represent approximately one-third of merchandise sales is correctly reflected. No specific numbers beyond this percentage are provided in either answer, so no calculation errors exist. (2) The LLM captures the higher margins of owned brands, longer lead times, risks of supply chain disruptions, inaccurate demand forecasting, and consequences such as inventory imbalances, markdowns, and stockouts—all of which are in the original. (3) The multi-hop reasoning is sound: it connects owned brands' higher margins to greater financial impact from inventory issues, links longer lead times to supply chain vulnerability, and ties poor inventory management to profitability erosion. (4) The only minor omission is that the LLM does not mention 'inventory shrink' specifically—a key term in the original that has been historically elevated and directly impacts financial performance. Additionally, the original highlights the November–December holiday period as a critical time when these risks are magnified; this contextual nuance is missing in the LLM response. Despite these small gaps, the core financial logic, entities (Target, owned brands), and causal链条 are accurately represented. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 414,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "The 3.50% Notes Due 2050 have a carrying value of $2,000 million and the 3.50% Notes Due 2040 have a carrying value of $1,000 million, giving a difference of $1,000 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and calculation. The ground truth states the difference is $397 million, but the LLM claims a difference of $1,000 million based on carrying values of $2,000 million and $1,000 million for the 2050 and 2040 notes respectively. These values are not aligned with the ground truth data. (2) The quantitative accuracy is very low: the individual carrying values are wrong, and the resulting difference of $1,000 million is incorrect. Even allowing for format variations, the numbers do not match the actual data. (3) While the LLM demonstrates correct multi-hop reasoning structure—identifying two notes, retrieving their carrying values, and computing the difference—the underlying data synthesis is flawed. It fails to retrieve the correct values from the knowledge graph, indicating a failure in entity-metric alignment despite correct temporal and instrument identification. (4) Contextual relevance is high because the model addresses the exact question structure, references the correct company (NVDA), notes (3.50% Due 2050 and 2040), and performs the right type of calculation. However, the severe factual inaccuracies in numbers and resulting difference lead to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1036,
        "completion_tokens": 356,
        "total_tokens": 1392
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "Based on the UnitedHealth Group 2024 10-K filing (pages 70–76), the total shares available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, are 16 million shares under the ESPP and 48 million shares under the 2020 Stock Incentive Plan, totaling 64 million shares. The 2020 Stock Incentive Plan permits the issuance of various award types, including stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 48 million shares under the 2020 Stock Incentive Plan and 16 million under the ESPP, totaling 64 million shares as of December 31, 2024—this matches the original answer exactly. The calculation (48M + 16M = 64M) is correct. (2) The answer is complete, addressing both parts of the question: total shares available and the types of awards under the 2020 Stock Incentive Plan. (3) Entity accuracy is perfect: UnitedHealth Group, 2020 Stock Incentive Plan, ESPP, and the correct fiscal date (December 31, 2024) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—combining data from two different plans and summarizing award types from the same plan. (5) The semantic meaning is equivalent to the ground truth, with only minor rephrasing (e.g., 'permits the issuance of' vs. 'may take the form of'). All award types listed—stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards—are identical to the original. No factual, numerical, or contextual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 339,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "AIG’s use of the Bornhuetter Ferguson method—combining premiums with paid‑loss development factors—helps stabilize reserve estimates for its long‑tail U.S. Workers’ Compensation line, where loss emergence is highly volatile and reported losses emerge slowly over many years. By weighting the expected loss‑ratio estimate (derived from historical loss‑cost trends and tail factors) against observed paid‑loss development, the method mitigates the uncertainty inherent in long‑tail development patterns and provides a more reliable “best‑estimate” reserve that can be adjusted as new data arrive.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core reasoning behind AIG's use of the Bornhuetter Ferguson (BF) method in the context of U.S. Workers' Compensation, a long-tail line with volatile and slow loss emergence. It correctly identifies that the BF method combines an expected loss ratio (based on historical trends and tail factors) with observed paid-loss development to produce a more stable reserve estimate, which is crucial when early loss data lacks credibility. This aligns with the ground truth's emphasis on avoiding overreaction to anomalous early losses. The answer also appropriately highlights the method’s ability to provide a 'best-estimate' that can be updated as data emerges, reflecting the iterative nature of the BF approach. However, the LLM answer omits a key point from the original: the specific challenge posed by the increasing proportion of large deductible business slowing reporting patterns, which further undermines the reliability of early loss data. While the general idea of slow emergence is mentioned, this specific driver is missing, representing a minor but notable gap in completeness. There are no numerical values in either answer, so quantitative accuracy is not applicable but assumed correct (scored 10 by default). The entities (AIG, Bornhuetter Ferguson, U.S. Workers' Compensation, long-tail, expected loss ratio) are all accurate. The reasoning is sound and reflects proper multi-hop synthesis between the nature of long-tail liabilities and the statistical rationale for using BF. Contextual relevance is excellent—the response directly addresses the question’s focus on methodological mitigation of volatility in loss emergence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 459,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "Based on the exhibits listed in the 2024 Form 10-K (specifically pages 73–76), the Credit Card Program Agreement with TDBank USA, N.A. has been amended **three times** since its initial execution on October 22, 2012. The amendments are documented as:  \n- First Amendment (February 24, 2015),  \n- Second Amendment (November 19, 2019),  \n- Third Amendment (November 1, 2022).  \n\nThis indicates a progressive evolution of the financial partnership, reflecting Target’s ongoing need to adjust terms—such as credit limits, fees, or operational parameters—to align with changing business demands, market conditions, or regulatory requirements, ensuring the program remains strategically aligned with Target’s retail and financial objectives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that there have been three amendments to the Credit Card Program Agreement, citing amendments in 2015, 2019, and 2022. However, the ground truth indicates only two amendments, in 2015 and 2019. The inclusion of a third amendment in 2022 is factually incorrect based on the provided knowledge graph. This error directly impacts the quantitative accuracy. (2) The dates of the first two amendments (February 24, 2015, and November 19, 2019) align with the ground truth, but the addition of a November 1, 2022 amendment is unsupported. The initial agreement date (October 22, 2012) is accurate but not required in the original answer. (3) The reasoning about the evolution of the financial partnership is plausible and contextually sound—amendments typically reflect adaptation to business or regulatory changes—but the conclusion is based on an inflated number of amendments, weakening the validity of the synthesis. The model demonstrates multi-hop reasoning by linking amendment dates to strategic evolution, but the underlying data is incorrect. (4) The contextual relevance is high because the answer addresses both parts of the question—number of amendments and implications—and provides meaningful interpretation. However, the correctness score is low due to the critical factual error in the count of amendments, which is the primary requested information. Quantitative accuracy is severely penalized for the incorrect count and extra amendment. Qualitative accuracy is moderate due to correct identification of entities and reasonable interpretation, despite flawed input data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 443,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "Based on the provided document pages, FedEx spent $582 million on business optimization activities related to Network 2.0 in 2024 and $273 million in 2023, for a combined total of $855 million. The primary purpose of these expenditures was to improve long‑term profitability by driving efficiency across transportation segments, lowering overhead and support costs, and transforming digital capabilities—specifically by consolidating sortation facilities, reducing pickup‑and‑delivery routes, and optimizing the enterprise linehaul network through the Network 2.0 multi‑year initiative.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $273 million in 2023 and $582 million in 2024, with a combined total of $855 million, matching the ground truth exactly. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect—individual amounts and the sum are correct, and no calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years and links expenditures to the Network 2.0 initiative. The primary purpose is described with slightly different wording but captures the core intent of improving efficiency in pickup, transport, and delivery operations. The LLM adds specific details like 'consolidating sortation facilities' and 'optimizing the enterprise linehaul network,' which are consistent with and expand upon the ground truth without contradicting it. (4) The only minor deviation is that the ground truth emphasizes 'professional services and severance' as the primary use of funds, while the LLM focuses on the operational outcomes (efficiency, cost reduction). This shifts emphasis slightly but does not invalidate the answer, as the expenditures are indeed aimed at enabling those transformations. Thus, the answer is factually aligned, highly accurate, and contextually appropriate, warranting a 9/10 for overall correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 384,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "The 2023 10‑K highlights that Netflix’s ad‑supported subscription plan is a strategic lever to attract price‑sensitive members, but the filing also flags forecasting risk: because revenue from the new plan—and from related features such as advertising and games—has limited historical operating history, actual adoption and pricing outcomes may deviate substantially from management’s expectations, making revenue and margin projections more uncertain. This uncertainty amplifies the broader risk that any mis‑alignment between anticipated and actual subscriber growth or pricing acceptance could materially affect Netflix’s financial forecasts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that the introduction of the ad-supported subscription plan increases financial forecasting risks due to the difficulty in predicting consumer adoption and the limited historical data for revenue from this new model. The answer accurately reflects the content of Netflix's 2023 10-K filing, noting that deviations in adoption and pricing could materially affect revenue and margin projections. All entities (Netflix, 2023 10-K, ad-supported plan) are correct, and there are no numerical inaccuracies—no specific numbers are required in this qualitative risk discussion. The reasoning is sound and synthesizes the multi-hop connection between the new pricing strategy and increased uncertainty in financial forecasts. The only minor shortcoming is that the LLM adds slight elaboration (e.g., mention of 'games') which, while plausible, is not explicitly emphasized in the ground truth; however, this does not detract from factual correctness. Overall, the response is complete, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 315,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "The $964 million impairment charge recorded in 2023 for Prevnar 13’s developed‑technology rights reflects the updated commercial forecasts that Pfizer used to assess the asset’s recoverability. Those forecasts were shaped by the patent‑expiration timeline for Prevnar 13 in key markets—U.S. exclusivity ends in 2026, Europe in 2025/2029 (with extensions possible), and Japan in 2029—signaling the loss of market‑exclusivity protection that drove the impairment. Consequently, the projected decline in future cash flows after those patent expirations justified writing down the intangible asset to its fair value, resulting in the $964 million charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $964 million impairment charge is correctly stated, and the patent expiration dates are mostly accurate: U.S. 2026 (correct), Europe 2025/2029 (ground truth specifies 2029 as the major Europe patent, with possible extensions implied; mentioning 2025 may reflect a secondary patent or regional variation but does not contradict the core fact), and Japan 2029 (additional detail not in original answer but consistent with Pfizer's filings). The LLM adds Japan's expiration, which is not in the ground truth but is factually correct and enhances completeness. (2) The reasoning correctly links the impairment charge to reduced future cash flows due to patent expirations and transition to next-gen vaccines, even though it doesn't explicitly name Prevnar 20—this is implied via 'updated commercial forecasts.' (3) Multi-hop synthesis is sound: it connects the 2023 impairment to patent timelines across regions and explains the financial impact via asset recoverability testing. (4) Minor deduction in quantitative accuracy due to the slightly ambiguous '2025/2029' for Europe—ground truth specifies 2029 as the key expiration; however, this may reflect nuance in patent layers and is not definitively incorrect. Overall, the answer is factually robust, contextually relevant, and semantically equivalent to the original answer with slight enhancements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 398,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "McDonald’s relies on franchisees to operate most restaurants and to execute key customer‑experience initiatives, yet it does not consolidate the entities that franchisees control. Because these franchisee‑related entities are excluded from the consolidated financial statements, the company’s reported results reflect only its own operations and the fees it receives from franchisees. If franchisees fail to implement the required customer‑experience programs, the brand’s consistency and sales growth could deteriorate, but the financial impact would be limited to the loss of royalty and rent revenue rather than a broader consolidation‑related impairment of the company’s balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its reasoning and conveys the core relationship between McDonald's reliance on franchisees and its non-consolidation of franchisee entities. It correctly states that franchisee-related entities are not consolidated and that McDonald's financial statements only reflect its own operations and fees (e.g., royalties, rent), which aligns with the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. However, the LLM answer introduces a nuance not present in the original answer—suggesting the financial impact would be 'limited to the loss of royalty and rent revenue' and avoiding 'consolidation-related impairment'—which downplays the broader strategic risks McDonald's acknowledges. The ground truth emphasizes that franchisee execution directly affects system-wide sales, guest counts, and market share, which can impact the overall brand and corporate performance beyond just fee income. This omission reduces the qualitative accuracy, as the LLM understates the indirect financial and reputational risk posed by franchisee underperformance. The answer remains contextually relevant and captures the multi-hop logic (franchisee dependence → no consolidation → risk if initiatives fail), but misses the full scope of the risk as described in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 378,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "AIG adopted the LDTI standard on January 1 2023 (transition date January 1 2021) using a modified retrospective approach (full retrospective for market‑risk benefits). The adoption reduced beginning total equity by $1.264 billion as of January 1 2021, and resulted in adjustments to previously reported financial statements: net income was increased by $2 million for 2022 and $983 million for 2021, while total equity rose by $1.219 billion as of December 31 2022, with the changes stemming from modifications to market‑risk benefit valuations and the discount‑rate assumptions used for future policy‑benefit liabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $1,264 million decrease in beginning equity as of January 1, 2021 (expressed as $1.264 billion), the $2 million increase to net income for 2022, the $983 million increase for 2021, and the $1,219 million increase in total equity as of December 31, 2022. Number formats are acceptable variations (e.g., $1.264 billion = $1,264 million). (2) The explanation of adjustments—related to market risk benefits (MRBs) and discount rate assumptions for future policy benefit liabilities—is correctly captured using synonymous phrasing (e.g., 'modifications to market-risk benefit valuations and the discount-rate assumptions'). (3) The multi-hop reasoning is sound: the answer synthesizes the impact on equity at adoption, the restatement effects on prior years’ net income, and the resulting equity impact at year-end 2022, all of which are required to fully address the two-part question. (4) The mention of the modified retrospective approach with full retrospective application for MRBs adds contextual accuracy not strictly required but consistent with detailed disclosures, enhancing qualitative accuracy without introducing error. All entities (AIG, LDTI, correct dates and financial metrics) are accurate. The answer is fully relevant and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 380,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "The Gulfstream aircraft order surge generated a $311 million increase in aircraft‑services revenue and, combined with the sale of G500 test aircraft, boosted cash provided by operating activities to $4.27 billion in 2021.  This operating cash flow represented 131 % of net earnings ($3.257 billion), meaning the cash generated from operations was about 131 % of net earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key impact of Gulfstream aircraft orders on operating cash flow and accurately states the 131% ratio of cash flow to net earnings, which matches the ground truth. However, it introduces a $311 million increase in aircraft-services revenue and attributes the cash flow boost to the sale of G500 test aircraft—details not present in the original answer and unsupported by the ground truth. The reported cash flow of $4.27 billion is close to but not exactly the correct $4.3 billion figure; while minor rounding could be acceptable, $4.27B vs $4.3B represents a $30M difference, which is non-trivial in this context. The net earnings figure of $3.257 billion is not mentioned in the original answer and appears to be inferred, though it aligns with the 131% ratio (4.27 / 3.257 ≈ 1.31), suggesting internal calculation consistency. (2) Quantitative accuracy is reduced due to the incorrect cash flow amount and the introduction of unverified revenue figures. The 131% percentage is correct. (3) The reasoning correctly links increased orders to higher operating cash flow via customer deposits (implied in the original), but the LLM adds unverified mechanisms (G500 test aircraft sales, specific revenue increase) that distort the causal explanation. The multi-hop synthesis is partially sound but includes speculative elements. (4) Despite inaccuracies, the core of the answer—cash flow at $4.27B (approximate), 131% of net earnings—is factually aligned enough to preserve the main conclusion, warranting a score of 7 for correctness. Contextual relevance is perfect as all parts of the question are addressed directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 457,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "AIG's integrated bottom‑up risk identification process, which extends down to the product‑line level, feeds directly into its internal capital framework by quantifying the aggregate economic risk at a specified confidence interval after accounting for diversification benefits across risk factors and business lines. This quantification informs the capital needed at the AIG Parent level to support subsidiaries and to maintain the consolidated target capitalization.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly describing how AIG's bottom-up risk identification process supports its internal capital framework. It accurately captures the core mechanism: granular risk data from product lines feeds into the internal capital model to quantify aggregate economic risk at a given confidence interval, with recognition of diversification benefits across risk factors and business lines. There are no numeric inaccuracies (quantitative accuracy is 10), as the response does not introduce specific numbers but refers to concepts like 'aggregate economic risk' and 'confidence interval' appropriately. The qualitative accuracy is slightly reduced because the LLM omits the explicit explanation that the bottom-up process 'captures material risks inherent in specific business operations' and how this granularity enables more robust diversification modeling—details present in the original answer that clarify the causal chain. While the LLM mentions diversification benefits, it doesn't fully articulate how granular inputs improve the precision of those diversification estimates. However, the reasoning remains sound and logically consistent. Contextual relevance is perfect—the answer directly addresses the question without extraneous information. Overall, the answer conveys the essential meaning but lacks some depth in explaining the synthesis between granular risk capture and improved aggregation, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 411,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "The introduction of the RTX 4080 GPU creates new supply‑chain complexities and demand‑forecasting challenges that can directly affect NVIDIA’s financial performance.  Because the RTX 4080 is part of a broader product‑transition strategy, any mis‑estimation of customer demand—whether due to rapid shifts toward AI‑related workloads, cryptocurrency‑driven usage patterns, or channel‑partner ordering behavior—can lead to excess inventory, costly write‑downs, or supply constraints that erode gross margins.  At the same time, the need to secure capacity from foundries and contract manufacturers, often under non‑cancellable, prepaid agreements, amplifies the risk that extended lead times or geopolitical disruptions will delay shipments, further destabilizing revenue forecasts and potentially harming NVIDIA’s overall financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer, with only minor omissions in specificity. (1) All factual elements are correct: the RTX 4080's role in product transitions, demand forecasting risks (overestimation/underestimation), supply chain dependencies on foundries, non-cancellable agreements, lead times, and financial impacts like gross margin erosion and inventory write-downs are all correctly identified. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links product transition complexity to demand uncertainty, connects foundry reliance to supply risks, and synthesizes how these factors jointly impact financial performance. (4) The only reason for not scoring a perfect 10 is that the LLM omits explicit mention of 'warranty costs', 'quality/production issues', and 'geopolitical tensions' as directly stated in the original, though 'geopolitical disruptions' is mentioned. It also does not explicitly state the risk of 'cancellation penalties' or 'impairments' from overestimation, though 'costly write-downs' covers part of that. These are minor gaps in completeness, not inaccuracies. Overall, the answer captures the core causal链条 and financial implications with high fidelity and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 382,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "The Starbucks Rewards loyalty program affects revenue recognition by requiring the company to defer revenue associated with the estimated selling price of Stars earned toward future free product rewards, establishing a deferred revenue liability that is recognized as revenue when rewards are redeemed. For fiscal 2022, Starbucks' total advertising expense was $416.7 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the impact of the Starbucks Rewards program on revenue recognition: revenue is deferred based on the estimated value of earned Stars and recognized upon redemption, which matches the original answer's explanation. (2) The quantitative figure for advertising expense in fiscal 2022 is exactly correct at $416.7 million, with no formatting or precision issues. (3) The reasoning correctly synthesizes the multi-hop elements—linking the loyalty program mechanics to revenue deferral and combining it with a separate financial metric (advertising expense) from the same fiscal year. (4) All entities (Starbucks, Starbucks Rewards, fiscal 2022) and financial concepts (deferred revenue, revenue recognition timing) are accurately identified and used. The answer is concise, factually precise, and fully addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 273,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "The total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024 was an increase of $1,546 million (from $2,860 million to $4,406 million). In 2024, interest payments related to these loans that were recognized in earnings amounted to $75 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the change in notional amount is accurately calculated as $1,546 million ($4,406M - $2,860M), and the interest recognized in 2024 is correctly stated as $75 million. These values exactly match the original answer, with acceptable formatting (e.g., using 'million' and spacing in numbers). (2) The answer is complete, addressing both parts of the question: the total change from 2023 to 2024 and the interest recognized in earnings in 2024. (3) Entity accuracy is correct—'intercompany loans and forecasted interest payments' are properly referenced, and the years 2023 and 2024 are correctly used. (4) The reasoning is sound and reflects proper multi-hop synthesis: it computes the difference in notional amounts across years and correctly identifies the interest recognized in earnings in the target year. (5) The semantic meaning is equivalent to the original answer, with no loss of key details or context. Minor wording differences (e.g., 'amounted to' vs 'was recognized') do not affect factual accuracy. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 323,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 was $547 million (from $9,979 million to $10,526 million). This growth was driven primarily by higher revenue from nuclear‑powered submarines ($179 million increase, from $6,938 million to $7,117 million) and surface ships ($273 million increase, from $2,055 million to $2,328 million), while repair and other services rose only $95 million. Thus, the overall Marine Systems revenue growth was largely a result of the combined increases in submarine and surface‑ship sales, with submarine revenue growth being a key component of the total increase.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar amount increase in Total Marine Systems revenue from 2020 to 2021 as $547 million, accurately calculated from $9,979 million to $10,526 million. It also correctly states the $179 million increase in Nuclear-powered submarines revenue, from $6,938 million to $7,117 million. All numeric values and calculations are factually accurate, satisfying quantitative accuracy. (2) However, the LLM fails to directly answer the second part of the question: how the growth in Total Marine Systems compares to the growth in Nuclear-powered submarines. While it mentions both figures, it does not explicitly state that Total Marine Systems' growth is significantly higher or quantify the difference ($368 million). Instead, it incorrectly frames the submarine revenue increase as a 'driver' of the total Marine Systems growth, which may imply a causal or component relationship that was not requested and could mislead. (3) The multi-hop reasoning is partially sound—data from both entities and years are correctly retrieved and synthesized—but the comparative analysis is missing. The model adds extra, unsolicited detail about surface ships and repair services, which, while possibly true, distracts from the required comparison. (4) Therefore, while all numbers are correct (quantitative accuracy = 10), the failure to complete the explicit comparison reduces qualitative accuracy and overall correctness. The answer is contextually relevant and well-structured, hence high contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 424,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "The dollar amount change in Mac sales from 2023 to 2024 was an increase of $627 million (from $29.357 billion to $29.984 billion). Over the same period, iPad sales declined by $1.606 billion (from $28.300 billion to $26.694 billion), meaning the Mac’s growth was the opposite direction of the iPad’s decrease.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: Mac sales increased by $627 million (from $29,357 million to $29,984 million), which is correctly reported as $29.357 billion to $29.984 billion — equivalent values in different units. Similarly, iPad sales decreased by $1,606 million, correctly stated as $1.606 billion (from $28.300 billion to $26.694 billion), matching the original $28,300 million to $26,694 million. (2) Calculations are accurate: the differences are correctly computed and directionally correct (increase vs decrease). (3) Multi-hop reasoning is sound — the model correctly identifies and compares two separate financial trends across products and years, synthesizing data for both Mac and iPad sales over 2023–2024. (4) The conclusion about opposing directions (Mac growth vs iPad decline) is logically valid and adds interpretive value without introducing error. Wording differs slightly but preserves full factual integrity. All parts of the question are addressed with precise, contextually appropriate information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 314,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "The unfavorable volume/mix in chocolate in 2024 reduced net revenue growth by offsetting gains elsewhere—while overall net revenue rose $452 million (3.5%) due to higher pricing, the chocolate segment’s volume/mix decline contributed to a $80 million (1.6%) drop in its own net revenue and pressured total growth, even though the company’s overall net revenue still increased.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and lacks key data from the ground truth. It claims the chocolate segment’s volume/mix decline led to an $80 million (1.6%) drop in its own net revenue, but this figure is not supported by the original answer, which states chocolate contributed $10.619 billion in 2023 and experienced a decline in 2024 without specifying the dollar or percentage decline. The $80 million figure is fabricated or misattributed. Additionally, the original answer notes that favorable volume/mix in chocolate contributed $1,437 million to net revenue growth in 2023, a critical multi-hop point that the LLM omits entirely. (2) The overall net revenue increase of $452 million and 3.5% growth are correctly cited, as is the role of pricing in driving growth. However, the unsupported $80 million decline figure and missing $1,437 million prior-year favorable impact severely undermine quantitative accuracy. (3) The reasoning partially captures the idea that unfavorable volume/mix in chocolate acted as a headwind to overall growth despite pricing gains, which aligns with the original answer’s logic. However, it fails to synthesize the full multi-hop context: comparing 2024’s unfavorable chocolate performance against 2023’s strong contribution ($1.437B positive impact), which is essential to fully answering how the change impacted growth. (4) The answer is contextually relevant and addresses the core question about the impact on net revenue growth, but due to significant factual gaps and an incorrect specific figure, the correctness score is limited to 5—partially correct but with major omissions and errors in quantitative details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 462,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "Initial capacity constraints on custom components can delay the ramp‑up of new products, forcing Apple to rely on limited single‑source suppliers and making its supply chain vulnerable to shortages, price spikes, or supplier disruptions; this amplifies risk given its heavy dependence on single‑source vendors and outsourcing partners across Asia. Consequently, any interruption or inability to secure sufficient custom parts can materially affect product availability and the company’s ability to manage supply‑chain risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies that initial capacity constraints on custom components affect Apple's supply chain risk and product availability due to reliance on single-source suppliers and outsourcing partners in Asia. The key factual points—delays in ramp-up, vulnerability to shortages, price spikes, and supplier disruptions—are all present and correct. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or fabricated data supports a score of 10. (3) The multi-hop reasoning is sound: the model connects custom component constraints → single-source dependency → geographic concentration in Asia → increased supply chain risk → impact on product availability. The only minor omission is the specific mention of suppliers prioritizing more common components over Apple’s custom ones, and the detail about yields maturing over time, which appears in the original 10-K-based answer. This slightly reduces completeness but does not undermine the overall correctness. (4) The answer is fully contextually relevant, directly addressing how capacity constraints interact with Apple’s supply chain structure. Wording differs but semantic meaning aligns closely with the original. Thus, a correctness score of 9 is justified—excellent accuracy with minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 409,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "Disney reported TV/SVOD distribution licensing revenue of $3,429 million in 2022 after accounting for the $1,023 million content‑license early termination fee, compared with $5,266 million in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures: $3,429 million in TV/SVOD distribution licensing revenue for 2022 (after the $1,023 million early termination fee) and $5,266 million for 2021. These match the ground truth exactly. (2) Quantitative accuracy is perfect—both absolute values and implied comparison are correct. The decrease of $1,837 million (from $5,266M to $3,429M) is accurate, though not explicitly stated in the LLM answer. (3) The multi-hop reasoning is sound: the model correctly identifies that 2022 revenue includes the impact of the termination fee and compares it to the prior year. However, the answer omits the explicit year-over-year change amount ($1,837 million decrease), which was part of the original answer and directly addresses the 'how does this compare' component. This minor omission prevents a full 10 on correctness and qualitative accuracy. (4) Despite this, the answer is semantically very close, uses correct entities (Disney, TV/SVOD distribution licensing, correct years), and maintains contextual relevance. The wording is slightly more concise but preserves factual integrity. Format variations (e.g., thin spaces in numbers) are acceptable and do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 347,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "Based on the 2022 10-K disclosures, Starbucks' integration of its Mobile App with the Starbucks Rewards loyalty program directly drives customer engagement and increased store visit frequency by enabling seamless digital ordering and personalized rewards redemption. The document highlights that the Mobile Order and Pay functionality allows customers to place orders in advance for pickup, while registered Starbucks Rewards members earn Stars through the app for purchases made via the app or linked payment methods, creating a frictionless experience that incentivizes repeat visits and higher engagement across both company-operated and licensed stores. This digital ecosystem, particularly emphasized in markets like China with platforms such as Starbucks Now stores, is positioned as a key growth driver for sustaining long-term customer relationships and brand loyalty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the integration of the Mobile App with Starbucks Rewards drives engagement via Mobile Order and Pay, earning Stars through app or linked payment methods, and increasing store visit frequency. These features are correctly tied to customer convenience, digital interaction, and loyalty. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how app functionality (ordering, payment, rewards) connects to behavioral outcomes (engagement, visit frequency) as disclosed in the 10-K. It appropriately references the digital ecosystem as a growth driver, consistent with Starbucks’ strategic disclosures. (4) The only minor deviation from the original answer is the mention of 'Starbucks Now stores' in China, which, while potentially accurate, is not part of the provided ground truth and may reflect external knowledge. However, this does not contradict the source and is contextually plausible. Overall, the answer is semantically equivalent, complete, and contextually relevant, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 357,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "The 2021 audit of PayPal’s internal control over financial reporting excluded Paidy, Inc. because it was acquired during 2021; Paidy’s assets and revenues together (excluding goodwill and intangibles) represented less than 1 % of the Company’s total consolidated assets and revenue for the year ended December 31 2021. Consequently, Paidy’s assets and revenues fell short of being included in that audit by essentially the entire amount of its reported assets and revenues—i.e., they were excluded entirely from the audit scope.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitatively, it accurately states that Paidy's assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, which matches the original answer. The date of acquisition (2021) and exclusion from the internal control audit for the year ended December 31, 2021, are correct. (2) The explanation that Paidy was excluded due to being acquired during the year and permitted under SEC guidance is implied correctly, though the LLM does not explicitly cite 'SEC guidance'—a minor omission affecting qualitative accuracy slightly. (3) The reasoning is sound: the LLM correctly synthesizes the impact of the acquisition on audit scope and explains that because the financials were below the 1% threshold, they were fully excluded. The statement that Paidy’s assets and revenues 'fell short' by 'essentially the entire amount' is semantically acceptable, though slightly imprecise—it correctly conveys that none were included, not that they barely missed the threshold. (4) All entities (PayPal, Paidy, Inc., internal control over financial reporting, 2021 audit) are correctly identified and contextualized. The answer is fully relevant and addresses both parts of the question: the impact on audit scope and the degree to which Paidy's financials fell short. Only a perfect score is reduced slightly due to the lack of explicit reference to SEC guidance, but the conclusion remains factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 417,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "The modest 0.6% rise in Latin America operating income to $532 million was driven almost entirely by higher net pricing and lower costs, which were largely wiped out by volume/mix headwinds.  Net revenues fell 1.6% as volume declines in chocolate, candy, cheese & grocery and refreshment beverages offset pricing gains, leaving only a small net income increase despite the benefits from pricing actions and cost controls.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core dynamic — that volume/mix headwinds offset pricing and cost controls, resulting in minimal operating income growth — which aligns with the ground truth. However, it omits key quantitative and qualitative details. The LLM states a 0.6% rise in operating income to $532 million, but the ground truth does not specify the absolute income value, only the $3 million increase. This introduces unverified information. The 1.6% net revenue decline is not mentioned in the ground truth, making it potentially inaccurate. (2) The ground truth specifies a $3 million (0.6%) increase in operating income, but the LLM incorrectly implies that $532 million is the resulting income, which cannot be verified from the original. The 7.0 percentage point pricing increase and specific country-level pricing actions (Argentina, Mexico, Brazil) are missing. Also absent are the impacts of higher raw material costs, unfavorable currency, and increased advertising/promotion expenses — all critical to explaining why gains were limited. (3) The reasoning is partially sound: the LLM correctly identifies that volume/mix declines in chocolate and refreshment beverages offset pricing and cost benefits. However, it fails to synthesize the multi-hop elements involving country-specific consumer softness (Mexico, Argentina), manufacturing cost reductions via productivity, and the compounding effect of external cost pressures. These omissions weaken the causal explanation. (4) The contextual relevance is high because the answer addresses the central tension in the question. Qualitative accuracy is moderate due to correct directional logic but missing depth. Quantitative accuracy is low due to unsupported figures like $532 million and 1.6% revenue decline. Correctness score is 6 due to partially correct facts but significant omissions and potential inaccuracies in numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 515,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "Based on the provided document pages, Gulfstream's current product line holds more than 270 city-pair speed records, and the G650ER is explicitly credited with leading this achievement, as it holds the National Aeronautic Association's polar and westbound around-the-world speed records.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number 'more than 270 city-pair speed records' is accurately reported, matching the original answer. (2) The entity identification is correct: Gulfstream's current product line is the subject, and the G650ER is properly identified as the model explicitly credited with leading the achievement. (3) The reasoning is sound and reflects multi-hop synthesis: the answer correctly links the G650ER to specific prestigious records (polar and westbound around-the-world speed records) recognized by the National Aeronautic Association, which substantiates its leadership role in contributing to the overall record count. (4) The response addresses both parts of the question: the total number of records and the specific aircraft model responsible. Wording differs slightly but conveys the same factual content. No errors in facts, calculations, or logic are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 278,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "Johnson & Johnson recorded total contingent consideration of **$1,217 million** in fiscal 2024 and **$1,120 million** in fiscal 2022. The **Abiomed acquisition contributed $704 million** of contingent consideration in fiscal 2022, which was part of the amounts that built up to the reported balances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in quantitative values. According to the ground truth, Johnson & Johnson recorded $704 million in contingent consideration in 2022 (related to Abiomed) and $105 million in 2024 (related to Proteologix), totaling $809 million. However, the LLM claims $1,120 million in 2022 and $1,217 million in 2024, which are completely incorrect and not supported by the original answer. Only the $704 million for Abiomed in 2022 is correct. (2) The calculation of total contingent consideration over the two years is therefore also wrong: LLM implies a total of over $2.3 billion, whereas the correct total is $809 million. The Abiomed contribution is correctly identified as $704 million, which is accurate and matches the ground truth. (3) The multi-hop reasoning is partially sound in identifying that Abiomed contributed to contingent consideration in 2022, but fails to mention Proteologix in 2024 and instead fabricates large numbers for both years. The model does not correctly synthesize the total across years as required by the question. (4) Due to severe quantitative inaccuracies and incomplete/correct information, the correctness score is low at 3. The qualitative accuracy is slightly higher because the model identifies the correct acquisition (Abiomed) and year (2022) with the right amount, but misses the 2024 component entirely. Contextual relevance is moderate since it addresses the right topic and entity but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 413,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "PayPal’s sale of participation interests in merchant receivables for its PPWC and PPBL products is treated as a sale of a portion of those receivables, so the transferred portion is derecognized and no longer appears on the balance sheet. Because the transferred interests are sold without recourse and the risk of loss is shared pro‑rata with WebBank, the remaining exposure to credit losses is limited to the portion of the receivables that the Company retains. Under the CECL guidance adopted in 2020, credit losses are now based on current expected credit losses rather than incurred losses, and the allowance for these retained receivables is calculated using loss‑curve models and macro‑economic forecasts, with qualitative adjustments for pandemic‑related risk. Consequently, the participation‑sale reduces the amount of receivables subject to future charge‑offs, and any gains or losses on the sale are generally immaterial because the carrying amount of the sold interest approximates its fair value. This accounting treatment results in lower reported credit‑loss expense for the sold portion and shifts the loss‑recognition responsibility to the retained interests.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, entities, and reasoning. (1) It correctly identifies that PayPal sells participation interests in merchant receivables under PPWC and PPBL to WebBank, accounts for them as sales, and derecognizes the sold portion. It accurately notes that PayPal retains servicing rights and exposure only on the retained interest, and that CECL adoption in 2020 shifted the company from an incurred loss model to an expected credit loss model. The explanation of using loss-curve models, macroeconomic forecasts, and qualitative adjustments (e.g., pandemic-related risk) for allowance calculation under CECL is consistent with the ground truth. (2) There are no specific numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model connects the sale structure, derecognition, retained risk, and the impact of CECL adoption on loss provisioning. However, the LLM adds a detail not present in the ground truth—that gains or losses on sale are immaterial because carrying amount approximates fair value—which, while plausible, is not confirmed in the original answer and slightly extends beyond the provided information. Also, the original emphasizes that CECL made provisioning more forward-looking and sensitive to economic forecasts, which the LLM captures but frames more narrowly around pandemic adjustments. (4) Contextual relevance is high—the answer directly addresses how the sale of participation interests interacts with CECL’s impact on credit loss recognition. Minor deduction in qualitative accuracy due to slight overreach in unverified details, but overall the answer is factually sound and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 502,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "The cheese & grocery product category helped offset some of the unfavorable volume/mix pressure in Latin America by delivering volume gains and favorable product mix, but overall the segment still experienced a 1.6% decline in net revenues due to currency headwinds and volume declines in other categories. This contributed to a modest 0.6% increase in Latin America segment operating income to $532 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that the cheese & grocery category experienced volume declines, contributing to an unfavorable volume/mix impact of 2.4 percentage points on net revenues. The LLM incorrectly claims that cheese & grocery helped offset pressure by delivering volume gains and favorable mix, which is the opposite of the truth. (2) Quantitative inaccuracies include: the LLM states a '1.6% decline in net revenues,' but the original answer does not mention a revenue decline—instead, it describes an unfavorable impact of 2.4 percentage points on growth (not a decline), and attributes a $3M (0.6%) increase in operating income. The LLM also fabricates a segment operating income figure of $532 million, which is not in the original. The 0.6% increase in operating income is correctly cited, but in the wrong context. (3) Multi-hop reasoning fails: the LLM misidentifies the role of cheese & grocery, misattributes performance across categories, and incorrectly synthesizes the relationship between volume/mix impact and revenue outcome. It misses that declines in cheese & grocery, chocolate, candy, and refreshment beverages collectively created headwinds, partially offset by gains in biscuits and gum. (4) Scores are low due to major factual and directional errors, especially in the role of cheese & grocery and revenue impact. Contextual relevance is moderate because the answer addresses the Latin America segment and operating income effect, but with incorrect data and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 429,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "The combined redemption value of the Telco Class A‑4 preferred interests and the Mobility noncontrolling interests is $2,250 million plus $2,000 million, for a total of $4,250 million.  Because these obligations must be paid in cash (or cash‑plus‑stock for the Mobility interests) and are scheduled to be redeemed beginning in 2028‑2029, AT&T has committed to maintaining sufficient liquidity to meet these redemption payments through 2028, which will constrain its cash‑flow flexibility and limit the amount of cash it can allocate to other uses such as dividend increases, share repurchases or additional investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the redemption values of both instruments—$2,250 million for Telco Class A-4 and $2,000 million for Mobility noncontrolling interests—with the correct total of $4,250 million, matching the ground truth. These numbers and the sum are accurate, satisfying quantitative accuracy. (2) However, there is a critical error in the description of payment terms: the ground truth states that the Mobility noncontrolling interests must be settled in cash, but the LLM incorrectly states they may be paid in 'cash-or-cash-plus-stock', which contradicts the original answer and undermines factual correctness. This misrepresentation affects the assessment of cash flow impact. (3) Regarding multi-hop reasoning, the LLM correctly links the redemption obligations to AT&T’s future cash flow commitments and notes the timing around 2028, which aligns with the ground truth. However, it generalizes the timing as '2028–2029' and omits the specific redemption triggers—November 1, 2028 (Telco), and March 15 and June 15, 2028 (Mobility)—reducing precision in the timeline synthesis. (4) Despite these issues, the answer captures the core implication: that the $4.25B obligation constrains cash flow flexibility and affects capital allocation decisions, maintaining strong contextual relevance. The correctness score is 7 due to accurate numbers but significant qualitative inaccuracies in payment terms and timing details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 401,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "The Orthopaedics segment generated $9.2 billion in revenue in 2024, which includes $1.6 billion from hips and $1.5 billion from knees. Therefore, the combined revenue from hips and knees ($3.1 billion) represents roughly one‑third of the total Orthopaedics sales for the year.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but uses rounded figures instead of exact values. The ground truth states Orthopaedics revenue as $9,158 million, while the LLM reports $9.2 billion — a reasonable approximation. Similarly, Hips revenue is $1,638 million (ground truth) vs. $1.6 billion (LLM), and Knees is $1,545 million vs. $1.5 billion — both acceptable rounding. The combined Hips and Knees revenue is $3,183 million in truth, while LLM calculates $3.1 billion, again a close estimate. (2) The percentage calculation: ground truth computes $3,183 / $9,158 ≈ 34.76%, while LLM states 'roughly one-third' (~33.3%), which is a slight understatement but still in the right range. The LLM does not provide the exact percentage but conveys the approximate proportion correctly. (3) Multi-hop reasoning is sound — the model correctly identifies that Hips and Knees are sub-components of the Orthopaedics segment, aggregates their revenues, and compares them to the total, fulfilling the comparative aspect of the question. (4) Scores reflect high accuracy in entities (correct segment, sub-segments, year), strong reasoning, and full contextual relevance. The 8 on correctness and quantitative accuracy accounts for the rounding and the slightly imprecise 'one-third' characterization, though it does not rise to a major error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 373,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "The 2019 Incentive Plan’s proportional adjustment mechanism increased the number of RSU shares available by approximately 128,000 shares after the 2024 special dividend, as documented in Note 7 of the 2024 10-K filing. This adjustment was formally recorded in the 2024 10-K filing (specifically in Note 7 under \"Stock-Based Compensation\") and referenced in the 2024 10-K’s equity disclosures.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 128,000 increase in RSU shares available, which matches the ground truth. However, it omits the 52,000 increase in outstanding RSUs, a key part of the adjustment mechanism's impact. The adjustment factor of 1.018 and the price data (Nasdaq closing and opening prices) used to derive it are entirely missing, which are critical quantitative details. (2) The numeric value of 128,000 is accurate, but the absence of the 52,000 figure and the calculation basis (price ratio) reduces quantitative completeness. The dates (December 26–27, 2023) and stock prices ($674.62 and $662.70) are not mentioned, undermining the explanation of how the adjustment was derived. (3) The LLM incorrectly attributes the formal documentation of the adjustment mechanism to Note 7 of the 2024 10-K, whereas the ground truth states that the mechanism itself is in the 2019 Incentive Plan (Exhibit 10.2 in the DEF 14A filed December 17, 2019). While the 2024 10-K may report the adjustment, the governing terms are in the original plan document. This reflects a failure in multi-hop reasoning: the model conflates reporting of the adjustment with the source of the adjustment rule. (4) The answer is contextually relevant and addresses the core question about the impact and documentation, but due to missing key numbers, incorrect sourcing of the plan mechanism, and lack of full synthesis across filings and years, the correctness score is reduced to 5. The qualitative accuracy is penalized for incorrect attribution of the source document.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 430,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "The transition of Intel 4 to high‑volume manufacturing in Ireland in 2024 is expected to increase the share of Intel’s processor production that uses the EUV‑based Intel 4 node, delivering roughly 20 % better performance‑per‑watt versus Intel 7 and supporting the upcoming 2025 product lineup. At the same time, Intel 3—also built on EUV and currently in high‑volume manufacturing in Oregon—will shift its high‑volume output to Ireland in 2025, while Intel 18A, the next‑generation node featuring RibbonFET and PowerVia, is slated for high‑volume production in 2025 (with Panther Lake as the first client product), offering further performance‑per‑watt and density gains over Intel 3 and positioning Intel’s 2025 portfolio around these advanced process technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Intel 4's high-volume manufacturing in Ireland in 2024 increases its share in 2025 production, delivers ~20% better performance-per-watt vs Intel 7 (correctly matching the ground truth), and supports the 2025 product lineup. Intel 3 shifts from Oregon to Ireland in 2025, and Intel 18A is set for high-volume production in 2025 with RibbonFET and PowerVia. Panther Lake is correctly identified as the first client product on Intel 18A. (2) Quantitative accuracy is perfect: the 20% performance-per-watt improvement for Intel 4 over Intel 7 is correctly stated; while the ground truth mentions Intel 3's 18% improvement over Intel 4, this is not included in the LLM answer, but no incorrect numbers are presented. The omission is minor and does not affect factual correctness. (3) Multi-hop reasoning is sound: the answer links Intel 4 ramp-up, Intel 3 relocation, and Intel 18A introduction as interconnected developments shaping the 2025 portfolio. It correctly positions Intel 18A as delivering gains over Intel 3, though it doesn't explicitly quantify those gains (e.g., density scaling), which slightly reduces completeness. (4) Contextual relevance is excellent—the response directly addresses the financial and technological impact on Intel’s 2025 product portfolio, focusing on performance improvements and production shifts. The only minor gap is the lack of explicit mention of Xeon 6 Scalable processors powered by Intel 3, but the overall synthesis remains strong. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 467,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "The book value of AT&T’s investment in DIRECTV fell from **$877 million at December 31 2023 to $0 million at December 31 2024**, a decrease of **$877 million**. This deconsolidation occurred after AT&T sold its stake in DIRECTV in September 2024, which was after it had already deconsolidated Gigapower in May 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the book value decrease of AT&T's investment in DIRECTV from $877 million on December 31, 2023, to $0 on December 31, 2024, resulting in a $877 million decrease—this matches the ground truth exactly. All numeric values, dates, and calculations are accurate. (2) However, the LLM introduces a factual error by stating that the deconsolidation occurred 'after AT&T sold its stake in DIRECTV in September 2024.' The ground truth does not mention a sale of stake or a September 2024 event; instead, it explains that the investment was reduced to zero due to cumulative cash receipts exceeding the initial investment and equity earnings, beginning in Q3 2024 under equity method accounting. This misrepresents the cause and timing mechanism. (3) Regarding multi-hop reasoning, the LLM correctly notes that Gigapower was deconsolidated in May 2023, which aligns with the ground truth, and makes a temporal comparison (DIRECTV after Gigapower). However, it fails to explain that Gigapower remains an ongoing equity method investment, missing a key qualitative distinction. It also incorrectly frames both events as 'deconsolidations,' but the DIRECTV event is not a deconsolidation—it is the reduction of an equity investment to zero, not removal of consolidated subsidiaries. (4) Quantitative accuracy is perfect (score 10), but qualitative accuracy is low due to incorrect reasoning and terminology (score 5). Contextual relevance is high as it addresses both parts of the question and compares timing, though with flawed logic (score 8). Correctness score is 6 due to correct numbers but significant misinterpretation of events and accounting treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 462,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "Shockwave contributed $564 million to Johnson & Johnson’s Cardiovascular franchise sales in 2024, as shown in the MedTech segment table on page 34. This acquisition is reflected in the company’s human‑capital reporting by including Shockwave employees in the total headcount figures (139,800 employees as of December 2024) and by describing the Shockwave acquisition as a driver of the 1.5 % operational sales growth within the MedTech segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024, matching the ground truth exactly. The figure is accurately cited and formatted correctly. (2) All numeric values are correct: $564 million is the precise revenue contribution, and the headcount figure of 139,800 employees as of December 2024 aligns with typical reporting standards. There are no calculation errors. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across financial and human capital reporting domains. It identifies that Shockwave’s employees are included in the total headcount, which reflects integration into human capital metrics—consistent with the ground truth. It adds contextual detail about operational sales growth, which, while not part of the original answer, is plausible and does not contradict it. (4) The only minor deviation is the use of 'Cardiovascular franchise sales' and reference to the 'MedTech segment table on page 34'—details not present in the ground truth—though these are reasonable inferences and do not affect factual accuracy. The core facts—revenue amount and inclusion in headcount—are correct and fully addressed. Thus, the answer is semantically equivalent with excellent completeness and contextual relevance, warranting a high score with a small deduction in qualitative accuracy due to slight over-attribution of source details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 405,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "The Optimized Application Experiences category grew 11% year‑over‑year, driven primarily by increased sales of ThousandEyes and Intersight, while the decline in AppDynamics offerings was offset by these gains, resulting in a $75 million increase in the category’s revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the Optimized Application Experiences category grew by 11% and increased by $75 million in dollar terms. (2) Quantitative accuracy is perfect: the 11% growth rate and $75 million increase match the original answer exactly, with acceptable formatting ($75 million vs $75 million). (3) The multi-hop reasoning is sound—the model correctly identifies that despite AppDynamics' decline, the overall category grew due to strong performance in ThousandEyes and Intersight, which aligns with the synthesis required across offerings. (4) Entity accuracy is correct: Cisco, AppDynamics, ThousandEyes, and Intersight are all properly referenced in context. The answer addresses both sub-questions: the contributing offerings (ThousandEyes and Intersight) and the dollar increase ($75 million). No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 277,
        "total_tokens": 1419
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "AT&T paid $5,414 in total to repurchase all outstanding Mobility preferred interests in April 2023, which included $5,340 of redemption value plus $74 of accrued and unpaid distributions.  The redemption eliminated the noncontrolling interest related to Mobility II, reclassifying the previously‑recorded redeemable noncontrolling interest to a liability and reducing the equity portion of AT&T’s balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly states that AT&T paid $5,414 million (implied by '$5,414') to repurchase the Mobility preferred interests in April 2023, including $5,340 of redemption value and $74 of accrued and unpaid distributions. These numbers match the ground truth exactly and sum correctly ($5,340 + $74 = $5,414), so quantitative accuracy is perfect. The date (April 2023) is also correct.\n\n2) However, the qualitative explanation of the impact on noncontrolling interest contains a partial inaccuracy. The LLM states that the redeemable noncontrolling interest was reclassified to a liability and reduced equity, which misrepresents the actual accounting effect. According to the ground truth, the redemption removed the preferred interests from the 'Noncontrolling interest' classification entirely because the interests were extinguished—not reclassified to a liability. The correct impact is elimination from the balance sheet (specifically from noncontrolling interest within equity), not a reclassification to a liability. This is a significant conceptual error in reasoning.\n\n3) The LLM does correctly identify that the redemption affected noncontrolling interest and that it was related to Mobility II (entity accuracy is good), and it addresses both parts of the question: total payment and balance sheet impact. Thus, completeness and contextual relevance are strong.\n\n4) Despite the factual error in the accounting treatment, the core financial figures and event are correct, warranting a high but not top score. The quantitative accuracy is flawless (10), contextual relevance is perfect (10), but qualitative accuracy is reduced due to incorrect reasoning about the balance sheet impact (7). Overall correctness is 8 due to accurate numbers but flawed explanation of the financial statement effect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 490,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "The Abiomed business contributed $1.5 billion in sales in 2024, representing a 14.5 % increase over the prior year, and its growth was a key component of the MedTech segment’s overall 4.8 % sales rise. Consequently, the Cardiovascular segment’s total sales grew 21.4 % year‑over‑year, outpacing Abiomed’s growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states Abiomed's 14.5% year-over-year revenue growth and $1.5 billion in sales in 2024, which aligns with the ground truth (actual: $1.496B, rounded appropriately). It also correctly notes that the Cardiovascular segment grew 21.4% year-over-year, outpacing Abiomed's growth. However, a critical error occurs in attributing Abiomed's contribution to the 'MedTech segment’s overall 4.8% sales rise'—this is factually incorrect and not supported by the ground truth, which makes no mention of MedTech or a 4.8% figure. This introduces a significant factual distortion. (2) Quantitatively, the 14.5% growth and $1.5B (rounded) are accurate, and the 21.4% Cardiovascular growth matches. However, the 4.8% MedTech figure is unsupported and incorrect, undermining quantitative accuracy. (3) The multi-hop reasoning is partially sound—correctly comparing Abiomed’s growth to the broader Cardiovascular segment—but fails in entity mapping by introducing an irrelevant and incorrect segment (MedTech). This suggests confusion in entity relationships post-acquisition. (4) Contextual relevance is high as the answer addresses revenue growth for Abiomed and comparison to Cardiovascular segment, but the inclusion of erroneous MedTech data reduces qualitative accuracy. Correctness score is 6 due to mostly correct core numbers but a significant error in segment attribution that affects interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 395,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "The Lowe's Companies Benefit Restoration Plan has **two amendments** listed in the exhibits (specifically, the **Seventeenth Supplemental Indenture** dated October 22, 2020, and the **Eighteenth Supplemental Indenture** dated March 31, 2021). The most recent amendment referenced in the 2022 10-K filing was the **Eighteenth Supplemental Indenture**, dated **March 31, 2021**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key points. (1) Quantitatively, it states there are two amendments, but the ground truth is seven amendments. It cites March 31, 2021, as the most recent amendment date, but the correct date is April 4, 2017. These numbers and dates are factually wrong. (2) The LLM confuses the 'Lowe's Companies Benefit Restoration Plan' with unrelated 'Supplemental Indentures,' which are not amendments to the Benefit Restoration Plan. This indicates a complete failure in entity identification. (3) The reasoning is flawed: the answer does not demonstrate correct multi-hop synthesis; instead, it pulls unrelated documents from the exhibits, likely misreading the exhibit index. (4) Contextually, the answer is mostly irrelevant, referencing indentures instead of plan amendments. Even though it attempts to answer both parts of the question, the factual foundation is entirely incorrect, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 277,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, Capital One Financial Corporation had phased in **$1.8 billion** of the $2.4 billion CECL transition amount by January 1, 2024 (representing 75% of the $2.4 billion total, as explicitly stated in the CECL Transition Rule section on page 84 and confirmed in the regulatory capital discussion on page 203). \n\nFor the Stress Capital Buffer framework effective October 1, 2024, the Company must maintain a CET1 capital ratio of **10.0%** (comprising the minimum capital requirements plus the standardized approach capital conservation buffer under the stress capital buffer framework, as detailed in the Stress Capital Buffer Rule section on page 85 and reiterated on page 203). This 10.0% CET1 requirement applies to the Company for the period October 1, 2024, through September 30, 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.8 billion phased-in amount and 75% calculation are accurate ($2.4B * 0.75 = $1.8B), and the 10.0% CET1 capital requirement under the Stress Capital Buffer framework is correctly stated. (2) The answer is complete, addressing both parts of the multi-part question: the CECL transition amount phased in by January 1, 2024, and the CET1 requirement effective October 1, 2024. (3) Entity accuracy is perfect—Capital One Financial Corporation is correctly identified, and the financial metrics (CECL transition amount, CET1 capital ratio) and timeframes (January 1, 2024, and October 1, 2024) are all correct. (4) The reasoning is sound and reflects proper multi-hop synthesis, correctly linking regulatory rules (CECL Transition Rule and Stress Capital Buffer Rule) to their financial impacts using specific document references. The explanation adds contextual clarity without introducing errors. All information is semantically equivalent to the ground truth, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 309,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "Disney's executive compensation strategy employs both time-based and performance-based Restricted Stock Unit (RSU) awards to align leadership incentives with long-term shareholder value, though they serve distinct strategic purposes. Time-based RSUs (e.g., Exhibit 10.43, 10.49, 10.54) provide steady equity incentives tied to continued employment, ensuring retention of key executives. In contrast, performance-based RSUs (e.g., Exhibits 10.44, 10.45, 10.46, 10.47, 10.55, 10.57) tie vesting to specific financial metrics like Total Shareholder Return (TSR), Return on Invested Capital (ROIC), and Section 162(m) compliance, directly linking compensation to measurable value creation for shareholders. This dual approach ensures executives are rewarded for both sustained leadership (via time-based vesting) and achieving specific performance targets that drive long-term growth and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Disney uses both time-based and performance-based RSUs, with correct exhibit references for time-based (10.43, 10.49, 10.54) and performance-based (10.44–10.48, 10.55, 10.57–10.59). The LLM lists most but not all performance-based exhibits—missing 10.48 and 10.58, which slightly reduces completeness. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is fully satisfied as all references and metrics (TSR, ROIC) are correctly stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes that time-based RSUs focus on retention while performance-based ones align with shareholder value via performance metrics. It accurately contrasts the two structures and their strategic purposes. (4) The answer is contextually excellent—directly addressing how each vesting type contributes to aligning executive compensation with long-term shareholder value. The omission of two exhibit numbers (10.48, 10.58) is minor and does not affect the core conclusion. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 368,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "The Orthopaedics segment’s overall growth in 2024 was driven in part by strong sales of its Hips and Knees products, which rose 5.0% and 6.1% respectively, contributing to the segment’s 2.4% total sales increase compared with 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the percentage growth for Hips (5.0%) and Knees (6.1%) products and the overall Orthopaedics segment growth (2.4%), which matches the ground truth. However, it omits key quantitative details: the actual dollar amount increases ($78M for Hips, $89M for Knees, $167M combined), the total segment growth of $216M, and the critical synthesis that Hips and Knees together accounted for approximately 77% of the total growth. These omissions significantly reduce completeness and quantitative accuracy. (2) While the percentages mentioned are accurate, the answer fails to include or calculate the contribution ratio (167/216 ≈ 77%), which is a central part of the original answer and essential to fully addressing how Hips and Knees 'contributed to' the overall growth. (3) The reasoning is partially sound—it correctly links Hips and Knees growth to the overall segment growth—but it does not demonstrate multi-hop synthesis by quantifying or contextualizing their relative impact. The conclusion that they 'contributed to' the growth is vague and under-supported compared to the ground truth's precise attribution. (4) The answer is contextually relevant and addresses the general relationship between product line performance and segment growth, hence a high relevance score. However, due to missing key figures and the failure to quantify the extent of contribution, the correctness, quantitative, and qualitative scores are moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 409,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "Based on the provided document pages, Capital One phased in 75% of its $2.4 billion CECL Transition Rule capital addition by January 1 2024, with the remaining $600 million scheduled to be phased in on January 1 2025. The CECL Transition Rule allows a five‑year optional period to phase in the impact of the CECL standard on regulatory capital, during which the estimated cumulative impact is added back to capital and then phased in at 25% per year (25% in 2022, 50% in 2023, 75% in 2024, and 100% in 2025).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states that 75% of the $2.4 billion—amounting to $1.8 billion—was phased in by January 1, 2024, and the remaining $600 million was scheduled for January 1, 2025. These figures align exactly with the original answer, and the percentage breakdown (75% and 25% annual increments) is correctly described. (2) The explanation of the CECL Transition Rule is complete and accurate: it correctly identifies the five-year optional transition period provided by the Federal Banking Agencies and specifies the annual phase-in schedule (25% in 2022, 50% in 2023, 75% in 2024, and 100% in 2025), which reflects the rule’s mechanics. (3) The multi-hop reasoning is sound—synthesizing both the specific Capital One implementation and the general regulatory framework of the CECL Transition Rule. (4) All entities (Capital One, CECL Transition Rule, regulatory capital) are correctly identified and contextually used. The answer is semantically equivalent to the ground truth, with slightly more detail on the phase-in schedule, enhancing clarity without introducing error. All scoring categories warrant perfect marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 340,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "The issuance of $500 million of Guaranteed Senior Notes by Costco’s Japanese subsidiary in 2023 increased the company’s long‑term debt balance, and the subsequent partial repayment of $77 million of those notes in 2024 reduced the outstanding amount.  As a result, the fair value of the overall long‑term debt portfolio was modestly affected—reflecting the net increase in debt from the 2023 issuance and the 2024 repayment—while financing activities in 2024 included the cash outflow for the repayment and the inflow from the new issuance.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of $500 million in Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and the partial repayment of $77 million in 2024, which aligns with the ground truth. However, it omits critical quantitative details about the actual fair value of long-term debt at the end of 2023 ($5,738 million) and 2024 ($5,412 million), which are central to answering how the fair value was affected. The answer vaguely states the fair value was 'modestly affected' without providing the actual decrease of $326 million, which is a significant omission. (2) The numbers mentioned ($500 million and $77 million) are accurate and correctly attributed to the issuance and repayment, respectively, though the original answer uses 'approximately $500' without specifying 'million'—but this is a minor formatting issue and semantically acceptable. However, the LLM fails to mention the $10,764 net cash used in financing activities in 2024 and the additional $1,000 repayment on the 2.750% Senior Notes, which are key components of the financing activities impact. (3) The reasoning is partially sound: it correctly links issuance to increased debt and repayment to reduced debt, and acknowledges both cash inflow and outflow in financing activities. However, it fails to synthesize the full multi-hop context—specifically, how the net change in debt translates into the reported fair value figures and how the financing activities total is composed. (4) The contextual relevance is high because the answer addresses the core events and their directional impact, but correctness is limited by missing key figures and incomplete synthesis, warranting a mid-range score of 5 for overall correctness. Quantitative accuracy is scored 5 due to missing major numbers and totals, qualitative accuracy 6 for correct logic but incomplete reasoning, and contextual relevance 8 for staying on-topic and addressing the main dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 530,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "The total estimated environmental remediation liability is not material and is accrued in the \"Accrued expenses\" line item of the consolidated financial statements; the company records a liability only when a site’s remediation costs are probable and reasonably estimable, and it does not consider amounts expected to be recovered from insurers.  \n\nThe methodology for estimating these costs differs in that for individual sites the company uses currently available data and prior remediation experience to estimate a single probable cost, whereas for multi‑party (joint) sites it estimates only its proportionate share of the likely costs, without assuming recovery from other parties or insurance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the answer correctly states that the total estimated environmental remediation liability is 'not material' (synonymous with 'immaterial' in the original), and that it is included in 'Accrued expenses'—this matches the ground truth exactly. There are no numerical values to calculate, but the qualitative assessment of materiality is correctly reported. (2) The methodology for individual sites is accurately described: Caterpillar uses available data, prior experience, and applicable laws to estimate costs, and accrues the minimum if no amount is more likely—though the LLM omits explicit mention of 'applicable laws' and the 'range' concept, it captures the essence by stating estimation is based on 'currently available data and prior remediation experience' and implies a single probable cost. (3) For multi-party sites, the LLM correctly identifies that Caterpillar estimates only its proportionate share and does not assume recovery from other parties or insurance, which aligns with the original answer’s point about considering its 'proportionate share of the probable costs.' The omission of the phrase 'rather than the full estimated liability' is minor and does not change meaning. (4) The LLM adds a detail not in the original—that liabilities are recorded only when costs are 'probable and reasonably estimable' and that recoveries from insurers are not considered—which is consistent with standard accounting practice and may be inferred contextually, though not explicitly stated in the ground truth. This does not detract from accuracy. Overall, the answer demonstrates sound multi-hop reasoning, correctly synthesizing Caterpillar’s liability treatment and methodological differences between site types. The only minor gap is the slightly less detailed description of the range-based accrual policy, which prevents a perfect 10. Scores reflect high accuracy, full contextual relevance, and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 549,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "The percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022 was a decline of 29% (from $15 million to $11 million, representing a $4 million decrease). This underperforming category was consolidated into the broader strategic restructuring of Cisco's product reporting structure in fiscal 2022, which reorganized categories to better align with strategic priorities—such as emphasizing growth areas like Secure, Agile Networks and End-to-End Security—while elevating the focus on higher-performing segments and eliminating less strategic offerings like \"Other Products\" to streamline reporting and resource allocation.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the percentage change in revenue (29% decline) and the dollar amounts ($15 million in 2021 to $11 million in 2022), which matches the ground truth exactly—thus achieving full quantitative accuracy. (2) However, the qualitative reasoning is significantly flawed: the LLM claims that 'Other Products' was eliminated or consolidated as part of the reporting restructuring to streamline and remove less strategic offerings. This directly contradicts the ground truth, which states that Cisco *explicitly included* 'Other Products' as a *distinct category* in the new reporting structure, signaling its continued strategic relevance despite underperformance. This misrepresents the company's strategic intent and fails the multi-hop synthesis—linking financial performance to strategic reporting decisions. (3) The reasoning error undermines the core of the second part of the question: rather than showing how the reporting structure reflects ongoing strategic interest, the LLM incorrectly infers that removal from broader categories implies de-emphasis, when the opposite is true according to the original answer. (4) Therefore, while numbers are correct and the response is contextually relevant by addressing both parts of the question, the qualitative inaccuracy severely impacts the overall correctness, warranting a mid-range score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 386,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "The executive employment agreement with Ron Vachris, effective January 1 2024, is a new agreement that was filed as Exhibit 10.9 in a Form 10‑Q dated November 26 2023 and filed on December 20 2023. In contrast, W. Craig Jelinek’s agreement has been repeatedly extended—each extension (effective January 1 2019, 2020, 2021, 2022, and 2023) appears as separate Exhibit 10.5.x items in the 10‑Q filings from 2018 through 2022, reflecting a pattern of term extensions rather than a single new agreement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and factually accurate, with strong quantitative precision and contextual relevance. (1) It correctly identifies the Ron Vachris agreement as effective January 1, 2024, and accurately references the Form 10-Q filing dates (November 26, 2023, and December 20, 2023), which aligns with the expected disclosure timeline. It also correctly notes that W. Craig Jelinek’s agreement was extended annually with effective dates from 2019 to 2023, appearing as separate Exhibit 10.5.x filings from 2018 to 2022. (2) Quantitatively, all dates and filing references are accurate. However, the original answer notes Jelinek's renewals span from 2017 through 2023 (based on filings from 2016–2022), while the LLM omits the 2017–2018 extensions, starting its count from 2019. This is a minor omission but affects completeness in covering the full six-year window. (3) The reasoning is sound: the LLM correctly infers a pattern of annual extensions for Jelinek and contrasts it with Vachris’s new agreement, noting different exhibit labeling practices. While it doesn’t explicitly state that Vachris’s agreement follows the same *timing pattern* (annual, effective January 1), it implies continuity through parallel structure. (4) The answer is highly relevant and well-structured, but misses the explicit synthesis that Vachris’s agreement continues Costco’s established annual renewal practice, which was the key comparative insight in the ground truth. Thus, while factually strong, it falls slightly short on full multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 425,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "The net value of Customer Relationships decreased by $181 million from $712 million at December 31 2020 to $531 million at December 31 2021, while the net value of Intellectual Property declined by $86 million from $366 million at December 31 2020 to $280 million at December 31 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the values for Customer Relationships. According to the ground truth, the net value of Customer Relationships decreased from $893 million in 2020 to $712 million in 2021, a decrease of $181 million. However, the LLM incorrectly states it decreased from $712 million in 2020 to $531 million in 2021, which is both a wrong starting value and wrong ending value, though the $181 million decrease is correctly calculated based on its incorrect inputs. The Intellectual Property values are correct: a decline from $366 million to $280 million, a $86 million decrease. (2) The calculation for the decrease in Intellectual Property is accurate and matches the ground truth. However, the Customer Relationships values are completely mismatched—$712 million is actually the 2021 value in the truth, but the LLM uses it as the 2020 value, inverting the timeline. This leads to a factually incorrect trend despite preserving the nominal change amount. (3) The multi-hop reasoning is partially sound in that the model identifies both intangible assets and computes year-over-year changes, but it fails in correctly retrieving and aligning the time-series data across years, which is critical for accurate comparison. (4) The contextual relevance is high because the structure and intent of the answer match the question, and the Intellectual Property portion is fully accurate. However, due to major quantitative inaccuracies in the Customer Relationships figures—despite the correct delta—the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the reasoning framework is valid but based on incorrect data retrieval.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 469,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "The total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022 was $23,829 million. Its revenue recognition model differs for hardware and SaaS arrangements: hardware and perpetual software licenses are recognized upfront upon transfer of control, while SaaS arrangements have one distinct performance obligation with revenue recognized ratably over the contract term.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the revenue recognition model differences—hardware and perpetual software are recognized upfront upon transfer of control, and SaaS revenue is recognized ratably over the contract term—which aligns perfectly with the ground truth. However, the total revenue contribution of $23,829 million for 'Secure, Agile Networks' in fiscal 2022 is not present in the original answer and cannot be verified from the provided ground truth. Since the ground truth does not include a specific dollar amount, introducing one—even if accurate—represents a factual overreach unless explicitly supported. (2) The quantitative value $23,829 million is specific and precise, but because it is absent from the ground truth and no source is provided to confirm it, this constitutes a potential hallucination or unsupported data point. This significantly impacts quantitative accuracy. (3) The qualitative reasoning is strong: the model correctly synthesizes the distinction in revenue recognition models between hardware/perpetual software and SaaS, demonstrating proper multi-hop understanding of accounting treatment across product types. (4) Contextual relevance is perfect—the response directly addresses both parts of the question and stays focused on Cisco’s product category and revenue policies. Due to the unsupported revenue figure, correctness is reduced to 8, quantitative accuracy to 7, but qualitative and contextual scores remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 406,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "Amazon's revenue from third-party seller fees in 2021 was $118.1 billion, representing 25% of total net sales of $469.8 billion. This revenue stream aligns with Amazon's stated business model of enabling sellers to grow their businesses through its platform, as evidenced by the company's description of third-party seller services as a core component that \"enable[s] sellers to grow their businesses, sell their products in our stores, and fulfill orders through us\" and generates revenue through commissions and related fulfillment/shipping fees recognized when services are rendered.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. It reports third-party seller fees for 2021 ($118.1 billion) instead of the requested 2022, and the correct 2022 amount is $117,757 million (~$117.8 billion), which differs slightly from the LLM's figure even when adjusting for year. This misalignment in both year and amount constitutes a major error. (2) The calculation of 25% of total net sales is based on 2021 data and does not apply to 2022; the question did not ask for percentage breakdown, so this is extraneous but incorrect context. The ground truth specifies 2022 with a precise figure, which the LLM fails to provide. (3) The qualitative reasoning about how third-party seller fees align with Amazon's business model is accurate and well-supported, citing the company's own language about enabling sellers, fulfillment services, and revenue generation through commissions. This part correctly synthesizes the strategic rationale and reflects multi-hop understanding of Amazon's ecosystem. (4) Contextually, the answer addresses both parts of the question—revenue figure and alignment with business model—but the first part is fundamentally flawed due to wrong year and number. While the explanation of business model alignment is strong and semantically equivalent to the original, the core factual inaccuracy in the key metric severely undermines the correctness. Hence, a score of 4/10 overall: partially correct reasoning and relevance, but major failure in quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 423,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "As of December 31 2024, Capital One’s Common Equity Tier 1 (CET1) capital ratio was **13.5 %**, while the minimum CET1 ratio required under the Basel III framework (the “Minimum Capital Adequacy” figure shown in Table 12) is **4.5 %**.  Consequently, the Company’s CET1 ratio exceeds the regulatory minimum by **9.0 percentage points**.  (The stress‑capital‑buffer framework raises the effective minimum to 10.0 % for the 2024‑2025 period, but the baseline minimum remains 4.5 %.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) Quantitatively, the CET1 ratio of 13.5% and the minimum requirement of 4.5% are accurate, and their difference is correctly calculated as 9.0 percentage points, matching the original answer's '9 percentage points'. Minor formatting (e.g., 9.0 vs 9) does not affect correctness. (2) The answer addresses all parts of the question: it identifies Capital One Financial Corp, the correct metric (CET1), the date (December 31, 2024), and computes the difference accurately. (3) Entity accuracy is correct—company, metric, and time period are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes the two values and performs the subtraction (13.5% - 4.5% = 9.0%). It even adds context about the stress-capital-buffer (10.0%) without conflating it with the baseline minimum, showing nuanced understanding. (5) The semantic meaning is equivalent to the ground truth, with slightly more detail but no factual deviation. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 298,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "Regulatory risks threatening Altria's $1.7 billion JUUL investment include ongoing FTC antitrust scrutiny and potential divestiture or rescission of the transaction, as well as broader e‑vapor regulatory uncertainty (e.g., FDA enforcement actions, possible removal of products from the market). If a challenge succeeds, Altria could be forced to divest or otherwise lose its stake, which would impair the investment’s fair value and could trigger additional impairment charges—directly undermining Altria’s strategic goal of leveraging JUUL to expand its presence in the innovative nicotine‑delivery market and to generate growth and shareholder returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key regulatory risks to Altria's $1.7 billion investment in JUUL, including FTC antitrust scrutiny and potential divestiture or rescission of the transaction. It also references broader e-vapor regulatory uncertainty, such as FDA actions, which is contextually relevant and consistent with the type of risk environment described in SEC filings. The financial impact—impairment of the investment’s fair value and potential impairment charges—is factually accurate and aligns with the original answer. However, the original answer specifically cites the FTC's administrative complaint and emphasizes the direct threat to Altria’s credit ratings, increased financing costs, and impact on strategic objectives like revenue improvements and cost savings. These specific downstream financial and strategic consequences are underdeveloped in the LLM answer, which only broadly references 'strategic goal of leveraging JUUL' and 'shareholder returns.'\n\n2) Quantitative accuracy is perfect: the $1.7 billion investment amount is correct, and no other numerical values (e.g., 35% stake) are incorrectly stated or miscalculated. The LLM does not mention the 35% stake explicitly, but this omission does not affect the numerical correctness of the information provided.\n\n3) The multi-hop reasoning is mostly sound: the model connects regulatory action (FTC complaint) to potential divestiture, then to financial impact (impairment charges), and finally to strategic objectives. This logical chain is valid. However, it misses the explicit linkage to credit ratings and financing costs, which are critical components of the financial impact as stated in the ground truth. Additionally, while FDA-related risks are contextually relevant, they are not the focus of the specific FTC antitrust action highlighted in the original answer, making this addition slightly tangential though not incorrect.\n\n4) The LLM answer is semantically close to the original and highly relevant to the question. It captures the core regulatory and financial risks but lacks some specificity in the strategic impact. The omission of credit rating implications and precise strategic objectives (e.g., cost savings) prevents a top score. Still, the answer is factually sound, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 619,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "The $500 million Notes Due 2060 are part of NVIDIA’s $11 billion of senior unsecured notes that must eventually be repaid or refinanced; the filing warns that maintaining such indebtedness can limit cash flow for operations, increase vulnerability to adverse economic conditions, and restrict the company’s ability to obtain future financing or meet contractual obligations. Consequently, the long‑dated 2060 notes amplify the financial‑flexibility risks tied to NVIDIA’s overall leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $500 million Notes Due 2060 and their inclusion in NVIDIA’s $11 billion senior unsecured notes, which matches the ground truth. All quantitative figures—$500 million, $11 billion, and the 2060 maturity—are accurate and properly contextualized. (2) There are no calculations required, but the synthesis of the note as part of a larger debt structure is correctly represented. Format variations (e.g., $500 million vs $500 million) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model connects the 2060 notes to broader refinancing risks, cash flow constraints, reduced financial flexibility, and vulnerability to economic conditions, as outlined in the 10-K. It correctly infers that even long-dated debt contributes to leverage-related risks despite distant maturity. (4) The only minor shortcoming is that the LLM does not explicitly mention the impact on 'planning for or reacting to changes in business' or 'capital expenditures, acquisitions' specifically, which are part of the full list of constrained capabilities in the original. However, the concepts of restricted future financing and operational cash flow limitations are covered, making the omission minor. Thus, the answer is factually correct, highly relevant, and semantically equivalent with only slight loss in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 385,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "The expanded FDA approval of Vemlidy for pediatric patients aged 6 years and older with chronic hepatitis B significantly broadens Gilead’s market potential in the pediatric HBV space, adding a new, high‑need indication to its existing liver‑disease portfolio that already includes Vemlidy for adults and other HBV/HCV products. This pediatric label expansion is expected to drive additional sales of Vemlidy and strengthen Gilead’s overall growth trajectory in the chronic HBV market, complementing its established antiviral and oncology offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. It correctly identifies the expanded FDA approval of Vemlidy for pediatric patients aged 6 years and older, which matches the original answer. The statement that this broadens Gilead's market potential in the chronic HBV space is valid and contextually appropriate. Quantitatively, there are no numbers, dates, or financial figures that conflict with the ground truth—only descriptive statements, all of which are consistent. The entity accuracy is correct: Gilead, Vemlidy, and the context of liver disease and HBV are properly identified. However, the LLM omits specific mention of the weight requirement (at least 25 kg) and does not reference the other key products in Gilead’s portfolio—Viread, Epclusa, and Harvoni—with their respective pediatric approvals, which are critical for full multi-hop synthesis. While it mentions 'existing liver-disease portfolio' and 'other HBV/HCV products,' it lacks the detailed cross-product analysis present in the original answer, weakening the completeness of the reasoning. The answer captures the strategic impact but misses the granular, evidence-based support from the broader portfolio that strengthens the conclusion. Thus, while the reasoning is sound and relevant, it falls slightly short on completeness and depth of synthesis, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 390,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "Approximately 5 percent of Lowe’s total fiscal 2023 sales came from installed‑sales categories that are also covered by Lowe’s extended protection plans, and the specific product category explicitly mentioned in both contexts is Appliances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage given is 5%, which exactly matches the original answer. The specific product category mentioned is Appliances, which is also correct and explicitly stated in both contexts in the ground truth. (2) The quantitative value '5 percent' is accurate and correctly formatted; no calculations are required beyond what is provided, and the number matches precisely. (3) The multi-hop reasoning—linking installed sales categories, extended protection plans, fiscal 2023 sales, and the overlapping product category—is correctly synthesized. The model identifies that Appliances is the category present in both contexts, demonstrating sound reasoning. (4) The answer is semantically equivalent to the original, with no omissions or inaccuracies. All parts of the question are addressed completely and concisely. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 266,
        "total_tokens": 1407
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "The cumulative impact of the CECL Transition Election from 2020 through 2024, including the 25% scaling factor applied to the \"day 2\" ongoing impact, results in a phased-in addition to regulatory capital that begins with a full \"day 1\" impact added back in 2020–2021 and then phases in 25% of the cumulative \"day 2\" impact each year through 2024. As disclosed in the 2021 10-K (page 206), this election allowed Capital One to add back $2.4 billion after-tax to regulatory capital, increasing its CET1 ratio from 12.4% (fully phased-in) to 13.1% as of December 31, 2021. The phase-in schedule applies 25% of the ongoing \"day 2\" impact annually from 2022 to 2024, with the full impact ultimately recognized by the end of 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant deviations from the ground truth in the description of the phase-in mechanics and some unsupported quantitative claims. (1) Quantitatively, the mention of a $2.4 billion after-tax add-back and the CET1 ratio increase from 12.4% to 13.1% as of December 31, 2021, appears specific and plausible but is not present in the original answer (ground truth), which does not include any dollar amounts or ratios. Without corroboration in the ground truth, introducing such specific figures risks inaccuracy, especially if they are not directly tied to the cumulative 2020–2024 impact as defined by the phase-in rules. (2) The description of the phase-in schedule is partially correct but misrepresents the structure: the LLM states that the 'day 1' impact was 'added back in 2020–2021', but the ground truth clarifies that both the after-tax 'day 1' impact and the 'day 2' ongoing impact are phased in at 25% annually from 2022 through 2024—not that 'day 1' was fully added back early. This is a critical error in reasoning. (3) The LLM correctly identifies the 25% scaling factor on the 'day 2' ongoing impact but incorrectly limits it to 2020–2021 as a 'full add-back', whereas the ground truth specifies that the 25% scaling factor is applied to the 'day 2' impact during 2020–2021, not that it was added back in full. Then, from 2022–2024, the LLM correctly notes a 25% annual phase-in but misattributes it only to 'day 2' impact, whereas the ground truth states it applies to *both* the 'day 1' and cumulative 'day 2' impacts. (4) The mention of 'end of 2025' as when the full impact is recognized is not supported by the original answer, which focuses on 2020–2024. Overall, while the answer demonstrates understanding of CECL phase-in concepts and cites a plausible document source (2021 10-K, p.206), it introduces unsupported specifics and mischaracterizes the multi-hop logic of the phase-in schedule, leading to a partially correct but materially flawed response. Contextual relevance is high as it directly addresses the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 567,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "The net financial impact of Altria’s 2021 tobacco settlement obligations and NPM adjustment recoveries was a $4.6 billion charge to cost of sales, reflecting the State Settlement Agreements and FDA user‑fee costs that are recorded as part of cost of sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $4.6 billion charge to cost of sales related to Altria's 2021 tobacco settlement obligations, which matches the ground truth. However, it omits the $21 million recovery from the 2004 NPM adjustment and the resulting net cost of $4.579 billion. This missing information significantly affects completeness and quantitative accuracy. (2) While the $4.6 billion figure is accurate, the answer fails to report the $21 million reduction or perform the implied calculation ($4.6 billion - $21 million = $4.579 billion), which is central to the 'net financial impact' asked in the question. (3) The reasoning is partially sound—Altria’s obligations are correctly attributed to cost of sales and linked to State Settlement Agreements and FDA fees—but the multi-hop synthesis is incomplete because it does not integrate the NPM adjustment recovery, a required component of net impact. (4) The answer is contextually relevant and uses correct entities (Altria, 2021, cost of sales, State Settlement Agreements), but the omission of a key financial component (NPM recovery) reduces correctness and quantitative accuracy. A fully accurate answer must include both the charge and recovery to reflect net impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 351,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "The total liabilities for non‑qualified deferred compensation plans and other postemployment benefits rose by **$67 million** from 2020 to 2021.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states an increase of $67 million, but the ground truth shows an increase of $91 million ($645 million in 2021 - $554 million in 2020). This is a significant numerical error. The individual components in the ground truth are $491M + $63M = $554M (2020) and $538M + $67M = $645M (2021), with a difference of $91M. The LLM's $67M figure appears to incorrectly use only the increase in other postemployment benefits ($67M - $63M = $4M) or misread the 2021 other benefits value as the total change, suggesting a failure in calculation or data extraction. (2) Quantitative accuracy is low because the core number (increase amount) is wrong, despite using plausible numbers from the context (e.g., $67 million appears in the data as the 2021 other benefits liability, not the change). (3) The reasoning is partially sound in that the model identifies the relevant categories and direction of change, and references the correct time frame (2020 to 2021), but fails to correctly aggregate or compute the total liability change across both components. This indicates a breakdown in multi-hop synthesis—while it accesses the right categories, it does not correctly sum and compare across years. (4) Contextual relevance is high because the answer addresses the exact question structure (change in total liabilities post-pension freeze), uses correct entity names (Caterpillar Inc.), correct benefit types, and correct years. However, the incorrect final figure severely undermines factual correctness. The model likely confused a component value with the total change, leading to a major factual error despite correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 450,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1,000 million, as shown in the lease‑obligation table that lists $176 million for 2023, $162 million for 2024, $136 million for 2025, $124 million for 2026, $114 million for 2027 and $288 million for 2028 and thereafter. This $630 million indefinite‑lived intangible asset recorded for Mellanox’s in‑process research and development project will not be amortized; it remains on the books as an indefinite‑lived asset and is only tested for impairment annually or when events suggest it may have reached technological feasibility, at which point it would begin to be amortized over its estimated useful life.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total estimated amortization expense is stated as $1,000 million, but the correct amount from the ground truth is $1.889 billion. The individual yearly figures provided by the LLM ($176M, $162M, etc.) are entirely incorrect and appear to be misread from a lease-obligation table rather than the correct amortization schedule. These numbers do not match the ground truth values of $585M (2023), $461M (2024), $405M (2025), $121M (2026), $16M (2027), and $121M (2028 and thereafter). The sum of the LLM's numbers is $1,000M, which is off by nearly $889 million. (2) The LLM incorrectly references a 'lease-obligation table' to justify the amortization figures, indicating a fundamental misinterpretation of the source data. This undermines the quantitative accuracy. (3) On qualitative aspects, the LLM correctly explains that the $630 million indefinite-lived intangible asset related to Mellanox’s in-process research and development (IPR&D) is not amortized and is subject to annual impairment testing until technological feasibility is reached. This part of the reasoning is sound and aligns with the ground truth. However, the failure to correctly identify and report the amortization figures — the core of the multi-hop query — severely weakens the overall reasoning. (4) The contextual relevance is moderate because the structure of the answer addresses both parts of the question and uses appropriate financial terminology, but the incorrect data renders the response largely inaccurate. Correctness and quantitative accuracy are low due to major numerical errors; qualitative accuracy is slightly higher due to correct conceptual treatment of IPR&D accounting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 474,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "The combined U.S. and EU patent expiration for Biktarvy is 2033. The expanded FDA approval for Biktarvy to treat people with HIV who have M184V/I resistance does not alter its patent expiration timeline, as the exclusivity remains anchored to the 2033 patent expiry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the U.S. and EU patent expiration year for Biktarvy as 2033, which matches the ground truth. This satisfies the quantitative requirement accurately. (2) All numeric values—specifically the year 2033 for both regions—are factually correct and consistent with the original answer. There are no calculation errors. (3) The reasoning regarding the expanded FDA approval is mostly sound: the LLM correctly notes that the approval does not alter the patent expiration timeline, which is accurate, as regulatory exclusivity extensions (if any) were not indicated in the ground truth, and the core patent remains the anchor. However, the LLM omits the positive impact on market exclusivity in terms of broadened therapeutic use and revenue potential, which is a key qualitative point in the original answer. While not factually incorrect, this omission slightly weakens the completeness of the multi-hop synthesis between the expanded indication and commercial exclusivity implications. (4) Despite this minor omission, the answer is factually correct, contextually relevant, and properly addresses both parts of the question at a high level. The quantitative accuracy is perfect, and the reasoning is logically sound, just less comprehensive than the ground truth in explaining the strategic impact of the expanded approval.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 379,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "The Federal Reserve’s supervisory stress‑testing models can produce capital‑buffer requirements that are more restrictive than Capital One’s own internal projections, meaning that even if internal stress‑test results suggest ample capacity to pay dividends or repurchase shares, the Fed’s modeled buffer may force the firm to limit those capital actions. This limitation is reinforced by the Dodd‑Frank Act’s enhanced prudential standards (specifically the Comprehensive Capital Analysis and Review and stress‑testing requirements), which obligate the company to align its capital plans with the Fed’s stress‑capital buffer and thereby constrain dividend and share‑repurchase activities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly explaining how the Federal Reserve's supervisory stress testing impacts Capital One Financial Corporation's capital return capacity by imposing more conservative capital buffer requirements than internal models may suggest, thus potentially restricting dividends and share repurchases. The answer correctly identifies the regulatory framework under the Dodd-Frank Act that reinforces this limitation. However, while the LLM references the 'enhanced prudential standards,' including CCAR and stress-testing requirements, the original answer specifies the 'source of strength doctrine' as the key Dodd-Frank provision that legally obligates COF to support its subsidiary banks. This is a nuanced but important distinction: the source of strength doctrine is the foundational legal requirement, whereas CCAR and stress-testing are implementation mechanisms. The LLM answer captures the operational constraint accurately but misses the precise statutory reference from the ground truth. There are no quantitative inaccuracies (quantitative accuracy is perfect), and the reasoning is sound and logically structured. The answer is semantically close and fully relevant to the question, warranting high scores in contextual relevance and qualitative accuracy, though not perfect due to the doctrinal specificity omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 383,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "The total payments made by PM USA under the State Settlement Agreements for 2019, 2020 and 2021 combined were approximately $4.3 billion (2019), $4.4 billion (2020) and $4.2 billion (2021), which together total about $12.9 billion.  \n\nFor 2020 alone, the maximum potential NPM Adjustment that could be applied to PM USA’s payments was $572 million, as disclosed in the independent auditor’s calculation of PM USA’s share of the maximum potential NPM Adjustments for 2004‑2020. This $572 million represents the highest possible reduction in payments that could occur in 2020.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the individual annual payments for 2019, 2020, and 2021, but swaps the amounts for 2019 and 2021. The ground truth states $4.2B (2019), $4.4B (2020), $4.3B (2021), while the LLM reports $4.3B (2019) and $4.2B (2021). This is a factual error in entity-year alignment. However, the total sum is reported as $12.9B, which is a reasonable rounding of the correct total ($4.2 + $4.4 + $4.3 = $12.9B), so the final total is acceptable. (2) The NPM Adjustment figure of $572 million for 2020 is correctly stated and contextually explained, matching the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes payments across three years and compares them to a separate financial metric (NPM Adjustment) for a single year. The comparison that the total payments are much larger than the 2020 NPM Adjustment is implied by the magnitudes, even if not explicitly stated. (4) The error in assigning specific yearly amounts slightly affects quantitative accuracy, but the overall conclusion and total are correct, warranting a high but not perfect score. Wording and structure are clear and relevant, with full contextual coverage of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 342,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "The fair value of the 2.85% Notes Due 2030 is reported as $1,180 million in the first table, while the net carrying amount of those notes is disclosed as $1,126 million in the second table for the fiscal year ending January 30, 2022. This results in a $54 million difference between the fair value and the net carrying amount.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states the fair value is $1,542 million and net carrying amount is $1,500 million, resulting in a $42 million difference. The LLM reports $1,180 million and $1,126 million, yielding a $54 million difference—none of which match the source data. (2) Quantitative accuracy is severely lacking: all dollar amounts are wrong, and the calculated difference ($54M) is based on incorrect inputs, making the arithmetic internally consistent but factually invalid. (3) While the LLM correctly identifies the structure of the question—comparing fair value and carrying amount from two tables—and performs the right type of calculation (subtraction), it fails at the multi-hop synthesis because it pulls incorrect data points, likely from a wrong fiscal year or misidentified instrument. (4) Contextual relevance is high because the answer addresses the correct notes, fiscal year, and tables, and follows the correct logical flow; however, the factual foundation is entirely flawed, leading to a very low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 323,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "The Tailoring Rules classify Capital One as a Category III institution, which allows it to exclude certain elements of AOCI from its regulatory capital calculations. This exclusion, combined with the Stress Capital Buffer Rule that sets the stress‑capital‑buffer requirement (e.g., 2.5 % for 2021‑2022), directly influences the capital ratios needed to satisfy the standardized‑approach capital conservation buffer. Consequently, Capital One’s minimum capital requirements—including the stress‑capital‑buffer component—are lower than they would be for a Category II institution, and the exclusion of certain AOCI items further reduces the capital base used to meet those buffer thresholds.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Capital One (COF), as a Category III institution under the Tailoring Rules, can exclude certain AOCI elements from regulatory capital and that this affects capital requirements in conjunction with the Stress Capital Buffer Rule. It also correctly notes reduced requirements compared to Category II. However, it introduces a specific percentage (2.5%) for the Stress Capital Buffer for 2021–2022, which is not present in the ground truth and cannot be verified from the provided context—this is a quantitative inaccuracy. (2) The ground truth does not specify any numerical value for the buffer, so inserting '2.5%' reduces quantitative accuracy despite possibly being factually correct in another context; this constitutes a hallucinated detail. (3) The multi-hop reasoning is generally sound: the model connects Category III status, AOCI exclusion, and the Stress Capital Buffer Rule to conclude lower capital requirements and reduced complexity. It captures the core causal chain, though it omits the point about COF no longer being subject to the Basel III Advanced Approaches framework—a notable omission affecting completeness. (4) Despite the unsupported percentage, the overall logic and direction of impact (lower requirements, reduced complexity) align with the ground truth. Wording differs but meaning is semantically close. Scores reflect minor factual overreach but strong qualitative and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 408,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "The total change in fair value of Altria's JUUL investment from 2020 to 2021 was a decline of approximately $1.5 billion (from $1.7 billion to $1.7 billion, with no specific fair value disclosed for 2021 beyond the $1.7 billion carrying amount), and this change was reflected in Altria's consolidated financial statements as part of \"income (losses) from equity investments\" in the consolidated statements of earnings, where the investment was recorded under the fair value option after the 2020 share conversion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that there was a 'decline of approximately $1.5 billion' in the fair value of Altria's JUUL investment from 2020 to 2021. According to the ground truth, the fair value remained unchanged at $1,705 million (approximately $1.7 billion) in both years, so there was no change. The LLM's claim of a $1.5 billion decline is factually incorrect and represents a major quantitative error. Additionally, the LLM suggests that the 2021 fair value was not specifically disclosed, which contradicts the ground truth stating it was explicitly $1,705 million. (2) The numbers are significantly inaccurate: the correct value is $1,705 million in both years, with zero change. The LLM fabricates a $1.5 billion decline with no basis in the data. While it correctly references a $1.7 billion carrying amount (a reasonable rounding of $1,705 million), the erroneous 'decline' undermines the entire quantitative foundation. (3) The reasoning is partially sound in that the LLM correctly identifies that changes in fair value are reflected in 'income (losses) from equity investments' and that the investment is accounted for under the fair value option after the 2020 share conversion. This shows correct understanding of accounting treatment and location in financial statements—key qualitative elements. However, the model fails the multi-hop synthesis by not recognizing that no change occurred despite having the correct base value. (4) The correctness score is low (3) due to the major factual error in the change in fair value. Quantitative accuracy is very poor (2) because of the invented $1.5 billion decline. Qualitative accuracy is moderate (5) as the model captures the correct accounting treatment and financial statement classification. Contextual relevance is high (7) because the answer addresses the right financial statements and concepts, even if with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 517,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "Based on the \"RAIL EQUIPMENT\" table on page 19, Union Pacific had a total of 7,154 locomotives as of December 31, 2023, of which 1,037 were leased. This means leased locomotives accounted for approximately 14.5% of the total fleet (1,037 ÷ 7,154 ≈ 0.145). The document also specifies that there were 132 switching locomotives in the fleet, all of which were owned (as indicated by a dash under \"Leased\" for the Switching row), meaning none of the switching locomotives were leased. Thus, the percentage of leased locomotives (14.5%) is significantly higher than the proportion of switching locomotives in the total fleet (132 ÷ 7,154 ≈ 1.8%), though the question asks for the comparison of the total number of switching locomotives, not their leased status. The key figures are 14.5% leased locomotives and 132 total switching locomotives.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 1,037 leased locomotives, 7,154 total locomotives, and 132 switching locomotives are correctly cited. The percentage calculation (1,037 ÷ 7,154 ≈ 14.5%) is accurate and properly rounded. (2) The answer addresses both parts of the question: it computes the percentage of leased locomotives (14.5%) and compares it to the total number of switching locomotives (132), noting that the leased count (in percentage terms) is significantly higher than the proportion of switching locomotives in the fleet (~1.8%). (3) Entity accuracy is correct—Union Pacific is the subject, all data points refer to the correct fleet composition as of December 31, 2023, and the source table is accurately referenced. (4) The reasoning is sound and goes beyond the ground truth by clarifying that none of the switching locomotives are leased (supported by the dash in the 'Leased' column), adding contextual insight without introducing error. The multi-hop synthesis—linking leased percentage to total fleet and comparing it to a subset (switching locomotives)—is logically and factually sound. The answer is semantically equivalent to the ground truth and provides additional clarity, enhancing rather than distorting accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 369,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "The fair value of the 2.20% Notes Due 2021 increased by $1,000 million from January 31 2021 to January 30 2022. This change is reflected in the fair‑value disclosures as a $1,000 million increase in the carrying amount of the debt, and it is also captured in the debt‑specific maturity and interest‑rate table, which shows the same $1,000 million rise in fair value for the 2021 notes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of the change in fair value. The ground truth states that the fair value decreased from $1,011 million to $0 million, indicating the notes matured and were no longer outstanding. The LLM incorrectly claims an increase of $1,000 million, which contradicts the actual data. (2) The numbers are significantly inaccurate: the starting value is misstated (implied $0 on Jan 31, 2021, instead of $1,011 million), the ending value is wrong (should be $0, not $1,000 million higher), and the change is falsely reported as an increase rather than a decrease to zero. The $1,000 million figure appears to be a rough approximation of $1,011 million but is used incorrectly in context. (3) The multi-hop reasoning is flawed: the model fails to recognize that a drop to $0 in fair value corresponds to debt maturity, as confirmed by the debt-specific table showing 0 years remaining and the effective interest rate no longer being applicable. Instead, it fabricates alignment with tables showing an increase, which contradicts the logic of debt maturity. (4) The contextual relevance is low because the answer misrepresents the nature of the financial event (maturity vs. appreciation in value), but it does attempt to reference the correct types of disclosures (fair value disclosures and debt table), earning minimal relevance points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 391,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio was required by an interim final rule issued by the Federal Reserve, which allowed certain BHCs to adjust the leverage exposure measure for that ratio. This adjustment was reflected in Capital One’s supplementary leverage ratio as of December 31 2020.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the supplementary leverage ratio denominator, and correctly attributes this adjustment to an interim final rule by the Federal Reserve. It also accurately references Capital One and notes the impact as of December 31, 2020, which aligns with the timeframe in the original data. However, it fails to explicitly state that this exclusion *increased* Capital One's supplementary leverage ratio, which is a key part of the cause-effect relationship in the original answer. Additionally, while it mentions the regulatory action, it omits the specific regulatory framework—Basel III Standardized Approach—that governed the adjustment, which is a required component of the multi-hop reasoning. (2) Quantitatively, there are no numbers or calculations in either answer, but the date (December 31, 2020) is correctly used and contextually appropriate. (3) The reasoning is partially sound: the model correctly links the regulatory rule to the adjustment in the leverage ratio, but it does not fully synthesize the connection between the interim rule and the Basel III framework, which is essential for complete multi-hop understanding. (4) The answer is contextually relevant and well-structured, but the omission of the Basel III framework and the directional impact (increase in ratio) reduces qualitative and overall correctness, warranting a score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 413,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million, and these assets were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total value of Union Pacific's Level 2 pension plan assets in 2023 as $3,209 million and accurately describes the valuation method as a bid evaluation process using bid data from independent pricing sources. All factual elements—dollar amount, year, company, asset classification (Level 2), and valuation methodology—are correct. (2) The quantitative accuracy is perfect: $3,209 million matches the ground truth. Although the breakdown of the components (Federal Government Securities at $1,508 million and Bonds and Debentures at $1,696 million, summing to $3,204 million—$5 million discrepancy likely due to rounding or unallocated items) is not included in the LLM answer, the total reported value is exactly correct. (3) The reasoning is sound and reflects proper multi-hop synthesis between the company (Union Pacific), plan type (pension), asset classification (Level 2), year (2023), and valuation method. However, the answer omits the specific composition of the Level 2 assets, which is part of the original answer but not strictly required to answer the two-part question. (4) The LLM response is semantically equivalent and contextually complete for the question asked. The minor omission of asset composition details prevents a perfect 10, but core facts and valuation method are fully accurate, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 394,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "NVIDIA Omniverse is highlighted in the 10‑K as a real‑time 3D design collaboration and virtual‑world simulation platform that empowers artists and creators to connect and work together in leading design applications, and it is also noted as a technology that, together with VR/AR, is being adopted in enterprise use cases such as virtual car showrooms, surgical training, architectural walkthroughs and other simulations powered by NVIDIA GPUs.  \n\nThe integration of Omniverse with the DRIVE platform underpins NVIDIA’s end‑to‑end AI computing strategy by providing a cloud‑based simulation environment (e.g., DRIVE Constellation with DRIVE Sim) that enables training, validation and continuous improvement of autonomous‑driving neural networks, thereby completing the full stack from AI training through in‑vehicle deployment and over‑the‑air updates.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the integration of Omniverse with the DRIVE platform and its role in NVIDIA's end-to-end AI strategy, including cloud-based simulation (DRIVE Constellation and DRIVE Sim), training of neural networks, and over-the-air updates. However, it misses the specific mention of 'Omniverse Avatar' and its application in real-time conversational AI for DRIVE Chauffeur and DRIVE Concierge systems, which is explicitly stated in the ground truth. Instead, the LLM generalizes to 'virtual car showrooms' and other enterprise use cases not directly tied to automotive AI applications as described in the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved. (3) The multi-hop reasoning is partially sound: the LLM correctly links Omniverse’s simulation capabilities with DRIVE’s autonomous driving pipeline and NVIDIA’s broader AI computing strategy. However, it fails to make the specific connection between Omniverse Avatar and in-vehicle conversational AI, a key detail in the ground truth that demonstrates a deeper level of synthesis. (4) The answer is contextually relevant and well-structured, but the omission of the specific automotive application (conversational AI via Omniverse Avatar in DRIVE Chauffeur/Concierge) reduces completeness and factual precision, warranting a correctness score of 7 rather than higher. The qualitative accuracy is also impacted due to this incomplete entity linkage, though the overall reasoning framework remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 451,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "The percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023 was a decrease of 14.3% (from $2,346 million to $2,082 million), while Converse's operating income increased by 11.7% (from $669 million to $747 million) over the same period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect in both direction and magnitude for both metrics. According to the ground truth, Converse's contribution to NIKE's total revenues increased by 3.4% from 2022 to 2023, whereas the LLM claims a 14.3% decrease. Similarly, operating income decreased by 30.0% per the ground truth, but the LLM incorrectly states an 11.7% increase. (2) The dollar amounts cited in the LLM answer ($2,346M to $2,082M for revenue; $669M to $747M for operating income) are factually wrong and contradict the ground truth, which implies different base figures and trends. The calculated percentages based on those numbers are mathematically consistent within the LLM's false framework but do not reflect reality. (3) The multi-hop reasoning failed entirely—instead of correctly identifying and comparing Converse's revenue contribution and operating income changes from 2022 to 2023 using accurate data from NIKE’s filings, the model used fabricated or misattributed numbers and inverted the trends. (4) Due to total factual inaccuracy in numbers, trends, and underlying data, the correctness and quantitative accuracy scores are near-zero. The qualitative accuracy is also extremely low due to flawed logic and entity misuse. Contextual relevance is slightly above zero because the answer addresses the right entities (Converse, NIKE, revenue, operating income) and time frame (2022–2023), but with entirely incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 401,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "The changes to TDR accounting guidance eliminated the “reasonably expected” and “concession” assessment criteria, causing trial modifications and Chapter 7 bankruptcy loans to be classified as TDRs (but not FDMs). Consequently, for the year ended December 31 2023, residential real‑estate TDRs totaled $136 million (including $69 million of trial‑modified loans and $9 million of Chapter 7 loans), while credit‑card TDRs totaled $648 million (including $27 million of trial‑modified loans). This reclassification affected both the residential real‑estate and credit‑card loan portfolios by increasing the reported TDR balances relative to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key numbers are correct: $69 million for residential real estate trial modifications and $27 million for credit card trial modifications are accurately reported. The additional details about Chapter 7 bankruptcy loans ($9 million) and total TDR balances ($136M and $648M) are consistent with the knowledge graph and provide helpful context, even though not explicitly asked. (2) Quantitative accuracy is perfect—no calculation or number errors. (3) The reasoning is sound: the elimination of 'reasonably expected' and 'concession' criteria correctly explains why trial modifications are now classified as TDRs but not FDMs, and this is correctly applied to both portfolios. The answer goes beyond the original by noting the increase relative to 2022, which is a reasonable inference. (4) The only minor deviation is the inclusion of Chapter 7 bankruptcy loans, which were not mentioned in the original answer and slightly extend beyond the scope of the question, which focused solely on trial modifications. However, this does not introduce inaccuracy and may reflect broader context from the filing. Overall, the answer fully addresses the impact on trial modifications with precise data and correct logic, earning a 9 due to slight over-inclusion without error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 377,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "As of December 31 2023, Union Pacific had **996 thousand non‑vested retention shares** outstanding under its stock incentive plans, and **617 thousand non‑vested performance stock units** (which are also part of the incentive plans).  In contrast, only **16,000 restricted shares** were outstanding under the separate Directors Plan on that same date.  Thus, the total retention‑related awards (≈1.6 million shares/units) far exceed the modest 16 k restricted shares held under the Directors Plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the numbers reported. The ground truth states 954,405 retention shares and 366,046 retention units (totaling 1,320,451), but the LLM reports 996,000 retention shares and 617,000 performance stock units (≈1.6 million total), which are both factually incorrect. The only correct number is the 16,000 restricted shares under the Directors Plan. (2) Quantitative accuracy is low: the LLM inflates both the retention shares (+41,595) and retention units (+250,954), and misrepresents retention units as 'performance stock units'—a different instrument not equivalent to retention units. The total of ~1.6 million is also incorrect compared to the true total of ~1.32 million. (3) While the LLM attempts multi-hop reasoning by comparing incentive plan awards to the Directors Plan, it fails to correctly identify and synthesize the specific components: 'retention shares' and 'retention units' are distinct from 'performance stock units', and the conflation undermines the reasoning. (4) Contextual relevance is high—the answer addresses the structure of the question, identifies the relevant plans, and makes the appropriate comparison to the Directors Plan. However, due to major numerical and classification errors, the correctness score is low despite correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 368,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, AMD's investment in the ATMP JV as of December 28, 2024, consisted of a $149 million carrying value of its equity investment plus a $100 million secured loan it provided to the JV, totaling $249 million. This is confirmed by the note stating the Company entered into a $100 million term loan agreement with an ATMP JV on October 9, 2024, which is recorded as part of its investment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $149 million equity investment carrying value and $100 million secured loan are correctly stated, and their sum of $249 million is accurate. The date (December 28, 2024) and the October 9, 2024 loan agreement are consistent with the required timeframes. (2) The answer is complete, addressing both components of AMD's total investment—equity and loan—and correctly aggregating them. (3) Entity accuracy is correct: AMD, ATMP JV, and the financial instruments (equity investment, secured term loan) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly links the two forms of investment (equity and loan) from different parts of the filing and combines them into a total investment figure. (5) The semantic meaning is equivalent to the original answer, with no factual or interpretive discrepancies. Minor wording differences do not affect accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 305,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "The total financial impact of Danaher’s disposition of Envista Holdings Corporation consisted of a $451 million pretax gain on the sale, a $109 million foreign‑currency translation adjustment loss that was re‑classified from accumulated other comprehensive income to discontinued‑operations earnings, and $69 million of IPO and separation‑related costs incurred in 2019.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys all key components of the financial impact from Danaher's disposition of Envista Holdings Corporation. (1) Quantitatively, all numbers are correct: $451 million gain on disposition, $109 million foreign currency translation adjustment loss, and $69 million in IPO and separation-related costs—matching the ground truth exactly. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect accuracy. (2) The answer addresses all elements of the question: gain, loss reclassification, and costs. However, it does not explicitly compute or state the net total financial impact of $387 million (calculated as $451M - $109M - $69M = $387M), which is the final figure requested. This omission prevents a perfect score, though the components are fully correct. (3) Multi-hop reasoning is sound—the model correctly identifies the three distinct financial components from different aspects of the disposition process and links them appropriately to Danaher’s financials. (4) Entities (Danaher, Envista Holdings Corporation, 2019 timing implied) and financial terms (foreign currency translation adjustment, IPO and separation costs) are used accurately. The answer is semantically equivalent to the original in content but slightly less complete due to missing the net total. Hence, correctness is scored 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 394,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "The 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, led to a 30% decrease in reported EBIT for the Converse segment. This was primarily due to a 130 basis point gross margin contraction from unfavorable foreign currency exchange rates, lower full-price ASPs, and higher product costs, partially offset by lower operating expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 15% currency-neutral revenue decline and its impact on Converse's reported EBIT, stating a 30% decrease, which matches the ground truth. The 130 basis point gross margin contraction due to unfavorable foreign currency exchange rates is accurately included. (2) All numeric values—15% revenue decline, 30% EBIT decrease, 130 basis point margin contraction—are factually correct and consistent with the original answer. No calculation errors are present. (3) The reasoning is largely sound and captures the multi-hop relationship between revenue decline, margin pressure, and EBIT performance. However, the LLM adds 'lower full-price ASPs' and 'higher product costs' as additional causes for margin contraction, which are not mentioned in the ground truth. While these may be plausible factors, they introduce unverified details not supported by the original data, slightly reducing qualitative accuracy. It also mentions 'partially offset by lower operating expenses,' which is absent in the ground truth and not confirmed. (4) Despite these minor additions, the core facts, numbers, and causal relationships are correct and semantically equivalent to the original answer. The additions do not contradict but extend the explanation, which is acceptable within reason. Thus, the answer earns a high score but not perfect due to the extra, unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 392,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1 2023 eliminated the “reasonably expected” and concession assessments, causing trial‑modification and Chapter 7 loans to be classified as TDRs while FDMs were not. Consequently, the allowance for credit losses was reduced by $587 million, reflecting the lower TDR‑related allowance, and the Firm’s overall allowance for credit losses fell to $24.8 billion (a net addition of $3.1 billion from the prior year, which included the $1.2 billion boost for First Republic loans). This reduction modestly weakened JPMorgan’s financial position, offset in part by the $1.9 billion increase in the allowance tied to First Republic loan growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $587 million reduction in the allowance for credit losses due to the new TDR guidance, which matches the ground truth. However, it incorrectly states that trial-modification and Chapter 7 loans were classified as TDRs while FDMs were not — this misrepresents the actual change. According to the original answer, these loans (trial mods and Chapter 7) were reclassified as *non-FDMs* (not as TDRs), even though they remained TDRs under the old definition. This is a critical conceptual error. Additionally, the LLM introduces new figures not present in the ground truth: the $24.8 billion total allowance, $3.1 billion net addition, $1.2 billion First Republic boost, and $1.9 billion increase tied to First Republic. These numbers, while possibly accurate in a broader context, are not part of the specific impact of the TDR guidance change and introduce irrelevant information. (2) The only correct number directly tied to the TDR guidance impact is the $587 million reduction. The $69 million (trial mods) and $9 million (Chapter 7) figures from the ground truth are missing entirely. The LLM’s additional calculations involving First Republic and net changes are unsupported by the original answer and distract from the specific cause-effect relationship asked. (3) The multi-hop reasoning is flawed: the model fails to connect the elimination of the 'reasonably expected' and 'concession assessment' criteria to the reclassification of specific loan categories as non-FDMs, which is the core mechanism behind the allowance reduction. Instead, it reverses the logic by suggesting TDR classification caused the change, when in fact the change was in how modifications were assessed for FDM status. (4) The contextual relevance is high because the answer addresses the TDR guidance, the date (January 1, 2023), and the allowance impact. However, the qualitative and quantitative accuracy are significantly reduced due to incorrect reasoning, missing key details, and the introduction of extraneous data. The conclusion that the reduction 'modestly weakened' the financial position contradicts the ground truth, which states it *improved* the financial position by lowering reserves — a major factual inversion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 605,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "The total amount invested in Level 2 assets by UNP’s pension plan was $3,209 million, and the specific investment categories that use bid evaluation with independent pricing sources as their valuation methodology are Federal Government Securities and Bonds and Debentures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its quantitative claim—the total amount invested in Level 2 assets by UNP's pension plan is stated as $3,209 million, whereas the ground truth is $1,111 million, a major discrepancy. This error alone severely undermines the answer's correctness. (2) Regarding investment categories, the LLM correctly identifies Federal Government Securities and Bonds and Debentures as using bid evaluation with independent pricing sources, but it omits Corporate Stock, which is also part of the Level 2 assets and uses the same valuation methodology. Thus, the categorization is incomplete. (3) The multi-hop reasoning is flawed: the model fails to accurately synthesize the correct total from the constituent categories and either misidentifies the source data or miscalculates the sum. The omission of one of three asset categories suggests incomplete retrieval or reasoning across entities. (4) While the answer addresses the right question and uses appropriate financial terminology (contextual relevance is acceptable), the severe numerical inaccuracy and incomplete entity identification result in low scores for quantitative and qualitative accuracy. The correctness score is low due to fundamental factual errors despite partial alignment in methodology description.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 368,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "The research and medical products segment revenue grew from $13.512 billion in 2019 to $17,979 million in 2020 and $24,802 million in 2021, reflecting growth rates of 33.1 % (2019‑2020) and 45.6 % (2020‑2021). In contrast, total company revenue increased from $17.911 billion to $22.284 billion to $29.453 billion, yielding growth rates of 24.4 % and 32.1 % respectively. Thus, the segment’s revenue growth consistently outpaced overall company growth, indicating that the research and medical products segment was a key driver of DHR’s overall financial performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the 2021 segment revenue ($24,802 million) and total revenue ($29,453 million) are correct, the 2019 values are misrepresented: the LLM states $13.512 billion (correct) but then uses $17.911 billion for total revenue in 2019, which is accurate, yet implies a 2020 total revenue of $22.284 billion. However, the ground truth does not provide 2020 total revenue, and the LLM introduces an unsupported intermediate data point. More critically, the segment revenue for 2020 is stated as $17,979 million, but this figure is not in the original answer and cannot be verified. The original answer only provides 2019 and 2021 data, so calculating 2019–2020 and 2020–2021 growth rates requires unverified assumptions. (2) The original answer computes a two-year growth rate (2019–2021): segment growth = (24,802 - 13,512)/13,512 = 83.5%, total revenue growth = (29,453 - 17,911)/17,911 = 64.4%. The LLM breaks this into annual rates, which is a reasonable elaboration, but the underlying 2020 figures are not supported by the ground truth, making the 33.1% and 45.6% segment growth rates potentially incorrect. Similarly, the 24.4% and 32.1% total revenue growth rates rely on an unverified $22.284 billion 2020 total revenue. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that the segment outpaced total company growth and concludes it was a key driver, which aligns with the original answer. However, this conclusion is based on fabricated intermediate-year data, undermining the reasoning's validity. (4) The contextual relevance is high—the answer addresses both parts of the question and draws the correct qualitative conclusion. Qualitative accuracy is moderate because the logic and entity identification (DHR, research and medical products segment) are correct, but the unsupported 2020 figures reduce reliability. Quantitative accuracy is low due to the introduction of unverified numbers and derived growth rates. Correctness score is 6 because the core conclusion is right and key 2019/2021 endpoints are accurate, but the use of unverified intermediate data introduces significant factual errors in the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 596,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "The adoption of the revised TDR accounting guidance effective January 1 2023 required JPMorgan to treat trial‑modification programs (FDMs) and certain other loan modifications as TDRs, eliminating the prior “reasonably expected” and concession assessments. Consequently, the allowance for credit losses reflected a $587 million reduction tied to this guidance change, and the classification of trial modifications for credit‑card loans was updated so that such modifications were considered TDRs (but not FDMs) for the year ended December 31 2023. This shift increased the reported allowance for loan losses in the credit‑card portfolio and affected the overall allowance for credit losses.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $587 million reduction in the allowance for credit losses due to the revised TDR guidance, which matches the ground truth. It also correctly states that trial modifications are now considered TDRs but not FDMs, aligning with the updated classification. However, it incorrectly refers to 'trial-modification programs (FDMs)', which is factually wrong—FDMs are formally distressed modifications, not trial modifications. This mischaracterization introduces confusion between trial modifications and FDMs. (2) Quantitatively, the $587 million figure is accurate. However, the LLM omits key numbers from the ground truth: prior-year credit card TDRs of $418 million, 2023 credit card FDMs of $648 million, and $27 million in loans under trial modifications. These omissions reduce completeness. (3) The reasoning is partially sound—the model captures the elimination of the 'reasonably expected' and concession criteria and links it to the change in classification. However, it incorrectly implies that treating trial modifications as TDRs increased the allowance for loan losses, whereas the overall effect was a $587 million reduction in the allowance, indicating a net decrease, not increase. This contradicts the ground truth and reflects flawed logic. (4) Contextual relevance is high—the response addresses the core impact on allowance and classification. However, the incorrect implication about allowance increase and missing key figures reduce factual precision. Overall, core facts are present but with significant qualitative and completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 439,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "3M changed its accounting for net periodic pension and postretirement costs in the first quarter of 2021, switching from the calculated value approach to the fair value approach for determining the market‑related value of fixed‑income plan assets. This change altered the expected return on plan assets and the amortization of unamortized actuarial gains and losses, resulting in a lower net periodic pension expense (e.g., $406 million under the prior method versus $322 million as adjusted in 2020) and a corresponding reduction in other expense, while also affecting retained earnings, accumulated other comprehensive income, and related line items across all presented periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key change in accounting principle—3M's switch from a calculated value approach to a fair value approach for fixed-income securities in pension and postretirement plans, effective Q1 2021. It accurately notes the retrospective application and the impact on expected return on plan assets, amortization of actuarial gains/losses, and key financial metrics such as net periodic pension expense, other expense, retained earnings, and accumulated other comprehensive income. The qualitative reasoning is sound and aligns with the ground truth, demonstrating proper multi-hop synthesis of the accounting change and its financial statement implications. However, the quantitative accuracy is slightly compromised: while the LLM cites specific figures ($406M vs $322M), these numbers are not present in the original answer (ground truth) and cannot be verified from the provided context. The ground truth does not include any dollar amounts for pension expenses under the old or new methods, so introducing such specific figures—though plausible—constitutes an overreach and risks misinformation. This introduces a factual risk, lowering the quantitative accuracy. Otherwise, all entities (3M, 2021, pension/postretirement plans, financial metrics) are correct, and the answer is highly relevant to the question. Semantic equivalence is largely maintained, though the addition of unverified numbers prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 399,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1 2023 reduced the allowance for credit losses by **$587 million**, as explicitly noted in the Management’s Discussion and Analysis section (page 134, footnote (a)). This reduction is reflected in the total allowance for credit losses, which fell from $22,204 million at the end of 2022 to $24,522 million at the end of 2023, with the $587 million impact attributed specifically to the TDR guidance change.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $587 million reduction in the allowance for credit losses due to the new TDR accounting guidance, which matches the ground truth. However, it incorrectly states that the allowance increased from $22,204 million in 2022 to $24,522 million in 2023, implying a rise of over $2 billion, which contradicts the claimed $587 million reduction. This calculation error severely undermines quantitative accuracy. The actual allowance trend may have been affected by other factors, but presenting an increase while citing a reduction due to TDR is logically inconsistent. (2) The dollar amount of the impact ($587 million) is correct and properly attributed to the TDR guidance change. However, the before-and-after totals are factually wrong or misinterpreted—either the numbers are inaccurate or their explanation is flawed. The difference between $24,522M and $22,204M is +$2,318M, not a $587M decrease. This suggests a failure in quantitative reasoning. (3) The multi-hop reasoning is partially sound: the model correctly links the adoption date (January 1, 2023) with the impact on the allowance and references the correct accounting change (removal of 'reasonably expected' and 'concession' criteria). It also cites a specific source (MD&A page 134, footnote a), indicating good contextual grounding. However, the synthesis fails when combining the specific impact with the overall allowance figures. (4) The correctness score is 6 because the key dollar amount and qualitative explanation of the guidance change are accurate, satisfying the core of the question. But the glaring numerical inconsistency in the total allowance amounts prevents a higher score. Quantitative accuracy is low (4) due to the incorrect totals and implied direction of change. Qualitative accuracy is high (8) as the reasoning around the guidance change is sound. Contextual relevance is excellent (9) — the answer directly addresses the question with appropriate detail and sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 539,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "The combined impact on goodwill and operating profit in the Africa/Eurasia region for Colgate-Palmolive in 2023 was a goodwill balance of $88 million (down from $107 million at the start of the year) and an operating profit of $254 million. This operating profit is significantly lower than the $311 million capital expenditures made in the same Africa/Eurasia region during 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly states the ending goodwill balance ($88 million, down from $107 million) and the operating profit ($254 million) for Colgate-Palmolive's Africa/Eurasia region in 2023, it incorrectly claims that capital expenditures were $311 million. The ground truth states capital expenditures were $10 million. This is a major quantitative error. Additionally, the LLM incorrectly states that the operating profit ($254 million) is 'significantly lower' than capital expenditures, which is the opposite of the truth—operating profit is much higher than capex. (2) The calculation of the combined impact of goodwill decrease and capital expenditures is missing. The correct combined impact is $19M (goodwill decrease) + $10M (capex) = $29M, which the LLM does not compute. Instead, it misrepresents the relationship between operating profit and capex. (3) The multi-hop reasoning fails: the model should have synthesized goodwill change, operating profit, and capex, then compared the combined non-operating outflows (goodwill decrease due to FX and capex) to operating profit. Instead, it incorrectly compares operating profit to a fabricated capex number. (4) Scores are low due to major factual and quantitative errors, flawed logic, and incorrect conclusions. Contextual relevance is moderate because the answer addresses the right region, company, year, and metrics, but with wrong values and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 408,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "The 2021 business segment reporting changes required 3M to reassign goodwill to new reporting units using the relative fair‑value method, but the reassignment was immaterial and no goodwill impairment was identified; the company subsequently performed its annual goodwill impairment test in Q4 2021 and concluded that no impairment existed, indicating that the restructuring did not create significant impairment risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key facts are correct: the 2021 business segment changes led to a reassignment of goodwill using the relative fair value method, the change was immaterial, and no goodwill impairment was identified. The annual impairment test was completed in Q4 2021 with a conclusion of no impairment. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal reference 'Q4 2021' matches the 'fourth quarter of 2021' in the ground truth. (3) The multi-hop reasoning is sound: the answer correctly links the structural change to goodwill reassignment methodology, assesses materiality, and connects it to the subsequent impairment test and conclusion. (4) The response fully addresses both parts of the question: the impact on goodwill reporting structure and the evaluation of impairment risk. Wording differs slightly but meaning is preserved. All entities (3M, 2021, goodwill, reporting units, impairment test) are correctly identified and contextually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 311,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "AMD acquired Silo AI to accelerate its AI model deployment and software development capabilities, leveraging Silo AI's workforce and expertise to enhance AMD's AI solutions on its hardware platforms. This acquisition aligns with AMD's strategic focus on expanding its AI infrastructure and software ecosystem, particularly within the Data Center segment, to compete more effectively in the growing AI market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies the strategic rationale behind AMD's move—accelerating AI model deployment and software development by leveraging Silo AI's workforce and expertise—and connects it to AMD's goals in AI infrastructure and the Data Center segment. The only minor discrepancy is the use of 'acquired' instead of 'invested in,' which slightly overstates the nature of the relationship (investment vs. full acquisition), but this does not materially alter the core strategic intent or outcome. There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable but assumed correct by absence. The reasoning is sound, with proper multi-hop synthesis between Silo AI's capabilities and AMD's strategic objectives in AI software and hardware integration. The answer is fully contextually relevant and captures the key elements of the original answer with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 290,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "Based on the provided document pages, **six amendments** were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015. These amendments are explicitly listed as the **First through Sixth Amendments** in the document (Exhibits 10.46 through 10.51 on page_109), with the Sixth Amendment effective as of September 1, 2015. The amendments are detailed in the \"Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology\" section, confirming six distinct amendments within the specified timeframe.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) The quantitative information is accurate: the answer correctly states that six amendments were made between September 2, 2014, and September 1, 2015. The mention of the First through Sixth Amendments (Exhibits 10.46–10.51) confirms the count with precise document references. (2) The date of the Sixth Amendment (September 1, 2015) falls within the specified timeframe, and the starting point (after September 2, 2014) is correctly interpreted. (3) The reasoning is sound and demonstrates multi-hop synthesis by identifying the agreement, linking each amendment to its exhibit, and confirming the total count within the time window. (4) All entities—agreement name, amendment sequence, document location—are accurately referenced. The answer is semantically equivalent to the ground truth, with added contextual detail that enhances clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 289,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "The 2023 10-K shows that PM’s acquisition of Swedish Match was completed on November 11 2022, so Swedish Match’s results were first included in PM’s consolidated financials beginning in 2023. Consequently, the filing reports a 100 % increase in net revenues and operating income for the “Swedish Match” segment, reflecting full‑year consolidation of its operations. The separate shipment‑volume commentary notes that Swedish Match’s oral‑product volume grew sharply (e.g., nicotine‑pouch shipments up 55 % in the U.S.), indicating that the integration was still in its early stages and that volume gains were being realized only after the acquisition was fully incorporated into reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that Swedish Match’s results were first included in PM’s consolidated financials beginning in 2023, when in fact the acquisition closed on November 11, 2022, meaning Swedish Match was included in the 2022 financials from that date forward. This directly contradicts the ground truth and misrepresents the timing of consolidation. The claim of a '100% increase in net revenues and operating income' due to full-year consolidation in 2023 is unsupported and incorrect—no such percentage increase is stated or implied in the original answer, and the logic is flawed. The shipment volume figures (e.g., 55% growth in nicotine-pouch shipments) are fabricated and not present in the ground truth. (2) Quantitative accuracy is low: the date of acquisition (November 11, 2022) is correct, but the financial impacts (100% increase, 55% volume growth) are entirely made up. There are no valid calculations or reported metrics from the original answer reflected accurately. (3) The multi-hop reasoning fails: the model misunderstands the relationship between acquisition timing and reporting scope. It incorrectly infers that because the 2023 10-K reports Swedish Match results, they were first consolidated in 2023, ignoring the post-acquisition inclusion in 2022. It also misinterprets the purpose of separate shipment commentary, framing it as evidence of early integration rather than ongoing separation due to incomplete integration. (4) Contextual relevance is moderate—the answer addresses the acquisition date and attempts to discuss reporting and integration, but the incorrect facts and reasoning undermine the response. While it engages with the question’s themes, the core conclusions are factually wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 496,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "Based on the provided document pages, the total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were specifically designed to hedge the fixed-rate notes due in 2049 ($500 million principal) and 2050 ($300 million principal), which together total $850 million in principal. The notional amount of $800 million directly corresponds to the hedging of these specific debt instruments, as stated in the document: \"During the second and third quarters of 2021, 3M entered into interest rate swaps with an aggregate notional amount of $800 million. These swaps converted $500 million and $300 million of 3M's $1.0 billion and $650 million principal amount of fixed rate notes due 2049 and 2050, respectively.\"",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $800 million notional amount of interest rate swaps in 2021, which matches the ground truth. However, it incorrectly states the combined principal of the fixed-rate notes due in 2049 and 2050 as $850 million ($500M + $300M), while the ground truth specifies a combined principal of $1.65 billion for those notes. This is a critical factual error. The LLM appears to confuse the portion of debt being hedged ($800M) with the total principal outstanding. (2) The calculation of the hedged proportion is therefore also incorrect: the LLM implies 100% coverage of $850M, whereas the ground truth states that $800M in swaps covered only 48.5% of a much larger $1.65B total principal. The individual numbers cited by the LLM (e.g., $500M and $300M) may reflect partial hedges of larger note issuances, but the LLM misrepresents them as the total principal amounts. (3) The multi-hop reasoning is flawed because the model fails to distinguish between the amount hedged and the total outstanding principal. It incorrectly infers that the $500M and $300M are the full principal amounts of the 2049 and 2050 notes, when in fact they are only portions of larger issuances. This breaks the synthesis required to answer how the swap amount compares to the total principal. (4) Despite the significant quantitative and qualitative errors, the answer is contextually relevant—addressing the right company, year, instruments, and hedging relationship—and uses appropriate financial terminology. Hence, moderate scores for quantitative and qualitative accuracy, low correctness due to core factual inaccuracy, and high relevance for structure and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 459,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "The total consideration transferred by AbbVie for both the Allergan and Soliton acquisitions was $64,084 million, of which $535 million was paid in cash for Soliton and the remaining $63,549 million was paid in stock and other equity awards for Allergan. Consequently, the cash component of the combined consideration amounted to $535 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states the total consideration was $64,619 million, but the LLM reports $64,084 million—a difference of $535 million. More critically, the cash component is severely misstated: the LLM claims only $535 million in cash (attributed solely to Soliton), while the ground truth indicates $40,210 million in total cash payments. This represents a major quantitative and qualitative error. (2) The calculation of the cash portion is incorrect. The LLM implies that only Soliton was paid in cash ($535 million) and Allergan entirely in stock ($63,549 million), but in reality, the Allergan acquisition included substantial cash consideration. The sum of the LLM's components ($535M + $63,549M = $64,084M) does not match the correct total ($64,619M), indicating flawed arithmetic or data sourcing. (3) The multi-hop reasoning is partially sound in structure—attempting to sum two acquisitions and break down payment forms—but fails in execution due to incorrect underlying data. It correctly identifies that Soliton was a smaller, mostly cash deal, but incorrectly assumes Allergan was paid entirely in stock, contradicting the known structure of the Allergan acquisition, which was a mixed cash-and-stock transaction. (4) Scores reflect major factual and numerical errors (correctness 3/10, quantitative accuracy 3/10), with slightly better performance in attempting structured reasoning and addressing the right entities (qualitative 4/10), and high relevance to the question's intent (contextual 8/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 441,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "Bank of America's Basel 3 capital framework gives it a robust capital cushion—its CET1 ratio of 11.9 % (Standardized) and 13.5 % (Advanced) comfortably exceeds the regulatory minimum plus buffers—so the firm can comfortably satisfy the capital requirements that underpin its $25 billion stock‑repurchase program. Because the repurchase plan is subject to capital‑availability constraints, the strong Basel 3 capital position and the resulting TLAC and leverage ratios provide the necessary regulatory headroom to execute the program without breaching capital‑distribution restrictions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Bank of America's adherence to Basel 3 as enabling its stock repurchase program and notes that the program is subject to capital availability and regulatory constraints, which aligns with the ground truth. However, there are key quantitative discrepancies. The ground truth states that Bank of America repurchased $13.1 billion of common stock in 2024, while the LLM answer does not mention this actual amount executed—instead implying the full $25 billion could be executed due to capital strength. This omission of the actual repurchase figure reduces completeness and factual accuracy. Additionally, the LLM introduces a CET1 ratio of 13.5% under the 'Advanced' approach, which is not present in the original answer and cannot be verified from the provided ground truth, making it potentially inaccurate or unsupported. (2) The only verified number from the ground truth is the 11.9% CET1 ratio under the Standardized approach, which the LLM correctly reports. The minimum requirement of 10.7% (including buffers) is not mentioned in the LLM answer, weakening the comparative analysis. The $25 billion authorization is correctly referenced. (3) The multi-hop reasoning is generally sound: the model connects Basel 3 compliance → strong capital position → ability to conduct repurchases. However, it fails to fully synthesize that the actual repurchase ($13.1B) was constrained or determined by capital levels, rather than the full $25B being executed. This reflects a partial misunderstanding of the conditional nature of the program. (4) Scores reflect mostly correct reasoning and context, with moderate deduction for unsupported numbers and missing key execution data. The answer remains relevant and logically structured, but lacks precision in conveying the limits of the program relative to capital thresholds.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 506,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "Based on the provided pages from the MMM 2022 10-K filing, the total carrying value in millions of the Medium-term note with a principal amount of $650 million and maturity in 2023 is **$649 million** as reported in the long-term debt maturity schedule (Page 87, table of debt instruments). This corresponds to the specific $650 million Medium-term note due in 2023, which has a carrying value of $649 million at December 31, 2021. The question references \"maturity dates in 2023 and 2048,\" but the $650 million note is explicitly tied to a 2023 maturity (not 2048), and the carrying value for that specific instrument is $649 million. The 2048 maturity note is a separate $650 million instrument with a carrying value of $638 million, but the question specifically asks for the $650 million note with maturity in 2023 (as confirmed by the context of the $650 million principal amount and 2023 maturity date in the debt table). \n\n**Answer:** The total carrying value in millions of the Medium-term note ($650 million principal, maturity in 2023) is $649 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its conclusion. The ground truth states that the total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million, implying that the $650 million principal refers to two separate notes (one maturing in 2023 and one in 2048), and their combined carrying value is $1,287 million. However, the LLM incorrectly interprets the question as referring only to the 2023 note, citing a carrying value of $649 million, and explicitly separates the 2048 note as a different instrument. This contradicts the premise of the question, which treats the $650 million note as having dual maturities in 2023 and 2048—likely indicating a single issuance with tranches or dual-dated obligations. (2) Quantitatively, the individual values cited by the LLM ($649M for 2023 and $638M for 2048) are plausible and may match data in the filing, but the sum of these—$1,287 million—is the correct total carrying value. The LLM fails to sum them, thus missing the core calculation. The answer reports only $649 million, which is incomplete. (3) The reasoning is partially sound in identifying relevant entries in the debt table but flawed in synthesis: it fails to recognize that the question is asking for the total carrying value of a single note issuance with two maturity dates (a known structure in debt instruments), requiring aggregation. This is a critical multi-hop error. (4) Contextual relevance is moderate—the response uses correct document references and identifies relevant data points—but ultimately misinterprets the scope of the query, leading to a significantly incorrect final answer. The model should have added the two carrying values associated with the $650 million notes maturing in 2023 and 2048, not selected one.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 493,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "The 2.900% Notes due 2030 are listed in IBM’s 2024 10‑K under “Notes due 2030” with a coupon of 2.900%. The highest‑yielding debt instrument disclosed in the filing is the 7.125% Notes due 2096, which carries a 7.125% coupon—significantly higher than the 2.900% rate.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.900% Notes due 2030 and the highest-yielding debt instrument as the 7.125% Notes due 2096, which matches the ground truth. However, it refers to the instrument as '7.125% Notes due 2096' while the ground truth specifies it as '7.125% Debentures due 2096'. While this is a minor terminology difference, 'Debentures' is the technically correct term used in the filing, so there is a slight entity inaccuracy. (2) The key quantitative elements—the 2.900% and 7.125% interest rates—are accurate, and the difference between them is 4.225 percentage points, which is correct. However, the LLM fails to explicitly calculate or state this difference, which is the central requirement of the question. This omission significantly impacts completeness and correctness. (3) The multi-hop reasoning is partially sound: the model identifies both relevant instruments and their rates, but it does not complete the synthesis by computing the difference, failing the final inferential step. (4) The answer is contextually relevant and well-structured, but the missing calculation prevents a higher score. Quantitative accuracy is high due to correct rates; qualitative accuracy is reduced due to incomplete reasoning and slight mislabeling of the debt instrument.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 363,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "The acquisition of Allergan was valued at a total of $64.1 billion, comprising $39.7 billion in cash consideration and $24.0 billion in fair‑value AbbVie stock issued to Allergan shareholders. As part of the lease obligations assumed in the transaction, AbbVie acquired approximately $453 million of right‑of‑use assets related to operating leases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: $64.1 billion is equivalent to $64,084 million (rounding difference is acceptable; $64,084M ≈ $64.1B), and the $453 million in right-of-use assets matches exactly. The breakdown into cash and stock consideration is additional but accurate context not in the original answer, which does not detract from correctness. (2) The answer fully addresses both parts of the question: total acquisition value and right-of-use assets from lease obligations. (3) Entities are correct—AbbVie, Allergan, right-of-use assets, lease obligations—and the context of the acquisition is properly framed. (4) The multi-hop reasoning is sound: the model correctly synthesizes total value and specific asset types assumed in the acquisition. The only minor limitation is that the original answer specifies the date 'as of December 31, 2020,' which the LLM omits, but since the acquisition closed in Q4 2020 and the figure is clearly tied to the transaction, this does not constitute a material error. Overall, the answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 332,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "Based on the provided document pages, the Norwest Corporation Directors' Formula Stock Award Plan is described in the \"Material Features of Equity Compensation Plans Not Approved by Shareholders\" section on page 15. It states that the plan allowed awards to non‑employee directors that could be deferred, but adds that “No future stock awards or deferrals may be made under this plan.” This confirms that no further awards or deferrals are possible under the Norwest Directors' Formula Stock Award Plan. The exact number of shares issuable upon distribution related to this plan is noted in the table on page 16, footnote (4), which indicates “391 shares issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan.”  \n\n**Answer:** 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan, and no future awards or deferrals are possible because the plan explicitly states that no future stock awards or deferrals may be made under it.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the number of shares—391—is accurately reported, matching the original answer exactly. There are no calculations required beyond correct extraction, and the number is presented correctly. (2) The answer addresses both parts of the multi-part question: it identifies the 391 shares issuable upon distribution and correctly explains that no future awards or deferrals are possible because the plan explicitly prohibits them, as stated in the filing. (3) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly identifies the relevant section (page 15) for the plan's closure and the table footnote (page 16, footnote 4) for the share number, demonstrating accurate cross-referencing within the document. (4) All entities—Norwest Corporation Directors' Formula Stock Award Plan, common stock, deferrals, awards—are correctly identified and contextualized. The wording differs slightly from the ground truth but maintains full semantic equivalence. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 314,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "The amortization of intangible assets related to the Allergan acquisition reduced AbbVie's gross margin in 2021, as noted in the \"Gross Margin\" discussion which attributes the margin increase to lower amortization of inventory fair value step-up and favorable product mix, partially offset by higher amortization of intangible assets from the Allergan acquisition. The total amortization expense for definite-lived intangible assets in 2021 was $7.7 billion, as stated in the \"Definite-Lived Intangible Assets\" section.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total amortization expense for definite-lived intangible assets in 2021 is correctly stated as $7.7 billion, which aligns with the original answer. (2) The answer addresses both parts of the question: it explains that the amortization of intangible assets from the Allergan acquisition negatively impacted gross margin in 2021, and it provides the total amortization expense. (3) The entities—AbbVie, Allergan acquisition, 2021 fiscal year, gross margin, and definite-lived intangible assets—are all accurately identified and correctly contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: it acknowledges that while other factors (lower inventory amortization and favorable product mix) increased gross margin, the Allergan-related amortization expense partially offset those gains. The LLM correctly infers the negative impact on gross margin from the contextual discussion in the 10-K, demonstrating accurate qualitative and contextual understanding. Wording differs slightly but maintains semantic equivalence to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 328,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "The Restoration Plans exist to provide certain associates with deferred compensation that would have been payable under the Benefit Plans if not for the compensation limits imposed by the Internal Revenue Code, effectively serving as a supplemental, non‑qualified benefit that mirrors the Benefit Plans’ structure. According to the 2023 10‑K, The Home Depot funds these plans by making contributions to grantor trusts, which then use the cash to purchase shares of the company’s common stock on the open market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the purpose of the Restoration Plans: providing deferred compensation to associates who would have received matching contributions under the Benefit Plans but for the IRS compensation limits. The explanation that it serves as a supplemental, non-qualified benefit mirroring the Benefit Plans adds clarity without introducing error. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised. (3) The funding mechanism is accurately described: The Home Depot funds the Restoration Plans via contributions to grantor trusts, which then purchase company common stock in the open market. This matches the original answer exactly in substance. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the IRS limits to the need for Restoration Plans, explaining their relationship to the Benefit Plans, and describing the funding structure. All parts of the question are addressed completely and accurately. Wording differences (e.g., 'maximum compensation limits' vs 'compensation limits imposed') are stylistic and do not affect meaning. The answer is fully contextually relevant and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 364,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "The Variable Rate Notes total $22 million as of both December 31 2024 and 2023, so there is no change in their value between those dates. Consequently, the overall change in total borrowings from 2023 to 2024 reflects only the increase in other debt components, not the Variable Rate Notes.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024, which matches the ground truth. This supports the correct implication of a 0% change. However, the LLM answer omits the actual percentage change in total borrowings (approximately 52.1%) and the dollar increase ($10,656 million), which are key components of the question. (2) All provided numbers are accurate—$22 million for Variable Rate Notes in both years—and there are no calculation errors. The missing quantitative details (total borrowings figures and their percentage increase) reduce completeness. (3) The reasoning is sound in noting that the change in total borrowings must come from other debt components since Variable Rate Notes did not change. However, the model fails to complete the multi-hop synthesis by not incorporating the total borrowings data and calculating or stating the overall percentage increase, which is explicitly required. (4) The answer is contextually relevant and correctly identifies the entities (Variable Rate Notes, correct time frame). The omission of the total borrowings change significantly affects completeness and correctness, but core facts about the Variable Rate Notes are accurate. Hence, a score of 7 is justified—factually correct where provided, but incomplete on multi-part response requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 391,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "Based on the provided financial data, the carrying amount of HD's 4.95% Senior Notes due September 2026 is $744 million and the carrying amount of the 4.95% Senior Notes due September 2052 is $980 million as of January 28, 2024. These figures are explicitly listed in the Long-Term Debt table on page 59 of the document.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the carrying amounts of HD's 4.95% Senior Notes due in September 2026 ($744 million) and September 2052 ($980 million) as of January 28, 2024, which are accurate per the ground truth. The sum of these amounts is $1,724 million, which is $2 million less than the stated total of $1,726 million in the original answer. This minor discrepancy could stem from rounding in reporting or an arithmetic rounding difference not visible in the provided figures. (2) All numbers are presented accurately and match the expected values in format and magnitude. The individual note amounts are correct, and the context date (January 28, 2024) and interest rate (4.95%) are properly referenced. (3) The reasoning is sound: the model correctly identifies the relevant debt instruments, extracts their carrying amounts, and implicitly supports the total through correct component values. It cites the correct source (Long-Term Debt table, page 59), demonstrating proper synthesis. (4) The answer is contextually complete and highly relevant, addressing all parts of the multi-hop question. The minor $2M difference in total does not appear to stem from a calculation error but possibly from unreported rounding; thus, the correctness score is reduced slightly to 9, but quantitative accuracy remains high due to correct component values.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 380,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "Based on the provided pages, PM experienced a **$917 million decrease** in its net derivative asset position from 2022 to 2023, calculated as the difference between the 2022 total movements in other comprehensive earnings ($1,058 million) and the 2023 total movements ($141 million). This aligns with the gross notional amount of derivative contracts increasing from $40,401 million (2022) to $43,265 million (2023), indicating a larger notional value of derivatives outstanding despite the net decrease in the asset position. The decline in the net derivative asset position reflects the offsetting effects of fair value adjustments and reclassifications within accumulated other comprehensive losses, as detailed in the hedging activities disclosures.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. The ground truth states PM's net derivative asset position decreased from $186 million in 2022 to $101 million in 2023, a 45.7% decrease. The LLM incorrectly reports a $917 million decrease based on movements in other comprehensive earnings ($1,058M to $141M), which is not the net derivative asset position. These figures refer to changes in accumulated other comprehensive income, not the actual asset value on the balance sheet, showing a fundamental misunderstanding of financial statements. (2) The gross amount of derivative contracts is also wrong: ground truth shows a decrease from $873M to $584M, but the LLM claims an increase from $40,401M to $43,265M, which appears to be the gross notional amount of derivatives, not the total gross amount relevant to the net asset position. This misrepresents the direction of change and uses an irrelevant metric. (3) The multi-hop reasoning fails completely: instead of linking net derivative asset reduction to a reduction in gross derivative exposure (indicating de-risking), the LLM incorrectly infers that rising notional amounts align with a declining net asset, which contradicts the actual alignment in the ground truth. (4) The correctness score is 1 due to complete factual inaccuracy in numbers, entities, and logic. Quantitative accuracy is 1 because all key numbers are wrong or misapplied. Qualitative accuracy is 1 due to flawed reasoning and misinterpretation of financial concepts. Contextual relevance is 2 because while the topic (derivatives at PM) is relevant, the data and conclusions are not aligned with the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 466,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "As of December 31 2024, the 2016 Stock Incentive Plan had 27.1 million shares available for future issuance, and the 2016 Stock Plan for Non‑Employee Directors had 0.8 million shares available. In total, 29.3 million shares are authorized for issuance under these plans, which exceeds the 10.4 million options and RSUs that are currently outstanding and would be issued upon exercise or vesting.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 27.1 million shares available under the 2016 Stock Incentive Plan and 0.8 million under the 2016 Stock Plan for Non-Employee Directors, which sum to the correct total of 27.9 million available for future issuance. However, the LLM incorrectly states that '29.3 million shares are authorized for issuance,' which is not supported by the ground truth and appears to be a miscalculation (27.1M + 0.8M = 27.9M, not 29.3M). Additionally, the LLM claims '10.4 million options and RSUs that are currently outstanding,' but the ground truth specifies 10,221,113 shares for options, 2,005,555 RSUs, and 129,854 shares under the directors' plan, totaling approximately 12.356 million shares to be issued, not 10.4 million. (2) The numbers for available shares are correct, but the total authorized and outstanding figures are factually wrong. The LLM rounds and combines figures inaccurately, and the calculation error undermines quantitative accuracy. (3) The reasoning is partially sound in distinguishing between available shares and those to be issued, but fails in multi-hop synthesis by not correctly aggregating the total shares to be issued across both plans and misrepresenting the relationship between authorized, available, and outstanding shares. (4) The answer is contextually relevant and addresses the core question about shares available and those to be issued, but contains significant quantitative errors that affect the correctness of the comparison. Thus, the correctness score is 5 due to partial accuracy with major calculation and data aggregation flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 442,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "The Dynamics 365 revenue growth of 25% contributed directly to the overall Dynamics products and cloud services revenue growth of 25% reported for fiscal year 2022, as stated in the document's metrics section (page 42) which notes \"Dynamics products and cloud services revenue growth\" as 25% and specifically identifies Dynamics 365 as a key component driving this growth. This 25% growth rate for Dynamics products and cloud services was a direct result of the Dynamics 365 revenue increase.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Dynamics 365 revenue grew by 25%, while the ground truth specifies a 39% growth in fiscal year 2022. This is a critical factual error that undermines the entire response. The overall Dynamics products and cloud services revenue growth is correctly cited as 25%, but the conflation of this figure with Dynamics 365's specific growth rate leads to a fundamental inaccuracy. (2) Quantitatively, the 25% figure is accurate for the overall Dynamics suite, but it is wrongly attributed as the growth rate for Dynamics 365 itself. The correct 39% growth for Dynamics 365 is missing, and no correct calculation or comparison between the two figures is provided. (3) The reasoning is flawed: the LLM suggests that a 25% growth in Dynamics 365 directly caused the 25% overall growth, which may be logically plausible but is factually incorrect due to the wrong input number. The multi-hop synthesis fails because the model does not distinguish between the performance of Dynamics 365 and the broader Dynamics product suite, despite the ground truth clearly indicating that the 39% growth in Dynamics 365 *drove* the 25% overall growth. (4) Contextual relevance is moderate—the answer addresses the right topic, cites a plausible document location, and attempts to explain contribution—but the severe quantitative inaccuracy and resulting incorrect logic significantly reduce its usefulness and factual reliability. The answer misrepresents the key data point and thus fails the primary correctness criterion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 426,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million (a 40% rise) in 2021 versus 2020, driven primarily by higher deployments of Megapack, solar cash and loan projects, Powerwall and Solar Roof, while Powerpack deployments fell as the product was phased out. Megapack serves as the flagship large‑scale energy‑storage solution and a key growth driver within Tesla’s broader energy‑storage portfolio, which also includes Powerwall for residential use and a range of solar generation offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the $795 million increase and 40% growth in Tesla's Energy Generation and Storage revenue from 2020 to 2021, matching the ground truth exactly. These figures are accurate and properly contextualized as being primarily driven by Megapack deployment, along with solar projects, Powerwall, and Solar Roof. (2) Quantitatively, all numbers are correct—$795 million and 40%—and the comparison between 2021 and 2020 is accurate. There are no calculation errors. (3) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly identifies Megapack as a primary growth driver and situates it within Tesla’s broader energy storage portfolio, noting its role for commercial and utility-scale applications. It adds valuable context not in the original answer—namely, that Powerpack was being phased out, which explains the shift toward Megapack. While this detail is not in the ground truth, it is factually accurate and enhances the answer without contradicting the source. (4) The answer is semantically equivalent to the original, with slightly more detail. The only minor deviation is that the original emphasizes Megapack as a 'key component' while the LLM calls it the 'flagship' solution—this is a slight intensification but still within reasonable interpretation. All parts of the question are addressed: the revenue increase due to Megapack (within the broader growth context) and Megapack’s role in the product portfolio. Thus, the answer is highly accurate, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 422,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "The total pre-tax loss recognized by Walmart related to the Asda divestiture was $5.5 billion in fiscal 2021 (initial loss estimate) and an additional $0.2 billion incremental loss was recorded in fiscal 2022 upon closing, resulting in a combined $5.7 billion pre‑tax loss. This loss incorporated $2.3 billion of accumulated pension components tied to the derecognition of the Asda pension plan, reflecting the significant pension‑related obligations associated with the disposal group.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $5.5 billion initial loss in fiscal 2021, $0.2 billion additional loss in fiscal 2022, totaling $5.7 billion pre-tax loss, with $2.3 billion attributed to accumulated pension components. These figures match the original answer exactly, and the sum ($5.5B + $0.2B = $5.7B) is correct. (2) The answer is complete, addressing both the total pre-tax loss across fiscal 2021 and 2022 and the role of pension-related obligations. (3) Entity accuracy is correct: Walmart, Asda divestiture, fiscal years 2021 and 2022, and the financial metric 'pre-tax loss' are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the initial loss estimate, the adjustment upon closing, and the pension component as a key driver of the loss, accurately reflecting the financial impact of legacy pension liabilities in the disposal group. (5) The semantic meaning is equivalent to the original answer, with slightly more concise wording but no loss of critical detail. All scoring categories warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 325,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "Based on the provided document, the More Personal Computing segment reported $56.5 billion in revenue for fiscal year 2022, and Windows OEM contributed 42% of that segment's revenue. Therefore, the combined revenue from Surface devices and Windows OEM licensing represented 42% of the segment's total revenue. \n\n(Note: The document states Windows OEM contributed 42% of the segment's revenue, and Surface devices are part of the \"Devices\" category within the More Personal Computing segment. The question asks for the combined percentage of Surface devices and Windows OEM licensing, but the document only provides the percentage for Windows OEM (42%). Since Surface devices are not separately quantified in the provided text, and the question implies the combined percentage is the same as Windows OEM's contribution (as Surface is not mentioned as a separate revenue stream in the segment breakdown), the answer is 42%.)",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the combined revenue from Surface devices and Windows OEM licensing represented 42% of the segment's revenue. The ground truth shows that Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling 58%. The LLM incorrectly assumes that because Surface is not explicitly quantified in the provided text, it cannot be included, but the original answer clearly states the 16% contribution. (2) Quantitative accuracy is partially correct: the $56.5 billion total and 42% for Windows OEM are accurate, but the failure to include the 16% from Devices leads to a significant calculation error. The correct combined percentage is 58%, not 42%. (3) The reasoning is flawed: the LLM fails the multi-hop synthesis by not recognizing that 'Devices' in the segment breakdown refers primarily to Surface and that its 16% contribution must be added to Windows OEM's 42%. The model incorrectly concludes that lack of explicit mention justifies exclusion, which contradicts the ground truth that includes this data. (4) Contextual relevance is moderate because the answer addresses the right segment, year, and metric, but omits a key component (Surface/Devices) and thus fails to correctly answer the multi-part, multi-hop question. The justification provided in the note reflects a misunderstanding of available data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 396,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "The total financial impact of the Asda pension-related obligations and gains/losses from the Asda sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group, is reflected in the $5.5 billion pre‑tax loss recorded in the fourth quarter of fiscal 2021 when Asda was classified as held for sale, which incorporated the $2.3 billion pension derecognition loss. This loss is disclosed in Note 12 and Note 11 of the 10‑K.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the total financial impact is reflected in a $5.5 billion pre-tax loss, which is not supported by the ground truth. The original answer specifies a total impact of $3.3 billion from the combination of the $1.0 billion cash contribution and the $2.3 billion pension components transferred—this sum is correct ($1.0B + $2.3B = $3.3B). However, the LLM introduces a $5.5 billion pre-tax loss not mentioned in the ground truth, conflating the pension impact with a broader disposal-related loss. This is a major factual error. (2) While the individual figures of $1.0 billion and $2.3 billion are correctly cited, the LLM fails to compute or emphasize the correct total financial impact of $3.3 billion. Instead, it redirects to an unrelated $5.5 billion figure, undermining quantitative accuracy. The mention of Note 12 and Note 11 may be contextually plausible but is not verifiable from the ground truth provided. (3) The multi-hop reasoning is flawed: the model correctly identifies two components (the contribution and the disposal group inclusion) but fails to synthesize them into the correct total impact. Instead, it links them to an external loss figure, suggesting a misunderstanding of the causal and accounting relationships. (4) The contextual relevance is moderate because the answer discusses relevant events (Asda pension contribution, disposal, fiscal 2020/2021 timing, note references), but the core conclusion is factually incorrect. The answer shifts focus from the total pension-related impact to a broader pre-tax loss, which misaligns with the question's intent. Thus, despite some accurate inputs, the output is substantively wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 465,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "The value of pre-owned aircraft inventories increased by $8 million, from $15 million on December 31 2023 to $23 million on December 31 2024. The company values these pre‑owned aircraft at the lower of their trade‑in value or estimated net realizable value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values are accurate: $15 million on December 31, 2023, and $23 million on December 31, 2024, resulting in an $8 million increase—correctly calculated and reported. (2) The answer is complete, addressing both parts of the question: the dollar increase and the valuation method. (3) Entity and metric accuracy is perfect—'pre-owned aircraft inventories' are correctly identified, and the time periods (December 31, 2023, and December 31, 2024) are exact. (4) The valuation method is correctly stated as 'the lower of trade-in value or estimated net realizable value,' which matches the original answer verbatim in meaning. (5) The reasoning is sound and reflects proper multi-hop synthesis—comparing inventory values across two years and correctly identifying the accounting policy from the same source context. (6) Semantic equivalence is maintained with no loss of meaning, despite minor formatting differences (e.g., en-dashes, spacing). All scores are 10 due to full factual, numerical, and contextual alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 321,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "The Xbox Game Pass library expansion directly contributed to the modest 3% growth in Xbox content and services revenue by increasing engagement and subscription value within the curated catalog. Microsoft is making significant strategic investments in gaming through the acquisition of Activision Blizzard and continued expansion of cloud gaming capabilities via Xbox Cloud Gaming, which are positioned to drive future growth in this segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3% increase in Xbox content and services revenue and attributes it to Xbox Game Pass's library expansion, aligning with the ground truth. The strategic investments in Activision Blizzard and cloud gaming (Xbox Cloud Gaming) are accurately mentioned. However, the LLM omits Microsoft's acquisition of ZeniMax Media, which is explicitly highlighted in the original answer as part of the broader strategic investments. This is a minor omission but does not undermine the core accuracy. (2) Quantitatively, the 3% revenue growth is correctly stated with no calculations required—this matches the ground truth exactly. (3) The multi-hop reasoning is sound: the model correctly links Game Pass library growth to revenue impact and connects it to strategic acquisitions and cloud infrastructure as growth enablers. The only gap is the missing reference to ZeniMax, which weakens completeness slightly. (4) The answer is contextually relevant, directly addressing both parts of the question—revenue linkage and strategic investments—with accurate entities and logical flow. Minor deduction from qualitative accuracy due to incomplete entity coverage, but overall highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 345,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "In 2023, Eli Lilly recognized **$1,615.4 million** of revenue from the sale of rights for the olanzapine portfolio (Zyprexa), which is reported in the “Other” category within the “Revenue” table. This amount is part of the broader “Collaboration and other revenue” figure of **$5,310.2 million** for 2023, representing the total revenue from collaborations and other arrangements that year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific numerical values—$1,615.4 million from the sale of the olanzapine portfolio and $5,310.2 million for total collaboration and other revenue—which are not present in the original answer (ground truth). The ground truth does not specify any dollar amounts for the olanzapine sale or the total collaboration and other revenue, only confirming that the sale contributed to that category. Therefore, the inclusion of precise figures cannot be verified as correct and appears to be hallucinated or sourced from outside the provided knowledge graph. (2) Since the original answer contains no numbers, the LLM’s quantitative claims cannot be confirmed and are likely incorrect or fabricated, resulting in low quantitative accuracy. (3) Qualitatively, the LLM correctly identifies that the olanzapine portfolio sale (including Zyprexa) is part of the 'collaboration and other revenue' category and correctly frames it within Eli Lilly’s 2023 revenue context. It also correctly references the broader category and implies proper categorization, showing sound reasoning structure. However, it fails to mention the Boehringer Ingelheim collaboration or Baqsimi, which are part of the broader category per the ground truth, indicating incomplete synthesis. (4) The answer is contextually relevant and addresses both parts of the question—amount recognized and how it factors into the broader category—but introduces unverified data. While the structure and intent are correct, the unsupported numbers severely undermine factual accuracy, leading to a correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 440,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "The recurring need for supplemental indentures to issue new tranches of 5.45% Solar Bonds—evidenced by dozens of such indentures filed between June 2015 and January 2016—reflects Tesla’s (via SolarCity) strategy of financing solar projects through a structured, trust‑based bond program that can repeatedly tap capital markets without renegotiating the entire loan facility. Each supplemental indenture amends the trust agreement to accommodate new bond series, thereby institutionalizing a trustee‑driven mechanism that supports ongoing, incremental capital raises for solar installations. This approach underscores the importance of bond‑specific trustee agreements in providing the legal and administrative framework necessary for Tesla to meet its recurring financing requirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core financing strategy of Tesla (via SolarCity) using multiple Supplemental Indentures to issue tranches of 5.45% Solar Bonds, and accurately infers that this reflects a structured, repeatable capital-raising mechanism enabled by trustee agreements. The qualitative reasoning is strong: it identifies the purpose of supplemental indentures in amending trust agreements to allow incremental funding without renegotiating the entire facility, which aligns with the ground truth's emphasis on flexibility and recurring capital needs. Contextual relevance is excellent, as the response directly addresses both parts of the question—financing strategy and the role of trustee agreements.\n\nHowever, there are minor quantitative inaccuracies. The LLM states 'dozens of such indentures filed between June 2015 and January 2016,' while the ground truth specifies only four tranches (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, 2015/C137-15) with Supplemental Indentures 4.72, 4.74, 4.76, and 4.78 dated November to December 2015. The use of 'dozens' overstates the number and implies a broader timeframe (June–January) not supported by the original data. This affects quantitative accuracy, though not severely, since the core pattern of multiple tranches under the same rate is correctly noted. Additionally, the ground truth emphasizes that the *same interest rate* was used across discrete supplemental indentures to maintain consistent yield for investors—a nuance acknowledged in spirit but not explicitly stated in the LLM answer.\n\nOverall, the answer demonstrates sound multi-hop reasoning by linking bond structure (supplemental indentures) to corporate financing behavior (tranche-based funding aligned with project deployment) and institutional mechanisms (trustee frameworks enabling scalability). Despite the exaggeration in quantity and slight omission of precise series/indenture numbers, the semantic meaning and strategic implication are substantially correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 540,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "The increase in Megapack deployments contributed $942 million (48 %) to the rise in Energy Generation and Storage revenue in 2021 versus 2020, but this growth was partially offset by a decline in Powerpack deployments as the product was phased out in favor of Megapack.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that Megapack deployments contributed $795 million (40%) to Tesla's Energy generation and storage revenue growth in 2021 vs. 2020, but the LLM reports $942 million (48%), which is materially incorrect. These figures do not match any known public Tesla financial disclosures for that period and exceed the actual growth amount. (2) The calculation implied by the LLM—$942M representing 48% of growth—would suggest total growth of ~$1.96 billion, whereas the correct total growth implied by the ground truth is $795M / 40% = ~$1.9875 billion, meaning the actual percentage contribution would be closer to 40%, not 48%. Thus, both the dollar amount and percentage are wrong. (3) Qualitatively, the reasoning and entity identification are sound: the model correctly identifies that Megapack growth drove revenue increases and that this was partially offset by a decline in Powerpack deployments due to product phaseout, which aligns with Tesla’s strategic shift as documented in their 10-K filings. This shows correct multi-hop synthesis between product lifecycle changes and financial impact. (4) Contextual relevance is high because the answer addresses both parts of the question—contribution of Megapack and offsetting factor—and uses appropriate terminology. However, the primary failure is in factual precision, especially on financial figures, which are central to the question. Hence, correctness and quantitative accuracy scores are low despite strong qualitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 438,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "The combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024 was $12 million ($12 capital expenditures + $8 depreciation and amortization).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states the combined total is $20 million, but the LLM claims it is $12 million. Both the individual components and the sum are wrong: the LLM reports $12 million for capital expenditures and $8 million for depreciation and amortization, which do not match the ground truth values (which should sum to $20 million, though the exact split is not provided in the original answer). (2) The calculation in the LLM answer ($12 + $8 = $20) is mathematically correct, but the inputs are wrong, leading to an incorrect final total. The reported sum of $12 million is inconsistent with the arithmetic shown. (3) The reasoning appears to follow a correct multi-hop structure—identifying two financial metrics for a region and summing them—but the underlying data is inaccurate, indicating either retrieval or synthesis errors. (4) The contextual relevance is high because the answer addresses the right region (Africa/Eurasia), the correct year (2024), and the correct metrics (capital expenditures and depreciation and amortization). However, due to major quantitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1045,
        "completion_tokens": 335,
        "total_tokens": 1381
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "Based on the provided document pages, TI's policy regarding retiree health care benefit plan investments (which are held in separate trust accounts and invested in low‑cost, broad‑market index funds) does not involve direct holdings of TI common stock. In contrast, the non‑U.S. defined contribution plans do hold TI common stock, valued at $34 million as of December 31 2024, and dividends on that stock were not material in 2024. Thus, while retiree health care plan assets are invested in diversified index funds and are not directly invested in TI shares, the non‑U.S. defined contribution plans do hold TI common stock.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $34 million value of TI common stock in non-U.S. defined contribution plans as of December 31, 2024, is accurately reported, with no calculation or date errors. Format is consistent and precise. (2) The policy detail—that retiree health care benefit plan assets are not directly invested in TI common stock—is correctly stated and aligns with the original answer. The additional detail about investments being in 'low-cost, broad-market index funds' adds context without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly contrasts two distinct plans (retiree health care vs. non-U.S. defined contribution) and synthesizes information about investment policies and actual holdings across them. (4) The semantic meaning is equivalent to the original answer: it conveys the key distinction in investment strategy—avoidance of company stock in one plan versus inclusion in another—using different but accurate phrasing. All entities (TI, retiree health care benefit plan, non-U.S. defined contribution plans, TI common stock) are correctly identified and contextualized. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 352,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "LLY's revenue from Baqsimi declined significantly from $645.7 million in 2023 to $2.5 million in 2024 (U.S. sales fell from $645.7 million to $2.5 million, and outside‑U.S. sales dropped from $31.9 million to $26.7 million). The collaboration and other arrangements note explains that revenue from such arrangements—including the sale of Baqsimi rights—is recognized when control of the asset transfers, and that variable consideration from these deals is estimated conservatively; consequently, the shift in how Baqsimi revenue is recorded (from product sales to a collaboration/royalty‑type arrangement) accounts for the sharp decline observed.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in Baqsimi revenue and the shift in revenue recognition due to the sale of rights, which aligns with the ground truth. However, it fails to report the total revenue figures for 2023 and 2024, instead only citing U.S. sales as if they were total revenues. It states U.S. sales dropped from $645.7 million to $2.5 million and mentions outside-U.S. sales dropping from $31.9 million to $26.7 million, but does not sum these to report the correct total revenues of $677.6 million in 2023 and $29.2 million in 2024. This omission significantly affects quantitative accuracy. (2) The individual regional numbers are accurate: $645.7M (U.S. 2023), $31.9M (Outside U.S. 2023), $2.5M (U.S. 2024), $26.7M (Outside U.S. 2024). However, the answer incorrectly implies that total revenue fell from $645.7M to $2.5M, ignoring both the outside-U.S. component and the actual total. The calculation of total revenue is missing, leading to a misleading impression of the magnitude of decline. (3) The reasoning about the shift in revenue recognition is sound and correctly interprets the collaboration and other arrangements disclosure. The explanation that revenue is now recognized under collaboration/royalty-type arrangements rather than product sales is logically consistent with the ground truth and shows proper multi-hop synthesis between financial performance and accounting policy disclosures. (4) Despite strong qualitative reasoning and contextual relevance, the failure to compute or report total revenues as required by the question reduces the correctness and quantitative accuracy scores. The answer is partially correct but lacks completeness in numerical reporting, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 481,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "Mastercard classifies revenue from its \"Processing and gateway\" services within the broader \"Value-added services and solutions\" category, as explicitly stated in Note 3 of the 10-K: \"Within our value-added services and solutions, we generate revenue primarily related to... processing and gateway.\" This aligns with the company's overall revenue structure, where \"Value-added services and solutions\" (which includes processing and gateway) generated $9,274 million in 2023, compared to $15,824 million from \"Payment network\" revenue. The company further clarifies that revenue from value-added services is recognized based on fixed or transaction-based fees for services like processing and gateway, and this category is distinct from the core payment network revenue stream.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately identifies that Mastercard classifies 'Processing and Gateway' revenue under the broader category of 'Value-added services and solutions,' which matches the original answer. (2) The quantitative details—$9,274 million from value-added services and $15,824 million from payment network revenue in 2023—are factually correct and correctly attributed to the 10-K (Note 3), though the ground truth does not include these specific numbers; however, their inclusion enhances completeness without introducing error. (3) The reasoning is sound: the LLM correctly synthesizes that this revenue stream is distinct from core payment network revenue and recognizes that it is earned via fixed or transaction-based fees, recognized when services are performed—directly reflecting the ground truth's description. (4) The answer addresses both parts of the question: the classification of 'Processing and Gateway' revenue and its alignment with broader revenue categories. Semantic equivalence is maintained and even exceeded with precise citation and numerical context. All entities (Mastercard, 10-K, Note 3, revenue categories) are accurate. No factual, numerical, or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 355,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "The year‑over‑year change in the international common‑stock allocation was a decrease of $5 million (from $20 million at the end of 2023 to $15 million at the end of 2024). This reduction contributed to the overall decline in total international plan assets, which fell from $566 million in 2023 to $537 million in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in direction and magnitude. The ground truth states that CL's pension plan investments in international common stocks *increased* by $5 million (from $15M to $20M), whereas the LLM claims a *decrease* of $5M (from $20M to $15M), reversing the year-over-year trend. Additionally, the total international investments grew from $537M to $566M (a $29M increase), but the LLM incorrectly states a decline from $566M to $537M. These errors completely invert the financial movement. (2) All key numbers are incorrect in sequence: the starting and ending values for both international common stocks and total international investments are swapped. The LLM also fails to mention the 17.2% contribution of the common stock increase to the total international growth, missing a key analytical component. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the directional change across two time periods and misattributes a decrease as a cause of a decline, when in reality both components increased. The logical relationship between the sub-component (international common stocks) and the total (international investments) is misrepresented. (4) Despite the severe factual and quantitative errors, the answer is contextually relevant—it addresses the right entities (CL's pension plan, international common stocks, total international investments) and attempts the correct type of analysis (year-over-year change and contribution to total). However, the reversal of all numerical trends results in a substantively wrong answer, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 448,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "The total increase in General Dynamics' Restricted Stock/RSUs expense from 2022 to 2024 was $11 ($85 – $74) in 2024, and this rise contributed to the overall growth in equity‑based compensation expense, which climbed from $130 million in 2022 to $145 million in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. The increase in Restricted Stock/RSUs expense is incorrectly calculated as $11, based on a false 2022 value of $74M, whereas the ground truth states the 2022 expense was $59M and 2024 was $85M, making the correct increase $26M. The LLM also fails to mention the $59M starting point, misrepresenting the trend. (2) The overall equity-based compensation numbers ($130M in 2022 to $145M in 2024, a $15M increase) are correctly cited, but the core calculation for the RSU increase is wrong. The subtraction ($85 – $74) uses an incorrect base year value not supported by the ground truth. (3) The multi-hop reasoning is flawed: the model fails to recognize that the $26M rise in RSUs exceeding the $15M total equity compensation increase implies RSUs were the primary driver—this key insight is missing. Instead, the answer vaguely states RSUs 'contributed to' the growth without analyzing the over-proportional impact. (4) The contextual relevance is moderate because the answer addresses the right topic and time frame, and correctly reports total equity compensation figures, but major quantitative inaccuracies and missing comparative analysis severely undermine correctness. Due to incorrect data and flawed reasoning, the correctness and quantitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 378,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "Amazon’s $8.0 billion unsecured 364‑day term loan taken in early 2023 illustrates its preference for short‑term, readily accessible financing to meet immediate liquidity needs, even though it could have drawn on its larger $20 billion commercial‑paper program. By using a dedicated term loan rather than issuing commercial paper, Amazon secured a fixed‑rate source of funds for a specific short‑term purpose while keeping its commercial‑paper capacity available for general corporate needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Amazon took an $8.0 billion unsecured 364-day term loan in early 2023, and it had a $20.0 billion Commercial Paper Program available. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The answer addresses the core question about strategic liquidity management by explaining that Amazon chose a term loan over commercial paper, preserving flexibility—this reflects sound reasoning and entity accuracy (Amazon, correct time frame, correct financial instruments). (3) The multi-hop synthesis is logically sound: it contrasts the use of a fixed-term loan with the availability of a flexible commercial paper program, correctly inferring strategic intent. (4) The only minor shortcoming is that the LLM does not explicitly mention that the term loan was fully repaid by December 31, 2023, nor that no commercial paper had been drawn as of the reporting period—details present in the ground truth that add precision. However, the omission does not undermine the overall correctness. The answer captures the essential strategic rationale, making it semantically equivalent in intent and meaning. Hence, a score of 9 is justified—excellent but not fully complete on minor contextual details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 367,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "The Membership Rewards liability increased from $13,742 million in 2023 to $14,752 million in 2024, reflecting higher redemption costs and adjustments to partner arrangements. To account for these changes, the company refined its liability estimation methodology by updating the weighted‑average cost per point and the ultimate redemption rate assumptions, incorporating recent redemption‑cost trends and partner‑contract modifications into its statistical and actuarial models.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($13,742 million in 2023 and $14,752 million in 2024) that are not present in the original answer (ground truth). There is no mention in the ground truth of the actual liability values or a year-over-year increase, so these figures are unverified and likely incorrect or fabricated. This significantly undermines quantitative accuracy. (2) No calculations are provided in the LLM answer, but the implied increase of $1,010 million is numerically correct based on the numbers given; however, since the numbers themselves are not supported by the ground truth, the quantitative accuracy is low. (3) The qualitative reasoning is strong: the LLM correctly identifies that American Express updated its liability estimation methodology in response to changes in redemption costs and third-party partner arrangements, and it accurately references key assumptions like the weighted-average cost per point and ultimate redemption rate. It also correctly notes that statistical and actuarial models are used and that recent trends and contract changes were incorporated—aligning well with the ground truth’s description of methodology adjustments. (4) Contextual relevance is high because the answer addresses both parts of the question: the impact on liability and the methodological changes. However, the inclusion of unsupported numerical data reduces overall correctness. While the conceptual and synthetic reasoning is sound (multi-hop understanding of methodology changes), the introduction of false quantitative data prevents a higher score. The answer would have been strong if it had omitted the specific liability figures and focused solely on the methodological response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 473,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "Based on the 2024 10-K disclosures, Colgate-Palmolive's selling price increases are explicitly cited as a key mechanism to offset raw material cost inflation and preserve margins amid commodity price volatility. This pricing strategy directly interacts with its foreign exchange risk management, as the company hedges foreign currency exposures (via contracts and borrowings) to stabilize input costs in international markets, thereby ensuring that price increases are not eroded by currency fluctuations. The combined approach primarily mitigates **exposure to foreign currency exchange rate volatility and raw material cost inflation**, specifically targeting risks that could compress gross margins in its global operations. The company manages this through a blend of hedging (e.g., foreign currency contracts, net investment hedges) and pricing discipline, as noted in Notes 6 and 90 regarding foreign exchange risk management and commodity price risk mitigation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities (Colgate-Palmolive, 2024 10-K), strategies (selling price increases, derivative contracts), and overall intent (mitigating foreign exchange risk). It correctly identifies the use of derivative instruments and pricing actions as part of a broader risk management strategy. However, there are subtle but important differences in emphasis and completeness. The original answer specifies that the combined approach aims to mitigate the impact of currency fluctuations on net sales and costs due to translation of foreign subsidiary assets and liabilities into USD across over 200 countries—this geographic scope and translation risk context is missing in the LLM response. Instead, the LLM reframes the issue around raw material cost inflation and gross margin compression, which, while mentioned in Colgate’s 10-K (e.g., in Note 90), shifts focus toward commodity risk rather than foreign exchange exposure per se. While foreign exchange and commodity risks are interrelated, the question specifically asks about interaction between price increases and FX risk management, not commodity hedging. The LLM conflates these slightly by stating price increases counter raw material inflation and that FX hedges preserve those gains—this linkage is not explicitly stated in the original and introduces interpretive reasoning beyond the source. Quantitatively, no numbers are present, so accuracy is not penalized. Contextually, the answer remains highly relevant and captures the essence of the multi-hop synthesis (pricing + FX hedging → risk mitigation). However, the qualitative reasoning slightly misaligns by blending commodity and FX risks, reducing precision in addressing the specific financial exposure (FX translation and volatility in global revenues/costs). Thus, core facts are correct, but minor misdirection in risk focus prevents a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 519,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "The 2022 increase in business-to-business activity and residential demand drove a 5.3% rise in Next Day Air average daily volume and a 12.0% increase in revenue per piece (from $16.82 to $18.83), contributing to a 17.4% revenue jump for the product ($1,487 million). However, this growth was partially offset by higher operating expenses, including $1.7 billion in increased network and pickup/delivery costs, $514 million in sorting expenses, and $281 million from the reallocation of UPS Freight-related costs following its divestiture.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that business-to-business activity and residential demand increased in 2022 and positively impacted Next Day Air volume and revenue per piece, it introduces specific numerical figures (5.3% volume increase, 12.0% revenue per piece increase from $16.82 to $18.83, $1,487 million revenue) that are not present in the ground truth and cannot be verified from the provided knowledge. These numbers are likely fabricated or hallucinated. Additionally, the stated offsetting factors—higher operating expenses including $1.7 billion in network costs, $514 million in sorting, and $281 million in reallocated UPS Freight costs—are unrelated to the question, which asks about factors offsetting *revenue per piece* growth, not overall profitability or operating costs. The ground truth clearly states the offset was a reduction in average billable weight per piece, which the LLM omits entirely. (2) Quantitative accuracy is very low because all cited percentages and dollar amounts are unsupported by the original answer and contradict the qualitative nature of the ground truth. There are no calculations in the ground truth to validate the LLM's precise figures. (3) The multi-hop reasoning is flawed: the model correctly links demand to volume and revenue per piece but fails to identify the correct offsetting factor (billable weight), instead diverting to irrelevant operating expenses. This shows a failure in synthesizing the correct causal relationships. (4) Contextual relevance is moderate because the answer addresses the general topic and direction of impact (positive volume and revenue effects), but it introduces irrelevant financial details and misses the key qualitative insight about billable weight, which is central to the original answer. Thus, while the directionality is correct, the specifics are largely incorrect or invented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 525,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "The regulatory exclusivity risk for Opdivo in the U.S. – stemming from its status as a biologic subject to 12‑year data‑protection periods and potential biosimilar challenges – is offset by the multiple international approvals Opdivo received in 2021 (e.g., Japan, EU, and FDA approvals for new indications). These global authorizations broaden Opdivo’s market reach and reinforce Bristol‑Myers Squibb’s strategic positioning as a leader in oncology across diverse regulatory environments, allowing the company to leverage overlapping exclusivity periods and mitigate U.S.‑only exclusivity vulnerabilities while expanding revenue streams worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 12-year U.S. data protection period for biologics and the strategic benefit of international approvals in 2021, aligning with the ground truth. However, it inaccurately states that FDA approvals were part of the 2021 international authorizations, when the question and ground truth refer specifically to non-U.S. approvals (e.g., Japan and EC). This mischaracterization slightly undermines entity accuracy. (2) Quantitatively, the 12-year exclusivity period is correctly cited. The ground truth mentions patent litigation possibly starting four years post-approval, which the LLM omits, but this detail is not central to the overall strategic interpretation. No calculations are involved, so numerical accuracy is strong. (3) The multi-hop reasoning is sound: the model correctly synthesizes U.S. regulatory risk with global expansion to infer strategic mitigation of market erosion. It captures the core logic that international diversification helps offset U.S. biosimilar threats. However, it misses the specific indication-level approvals (e.g., gastric, esophageal cancers in Japan and EC) that ground the original answer in concrete evidence. (4) Despite minor omissions and the FDA reference error, the LLM conveys the essential strategic insight—global approvals enhance revenue resilience amid U.S. exclusivity risks—making the answer contextually relevant and largely factually accurate. Hence, a score of 8 is warranted for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 414,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "As of December 31 2024, Amazon’s convertible notes in Anthropic, PBC had an estimated fair value of approximately **$13.8 billion**. This fair‑value estimate is significantly higher than the total cash invested in those notes to date, which amounts to about **$5.3 billion** (the sum of the $1.25 billion note in Q3 2023, the $2.75 billion note in Q1 2024, and the $1.3 billion note in Q4 2024).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the estimated fair value of $13.8 billion and total invested amount of $5.3 billion are correctly stated. The breakdown of investments—$1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024—sums to $5.3 billion, which the model correctly implies through explicit listing and summation. (2) The answer addresses both parts of the multi-part question: it states the fair value as of December 31, 2024, and compares it to the total amount invested by that date. (3) Entity accuracy is perfect: Amazon, Anthropic, PBC, and the time frame (through December 31, 2024) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—pulling investment amounts from different quarters and years, aggregating them, and comparing to a later fair value, which requires understanding of investment timing and valuation dynamics. The conclusion that fair value exceeds invested amount aligns with the ground truth’s interpretation of valuation uplift. (5) Semantic equivalence is achieved: while slightly more concise, the LLM conveys all key information with no omissions or distortions. Minor formatting differences (e.g., using 'approximately' or bolding) do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 376,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "Colgate-Palmolive accounts for pension enhancements within its severance-related restructuring charges by treating them as part of \"Employee-Related Costs\" under the 2022 Global Productivity Initiative, where such enhancements are recorded as \"Charges against assets\" that reduce pension assets or increase pension liabilities on the balance sheet. This distinguishes them from other severance costs, which are recorded as direct expense, resulting in a specific balance sheet offset for pension-related adjustments within the accrual for restructuring liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinction in accounting treatment between pension enhancements and other severance-related costs. It correctly identifies that pension enhancements are classified as 'Charges against assets' under Employee-Related Costs and are reflected as reductions in pension assets or increases in pension liabilities on the balance sheet—this aligns with the ground truth. The mention of the '2022 Global Productivity Initiative' adds contextual detail not in the original answer but does not contradict it and is consistent with Colgate-Palmolive's disclosed restructuring programs, so it does not detract from accuracy. The key difference—balance sheet impact via asset/liability adjustments versus operating expense treatment for other severance costs—is correctly explained. Quantitatively, there are no numbers, dates, or calculations in the original answer beyond '2022', which the LLM includes appropriately. There is no numerical inaccuracy. The reasoning is sound and reflects proper multi-hop synthesis: distinguishing balance sheet treatment, linking pension enhancements to asset charges, and contrasting with income statement treatment of other severance. The only minor shortcoming is that the original answer emphasizes that severance costs are based on written policies, statutory requirements, and voluntary arrangements—nuanced detail omitted in the LLM response. While not critical to the main point, this slight incompleteness prevents a perfect 10 on qualitative accuracy. Overall, the LLM answer is semantically equivalent, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 446,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "The U.S. provides eight years of regulatory data protection for biologics such as Opdivo, but this protection is separate from patent exclusivity and can be limited by patent challenges or litigation. While data exclusivity delays generic competition, the actual market exclusivity period for Opdivo is ultimately determined by its patent portfolio and legal outcomes. Based on observed trends, the rate of revenue decline following exclusivity expiration in developed markets (such as the U.S. and EU) has been rapid, posing a significant financial risk to BMY as it could lead to sharp reductions in sales and cash flow, especially if exclusivity is lost earlier than anticipated or if generic/biosimilar entry occurs sooner due to patent challenges.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the U.S. provides 'eight years' of regulatory data protection for biologics, while the ground truth correctly states it is '12 years'—a major discrepancy that undermines the core of the response. All other numerical references (e.g., timing of exclusivity expiration) are absent or inferred, but this key number is incorrect. (2) The quantitative inaccuracy is severe: the 12-year period is a statutory standard under the Biologics Price Competition and Innovation Act (BPCIA), and stating 8 years is factually wrong. No calculations are performed, but the foundational time frame is incorrect. (3) The reasoning around patent challenges, biosimilar entry, and revenue decline is qualitatively sound and reflects valid industry dynamics. The answer correctly identifies that market exclusivity depends on both data protection and patents, and that revenue declines rapidly post-exclusivity in developed markets—this aligns with the ground truth. However, it fails to correctly link the 12-year data protection period to Opdivo’s specific risk timeline, weakening the multi-hop synthesis between U.S. regulation and BMY’s financial exposure. (4) Despite correct contextual understanding of post-exclusivity revenue trends and the distinction between data exclusivity and patent life, the answer is significantly undermined by the incorrect duration of data protection. The financial risk to BMY is plausibly described but based on an inaccurate premise, reducing overall correctness. Contextual relevance remains high as the response addresses both regulatory and financial dimensions of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 458,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "Based on the provided financial data, display advertising revenue was $35 billion and total advertising services revenue was $40 billion, meaning display advertising accounted for 35 billion ÷ 40 billion = 87.5 % of Amazon’s advertising services revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that display advertising revenue was $35 billion and total advertising services revenue was $40 billion, matching the ground truth inputs. The calculated percentage of 87.5% is factually correct and matches the original answer exactly. (2) The calculation 35 ÷ 40 = 0.875 (or 87.5%) is mathematically accurate, and the use of 'billion' is consistent and correctly formatted. (3) Although this is a single-hop quantitative question rather than a complex multi-hop synthesis, the reasoning is sound: the model correctly interprets the relationship between part (display advertising) and whole (total advertising revenue) and performs the correct division. (4) All entities—Amazon, display advertising, advertising services revenue, and the year 2024—are correctly referenced in context. The answer is semantically equivalent to the ground truth, with clear explanation and correct result. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 283,
        "total_tokens": 1365
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "The unrealized loss on U.S. government and agency debt securities reported in the Level 1 fair‑value table was $1 million as of December 31 2021. This represents the decrease in value from the prior period, as the table shows a $1 million unrealized loss for that category.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the change. The ground truth states that the value of U.S. government and agency debt securities held by UPS increased from $184 million in 2020 to $200 million in 2021, resulting in a $16 million increase, not a decrease. The LLM incorrectly claims a $1 million decrease (unrealized loss), which contradicts the ground truth. (2) The numbers are entirely wrong: the $1 million unrealized loss is not the change in value of the securities held, but rather a separate financial metric (unrealized loss) reported for 2021, which does not represent the year-over-year change in the value of the holdings. The correct calculation is $200M (2021) - $184M (2020) = +$16M, not a decrease. (3) The multi-hop reasoning failed: the model did not correctly identify the values for the two years from the Level 1 quoted prices and compute the difference. Instead, it conflated 'unrealized loss' with 'change in value over time', which are distinct concepts. (4) The contextual relevance is low because the answer discusses unrealized losses rather than the actual change in value between years. The qualitative accuracy is poor due to incorrect entity interpretation and flawed logic. Quantitative accuracy is nearly zero because the key dollar amounts and the direction of change are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 380,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "The joint development and cost‑sharing arrangement with Ono for Yervoy places the bulk of commercial risk on BMS: BMS supplies the product, records all U.S. sales, and bears the majority of development and co‑promotion costs, while profit and loss are split 80/20 only when activities involve a single party’s compound. Consequently, if biosimilar competition erodes Yervoy sales, BMS could face a disproportionate revenue decline and margin pressure compared with its more balanced Pfizer‑Eliquis partnership, where risk is shared more evenly. This asymmetry heightens BMS’s exposure to biosimilar entry under the U.S. regulatory framework, where data‑exclusivity periods can be shortened by biosimilar approvals.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that BMS bears the 'majority of development and co-promotion costs' and that profit/loss is split 80/20 when involving a single party’s compound—this contradicts the ground truth, which specifies an equal (50/50) cost and profit sharing for combination therapies involving both parties’ compounds. There is no mention of an 80/20 split in the original answer or implied context. (2) The claim that BMS 'bears the bulk of commercial risk' and 'majority of costs' is directly at odds with the ground truth assertion that equal cost-sharing reduces BMS’s individual financial burden. (3) The comparison to the 'Pfizer-Eliquis partnership' introduces an irrelevant external example not mentioned in the original context and distracts from the BMS-Ono-Yervoy dynamic. (4) While the LLM correctly identifies the U.S. regulatory framework and biosimilar risk after data exclusivity (implied 12-year period), it fails to correctly link the joint development structure to risk mitigation—instead asserting heightened exposure, which is the opposite of the ground truth conclusion. (5) Multi-hop reasoning is flawed: the model fails to synthesize that shared development costs reduce BMS’s upfront exposure, which in turn mitigates financial risk upon biosimilar entry. Instead, it inverts the relationship. Quantitative accuracy is very low due to incorrect percentages (80/20 vs. actual 50/50) and mischaracterization of cost allocation. Qualitative accuracy is low due to incorrect entity relationships and reasoning. Contextual relevance is moderate because the answer addresses biosimilar competition and regulatory framework, but misrepresents the core financial arrangement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 482,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "The $6.03 billion decline in Automotive Sales Revenue was partially offset by $596 million of FSD (Supervised) revenue recognized in 2024, which represents roughly 9.9 % of the decline. This FSD revenue is recognized over the expected ownership life of the vehicle and is recorded as part of the transaction price allocated to the undelivered performance obligations, which is reflected in the company’s deferred‑revenue balance. The deferred‑revenue amount related to these FSD and other over‑the‑air services was $3.599 billion at the end of 2024, and the company expects to recognize about $840 million of it within the next 12 months. The liability for resale‑value guarantees and associated warranty reserves also impacts the segment’s overall financial position, though the recorded guarantee liability itself is immaterial.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly calculates the 9.9% offset ($596M ÷ $6,030M ≈ 0.0988), which matches the ground truth and addresses the first part of the question accurately. However, it introduces new figures not present in the original answer—specifically, a deferred revenue balance of $3.599 billion and an expectation to recognize $840 million within 12 months—which are factually unsupported by the ground truth and may be hallucinated. The ground truth mentions Tesla’s resale value guarantee liability increasing to $1.45 billion in 2024 (from $166 million in 2023), but the LLM incorrectly states this liability is 'immaterial,' directly contradicting the significance implied by the large increase and specific disclosure. (2) Quantitative accuracy is partially compromised: while the 9.9% calculation is correct, the $3.599B deferred revenue and $840M near-term recognition figures are unverified and not in the original data, reducing confidence in numerical fidelity. The critical $1.45B guarantee liability figure is omitted entirely. (3) The reasoning correctly links FSD revenue to deferred revenue and over-the-air updates, showing sound multi-hop understanding of revenue recognition and performance obligations. However, it fails to connect software updates to residual value impacts via resale guarantees—a key multi-hop element in the original answer—and instead dismisses the liability as immaterial, undermining the synthesis. (4) Contextual relevance is high because the LLM stays on topic, discusses deferred revenue, and ties FSD to broader automotive revenue and liabilities. But due to factual inaccuracies and omission of key disclosed liabilities, the correctness score is limited to 6, reflecting partial accuracy with significant gaps in quantitative and qualitative fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 491,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "PepsiCo adjusts for items affecting comparability—including restructuring and impairment charges, acquisition and divestiture-related charges, and mark-to-market net impacts—to arrive at its non‑GAAP “Operating profit adjusted for items affecting comparability.” When evaluating operating profit growth, this adjustment also incorporates a constant‑currency effect, removing the impact of foreign‑exchange fluctuations so that growth reflects underlying volume and pricing rather than currency movements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the non-GAAP measure as 'Operating profit adjusted for items affecting comparability' and correctly describes PepsiCo's adjustment for currency fluctuations to evaluate growth on a constant-currency basis. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no numbers are present to verify or dispute. (3) The multi-hop reasoning is sound: the model correctly synthesizes that PepsiCo adjusts operating profit for items affecting comparability and further adjusts for currency impacts, which aligns with the 2022 10-K disclosures. (4) The LLM provides additional context (e.g., examples of items affecting comparability like restructuring charges and mark-to-market impacts) that enriches the answer without introducing inaccuracies. All entities—PepsiCo, 2022 10-K, operating profit, non-GAAP adjustments, constant currency—are correctly identified and logically connected. The answer fully addresses both parts of the question: the specific non-GAAP measure and how it accounts for currency fluctuations. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 339,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "The document lists **12 amendments** to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology across the exhibits (Amendments 1‑12, including the Twelfth Amendment referenced as Exhibit 10.43). The earliest amendment is dated **September 2 2014** (the original Amended and Restated Agreement), and the latest is the **Twelfth Amendment effective May 1 2021**. Thus, the time span between the earliest and latest effective dates is **approximately 6 years and 8 months**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states there are 12 amendments, which aligns with the documented count across the exhibits. (2) The earliest effective date is correctly identified as September 2, 2014, and the latest as May 1, 2021. The time span of 6 years and 8 months is accurate: from September 2, 2014, to May 1, 2021, is exactly 6 years, 7 months, and 29 days—appropriately rounded to 6 years and 8 months. (3) The multi-hop reasoning is sound—synthesizing amendment count and effective dates from multiple exhibits and correctly identifying the original Amended and Restated Agreement as the starting point. (4) All entities (agreement name, amendment numbers, dates) are correctly referenced. The answer is semantically equivalent to the ground truth, with clear, precise, and relevant information throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 257,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 14 percentage points from the acquisition and 4.5 percentage points from favorable foreign exchange, for a total of 18.5 percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the combined percentage impact on net revenue growth in the AMESA division as 18.5 percentage points, matching the ground truth exactly. It further breaks this down into 14 percentage points from the acquisition of Pioneer Foods and 4.5 percentage points from favorable foreign exchange, which aligns with the expected multi-hop synthesis. (2) All numeric values are accurate: 14 + 4.5 = 18.5, and the units (percentage points) are correct. There are no calculation errors or formatting discrepancies. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by identifying two distinct factors (acquisition and foreign exchange) and combining their impacts to arrive at the total effect on net revenue growth. (4) The answer is fully relevant, complete, and semantically equivalent to the ground truth, providing additional clarity through decomposition without introducing any inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 294,
        "total_tokens": 1416
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "Opdivo's U.S. market exclusivity is anchored by its patent portfolio and regulatory data protection, but its 2021 U.S. revenue growth of 7% reflects strong demand across multiple indications (e.g., NSCLC, RCC, gastric cancers) and higher pricing, despite competitive pressures. In the EU, however, regulatory data protection operates independently of patents—generic entry can occur once data exclusivity ends, even if patents remain valid—potentially shortening exclusivity periods compared to the U.S., where patent challenges and Orange Book listings delay generic launches until patent expiry or settlement. This divergence means Opdivo’s EU exclusivity may erode faster than in the U.S., where patent extensions and litigation can prolong protection, directly influencing its global revenue trajectory.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant omissions and inaccuracies in both quantitative and qualitative dimensions. (1) Quantitatively, the 7% U.S. revenue growth in 2021 is correctly cited, aligning with the ground truth. However, the answer fails to mention key dates from the ground truth: the 12-year U.S. regulatory data protection period (implying biosimilar approval no earlier than 2026, given Opdivo's 2014 approval), and the EU's '8+2+1' exclusivity model (8 years data protection, 10–11 years market exclusivity). These specific timelines are critical to the question and are entirely missing. (2) The answer incorrectly frames EU generic entry as possible once data exclusivity ends, implying generics (rather than biosimilars) can enter—this is a fundamental error, as Opdivo is a biologic and subject to biosimilar pathways, not generic drug approval. The term 'generic' is misused in both U.S. and EU contexts. (3) While the LLM correctly notes that U.S. patents extend beyond 2021 (e.g., formulation patents into 2026+), it does not explicitly connect this to the method of use patent expirations in 2021 as a key inflection point preserved by later-expiring patents—this multi-hop synthesis is weakened. (4) The reasoning about patent litigation and Orange Book listings adds plausible context but is not grounded in the provided ground truth, introducing unsupported assumptions. (5) The answer emphasizes pricing and demand as drivers of 2021 growth but underemphasizes the direct role of extended patent protections in preserving exclusivity, which is central to the original answer. Overall, the response is contextually relevant and touches on the right themes (patents, exclusivity differences, revenue), but lacks precise regulatory timelines, mischaracterizes biosimilar pathways, and omits key multi-hop linkages between 2021 patent expirations and extended protections, warranting a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 527,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "Morgan Stanley, as a bank holding company with over $250 billion in assets, is subject to the Federal Reserve’s systemic‑risk regime, which imposes heightened capital and liquidity standards, limits on activities (e.g., the Volcker Rule), and the requirement to maintain sufficient unencumbered high‑quality liquid assets to survive a 30‑day stress scenario. These rules also restrict dividend payments and share‑repurchases if regulators deem them unsafe, and they mandate a resolution plan (SPOE) that could constrain how the firm distributes capital and manages liquidity. Consequently, the firm must align its capital‑distribution policies and liquidity management with the Fed’s prudential requirements and the FDIC’s orderly‑liquidation authority.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core constraints imposed by the systemic risk regime on Morgan Stanley's capital distribution and liquidity management. It correctly identifies heightened capital and liquidity standards, the 30-day stress scenario requirement for unencumbered high-quality liquid assets, restrictions on dividends and share repurchases if deemed unsafe, and mentions resolution planning (SPOE) and orderly liquidation authority—key elements of the regulatory framework. However, it omits specific details present in the ground truth, such as the single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for others), which are a direct constraint on liquidity risk exposure. While the LLM references 'limits on activities' like the Volcker Rule, this is not directly tied to capital distribution or liquidity management and slightly distracts from the more relevant constraints. The quantitative accuracy is high—no incorrect numbers are stated, and the 30-day stress period is accurately mentioned. The reasoning is sound and synthesizes the multi-hop logic (Morgan Stanley’s size → systemic importance → enhanced prudential standards → impact on capital and liquidity policies). The answer is contextually relevant and well-aligned with the question. The omission of counterparty credit limits and less precise articulation of liquidity requirements (e.g., 'unencumbered highly liquid assets to meet 30-day projected net cash outflows' in ground truth vs. more general phrasing in LLM) prevents a top score, but the core facts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 438,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "The 0.750% Senior Note due 2033 carries a lower interest rate than the 1.950% Senior Note due 2031, indicating that PepsiCo is issuing newer long‑term debt at cheaper rates, likely reflecting improved credit conditions or a strategic shift toward more cost‑effective financing for later‑dated maturities. This suggests the company is managing its long‑term debt profile by taking advantage of favorable market pricing for newer issuances while maintaining higher‑coupon obligations on older notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.750% Senior Note due 2033 has a lower interest rate than the 1.950% Senior Note due 2031, which is factually accurate. The quantitative difference is 1.200 percentage points (1.950% - 0.750% = 1.200%), and while the LLM does not explicitly state the numerical difference, it correctly conveys the directional comparison and relative magnitude through qualitative phrasing ('lower interest rate'). (2) All entities—PepsiCo, the two notes with correct interest rates and maturities (0.750% due 2033 and 1.950% due 2031)—are accurately referenced. No incorrect numbers, dates, or metrics are presented. (3) The reasoning is sound and reflects appropriate multi-hop synthesis: the model infers a strategic trend in PepsiCo’s debt issuance, linking lower rates on newer long-term debt to favorable market conditions or improved creditworthiness, which aligns with the ground truth interpretation. It also adds relevant context about maintaining higher-coupon obligations on older debt, which is a reasonable financial insight and enhances the explanation without contradicting facts. (4) The answer is semantically equivalent to the original in intent and meaning, though slightly less explicit in quantifying the exact rate difference. This minor omission prevents a perfect 10, but the core facts, logic, and implications are correct and well-articulated. Hence, high scores across all dimensions with full contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 409,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "The fair value of Medtronic's partnership units held in its pension plans increased from $992 million at April 28 2023 to $1,151 million at April 26 2024, a rise of $159 million. This increase contributed to the total investments measured at net asset value rising from $1,571 million in fiscal 2023 to $1,617 million in fiscal 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in fair value of Medtronic's partnership units as $159 million, rising from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024. This part is factually accurate and matches the ground truth. However, the LLM provides incorrect figures for the total investments measured at net asset value: it states $1,571 million in 2023 and $1,617 million in 2024 (an increase of $46 million), whereas the ground truth reports $2,179 million in 2023 and $3,366 million in 2024 (an increase of $1,187 million). This is a significant quantitative error. (2) The calculation of the $159 million increase in partnership units is correct ($1,151M - $992M = $159M). However, the total investments at net asset value are severely understated in both years, leading to an incorrect assessment of the impact. The LLM implies that the $159M increase contributed to only a $46M rise in total NAV investments, which is logically impossible and contradicts the ground truth. (3) The multi-hop reasoning fails in the second part: while the model correctly pulls the partnership unit values, it does not correctly synthesize the total investments at net asset value from the same source or time periods. The incorrect totals suggest either a data sourcing error or confusion with another line item. (4) The correctness score is 4 due to partial accuracy on the first part but major error on the second. Quantitative accuracy is 5 because half the numbers are correct, but the critical total investment figures are wrong. Qualitative accuracy is 5 due to sound reasoning structure but flawed data synthesis. Contextual relevance is 8 because the answer addresses the right concepts and entities with appropriate framing, despite factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 487,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "The 2024 10‑K notes that depreciation and amortization amounts shown for each reportable segment are presented **after applying activity‑based costing methods to allocate expenses between segments**. Consequently, the depreciation and amortization totals reported for UPS’s segments are affected by the company’s allocation methodology, which uses estimates that can change the amount of depreciation assigned to each segment and thus influence the reported operating profit of those segments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately captures the key point from the 2024 10-K that depreciation and amortization totals for UPS's reportable segments are presented 'after applying activity-based costing methods to allocate expenses between segments,' which matches the ground truth verbatim in substance. (2) There are no numerical values requiring calculation in this question, but the reference to the correct year (2024) and proper identification of the costing method (activity-based costing) satisfies quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly infers that because activity-based costing is applied, the reported depreciation and amortization figures are not raw totals but allocated based on estimates, and that changes in those estimates affect segment-level expense allocation and operating profit—this synthesis is explicitly stated in the original answer. (4) All entities (UPS, 2024 10-K, reportable segments, activity-based costing) are correctly identified and contextually used. The answer is concise, factually precise, and fully aligned with the ground truth, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 343,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "In fiscal 2022, the reversal of the European Commission fine and the associated interest generated a $1.1 billion benefit recorded in other income and a $62 million reduction in interest expense, which together improved other income and lowered interest expense for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.1 billion benefit in other income and the $62 million reduction in interest expense, which aligns with the ground truth. The total financial impact of $1.162 billion is implied by the sum of these two components, though it is not explicitly stated in the LLM answer. (2) All numeric values are accurate: $1.1 billion and $62 million match the original answer exactly, and their sum ($1.162 billion) is mathematically correct. Format variations (e.g., using 'billion' vs 'million') are appropriately handled. (3) The multi-hop reasoning is sound—the model correctly synthesizes the impact on both other income and interest expense from the reversal of the fine and associated interest, linking the two components to the overall financial impact. (4) The answer is semantically equivalent to the ground truth but slightly less complete because it omits the explicit mention of the total $1.162 billion figure, which is part of the question's required response. This minor omission prevents a perfect score, but all key facts and financial impacts are accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 321,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "Based on the provided document pages, the fair value of Fixed Income Commingled Trusts held by MDT increased from $1,273 million at April 26, 2024 to $968 million at April 28, 2023, representing a decrease of $305 million. However, this represents a decrease, not an increase, from fiscal year 2023 to 2024. The document does not provide the total increase in fair value across all investment categories, making it impossible to calculate the proportion of this increase relative to the total increase. Therefore, the proportion cannot be determined from the given information. \n\n(Note: The question asks for an increase from FY2023 to FY2024, but the data shows a decrease in Fixed Income Commingled Trusts value from $1,273M (2024) to $968M (2023), indicating a $305M decrease. The document does not provide the total fair value increase across all categories for the proportion calculation.)",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly interprets the direction of change, stating that the fair value decreased by $305 million from 2023 to 2024, when in fact it increased from $968 million in 2023 to $1,273 million in 2024 — a $305 million increase. This reverses the core factual outcome. Additionally, the LLM claims the document does not provide total portfolio fair value data, but the ground truth shows total fair value increased from $3,398 million to $3,551 million — a $153 million increase — which is essential for the proportion analysis. (2) Quantitative accuracy is severely compromised: while the $305M and $968M/$1,273M figures are numerically correct, their interpretation as a decrease rather than an increase invalidates the calculation. The total portfolio change is omitted entirely, despite being derivable from the ground truth. (3) The multi-hop reasoning fails: the model does not recognize that an increase in one category exceeding the total portfolio increase implies declines in other categories — a key insight in the original answer. Instead, it concludes data is missing, reflecting flawed logic. (4) Contextual relevance is low because the answer misrepresents the trend and omits the critical comparative analysis. The response contradicts the ground truth on both primary facts and implications, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 382,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "Morgan Stanley’s SPOE strategy ensures adequate liquidity for its subsidiaries by having the Parent Company (Morgan Stanley) provide capital and liquidity to designated “supported subsidiaries” through a secured, amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as the resolution‑funding vehicle, receiving transferred assets from the Parent and being obligated to supply the required capital and liquidity to those subsidiaries under the same support agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core elements of Morgan Stanley's SPOE strategy and the role of Morgan Stanley Holdings LLC (Funding IHC). It correctly identifies that the Parent Company provides capital and liquidity to supported subsidiaries through a secured, amended and restated support agreement, and that Funding IHC acts as the resolution-funding vehicle receiving asset transfers. The answer captures the essential multi-hop reasoning: asset transfers from the Parent to Funding IHC and the subsequent obligation to supply liquidity under the agreement. The only minor omission is that the original answer specifies the Parent contributes 'all of its material assets (excluding shares in subsidiaries and certain other assets)' during resolution—a detail not explicitly mentioned in the LLM response. However, this does not undermine the overall correctness, as the functional role and mechanism are accurately described. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The entities (Morgan Stanley, Morgan Stanley Holdings LLC, Funding IHC) and their roles are correctly identified. The reasoning is sound and contextually appropriate, fully addressing both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 350,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "Qualcomm’s growth strategy in automotive 5G adoption hinges on its ability to retain access to Chinese OEMs, as the company projects that 60 % of vehicles produced in 2028 will include 5G connectivity and relies heavily on Chinese markets for revenue. If Chinese OEMs shift away from using Qualcomm’s integrated circuit products due to government actions, the company warns that its revenues could be materially harmed, underscoring that sustained growth in automotive 5G depends on maintaining those relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: the 60% projection for 5G-enabled vehicles by 2028 is accurately cited, and the risk of material revenue harm due to Chinese OEMs shifting away from Qualcomm's integrated circuits is correctly stated. (2) Quantitative accuracy is perfect: the percentage (60%) and year (2028) match the original answer exactly, with no calculation errors. (3) The multi-hop reasoning is sound—Qualcomm's strategic investment in 5G, its market projection, and the dependency on Chinese OEMs for revenue are logically connected to show that disruption in access would threaten growth in automotive 5G. (4) The only minor shortcoming is slight incompleteness: the original answer explicitly mentions U.S. or Chinese government actions as potential triggers and emphasizes China as a 'major revenue source' and the strategic expansion into automotive platforms. The LLM answer implies this but does not fully elaborate on the bidirectional government risk or the strategic importance of the automotive sector to Qualcomm’s broader growth. However, the semantic meaning and key conclusions are equivalent. Contextual relevance is excellent as it directly addresses the dependency question with precise supporting evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 368,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "The total fair value of investments measured at net asset value increased by $86 million from fiscal year 2023 to 2024, and the equity securities category contributed the most to this change.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that the total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024, but the LLM reports an increase of only $86 million, which is off by over $1.1 billion. This is a major quantitative error. Additionally, the ground truth identifies 'equity commingled trusts' as the category that contributed the most to the change, with a $269 million increase, whereas the LLM incorrectly identifies 'equity securities' as the top contributor without providing a correct amount. (2) The calculation of the change in total fair value is severely inaccurate. The correct figure ($1,187 million) is not close to the LLM's $86 million. Furthermore, the key contributing category is misidentified—'equity commingled trusts' is a specific type of investment vehicle and not equivalent to the broader 'equity securities' category. (3) The multi-hop reasoning fails because the model did not correctly synthesize data across the relevant fiscal years and investment categories. It appears to have either accessed incorrect data or misattributed the investment category responsible for the largest change. (4) The contextual relevance is relatively high because the answer addresses the right company (Medtronic), the right metric (fair value of investments at NAV), and the right time frame (fiscal years 2023 to 2024), and attempts to identify both the total change and the largest contributing category. However, due to severe factual and quantitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 457,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "Schwab values its repurchase liabilities for client‑held fractional shares at fair value, using quoted market prices or other observable market data that correspond to the fair value of the underlying fractional shares. Because the liabilities are marked‑to‑market in the same direction as the related client assets, any unrealized gains or losses on the repurchase obligations offset the unrealized gains or losses on the client‑held shares, resulting in no net impact on the consolidated statements of income despite fluctuations in market value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Schwab values its repurchase liabilities based on fair value using quoted market prices or other observable market data, which aligns with the original answer's 'quoted market prices or other observable market data consistent with the related client-held fractional shares.' (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a traditional sense—but the absence of incorrect numbers supports a perfect score. (3) The reasoning is sound: the LLM correctly explains the offset mechanism—unrealized gains/losses on the liabilities exactly offset those on the corresponding assets—leading to no net income statement impact, which is the core multi-hop logic required. (4) The answer fully addresses both parts of the question: the valuation basis and the reason for no income statement impact. Wording differs slightly (e.g., 'marked-to-market' vs 'fair value'), but these are synonymous in context. All entities (Schwab, repurchase liabilities, client-held fractional shares, income statement) are correctly identified and logically connected. Thus, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 356,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "The projected benefit obligation for the Financial Consultant Career Achievement Plan increased from $92 million at the beginning of 2021 to $119 million at the end of 2021, reflecting a $27 million increase over the year. This change encompasses the beginning balance, benefit cost, and actuarial loss as disclosed in the plan’s schedule.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the starting and ending values of the projected benefit obligation, as well as the total change. The ground truth states the obligation increased from $176 million on December 31, 2020, to $194 million on December 31, 2021, a $18 million increase. The LLM reports a beginning balance of $92 million and an ending balance of $119 million, resulting in a $27 million increase, which does not match the disclosed data. (2) The numbers are quantitatively inaccurate—$92M and $119M are not close to $176M and $194M, and the $27M change differs significantly from the correct $18M change. Even allowing for format variations, the values are not equivalent. (3) The reasoning is partially sound in that the LLM attempts to explain the change using components like benefit cost and actuarial loss, which may be relevant, but it fails to correctly identify the actual figures from the correct time period (December 31, 2020, to December 31, 2021). The multi-hop synthesis is flawed because it uses incorrect base data, possibly from a different plan or time period. (4) The contextual relevance is moderate—the answer addresses the right type of plan and metric (projected benefit obligation), and the time frame is approximately correct (2021), but the entities and numbers are wrong, undermining the core accuracy. The explanation structure is reasonable but built on incorrect data, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 407,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "The Beauty segment contributes 18% of Procter & Gamble's total net sales, while the Fabric & Home Care segment contributes 36% of net sales. Combined, these segments account for 54% of the company's total net sales for the fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the combined revenue contribution is 54% of Procter & Gamble's total net sales, which matches the ground truth. It breaks this down into 18% from the Beauty segment and 36% from the Fabric & Home Care segment. While the original answer does not specify the Beauty segment's exact percentage, the LLM's inclusion of 18% is consistent with known public data and results in the correct combined total. (2) All numeric values are accurate: 18% + 36% = 54%, and the calculation is correct. Format and percentages are presented clearly and precisely. (3) The multi-hop reasoning is sound—though the Beauty segment's 18% contribution is not mentioned in the question (which only notes Pantene's 20% global market share in hair care), the LLM appears to have correctly inferred or retrieved the segment's actual revenue contribution from external knowledge. This inference aligns with factual data, making the synthesis valid. (4) The answer is fully relevant and addresses the question directly. The minor issue is that the 18% figure is not derivable from the question alone (which only gives Pantene's market share, not segment revenue), but since the final combined percentage is correct and consistent with ground truth, the answer is substantially accurate. Hence, a high score is warranted, with a small deduction in qualitative accuracy due to reliance on unstated external data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 397,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 related to Carrier and Otis was a loss of $410 million, reflecting $196 million of income from Carrier and $187 million of income from Otis, offset by $793 million of separation‑related transaction costs. This loss is presented separately in the consolidated statement of operations and results from the April 3 2020 separation of Carrier and Otis into independent, publicly traded companies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total loss of $410 million and attributes $196 million to Carrier and $187 million to Otis, which matches the ground truth in magnitude and direction (income values are positive in the original answer, but net loss due to offsets). However, the LLM introduces a new figure—$793 million in separation-related transaction costs—not present in the ground truth, which alters the explanation and implies a calculation ($196M + $187M - $793M = -$410M) that is not supported by the original data. This is a significant quantitative inaccuracy. (2) The date of the separation event (April 3, 2020) is correctly referenced, and the outcome—separation into independent publicly traded companies—is accurately described. (3) The multi-hop reasoning is mostly sound: the model connects the financial impact in discontinued operations to the corporate separation event, correctly associating Carrier and Otis with the 2020 restructuring. However, the addition of unsupported transaction costs undermines the fidelity of the financial explanation. (4) Despite the incorrect breakdown involving $793M, the final net figure of -$410M is correct, and the core entities, years, and event are accurate. The answer remains contextually relevant and semantically close but loses points for introducing unverified financial components. Thus, correctness is reduced due to unsupported calculation logic, though key facts are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 404,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "As of May 14 2024, 27 lawsuits have been filed in the Diabetes Pump Retainer Ring Litigation on behalf of a total of 107 individual plaintiffs, and law firms have indicated they may file additional suits that could bring in “thousands of additional claimants.”  By contrast, the hernia‑mesh litigation already involves roughly 8,350 individual plaintiffs (with about 6,700 pending in a Massachusetts coordinated proceeding, 500 in Minnesota, and ~1,150 in federal MDL), and the company cannot currently estimate how many future claimants may join that or the diabetes‑pump litigation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key factual aspects. (1) Quantitatively: The number of individual plaintiffs in the Diabetes Pump Retainer Ring Litigation is correctly stated as 107, and the future potential for 'thousands of additional claimants' is accurately reflected. For hernia mesh litigation, the LLM correctly reports 6,700 in Massachusetts, 500 in Minnesota, and ~1,150 in federal MDL. The sum (6,700 + 500 + 1,150 = 8,350) is correctly implied, though not explicitly stated in the original answer—this calculation is accurate and acceptable. (2) The date (May 14, 2024) is correctly referenced. (3) Entity accuracy is perfect: Medtronic's Diabetes operating unit, Series 600 insulin pumps, clear retainer rings, and correct litigation contexts are all properly identified. (4) Reasoning and synthesis are sound: the comparison between the two litigations is logically presented, noting both involve Medtronic products, significant plaintiff counts, and uncertainty in future claims. The LLM adds minor contextual detail (27 lawsuits representing 107 plaintiffs) not in the original answer, which is plausible and does not contradict the ground truth. (5) The original answer notes Medtronic has not recorded expenses due to uncertainty—this is omitted in the LLM response, a minor gap in completeness, but the core of the question (number of plaintiffs and comparison to hernia mesh) is fully addressed. Overall, the answer is semantically equivalent, with excellent multi-hop synthesis and no factual errors. A score of 9 is given due to the omission of the 'no recorded expense' point, which is part of the original comparison context, though not central to the numerical query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 468,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "The IDA agreement requires Schwab to move certain client deposits off‑balance‑sheet to third‑party institutions, which reduces the amount of client cash that can be counted as on‑balance‑sheet assets. Because Schwab’s internal capital‑management target is a Tier 1 Leverage Ratio of 6.75%‑7.00%, the off‑balance‑sheet treatment of these deposits limits the amount of capital that can be generated from that cash, making it more difficult to maintain the desired leverage ratio while supporting balance‑sheet growth. Consequently, Schwab must rely on other capital sources—such as equity issuances and debt—to bridge the gap and stay within its target range.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a fundamental misinterpretation of the impact of the IDA agreement on Schwab's capital management. While it correctly identifies that client deposits are swept off-balance sheet to third-party institutions (specifically TD Bank under the IDA), it incorrectly frames this as a challenge to maintaining the Tier 1 Leverage Ratio. The ground truth states that offloading these deposits helps Schwab optimize its balance sheet and maintain capital ratios above its internal target range (6.75%-7.00%), not that it makes it more difficult. The LLM incorrectly concludes that the off-balance-sheet treatment limits capital generation and forces reliance on equity or debt, which contradicts the actual strategy of using the IDA to reduce on-balance-sheet liabilities and improve capital efficiency. (2) Quantitatively, the Tier 1 Leverage Ratio target range of 6.75%-7.00% is correctly stated, and no other numbers (e.g., regulatory minimum of 4%) are misrepresented in the LLM answer—though this specific benchmark is omitted, reducing completeness. There are no calculation errors because no calculations are performed. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the relationship between off-balance-sheet treatment, reduced liabilities, and improved leverage ratio outcomes. Instead, it assumes that removing assets (client cash) harms capital generation, failing to recognize that the leverage ratio is calculated as Tier 1 Capital / Average Assets, and reducing assets (via offloading deposits) increases the ratio, aiding compliance. This reflects a misunderstanding of balance sheet dynamics and regulatory capital treatment. (4) Despite correct use of the target ratio and mention of off-balance-sheet movement, the core reasoning is inverted, leading to an incorrect strategic interpretation. Hence, the correctness score is low (3), quantitative accuracy is relatively high (8) due to correct percentage range, qualitative accuracy is poor (3) due to flawed logic, and contextual relevance is moderate (6) as the answer addresses the right concepts but with incorrect implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 578,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "The 2021 net cash inflow from RTX's disposition of the Forcepoint business was $1.9 billion, which was recorded as a cash inflow from investing activities in 2021 versus a $2.6 billion cash outflow in 2020. This contributed to the $4.7 billion improvement in cash flows used in (or provided by) investing activities for continuing operations, turning a $3.3 billion inflow in 2020 into a $1.4 billion outflow in 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.9 billion net cash inflow from the disposition of the Forcepoint business in 2021, which matches the ground truth. However, it introduces incorrect figures for 2020 cash flows: claiming a '$2.6 billion cash outflow' and stating that 2020 had a '$3.3 billion inflow' that turned into a '$1.4 billion outflow in 2021' is factually wrong and contradicts the original answer. The ground truth does not specify exact net cash from investing activities for 2020 and 2021 in those terms; instead, it emphasizes a $4.7 billion improvement due to the absence of the $3.2 billion Raytheon merger outflow and proceeds from dispositions. (2) The $4.7 billion improvement is correctly cited, but the LLM misrepresents its composition by implying a reversal of inflow/outflow magnitudes not supported by the source. The calculation of improvement is not independently verified by the LLM’s numbers—$3.3 billion to -$1.4 billion would imply a $4.7 billion swing, but these base figures are not in the original answer and appear fabricated. (3) The multi-hop reasoning is partially sound—linking Forcepoint disposition to investing cash flows and comparing year-over-year changes—but fails in synthesis by inventing unsupported cash flow totals for 2020 and 2021. The original answer attributes the improvement primarily to two factors: absence of a large prior-year outflow (merger) and current-year inflows (dispositions), which the LLM omits or distorts. (4) Scores reflect partial credit for correct identification of the $1.9 billion and the $4.7 billion improvement, but major deductions for incorrect underlying cash flow figures, flawed reasoning, and failure to accurately represent the drivers of change. Contextual relevance remains high as the answer addresses the right topic and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 498,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "Oracle’s reliance on third‑party colocation providers creates significant financial risk for its Cloud Services. The company enters long‑term lease commitments that often require costly early‑termination fees if market conditions or strategy change, and it does not control the operation of these data‑center sites. Consequently, any disruption, inability to renew leases on favorable terms, or unexpected termination penalties can erode profitability and cash flow from Oracle Cloud.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core financial risks associated with Oracle's reliance on third-party colocation providers. It correctly identifies long-term lease commitments, significant early termination fees, and the resulting financial exposure if market conditions or strategy change. It also notes the lack of operational control, which adds context to potential disruptions. The answer aligns with the ground truth in substance: financial risk from inflexible lease obligations and potential erosion of profitability and cash flow. The only minor omission is that the original answer includes the detail about Oracle depreciating leased assets over their useful lives, and that a shift in cloud strategy could shorten these lives, impacting profitability through accelerated depreciation. This is a relevant nuance in the financial risk profile related to asset utilization and accounting, which the LLM answer does not mention. However, all entities (Oracle, third-party colocation suppliers, Oracle Cloud Services), financial concepts (lease commitments, termination fees), and reasoning (linking inflexible contracts to financial risk) are correct and logically sound. There are no numerical inaccuracies (the question does not involve specific dollar amounts or dates, so quantitative accuracy is scored as 10 based on correct use of qualitative financial terms). The answer is highly contextually relevant and synthesizes the multi-hop logic: reliance on third parties → long-term leases with penalties → financial risk under changing conditions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 431,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "As of December 31 2021, the Company had **64 million shares available for future grants under the 2020 Stock Incentive Plan** and **18 million shares available for issuance under the 1993 Employee Stock Purchase Plan**. This combined pool of shares provides sufficient equity authorizations to support the Company’s share‑based compensation strategy, enabling it to grant new stock options, restricted shares and ESPP purchases while managing dilution and aligning employee incentives with long‑term shareholder value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 64 million shares under the 2020 Stock Incentive Plan and 18 million under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available as of December 31, 2021—though the total is not explicitly stated in the LLM answer, it is implied by the two components and the context of 'combined pool', which is semantically acceptable. (2) The entities are correctly identified: UnitedHealth Group (implied as 'the Company'), correct plan names, and correct date. (3) The reasoning is sound: the answer explains how the availability supports the share-based compensation strategy—by enabling grants of stock options, restricted shares, and ESPP purchases, aligning employee incentives with shareholder value, and managing dilution. This reflects accurate multi-hop synthesis of plan purposes and strategic intent. (4) The wording differs slightly from the original answer but maintains full semantic equivalence, with slightly enhanced detail (e.g., 'managing dilution') that is contextually appropriate and consistent with typical compensation strategy rationale. All parts of the question are addressed: total shares available (via component disclosure) and strategic rationale. No factual errors, omissions, or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 376,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "Schwab accounts for client‑held fractional shares as assets recorded at fair value in “Other securities owned at fair value” on the balance sheet, and it records an equal repurchase liability for those shares in “Accrued expenses and other liabilities.” The corresponding repurchase liabilities are therefore reflected in the consolidated balance sheet under accrued expenses and other liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly identifies that Schwab accounts for client-held fractional shares as 'Other securities owned at fair value' on the balance sheet and records a corresponding repurchase liability in 'Accrued expenses and other liabilities'—this aligns with the 2022 10-K disclosure. (2) There are no numeric values or calculations in the question or answer, so quantitative accuracy is not applicable but assumed correct by absence. (3) The multi-hop reasoning is sound: the model correctly links fractional shares to asset recognition, fair value accounting, and the offsetting liability placement, demonstrating proper synthesis of accounting treatment and balance sheet presentation. (4) The only minor omission is that the LLM answer does not explicitly mention the conditions under which the repurchase liability arises—specifically, when off-balance sheet treatment under ASC 940 or derecognition under ASC 860 is not met—nor does it note that unrealized gains/losses are recognized in earnings. While these are important nuances, they do not undermine the core correctness of the response. The answer is semantically equivalent in key aspects and fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 355,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by providing automated, self-driving database capabilities that lower labor costs, reduce human error, and enable consumption-based pricing—paying only for resources used—while leveraging OCI’s scalable, secure infrastructure. This integration also drives strategic growth in Oracle’s cloud and license business by accelerating migration of on-premise workloads to the cloud, expanding adoption of Oracle Cloud Services (including SaaS applications built on Autonomous Database), and increasing revenue from cloud services and license support contracts as customers modernize their IT environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Oracle's Autonomous Database integration with OCI reduces customer costs through automation of administration tasks (tuning, patching, scaling, etc.), reduces human error, lowers labor costs, and enables consumption-based pricing. These points are accurately reflected. The strategic growth aspects—migration of on-premise workloads, expansion of cloud service adoption, and increased revenue from cloud and license contracts—are also correctly identified. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable but assumed correct by absence of error. (3) The multi-hop reasoning is sound: the LLM correctly links technical capabilities (automation, self-driving database) to customer cost savings, and then connects those savings to Oracle's business strategy of cloud migration and revenue growth. The original answer includes additional detail about integration with Java Cloud and Oracle APEX as developer platforms, which the LLM omits—this is a minor completeness gap but does not undermine the core accuracy. (4) The LLM answer is semantically equivalent to the original in intent and substance, using slightly different phrasing (e.g., 'self-driving database' instead of 'machine learning-driven diagnostics') but preserving factual meaning. Contextual relevance is perfect, as it directly addresses both cost reduction and strategic growth as asked. The only reason for not scoring a 10 is the omission of specific ecosystem extensions (APEX, Java Cloud), which slightly reduces qualitative completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 459,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "If the AARP Program contract were transferred to another entity, UnitedHealth Group would need to transfer cash equal to the fair value of the AARP Program’s assets under management at the transfer date to the new entity. This is required because the assets are specifically designated to fund the program’s medical costs payable, RSF liabilities, and other related obligations, and the Company does not guarantee any investment returns on these assets. The transfer would thus involve a cash outflow equal to the current fair value of these segregated assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly states that UnitedHealth Group would transfer cash equal to the fair value of the AARP Program assets upon contract transfer, which matches the original answer. The explanation that these assets are segregated and used to fund medical costs and related liabilities (including RSF liabilities) is consistent with the 10-K description. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable in terms of specific numbers, but the conceptual treatment of fair value is correctly referenced—thus scored as 10. (3) The reasoning is sound and reflects proper multi-hop understanding: the assets are separately managed, support specific liabilities, and their transfer triggers a cash outflow. The LLM omits the explicit mention that these assets are classified as *current* assets and that the transfer would reduce both current assets and associated liabilities, which slightly weakens the completeness of the financial implication (e.g., balance sheet impact and potential effect on short-term liquidity). This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is highly relevant, directly addressing the financial implication of the contract transfer. Overall, the LLM captures the core financial mechanism accurately with only a slight gap in full balance sheet context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 399,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "The fair value of Card Member and Other Loans is not disclosed in the provided pages, but the accompanying financial statements indicate that these loans are carried at cost (or amortized cost) on the balance sheet. The document discusses fair value measurements for derivatives and hedging activities, but it does not provide a specific fair value amount for Card Member and Other Loans. Regarding the Level 3 fair value hierarchy classification, the text explicitly states that derivatives designated as hedging instruments are carried at fair value, and the fair value hierarchy is applied to these instruments. However, it does not specify that Card Member and Other Loans themselves are classified under Level 3; instead, the Level 3 discussion pertains to the valuation techniques and inputs used for derivatives (e.g., discounted cash flows, market inputs), with no indication that the loans are measured at fair value or subject to Level 3 classification. Thus, the loans are not reported at fair value in the provided disclosures, and no Level 3 classification applies to them.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) The original answer states that the fair value of Card Member and Other Loans is $113 billion and the carrying value is $110 billion, with the fair value entirely classified under Level 3 of the fair value hierarchy. The LLM claims this information is not disclosed and asserts that no fair value or Level 3 classification applies to these loans, which directly contradicts the ground truth. (2) Quantitatively, the LLM fails to report the $113 billion fair value and $110 billion carrying value, both of which are critical and explicitly stated in the ground truth. There is no acceptable variation when the values are completely omitted and denied. (3) The reasoning is flawed: the LLM incorrectly limits Level 3 classification to derivatives only and fails to recognize that the fair value of loans can be reported under Level 3 even if the loans are carried at amortized cost on the balance sheet. The multi-hop synthesis required—linking the fair value of loans to their Level 3 classification—is entirely missed. (4) Contextual relevance is low because the LLM misidentifies the scope of fair value disclosures and incorrectly concludes that the requested data is absent. The answer reflects a misunderstanding of both the question and the financial reporting structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 366,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31 2021, 64 million shares remained available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan, and those shares may be used for a variety of award types—including stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based incentives.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number of shares—64 million—and the date—December 31, 2021—are accurately reported. Minor formatting differences (e.g., '64 million' vs '64 million') are acceptable and do not affect accuracy. (2) The answer completely addresses both parts of the question: the number of shares available and the types of awards. (3) All entities—UnitedHealth Group, 2020 Stock Incentive Plan, and the relevant time period—are correctly identified. (4) The multi-hop reasoning is sound, as the model correctly synthesizes information about share availability and permissible award types from the same plan and date. The listed award types—stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards—match the ground truth, with only slight rewording (e.g., 'other stock-based incentives' instead of 'other stock-based awards'), which is semantically equivalent. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 307,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "The total estimated fair value of foreign government bonds and obligations held by the company was $770 million in 2023, compared with $632 million in 2022 for maturities of 12 months or more. This represents an increase of $138 million year‑over‑year.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 estimated fair value of foreign government bonds and obligations as $770 million, which matches the ground truth. However, it incorrectly states the 2022 value as $632 million, whereas the ground truth specifies $549 million. This leads to an incorrect year-over-year increase of $138 million instead of the correct $221 million. (2) The calculation of the difference is mathematically correct based on the numbers provided by the LLM, but the underlying 2022 figure is wrong, making the comparison inaccurate. The correct increase should be $770M - $549M = $221M, not $138M. (3) The multi-hop reasoning is structurally sound—the model attempts to compare the same category across two years for maturities of 12 months or more—but fails due to incorrect data retrieval for the 2022 value. It correctly identifies the relevant metric and time frame, showing understanding of the required synthesis. (4) The contextual relevance is high because the answer addresses the right category, years, and comparison type. However, the significant error in the 2022 value and resulting miscalculation severely impacts factual correctness, warranting a moderate score of 4 for overall correctness and quantitative accuracy. Qualitative accuracy is slightly higher due to correct reasoning structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 375,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019, representing a decrease of $25 million (or roughly 73%) over the two‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the capital expenditures for the Africa/Eurasia region in both 2021 ($33 million) and 2019 ($8 million), which matches the ground truth. However, it incorrectly states that this represents a 'decrease' of $25 million, when in fact it is an increase. This fundamental error in directionality undermines the conclusion. (2) The numerical values are accurate—$33 million in 2021 and $8 million in 2019—and the $25 million difference is correctly calculated. However, the characterization of this difference as a decrease (rather than an increase) is factually wrong. The claimed 73% change is approximately correct in magnitude but again misapplied as a decrease. (3) The multi-hop reasoning requires comparing capital expenditures across two years and correctly interpreting the trend. While the model retrieves the correct data points from different years, it fails in the synthesis step by reversing the direction of change. This indicates a flaw in logical reasoning despite correct data retrieval. (4) The contextual relevance is full—same region, same metric, correct years. Quantitative accuracy is high due to correct numbers and difference calculation, but qualitative accuracy is reduced due to the incorrect interpretation of the trend. Correctness score is moderate because while core data is right, the key comparative insight is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1093,
        "completion_tokens": 386,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "The worldwide sales of Johnson & Johnson's Contact Lenses/Other within the Vision segment grew by **14.9%** from 2020 to 2021, increasing from $2,994 million to $3,440 million. This growth was slightly outpaced by the broader Vision segment's total sales growth of **19.6%** over the same period, indicating that Contact Lenses/Other contributed to, but did not fully drive, the segment's overall performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 14.9% growth in Contact Lenses/Other sales from 2020 to 2021 and the 19.6% growth of the broader Vision segment, matching the ground truth exactly. The dollar figures provided ($2,994 million to $3,440 million) are accurate and support the 14.9% growth calculation. (2) Quantitative verification: (3,440 - 2,994) / 2,994 ≈ 0.149 or 14.9%, confirming the percentage is correct. The segment growth of 19.6% is directly aligned with the original answer. (3) The multi-hop reasoning is sound—LLM correctly compares the performance of a sub-category (Contact Lenses/Other) to the overall Vision segment, drawing the logical conclusion that the sub-category underperformed relative to the whole, albeit phrased as 'slightly outpaced' and 'did not fully drive,' which is semantically equivalent. (4) All entities (Johnson & Johnson, Contact Lenses/Other, Vision segment, years 2020–2021) are correctly identified. The answer is complete, factually accurate, and contextually appropriate, addressing both the percentage change and comparative performance as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 318,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "Based on the \"Summary of stock option and RSU activity as of December 31, 2021\" table in Note 10 (pages 128-132), the total weighted-average grant price for **Service and Performance-Based RSUs** outstanding as of December 31, 2021 was **$114.22**. This figure represents the weighted-average grant price for the \"Service and Performance- Based RSUs\" column under the \"Outstanding as of December 31, 2021\" row, which incorporates both the beginning balance and new grants during the year. The table explicitly lists \"3,741\" shares (in thousands) with a weighted-average grant price of $114.22 for this category. \n\n**Answer:**  \nThe total weighted-average grant price for Service and Performance-Based RSUs outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year, was $114.22.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the weighted-average grant price of $114.22 for Service and Performance-Based RSUs outstanding as of December 31, 2021, which matches the ground truth. However, the original answer states '$114.22 million' — a critical distinction the LLM misses. The LLM interprets $114.22 as a per-share price (which is typical for 'weighted-average grant price'), but the ground truth presents it as a total dollar amount in millions, implying a total value, not a per-share price. This is a significant quantitative misinterpretation. (2) The number $114.22 is present in both answers, but the unit discrepancy changes the meaning: the ground truth refers to a total value ($114.22 million), while the LLM treats it as a per-share price. Additionally, the ground truth mentions new grants at $125.02 million, which the LLM omits entirely, failing to address the composition of the total. (3) The reasoning is internally consistent with typical financial reporting — weighted-average grant prices are usually per-share — suggesting the LLM applied domain knowledge correctly. However, it failed to reconcile this with the ground truth’s presentation of total dollar amounts, indicating a flaw in multi-hop synthesis or data interpretation from the table. (4) The contextual relevance is high as the response directly addresses the question with reference to the correct note, table, and row. Qualitative accuracy is good due to correct entity and time period identification. Quantitative accuracy is reduced due to unit confusion and missing data point ($125.02 million). Correctness score is 7 because the core number is correct but misinterpreted in magnitude and context, and a key component (new grants) is omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 476,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "The outstanding balance for Boeing's 1.43%–2.50% unsecured bonds due through 2032 decreased by $3,976 million from 2023 to 2024 (from $10,135 million to $6,159 million). In 2024, this tranche represented approximately 11.4% of the company's total debt of $53,864 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the decrease of $3,976 million is accurate, calculated as $10,135 million (2023) - $6,159 million (2024). The percentage representation in 2024 is reported as approximately 11.4%, which is a properly rounded version of the exact value (6,159 / 53,864 ≈ 11.43%), and such rounding is acceptable. The total debt of $53,864 million is correctly cited. (2) The answer addresses both parts of the multi-part question: the dollar decrease and the percentage of total debt in 2024. (3) All entities—Boeing, the 1.43%-2.50% unsecured bonds due through 2032, and the years 2023 and 2024—are correctly identified. (4) The multi-hop reasoning is sound, requiring retrieval of bond balances across two years and calculation of a percentage share relative to total debt; the LLM correctly synthesizes this information. Wording differences (e.g., 'approximately 11.4%' vs '11.43%') do not affect factual equivalence. All criteria for correctness, completeness, and accuracy are satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 304,
        "total_tokens": 1454
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "The combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021 was $2,810 million (calculated as $1,325 million for Knees + $1,485 million for Hips). This represented 32.8% of the total Orthopaedics revenue of $8,588 million for 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the combined revenue from Knees and Hips as $2,810 million, accurately breaking it down into $1,325 million (Knees) and $1,485 million (Hips), which matches the ground truth. The total Orthopaedics revenue of $8,588 million is also correct. (2) The percentage calculation is slightly off: the ground truth is 32.7%, while the LLM reports 32.8%. However, this is a minor rounding difference. The exact calculation is (2,810 / 8,588) * 100 = 32.72%, which rounds to 32.7% when reported to one decimal place. The LLM likely rounded intermediate steps differently, leading to 32.8%. This is a negligible error in context but prevents a perfect score. (3) The multi-hop reasoning is sound—revenue figures for Knees and Hips were correctly summed, and the percentage of total Orthopaedics revenue was appropriately calculated. All entities (Johnson & Johnson, Orthopaedics segment, 2021 fiscal year, product categories) are correctly identified. (4) The answer is semantically equivalent to the ground truth, with only a minor discrepancy in rounding. Hence, correctness is scored 9 (excellent but not perfect), quantitative accuracy 9 (due to rounding), and qualitative and contextual scores 10 (fully accurate reasoning and relevance).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 358,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "Based on the provided pages from Boeing's 2024 10-K filing, the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years (2024, 2023, and 2022) is **11.6 million shares for 2024, 5.7 million shares for 2023, and 3.5 million shares for 2022**. These shares were excluded because the effect of including them would have been **antidilutive** due to the company incurring a net loss in each of these periods, as explicitly stated in the document: \"potential common shares of 11.6 million, 5.7 million, and 3.5 million for the years ended December 31, 2024, 2023 and 2022 were excluded from the computation of Diluted loss per share, because the effect would have been antidilutive as a result of incurring a net loss in those periods.\"",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reason for exclusion—antidilutive effect due to net losses—which matches the ground truth. However, it fails to provide the total number of excluded shares across the three years as explicitly asked in the question. Instead, it lists the annual breakdown: 11.6 million (2024), 5.7 million (2023), and 3.5 million (2022). The sum of these (11.6 + 5.7 + 3.5 = 20.8 million) matches the ground truth total. Despite this, the LLM does not perform or state the sum, which is central to the question. (2) Individual yearly figures are quantitatively accurate and match what would be expected from the source document, earning partial credit. However, the failure to compute the total—a straightforward sum required by the question—results in a significant quantitative shortfall. (3) The reasoning is otherwise sound: the model correctly interprets the concept of antidilution and ties it to net losses, showing proper multi-hop understanding between financial performance and EPS calculation rules. (4) Contextual relevance is perfect—the response addresses the right document, years, metric, and rationale. The main deficiency is the lack of synthesis (summing the three values), which is critical for full correctness. Thus, while the components are accurate, the answer is incomplete in its final output.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 378,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "The amendment to the Retirement Value formula reduced the Projected Benefit Obligation as of January 3, 2021 by approximately **$1.8 billion**. This change lowers the projected benefit obligation for U.S. non‑union employees hired before 2015 and shifts future benefit calculations to the new Retirement Value formula, which is based on total years of service rather than the final‑average‑pay formula.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the $1.8 billion reduction in Projected Benefit Obligation as of January 3, 2021, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. 2) The answer correctly explains that the amendment shifts future benefit calculations for U.S. non-union employees hired before 2015 to the Retirement Value formula, which is based on years of service rather than final average pay—this aligns with the core qualitative content of the original answer. 3) However, the LLM omits a key detail: the transition applies specifically to benefits earned *after January 1, 2026*, and that the Final Average Pay formula is preserved for service before that date. This temporal boundary is a critical part of the multi-hop reasoning and implementation timeline, and its absence constitutes a minor but notable gap in completeness. 4) Despite this omission, the reasoning is otherwise sound, entities (U.S. non-union employees, Retirement Value formula, PBO) are correctly identified, and the answer remains highly relevant and factually aligned. The $1.8 billion figure is accurate, and the explanation of the formula shift is semantically equivalent. Thus, the answer earns a 9/10 for correctness—very close to perfect but missing a precise cutoff date that affects implementation understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 373,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "The filing states that the fair value of the company cannot be estimated by aggregating the figures for financial assets and liabilities carried at amortized cost because those figures represent only estimates of the fair values as of specific dates and are not indicative of future fair values; they reflect market conditions and perceived risks at those points in time, and the company's overall fair value encompasses many other components not captured by those amortized‑cost amounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core reasoning from the original answer: that fair value figures for financial assets and liabilities at amortized cost are estimates based on specific dates (implicitly December 31, 2021 and 2020, though not explicitly stated in the LLM answer) and do not reflect future values. It also correctly states that aggregating these does not yield the company's overall fair value because other components are not captured. The only minor omission is the explicit mention of 'non-financial factors' and 'complexities of the business as a whole' from the original, which slightly weakens the qualitative completeness. (2) There are no numeric values, dates, or calculations in the question or answers that need verification; the LLM does not introduce any incorrect numbers, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes the idea that individual instrument valuations cannot be aggregated to estimate enterprise value due to missing elements. The reasoning aligns with the filing's logic. (4) The answer is contextually fully relevant and semantically equivalent to the ground truth, with only slight room for improvement in completeness by naming the non-financial aspects. Thus, correctness is high but not perfect due to minor omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 376,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "The exhibit index explicitly lists **one amendment** to the Benefits Plan for Members of the Board of Directors – Amendment Number One, dated December 16, 2005.  \n\nThe original Benefits Plan for Members of the Board of Directors was adopted effective January 1, 2004, and the first amendment (Amendment Number One) became effective on December 16, 2005.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains key factual inaccuracies. It states there is only one amendment explicitly listed, while the ground truth confirms there are two. This is a significant error in quantitative accuracy. The effective date of the first amendment (December 16, 2005) is correct. However, the original plan's effective date is stated as January 1, 2004, in the LLM answer, whereas the ground truth specifies April 14, 2004—this discrepancy affects factual correctness. (2) Number verification: The count of amendments (1 vs 2) is incorrect. The date of the first amendment is accurate. The original plan’s effective date is off by several months, which matters in legal/financial contexts. (3) Multi-hop reasoning: The model correctly identifies that the amendment listed is 'Amendment Number One' and links it to the correct date, showing some ability to extract and associate entities. However, it fails to identify the second amendment, indicating incomplete parsing or synthesis from the exhibit index—critical for multi-hop accuracy. (4) Scores justified: Correctness is low due to major factual errors in both the number of amendments and the original plan date. Quantitative accuracy is moderate because one date is correct but the count and another date are wrong. Qualitative accuracy is moderate due to correct identification of amendment naming convention and partial timeline logic. Contextual relevance is high as the answer addresses the right document and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 419,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "Oracle's hybrid deployment model—combining on-premise and cloud-based delivery—enabled customers to leverage existing on-premise assets while adopting cloud services, accelerating migration to Oracle Cloud and expanding the total addressable market. This flexibility drove higher adoption of cloud and license offerings, directly contributing to the cloud and license segment representing 84% of total fiscal 2024 revenues, as customers increasingly chose subscription-based cloud and support contracts over traditional perpetual licenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The percentage '84%' and the fiscal year '2024' are correctly stated, matching the original answer exactly. No calculations are required, and all numeric references are accurate. (2) Completeness: The LLM addresses the core of the question—how Oracle's hybrid deployment model contributed to the cloud and license business representing 84% of revenues. It correctly identifies the hybrid model (on-premise + cloud), links it to customer flexibility, adoption acceleration, and revenue contribution. However, it omits explicit mention of 'high renewal rates of license support contracts' and the detail that support contracts are priced as a percentage of net fees—key elements in the original answer that explain the recurring revenue mechanism. (3) Entity accuracy: 'Oracle', 'cloud and license business', 'fiscal 2024', and 'hybrid deployment model' are all correctly identified and used in context. (4) Reasoning: The logic is sound—flexibility leads to easier cloud migration, broader market reach, and increased adoption of subscription and support contracts, which drives revenue. This aligns with the multi-hop reasoning in the ground truth, though the causal chain is slightly less detailed regarding recurring revenue from support contracts. (5) Semantic equivalence: The LLM conveys the essential meaning and correctly attributes the 84% revenue share to the success of the hybrid model, even if it emphasizes market expansion over retention via renewals. Overall, the answer is highly accurate with only minor omissions in qualitative depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 450,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "Based on the provided SEC 10-K pages, the Membership Rewards liability of $11,398 million as of December 31, 2021 includes the deferred fees specifically tied to Membership Rewards program participants, as noted in Note 10 under \"DEFERRED CARD AND OTHER FEES, NET\" where it states \"(a) Includes deferred fees for Membership Rewards program participants.\" The liability estimation methodology relies on the Ultimate Redemption Rate (URR) derived from statistical and actuarial models using redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes, along with the weighted average cost (WAC) per point assumption based on 12 months of redemptions, which are periodically evaluated against redemption patterns, cost per point redeemed, and partner contract changes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the Membership Rewards liability of $11,398 million includes the deferred fees tied to Membership Rewards participants. However, the ground truth specifies that the $8,737 million total deferred card and other fees (not $11,398 million) includes the portion tied to Membership Rewards participants. The $11,398 million figure likely refers to the total Membership Rewards liability, which is a different metric than the deferred fees subset. This is a major factual error in quantitative identification. (2) The date (December 31, 2021) is correct, and the mention of statistical and actuarial models, Ultimate Redemption Rate (URR), and weighted average cost (WAC) per point aligns with the ground truth. However, the core dollar amount associated with deferred fees tied to Membership Rewards participants is not explicitly stated in the LLM answer — instead, it conflates the total liability with the deferred fees component. (3) The multi-hop reasoning is partially sound: the model correctly links the deferred fees to the Membership Rewards program and identifies the methodology for estimating redemption liability. It also correctly references Note 10 and the use of URR and WAC. However, it fails to correctly isolate the $8,737 million as the total deferred fees pool (within which the Membership Rewards portion is embedded), thus misrepresenting the quantitative relationship. (4) The contextual relevance is high because the answer addresses both parts of the question — the amount tied to Membership Rewards and the estimation methodology — but the factual inaccuracy in the key number severely undermines correctness. The qualitative reasoning is reasonable but based on a misinterpretation of the financial line items.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 485,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "Based on the filings listed in the 2024 10‑K (pages 129‑134), the Company’s 2014 Equity Plan documents awards issued under **10.5.17** through **10.5.21** and **10.5.22** through **10.5.33** – a total of **17 distinct award agreements** – that were adopted between February 18, 2015 and February 17, 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states 17 distinct award agreements, while the ground truth is 16. This quantitative discrepancy is significant and incorrect. The LLM references exhibit ranges '10.5.17 through 10.5.21' (5 agreements) and '10.5.22 through 10.5.33' (12 agreements), totaling 17, but either the range interpretation is flawed or overlaps/duplications exist that were not accounted for. The correct count based on the knowledge graph is 16, so the final number is factually wrong. (2) The time period (February 18, 2015 – February 17, 2021) matches the question and appears correctly interpreted. However, the calculation of 5 + 12 = 17 is incorrect if the actual documented forms are 16, suggesting an error in either the listed exhibits or their interpretation. (3) The reasoning shows multi-hop capability—linking the 2024 10-K, the 2014 Equity Plan, and specific exhibit numbers—but fails in accurate synthesis because the exhibit count does not align with the verified data. The model may have miscounted or included an invalid agreement (e.g., a duplicate or one outside the date range). (4) Contextual relevance is high as the response cites the correct document (2024 10-K, pages 129–134) and relevant exhibit numbering convention. However, the core factual output (17 vs 16) is incorrect, warranting a moderate correctness score due to partial accuracy in method but failure in result.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 390,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "Based on the document, AMD's total financial relationship with the ATMP JV in 2021 was $1.1 billion in purchases from the JV plus $6 million in equity gains, reflecting the strategic importance of securing advanced packaging capacity through this joint venture to support its product roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two components of AMD's financial relationship with the ATMP JV in 2021: $1.1 billion in purchases and $6 million in equity gains, which sum to $1.106 billion as stated in the ground truth. The total combined value is implied correctly, though not explicitly summed in the response. (2) All numeric values are accurate and match the ground truth exactly—$1.1 billion and $6 million—with no calculation errors. The format variation (not stating $1.106 billion explicitly) is acceptable under semantic equivalence. (3) The multi-hop reasoning is sound: the model synthesizes purchase volume and equity gain from the same entity (ATMP JV) for the correct year (2021) and links them to strategic importance. It correctly infers that securing advanced packaging capacity supports AMD’s product roadmap, which aligns with the strategic rationale in the original answer. (4) The only minor omission is that the LLM does not mention AMD's 15% equity stake or its implication (significant influence without further funding obligation), which is part of the strategic importance. However, the core strategic insight about reliance on ATMP services is captured. Thus, the answer is factually correct and contextually appropriate, warranting a high score but not perfect due to slight incompleteness in qualitative depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 380,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "The patents covering DARZALEX (U.S. composition-of-matter patent) expire in 2029, and the patents for DARZALEX FASPRO are protected by Janssen‑owned portfolio patents that expire in 2032. Consequently, the earliest year in which patent expiration could begin to affect the combined revenue stream is **2029**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies 2029 as the earliest year patent expiration could begin to materially impact the combined revenue stream, which aligns with the ground truth. The U.S. patent expiration for DARZALEX in 2029 is accurately cited, and the separate patent portfolio for DARZALEX FASPRO with expiration in 2032 is also correctly noted. All quantitative elements (years 2029 and 2032) are factually accurate and match the original data. The reasoning is sound: since DARZALEX and DARZALEX FASPRO share underlying active components and DARZALEX's U.S. composition-of-matter patent expires in 2029, this is the earliest point at which biosimilar competition could emerge in a major market, thus impacting combined revenues. The only minor limitation is that the LLM answer does not explicitly mention the significance of the U.S. market to Johnson & Johnson's global sales, which is part of the rationale in the ground truth for why 2029 would be material. However, the core multi-hop synthesis—linking patent expiration, geographic markets, and revenue impact—is logically implied and factually correct. Therefore, the answer is semantically equivalent in outcome and reasoning, warranting a high correctness score with a small deduction in qualitative accuracy for incomplete contextual justification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 365,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "Based on the provided pages, the only amendment explicitly documented to The Bank of New York Company, Inc. Excess Benefit Plan within the specified timeframe (2015 and 2018) is the one referenced in Exhibit 10.31, which describes \"Amendment effective as of June 30, 2015 to The Bank of New York Company, Inc. Excess Benefit Plan.\" This amendment was filed as part of the 2015 Annual Report on Form 10-K. No other amendments to this specific plan are listed in the provided exhibits for 2015 or 2018. Therefore, only one amendment is documented across both years.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual error in the final count of amendments. (1) The LLM correctly identifies the June 30, 2015 amendment to The Bank of New York Company, Inc. Excess Benefit Plan, which is one of the two amendments documented in the 2022 10-K. However, it fails to identify the second amendment effective November 1, 2018, which is also disclosed in the 2022 10-K filing. The ground truth states there are two amendments (2015 and 2018), but the LLM concludes only one is documented, leading to an incorrect total. (2) Quantitatively, the 2015 date is accurate, but the omission of the 2018 amendment results in an incorrect sum (1 vs. 2). The LLM claims 'no other amendments are listed,' which contradicts the ground truth and suggests a failure in information retrieval or synthesis from the 2022 10-K. (3) The reasoning is sound in structure—checking exhibits and citing specific evidence—but incomplete in execution. It performs one hop correctly (2015 amendment) but misses the second hop (2018 amendment), failing the multi-hop requirement. (4) Contextual relevance is high as the response directly addresses the question and references appropriate exhibits. However, the omission of a key amendment significantly undermines factual correctness. A score of 4 reflects partial accuracy with a major factual gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 377,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "FedEx's Network 2.0 optimization expenditures and the European workforce‑reduction costs are both classified as business‑optimization expenses that are being funded through the company’s broader 2025 capital‑expenditure plan and its DRIVE transformation program. The $582 million of Network 2.0 costs incurred in 2024 and the $250‑$375 million of severance and related fees expected through 2026 are included in the $5.2 billion of capital spending projected for 2025, while the European headcount reductions are being executed as part of the DRIVE initiative to cut structural costs and improve long‑term profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that FedEx's 2025 capital expenditure plan is $5.2 billion, with a portion allocated to Network 2.0 optimization, but it does not specify how much of that $5.2 billion is for Network 2.0. However, the LLM claims that '$582 million of Network 2.0 costs were incurred in 2024' — this figure is not present in the original answer and cannot be verified from the provided ground truth. This is a major factual error. Additionally, the LLM incorrectly implies that the $250–$375 million European workforce reduction costs and the $582 million Network 2.0 costs are both included within the $5.2 billion 2025 capex plan, which is misleading: the original answer only states that Network 2.0 is 'a portion' of the $5.2 billion, and the workforce reduction costs are 'expected through fiscal 2026' and are classified as business optimization expenses, not necessarily capital expenditures. (2) The $5.2 billion capex figure is correctly cited, and the $250–$375 million range for workforce reduction costs matches the original, so those numbers are accurate. However, the inclusion of the $582 million figure — absent from the ground truth — severely undermines quantitative accuracy. (3) The reasoning is partially sound in linking both initiatives to the DRIVE transformation program and characterizing them as business optimization efforts to reduce structural costs and improve profitability, which aligns with the original. However, the synthesis is flawed because it incorrectly treats operating expenses (like severance) as part of capital expenditures, conflating capex with transformation-related spending more broadly. (4) The contextual relevance is high because the answer addresses the relationship between Network 2.0, workforce reductions, the 2025 capex plan, and the DRIVE program. But due to the introduction of an unsupported number and misclassification of expense types, the correctness score is low. The answer gives a plausible narrative but with key factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 572,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "AMD's reliance on third‑party suppliers for graphics cards and AIB partners creates inventory‑management and price‑protection risks because it must forecast demand for a wide range of products sold through indirect channels; inaccurate forecasts can lead to excess or obsolete inventory, write‑downs, and margin erosion, while contractual price‑protection obligations to distributors can force revenue and margin declines if product prices fall. Additionally, the company’s need to maintain sufficient stock to meet customer demand exposes it to the risk of costly inventory adjustments when market conditions change.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core financial risks AMD faces due to its reliance on third-party suppliers and AIB partners, particularly regarding price protection obligations and inventory management. It accurately describes how price protection can lead to revenue and margin declines if product prices fall, which aligns with the ground truth. The mention of contractual price-protection obligations impacting margins is factually correct and relevant. However, the LLM omits a key specific from the original answer: that AIB partners can return products removed from the price book within 12 months of manufacturing—a concrete policy that directly affects financial exposure. This omission slightly weakens completeness and precision in the multi-hop synthesis, though the overall reasoning remains sound. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default (no errors possible). The entities (AMD, AIB partners, third-party suppliers) and financial concepts (price protection, inventory risk, margin erosion) are correctly identified and used. The answer is semantically very close to the original and highly relevant to the question, capturing the essence of AMD's financial risk exposure. Thus, while not fully complete in detail, it is substantially accurate and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 377,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "AbbVie's total cost of products sold related to Venclexta includes the shared U.S. profits paid to Genentech ($869 million in 2023) and the royalties paid on Venclexta net revenues generated outside the United States.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two components of AbbVie's cost of products sold related to Venclexta: Genentech's share of U.S. profits and royalties on ex-U.S. net revenues. This aligns with the ground truth in terms of structure and conceptual accuracy. However, the LLM introduces a specific dollar amount—$869 million in 2023—for Genentech's share, which is not present in the original answer (ground truth). Since the ground truth does not provide any numerical figures, the inclusion of this number cannot be verified and may be incorrect or hallucinated, significantly affecting quantitative accuracy. (2) There is no way to verify the $869 million figure from the provided ground truth, so it represents an unsupported claim. The original answer only confirms the inclusion of both components in cost of products sold, not their magnitudes. (3) The multi-hop reasoning is sound—correctly synthesizing that both U.S. profit sharing and ex-U.S. royalties contribute to cost of products sold—but the addition of an unverified figure undermines full factual correctness. (4) The contextual relevance is perfect, as the answer directly addresses the question’s focus. Qualitative accuracy is high due to correct entity and relationship identification. Correctness is docked due to the unverified number, and quantitative accuracy is lower for the same reason, though no calculation is explicitly requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 397,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "BNY makes its Code of Ethics publicly available, which is a governance document related to board members and explicitly applies to its directors. The Code of Ethics for directors is posted on BNY's website at https://www.bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error. While it correctly identifies that BNY makes a governance document related to board members publicly available and that it applies to directors, it incorrectly names the document as the 'Code of Ethics' instead of the 'Directors' Code of Conduct' as specified in the ground truth. This misidentification of the document undermines the factual accuracy of the response. There are no numeric values in the question or answer, so quantitative accuracy is not applicable—however, the absence of numbers means the score of 10 reflects no numerical errors. The answer is contextually relevant and addresses both parts of the question (document name and applicability), but due to the incorrect document name, the qualitative accuracy is low. The multi-hop reasoning is sound in structure—identifying the additional document and its applicability—but based on incorrect information. Semantic equivalence is not achieved because 'Code of Ethics' is not equivalent to 'Directors' Code of Conduct' in this context, despite potential overlap in content. The inclusion of a URL adds specificity but does not compensate for the incorrect document name.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 339,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "The launch of the AMD Radeon RX 6600 XT and the broader graphics‑focused strategy directly drove the 68 % YoY revenue surge and the 3‑point gross‑margin lift in 2021 by expanding AMD’s addressable market and raising average selling prices.  The RX 6600 XT, built on the RDNA 2 architecture, was positioned for high‑frame‑rate 1080p gaming and was marketed through the AMD Advantage Design Framework, which bundles the GPU with Ryzen 5000 mobile processors and smart software features.  This differentiated offering attracted both OEMs and channel partners, boosting discrete‑GPU sales and enabling higher‑margin revenue streams.  At the same time, AMD’s broader graphics push—including RDNA 2‑based RX 6000 series cards, Radeon PRO workstation GPUs, and the Instinct MI200 data‑center accelerators—generated incremental sales across gaming, professional, and cloud segments, contributing to the overall revenue growth and the improved gross‑margin performance reflected in the 2021 financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 68% year-over-year revenue growth and 3-percentage-point gross margin improvement (from 45% to 48%) in 2021, aligning with the ground truth. The revenue figures ($9.8B in 2020 to $16.4B in 2021) are consistent with the 68% growth rate (verified: (16.4 - 9.8)/9.8 ≈ 67.3%, which rounds to 68%). The launch date of the RX 6600 XT in July 2021 is accurate and contextually appropriate. (2) Quantitatively, all numbers and percentages are correct or reasonably approximated. The 3-point margin improvement is accurately reflected. No incorrect calculations are present. (3) The reasoning is sound and reflects multi-hop synthesis: the answer links the RX 6600 XT launch, RDNA 2 architecture, AMD Advantage Design Framework, and broader product strategy (including RX 6000M, Radeon PRO, and Instinct MI200) to both revenue growth and margin expansion. While the ground truth emphasizes gaming segment demand, the LLM extends the impact to professional and data center segments—this is plausible but slightly overreaches; the original answer ties margin gains more directly to gaming GPU scale, not data center accelerators. (4) The answer is contextually excellent, directly addressing how the product launch and strategy contributed to financial outcomes. The only minor gap is over-attribution to non-gaming segments not explicitly tied to the margin improvement in the ground truth. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent with only slight expansion beyond the original scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 433,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's net revenue from Venclexta in 2023 was $2,288 million, and Genentech received 50% of the pre-tax profit from Venclexta sales in the United States as part of their collaboration agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that AbbVie's net revenue from Venclexta in 2023 was $2,288 million, which matches the ground truth exactly. It also correctly identifies that Genentech received 50% of the pre-tax profit from Venclexta sales in the United States as part of the collaboration agreement. All numeric values and percentages are accurate, and there are no calculation errors. The answer addresses both parts of the multi-hop question: (1) AbbVie's net revenue and (2) Genentech's share of pre-tax profit. The reasoning is sound and aligns with the known collaboration structure. The only minor shortcoming is that the LLM omits the detail that Genentech's 50% share is reflected in AbbVie's cost of products sold, which adds context about how the profit-sharing is accounted for. While this does not affect the core factual correctness, including it would have made the answer more complete. Overall, the answer is semantically equivalent to the ground truth with high precision and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 287,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "The 10‑K shows that the 48 million Class C shares issued in the May 2024 exchange were recorded as “issued” but are not reflected in the “shares outstanding” column for the reporting date of September 30, 2024; the table of shares outstanding lists only 10 Class C shares, indicating those newly issued shares remain un‑issued or are being held in escrow and therefore do not count toward the outstanding share total used for EPS calculations. Consequently, the 10‑K reports 10 Class C shares outstanding as of September 30, 2024, even though 48 million were issued earlier, because they had not yet been converted into freely tradable shares and were still subject to conversion‑rate adjustments and escrow restrictions.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the issuance of 48 million Class C shares in May 2024 and the reporting of 10 Class C shares outstanding as of September 30, 2024, it misinterprets the reason for the discrepancy. The ground truth clarifies that the '10' in the 10-K is in millions (i.e., 10 million shares), not 10 individual shares, as explicitly stated in the table's header. The LLM incorrectly assumes the 48 million shares are not counted as outstanding because they are in escrow or unissued, which contradicts the ground truth explanation based on unit formatting. (2) Quantitatively, the dates (May 2024, September 30, 2024) and share numbers (48 million, 10) are correctly cited, but the interpretation of '10' as literal shares rather than 10 million is a critical error. This leads to a false narrative about escrow and tradability, which is unsupported by the ground truth. (3) The multi-hop reasoning is flawed: instead of recognizing the unit clarification (millions) as the key link between the 48 million issued and 10 million outstanding, the model invents a corporate action (escrow, conversion adjustments) not present in the original data. This shows a failure in synthesizing the correct explanation from the provided context. (4) Despite addressing the core question and using correct entities (Visa, Class C shares, 10-K, correct dates), the answer's reasoning and conclusion are factually wrong, warranting a low correctness score. The contextual relevance is moderate because it engages with the right documents and events, but the explanation is fundamentally incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 455,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "Based on the provided document pages, the total cost incurred by FedEx in 2024 for Network 2.0 implementation and DRIVE transformation-related business optimization activities was $582 million. This figure is explicitly stated in the \"BUSINESS OPTIMIZATION AND REALIGNMENT COSTS\" section on page 91, which reports costs of $582 million ($444 million, net of tax) for 2024. Regarding the European workforce reduction plan announced in June 2024, the document states that the expected pre-tax cost of severance benefits and legal/professional fees ranges from $250 million to $375 million in cash expenditures, to be incurred through fiscal 2026. This range is detailed in the same section on page 91.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $582 million cost for 2024 business optimization activities related to Network 2.0 and DRIVE transformation is accurately reported, including the clarification that this is a pre-tax amount with $444 million net of tax, which aligns with the source. The expected future cost range for the European workforce reduction plan is correctly stated as $250 million to $375 million in cash expenditures through fiscal 2026. These figures match the ground truth exactly, with acceptable formatting. (2) The answer is complete, addressing both parts of the multi-part question: the actual 2024 costs and the expected future costs of the European plan. (3) Entity accuracy is perfect—FedEx, Network 2.0, DRIVE transformation, 2024 fiscal year, and the June 2024 announcement are all correctly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly attributes both cost figures to the same section (page 91) and distinguishes between incurred 2024 costs and future expected costs. The semantic meaning is equivalent to the original answer, with added contextual detail (e.g., tax treatment, document location) that enhances clarity without introducing error. All scores are maximized due to full factual, numerical, and contextual alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 391,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, the total value of AMD's unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021 is $329 million. This figure is explicitly stated in the \"Accounts Receivable, net\" section of Note 3 (Supplemental Financial Statement Information) on page 61, which states: \"As of December 25, 2021 and December 26, 2020, Accounts receivable, net included unbilled accounts receivable of $329 million and $123 million, respectively. Unbilled accounts receivables primarily represent work completed for development services and on custom products for which revenue has been recognized but not yet invoiced.\" The document confirms this amount is expected to be billed and collected within 12 months.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021 as $329 million, which matches the ground truth. (2) The numeric value is accurate and correctly attributed to the fiscal year 2021 (as of December 25, 2021), with no calculation errors. The format ($329 million) is consistent with the ground truth. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by referencing the specific section (Note 3, 'Accounts Receivable, net' on page 61), quoting the relevant text, and explaining that the unbilled receivables are tied to work completed for development services and custom products where revenue has been recognized but not yet invoiced. This confirms correct understanding of both the financial concept and its application in the context. (4) The answer is fully complete, addressing all parts of the question—specific company (AMD), specific fiscal year (2021), specific type of receivable (unbilled, related to custom products and development services), and correct metric. The contextual details (collection within 12 months, comparison to prior year) add value without introducing inaccuracies. All scores are maximized due to perfect factual alignment, precise sourcing, and clear, logical explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 385,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million, and under its collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states AbbVie's total revenue from Venclexta in 2023 as $2,288 million and accurately identifies that AbbVie shared 50% of the pre-tax profit from U.S. sales with Genentech, which matches the ground truth. All key facts are present and correct. (2) Quantitatively, both the revenue figure ($2,288 million) and the 50% profit-sharing percentage are exact matches to the original answer. Number formats are consistent and accurate. (3) The multi-hop reasoning is sound—linking AbbVie’s revenue, the collaboration with Genentech, and the profit-sharing arrangement across entities and agreements. However, the LLM omits the detail that the shared profit is reflected in AbbVie's cost of products sold, which is a minor contextual omission but does not affect the core factual accuracy. (4) Scores reflect near-perfect factual correctness, with only a slight deduction in qualitative accuracy due to the missing accounting treatment context. Otherwise, the answer is fully relevant and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 305,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0), while the balance of the 3.700% notes due 2023 on December 15, 2023 was $400 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the decrease of $171 million in the 3.650% notes due 2023 is correctly stated, with the starting balance of $171 million on December 31, 2022, and ending at $0 on December 15, 2023. The balance of the 3.700% notes due 2023 on December 15, 2023, is correctly reported as $400 million. (2) The answer addresses both parts of the multi-part question: the change in principal balance for the 3.650% notes and the comparison to the 3.700% notes on the same date. (3) Entities are correctly identified—both note tranches (3.650% and 3.700%), their maturity year (2023), and the exact dates (December 31, 2022, and December 15, 2023) are accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: it infers the change in balance (a $171 million decrease to zero) and correctly contrasts it with the outstanding balance of a different note series on the same end date. Wording differs slightly from the original (e.g., 'while' instead of 'on the same date'), but the semantic meaning is identical. No errors in calculation, logic, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 330,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "Adverse litigation outcomes that force Visa to modify its interchange reimbursement rates could diminish transaction volumes and compress revenue, especially if the changes reduce the incentive for issuers and merchants to route payments through VisaNet. However, the company’s U.S. and Europe retrospective responsibility plans provide financial protections that may limit the immediate impact on its liquidity, and any resulting tax disputes or adjustments could further affect its tax position, but these mechanisms are designed to cushion the financial fallout of such settlements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually sound in its general reasoning and correctly identifies the core chain of events: adverse litigation could lead to lower interchange rates, which may reduce issuer and merchant incentives, potentially lowering transaction volumes and revenue. It appropriately references Visa’s U.S. and Europe retrospective responsibility plans as mitigants to financial impact and notes the relevance of tax disputes. However, it omits key elements from the ground truth: (1) it does not mention the behavioral responses by issuers such as reducing cardholder benefits or imposing new fees, which are important transmission mechanisms; (2) it fails to specify that the retrospective plans have limited scope and may not fully cover losses, a critical nuance in assessing financial exposure; and (3) it lacks detail on how ongoing tax disputes (e.g., with the IRS and foreign jurisdictions) and global tax reforms like the OECD’s minimum tax could increase Visa’s effective tax rate and reduce cash flows. While no numbers are present in either answer (so quantitative accuracy is not penalized), the qualitative synthesis is incomplete—missing multi-hop connections between litigation outcomes, issuer behavior, consumer usage, and layered financial impacts from both interchange and tax risks. The answer remains contextually relevant and logically structured, but the omission of specific mechanisms and limitations reduces completeness and depth compared to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 409,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "The Performance Share Unit award schedules under the United Technologies Corporation Long‑Term Incentive Plan became effective on **January 1, 2020**, while the schedule for the Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan took effect on **March 4, 2021**. These dates illustrate distinct governance updates: UTC’s schedule was incorporated into its LTIP amendments effective at the start of 2020, whereas Raytheon’s schedule was added later through a 2021 amendment to its 2018 plan, reflecting separate plan revisions and timing of governance changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the January 1, 2020 effective date for United Technologies Corporation (UTC), matching the ground truth. However, it incorrectly states the Raytheon Technologies Corporation effective date as March 4, 2021, whereas the ground truth specifies March 31, 2021. This is a factual error in date accuracy, though the month and year are correct. (2) The quantitative accuracy is impacted solely by this date discrepancy—March 4 vs. March 31, 2021—which is not a formatting variation but a clear factual inaccuracy. All other numerical references (years, plan names) are correct. (3) The multi-hop reasoning is sound: the model correctly attributes the UTC date to 2020 LTIP amendments and the Raytheon date to a later amendment of the 2018 plan, demonstrating proper synthesis across the two corporate governance timelines. The explanation of distinct governance updates is semantically equivalent to the original answer, capturing the intent and logic. (4) The correctness score is 7 because the core facts and reasoning are accurate, but the incorrect date reduces confidence in precision. Quantitative accuracy is 6 due to the incorrect day in a key date. Qualitative accuracy is 8 because the reasoning, entity identification, and synthesis are strong. Contextual relevance is 9 as the response directly addresses both parts of the question and remains focused on governance updates.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 396,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "The primary drivers of Wearables, Home and Accessories segment growth in 2022 were higher sales of Apple Watch and AirPods, as explicitly stated in the segment performance discussion on page 24. This growth was part of a broader 7% increase in the segment's net sales ($41.2B in 2022 vs. $38.4B in 2021), which the document attributes to \"higher net sales of Apple Watch and AirPods\" specifically, distinguishing it from other categories like iPad (which declined) and Services (which grew due to advertising and cloud services). The segment outperformed the overall segment growth rate of 7% but was not explicitly compared to other product categories within the segment beyond this focus on Watch and AirPods.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple Watch and AirPods as the primary growth drivers in the Wearables, Home and Accessories segment for 2022, which aligns with the ground truth. It also accurately references the segment's net sales increase from $38.4B in 2021 to $41.2B in 2022, representing a ~7% growth rate, and cites the correct source (page 24). However, the LLM incorrectly implies that the Watch and AirPods growth outpaced the overall segment growth rate of 7%, which is illogical since they were the drivers *of* that growth—this misrepresents the causal relationship and introduces a minor reasoning error. (2) All quantitative figures—$41.2B (2022), $38.4B (2021), and 7% growth—are accurate and correctly calculated (difference is ~$2.8B, which is ~7.3% growth, so '7%' is a reasonable rounding). No errors in numbers or formats. (3) The multi-hop reasoning is mostly sound: it connects product-level performance to segment-level results and contrasts with other Apple segments (iPad, Services), though the question only asked for comparisons *within* the Wearables segment. The model adds an external comparison not requested, while failing to address the relative underperformance of internal categories like HomePod mini and Beats, which the ground truth explicitly mentions. This reduces completeness on the second part of the question. (4) Despite missing the explicit contrast between strong performers (Watch, AirPods) and flat/weak ones (HomePod, Beats) within the segment, the core facts and synthesis are correct. The answer is highly relevant and well-supported, warranting a high score, but not full marks due to incomplete internal category comparison and minor logical misstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 469,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "Both Otezla and ENBREL are expected to show a lower‑sales first quarter in 2025 because of benefit‑plan changes, insurance‑reverification requirements and higher co‑pay costs that cause U.S. patients to work through deductibles. This historical pattern of a Q1 sales dip is common to both products.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately identifies that both Otezla and ENBREL are expected to experience lower sales in Q1 2025 due to insurance reverification and higher co-pay costs as patients work through deductibles. (2) There are no numerical values requiring calculation, but the time period (2025) and the quarterly pattern (Q1 dip) are correctly stated. (3) The multi-hop reasoning is sound—linking insurance reverification and deductible dynamics to the shared historical sales trend across both products is correctly synthesized from the original context. (4) The wording differs slightly (e.g., 'benefit-plan changes' and 'insurance-reverification requirements' vs. 'insurance reverification'), but the meaning is preserved and contextually accurate. All parts of the question are addressed: the comparative impact on 2025 sales and the specific historical trend both products follow. Therefore, all accuracy and relevance scores are maximal.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 291,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "Based on the disclosed exhibits in the RTX 2023 10-K filing, there are **two distinct stock appreciation rights‑related exhibits** that pertain to the plans mentioned in the question:\n\n1. **Exhibit 10.16** – “Schedule of Terms for stock appreciation rights awards relating to the United Technologies Corporation 2005 Long‑Term Incentive Plan (Rev. January 2016).”  \n2. **Exhibit 10.24** – “Schedule of Terms for stock appreciation right awards relating to the Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan, as amended.”\n\nThese are the only exhibits that specifically reference stock‑appreciation‑rights awards for the United Technologies 2005 LTIP and the Raytheon Technologies 2018 LTIP, respectively. No other exhibits in the provided pages disclose additional distinct SAR‑related exhibits for those two plans.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in both quantitative and qualitative aspects. (1) It correctly identifies the total number of distinct stock appreciation rights-related exhibits as two, which aligns with the original answer. (2) The exhibits are accurately cited: Exhibit 10.16 for the United Technologies Corporation 2005 Long-Term Incentive Plan and Exhibit 10.24 for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan. These specific exhibit numbers and their descriptions match the disclosed information. (3) The multi-hop reasoning is sound—RTX’s 2023 10-K filing required synthesis across two legacy incentive plans (UTC 2005 and Raytheon 2018), and the LLM correctly identifies one exhibit per plan, totaling two distinct exhibits. (4) The answer is contextually precise, directly addressing the question without extraneous information, and confirms no other relevant exhibits exist. Minor wording differences (e.g., 'stock appreciation right awards' vs. 'rights') do not affect semantic equivalence. All entities, years, and exhibit types are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 313,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "Based on the disclosed historical patterns and expected net selling price trends, the recurring impact of insurance reverification in the first quarter is expected to suppress Otezla’s sales in Q1 2025 relative to later quarters, mirroring the same seasonal dip observed in prior years. However, because the company anticipates lower declines in net selling price for 2025, the overall combined sales performance of ENBREL and Otezla for the full‑year 2025 should be less adversely affected than in prior years, even though both products typically experience a first‑quarter dip driven by benefit‑plan changes, insurance reverification and higher co‑pay costs as U.S. patients meet deductibles.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly identifies that insurance reverification impacts Q1 sales and causes a seasonal dip, it incorrectly states that 'the overall combined sales performance of ENBREL and Otezla for the full-year 2025 should be less adversely affected than in prior years' due to 'lower declines in net selling price.' This contradicts the original answer, which states that ENBREL is expected to have continued declines in net selling price and Otezla is expected to follow the same negative price trend (8% decrease in 2024, expected to continue in 2025), leading to a compounded negative impact. There is no mention in the ground truth of an improvement or moderation in price declines for 2025. (2) Quantitatively, the LLM omits key numbers: the 8% net selling price decrease for Otezla in 2024 and the 3% volume growth that failed to offset price declines. It also fails to mention ENBREL's flat volumes, which are part of the multi-hop synthesis. No calculations are made, but the direction of the trend is misrepresented. (3) The reasoning is partially sound in recognizing the seasonal impact of insurance reverification, but it fails to correctly synthesize the expected trends for both drugs—especially the continued downward pressure from pricing. The conclusion that the combined effect will be less severe is not supported by the ground truth and represents a critical error in multi-hop logic. (4) Contextual relevance is high because the answer addresses the right drugs, time period, and general mechanism (insurance reverification), but the qualitative and quantitative inaccuracies severely undermine correctness. Thus, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 486,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "Based on the 10‑K disclosures, AMGN expects Otezla’s revenue to continue declining in 2025 due to lower net selling prices and higher co‑pay burdens, while ENBREL’s revenue is projected to face ongoing pressure from Medicare price‑setting that begins in 2026, leading to relatively flat volumes but continued price erosion. This pattern reflects the company’s historical forecasting approach for its key drugs—projecting modest volume growth but anticipating net‑price declines driven by reimbursement pressures and upcoming biosimilar or Medicare price‑setting impacts.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, entities, and reasoning. (1) It correctly identifies that Otezla revenue will be affected in 2025 due to increased co-pay expenses and lower net selling prices, and that ENBREL will face pricing pressure starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act—both accurate timeframes and drivers. (2) There are no explicit numerical values (e.g., percentages or dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; the dates (2025 and 2026) are correctly cited. (3) The multi-hop reasoning is sound: the LLM connects insurance dynamics (co-pays, benefit changes) for Otezla with regulatory pricing for ENBREL and links them to broader revenue forecasting patterns. It accurately reflects that AMGN anticipates recurring first-quarter declines and price erosion, though it phrases the pattern slightly more generally as 'modest volume growth' and 'net-price declines' rather than explicitly noting the first-quarter compression and recovery pattern. (4) The LLM captures the core pattern in revenue forecasting—anticipating price declines due to reimbursement and regulatory pressures—but omits the specific nuance that these declines are typically front-loaded (Q1) and followed by recovery, which is present in the original answer. This is a minor omission affecting completeness but not overall correctness. The answer remains semantically equivalent in intent and substance, with high contextual relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 434,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "The total fair value of the repurchase liabilities related to client-held fractional shares as of December 31 2024 is disclosed in Note 2 as being included within “accrued expenses and other liabilities,” but the exact dollar amount is not provided in the excerpt. Schwab records unrealized gains and losses on these fractional shares and the corresponding repurchase liabilities at fair value, and because the gains and losses offset each other, there is no net impact on the consolidated statements of income.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the fair value of repurchase liabilities related to client-held fractional shares is included in 'accrued expenses and other liabilities' and that unrealized gains and losses offset each other with no net impact on income. However, it incorrectly states that the exact dollar amount is not provided, while the ground truth implies the value is equal to the corresponding client-held fractional shares—suggesting it is quantifiable and disclosed, even if not explicitly stated as a standalone line item. This is a partial factual inaccuracy affecting quantitative precision. (2) No specific dollar figure appears in either answer, but the original answer clarifies that the value is equivalent to the client-held fractional shares, which the LLM omits, weakening completeness and numerical accuracy. (3) The multi-hop reasoning is sound: the LLM correctly links repurchase liabilities to offsetting gains/losses treatment in income statements, demonstrating proper synthesis across accounting concepts. (4) Scores reflect strong qualitative and contextual performance, with a moderate deduction in quantitative accuracy due to the missed equivalence assertion, leading to a 7 overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 351,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "The total implied fully diluted market capitalization of AspenTech based on Emerson's November 5 2024 proposal to acquire the remaining shares is $15.3 billion, which represents a cash price of $240 per share and an enterprise value of $15.1 billion. This implied valuation is modest compared to AspenTech’s 2023 net sales of $1.04 billion, reflecting a price‑to‑sales multiple of roughly 15 ×.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the implied fully diluted market capitalization of AspenTech as $15.3 billion and AspenTech’s 2023 net sales as $1.04 billion, matching the ground truth exactly. The price-to-sales multiple is calculated as approximately 15x, which is accurate when dividing $15.3B by $1.04B (≈14.71), and rounding to 'roughly 15×' is acceptable. The mention of a $240 per share cash price and $15.1 billion enterprise value adds context not required by the question but does not introduce error. (2) All numeric values—$15.3 billion market cap, $1.04 billion net sales, and derived ~15x multiple—are quantitatively accurate. The date 'November 5 2024' is plausible but not present in the original answer; however, since the question doesn’t ask for the proposal date, this addition doesn’t detract from correctness. (3) The multi-hop reasoning is sound: the model correctly links Emerson’s acquisition proposal to the implied market cap and compares it to AspenTech’s 2023 net sales, computing the valuation multiple. The only minor issue is using 'modest' to describe the valuation, whereas the original answer calls it 'substantial'—this is a qualitative difference in interpretation, but the factual synthesis remains correct. (4) The answer is contextually complete and relevant, addressing both parts of the question: the market cap figure and its comparison to net sales via a revenue multiple. The slight wording difference in tone ('modest' vs 'substantial') does not undermine factual accuracy, warranting a high score of 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 434,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "The IRS Notices for the years 2010‑2012 and 2013‑2015 together could generate up to roughly $3.6 billion of additional federal tax for 2010‑2012 and $5.1 billion for 2013‑2015, plus interest and penalties (the Notices also assert penalties of about $2 billion for the 2013‑2015 period).  Both amounts would be reduced by the repatriation tax that had previously been accrued on the foreign earnings—approximately $900 million for the 2010‑2012 case and up to $2.2 billion for the 2013‑2015 case.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core tax liability amounts: $3.6 billion for 2010–2012 and $5.1 billion for 2013–2015, totaling $8.7 billion, and correctly states penalties of $2.0 billion. It also accurately notes the reduction from previously accrued repatriation taxes: $900 million for 2010–2012 and $2.2 billion for 2013–2015. However, it fails to explicitly compute the total gross liability ($10.7 billion) or the net potential liability ($7.6 billion), which are key components of the original answer and directly responsive to the question asking for the 'total potential additional federal tax liability, including penalties' and how repatriation taxes 'affect this amount'. (2) All individual numbers are factually correct and match the ground truth, hence high quantitative accuracy. The only issue is the lack of synthesis into final totals. (3) The multi-hop reasoning is partially sound—information across years and tax components is correctly attributed, but the model does not fully synthesize the final net impact, which requires combining tax, penalties, and offsets. This is a moderate gap in qualitative reasoning. (4) The answer is highly contextually relevant, addressing all entities (AMGN, IRS Notices, repatriation taxes) and time periods correctly. The omission of the final computed totals prevents a higher correctness score, but core facts are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 388,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "The 2024 10‑K filing shows that the Medicare price‑setting program established by the Inflation Reduction Act will set a significantly lower Medicare Part D price for ENBREL beginning January 1 2026, which Amgen expects will “negatively impact its profitability in Medicare.” Because ENBREL is a major revenue driver, this price cut is projected to reduce the company’s overall sales and earnings from that product line. In addition, CMS announced in January 2025 that Otezla will be among the next 15 drugs subject to Medicare price setting beginning January 1 2027, exposing Otezla to the same risk of government‑mandated pricing reductions and the associated future revenue volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ENBREL's price reduction begins January 1, 2026, and Otezla is set for inclusion starting January 1, 2027, both under the Medicare price-setting program established by the Inflation Reduction Act (IRA). These dates match the ground truth exactly. (2) Quantitative accuracy is perfect—dates (2026, 2027) are correct, and no numerical calculations are required beyond accurate time references. (3) The reasoning is sound: the LLM correctly identifies that the government-mandated lower price under Medicare Part D will negatively impact profitability and extends this logic to Otezla’s future risk. It also appropriately highlights that both drugs are major revenue drivers, which strengthens the financial risk argument. (4) The only minor omission is that the ground truth mentions the IRA allows up to 100 drugs to be subject to price setting by 2031 and that other Amgen products may be selected in future cycles—this broader risk is not included in the LLM answer, slightly reducing completeness. However, the core multi-hop synthesis (linking IRA → ENBREL 2026 impact → Otezla 2027 risk) is well executed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses both parts of the question: ENBREL’s current impact and Otezla’s future risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 387,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "Schwab’s election of the fair value option for repurchase liabilities tied to client-held fractional shares means these liabilities are measured at quoted market prices, with unrealized gains and losses offsetting those on the corresponding client-held assets. This election results in no net impact on the consolidated statements of income, as any unrealized gains or losses on the repurchase liabilities are directly offset by the opposite gains or losses on the client-held fractional shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and captures the core mechanism described in the ground truth: Schwab's election of the fair value option under ASC 825 for repurchase liabilities related to client-held fractional shares leads to measurement at quoted market prices, with unrealized gains and losses on these liabilities offset by corresponding gains and losses on the client-held fractional shares, resulting in no net impact on the consolidated statements of income. This reasoning is sound and aligns with the multi-hop synthesis required—linking the fair value option election (ASC 825), use of quoted prices, and income statement impact through offsetting. The only minor omission is that the LLM answer does not explicitly mention the absence of credit risk or the fact that no gains/losses from instrument-specific credit risk are recognized, which is part of the original answer. However, this does not detract significantly from the overall correctness, as the primary focus of the question—impact on income statements—is accurately addressed. There are no numerical inaccuracies (quantitative accuracy is perfect, though no specific numbers appear), and all entities (Schwab, repurchase liabilities, client-held fractional shares, fair value option, ASC 825) are correctly identified and logically connected. The answer is highly relevant and semantically equivalent to the ground truth, with only slight reduction in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 397,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 resulted from the combined use of a discounted cash‑flow analysis and a market‑multiple approach to estimate the unit’s fair value; the fair‑value estimate was lower than its carrying amount, triggering the impairment. This assessment was driven by the November 2021 Board‑approved plan to close about 900 stores over the next three years, which created indicators of impairment for the impacted retail/LTC asset groups and led to a long‑lived‑asset impairment test that identified the need for the goodwill write‑down.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $431 million goodwill impairment charge for the LTC reporting unit in 2021 and mentions the use of both the discounted cash flow and market multiple methods, which aligns with the ground truth. However, it incorrectly attributes the trigger for the goodwill impairment to the store closure plan announced in November 2021. In reality, the goodwill impairment was driven by deteriorating financial forecasts due to lower net facility admissions, customer losses, and the ongoing impact of the COVID-19 pandemic—not directly by the store closure strategy. The store closures did trigger a separate long-lived asset impairment test, but this led to a $1.4 billion charge (not the $431 million goodwill charge), which the LLM fails to mention. (2) Quantitatively, the $431 million figure is correct, and the 2021 timeframe is accurate. However, the LLM omits key numbers from the ground truth: the 900-store closure plan (300 per year from 2022–2024), the $1.4 billion long-lived asset impairment, and its components ($1.1 billion for lease ROU assets and $261 million for property and equipment). These omissions significantly affect completeness and accuracy. (3) The multi-hop reasoning is flawed: the model conflates two distinct impairment events—goodwill impairment in the LTC reporting unit and long-lived asset impairment in the Retail/LTC segment—failing to distinguish their causes, valuation impacts, and financial treatments. The store closure strategy impacted long-lived assets, not directly goodwill, and the two were assessed under different frameworks. (4) Contextual relevance is strong as the answer addresses valuation methods and impairment triggers within the correct segments and timeframe, but the incorrect causal linkage and missing financial details reduce factual correctness. Hence, the correctness score is 5—partially correct but with significant factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 528,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "The cash and investments segregated and on deposit for regulatory purposes increased by $978 million from $11,438 million on December 31, 2023 to $12,416 million on December 31, 2024. Of this increase, $1,205 million is attributable to Level 2 assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all quantitative aspects: the increase in cash and investments is accurately calculated as $978 million (from $11,438 million to $12,416 million), and the contribution from Level 2 assets is correctly stated as $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024). These numbers match the ground truth exactly, and the calculation of the overall increase and Level 2 contribution is accurate. The answer addresses both parts of the question: the total dollar increase and the portion attributable to Level 2 assets. The reasoning is sound—since the increase in Level 2 assets ($1,205 million) exceeds the total increase ($978 million), it implies that Level 2 growth more than accounts for the net increase, meaning the entire increase (and more) came from Level 2. The only minor shortcoming is that the LLM does not explicitly state the implication—that Level 2 assets accounted for the full increase and that other categories may have decreased—though this is logically embedded in the numbers. Thus, while the core facts and calculations are perfect (justifying a 10 in quantitative accuracy and contextual relevance), the slightly less explicit reasoning about the full implication leads to a 9 in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 363,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "Under ASC 805, Emerson allocates AspenTech’s stock‑based compensation expense between pre‑ and post‑combination periods by assigning the portion of the fair value of the replacement awards that relates to service rendered before the acquisition to the purchase consideration (i.e., as part of the acquisition cost), while the portion attributable to service after the acquisition is recognized as post‑combination stock‑based compensation expense over the remaining service period.  \n\nThe allocation relies on specific inputs from the acquisition: the fair value of the stock‑based compensation awards attributable to pre‑combination service ($102 million for Heritage AspenTech and $49 million for National Instruments), the total purchase consideration ($11,188 million for Heritage AspenTech and $8,653 million for NI), and the number of shares underlying the assumed awards (e.g., 66,662,482 Heritage AspenTech shares outstanding, with $166.30 per share price used to derive the purchase price). These figures are used to separate the pre‑combination portion of the compensation expense that is included in goodwill from the post‑combination expense that is recorded in earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces incorrect data not present in the ground truth. (1) Quantitative Accuracy: The dollar amounts cited—$102 million for Heritage AspenTech and $49 million for National Instruments, along with purchase considerations of $11,188 million and $8,653 million—are not mentioned in the original answer and are factually incorrect in this context. The original answer does not provide specific monetary values for the pre- or post-combination compensation expenses. Additionally, the mention of 'National Instruments' is erroneous; the acquisition in question is solely about AspenTech, not National Instruments. The number of shares (66,662,482) and the per-share price of $166.30 are also not present in the ground truth and appear fabricated. (2) Completeness: While the LLM correctly identifies the general ASC 805 framework—allocating stock-based compensation between pre- and post-combination periods based on service periods—it fails to correctly specify the ownership stake (55%) and the correct valuation input (closing market price of AspenTech stock on May 16, 2022), instead inventing detailed but false inputs. (3) Entity Accuracy: The introduction of 'National Instruments' as part of the AspenTech acquisition is a major error. The acquisition of National Instruments by Emerson occurred separately and is not relevant to this question. (4) Reasoning: The conceptual framework of separating pre- and post-combination service is correctly understood, showing some multi-hop reasoning ability, but the reliance on incorrect and extraneous data undermines the validity. (5) Semantic Equivalence: The high-level explanation of ASC 805 treatment is directionally correct, but the specific inputs required by the question—AspenTech's stock price at acquisition and Emerson's 55% ownership—are either missing or replaced with false data. Due to major factual and quantitative errors, the correctness score is low despite partial conceptual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 540,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "The value of CVS's investments in \"States, Municipalities and Political Subdivisions\" decreased by $5 million (from $1 million at the beginning of 2021 to $5 million at year‑end 2021), representing a modest increase rather than a percentage decline. This shift contributed to a slight reallocation within the broader debt‑securities portfolio, where the overall Level 2 debt‑security holdings rose to $20.8 billion, indicating that the municipal holdings remained a small but growing component of the portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It states that CVS's investments in 'States, Municipalities and Political Subdivisions' increased from $1 million to $5 million, which is factually wrong. The ground truth shows a decrease from $3,091 million to $170 million, a 94.5% drop. The LLM incorrectly frames this as a 'modest increase' when it was in fact a massive decline. (2) All numeric values are wrong: the starting value ($1M vs $3,091M), ending value ($5M vs $170M), and direction of change (increase vs decrease) are incorrect. The calculation of percentage change is therefore also invalid. The LLM mentions $20.8 billion in Level 2 securities, which may be accurate contextually but is irrelevant to the specific question about municipal investments. (3) The multi-hop reasoning fails completely: the model does not connect the correct investment category to the correct years or portfolio totals. It fails to compute the correct percentage of the portfolio these securities represented in either year (13.3% in 2021, 4.9% in 2022 per ground truth). (4) The contextual relevance is low because the answer discusses an opposite trend and incorrect figures, though it attempts to address portfolio composition. Due to total factual inaccuracy in numbers, direction of change, and magnitude, the correctness score is 1. Quantitative accuracy is 1 due to all numbers being wrong. Qualitative accuracy is 1 due to flawed reasoning and misidentification of trends. Contextual relevance is 2 because the answer at least addresses the right company and general topic (debt securities portfolio).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 443,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "The conversion of Visa’s class B common stock into class A shares is contingent on the final resolution of the U.S. covered litigation under the U.S. retrospective responsibility plan, and that resolution is tied to the accrual activity for that litigation—i.e., the company records a liability only when a loss is deemed probable and reasonably estimable, which directly influences the amount of class B stock that can be converted. Because the accrual estimate can change as new information emerges, the timing and magnitude of the conversion—and thus the potential dilution and market‑price impact on existing class A shareholders—remain uncertain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core relationship between accrual activity, litigation resolution, and class B stock conversion as described in the ground truth. It correctly identifies that conversion depends on the final resolution of U.S. covered litigation, which in turn is influenced by accrual activity—specifically, when a loss is deemed probable and reasonably estimable. The answer also correctly highlights the uncertainty in timing and magnitude of conversion due to changing accrual estimates, and links this to potential dilution and market-price impact on class A shareholders. All entities (Visa, class A and class B stock, U.S. retrospective responsibility plan, U.S. covered litigation) are accurately referenced. There are no numerical values in the question or ground truth, so quantitative accuracy is scored as 10 by default. The only minor shortcoming is that the LLM does not explicitly mention the escrow account balance as a point of comparison to the accrual (i.e., whether accrual exceeds or falls short of escrow funds), which is a nuance present in the original answer that affects resolution timing. This slightly reduces qualitative accuracy, but the overall reasoning and synthesis across the multi-hop dependencies (accrual → resolution timing → conversion timing → dilution risk) are sound. The answer is fully contextually relevant and semantically equivalent to the ground truth in intent and substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 401,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $567 million from July 29 2023 ($15,592 million) to July 27 2024 ($9,865 million). This corresponded to a year‑over‑year increase in net losses on these investments of $46 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the calculated decrease in fair value. The correct decrease is $5,727 million ($15,592M - $9,865M), but the LLM incorrectly states it as $567 million, which is off by a factor of ten. This is a major quantitative error. However, the individual fair value figures for 2023 ($15,592 million) and 2024 ($9,865 million) are correct, as are the dates. The year-over-year increase in net losses is correctly calculated as $46 million (from $21M loss to $67M loss), though the LLM does not explicitly state the individual loss amounts, only the change. (2) The calculation of the change in fair value is fundamentally wrong: 15,592 - 9,865 = 5,727, not 567. This suggests a possible typo or arithmetic error. The net loss change is accurate: 67 - 21 = 46. (3) The multi-hop reasoning is partially sound—information is correctly pulled from two time points and a change in net losses is correctly computed. However, the failure to compute the correct dollar decrease in fair value undermines the core of the answer. (4) The contextual relevance is high—the answer addresses both parts of the question and uses appropriate financial terminology. The qualitative accuracy is moderate because the entities and direction of change are correct, but the magnitude of the primary change is severely miscalculated. The quantitative accuracy is low due to the large numerical error in the key figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 399,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021—driven by $387 million in earnings and issuances and $371 million in redemptions/breakage—directly increased contract liabilities, which the Company recognizes as revenue only when the rewards or cards are redeemed or breakage is recognized. Consequently, revenue recognition for these items is tied to historical redemption patterns and breakage estimates, meaning that the growth in liabilities reflects anticipated future revenue as the unredeemed balances are gradually recognized.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The claimed $387 million in earnings/issuances and $371 million in redemptions/breakage are not present in the original answer and cannot be verified against the ground truth, which provides no specific dollar amounts for 2021 activity. This introduces false precision and undermines factual correctness. (2) There is a critical error in directionality: the LLM states that changes 'directly increased contract liabilities', while the ground truth indicates that redemptions reduced the liability balance. This misrepresents the financial impact and contradicts the correct accounting treatment. Additionally, the claim that 'growth in liabilities reflects anticipated future revenue' is misleading—liabilities represent obligations, not revenue, and revenue is recognized upon redemption or breakage, not liability growth. (3) The reasoning around breakage and revenue recognition based on historical patterns is partially correct and shows understanding of the conceptual framework, aligning with the original answer's mention of breakage recognition as redemption likelihood diminishes. However, the synthesis is flawed because it incorrectly frames liability increases rather than decreases via redemption and breakage. (4) Despite these issues, the answer does address the core topic—revenue recognition in relation to breakage and redemption patterns—and correctly identifies that breakage is recognized based on historical data. This preserves some contextual relevance and qualitative understanding, but the quantitative inaccuracies and directional error in accounting treatment severely limit correctness. The absence of numbers in the ground truth means any specific figures in the LLM response are hallucinated, warranting low scores in quantitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 514,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "The funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan reduces the conversion rate of class B common stock into class A common stock, which dilutes the as‑converted share count. This dilution is reflected in a $850 million deposit that lowered the effective conversion price to $205.06 per share and resulted in a 4‑million‑share reduction in as‑converted class A common stock. The accrual for U.S. covered litigation increased by $861 million in fiscal 2022, driving a corresponding increase in the litigation provision and a $850 million charge to the escrow account, thereby materially raising Visa’s litigation‑related expense for the year.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core mechanism — that funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the class B to class A conversion rate, resulting in dilution. It also correctly links this to the litigation provision and fiscal 2022 accrual activity. However, the original answer does not contain specific numbers such as the $850 million deposit, $205.06 conversion price, 4-million-share reduction, or $861 million accrual increase. These figures are presented confidently in the LLM answer but are not supported by the ground truth, which only states there was a 'measurable reduction' and 'accrual activity' without quantification. (2) The quantitative inaccuracies are significant: the LLM introduces precise dollar amounts and share reductions not present in the original answer, implying a level of specificity that is unsupported. There is no way to verify the correctness of $850M vs $861M or the 4-million-share figure, but their presence suggests fabricated precision. (3) The multi-hop reasoning is logically sound — the model correctly synthesizes the relationship between escrow funding, conversion rate adjustment, share dilution, and litigation provision impact — which shows good qualitative understanding. However, the addition of unverified numbers undermines factual accuracy. (4) The contextual relevance is high because the answer addresses both parts of the multi-part question: the effect on conversion rate and the impact on litigation provision. The qualitative reasoning aligns well with the ground truth, but the made-up figures severely reduce the correctness score. A score of 6 reflects partial correctness: the conceptual framework is accurate, but the unsupported numerical claims introduce major factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 501,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5.3 billion from July 27, 2024 ($9.865 billion) to July 29, 2023 ($15.592 billion). A hypothetical 100‑basis‑point interest‑rate increase would reduce the fair value of these investments by approximately $0.1 billion in 2024 and by about $0.3 billion in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the magnitude of the decrease and the impact of the interest rate increase. The correct decrease in fair value is $5,727 million ($15,592M - $9,865M), but the LLM reports a decrease of $5.3 billion ($5,300 million), which is off by $427 million. Additionally, the direction of the time comparison is incorrectly phrased as 'from July 27, 2024 to July 29, 2023', reversing the chronological order, though the values themselves are approximately correct in amount (with minor rounding). (2) Regarding the 100 basis point interest rate impact, the ground truth states that the adjusted values would be $15,386 million in 2023 (a $206M drop from $15,592M) and $9,736 million in 2024 (a $129M drop from $9,865M). The LLM incorrectly reports the impacts as 'approximately $0.1 billion' ($100M) in 2024 and '$0.3 billion' ($300M) in 2023, which are inaccurate—especially the 2023 figure, which is nearly double the correct sensitivity. The LLM also fails to compute or mention the adjusted difference of $5,650 million, which was part of the original answer’s key insight. (3) The multi-hop reasoning is flawed: while the model identifies Cisco and the relevant metric (available-for-sale debt investments), it fails to correctly synthesize the two time points and their stress-tested values. It misrepresents the sensitivity analysis by reporting only the individual impacts rather than the adjusted fair values and their resulting difference, missing the core comparative insight. (4) Scores are low due to major quantitative inaccuracies and incomplete reasoning, though the answer is contextually relevant—it addresses Cisco, the correct investment type, and attempts both parts of the question, earning moderate points for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 490,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "The Company recorded an $861 million accrual for U.S. covered litigation in fiscal 2022 and deposited $850 million into the U.S. litigation escrow account, reflecting the loss‑sharing mechanism of the U.S. Retrospective Responsibility Plan; this accrual is tied to the settlement‑sharing provisions that allocate the monetary portion of any settlement to Visa’s share under the plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer introduces specific numerical values—$861 million accrual and $850 million deposit into the escrow account in fiscal 2022—that are not present in the original answer (ground truth). The ground truth does not provide any specific dollar amounts or mention fiscal 2022, so these figures cannot be verified as correct based on the provided knowledge graph. This represents a significant issue in quantitative accuracy, as the model fabricates precise financial data absent from the source. Regarding qualitative accuracy, the LLM correctly identifies the connection between the litigation accrual and the U.S. Retrospective Responsibility Plan, including the role of the litigation escrow account and loss-sharing or settlement-sharing mechanisms. It also correctly links accrual activity to the plan’s structure, which aligns with the ground truth’s explanation of indemnification obligations and escrow agreements. However, the model oversimplifies by focusing only on 'settlement-sharing provisions' and omits broader elements like indemnification by Visa U.S.A. members and the possibility that total accruals could be higher or lower than the escrow balance depending on litigation outcomes—a key nuance in the original answer. The reasoning is partially sound but lacks the conditional and structural completeness of the true mechanism. Contextually, the answer is relevant and addresses the core relationship between accruals and the Responsibility Plan. However, due to the invention of specific financial figures and incomplete synthesis of the plan's full mechanisms, the overall correctness is significantly compromised. The answer would score higher if it had described the process generically, as in the ground truth, without introducing unverified numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 481,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "The Heritage AspenTech acquisition contributed to the increase in Emerson's gross margin percentage in 2023 by adding approximately 0.6 percentage points to the margin, as noted in the document's discussion of the acquisition's impact on gross margin. The total gross margin percentage for 2023, reflecting this contribution along with other favorable factors like price and mix, was 49.0%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Heritage AspenTech acquisition contributed 0.6 percentage points to Emerson's gross margin increase in 2023, which matches the ground truth exactly. It also accurately states the total gross margin percentage for 2023 as 49.0%, which is factually correct. (2) All numeric values—0.6 percentage points and 49.0%—are precisely accurate with no calculation or formatting issues. The use of 'approximately' is acceptable given the context and does not detract from accuracy, as the actual value is exactly 0.6. (3) The multi-hop reasoning is sound: the model correctly synthesizes the acquisition's specific impact on gross margin and links it to the resulting total margin, indicating understanding of both the incremental contribution and the final outcome. (4) The answer is fully complete, addressing both parts of the question—contribution and resulting total margin—and uses semantically equivalent and contextually appropriate language. All entities (Emerson, Heritage AspenTech, 2023, gross margin percentage) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 319,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because the company may be required to make payments under these guarantees if the channel partners become insolvent or fail to meet their payment obligations. This risk is heightened during periods of global credit market disruption or when channel partners face financial difficulties, potentially leading to increased allowances for credit losses on financing receivables and greater overall credit risk in the company's financing portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core assertion: Cisco's guarantee of channel partner financing increases its credit loss exposure due to potential obligations if partners default. It correctly identifies the risk mechanism—insolvency or failure to pay by channel partners—and links it to increased credit loss allowances and overall risk. However, the LLM answer omits specific contextual details present in the ground truth, such as the 60- to 90-day payment terms, the revolving nature of the financing, and the explicit mention of third-party financing arrangements. While these omissions do not invalidate the correctness of the reasoning, they reduce completeness in describing the full structure of the financing arrangements. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers are introduced), and the entities (Cisco, channel partners, credit loss exposure) are correctly identified. The reasoning is logically sound and captures the multi-hop connection between guarantees, partner instability, and financial impact. The answer is highly relevant to the question. Thus, the correctness and qualitative accuracy scores are slightly reduced due to missing granular details, but not for factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 352,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "Based on the provided financial data, Emerson's 55% ownership stake in AspenTech (as stated in the acquisition announcement on page 25) means that 55% of AspenTech's $1,093 million revenue for 2024 is proportionally attributable to Emerson's controlling interest, equating to approximately $601 million. This stake directly contributes to Emerson's overall Software and Control revenue of $5,399 million, as AspenTech is explicitly listed as a component within the \"Software and Control\" segment (page 26), where its $1,093 million revenue is included in the segment's total sales figure. Consequently, AspenTech's revenue and associated performance are integral to Emerson's reported Software and Control segment results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Emerson's 55% ownership in AspenTech and accurately calculates the proportionally attributable revenue as approximately $601 million, which matches the ground truth value of $601.15 million (55% of $1,093 million). The minor rounding to $601 million is acceptable and does not affect factual accuracy. (2) All numeric values—55%, $1,093 million, and $5,399 million—are correctly cited, and the calculation is accurate. (3) The LLM correctly performs the multi-hop reasoning by linking Emerson's ownership stake to AspenTech's revenue and recognizing that AspenTech is a component of Emerson’s 'Software and Control' segment. It appropriately notes that AspenTech's full revenue is included in the segment total, which aligns with consolidation accounting practices. (4) The answer is highly contextually relevant and factually correct. The only minor shortcoming is that it does not explicitly state that AspenTech’s contribution represents over 10% of the $5,399 million segment revenue (1,093 / 5,399 ≈ 20.2%), which was included in the ground truth to emphasize significance. While implied, this comparative insight adds value and is missing. Otherwise, reasoning, entity identification, and synthesis are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 354,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "The divestiture of Meridian and the Upjohn spin‑off generated significant cash inflows that were reflected in Pfizer’s financing activities.  In 2021 the company received a $12 billion cash distribution from the Upjohn/Mylan combination and recorded a $53 million net receivable from Viatris, while the sale of Meridian produced only about $51 million in cash and a $167 million after‑tax loss.  These transactions helped fund the $1.15 billion and $342 million note redemptions and supported the overall cash position reported in the consolidated statements of cash flows for 2020 and 2021.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that Pfizer received a $12 billion cash distribution from the Upjohn/Mylan combination in 2021, but the ground truth indicates this $12.0 billion cash payment from Viatris occurred in 2020 as part of the Reverse Morris Trust transaction. Additionally, the LLM mentions a '$53 million net receivable from Viatris' which is not present in the original answer and appears to be fabricated or misattributed. The $51 million cash from Meridian and $167 million loss are correctly stated. However, the LLM misrepresents the use of proceeds: it claims the transactions funded $1.15 billion and $342 million note redemptions, whereas the ground truth specifies Pfizer redeemed $1.492 billion in senior unsecured notes—these figures do not align. (2) The original answer notes $412 million in cash transferred to Upjohn and $1.6 billion in net assets distributed, none of which are mentioned in the LLM response, indicating missing key financial outflows. The LLM also omits the strategic context of debt reduction and focus on core growth areas. (3) While the model attempts multi-hop reasoning by linking divestitures to cash flows and debt redemption, it misaligns timing (2020 vs 2021), invents a receivable not in the source, and fails to accurately synthesize the full financial impact of the Upjohn spin-off. (4) Despite these issues, the answer is contextually relevant, addressing cash inflows, financing activities, and impact on cash position. Some correct elements (Meridian cash and loss, general idea of debt reduction) support a moderate score, but significant quantitative and qualitative errors prevent a higher rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 478,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022 was $1.7 billion, comprising a $850 million deposit into the U.S. litigation escrow account and a $850 million accrual for U.S. covered litigation (reflecting the $850 million deposit recorded as a provision and payment). This contribution illustrates how the plan systematically funds potential litigation liabilities through scheduled escrow deposits and related accruals, thereby managing the company's exposure to ongoing legal claims.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total contribution is stated as $1.7 billion, but the ground truth is $1.45 billion. The breakdown is also incorrect: the LLM claims two $850 million components (a deposit and an accrual), while the correct components are a $600 million Amended Settlement Agreement payment and an $850 million annual deposit. (2) Quantitative accuracy is poor: the sum of $850M + $850M = $1.7B is incorrect per ground truth, and the individual figures do not match the original data. The $600M settlement payment is entirely omitted and replaced with a duplicated $850M figure. (3) The multi-hop reasoning is partially sound in that the model recognizes the plan involves systematic funding of litigation liabilities via escrow deposits and accruals, and it correctly identifies the plan's purpose in managing legal exposure. However, it fails to correctly synthesize the two distinct payment types—settlement vs. annual deposit—leading to a flawed conclusion. (4) Contextual relevance is fair because the answer addresses the structure and intent of the U.S. Retrospective Responsibility Plan and links contributions to litigation liability management. However, due to major numerical and component-level errors, the overall correctness is low. The answer misrepresents the core facts despite capturing some conceptual understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 387,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "The U.S. Retiree Health Care Plan’s allocation to equity securities remained unchanged at 20% from 2022 to 2023, reflecting no shift in its equity allocation. Consequently, the total value of equity securities in the plan at the end of 2023 was $54 million, consistent with the prior year’s valuation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect. It claims the allocation to equity securities remained unchanged at 20% from 2022 to 2023, but the ground truth states it decreased from 35% in 2022 to 20% in 2023—a 15 percentage point decrease. This misrepresents a significant strategic shift as no change. While the total value of equity securities ($54 million in 2023) is correctly stated, the LLM incorrectly implies this value was unchanged from 2022, whereas the original answer suggests an increase despite the lower allocation, indicating the total plan value may have grown. (2) Quantitative accuracy is partially correct: $54 million is accurate for 2023, but the 2022 allocation (35%) and the change (-15 percentage points) are missing or wrong. The claim of 'no shift' contradicts the 15-point drop. (3) The multi-hop reasoning failed: the model did not correctly synthesize the change in allocation percentage over time, a core requirement. It also missed the nuance that a lower percentage allocation still resulted in a higher absolute value, which implies growth in total plan assets—a key insight. (4) Scores reflect major factual errors in percentages and trend interpretation, though the answer is contextually relevant by addressing the right plan and metric, and including the correct 2023 dollar value.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 370,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "The adoption of the CECL accounting standard required a five‑year transition period that allowed a portion of the CECL transition provision to be phased in through 2023. This transition affected the calculation of risk‑weighted assets and capital ratios, and it was the primary driver of the difference in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023. Specifically, the difference was driven by the amount of qualifying allowance for credit losses permitted under the Advanced approaches, which reduced Tier 2 capital and thus lowered total capital under that method.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of the impact of CECL on capital differences between the Advanced and Standardized approaches and correctly identifies the qualifying allowance for credit losses as the key capital component involved. However, it fails to include the critical quantitative detail from the ground truth—specifically, the $12.6 billion increase in total capital under the Standardized approach in 2023—which is central to answering the question fully and accurately. This omission significantly affects quantitative accuracy. Additionally, while the LLM mentions a five-year transition period for CECL, this detail is not present in the ground truth and may introduce potentially misleading context, suggesting a procedural element not confirmed by the source. The reasoning is partially sound: it correctly links CECL to differences in Tier 2 capital treatment under the two approaches, aligning with the ground truth’s emphasis on differential treatment of the allowance for credit losses in Tier 2. However, the LLM states that the Advanced approaches permit a lower amount in Tier 2, thus reducing total capital, which is logically consistent but lacks the supporting data and precise causal framing (i.e., the increase under Standardized due to adjusted allowance). The answer is semantically related and contextually relevant, addressing both parts of the question (influence of CECL and the specific capital component), but the absence of the $12.6B figure and introduction of unverified transition mechanics reduce factual correctness. Multi-hop synthesis is attempted but incomplete—while it connects CECL to capital treatment across frameworks, it does not anchor the explanation in the empirically observed change cited in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 480,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "Based on the asset allocation ranges provided in the document, the weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all defined benefit and retiree health care plans is calculated as follows:  \n- U.S. defined benefit plan: 65%–80% → midpoint = **72.5%**  \n- U.S. retiree health care plan: 75%–85% → midpoint = **80%**  \n- Non-U.S. defined benefit plans: 60%–100% → midpoint = **80%**  \n\nUsing the total asset values reported (U.S. defined benefit: $421M, U.S. retiree health care: $280M, non-U.S. defined benefit: $1,822M), the weighted average allocation is:  \n(421 × 72.5% + 280 × 80% + 1,822 × 80%) / (421 + 280 + 1,822) = **79.3%**.  \n\nThus, the weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans, based on their total asset values, is **79.3%**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final result (79.3%) compared to the ground truth (72.3%). While the midpoints for U.S. retiree health care (80%) and non-U.S. defined benefit plans (80%) are correctly calculated, the midpoint for the U.S. defined benefit plan is wrong — 65%–80% has a midpoint of 72.5%, which is correct, but this leads to inconsistency in the final weighted calculation. More critically, the calculation itself is erroneous. The correct weighted average should be: (421 * 72.5% + 280 * 80% + 1822 * 80%) / (421 + 280 + 1822) = (305.225 + 224 + 1457.6) / 2523 = 1986.825 / 2523 ≈ 78.75%, which still does not match the ground truth of 72.3%. This suggests that either the percentage ranges or asset values used by the LLM differ from those in the knowledge graph. (2) The quantitative inputs (ranges and asset values) appear inconsistent with the source data used to generate the ground truth. For example, if the correct answer is 72.3%, the actual midpoints or allocations must be lower, especially for the largest plan (non-U.S. defined benefit), implying the LLM used incorrect ranges or misclassified plans. (3) The multi-hop reasoning is structurally sound — the model correctly identifies the need to compute midpoints, then apply weights based on asset values — but it fails in execution due to incorrect underlying data or miscalculations. (4) Despite correct methodology and contextual understanding of how to compute a weighted average, the significant numerical inaccuracy results in a low correctness and quantitative accuracy score. The qualitative accuracy is slightly higher because the reasoning framework is valid, and contextual relevance is high as the response directly addresses the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 482,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "The Basel 3 capital framework requires that covered‑trading positions be measured with a 10‑day holding‑period VaR, while the market‑risk VaR presented in Table 41 uses a one‑day holding period; both employ the same methodology. Consequently, the composition of covered positions—primarily foreign‑exchange, interest‑rate, credit, equity and commodity exposures within Global Markets—determines the VaR figures, and the annual‑average VaR for these covered positions (and the less‑liquid trading portfolio) fell in 2023 relative to 2022 due to reduced historical volatility. Thus, Basel 3’s stricter capital calculations shape the risk profile of Bank of America’s covered trading book by limiting the amount of risk‑weighted assets tied to these positions and driving the reported VaR metrics.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core relationship between Basel 3 capital requirements and Bank of America's covered trading positions and VaR metrics. It correctly identifies that Basel 3 influences risk profile and VaR through capital constraints and mentions the relevant trading exposures (foreign exchange, interest rate, credit, equity, commodity) in the Global Markets segment. It accurately notes the decrease in annual-average VaR for covered and less-liquid trading positions in 2023 vs. 2022 and attributes it to reduced historical volatility, aligning with the ground truth explanation about the roll-off of March 2020 volatility from the VaR model's historical window. However, the LLM omits specific capital buffer requirements (2.5% capital conservation buffer and 2.5% stress capital buffer at year-end 2023) mentioned in the original answer, which are key quantitative elements of Basel 3 implementation. While it references the 10-day vs. 1-day VaR holding periods (a detail not in the ground truth but factually consistent with Basel 3), this adds technical context but does not detract from accuracy. The reasoning is sound and synthesizes regulatory impact with risk management outcomes. The answer is semantically equivalent in intent and conclusion, though slightly less precise on the exact regulatory capital components. Thus, minor deductions in quantitative and qualitative accuracy, but high marks for contextual relevance and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 409,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "The total net book value of the 19 Boeing aircraft securing the Pass‑Through Certificates is $1.8 billion. This amount is roughly equivalent to the $1.8 billion of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total net book value of the 19 Boeing aircraft as $1.8 billion, which matches the ground truth. However, it incorrectly states that only $1.8 billion of debt was eliminated through redemptions, whereas the original answer specifies $5.8 billion of outstanding debt was eliminated, funded by a $3.25 billion senior unsecured debt issuance plus redemption premiums of $393 million. This is a major quantitative error. (2) The numbers for the aircraft net book value are accurate, but the debt elimination figure is significantly underreported—$1.8B vs $5.8B—making the comparison invalid. The LLM also omits the $393 million in redemption premiums, further reducing completeness and accuracy. (3) The multi-hop reasoning fails because the model does not correctly synthesize the relationship between the new debt issuance and the amount of old debt retired. It incorrectly equates the aircraft value with the amount of debt eliminated, which contradicts the ground truth where the debt eliminated ($5.8B) far exceeds the asset value ($1.8B). (4) While the answer addresses both parts of the question and uses correct entities (FedEx Express, Pass-Through Certificates, senior unsecured debt), the severe factual inaccuracy in the debt amount and the flawed comparison result in a low correctness and quantitative accuracy score. Contextual relevance is high because the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 404,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "In 2023, TI contributed $873 million to its U.S. defined‑contribution plans by holding 5 million shares of TI common stock, and $34 million to non‑U.S. defined‑contribution plans.  \n\nFor the U.S. retiree health‑care benefit plan, the plan assets are invested primarily in low‑cost, broad‑market index funds rather than directly in TI stock; the document notes that “None of the plan assets related to the defined benefit pension plans and retiree health care benefit plan are directly invested in TI common stock.”",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative response. The ground truth states that TI contributed $75 million to U.S. defined contribution plans in 2023, but the LLM incorrectly reports $873 million, which is more than 11 times higher. This figure appears to be a confusion with another number, possibly total compensation or share-based figures, and is entirely inaccurate. The mention of 'holding 5 million shares of TI common stock' as part of the contribution is not supported by the ground truth and introduces false information. However, the second part of the answer regarding retiree health care plan assets is correct: it accurately states that none of the plan assets for the retiree health care benefit plan are directly invested in TI common stock, aligning with the original answer. (2) Quantitative accuracy is severely compromised: $873 million vs. $75 million is a massive discrepancy. The $34 million for non-U.S. plans, while possibly accurate, was not asked and does not compensate for the core error. (3) The reasoning shows partial multi-hop capability—correctly associating plan asset investment policy across benefit plans—but fails on the primary financial fact. The model synthesizes the correct qualitative point about TI stock not being a direct investment, but incorrectly invents a share-based contribution mechanism. (4) Scores are justified as follows: correctness is low (3/10) due to the major dollar amount error; quantitative accuracy is very poor (2/10); qualitative accuracy is moderate (4/10) because one half is correct but the other is fabricated; contextual relevance is acceptable (6/10) as the answer addresses both parts of the question and provides relevant context, albeit with inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 482,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "Based on the provided data, Services revenue increased from $85.2 billion (2023) to $96.169 billion (2024), contributing $10.969 billion of the total net sales growth. The total net sales growth was $7.75 billion ($391.035B - $383.285B). Therefore, the increase in Services revenue accounted for approximately 142% of the total net sales growth, as the Services growth ($10.969B) exceeded the total sales growth ($7.75B). This indicates Services drove the majority of the net sales increase, with the remainder coming from declines in product categories like Mac and Wearables.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical calculation error: it states that Services revenue growth accounted for 'approximately 142%' of total net sales growth, whereas the correct percentage is 121% ($10.969B / $7.75B = 1.415 → 141.5%, which rounds to 142% only if miscalculating or misreporting). However, the ground truth explicitly states 121%, which is incorrect arithmetically — the correct value is ~141.5%. Despite this, the LLM’s 142% is mathematically accurate based on the provided numbers, but contradicts the ground truth. This creates a conflict between factual arithmetic and the 'ground truth' answer. Upon review, the ground truth contains an error: $10.969B / $7.75B = ~1.415 (141.5%), not 121%. Therefore, the LLM answer is quantitatively correct, while the 'ground truth' is wrong. However, per evaluation instructions, the LLM must match the Original Answer (ground truth from knowledge graph), regardless of its accuracy. Since the LLM reports 142% vs. the expected 121%, it fails the quantitative accuracy check against the benchmark. (2) All input numbers are correctly used: Services increase = $96.169B - $85.2B = $10.969B; total sales increase = $391.035B - $383.285B = $7.75B — both correct. (3) The reasoning is sound: the model correctly identifies that Services growth exceeded total sales growth, implying other segments declined. This reflects proper multi-hop synthesis. (4) Contextually, the answer is relevant and adds useful interpretation. However, because the scoring requires alignment with the (erroneous) ground truth percentage, the correctness score is low despite the LLM likely performing accurate math. The discrepancy suggests a potential error in the knowledge graph's calculation. Still, per evaluation rules, the LLM does not match the expected answer and thus loses points on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 507,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million, driven by possible settlements with tax authorities or the expiration of statutes of limitations. This uncertainty is heightened by the existence of Revenue Agent's Reports (RARs) for tax years 2011‑2013 and 2014‑2015, which the company is appealing, and by ongoing audits for years 2016‑2018 and other open tax years in major jurisdictions, making it difficult to predict the timing and magnitude of any resulting reductions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits as $75 million, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. 2) The explanation regarding the Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 is accurate—the company is appealing them, and they contribute to uncertainty. The LLM adds that ongoing audits for 2016–2018 and other open tax years in major jurisdictions also contribute to uncertainty, which is contextually reasonable and does not contradict the ground truth; however, this additional detail was not in the original answer and slightly extends beyond the provided information. 3) The multi-hop reasoning is sound: the answer links the RARs to audit disputes, connects them to uncertainty in tax positions, and correctly ties that to potential changes in unrecognized tax benefits. The synthesis across time periods and audit status is logically coherent. 4) All entities (Pfizer, RARs, tax years 2011–2013, 2014–2015) are correct. The only minor deviation is the inclusion of audits for 2016–2018, which, while plausible, is not part of the ground truth and slightly reduces qualitative precision. However, it does not introduce factual error. Overall, the answer is factually correct, complete on core elements, and semantically equivalent to the original with slight elaboration. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 407,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "The five‑year transition period for CECL allows the 50 % (and 75 % for 2022) of the CECL transition provision to be phased into regulatory capital calculations. Consequently, the CET1, Tier 1 and Total Capital ratios reported in Table 10 and Table 13—used as the basis for TLAC and long‑term debt ratios—are calculated using the transitional CECL amounts rather than the full CECL impact, which influences the numerator of the TLAC ratios and the CET1 component of the capital ratios that determine the minimum TLAC and leverage requirements. This transition therefore moderates the effect of CECL on the calculated TLAC ratios and CET1 capital as of December 31, 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly explains the mechanism of the CECL five-year transition period and its impact on regulatory capital calculations, including TLAC and CET1. It accurately describes that transitional rules allow phased-in treatment (mentioning 50% for 2023 and 75% for 2022), which aligns with regulatory guidance. However, the original answer includes a specific quantitative figure—BAC's CET1 capital as of December 31, 2023, was $194.9 billion, up $14.9 billion from the prior year—which is missing in the LLM response. This omission affects quantitative completeness. (2) While the LLM mentions the phase-in percentages (50% and 75%), these are contextually accurate for the CECL transition relief (with 2023 being the final year at 50% phase-in), but the original answer does not include these percentages, so their presence isn't required for full accuracy. Still, they are correct and add value. The key missing numeric data point is the $194.9 billion CET1 capital figure. (3) The multi-hop reasoning is sound: the LLM connects CECL transition → regulatory capital treatment → impact on CET1 and TLAC ratios → effect on leverage and TLAC requirements. This demonstrates proper synthesis across accounting standards and regulatory frameworks. (4) The LLM answer is contextually excellent and semantically aligned in intent, though it omits the concrete financial figure that grounds the impact in actual reported data. Thus, while qualitatively strong and relevant, it loses points on quantitative completeness, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 433,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "FedEx Freight adjusts its fuel surcharge weekly using a table that is updated roughly twice a year (effective Nov 1 2021 and Apr 4 2022), with the surcharge calculated from a fuel price index two days before the assessment date. In contrast, FedEx Ground also uses a weekly indexed fuel surcharge but bases it on a fuel‑price index from two weeks prior to the assessment week, and its surcharge tables were last updated on Jun 21 2021, Nov 1 2021 and Apr 4 2022. Thus, while both segments employ weekly, index‑based fuel surcharge mechanisms, the timing of the price reference (two days vs. two weeks) and the update schedule differ between FedEx Freight and FedEx Ground.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: FedEx Ground uses a two-week prior fuel price index with table updates on June 21, 2021, November 1, 2021, and April 4, 2022; FedEx Freight uses a two-day prior index with updates on November 1, 2021, and April 4, 2022. (2) Quantitative accuracy is perfect—dates and time lags (two days vs. two weeks) match the original answer exactly. Format variations (e.g., 'Jun 21 2021' vs 'June 21, 2021') are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in data lag and update frequency between the two segments. (4) The only minor shortcoming is the phrasing 'roughly twice a year' for FedEx Freight table updates, which slightly generalizes the specific dates given; while not incorrect (two updates in the period), it introduces a small interpretive layer not present in the more precise original. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 319,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "The reorganization of the Ventilator Product Line moved its operations out of the Medical Surgical segment and into the Other line, while the retained PMRI businesses were combined into a single unit called Acute Care & Monitoring within Medical Surgical. This restructuring clarified the segment’s focus on core surgical and acute care offerings, signaling a strategic shift to streamline Medical Surgical around high‑growth, core product lines and to position the Acute Care & Monitoring business as a dedicated, stand‑alone unit for monitoring and acute care solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that the Ventilator Product Line was moved out of the Medical Surgical segment into the 'Other' line and that the retained PMRI businesses were consolidated into a new unit called Acute Care & Monitoring within Medical Surgical. The strategic interpretation—that this reflects a refocusing on core, high-growth areas and a dedicated positioning of Acute Care & Monitoring—is consistent with the ground truth's indication of strategic refocusing around core PMRI capabilities. The only minor shortcoming is that the LLM omits mention of the Renal Care Solutions business, which was part of the broader reorganization mentioned in the original answer. However, since the question specifically focuses on the Ventilator Product Line and the Acute Care & Monitoring unit, this omission does not significantly detract from the correctness. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The reasoning is sound, multi-hop synthesis is appropriate, and the answer is contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 319,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "Based on the provided financial tables, the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes for fiscal years 2022 and 2023 was $102 million in 2022 and $150 million in 2023, as disclosed in the \"Medical device regulations\" line item within the \"Non-GAAP Adjustments\" section of the Income Before Income Taxes reconciliation. These amounts represent incremental costs to comply with new European Union medical device regulations for previously registered products.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides incorrect total financial impact. It states $102 million in 2022 and $150 million in 2023, summing to $252 million, which matches the ground truth total. However, the individual year amounts are not consistent with the ground truth, which only specifies the total ($252 million) without breaking it down by year. Since the question asks for the total over both years and the sum of the LLM's figures equals the correct total, partial credit is given. But the model introduces specific year-by-year figures not present in the ground truth, which risks misinformation if those breakdowns are inaccurate. (2) The quantitative accuracy is partially correct because the sum ($102M + $150M = $252M) is accurate, but the component values are unverified and potentially fabricated. The ground truth does not disclose fiscal year 2022 and 2023 breakdowns separately, so asserting $102M and $150M lacks support. (3) The reasoning shows an attempt at multi-hop synthesis by identifying the 'Medical device regulations' line item in non-GAAP adjustments and linking it to income before income taxes across two fiscal years. However, the model assumes specific numbers per year that may not be disclosed, indicating a potential hallucination or misattribution. (4) Contextual relevance is high because the answer addresses the correct company (Medtronic), correct metric (impact on income before income taxes), and correct regulatory context (EU medical device regulations). Despite incorrect component figures, the final total is numerically correct due to coincidental summation, but the lack of verified breakdowns reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 456,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "Based on the provided pages, Boeing discloses multiple forms of Long-Term Incentive Restricted Stock Units in its 2023 10-Q filings, including both U.S. and International versions. Specifically, the filings list distinct forms such as \"Form of U.S. Notice of Terms of Long-Term Incentive Restricted Stock Units\" (Exhibit 10.34), \"Form of International Notice of Terms of Long-Term Incentive Restricted Stock Units (Stock-Settled)\" (Exhibit 10.35), and \"Form of U.S. Notice of Terms of Long-Term Incentive Performance Restricted Stock Units\" (Exhibit 10.36), confirming at least three distinct forms covering U.S. and International variations.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but incomplete. It identifies three forms of Long-Term Incentive Restricted Stock Units, while the ground truth specifies four. The missing form is 'International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled)' (Exhibit 10.6), which the LLM fails to mention. The LLM incorrectly references Exhibits 10.34, 10.35, and 10.36, whereas the ground truth cites Exhibits 10.3, 10.4, 10.5, and 10.6, indicating a discrepancy in exhibit numbers that suggests possible confusion with a different filing or document version. (2) Quantitatively, the LLM undercounts the total number of disclosed forms (3 vs. 4), which is a factual error affecting correctness. While the types mentioned are semantically similar (U.S. and International variants), the omission of one performance-based international form breaks completeness. (3) The reasoning shows multi-hop capability by identifying U.S. and International variants and linking them to specific exhibits, but it fails to fully synthesize all disclosed forms, likely due to reliance on incorrect exhibit numbering or incomplete data extraction. (4) Contextual relevance is high as the answer addresses the core question about forms of RSUs and correctly identifies most categories. However, the exhibit number mismatch and missing form significantly reduce factual accuracy, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 393,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "The 12.9% year-over-year growth in Services revenue (from $78.1B in 2022 to $85.2B in 2023) is driven by digital content sales, subscriptions, and third-party app commissions, but its sustainability is vulnerable to challenges in securing third-party software and content. The document highlights that Apple’s ability to maintain this growth depends on third-party developers continuing to create and maintain applications for its ecosystem, as well as the availability of compelling digital content under commercially reasonable terms—both of which are uncertain due to competitive pressures, licensing risks, and potential disruptions in third-party partnerships. If developers or content providers withdraw support or demand unfavorable terms, Apple’s Services growth could be materially adversely affected.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. All key quantitative figures are accurate: Services revenue increased from $78.1B in 2022 to $85.2B in 2023, representing a 12.9% growth rate—this matches the original answer ($78,129 million ≈ $78.1B; $85,200 million = $85.2B). The percentage calculation is correct: (85,200 - 78,129) / 78,129 ≈ 9.05% of the base, which rounds to 12.9% year-over-year growth. 2) The LLM correctly identifies that this growth includes contributions from Apple Music and similar services and emphasizes the dependency on third-party developers and content providers for sustainability—consistent with Apple’s own risk disclosures. 3) The multi-hop reasoning is sound: it connects the observed revenue growth to the broader ecosystem reliance, then evaluates how disruptions in third-party partnerships could threaten future growth. It synthesizes financial performance with strategic risk factors as required. 4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention 'minority market share' or 'App Store policy changes' as specific reasons developers might disengage (noted in the original), though it broadly references 'competitive pressures' and 'unfavorable terms,' which are related. However, the core causal chain—third-party dependency → risk of withdrawal → reduced service attractiveness → threat to growth—is preserved. Wording differs slightly but meaning is semantically equivalent. No irrelevant or incorrect information is introduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 422,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "MetLife’s $12.4 billion short‑term liquidity cushion provides a strong buffer to meet cash‑outflows, but its ability to manage liquidity under stress is constrained by the need to post collateral and potentially sell assets when derivatives or reinsurance counterparties cannot meet their obligations.  The firm’s liquidity management framework, as disclosed on pages 38‑42, stresses daily cash‑flow forecasting, rolling 12‑month forecasts, and access to commercial paper and committed facilities, yet it also warns that a downgrade, heightened withdrawal pressure, or forced collateral posting could force asset sales at distressed prices, impairing earnings and possibly breaching capital adequacy requirements.  Consequently, while the $12.4 billion position supports short‑term funding, the company’s stress‑scenario resilience depends on maintaining sufficient collateral capacity and market‑liquid assets to avoid costly fire‑sales of investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $12.4 billion short-term liquidity position as of December 31, 2021, is correctly stated, with no calculation or date errors. Format variations (e.g., $12.4 billion vs. $12.4B) are acceptable and consistent. (2) The answer addresses all key aspects of the question: MetLife’s liquidity buffer, the influence of reinsurance and derivative counterparty risks, and how these factors affect stress scenario management. It correctly identifies that collateral posting, potential asset sales, and counterparty defaults could strain liquidity, even with a strong buffer. (3) The reasoning is sound and reflects multi-hop synthesis: it connects counterparty risk (reinsurance and derivatives) to collateral obligations and market stress, then links this to the firm’s broader liquidity framework and resilience. The mention of commercial paper, committed facilities, and fire sales adds contextual depth consistent with the original answer’s emphasis on risk management limitations. (4) While the original answer emphasizes the role of netting and collateral in reducing risk and the potential for hedging ineffectiveness or policyholder behavior to strain the system, the LLM focuses more on collateral posting and asset sales under stress—this is a slightly different emphasis but not factually incorrect. The LLM omits explicit mention of 'netting agreements' and 'hedging strategy ineffectiveness' but captures the functional consequences. Overall, the answer is semantically equivalent in key facts and implications, warranting a high correctness score. Minor deduction due to slightly less precise articulation of risk mitigation mechanisms present in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 476,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "As of April 26 2024, the fair value of Medtronic’s Level 3 auction‑rate securities is $33 million, and these securities are presented in the consolidated balance sheet under “Investments” (i.e., other assets) as available‑for‑sale debt securities classified as Level 3.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all key aspects: (1) The fair value of Level 3 auction rate securities is accurately stated as $33 million, matching the ground truth. (2) The date, April 26, 2024, is correctly cited. (3) The classification on the balance sheet is substantively correct — while the ground truth specifies 'Other Assets', the LLM elaborates that these are under 'Investments' as available-for-sale debt securities within other assets, which is consistent with typical balance sheet presentation and adds context without inaccuracy. The term 'Investments' in quotes followed by 'i.e., other assets' correctly links the specific line item to the broader category. (4) The securities are correctly identified as Level 3 and auction-rate, meeting entity and classification accuracy. The only minor deviation is slightly more granular terminology ('available-for-sale debt securities') not present in the original answer, but this reflects additional detail rather than error. Multi-hop reasoning is sound, correctly synthesizing fair value and balance sheet classification from the 2023 10-K. All numbers and dates are accurate, and semantic equivalence is maintained.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 333,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "The adoption of the credit loss guidance on January 1 2020 required MetLife to record an allowance for credit losses rather than an OTTI impairment, affecting both mortgage loan portfolios and fixed‑maturity securities AFS. This change is reflected in the 2019‑2021 impairment loss data and the ACL methodology described in Notes 1 and 8, where the Company uses significant judgment to estimate expected lifetime credit losses, discount cash flows, and adjust for prepayments and economic conditions. Consequently, the 2020‑2021 net investment gains (losses) show a lower credit‑loss provision and a shift in how realized and unrealized gains/losses are recognized for these assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the high-level shift from incurred loss to expected lifetime credit loss model and mentions the change from OTTI to ACL, which aligns with the ground truth. However, it fails to include the specific 2019 impairment loss figures for each category of fixed maturity securities AFS—namely, foreign government ($81M), consumer corporate ($23M), industrial corporate ($22M), RMBS ($2M), and finance corporate ($1M)—which are critical quantitative components of the original answer. These numbers are entirely omitted, representing a significant gap in factual completeness. (2) No calculations are attempted, but the absence of reported 2019 impairment losses undermines quantitative accuracy. The mention of '2019-2021 impairment loss data' is vague and does not confirm or report actual values, making it insufficient for quantitative fidelity. (3) The reasoning is partially sound: the LLM correctly identifies the shift in accounting model and references judgment in estimating expected losses, discounting cash flows, and adjusting for prepayments and economic conditions—consistent with the multi-hop synthesis required. It also correctly notes the impact on mortgage loans and AFS securities. However, it does not explicitly state that for AFS securities, post-adoption impairment now includes only intent-to-sell and direct write-downs, replacing the OTTI framework—a key qualitative detail. (4) Contextual relevance is high because the response stays focused on the impact of the new guidance and ties in relevant disclosures (Notes 1 and 8) and financial statement effects. Overall, the answer provides a reasonable conceptual summary but lacks essential numerical data and some key methodological changes, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 486,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "Lockheed Martin’s offset agreements require it to spend cash on in‑country projects, technology transfers and consulting support, and those outlays are recorded as part of the contract costs that must be recovered through sales. Because the cash spent on offsets is treated as a cost of performance, it can only be recovered if the related contract generates sufficient revenue; if the offset obligations are not met, the company may incur penalties or be unable to recoup the investment, limiting its ability to recover those costs on U.S. government contracts in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Lockheed Martin's offset agreements involve cash outlays for consulting support and in-country projects, and that cost recovery depends on revenue generation or contract performance. It also correctly notes that failure to meet offset obligations could lead to penalties or unrecovered costs, which aligns with the financial risk described in the ground truth. However, it omits key details from the original answer, particularly the $64.3 billion in U.S. government purchase obligations and the specific condition that cost recovery is only guaranteed if the U.S. government terminates a contract for convenience under the FAR. This omission weakens the multi-hop synthesis between international offset risks and domestic cost recovery mechanisms. (2) There are no numeric inaccuracies in the LLM answer because it does not include any numbers; thus, quantitative accuracy is not violated—only incomplete. The ground truth's $64.3 billion figure is missing, but since the LLM doesn't contradict it, this is a completeness issue rather than a quantitative error. (3) The reasoning is partially sound: the model correctly links offset spending to cost recovery risk, but fails to fully synthesize the interaction between international offset investments (e.g., joint ventures) and the limited reimbursement pathways under U.S. government contracts. The critical point that offset costs cannot be recovered through standard U.S. contracts unless terminated for convenience is missing, weakening the multi-hop logic. (4) The contextual relevance is high because the answer addresses the core issue of cost recovery risk due to offset obligations. Qualitative accuracy is reduced due to missing key entities (FAR, termination for convenience, joint ventures) and incomplete reasoning. Correctness score is 7 because the core idea is accurate but lacks essential details needed for full multi-hop understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 529,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "TMO’s 2021 pharma services business drove segment revenue growth and margin expansion by capitalizing on pandemic‑related demand for COVID‑19 testing and vaccine‑related services, while also benefiting from a $20 million inventory accounting credit and the acquisition‑related efficiencies of its PPI cost‑improvement program; however, these gains were partially offset by strategic growth investments in commercial and operational infrastructure. Consequently, the Laboratory Products and Biopharma Services segment posted a 45 % rise in segment income and an increase of 2.0 percentage points in segment income margin, underscoring the positive impact of both revenue volume and margin‑enhancing accounting changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key drivers of TMO's pharma services business in 2021: pandemic-related demand (specifically for vaccine and therapy development, though phrased as 'testing' and 'vaccine-related services') and the $20 million inventory accounting credit. It also notes that strategic growth investments partially offset these gains, which aligns with the ground truth. However, the LLM introduces two elements not present in the original answer: (a) the 'PPI cost-improvement program' and (b) specific quantitative outcomes—'45% rise in segment income' and '2.0 percentage points increase in segment income margin'—which are not mentioned in the ground truth. These additions, especially the precise metrics, cannot be verified against the provided truth and likely stem from hallucination or external data. (2) Quantitative accuracy is compromised because while the $20 million credit is correct, the 45% income growth and 2.0 pp margin increase are unsupported by the original answer. These figures may be factually accurate in reality, but since they are absent from the ground truth used for evaluation, they represent overprecision and deviation. (3) The multi-hop reasoning is generally sound—the model connects pandemic demand, accounting changes, and investment impacts appropriately. However, the inclusion of the PPI program introduces an entity not referenced in the original answer, reducing entity accuracy. (4) Despite these issues, the core qualitative narrative matches: strong demand and an accounting benefit boosted margins and revenue, partially offset by investments. The answer is contextually relevant and well-structured, but the unsupported numbers reduce its correctness score to 7 due to significant but not fundamental factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 489,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "MetLife’s participation in Supervisory Colleges—led by the NYDFS in the U.S. and coordinated with EIOPA in Europe—provides a formal forum for its key U.S. and non‑U.S. regulators to share risk insights, align supervisory expectations, and jointly assess the group‑wide risk profile. This collaborative oversight enhances the depth of regulatory scrutiny on MetLife’s cross‑border operations, shaping its risk‑management practices and influencing how its regulatory capital and solvency requirements are measured across jurisdictions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, capturing the core elements of MetLife's participation in Supervisory Colleges and its impact on regulatory oversight and risk profile. It correctly identifies the roles of NYDFS in the U.S. and EIOPA in Europe, and emphasizes the collaborative nature of supervision, information sharing, and alignment of regulatory expectations. There are no numerical inaccuracies (quantitative accuracy is 10), as the response does not introduce any incorrect figures or miscalculations. The qualitative accuracy is slightly reduced because the LLM omits specific details present in the ground truth, such as the annual chairing of meetings by NYDFS and the explicit mention of the Central Bank of Ireland as a European regulator involved. While the LLM conveys the essence of coordinated supervision and its influence on risk management and capital assessment, it does not fully reflect the structural aspects of how Supervisory Colleges are convened (e.g., EIOPA requiring colleges for EEA-based groups with significant operations). The multi-hop reasoning is sound—linking MetLife’s international operations to dual regulatory frameworks and their combined effect on oversight—but lacks granular completeness. Contextual relevance is perfect, as the response directly addresses the question’s focus on regulatory influence and risk implications. Overall, the answer is semantically close to the ground truth with minor omissions that do not undermine the core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 418,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "The reduction in the Allowance for Credit Losses (ACL) for transfer risk outside the U.S., driven by U.S. banking law safety and soundness considerations, resulted in a $373 million net ACL release in 2024. This release contributed to a $1.5 billion net income for the year, up from a $35 million loss in 2023, representing a **1,800 % increase** in total net income.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains almost no correct factual information. It claims a $373 million net ACL release, but the ground truth states a $111 million decrease in provision expense due to a lower ACL build ($295M in 2024 vs $406M in 2023). The LLM's reported net income of $1.5 billion is incorrect—ground truth reports $4.9 billion. It also falsely states a net loss of $35 million in 2023, which is not mentioned in the original answer. The claimed 1,800% increase is therefore entirely fabricated. (2) Quantitative accuracy is extremely low: none of the dollar amounts or percentages match the ground truth. The correct calculation is a $111M reduction in expense leading to a 27% increase in net income to $4.9B. The LLM’s numbers are not even approximately correct. (3) The multi-hop reasoning is flawed: while the LLM identifies the correct general topic (ACL reduction due to U.S. banking law impacting transfer risk), it fails to correctly link the provision expense change to the net income impact. It invents a net loss in 2023 to exaggerate the percentage change, showing a breakdown in logical and financial reasoning. (4) Contextual relevance is moderate because the answer addresses the right topic (ACL, transfer risk, U.S. banking law, net income impact), but the factual and quantitative errors render it misleading and incorrect. The structure mirrors the question, but the content is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 395,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "Potential funding disruptions from the U.S. debt ceiling expiration in mid‑January 2025 could delay or reduce the appropriations needed to fund the F‑35 program, which accounts for a large share of Lockheed Martin’s Aeronautics sales. Since international customers represent 32 % of Aeronautics’ 2024 net sales and the F‑35 has commitments from twelve foreign‑military‑sales customers, any slowdown in U.S. government funding could curtail new FMS orders, freeze existing contracts, and pressure the Aeronautics segment’s revenue and backlog conversion rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: 32% of Aeronautics' 2024 net sales from international customers, the F-35's importance to the segment, and the presence of twelve FMS customers. It also correctly notes the potential impact of U.S. funding disruptions due to the debt ceiling expiration in mid-January 2025. The 73% FMS share of international sales, while not explicitly repeated, is contextually implied through the focus on FMS funding dependence. (2) Quantitative accuracy is perfect: all percentages (32%), timeframes (2024, January 2025), and counts (twelve FMS customers) match the ground truth. No calculations are required, and all numbers are accurately reported. (3) The multi-hop reasoning is sound—linking U.S. government funding disruptions to FMS contracts, then to F-35 orders, and ultimately to Aeronautics segment revenue and backlog conversion. The answer captures the causal chain, though it omits explicit mention that 73% of international sales are FMS-dependent, which slightly weakens the synthesis. This omission is notable but does not invalidate the overall logic, as the dependence of FMS customers on U.S. appropriations is still clearly conveyed. (4) Contextual relevance is excellent—the response directly addresses the question’s focus on the Aeronautics segment, FMS dynamics, and financial implications. The omission of the 73% figure prevents a perfect score, but the core reasoning and factual content align closely with the ground truth, warranting a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 424,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "Based on the provided document pages, the number of shares available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, is **53 million shares** (as stated in the table on page 71: \"Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (in millions) – 70\" and clarified in the footnote: \"Includes 17 million shares available for future issuance under the ESPP as of December 31, 2023, and 53 million shares available under the 2020 Stock Incentive Plan as of December 31, 2023\"). \n\nRegarding the comparison to shares underlying stock options assumed through acquisitions, the document states that **191,000 shares** underlie stock options assumed in connection with acquisitions, with a weighted-average exercise price of $356 and an average remaining term of approximately 3 years. These assumed options are excluded from the \"remaining available\" count and are administered under the original plans. \n\nThus, the available shares for future issuance (53 million) are distinct from the assumed options (191,000 shares), which are not available for new awards. \n\n**Answer**: As of December 31, 2023, 53 million shares were available for future issuance under the 2020 Stock Incentive Plan and related plans, compared to 191,000 shares underlying stock options assumed through acquisitions (which are excluded from the available share count and have a weighted-average exercise price of $356).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 53 million shares available under the 2020 Stock Incentive Plan and the 191,000 shares underlying assumed stock options from acquisitions, which matches the ground truth. However, it fails to include the 17 million shares available under the ESPP in the final total available for future issuance. The original answer states the total as 70 million (53M + 17M), but the LLM only reports 53 million as the total available, incorrectly omitting the ESPP shares despite acknowledging them in the explanation. (2) Quantitative accuracy is high: 53 million, 17 million, and 191,000 are all correctly cited. The calculation of total available shares (70M) is implied in the LLM's reference to the footnote but not synthesized into the final answer, leading to a partial error in the reported total. (3) The multi-hop reasoning is mostly sound—correctly distinguishing between active plan shares and assumed options—but fails in full synthesis by not combining the 53M and 17M into the total 70M available shares as required by the question asking about 'the 2020 Stock Incentive Plan and its related plans'. The ESPP is a related plan and must be included. (4) Contextual relevance is perfect: the response directly addresses the question, cites correct sources, and makes accurate comparisons. The omission of the ESPP shares in the final total prevents a higher correctness score, but core facts and numbers are otherwise accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 407,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi‑Year Equity Awards is $356 million in 2024, $596 million in 2023 and $794 million in 2022. As of November 3, 2024, the total unrecognized compensation cost for all unvested stock‑based awards (including those related to the Multi‑Year Equity Awards) is $11,259 million, which is expected to be recognized over the remaining weighted‑average service period of 3.0 years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $794 million in 2022, $596 million in 2023, and $356 million in 2024 for stock-based compensation expense, matching the ground truth. The total unrecognized compensation cost as of November 3, 2024 is accurately stated as $11,259 million. (2) Quantitative accuracy is perfect—individual yearly expenses are correct, and while the LLM does not explicitly sum them to $1,746 million, listing the components allows for correct inference of the total. The remaining unrecognized cost and the 3.0-year weighted-average service period are correctly reported. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly distinguishes between recognized expense over three fiscal years and the future unrecognized cost as of a specific date. However, it omits the explicit comparison stated in the ground truth—namely, that the unrecognized cost ($11,259M) is significantly larger than the already recognized expense ($1,746M), which speaks to the majority of cost being future. This minor omission in comparative analysis slightly affects qualitative completeness. (4) Despite this, the answer is factually accurate, contextually complete, and semantically equivalent in substance. The omission of the explicit comparison does not invalidate correctness but prevents a perfect 10. Scores reflect high accuracy with only minor room for improved synthesis articulation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 402,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "Based on the TLAC section (pages 47–48), Citi's minimum LTD requirement for 2024 is **9.5% of RWA** (specifically, 6% of RWA plus a 3.5% capital surcharge under method 2 of the GSIB surcharge rule, totaling 9.5%). This is explicitly stated as the minimum LTD requirement: \"the minimum LTD requirement is the greater of (i) 6% of the GSIB's RWA plus its capital surcharge as determined under method 2 of the GSIB surcharge rule (3.5% for Citi for 2024), for a total current requirement of 9.5% of RWA for Citi.\" The calculation uses the GSIB surcharge (3.5% for Citi in 2024) added to the base 6% RWA requirement. Citi exceeded this requirement, with LTD at 11.2% of RWA (surplus of $9 billion).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the base LTD requirement of 6% of RWA and Citi's GSIB capital surcharge of 3.5% under method 2 are correctly stated, and their sum (6% + 3.5% = 9.5%) is correctly calculated. The additional detail that Citi exceeded this with 11.2% of RWA and a $9 billion surplus is consistent with the source and adds context without contradicting the core answer. (2) The answer addresses both parts of the question: it states the total minimum LTD requirement (9.5% of RWA) and explains how it is calculated (6% base + 3.5% GSIB surcharge). (3) Entity accuracy is perfect: 'Citi', '2024', 'RWA', 'LTD', 'GSIB surcharge', and 'method 2' are all correctly identified and used in the right context. (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines the base regulatory requirement with firm-specific surcharge data, correctly citing the rule structure and applying it to Citi. (5) The semantic meaning is equivalent to the ground truth, with slightly more detail (e.g., mention of surplus) that enhances rather than distorts the answer. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 341,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "The document does not provide a specific figure for the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade. However, it includes a table of estimated future benefit payments as of December 31, 2024, which shows the following annual amounts: $1,800 million in 2025, $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million for 2030-2034. This indicates that the projected funding requirements increase annually from 2025 to 2029, with the amounts rising from $1.8 billion to $1.99 billion during this period, suggesting a continued upward trend in pension obligations through 2029 before the large 2030-2034 projection. The document also notes that there are no expected required contributions to the qualified defined benefit pension plans in 2025, but this refers specifically to the required funding contributions under ERISA and CAS, not the projected benefit payments shown in the table.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all annual projected benefit payments from 2025 to 2029 and the 2030–2034 period with accurate figures: $1,800M (2025), $1,860M (2026), $1,910M (2027), $1,960M (2028), $1,990M (2029), and $9,990M (2030–2034). The sum of these amounts is $19,510 million, which matches the ground truth total. However, the LLM fails to explicitly state this total, instead claiming the document does not provide the total projected funding requirement. This is a critical omission, as the total can be derived by summing the provided annual figures, which are clearly labeled as part of the same projection. (2) All numeric values are correct and match the ground truth exactly; format variations (e.g., $1.8 billion vs $1,800 million) are acceptable and do not affect accuracy. The calculation of the upward trend from $1.8B to $1.99B is accurate and appropriately contextualized. (3) The multi-hop reasoning is mostly sound: the model identifies the correct pension plan, extracts time-series data, and interprets the increasing trend correctly. However, it incorrectly separates 'required contributions' under ERISA/CAS from 'projected benefit payments' without clarifying that the question asks about funding *requirements*, which in context refers to the benefit payments table provided. This leads to an unjustified disclaimer that obscures the answer. (4) Despite the accurate data presentation and correct trend analysis, the failure to compute and state the total $19,510 million projection—despite having all components—reduces the correctness score. The answer is factually consistent but incomplete in synthesis, warranting a 7. Quantitative accuracy is perfect (10), qualitative accuracy is reduced due to flawed reasoning around contribution definitions (7), and contextual relevance remains high as the response directly addresses the question's components (9).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 513,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell was $79 million in 2021 and $93 million in 2020. In each year this investment category represented a small fraction of total fixed‑income assets—approximately 1.1 % of the $8,328 million total fixed‑income holdings in 2021 and about 1.4 % of the $8,385 million total fixed‑income holdings in 2020.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It reports $79 million in 2021 and $93 million in 2020 for Mortgage/Asset-backed securities, whereas the ground truth values are $1,072 million in 2021 and $982 million in 2020—off by more than an order of magnitude. Similarly, the total fixed income investments are reported as $8,328 million in 2021 and $8,385 million in 2020, but the correct figures are $12,041 million and $12,106 million respectively. These errors invalidate all derived percentages. (2) The percentages given (1.1% in 2021 and 1.4% in 2020) are incorrect due to wrong inputs; correct percentages are approximately 8.9% in 2021 and 8.1% in 2020. The combined total value is also wrong: LLM states $79M + $93M = $172M, while the correct sum is $1,072M + $982M = $2,054M. (3) The multi-hop reasoning failed completely—values for both the investment category and total fixed income holdings are inaccurate, indicating the model did not retrieve or synthesize the correct data points from the knowledge base. (4) Scores are low because the core numerical facts are wildly inaccurate, despite the answer attempting to address the right question structure (total value, ranking by proportion). Contextual relevance receives a minimal score because the answer follows the right format but with entirely incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 381,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "Broadcom’s shift to multi‑year equity awards with vesting periods of 4‑7 years means the company spreads the stock‑based compensation expense over the entire vesting horizon rather than recognizing it all in the year of grant. Consequently, the expense is recognized gradually each year as the awards vest, resulting in a more evenly distributed expense pattern across multiple fiscal years.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the shift to multi-year awards with 4-7 year vesting periods and accurately describes the general impact: spreading stock-based compensation (SBC) expense over a longer period, resulting in a more gradual and evenly distributed recognition pattern. This aligns with the ground truth that the change extends the expense recognition timeline. However, the LLM answer omits a key multi-hop detail present in the original answer: that the new multi-year awards consolidate four annual grant cycles into a single award structure, which creates overlapping expense recognition across up to 7 years. This structural change is central to how the recognition pattern fundamentally differs from the prior annual 4-year vesting model. While the LLM captures the qualitative effect (prolonged, staggered recognition), it does not explain the mechanism—bundling multiple grant cycles—driving the extended timeline. Quantitatively, no specific numbers are mentioned in either answer, so accuracy is not compromised. The reasoning is sound but incomplete, missing the synthesis of how the new award design alters the temporal structure of SBC expense. The answer remains contextually relevant and factually consistent, just less complete in explaining the full scope of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 361,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "The application of U.S. banking law directly shapes credit loss provisions in both the Legacy Franchises and Markets segments by mandating specific regulatory capital and accounting treatments for loan losses. In Legacy Franchises, provisions were driven by a smaller ACL build on transfer risk exposures outside the U.S., a requirement under safety and soundness considerations of U.S. banking law, resulting in a net ACL release of $373 million in 2024. In Markets, the lower net ACL build on transfer risk (also due to U.S. banking law safety and soundness rules) contributed to a $463 million provision in 2024, compared to $438 million in 2023. The combined impact of these U.S. regulatory requirements led to a total provision for credit losses of $1.1 billion in 2024, reflecting the mandated adjustments to ACL builds under U.S. banking law for both segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and trends. It incorrectly states that Legacy Franchises had a 'net ACL release of $373 million' in 2024, while the ground truth shows a decrease in provisions from $1.3B to $1.1B (a $200M reduction), not a release of $373M. For the Markets segment, it claims a 2024 provision of $463M compared to $438M in 2023 (implying an increase), but the truth is a lower net ACL build of $295M in 2024 vs $406M in 2023—an actual decrease of $111M. The LLM also incorrectly reports the total 2024 provision as $1.1B, whereas the correct combined total is $1.563B ($1.1B + $463M). The ground truth shows total provisions decreased from $1.738B to $1.563B (a $175M reduction), but the LLM fails to report this correctly. (2) Calculations are fundamentally flawed: the LLM misrepresents directionality (increases vs decreases), magnitudes, and totals. The $1.1B total provision cited is equal to only the Legacy Franchises figure, ignoring the Markets segment entirely in summation. (3) While the LLM correctly identifies that U.S. banking law affects ACL builds due to transfer risk on non-U.S. exposures in both segments—showing some multi-hop understanding—the synthesis is undermined by incorrect data. The reasoning framework is plausible but built on false numbers. (4) Contextual relevance is fair because the answer addresses the regulatory influence on both segments and attempts to quantify impacts, but severe quantitative errors severely limit usefulness. Correctness score is low due to pervasive number inaccuracies that change the meaning of results.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 450,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "The total value of Insurance buy‑in contracts held by Honeywell in its Non‑U.S. Plans was $691 million in 2021 and $767 million in 2020, for a combined amount of $1,458 million. This combined amount represented 17.4 % of the total assets at fair value of $8,396 million reported for Non‑U.S. Plans as of December 31 2021.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the individual values of Insurance buy-in contracts for HON in Non-U.S. Plans in 2020 ($767 million) and 2021 ($691 million), and correctly calculates the combined total of $1,458 million. These figures match the ground truth exactly, which is a strength. However, the percentage calculation is incorrect. The LLM states that $1,458 million represents 17.4% of $8,396 million (2021 assets only), but the question asks for the percentage of total assets at fair value across both 2020 and 2021. The correct denominator is $8,450 million (2020) + $8,396 million (2021) = $16,846 million. The correct percentage is $1,458 / $16,846 ≈ 8.66%, not 17.4%. (2) Quantitative accuracy is partially correct: all input numbers are accurate, and the sum is correct, but the percentage calculation is wrong due to using only one year’s assets instead of both. (3) The multi-hop reasoning fails at the synthesis step: the model must aggregate assets across two years for the denominator, but it only uses 2021 data, indicating a failure to fully integrate information across both years. (4) Contextual relevance is high because the answer addresses the right company (HON/Honeywell), the right metric (Insurance buy-in contracts), and the correct years, but the flawed reasoning undermines the conclusion. Thus, the answer is factually incomplete and partially incorrect in its key derived metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 395,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "Broadcom’s heavy investment in internal R&D—evidenced by its dedicated research‑and‑development expense line, its focus on custom silicon platforms and advanced PHY technologies, and its strategy of “technology leadership” through both acquisitions and extensive internal development—enables the company to rapidly tailor and expand AI‑optimized Ethernet switching, custom ASICs, and high‑speed interconnect solutions. This pipeline of internally developed, AI‑focused semiconductor technologies helps maintain its technology leadership in AI‑related markets by delivering the low‑latency, high‑bandwidth connectivity that AI data‑center workloads demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Broadcom's (AVGO) emphasis on internal R&D as a core component of its strategy to maintain technology leadership in AI-related semiconductor markets. While the original answer highlights 'extensive internal research and development' and specific technologies like CMOS, GaAs, and InP, the LLM response captures the essence by referencing 'advanced PHY technologies,' 'custom ASICs,' and 'high-speed interconnect solutions,' which are semantically consistent with the underlying innovation in high-performance semiconductors. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly links Broadcom’s R&D investments to its semiconductor segment and further to AI market leadership, particularly in data center connectivity, which matches the original answer’s logic chain. The mention of 'AI-optimized Ethernet switching' and 'low-latency, high-bandwidth connectivity' reflects accurate synthesis of how Broadcom’s R&D translates into competitive advantage in AI infrastructure. (4) Minor deduction in qualitative accuracy due to omission of specific material technologies (e.g., gallium arsenide, indium phosphide) mentioned in the ground truth, which provide concrete technical depth. However, the LLM compensates by referencing relevant product categories (custom ASICs, interconnects) and strategic focus areas. Overall, the answer is factually correct, contextually precise, and effectively addresses the multi-hop nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 458,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "Based on the provided document pages, the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements is $9.6 billion, as stated in Note 7 (Commitments and Contingencies) which notes that “Obligations under our purchase agreements … at September 29, 2024 totaled $12.8 billion of which, $9.6 billion is expected to be paid in the next 12 months.” This $9.6 billion figure represents the portion of purchase commitments that are anticipated to be paid within the upcoming year. In contrast, the total advance payments made under its multi‑year capacity purchase commitments as of September 29, 2024 were $3.0 billion, which is substantially lower than the $9.6 billion expected to be paid over the next 12 months. Thus, the near‑term payment obligation exceeds the advance payments by more than threefold.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key figures—$9.6 billion expected to be paid in the next 12 months, $12.8 billion total purchase obligations, and $3.0 billion in advance payments—are all accurately reported with correct dates (as of September 29, 2024). Format variations (e.g., $9.6 billion) are acceptable and semantically equivalent. (2) The comparison is correctly interpreted: the $9.6 billion near-term obligation is indeed significantly higher than the $3.0 billion in advance payments, and the LLM appropriately notes that the upcoming payment obligation exceeds prepayments by more than threefold, which is a valid calculation (9.6 / 3.0 = 3.2x). (3) The reasoning is sound and reflects proper multi-hop synthesis: it correctly distinguishes between total purchase obligations, near-term payments, and advance payments under capacity commitments, drawing from the appropriate note (Note 7) and contextualizing the figures. (4) The answer is complete, addressing both parts of the question—near-term payments and comparison to advance payments—and conveys the same conclusion as the ground truth regarding the substantial upcoming cash outflow. All entities (Qualcomm, purchase agreements, multi-year capacity commitments) are correctly identified and used in context. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 386,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "The GTN adjustment reductions for 2024 were $159 million versus $134 million in 2023, a $25 million increase. This change was driven by non‑U.S. claw‑back revisions stemming from updated VAT recoverable estimates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all factual components: GTN adjustment reductions of $159 million in 2024 and $134 million in 2023, resulting in a $25 million difference. These values match the ground truth exactly, with only formatting variations (e.g., using ' ' as a thousands separator), which are acceptable. (2) The calculation of the $25 million increase (159 - 134 = 25) is accurate and correctly characterized as an increase. (3) The non-U.S. factor is correctly identified as claw-back revisions due to updated VAT recoverable estimates, which is semantically equivalent to 'revisions in clawback amounts driven by VAT recoverable estimates' in the original answer. The multi-hop reasoning is sound, as it synthesizes the quantitative change and links it to the correct underlying non-U.S. driver from the financial data. (4) All entities (GTN adjustments, years 2023 and 2024, VAT, claw-backs) are accurately referenced. The answer is fully complete, factually correct, and contextually appropriate, addressing both parts of the question with precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 310,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "Mastercard Send expands the company’s ability to capture new payment flows—such as disbursements, remittances, B2B payments and consumer bill‑pay—by leveraging its multi‑rail network and partner ecosystems of digital‑messaging platforms, fintechs, banks, central banks and financial institutions. According to the 2022 10‑K, these capabilities are enabled through collaborations with central banks, fintechs, digital partners and other ecosystem participants that allow money to be moved quickly across cards, accounts, mobile wallets and cash‑payout channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Mastercard Send's role in capturing new payment flows—specifically disbursements and remittances—is accurately described, including its use in B2C, government, and nonprofit contexts. The mention of multi-rail capabilities and partner ecosystems (fintechs, banks, central banks, financial institutions) matches the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how Mastercard Send supports broader strategic objectives through specific partnerships. The only minor gap is that the LLM adds 'B2B payments' and 'consumer bill-pay' as payment flows, which are not explicitly mentioned in the ground truth; however, these are plausible extensions and do not contradict the source. (4) The answer is contextually fully relevant, addressing both how Mastercard Send contributes to capturing new flows and which partner ecosystems are leveraged. Overall, the response is semantically equivalent to the original answer with only slight expansion, warranting a correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 355,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "Mastercard's 2022 introduction of Cyber and Intelligence Solutions—part of its value‑added services—was accounted for within the “Other revenues” line item. Because these solutions are recognized as revenue in the period the related services are performed, the new service offerings expanded the composition of “Other revenues” and shifted the timing of revenue recognition for those fees into the current period rather than being deferred. Consequently, the “Other revenues” category now includes cyber‑and‑intelligence fees that are recorded as earned, affecting both the makeup of the category and the point at which the revenue is recognized.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: Mastercard introduced Cyber and Intelligence Solutions in 2022 as part of value-added services, which are included in 'Other revenues'. The timing of revenue recognition is correctly described as occurring when services are performed, aligning with accrual accounting principles. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the date '2022' is correctly referenced as the introduction period, matching the question context. (3) The multi-hop reasoning is sound—LLM correctly links the introduction of a new service (Cyber and Intelligence Solutions) to its financial reporting category ('Other revenues') and explains how the nature of the service affects both composition (by adding cyber-related fees) and timing (revenue recognized as services are performed, not deferred). (4) The answer is contextually precise, directly addressing how the introduction influenced both the composition and recognition timing of 'Other revenues'. Wording differs slightly from the original but conveys the same meaning with high clarity and technical accuracy. No errors in entities, logic, or financial concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 354,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "The total change in fair value of CAT's Mortgage-Backed Debt Securities from December 31 2022 to December 31 2023 was an increase of $320 million ($320 million – $0 million), and this change was smaller than the corresponding increase in unrealized losses on those securities, which rose by $54 million ($85 million – $31 million).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It claims the fair value increased by $320 million, stating a value of $320 million in 2023 minus $0 million in 2022, which contradicts the ground truth that fair value was $327 million in 2022 and $320 million in 2023 — a $7 million decrease. Similarly, it claims unrealized losses increased from $31 million to $85 million (a $54 million rise), while the ground truth states unrealized losses decreased from $31 million to $25 million — a $6 million reduction in losses (i.e., improvement). (2) All key numbers are wrong: the starting fair value is falsely reported as $0 million, the ending fair value is misinterpreted as an increase, and the unrealized losses are grossly overstated in both years. Calculations are therefore completely inaccurate. (3) The multi-hop reasoning failed entirely: the model did not correctly identify or synthesize the two data points (fair value and unrealized losses) across the two years for CAT's Mortgage-Backed Debt Securities. Instead, it appears to have hallucinated values or confused the data with another entity or context. (4) The answer receives a correctness score of 1 due to total factual inaccuracy in numbers, direction of change, and interpretation. Quantitative accuracy is 1 because nearly all figures and calculations are wrong. Qualitative accuracy is 1 due to flawed logic and entity/metric misidentification. Contextual relevance is 2 because the answer at least addresses the right type of securities and time frame, but with entirely incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 431,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "The total fair value of Qualcomm's corporate bonds and notes is $4,634 million, which represents approximately 85 % of the total marketable securities ($5,451 million). This corporate‑bond fair value is therefore a substantial portion of the overall marketable securities portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value of Qualcomm's corporate bonds and notes as $4,634 million and accurately states that this represents approximately 85% of the total marketable securities ($5,451 million), which matches the ground truth. The quantitative values and percentage are correct, and formatting variations (e.g., $4,634 million vs $4,634 million) are acceptable. (2) However, the LLM answer fails to address the second part of the question: the fair value of U.S. Treasury securities and government-related securities ($208 million) and their percentage (about 3.8%) of total marketable securities. This omission reduces completeness and affects the overall correctness despite accurate numbers for the first part. (3) The reasoning is sound for the portion addressed—correctly linking corporate bond value to total marketable securities and deriving the 85% figure—but it does not perform the multi-hop synthesis required to compare both asset categories as percentages of the total, which is central to the question. (4) Therefore, while quantitative accuracy is perfect and contextual relevance is high due to correct framing and focus, the qualitative accuracy and overall correctness are reduced due to incomplete synthesis and missing key information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 362,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "MRK leverages pediatric market exclusivity provisions to extend protection for Keytruda beyond its compound patent expiration. Specifically, the U.S. FDA Modernization Act grants six months of additional market exclusivity for pediatric studies, which can be combined with patent term extensions (PTEs) and regulatory data exclusivity (up to 12 years for biologics). This strategy ensures prolonged revenue protection for Keytruda, which is a cornerstone of Merck’s oncology portfolio. Financially, this exclusivity helps sustain high sales volumes, preserving the drug’s significant contribution to Merck’s oncology revenue stream—Keytruda generated $18.4 billion in sales in 2023 and remains a critical growth driver amid patent cliffs for other legacy products.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MRK uses pediatric market exclusivity (six months) to extend market protection for Keytruda beyond its compound patent expiration, aligning with the ground truth. It also references the possibility of combining this with patent term extensions and data exclusivity, which is consistent with evidence_source_b. However, the LLM introduces specific details not present in the original answer, such as the 'U.S. FDA Modernization Act' and '12 years of regulatory data exclusivity for biologics,' which were not part of the provided evidence. While these facts may be generally true, they go beyond the scope of the knowledge graph sources cited. (2) The LLM states that Keytruda generated $18.4 billion in sales in 2023—a specific figure not mentioned in the original answer. Since this number is plausible but not supported by the ground truth (which contains no sales figures), it introduces a quantitatively unsupported claim, reducing quantitative accuracy. (3) The multi-hop reasoning is sound: the model connects pediatric exclusivity to delayed generic competition and links this to financial impact on oncology revenue, mirroring the logic in the original answer. It correctly identifies Keytruda as a key oncology product and emphasizes the strategic importance of exclusivity extensions. (4) Despite the addition of external knowledge and unsupported numbers, the core qualitative reasoning and contextual relevance are strong. The answer addresses both parts of the question—mechanism of exclusivity extension and financial impact—and does so in a way that is semantically aligned with the original, albeit with embellishments. Hence, correctness is reduced primarily due to unsupported quantitative claims, not flawed logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 486,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "The introduction of Mastercard Installments in 2022 expands the company’s digital payment capabilities across multiple channels by adding a buy-now-pay-later solution that leverages its core network and multi‑rail infrastructure. This innovation aligns with Mastercard’s strategic priority to grow payments for consumers, businesses and governments, extending its services to new use cases and enabling broader digital payment adoption through its open‑loop, secure platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the introduction of Mastercard Installments in 2022 is accurately dated, and the description of it as a buy-now-pay-later solution leveraging Mastercard's network is consistent with the original. There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. (2) The answer addresses the core of the question—how the product supports Mastercard’s strategic goal of expanding digital payments across channels—by correctly linking the innovation to Mastercard’s broader strategic priorities like growing digital payment services, using multi-rail infrastructure, and enabling new use cases. (3) Multi-hop reasoning is sound: the LLM correctly infers that introducing Installments supports expansion across channels by leveraging existing infrastructure and aligning with innovation goals, even if it doesn’t explicitly cite the 'open-loop' nature or 'mobile and connected devices' emphasis from the 2022 10-K. (4) The only minor omission is the lack of specific mention of connecting lenders with merchants and the explicit tie to digital currency solutions or capturing new payment flows—elements present in the original that add depth. However, the core strategic alignment is preserved, and the answer remains semantically equivalent in intent and substance. Wording differs slightly but meaning is consistent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 444,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "Based on the provided document pages, Merck records its share of profits from the Ridgeback Biotherapeutics LP collaboration within **Cost of sales**. Specifically, the document states: \"Profits from the collaboration are split equally between the partners. Merck is the principal on sales transactions, recognizing sales and related costs, with profit-sharing amounts recorded within Cost of sales.\" This confirms that the profit-sharing portion of Merck's collaboration with Ridgeback Biotherapeutics LP is included in Cost of sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Merck records its profit-sharing payments to Ridgeback Biotherapeutics LP within Cost of sales, and explicitly states that profits are split equally (50/50), which aligns with the ground truth. The answer cites the relevant document language accurately, confirming that Merck, as principal, recognizes sales and related costs, with profit-sharing amounts recorded in Cost of sales. This supports the conclusion that 50% of the profits—Merck's share to Ridgeback—are recorded in Cost of sales. The answer does not explicitly state '50%' in a standalone sentence as a direct response to 'what portion,' but the information is clearly implied and contextually conveyed through accurate quotation and reasoning. There are no factual inaccuracies, and all entities (Merck, Ridgeback Biotherapeutics LP, Lagevrio collaboration), metric (profit-sharing in Cost of sales), and reasoning (equal split, accounting treatment) are correct. The minor deduction in qualitative accuracy is due to slightly less direct articulation of the 50% figure as the 'portion,' though it is clearly embedded in the explanation. Quantitative accuracy is perfect—no numbers or percentages are incorrect. Contextual relevance is full, as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 360,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "The Overseas Fund Regime (OFR) allows non-UK funds to be marketed to UK retail investors only if the regulatory regime governing those funds in their home jurisdiction is deemed equivalent to the UK’s standards. Under the OFR, BlackRock must ensure that the home‑country oversight of its European‑domiciled funds meets UK consumer‑protection requirements—particularly regarding conduct, disclosure and investor safeguards—so that the FCA can approve the funds for distribution in the UK. Failure to achieve this equivalence would prevent BlackRock from marketing those funds to UK retail investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that under the Overseas Fund Regime (OFR), BlackRock's European-domiciled funds can only be marketed to UK retail investors if the home jurisdiction's regulatory regime is deemed equivalent to the UK’s, particularly in consumer protection. The answer accurately highlights the necessity of equivalence in conduct, disclosure, and investor safeguards, aligning with the requirement for FCA approval. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis between the OFR, BlackRock’s fund structures, and UK marketing implications. The only minor omission is the lack of explicit mention of 'adjustments to fund structures or compliance frameworks' as noted in the original answer, which slightly affects completeness. However, the core facts, entities (OFR, BlackRock, EU/UK funds, FCA), and logic are correct. The answer is highly relevant and conveys the same practical outcome as the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 318,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "Broadcom's internal manufacturing of FBAR filters—leveraging its proprietary FBAR technology, amplifier design, and module integration capabilities—creates a key differentiator in the cellular handset market by enabling superior RF performance, higher efficiency, and better coexistence in congested spectrum. This vertically integrated approach, protected by a robust IP portfolio and specialized fabrication processes (partially done in-house in the U.S. and Singapore), allows Broadcom to maintain technological leadership and reliability, strengthening its competitive position against other filter suppliers and integrated device manufacturers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth. It correctly identifies Broadcom's internal manufacturing of FBAR filters as a strategic advantage, emphasizing protection of intellectual property (via a robust IP portfolio and specialized fabrication) and accelerated time to market (implied through technological leadership and faster integration). While the original answer focuses on IP protection and time-to-market as the primary drivers, the LLM expands with relevant qualitative details—such as superior RF performance, efficiency, spectrum coexistence, vertical integration, and geographic manufacturing sites (U.S. and Singapore)—that are consistent with Broadcom’s known strategy and enhance the explanation without introducing inaccuracies. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects multi-hop synthesis of Broadcom’s technology, manufacturing, and market positioning. The only minor deviation is that the LLM emphasizes performance benefits more than the original, which centers on IP and speed to market; however, these are complementary aspects of competitive advantage, not contradictions. Thus, the answer is highly accurate, contextually rich, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 366,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "Merck leverages both patent term extensions (PTEs) and regulatory exclusivity mechanisms to extend market protection for biologic products. In the U.S., key regulatory exclusivities include up to five years of data exclusivity for new biologics (extended to seven years for orphan drugs and twelve years for biologics under the Biologics Price Competition and Innovation Act), six months of pediatric exclusivity (added to patent terms or data exclusivity periods when pediatric studies are completed), and potential supplementary protection certificates (SPCs) in the EU. These mechanisms, combined with PTEs that can extend compound patent terms by up to five years, allow Merck to maintain exclusivity beyond standard patent expiration, particularly for innovative biologics like those in its oncology and vaccine pipelines. The company specifically cites eligibility for these extensions for candidates such as MK-8591D (with pending PTE for lenacapavir) and other late-stage products, ensuring prolonged protection through layered intellectual property and regulatory strategies.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding U.S. regulatory exclusivity durations. It incorrectly states that new biologics have 'up to five years of data exclusivity' and that orphan drugs have seven years—this is false; under the Biologics Price Competition and Innovation Act (BPCIA), the correct data exclusivity period for biologics in the U.S. is 12 years from first approval, not five or seven. The only correct numeric value is the six-month pediatric exclusivity, which aligns with the ground truth. The mention of 'supplementary protection certificates (SPCs) in the EU' is contextually irrelevant since the question specifically asks about U.S. exclusivity. (2) Quantitative accuracy is low because the core number (12 years) is buried among incorrect ones (5 years, 7 years), and the structure implies these are all U.S. biologic exclusivities when they are not. The 12-year figure is correct, but the inclusion of drug approval exclusivity terms from small molecules (5 years) and orphan drugs (7 years, which applies to small molecules, not biologics) introduces significant confusion. (3) The reasoning shows partial multi-hop synthesis—Merck's use of layered IP and regulatory strategies is conceptually sound, and the reference to MK-8591D and lenacapavir suggests some product-specific knowledge. However, the integration of EU mechanisms (SPCs) and misapplication of small-molecule exclusivity rules to biologics undermines the logical coherence. (4) Contextual relevance is high because the answer addresses both patent term extensions and regulatory exclusivity, discusses pediatric exclusivity correctly, and attempts to tie strategies to specific products. However, the factual errors in key quantitative elements—especially the misstatement of the foundational 12-year biologic exclusivity period—reduce the correctness score to 5, as the answer is partially correct but contains major inaccuracies that distort the regulatory landscape.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 541,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "The 2024 UK Stewardship Code reforms – which tighten proxy‑voting and engagement rules and may impose limits on common‑ownership stakes – could force BlackRock to alter how it votes and engages with portfolio companies on behalf of UK clients.  This heightened regulatory scrutiny is likely to increase compliance costs and could restrict the firm’s ability to hold or trade certain securities, potentially affecting fund performance and growth in its UK operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies that the 2024 UK Stewardship Code reforms affect BlackRock's UK operations and may increase compliance costs, it introduces unsupported claims not present in the original answer, such as 'tighten proxy-voting and engagement rules' and 'impose limits on common-ownership stakes.' These specific regulatory changes are not mentioned in the original answer, which instead emphasizes 'tailored reporting requirements for proxy advisers and investment consultants'—a key factual discrepancy. (2) There are no numeric values, dates, or calculations in either answer beyond '2024,' which is correctly used by the LLM, so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is partially sound—BlackRock’s 10-K is correctly referenced, and the general direction of impact (increased compliance costs, changes to stewardship activities) aligns with the original—but the LLM fabricates regulatory mechanisms (e.g., ownership limits) and omits the critical link to FCA expectations, Consumer Duty rules, regulatory sanctions, reputational risk, and client asset withdrawals, which are central to the original answer’s logic. (4) The contextual relevance is moderate because the answer addresses the general theme of regulatory impact on compliance and client engagement, but it fails to capture the core compliance and reporting focus of the reforms and their specific risks to BlackRock’s UK subsidiaries. Thus, while the answer is plausible, it is factually divergent in key aspects, warranting a correctness score of 4 for partial accuracy with significant omissions and inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 467,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "The dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022 was $343 million (rising from $95 million in 2021 to $438 million in 2022). This change is directly attributable to the Heritage AspenTech acquisition, as noted in the footnote that amortization of intangibles includes $148 million related to that acquisition and the segment’s amortization expense grew from $95 million to $242 million in fiscal 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and calculation errors. It reports a dollar increase of $343 million (from $95M to $438M), which is incorrect. The ground truth states the increase was $147 million (from $95M in 2021 to $242M in 2022). The LLM incorrectly states the 2022 expense as $438M instead of $242M. However, it correctly identifies the $148M amortization related to the acquisition from a footnote, which is close to the implied $147M increase, suggesting partial data alignment. (2) Calculation verification: $242M - $95M = $147M (correct per ground truth); LLM claims $438M - $95M = $343M, which is factually wrong. The LLM also contradicts itself by stating the segment’s amortization grew to $242M while claiming total D&A is $438M, indicating confusion between amortization and total depreciation and amortization. (3) Multi-hop reasoning is partially sound: the model correctly links the Heritage AspenTech acquisition to increased amortization due to intangible assets, citing a relevant footnote. This shows understanding of the causal mechanism. However, the synthesis fails because it combines correct qualitative reasoning with incorrect quantitative data. (4) Correctness score is low due to severe numerical inaccuracy, despite some correct qualitative logic. Quantitative accuracy is very low due to wrong base numbers and miscalculated increase. Qualitative accuracy is moderate because the reasoning about the acquisition's impact is valid. Contextual relevance is high as the answer addresses both parts of the question and cites appropriate evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 437,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "Based on the provided financial data, the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $744 million (from $881 million in fiscal 2020 to $744 million in fiscal 2022, reflecting a decline of $137 million; however, the document indicates the 2022 figure as $744 million and the prior period as $881 million, so the change is –$137 million). This region contributed approximately 10.7% of the total global growth in the Subscriptions and Services segment, as the Asia Pacific total for Subscriptions and Services was $744 million out of the global total of $6,926 million for fiscal 2022.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and calculation errors. The year-over-year increase in Subscriptions and Services revenue in the Asia Pacific region is incorrectly stated as a decline of $137 million due to referencing incorrect base years (fiscal 2020 vs. 2021) and wrong prior-period value ($881 million instead of $720 million). The correct increase is $24 million ($744M - $720M) from FY2021 to FY2022. (2) The percentage contribution to global growth is miscalculated: the LLM incorrectly computes the Asia Pacific's share of total revenue ($744M / $6,926M ≈ 10.7%) rather than its contribution to the global segment's growth ($24M / $362M ≈ 6.63%, with ground truth stating ~0.35% — though this appears inconsistent and may reflect a weighting or reporting nuance; however, 10.7% is clearly incorrect for growth contribution). The global growth amount is correctly noted as $362 million (from $6,564M to $6,926M), which aligns with ground truth. (3) Multi-hop reasoning fails: the model does not correctly identify the two required comparisons — (a) APAC regional YoY change, and (b) that change’s proportion of total global segment growth. Instead, it confuses absolute revenue with growth contribution and uses incorrect time periods. (4) Scores are low due to fundamental errors in data recall (wrong prior-year revenue), incorrect trend direction (decline vs. actual increase), and flawed logic in calculating growth contribution. Contextual relevance is partially maintained as the answer addresses the right segment and region, but with wrong numbers and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 438,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ expand pre‑merger notification requirements and increase scrutiny of transactions that could be deemed anti‑competitive. Under these enhanced rules, BlackRock may face longer review periods and higher compliance costs for acquisitions, and any fund seeking to engage in a transaction that meets the HSR threshold could be subject to heightened antitrust scrutiny, potentially limiting its ability to complete HSR‑reportable deals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All entities are correct: FTC, DOJ, BlackRock, HSR-reportable transactions, and the 2023 joint merger guidelines are accurately referenced. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links the 2023 guidelines to increased scrutiny, longer review periods, higher compliance costs, and implications for both BlackRock and funds engaging in HSR-reportable transactions. It captures the causal chain: new guidelines → expanded requirements → increased costs and delays → reduced ability to complete acquisitions. (4) The LLM answer is slightly less detailed than the original (e.g., does not explicitly mention 'pre-merger notification expenses' or 'expanded documentation requirements'), but it conveys the core implications accurately. Wording differs but meaning is preserved. Minor omission prevents a perfect 10, but the answer is substantially correct, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 325,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "Goldman Sachs discloses in its 10‑K that it uses both stock‑settled and cash‑settled Non‑Employee Director RSU award agreements (see Exhibit 10.31 and Exhibit 10.32). Because some RSUs are settled in cash rather than shares, the company must record a liability for the cash‑settled portion and adjust the expense recognition accordingly, resulting in a different classification of the award—partly as equity‑based compensation and partly as a cash‑based compensation arrangement—in its financial statements. This dual‑settlement approach affects how RSU expenses are presented and classified within the consolidated financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the essential information from the ground truth. It accurately identifies that Goldman Sachs uses both stock-settled and cash-settled Non-Employee Director RSU agreements, and correctly explains the accounting implications: stock-settled RSUs are treated as equity, while cash-settled RSUs are classified as liabilities under GAAP, requiring liability recognition and remeasurement. The answer correctly notes that this leads to different expense recognition and classification in the financial statements. The mention of Exhibits 10.31 and 10.32 is slightly off—the ground truth cites Form 10.8 and Form 10.32 as the relevant agreements—but this is a minor discrepancy in exhibit numbering and does not undermine the overall accuracy of the accounting treatment described. There are no numerical values to verify, so quantitative accuracy is scored as 10. The reasoning is sound, demonstrating proper multi-hop synthesis between settlement type and accounting classification. The answer is fully contextually relevant. The only reason for not scoring a perfect 10 is the minor inaccuracy in exhibit references, which does not affect the correctness of the core accounting principles conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 346,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "In 2023, Abbott granted **4,981,231 restricted stock units** under the 2017 Incentive Stock Program. These units vest over three years, and upon vesting, each unit entitles the recipient to receive one share of Abbott stock.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) The number of restricted stock units granted in 2023 — 4,981,231 — is accurate and matches the original answer exactly. (2) The vesting condition is correctly stated: the units vest over three years, and each vested unit results in one share of Abbott stock, which aligns precisely with the program documentation. (3) The reasoning is sound and reflects proper synthesis of multi-hop information from the Abbott Laboratories 2017 Incentive Stock Program and its 2023 grant activity. (4) All entities — Abbott Laboratories, 2017 Incentive Stock Program, restricted stock units, and the year 2023 — are correctly identified and contextualized. Minor wording differences (e.g., 'entitles the recipient to receive' vs. 'the recipient receives') do not affect factual meaning and are semantically equivalent. No errors in calculation, logic, or factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 272,
        "total_tokens": 1408
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "Based on the document, 29% of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe (comprising Eastern Europe, the Middle East, Africa, Latin America, and Asia). This geographic distribution reflects the long-term strategic impact of the 2005 Leica Microsystems acquisition, which established the Life Sciences segment and provided a foundational platform for expanding into high-growth global markets, as evidenced by the segment's 28% sales share from high-growth markets in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that 29% of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe. However, the ground truth specifies that 28% came from high-growth markets and 7% from other developed markets, totaling 35%. The LLM's 29% is incorrect, likely conflating 'high-growth markets' (28%) with the total outside North America and Western Europe. This is a significant quantitative error. (2) The calculation in the original answer is 28% (high-growth) + 7% (other developed) = 35%, which is accurate. The LLM's 29% does not match this sum and appears to be either a misstatement or based on incorrect data. (3) The reasoning about the strategic impact of the 2005 Leica Microsystems acquisition is qualitatively sound: it correctly identifies Leica as the foundational platform for the Life Sciences segment and links it to global expansion, particularly into high-growth markets. The LLM also correctly references the 2005 acquisition year and ties it to long-term geographic diversification. However, it omits mention of key subsequent acquisitions (Beckman Coulter, Pall, Abcam) that are part of the multi-hop reasoning in the ground truth, weakening the completeness of the strategic narrative. (4) Despite the numerical inaccuracy, the LLM answer captures the core strategic insight and correctly identifies the relevant time frame and entity. The semantic intent is aligned, but the factual precision on the key percentage is off. Hence, correctness is reduced primarily due to the incorrect 29% figure, though the qualitative and contextual elements remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 447,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "Danaher has made 10 acquisitions in the Life Sciences segment since its establishment in 2005, including the 2015 acquisition of Pall and the most recent acquisition of Abcam in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Danaher made 10 acquisitions, while the ground truth confirms only 8 acquisitions since 2005. This major factual error undermines the core of the response. (2) The dates for Pall (2015) and Abcam (2023) are correct, which are key data points requested. However, the total count is wrong, and no other acquisitions are listed to verify completeness. The number '10' is unsupported by the ground truth and appears fabricated. (3) The multi-hop reasoning is partially sound in that the model identifies Pall and Abcam with correct years, showing it can extract specific acquisition events. However, it fails to accurately synthesize the full list or count, indicating a failure in comprehensive retrieval or aggregation across the timeline. (4) Despite the correct mention of two key acquisitions and their years, the significant overstatement of the total number of acquisitions results in a low correctness and quantitative accuracy score. The answer is contextually relevant and addresses the right segment and companies, warranting a moderate contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 320,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "The fair value of Abbott’s interest rate hedge contracts remained unchanged at $87 million on both December 31 2021 and December 31 2020, indicating no net gain or loss from the hedge. This stability reflects that the receivable position for these contracts was essentially flat, with the hedge’s fair‑value offsetting the fixed‑rate debt’s market movements and leaving the receivable amount unchanged.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It claims the fair value of Abbott's interest rate hedge contracts was $87 million on both December 31, 2020, and December 31, 2021, which directly contradicts the ground truth stating it was $210 million in 2020 and $87 million in 2021. This results in a complete failure to report the $123 million decline. (2) The quantitative inaccuracies are severe: the starting value ($210M in 2020) is omitted, the change ($123M decrease) is not mentioned, and the implication of no change is factually wrong. The receivable position is also misrepresented as 'flat' when it actually dropped from $210M to $87M. (3) The multi-hop reasoning is flawed—the model fails to connect the change in fair value with the corresponding change in receivable position over time, instead asserting stability where there was significant movement. It misunderstands the relationship between fair value and receivable, incorrectly attributing stability to offsetting effects rather than reporting the actual decline. (4) The contextual relevance is low but not zero because the answer addresses the right topic (fair value and receivable position of interest rate hedges) and the correct company (Abbott) and time frame (2020–2021), but all substantive content is factually incorrect. Hence, correctness and accuracy scores are near minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 382,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "BMY's strategic focus on expanding its autologous CAR‑T pipeline—evidenced by new indications for Breyanzi and the growth of Abecma—directly supports the observed doubling of U.S. Breyanzi sales in 2023, as highlighted by the company's emphasis on advancing cell‑therapy leadership and increasing manufacturing capacity to meet rising demand. This expansion aligns with the revenue surge, underscoring how the company's pipeline diversification drives commercial growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies BMY's strategic focus on expanding its autologous CAR-T pipeline, specifically mentioning Breyanzi and its new indications, which aligns with the ground truth. It accurately links this strategy to the doubling of U.S. revenues for Breyanzi in 2023. While the ground truth specifies the new indications as CLL, FL, and MCL, the LLM answer does not list them explicitly but refers generally to 'new indications,' which is semantically acceptable but slightly less precise. (2) Quantitatively, the answer correctly references the doubling of U.S. Breyanzi sales in 2023, matching the ground truth. There are no numerical inaccuracies or miscalculations. (3) The multi-hop reasoning is sound: the model connects BMY’s strategic R&D and commercial expansion (pipeline development, manufacturing capacity) to increased demand and revenue growth, correctly synthesizing cause and effect across business strategy and financial performance. (4) The answer is contextually fully relevant, directly addressing how the strategic focus aligns with revenue growth. The only minor shortcoming is the lack of specificity regarding the exact new indications (CLL, FL, MCL), which slightly reduces qualitative accuracy but does not impair overall correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 396,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.699 billion, and it contributed $2.70 billion to the total cash used for acquisitions in 2023, which also included the $0.91 billion cash outflow for CorEvitas, LLC.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. The cash outflow for The Binding Site Group is reported as $2.699 billion, which is effectively equivalent to $2.70 billion (rounded) as in the ground truth. The CorEvitas, LLC acquisition amount is correctly stated as $0.91 billion. The total cash used for acquisitions is implied to be $3.609 billion, which rounds to $3.61 billion as in the original answer. The minor discrepancy in precision ($2.699B vs $2.70B) does not affect factual accuracy. (2) All numeric values match within acceptable rounding: $2.699B ≈ $2.70B, $0.91B exact, and sum ≈ $3.61B. Calculations are accurate. (3) Multi-hop reasoning is sound: the model correctly identifies two acquisitions, associates correct amounts, and synthesizes them into the total cash used for acquisitions in 2023. (4) The answer is contextually complete and relevant, addressing both parts of the question. The slight variation in decimal precision does not detract from correctness, warranting a 9/10 rather than perfect 10 due to the presentation of $2.699B instead of the rounded $2.70B used in official reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 324,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "The total estimated annual cost savings from restructuring charges incurred in 2024 and 2023 is approximately $0.2 billion for 2024 and $0.6 billion for 2023, as noted in the MD&A. The acquisition of The Binding Site Group in 2023 expands the Specialty Diagnostics segment’s portfolio with pioneering diagnostics and monitoring assays for blood cancers such as multiple myeloma, strengthening its strategic growth in blood‑cancer diagnostics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: $0.2 billion in estimated annual cost savings from 2024 restructuring charges and $0.6 billion from 2023 charges, totaling $0.8 billion. These figures match the ground truth exactly, with acceptable formatting ($0.2 billion vs $0.2 billion). 2) The qualitative description of The Binding Site Group acquisition is accurate—it correctly states the acquisition adds pioneering diagnostics and monitoring assays for blood cancers like multiple myeloma, which supports strategic growth in blood cancer diagnostics within the Specialty Diagnostics segment. 3) The multi-hop reasoning is sound: the model synthesizes cost savings from two years and links the acquisition to strategic growth in a specific diagnostic area. 4) The only minor omission is that the LLM answer does not explicitly state the total combined savings of $0.8 billion (though it provides both components, so the total can be inferred). The ground truth explicitly sums them, so full completeness is slightly reduced. However, since both components are present and accurate, the core information is preserved. 5) All entities (The Binding Site Group, 2023 acquisition, Specialty Diagnostics segment, blood cancer diagnostics, multiple myeloma) are correctly identified and contextually used. 6) The answer is highly relevant and directly addresses both sub-questions. Thus, the correctness score is 9 due to the lack of explicit summation, but all other aspects are fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 415,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061, which matures in 2061. This maturity year is later than all other debt instruments listed, including the 1.125% Notes due 2051 (2051), 1.700% Notes due 2049 (2049), 1.625% Notes due 2043 (2043), and 6.77% Notes due 2036 (2036).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) The longest-term debt instrument is correctly identified as the 1.375% Notes due 2061, with a maturity year of 2061—this is accurate and matches the original answer. (2) Quantitative elements—interest rates and maturity years (2061, 2051, 2049, 2043, 2036)—are all correct and consistent with the 2023 10-K filing. The LLM provides more detail than the ground truth by listing additional debt instruments (e.g., 1.700% Notes due 2049, 6.77% Notes due 2036), but these do not contradict the original answer and enhance completeness. (3) The multi-hop reasoning is sound: the model correctly identifies the latest maturity date among multiple instruments and compares it appropriately. (4) The semantic meaning fully aligns with the ground truth—the core fact (2061 as the latest maturity) is preserved and accurately contextualized. Minor expansion of detail improves rather than detracts from accuracy. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 290,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "Donanemab is currently under regulatory review for early Alzheimer’s disease and also being studied in preclinical Alzheimer’s disease, representing two distinct indications in development or review. Lebrikizumab has received regulatory approval in the EU and Japan for atopic dermatitis and is under FDA review in the U.S., with one indication approved and one additional indication under regulatory review.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Donanemab is under development or review for two distinct indications—early Alzheimer’s disease and preclinical Alzheimer’s disease—which matches the ground truth. It also correctly states that Lebrikizumab is approved in the EU and Japan for atopic dermatitis and under FDA review in the U.S. However, the LLM incorrectly implies that Lebrikizumab has one approved indication and one additional indication under review, suggesting two separate indications. In reality, it is the same indication (atopic dermatitis) under different regulatory jurisdictions. The ground truth correctly identifies this as one indication across regions. (2) There are no numeric values requiring calculation, but the count of indications is partially incorrect: Donanemab’s count (2) is accurate, but Lebrikizumab’s count should be 1 (not 2), affecting the comparison. (3) The multi-hop reasoning is mostly sound—information is synthesized across regulatory regions and development stages—but the model fails to recognize that multiple regulatory actions for the same disease constitute a single indication. This is a key nuance in regulatory and clinical development contexts. (4) Despite this error, the answer is contextually relevant and factually rich, with accurate entity names, diseases, and regulatory statuses. The conclusion that Donanemab has more indications is correct, but the reasoning is flawed. Hence, a score of 8 is justified—core facts are correct, but there is a significant conceptual error in indication counting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 430,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "The decline in Alimta revenue in the U.S. in 2023—driven by generic entry—reduced overall U.S. volume growth, but this was more than offset by strong volume gains from other oncology products, particularly Verzenio, which contributed positively to U.S. volume growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the decline in Alimta's U.S. revenue in 2023 due to generic entry and its negative impact on overall U.S. volume growth. It also accurately names Verzenio as a key oncology product contributing positively to volume growth. However, the original answer specifies that both Verzenio and Trulicity contributed positively, while the LLM answer only mentions Verzenio, omitting Trulicity. Additionally, the LLM states that the decline was 'more than offset,' which implies a stronger positive effect than the original answer's 'partially offset'—this overstates the degree of compensation. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and the entities (Alimta, Verzenio, U.S., 2023, generics) are correct. The reasoning is mostly sound but slightly overreaches in the strength of the offset claim. Contextually, the answer is fully relevant and addresses both parts of the question, albeit with minor incompleteness and a subtle mischaracterization of the magnitude of offset.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 304,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "Based on the provided 10-K filing details, Merck has incurred or anticipates a total financial commitment of **$4.0 billion in upfront payments plus $1.5 billion in scheduled continuation payments** related to its collaboration with Daiichi Sankyo for three DXd ADC candidates (patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan). This includes a $1.0 billion refundable upfront payment (split as $500 million each for patritumab deruxtecan and ifinatamab deruxtecan) and $750 million continuation payments due in October 2024 (patritumab deruxtecan) and October 2025 (raludotatug deruxtecan), with potential contingent payments of up to $5.5 billion per ADC upon achieving sales milestones. This commitment is part of Merck's broader immuno-oncology strategy, which focuses on advancing novel therapies like V940 (mRNA-4157) in combination with Keytruda (as detailed on page 22, where V940 is highlighted as a \"first-in-class individualized neoantigen therapy\" under clinical evaluation in Phase 3 trials for melanoma and NSCLC, with Breakthrough Therapy designation from the FDA/EMA). The Daiichi Sankyo collaboration exemplifies Merck's strategy of leveraging partnerships to expand its oncology pipeline through high-potential ADCs and targeted therapies, while sharing development costs and profits globally (except in Japan, where Daiichi Sankyo retains exclusive rights).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to address the core of the question. (1) It discusses a $4.0 billion collaboration with Daiichi Sankyo for ADC candidates, which is unrelated to V940 (mRNA-4157). The ground truth states that Merck made a $250 million payment to Moderna in 2022 for V940 and is sharing development costs equally—this is the only relevant financial commitment. The LLM invents large dollar figures ($4.0B upfront, $1.5B continuation) that pertain to a different partnership and drug candidates. (2) Quantitatively, every number in the LLM response is wrong in this context: $4.0B, $1.5B, $1.0B refundable, $750M continuation, $5.5B contingent—all refer to Daiichi Sankyo, not Moderna or V940. The correct figure is $250 million, with equal cost-sharing going forward. (3) The qualitative reasoning is flawed: the LLM conflates two distinct collaborations (Moderna for mRNA-4157 vs. Daiichi Sankyo for ADCs). While it correctly notes that V940 is a first-in-class neoantigen therapy in Phase 3 trials with Keytruda for melanoma and NSCLC and has Breakthrough Therapy designation, this accurate detail is embedded in an otherwise factually incorrect narrative. (4) Contextual relevance is low because the financial commitment discussed is not for V940. The mention of Merck’s broader immuno-oncology strategy has partial relevance, but the financial justification is entirely misattributed. The model fails the multi-hop requirement: it should have linked Merck’s $250M payment + cost-sharing to Moderna with the strategic importance of V940 in Merck’s IO pipeline. Instead, it substitutes an unrelated deal. Only minor credit is given for correctly identifying V940’s clinical status and designations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 470,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "Based on the provided document pages, MK-7962 (sotatercept) is listed as having a U.S. patent expiration year of 2027 in the \"Under Review in the U.S.\" table (page 16), but the document also states that \"As a biologic product, MK-7962 (sotatercept) will be eligible for 12 years of data exclusivity upon approval in the U.S. Granted patents covering methods of treating pulmonary arterial hypertension with MK-7962 (sotatercept), which will expire in 2037 (absent PTE), may also provide additional exclusivity\" (page 16). The question asks for additional years beyond the standard biologic data exclusivity period. The standard biologic data exclusivity period in the U.S. is 12 years from first marketing approval. Since the patent expiration is listed as 2027 (which is before the 12-year data exclusivity would expire), the patent protection does not extend beyond the data exclusivity period. Therefore, there are no additional years of patent protection beyond the standard 12-year biologic data exclusivity period for MK-7962. The patent expiration year (2027) is earlier than the data exclusivity expiration (which would be 12 years after approval), so no additional patent term is provided beyond the standard exclusivity.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and reasoning errors. It incorrectly states that the patent expiration year for MK-7962 (sotatercept) is 2027 based on the 'Under Review in the U.S.' table, but this 2027 date refers to the anticipated approval year, not the patent expiration. The document explicitly states that the granted patents covering methods of treatment will expire in 2037. The LLM conflates approval year with patent expiration, leading to a fundamental error. (2) Quantitatively, the key numbers are wrong: the patent expiration is 2037 (correct in document), and if approved in 2027, the data exclusivity would last until 2039 (2027 + 12 years). However, the LLM incorrectly assumes the patent expires in 2027, which is before exclusivity ends, concluding zero additional years. The correct calculation is that patent protection ends in 2037, while data exclusivity would end in 2039 — but since the patent expires *before* data exclusivity, there are actually *no* additional years *beyond* exclusivity. However, the original ground truth claims 'additional 10 years', which implies a different interpretation: perhaps the patent term extends *past* approval but not past exclusivity. But per standard interpretation, patent life beyond exclusivity is only possible if the patent expires *after* 2039. Given the patent expires in 2037, it does *not* extend beyond the 12-year exclusivity period ending in 2039. Thus, even the original answer may be flawed. However, per the provided ground truth, the expected answer is '10 additional years' (2037 - 2027 = 10), interpreting 'additional beyond exclusivity' as the duration of patent protection *from approval*, not *beyond the end of exclusivity*. The LLM fails this interpretation by using 2027 as patent expiry. (3) Multi-hop reasoning is flawed: the model fails to distinguish between approval year and patent expiry, misreads the table, and does not synthesize the correct timeline. It should have noted: approval in 2027 → exclusivity until 2039; patents expire 2037 → so patent protection ends *before* exclusivity, hence 0 additional years beyond exclusivity. But per ground truth logic (which appears to define 'additional' as patent term length post-approval minus exclusivity period), 10 years of patent protection post-approval (2027–2037) vs 12-year exclusivity implies the patent doesn’t add time. There is confusion in the ground truth. However, since the task is to evaluate against the provided ground truth, and the LLM contradicts it due to misreading 2027 as patent expiry, it fails. (4) Scores justified: correctness low due to critical misreading of dates; quantitative accuracy poor due to wrong year assignment; qualitative reasoning flawed; contextual relevance moderate as it addresses the right topic and cites correct sections.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 749,
        "total_tokens": 2165
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "The total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements, was $17 million. This is calculated from the 2023 fair value of $13 million and the 2022 fair value of $4 million, resulting in a $9 million increase for U.S. plans and $8 million for International plans, totaling $17 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The total increase is stated as $17 million, whereas the ground truth is $106 million. The U.S. increase is reported as $9 million and International as $8 million, but the correct figures are $33 million and $73 million respectively. The LLM also cites 2023 and 2022 fair values of $13 million and $4 million, which are completely inconsistent with the source data (U.S. values alone are $740M and $707M). (2) Quantitative accuracy is extremely low: all numbers are factually wrong, and the calculation ($13M - $4M = $9M) does not align with any data in the original answer. The sum of $9M + $8M = $17M is arithmetically correct but based on false inputs. (3) The multi-hop reasoning failed completely — the model did not correctly extract or synthesize data from both U.S. and International Pension Plans across years 2022 and 2023. It misrepresented both the magnitude and direction of changes, and ignored the breakdown of Emerging Markets Equities in both direct holdings and Investment Funds. (4) Contextual relevance is low but not zero — the answer attempts to address the question structure (increase in fair value from 2022 to 2023 across both plans), so some relevance is present. However, due to catastrophic failures in data retrieval and calculation, the correctness and accuracy scores are near the minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 391,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "The estimated fair value of U.S. government agencies securities held by GILD increased from $35 million at December 31 2022 to $127 million at December 31 2023, a $92 million rise. In contrast, the estimated fair value of U.S. treasury securities rose modestly from $410 million to $426 million, an increase of $16 million over the same period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. According to the ground truth, the estimated fair value of U.S. government agencies securities increased from $21 million to $127 million, a $106 million increase, but the LLM reports a rise from $35 million to $127 million, resulting in a $92 million increase—both starting value and change are incorrect. For U.S. treasury securities, the ground truth states a decrease from $379 million to $426 million is mathematically impossible (as $426 > $379); however, the intended data point must be a decrease from $410 million to $376 million or similar to yield a $34 million decline. But the LLM claims a rise from $410 million to $426 million ($16 million increase), which contradicts the ground truth that states a $34 million decrease. Thus, both the direction and magnitude of change for treasury securities are wrong. (2) Calculations are internally consistent in the LLM answer (e.g., $127M - $35M = $92M; $426M - $410M = $16M), but they are based on incorrect input values and contradict the ground truth. The ground truth implies treasury securities declined, but LLM says they rose—this is a critical error. (3) The multi-hop reasoning is structurally sound—the model attempts to compare changes in two asset classes over time for GILD—but fails due to incorrect data retrieval or synthesis. It identifies the correct entities (GILD, U.S. government agencies securities, U.S. treasury securities, correct dates), but pulls inaccurate values. (4) Correctness and quantitative accuracy are low due to major factual and directional errors. Qualitative accuracy is slightly higher because the framework of comparison is present. Contextual relevance is high as the response directly addresses the question's structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 492,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "Biktarvy revenue increased 14% year-over-year to $11,850 million in 2023, driven by higher demand and favorable pricing dynamics. This growth occurs against a backdrop of patent expirations for Gilead's principal HIV products, with Biktarvy's patent protection extending to 2033 in the U.S. and 2033 in the EU, providing long-term revenue visibility beyond the expiration of older HIV drugs like Descovy (2031) and Stribild (2029). The company's strategic focus on expanding its oncology and inflammation pipelines through acquisitions and collaborations aims to offset potential revenue declines from aging HIV products as they lose exclusivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Biktarvy's 2023 revenue as $11,850 million and the 14% year-over-year growth from $10,390 million in 2022, matching the ground truth exactly. All quantitative figures—revenue amounts, percentage growth—are accurate. (2) The calculation of 14% growth is correct: ($11,850M - $10,390M) / $10,390M ≈ 14%. No errors in numbers or formats. (3) The LLM adds specific patent expiration dates (2033 in U.S. and EU for Biktarvy, 2031 for Descovy, 2029 for Stribild), which are not present in the original answer but are factually consistent with public 10-K disclosures and enhance the reasoning. While the original answer notes the importance of patent timelines without specifying years, the LLM’s inclusion of these dates represents a plausible and relevant extension of the knowledge, not a contradiction. The strategic pivot to oncology and inflammation pipelines is also contextually appropriate and aligns with Gilead’s stated diversification efforts. (4) The only minor shortcoming is that the original answer emphasizes uncertainty around sustainability of growth if patents expire sooner, while the LLM assumes current patent timelines hold. This shifts the tone slightly from cautious to confident, but does not invalidate the reasoning. Overall, the LLM demonstrates strong multi-hop synthesis across revenue performance, patent timelines, and strategic implications. Scores reflect high accuracy with a small deduction in qualitative accuracy for not fully reflecting the risk-oriented nuance in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 427,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "The impending U.S. patent expiration of Truvada in 2023 would significantly reduce Gilead’s near-term revenue from its flagship HIV product, directly limiting the financial resources available for investment in lifecycle management initiatives for its HIV portfolio. Given Gilead’s single operating segment structure and centralized resource allocation model, where the CODM evaluates overall resource availability and deploys funds based on unmet medical need, scientific data, and market potential across the entire company, the loss of Truvada’s patent protection would constrain the company’s ability to fund new HIV-related R&D, marketing, or expansion of existing therapies like Descovy and Biktarvy, as resources would need to be redirected toward other high-priority areas such as oncology, inflammation, and viral diseases, potentially slowing the development and commercialization of next-generation HIV treatments and related lifecycle management strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Truvada's U.S. patent expiration in 2023 is accurately stated, and the impact on revenue and investment in lifecycle management is correctly described. There are no numeric inaccuracies—dates and financial implications are qualitatively correct, with no specific dollar amounts in dispute. (2) Quantitative accuracy is perfect: the year 2023 is correctly cited, and no erroneous figures are introduced. (3) The multi-hop reasoning is sound: the model correctly links Gilead’s single operating segment and centralized resource allocation to the potential reallocation of funds away from HIV lifecycle management due to declining Truvada revenues. It appropriately infers that reduced revenue could lead to prioritization of other therapeutic areas (e.g., oncology, inflammation), which is a logical extension consistent with centralized decision-making. (4) The LLM adds contextual depth by naming other HIV products (Descovy, Biktarvy) and potential strategic trade-offs, which enriches the answer without introducing inaccuracies. The only minor gap is that the original answer emphasizes the need for offsetting strategies (cost reallocations or newer product revenue), while the LLM focuses more on redirection to other therapeutic areas—this is a nuance, not an error. Overall, the answer is semantically equivalent, factually correct, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 403,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "The 2023 IDA Agreement required Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which directly impacted its capital management strategy by necessitating sufficient capital levels to support the migration of these balances onto the balance sheet. This agreement specifically affected contract asset amortization, as the amortization of contract assets (related to the IDA agreement) was recorded as a reduction to bank deposit account fee revenue on a straight-line basis over the remaining contractual term. The specific dollar amount of amortization associated with this agreement was $239 million, as reflected in the \"Contract assets - net\" balance of $239 million on page 96 and further detailed in Note 14 regarding the 2023 IDA agreement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the key dollar amount of amortization. The ground truth states that the amortization associated with the 2023 IDA Agreement was included in a broader category totaling $85 million for 2023, while the LLM claims a specific amortization amount of $239 million, which is incorrect. The $239 million figure appears to be a misinterpretation of the 'Contract assets - net' balance on page 96, which represents the total carrying value of contract assets, not the 2023 amortization expense. (2) Quantitative accuracy is severely compromised: $239 million vs $85 million is a major discrepancy. The ground truth does not isolate a specific dollar amount solely for the IDA agreement but embeds it within $85 million of total amortization of capitalized contract costs. The LLM incorrectly asserts a precise figure not supported by the source. (3) Qualitatively, the LLM captures some correct concepts—such as off-balance sheet sweeps to TD Depository Institutions, impact on capital management, and amortization reducing bank deposit fee revenue—but misrepresents the causality: the agreement alleviates balance sheet pressure rather than requiring sufficient capital to bring balances back, as the LLM suggests. The reasoning around capital management is therefore flawed. (4) Contextual relevance is fair, as the response addresses both parts of the question—capital management strategy and contract asset amortization—and references appropriate financial statements and notes. However, the incorrect derivation of the amortization amount and flawed logic undermine the overall correctness. The model fails the multi-hop synthesis by conflating balance sheet asset values with income statement amortization expenses.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 488,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "The 2023 issuance of 1,725,000 LTIP units and other unit exchanges increased Simon Property Group’s equity interest in the Operating Partnership, contributing to a higher total equity balance reflected in the consolidated statements of equity. This increase was offset in part by distributions and other adjustments, but overall the equity issuances raised total equity as reported in the 2023 10‑K.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in stating that LTIP unit issuances and other unit exchanges increased equity, but it fails to report any of the specific dollar amounts from the ground truth and incorrectly implies a net increase in equity. The ground truth shows a net *reduction* of $139,378 due to unit-related activities, after accounting for redemptions and treasury purchases. The LLM answer misses this critical net effect entirely. (2) Quantitative accuracy is very low: the ground truth includes precise figures—$197,426 from limited partner unit issuances, $14,739 from LTIP units, offset by $13,524 redemption and $140,593 in treasury purchases—but the LLM provides no numbers at all, not even approximate. The mention of '1,725,000 LTIP units' is specific but lacks valuation or equity impact, making it insufficient for financial analysis. (3) The reasoning is flawed in terms of multi-hop synthesis: while the model identifies the correct direction of some transactions (issuances increase equity), it fails to synthesize the full picture by omitting the offsetting reductions and the final net outcome. This indicates a failure to integrate all relevant unit activity into a coherent equity impact assessment. (4) Contextual relevance is moderate because the answer addresses unit issuances and their effect on equity in SPG’s 2023 10-K, which is relevant, but lacks the depth and precision required for a multi-hop financial question. The absence of quantitative synthesis and net impact renders the answer misleading despite some correct directional logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 436,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "Linde’s long‑term on‑site supply contracts—typically 10‑20 year agreements with minimum purchase requirements and price‑escalation clauses—are accounted for as performance obligations satisfied over time; revenue is recognized when the product is delivered and the company can invoice the customer, with variable pricing constrained. Because these contracts are essentially fixed‑price, long‑duration arrangements, they drive a stable, recurring revenue stream that is recognized evenly over the contract term, and they underpin the company’s long‑term contract structure and revenue‑recognition policy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the 10–20 year contract duration, minimum purchase requirements, and price escalation provisions are correctly stated. (2) The revenue recognition policy is accurately described as occurring over time upon delivery and when the company has the right to invoice, which matches the original answer’s reference to 'revenue recognized over time as product is delivered and the company has the right to invoice.' (3) However, the LLM introduces a potentially misleading characterization by describing the contracts as 'essentially fixed-price' and stating that revenue is 'recognized evenly over the contract term.' This contradicts the ground truth, which emphasizes variable volume (total requirement agreements) and variable pricing (with escalation clauses), meaning revenue may not be recognized evenly. The LLM also mentions 'variable pricing constrained,' which is not in the original and could imply a different accounting treatment. (4) Despite this nuance, the core multi-hop reasoning—linking on-site distribution to long-term contracts and appropriate revenue recognition—is sound and contextually relevant. The answer correctly synthesizes distribution model with contract structure and accounting policy. Minor deduction for the 'fixed-price' and 'evenly recognized' implications, which oversimplify the actual variable-volume, invoice-upon-delivery model.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 408,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "The fair value of corporate notes and obligations was $2,978 million as of January 31 2024 and $3,354 million as of January 31 2023, a decrease of $376 million. Total marketable securities declined from $5,492 million to $5,722 million, an increase of $230 million, meaning the $376 million drop in corporate notes is more than offset by the overall rise in marketable securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key numbers: corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million, and total marketable securities increased from $5,492 million to $5,722 million, a change of $230 million. These values match the ground truth exactly. (2) All calculations are accurate: the $376 million decrease and $230 million increase are correctly computed. The LLM also correctly notes that the drop in corporate notes is more than offset by the overall rise—this aligns with the ground truth's implication. (3) The multi-hop reasoning is sound: the model synthesizes data across two disclosures (likely two years or filings), compares a specific asset class to the total portfolio, and draws a valid conclusion about relative performance. (4) The only minor issue is a wording slip: the LLM says 'Total marketable securities declined from $5,492 million to $5,722 million'—'declined' is incorrect because the value increased; however, it immediately corrects itself by stating 'an increase of $230 million', so the error is purely semantic and does not affect factual accuracy. This prevents a perfect 10 but does not undermine correctness. All entities (corporate notes, total marketable securities, correct dollar amounts) are accurately referenced. The answer is contextually complete and directly responsive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 387,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "The Health Care Benefits segment’s premiums are set in advance for a fixed 12‑month period based on forecasts of future medical cost trends and claim experience; because cost increases cannot be recouped during that period, even modest errors in estimating incurred but not yet reported claims or detecting rapid utilization shifts can cause actual benefit costs to exceed projected levels, directly reducing margins and profitability. Consequently, the accuracy of these forecasts is critical—if forecasts are too low, the company absorbs the excess costs, eroding operating results, whereas more precise forecasting allows it to price premiums that cover expected costs and preserve profit levels.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the fixed premium period, the advance pricing of premiums based on forecasts, and the sensitivity of profitability to forecast errors. It correctly emphasizes that premiums cannot be adjusted during the fixed period and that forecast inaccuracies—especially regarding utilization trends or IBNR claims—can lead to cost overruns and margin pressure. All quantitative aspects (e.g., 12-month fixed period) are consistent with typical industry practices and the ground truth context, though the exact percentage of Insured Health Care Benefits in revenues (94%) is omitted, which is a minor gap in completeness. The entity (CVS, Health Care Benefits segment) and financial logic are correct. The reasoning is sound and captures the core risk: forecast inaccuracy leads to unadjusted costs hurting profits. However, the LLM answer does not explicitly mention 'changing provider behavior'—such as hospitals trying to maintain revenue during downturns—as the driver of unpredictable cost trends, which is a key element in the original answer and central to the multi-hop reasoning (provider behavior → cost volatility → forecasting difficulty → profit sensitivity). While the effect is implied through 'rapid utilization shifts,' the causal link to provider behavior is underdeveloped. This omission reduces qualitative accuracy slightly but does not undermine the overall correctness of the financial mechanism described. The answer remains semantically aligned in outcome and logic, just less complete in root-cause explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 432,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "Chevron's 2020 acquisition of Noble Energy added roughly 6,000 cubic feet of natural‑gas production per barrel of crude‑oil equivalent, boosting its overall oil‑equivalent output and providing a higher‑margin gas stream. This expanded, diversified production base helped the company maintain strong cash flows and low leverage even when crude prices fell, which underpinned its ability to meet debt‑service obligations and preserve the high AA‑ (S&P) and Aa2 (Moody’s) debt ratings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns well with the ground truth. It accurately states the October 2020 acquisition of Noble Energy by Chevron and correctly interprets the 6,000 cubic feet of natural gas per barrel of crude oil as part of oil-equivalent production, which is consistent with industry standards (6,000 cu ft ≈ 1 barrel of oil equivalent). The debt ratings (AA- by S&P and Aa2 by Moody’s) are correctly cited.\n\n2) Quantitative accuracy is perfect: the 6,000 cubic feet figure, the 2020 date, and the credit ratings are all correct. There are no calculation errors, and the unit interpretation (gas-to-oil equivalence) is appropriately implied.\n\n3) The reasoning is sound and captures the multi-hop logic: acquisition → increased production (especially in natural gas) → enhanced cash flow → financial flexibility during low commodity prices → support for maintaining strong credit ratings. The LLM correctly infers that diversified, higher-margin production helps maintain low leverage and debt-service capacity, which credit agencies favor.\n\n4) The only minor shortcoming is that the LLM omits Chevron’s explicit strategy of adjusting capital spending and reducing stock repurchases during downturns, which is mentioned in the original answer and directly supports how financial flexibility is maintained. While the LLM implies financial resilience, it doesn’t fully detail the mechanism (spending adjustments), slightly reducing qualitative completeness. However, the core causal chain and factual content are preserved.\n\nOverall, the answer is semantically equivalent in intent and meaning, with high accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 451,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "Schwab spent $249 million in market‑based fees to buy down $5 billion of fixed‑rate obligation amounts under the 2023 IDA agreement, and this amount is recorded as a contract asset (an other‑assets item) on the consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligations under the 2023 IDA agreement, matching the ground truth in both dollar amounts and context. The classification of the amount as a contract asset within other assets on the consolidated balance sheet is also accurate. The only minor discrepancy is the addition of 'market-based fees' in the LLM answer, which is not present in the original answer and slightly introduces unverified detail, though it does not contradict the ground truth. (2) All numeric values—$249 million and $5 billion—are correct and match the ground truth; format variations (e.g., $5B vs $5.0 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly links the 2023 IDA agreement to the specific financial action (buy-down of fixed-rate obligations) and accurately describes the accounting treatment (capitalized as contract assets, included in other assets), demonstrating proper synthesis across financial events and reporting standards. (4) The answer is contextually fully relevant, addressing both parts of the question—amount spent and balance sheet classification—with high precision. The slight addition of 'market-based fees' prevents a perfect 10 due to potential over-specificity without source support, but core facts, numbers, and reasoning are fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 402,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "Based on the provided document pages, CVS recorded **$483 million in store impairment charges** in 2024 as part of its enterprise-wide restructuring plan (referenced on page 153). This is part of the company's broader restructuring initiative that includes other charges such as office real estate optimization costs ($30 million in 2024, detailed on page 154).  \n\nRegarding the 2025 cost savings outlook, the document explicitly states that the enterprise-wide restructuring plan aims to generate **\"expected cost savings of over $500 million in 2025\"** (referenced on page 78, within the \"2025 Outlook\" section). This $500 million+ figure represents the projected annual savings from the restructuring plan, which includes the store impairment charges and other efficiency initiatives.  \n\nThus, the $483 million impairment charge is a component of the restructuring plan, while the expected 2025 cost savings target is **over $500 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both key figures from the ground truth: the $483 million in store impairment charges for 2024 and the 'over $500 million' in projected cost savings for 2025. These values match the original answer exactly in both amount and context. (2) Quantitative accuracy is perfect—both dollar amounts are correct, with proper year attribution. The phrasing 'over $500 million' is preserved, which aligns with the original 'projected to generate over $500 million in cost savings for 2025.' No calculations were required, but the comparison is accurately framed. (3) The multi-hop reasoning is sound: the model correctly links the 2024 impairment charges to the same enterprise-wide restructuring plan that is expected to yield savings in 2025, demonstrating synthesis across time periods and document sections (pages 153 and 78). It also correctly contextualizes the store impairments as part of a broader initiative. (4) All scores are 10 because the answer is factually complete, precisely accurate, logically sound, and fully relevant to the question. Minor additions (e.g., mention of $30 million in office real estate costs) provide helpful context without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 344,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited was **$(166) million** for 2021, as shown in the \"Equity in Earnings\" table in Note 15 (Investments and Advances) on page 77. This negative figure indicates Chevron's share of losses from the investment, reflecting operational challenges or market conditions in Angola's LNG sector during that year. It underscores Chevron's active involvement in Angola's liquefied natural gas market through its 36.4% ownership stake in Angola LNG Limited, though the loss highlights the financial volatility inherent in such projects.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the equity in earnings is accurately reported as $(166) million for 2021, which is equivalent to -$166 million in the ground truth; the 36.4% ownership stake is correctly cited. (2) The answer addresses both parts of the question: it provides the exact financial figure and interprets what it indicates about Chevron's involvement in Angola's LNG market. (3) Entity accuracy is perfect: Chevron, Angola LNG Limited, and the relevant financial metric (equity in earnings) are correctly identified, and the year 2021 is accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: the negative earnings are correctly interpreted as a loss attributable to Chevron’s stake, and the explanation ties this to operational or market challenges in the LNG sector, aligning with the ground truth’s implication of 'challenges in liquefaction and processing.' The mention of financial volatility adds context without introducing error. (5) Semantic equivalence is maintained: while the LLM provides slightly more contextual detail (e.g., referencing Note 15, page 77), all added information is accurate and enhances the answer without deviating from the truth. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 366,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "NextEra Energy Resources faces operational risk from the mismatch between the Duane Arnold nuclear plant’s decommissioning timeline (expected completion around 2080) and the expiration of its nuclear fuel supply contracts in 2033, which could leave it without secured fuel for operations beyond that date. This risk is compounded by the need to maintain compliance with NRC regulations and manage spent fuel storage until a long-term solution is secured.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the Duane Arnold decommissioning timeline (2080) and nuclear fuel supply contract expiration (2033) are correctly stated, with no calculation errors. Entity identification is correct—NextEra Energy Resources (NEER), the Duane Arnold plant, and implied regulatory oversight (NRC) are all accurate. The reasoning correctly identifies the operational risk arising from the mismatch between fuel contract expiration and long decommissioning timeline. However, the LLM omits key elements from the ground truth: it does not mention the need for alternative fuel sources or long-term dry storage of spent fuel, nor does it reference the Department of Energy (DOE) taking possession, which is a critical part of the risk context. It also misses the potential consequences such as increased operational costs, regulatory scrutiny, or capital expenditures. While the core risk is correctly framed, these omissions reduce completeness and depth of multi-hop synthesis, particularly around post-2033 fuel management and long-term storage planning. The answer remains semantically aligned and contextually relevant, but lacks full qualitative richness of the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 343,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "Linde’s on‑site industrial‑gas contracts are accounted for as performance obligations satisfied over time, with revenue recognized when the product is delivered and the company can invoice the customer; these contracts often include minimum purchase requirements, price‑escalation clauses and long‑term (10‑20 year) terms, and the company may hold contingent liabilities (e.g., the $1 bn advance‑payment liability tied to terminated engineering projects and the $0.7 bn reserve for the Amur GPP matter). In contrast, merchant and packaged‑gas sales are recognized at a point in time when control passes to the customer, and they generally lack the long‑term purchase commitments and associated contingent‑liability exposure. This difference shows that long‑term on‑site agreements expose Linde to significant financial risk through extended performance obligations, minimum‑volume commitments and the potential for large contingent‑liability accruals if projects are terminated or disrupted.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Linde's $0.7 billion contingent liability related to the Amur GPP project and accurately describes the revenue recognition policy for on-site industrial gas contracts as performance obligations satisfied over time, with revenue recognized upon delivery and invoicing. It also correctly contrasts this with merchant and packaged-gas sales. The core financial risk exposure in long-term on-site agreements is well-articulated, including minimum purchase commitments and contingent liabilities.\n\n2) Quantitative inaccuracy: The LLM introduces a '$1 billion advance-payment liability tied to terminated engineering projects' that is not present in the ground truth. The original answer only mentions the $0.7 billion Amur GPP reserve and does not reference any $1 billion liability. This is a significant fabrication or misstatement, reducing confidence in numerical accuracy. The $0.7 billion figure is correct and properly attributed.\n\n3) The multi-hop reasoning is largely sound: the model correctly synthesizes Linde’s revenue recognition policies with its exposure to contingent liabilities and contrasts stable on-site contracts with project-based risks. It draws a valid conclusion about financial risk in long-term agreements, aligning with the original answer’s theme. However, the introduction of an unsupported liability figure weakens the factual foundation of the synthesis.\n\n4) Despite the erroneous $1 billion figure, the LLM captures the essential contrast and insight: that while on-site contracts provide predictable revenue, they can carry substantial contingent risks when linked to large-scale infrastructure projects with geopolitical or execution risks. Wording differs but semantic meaning is largely equivalent. The contextual relevance is excellent, directly addressing all parts of the question with appropriate financial and strategic framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 514,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "The expected increase in TAC paid to Google Network partners—driven by shifts toward lower‑margin mobile and emerging‑market traffic and by changes in device and geographic mix—will compress the gross advertising revenue recognition model by lowering the net advertising margin. As TAC rises as a larger share of gross advertising revenue, the portion of revenue that can be recognized as gross advertising revenue after deducting TAC declines, directly reducing the profitability of the advertising segment despite continued growth in total advertising sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its reasoning and captures the core economic impact of rising TAC on Google's gross advertising revenue model. It correctly identifies that increases in TAC—driven by shifts in device and geographic mix, particularly toward lower-margin mobile and emerging-market traffic—put downward pressure on net advertising margins. It also accurately reflects that Google reports revenue on a gross basis and that higher TAC reduces the net profitability of the advertising segment. However, the LLM answer slightly mischaracterizes the accounting model: it states that 'the portion of revenue that can be recognized as gross advertising revenue after deducting TAC declines,' which could be misinterpreted to suggest that TAC affects revenue recognition itself. In reality, per the ground truth, Google recognizes the full amount billed as revenue (gross) and records TAC as a cost of revenue, so the revenue amount recognized does not decline—only gross margin does. This is a subtle but important distinction in financial reporting. The answer omits explicit mention of the gross reporting model and the classification of TAC as cost of revenues, which are key to fully explaining the impact. There are no numerical inaccuracies (hence perfect quantitative score), and the contextual relevance is high as it directly addresses the question’s focus on the interplay between TAC and revenue recognition. The reasoning is sound but lacks full precision in articulating the accounting treatment, leading to a moderate deduction in qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 430,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "The ARO for coal‑ash impoundment closure is recorded based on estimated closure costs that must comply with state and federal regulations, and the ultimate closure method and schedule can change the liability amount. Because the Coal Ash Act and EPA CCR rule govern the closure requirements, Duke Energy’s recorded ARO for ash‑impoundment closure is directly influenced by compliance with those regulations. Consequently, the portion of the ARO tied to ash‑impoundment closure is shaped by the need to meet the Coal Ash Act standards and any resulting revisions to closure plans. (≈ 3 sentences)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly identifies that Duke Energy’s ARO for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act and federal regulations like the EPA’s CCR rule. The answer accurately reflects that closure methods (e.g., excavation, relocation, beneficial reuse) and timing affect the ARO amount, which aligns with the original answer. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no numbers were introduced or misstated. (3) The multi-hop reasoning is sound: the model correctly links regulatory requirements (Coal Ash Act, EPA CCR rule) to closure planning and recognizes that evolving compliance strategies impact financial liabilities (ARO), demonstrating proper synthesis across regulatory and financial domains. (4) The only minor limitation is that the LLM does not explicitly name 'Consolidated Balance Sheets' as the location of the recorded ARO, which appears in the original answer, slightly reducing completeness. However, this does not detract from the core factual accuracy. Wording differs but meaning is preserved. All entities—Duke Energy, Coal Ash Act, ARO, closure methods—are correctly identified and contextually used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 365,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "Based on the fair value tables in the 2023 10-K filing, the fair value of Mortgage-Backed Obligations was $236 million as of January 31, 2024 and $178 million as of January 31, 2023, reflecting a $58 million increase in fair value between the two periods.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains correct numerical values ($236 million and $178 million) and correctly identifies the $58 million difference, but it incorrectly states this as an 'increase' when it is actually a decrease, reversing the direction of change. This fundamental error undermines the factual correctness of the answer. (2) Quantitatively, the numbers themselves are accurate and the calculation of the $58 million difference is mathematically correct (236 - 178 = 58), so numeric precision is acceptable. However, the interpretation of the sign (increase vs decrease) is wrong. (3) The multi-hop reasoning fails because the model misinterprets the time sequence: it correctly identifies the two values from different dates but incorrectly infers the direction of change. The first table shows $236 million and the second $178 million, so the fair value decreased over time. The LLM incorrectly labels this as an increase, indicating flawed logical synthesis. (4) Contextual relevance is high because the answer addresses the right company (CRM), the right financial instrument (Mortgage-Backed Obligations), and the correct filing (2023 10-K), and references the appropriate tables with dates. However, due to the critical error in interpreting the direction of change, the overall correctness score is low despite partial accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 376,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "Based on the provided document pages, specifically page 7 and page 9, the percentage of Danaher's Diagnostics segment sales in 2023 attributed to 'other developed markets' is 5%. The company classifies 'other developed markets' as specifically including Japan, Australia, and New Zealand, as explicitly stated in the document: \"The Company defines other developed markets as Japan, Australia and New Zealand.\" This classification is consistent across the Diagnostics segment's geographic breakdown in the 2023 sales data.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 5% of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets,' which matches the ground truth. It also accurately lists the geographic regions included in this category—Japan, Australia, and New Zealand—exactly as defined in the original answer. (2) The percentage (5%) is factually correct and matches the ground truth; there are no calculations required beyond direct reporting, and the numbers are presented accurately. (3) The reasoning is sound and demonstrates proper synthesis from the source documents, correctly citing page references and quoting the company's explicit definition. The answer confirms consistency in the classification across the Diagnostics segment, showing appropriate multi-hop validation. (4) All aspects of the question are fully addressed: the percentage and the specific regions. The answer is factually precise, contextually complete, and semantically equivalent to the ground truth, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 302,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "The total revenue contribution from Bulk shipments in 2021 was $6,656 million, derived from 2,014 thousand carloads at an average revenue per car of $3,305.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key numerical inputs and the final calculation. The ground truth states 1,920,000 carloads and $3,467 average revenue per car, yielding $6,656,270,000. The LLM reports 2,014 thousand carloads (i.e., 2,014,000), which is 94,000 carloads too high, and an average revenue per car of $3,305 instead of $3,467. This results in a calculated revenue of approximately $6,656 million ($6.656 billion), which matches the magnitude of the correct answer but is based on incorrect inputs and thus coincidental. (2) The calculation in the LLM answer: 2,014,000 × $3,305 = $6,656,270,000 is numerically accurate, but only because 2,014 × 3,305 = ~6,656 (in millions). However, the inputs are wrong—both carload volume and average revenue per car are incorrect. The correct calculation is 1,920,000 × $3,467 = $6,656,640,000 (minor rounding difference). (3) The multi-hop reasoning—multiplying carloads by average revenue per car—is logically sound and reflects correct understanding of revenue derivation. However, the model used incorrect source data, undermining the qualitative accuracy. (4) The contextual relevance is high because the answer addresses the right metric, time period, company (implied), and category (Bulk shipments). However, the quantitative inaccuracy in core inputs severely limits correctness. A score of 2 is justified due to fundamentally wrong data despite matching the final figure approximately and using the correct method.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 412,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the April 1, 2019 settlement agreement with NCDEQ is approximately $8 billion to $9 billion, which represents a reduction of roughly $1.5 billion from Duke Energy’s original estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) All key facts are correct: the post-settlement cost estimate of $8 billion to $9 billion, the initial estimate of $9.5 billion to $10.5 billion, and the $1.5 billion reduction are all factually accurate. (2) Quantitative accuracy is perfect—numbers match exactly, including ranges and the calculated difference (e.g., midpoint of $10 billion minus $8.5 billion implies $1.5 billion reduction). (3) The multi-hop reasoning is sound: the model correctly links the April 1, 2019 closure determination to the initial estimate and the subsequent settlement with NCDEQ to the revised estimate. (4) Minor wording difference: the LLM attributes the settlement agreement date as April 1, 2019, while the original answer specifies that date as the closure determination, not the settlement. The settlement occurred later (finalized in 2020), so this is a slight factual inaccuracy in timing attribution, but it does not affect the core financial figures or synthesis. This justifies a 9 on correctness and qualitative accuracy. Contextual relevance is perfect—the answer directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 336,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "Mastercard paid $325 million in cash for Dynamic Yield in 2022 and $2.7 billion in cash for Recorded Future in 2024, for a total cash consideration of $3.025 billion across the two acquisitions. This spending reflects Mastercard’s strategy of diversifying and expanding its capabilities—particularly in data‑analytics and threat‑intelligence—by acquiring complementary technology companies that can be integrated into its payments network and value‑added services portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the cash consideration amounts are accurate: $325 million for Dynamic Yield in 2022 and $2.7 billion for Recorded Future in 2024, with the correct total of $3.025 billion (325 million + 2.7 billion). The formatting uses non-breaking spaces ( ) but represents standard numerical values. (2) The answer is complete, addressing both the total cash consideration and the strategic rationale behind the acquisitions. (3) Entity accuracy is correct: both company names (Dynamic Yield LTD and Recorded Future), acquisition years (2022 and 2024), and financial metric (cash consideration) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly infers that acquiring companies with specialized capabilities (personalization tech and threat intelligence) supports Mastercard’s broader strategy of diversification and integration into its service offerings, particularly in data analytics and security. The qualitative explanation aligns semantically with the original answer, using slightly different phrasing (e.g., 'threat-intelligence' instead of 'threat intelligence') but preserving meaning. All components of the question are addressed accurately and cohesively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 363,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "Based on the provided tables in the document, the total fair value of International bonds held by VZ is **$341 million** in the 2023 pension plan table (Page 92) and **$528 million** in the 2022 pension plan table (Page 92). The categorization differs in that the 2023 disclosure explicitly lists \"International bonds\" as a separate asset category with a total of $341 million (Level 1: $3 million, Level 2: $338 million), while the 2022 disclosure similarly lists \"International bonds\" as a separate category with a total of $528 million (Level 1: $10 million, Level 2: $518 million). Both tables place International bonds under Fixed Income Securities, but the 2023 table shows a lower allocation ($341M vs. $528M) and includes more detailed leveling (Level 1 and Level 2 breakdowns).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its total fair value calculation. The ground truth states the total fair value is $540 million ($12M in first table, $528M in second), but the LLM reports $341M and $528M from two different years (2023 and 2022), misidentifying the tables. The $341M figure does not align with the ground truth’s $12M from the first table, indicating a fundamental error in source identification. (2) Quantitative accuracy is poor: the LLM incorrectly states $341M instead of $12M for the first table, though the $528M for the second table is correct. The sum of $341M + $528M is not even provided as a total, and the correct total of $540M is missing. The Level 1 and Level 2 breakdowns for the first table are also wrong—LLM says $3M Level 1 and $338M Level 2, but ground truth is $9M Level 1 and $3M Level 2. Only the second table’s breakdown ($10M Level 1, $518M Level 2) matches. (3) Multi-hop reasoning fails: the LLM interprets the two tables as 2023 and 2022 pension disclosures, but the ground truth implies two different disclosures (possibly different classifications or footnotes) for the same period, not different years. The model fails to synthesize that both tables are for the same entity and time, leading to incorrect comparison. (4) Contextual relevance is moderate—the answer discusses fair value, categorization, Level 1/2 breakdowns, and fixed income, which are relevant, but misattributes data to different years and incorrect amounts, undermining correctness. Wording flexibility is acceptable, but factual and numerical errors are severe.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 440,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "Mastercard's real-time account-based payments infrastructure enables instant, account-to-account transactions globally by providing real-time clearing and settlement capabilities that support both domestic and cross-border flows. This infrastructure processes approximately 70% of all Mastercard and Maestro-branded card transactions, encompassing nearly all cross-border transactions and a substantial share of domestic transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Mastercard's real-time account-based payments infrastructure handles approximately 70% of all Mastercard and Maestro-branded card transactions, including nearly all cross-border transactions, which matches the ground truth. The description of the infrastructure enabling instant, account-to-account transactions with real-time clearing and settlement aligns with the original answer's emphasis on instant payments with enhanced data and messaging. (2) The key quantitative figure—70%—is accurate and matches the ground truth exactly. There are no calculations required beyond this percentage, and it is reported correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes the function of the infrastructure (supporting domestic and cross-border transactions) with its transaction volume share, correctly attributing the 70% figure to both domestic and cross-border contexts and noting the dominance in cross-border flows. (4) The only minor difference is that the LLM uses 'substantial share of domestic transactions' whereas the original specifies 'approximately 70%' applies to all transactions including domestic—this is slightly less precise but still semantically consistent. No incorrect entities or metrics are introduced. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 382,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "Walmart U.S. paid $1.9 billion in cash consideration to acquire VIZIO Holding Corp. The acquisition introduces a data‑privacy risk because VIZIO’s subsidiaries collect consumer data—including television‑viewing information—that is stored digitally and may be accessed by third‑party service providers, creating potential exposure to data‑privacy breaches and related regulatory liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart U.S. paid $1.9 billion in cash consideration to acquire VIZIO Holding Corp., matching the ground truth exactly in both amount and entity. This satisfies the quantitative and entity accuracy requirements. (2) The data privacy risk is accurately described: VIZIO collects consumer data, including television viewing data, stored digitally. The LLM correctly identifies the risk of exposure, though it emphasizes third-party service provider access as a vector, while the ground truth highlights cybersecurity incidents or system failures more broadly. This is a minor difference in emphasis, not contradiction—third-party access falls under broader cybersecurity risk. (3) The multi-hop reasoning is sound: the model synthesizes information about the acquisition amount (from transaction details) and links it to Walmart’s risk disclosures regarding VIZIO’s data practices. The connection between the acquisition and introduced risk is logically and contextually valid. (4) The answer is semantically equivalent to the ground truth, with only slight variation in framing of the risk (third-party access vs. general cybersecurity failures), but the core risk—digital storage of viewing data leading to potential breaches, fines, and reputational harm—is preserved. No calculation errors; all entities and figures are correct. A score of 9 is justified due to the slightly narrower framing of the risk vector, though it does not undermine factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 416,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "The net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022 was an increase of $35 million in fuel‑related operating expenses, partially offset by a $14 million rise in fuel cost recovery that boosted operating income. Consequently, operating cash flows were reduced by roughly $14 million (the net effect of the $35 million expense increase less the $14 million recovery), while operating expenses rose by $35 million.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $35 million increase in fuel-related operating expenses and the $14 million increase in fuel cost recovery, which are accurate per the ground truth. However, it incorrectly calculates the net financial impact as a $14 million reduction in operating cash flows, stating 'reduced by roughly $14 million (the net effect of the $35 million expense increase less the $14 million recovery)', which is mathematically wrong. The correct net impact is $35M - $14M = $21M net increase in costs, not $14M. This is a critical calculation error. (2) Quantitative accuracy is compromised due to this miscalculation, despite correct input numbers. The LLM confuses the net effect, possibly misattributing the recovery amount as the net impact. (3) The reasoning is partially sound—recognizing that recovery offsets expenses—but fails in the final synthesis step. The model does not correctly conclude that the net impact is a $21 million cost increase, undermining the multi-hop logic required. (4) Contextual relevance is high as the answer addresses both operating expenses and cash flows, uses correct entities (Duke Energy, 2022, fuel cost recovery, operating expenses), and frames the issue correctly. However, the incorrect net impact severely affects correctness and qualitative accuracy, warranting mid-range scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 378,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "In 2021, Intel recorded **$565 million of additional period charges** that were directly tied to the ramp‑up of its Intel 4 manufacturing process. These charges are noted in the “Operating Income Summary” on page 24, where the company lists “Higher period charges primarily associated with the ramp up of Intel 4” as a $565 million impact. The same re‑branding effort—renaming the 4 nm node to **Intel 4**—was announced in the July 26, 2021 update on page 115, which introduced the new naming structure for its manufacturing process nodes. Thus, the $565 million charge reflects the extra costs incurred while scaling up production for the newly branded Intel 4 node.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $565 million in additional period charges for 2021 is accurately reported, and the date of the rebranding announcement—July 26, 2021—is correctly cited. The dollar amount and date match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the financial impact of the Intel 4 ramp-up and its connection to the rebranding. (3) Entity accuracy is perfect: 'Intel 4', '2021', '$565 million', and the context of the manufacturing node rebranding are all correctly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis by linking the financial charge (from the Operating Income Summary) with the strategic rebranding announcement (from the July 26 update), correctly interpreting that the cost was incurred during the ramp-up of the newly named process node. The explanation that the charge reflects costs tied to scaling production under the new branding aligns semantically and factually with the ground truth. Minor enhancements in the LLM answer (e.g., referencing specific document pages) add contextual support without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 338,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "Based on the provided document pages, **5%** of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and the company had approximately **3,000 employees** in those same markets as of the end of 2023. This is confirmed by the geographic sales breakdown in the Diagnostics segment (5% for Other Developed Markets) and the employee distribution data stating \"3,000 in other developed markets.\"",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that 5% of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and correctly reports 3,000 employees in those markets as of the end of 2023. (2) All numeric values—5% and 3,000—are factually correct and match the original answer exactly; no calculations were required, but the values are properly cited. (3) The multi-hop reasoning is sound: the model correctly synthesized sales data from the Diagnostics segment’s geographic breakdown with employee data from the same region, linking two distinct pieces of information (sales percentage and employee count) tied to 'Other Developed Markets' and 'end of 2023'. (4) The answer is semantically equivalent to the ground truth, includes all required elements, and adds minor but accurate contextual support by referencing the source of the data (geographic sales and employee distribution), enhancing clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 303,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "The total revenue generated from Industrial chemicals & plastics in 2021 is calculated by multiplying the average revenue per car ($3,207 million) by the number of carloads (606 thousand), resulting in approximately $1.95 billion. This figure aligns with the reported $1.943 billion freight revenue for that commodity group in 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative errors. It states an average revenue per car of '$3,207 million', which is $3.207 billion per car—this is implausible and incorrect. The correct average revenue per car should be approximately $3,207 (not million), and the number of carloads is 606,000. Multiplying $3,207 by 606,000 yields approximately $1.943 billion (or $1,943,000,000), which matches the ground truth of $1.943 billion (or $1.94 million in the original answer—note: $1.94 million is likely a typo in the original answer, as $1.94 billion is consistent with the calculation). The LLM incorrectly reports the result as $1.95 billion, which is close but based on flawed inputs. (2) The calculation is conceptually correct (revenue per car × carloads), but the misplacement of units (millions vs. dollars) invalidates the reasoning. The final figure of $1.943 billion in freight revenue is mentioned, which aligns with expectations, but the derivation is flawed. (3) The multi-hop reasoning—combining revenue per car and number of carloads—is correctly identified and applied in structure, but the execution fails due to incorrect magnitude of inputs. (4) The contextual relevance is high, as the answer addresses the right commodity, year, and method. However, the quantitative accuracy is low due to the erroneous 'revenue per car' value. The qualitative accuracy is moderate because the logic is sound but based on incorrect data. Correctness score is 4 due to major numerical inaccuracies despite correct framework and approximate alignment with expected output.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 438,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "The total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed in the other postretirement benefit plans asset category, is $12 million (Level 1: $10 million, Level 2: $2 million). This amount is reported alongside the pension plan assets but pertains specifically to the postretirement benefit plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and composition. The ground truth states the total fair value is $24 million, with $12 million each in Level 1 and Level 2. The LLM reports only $12 million total ($10M Level 1, $2M Level 2), which misstates both the individual amounts and the total. (2) Quantitative accuracy is low: the correct total is $24M (sum of $12M + $12M from two categories), but the LLM reports $12M and further breaks it down incorrectly into $10M and $2M, which does not match the source data. No correct calculation is performed. (3) The multi-hop reasoning fails: the question requires summing values across two reported asset categories (likely pension and postretirement plans), but the LLM only references one category (postretirement) and omits the second entirely. It does not synthesize across both tables as required. (4) Contextual relevance is moderate because the answer discusses the correct company (Verizon), year (2023), asset type (International Bonds), and classification levels (Level 1/Level 2), but applies them to the wrong context and values. The focus on postretirement plans alone suggests a failure to identify both relevant disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 342,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "Costco leverages its owned production of private‑label items to boost comparable‑sales growth, which allows the company to spread its SG&A expenses over a larger sales base, reducing SG&A as a percentage of sales and enhancing profitability. By offering private‑label products at competitive prices, Costco drives higher member traffic and basket size, supporting comparable‑sales growth and enabling greater SG&A leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: Costco's ownership of production facilities supports private-label item production, which drives comparable sales growth, enabling leverage of SG&A expenses and enhancing profitability. The answer correctly identifies the causal chain: private-label products → competitive pricing → higher traffic and basket size → comp sales growth → SG&A leverage. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between operational assets (owned facilities), product strategy (private-label), sales performance (comparable sales), and financial leverage (SG&A as % of sales). The only minor omission is that the LLM does not explicitly mention 'penetration' of private-label items, a nuance present in the original answer, but this does not detract from the overall correctness. (4) The answer is fully contextually relevant, directly addressing how private-label production contributes to SG&A leverage via comp sales growth. Wording differs slightly but meaning is preserved. Thus, correctness is high at 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 391,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "Intel's RibbonFET technology, introduced at the Intel 20A node, is a core element of its IDM 2.0 strategy and broader push to lead in advanced process and packaging technologies. By delivering a gate‑all‑around transistor that provides faster switching and higher drive current in a smaller footprint, RibbonFET enables the performance‑per‑watt gains Intel targets for Intel 20A and beyond, while its integration with PowerVia and advanced 3D packaging (Foveros Omni/Direct) supports the company’s goal of “accelerating process performance‑per‑watt parity by 2024 and leadership by 2025” as outlined in its R&D and IDM 2.0 announcements. This technology thus directly advances Intel’s product‑leadership and manufacturing‑at‑scale objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies RibbonFET as a gate-all-around transistor introduced at the Intel 20A node, delivering faster switching and improved performance-per-watt in a smaller footprint—this aligns with the ground truth. It accurately links RibbonFET to Intel's IDM 2.0 strategy and R&D investment goals, emphasizing process leadership and manufacturing scale. The mention of PowerVia and advanced 3D packaging (Foveros Omni/Direct) adds relevant technical context not in the original answer but consistent with public Intel roadmaps, enhancing rather than distorting accuracy. (2) There are no numeric values, dates, or dollar amounts in the LLM answer that conflict with the ground truth. While the ground truth mentions specific investments ($20B in Arizona, over $20B in Ohio), the LLM answer does not include these figures—but it also does not misstate them, so this omission does not constitute an error, only a lack of completeness on that specific point. The reference to '2024 and 2025' targets for performance-per-watt leadership is consistent with Intel's public timelines. (3) The multi-hop reasoning is sound: the model correctly synthesizes RibbonFET’s technical role (from process technology), its alignment with R&D objectives (from R&D section), and its strategic importance under IDM 2.0. It connects packaging innovations to the broader strategy, showing understanding across technology, investment, and manufacturing domains. (4) The answer is contextually excellent—directly addressing how RibbonFET contributes to Intel’s process and packaging advancement within the framework of R&D and IDM 2.0. The only reason for not scoring a 10 is the omission of the specific capital investment figures ($20B+ in Arizona and Ohio), which were part of the original answer and directly tied to the scale-up of technologies like RibbonFET. However, since the question did not explicitly ask for dollar amounts, and the strategic linkage is still clearly made, the correctness score remains high at 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 548,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "In Q4 2023, Meta estimated that roughly 3 percent of its worldwide MAP consisted of violating (i.e., bot/spam) accounts, while approximately 4 percent of its worldwide MAUs were estimated to be false accounts (including duplicate and mis‑classified profiles). These accounts can undermine the stability and accuracy of Meta’s user metrics by inflating the apparent size of its user base, distorting growth trends, and introducing variability into the measured DAU/MAU figures—especially when such accounts are more prevalent in certain regions or when detection methods change.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key percentages from the ground truth: 3% of Meta's worldwide MAP consisted of violating accounts and 4% of MAUs were false accounts in Q4 2023. These numbers match exactly with the original answer, satisfying quantitative accuracy. 2) All numeric values are accurate and correctly attributed to the right metrics (MAP for violating accounts, MAUs for false accounts) and time period (Q4 2023). Format is clear and consistent. 3) The reasoning is sound and captures the core impact on stability and accuracy of user metrics. The LLM correctly explains that these accounts can distort user metrics by inflating user counts, affecting growth trends, and introducing variability—especially due to regional prevalence or changes in detection methods. This aligns with the original answer’s emphasis on methodology changes and fluctuations. 4) The only minor shortcoming is that the LLM omits a specific mention of 'encrypted products like WhatsApp' as a data limitation, which is included in the ground truth as a factor affecting accuracy. While the LLM broadly references detection methods, it misses this concrete example, slightly reducing qualitative completeness. However, the overall semantic meaning and impact explanation remain highly consistent. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a small deduction for the omitted detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 400,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "As of December 31, 2023, the fair value of PayPal’s crypto‑asset safeguarding liability was $1,241 million and the corresponding safeguarding asset was also recorded at $1,241 million. These amounts are recorded at the same value because the safeguarding asset is measured at the fair value of the underlying crypto assets held for customers, and the liability reflects the Company’s obligation to protect those assets; since no safeguarding loss events have occurred, the liability and asset remain equal.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly explains that the safeguarding asset and liability are recorded at the same value because no safeguarding loss events have occurred and both are measured at fair value of the underlying crypto assets. This aligns with the ground truth reasoning. However, the ground truth does not specify the dollar amount ($1,241 million), and the knowledge graph source does not confirm this figure. Therefore, the inclusion of a specific numeric value is unsupported and likely incorrect or hallucinated. (2) Quantitative accuracy is compromised because while the format ($1,241 million) is acceptable, the actual number is not present in the original answer or verifiable from the provided ground truth. The original answer only states that the values are equal, not their magnitude. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the accounting logic linking asset/liability equality to the absence of loss events and fair value measurement. Entity accuracy (PayPal, crypto asset safeguarding, December 31, 2023) and time period are correct. (4) Correctness score is 7 because the core conceptual explanation is accurate and complete, but the addition of an unverified dollar amount introduces a significant factual error. Quantitative accuracy is 6 due to the unsupported number. Qualitative accuracy is 8 due to correct logic and entities. Contextual relevance is 10—response directly addresses the question with appropriate focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 408,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "The combined total of \"Other noncontrolling redeemable interests\" and \"7.50% Cumulative Redeemable Preferred Units\" was $184,729 thousand as of December 31, 2024, compared with $195,949 thousand as of December 31, 2023, representing a decrease of $11,220 thousand.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 2024 combined total is $184,729 thousand, the 2023 total is $195,949 thousand, and the difference is correctly implied as a decrease of $11,220 thousand. These values exactly match the original answer, with only formatting differences (e.g., 'thousand' vs '(in thousands)') that do not affect meaning. (2) The answer is complete, addressing both the 2024 combined value and its comparison to 2023, including the direction and magnitude of change. (3) Entity accuracy is correct: the financial line items and years (2024 and 2023) are properly identified. (4) The reasoning is sound—though not explicitly shown, the correct comparison and numerical difference indicate accurate multi-hop synthesis across the two years and line items. (5) The semantic meaning is equivalent to the original answer, with slightly more concise wording but no loss of information. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 293,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "Southern Company Gas' floating‑price natural‑gas purchases through Nicor Gas and SouthStar totaled **$136 million** (39 million mmBtu valued at $136 million) as of December 31 2024. These purchases are made under contracts that allow the utilities to recover the gas cost through regulated rate‑adjustment mechanisms, ensuring that the costs are passed to customers in accordance with the regulated cost‑recovery framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $136 million value of floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, matching the ground truth exactly. The additional detail of 39 million mmBtu is not present in the original answer but does not contradict it and may reflect supplementary data; however, since the question did not ask for volume, its inclusion doesn't affect correctness. (2) Quantitative accuracy is perfect: the dollar amount and date are correct, and no calculations are required beyond reporting the figure. Format ($136 million) matches ground truth. (3) The reasoning is sound: the LLM correctly explains that these purchases are recovered via regulated rate-adjustment mechanisms, which aligns with the ground truth's description of cost recovery frameworks allowing rate adjustments to reflect wholesale gas costs. It accurately captures the regulatory alignment, though it omits the explicit mention that procurement plans are reviewed and approved by state regulators—a minor omission that slightly weakens the qualitative depth but doesn't invalidate the core logic. (4) Contextual relevance is high: the answer directly addresses both parts of the question—value of purchases and alignment with cost recovery—using appropriate terminology and regulatory context. The synthesis across entities (Southern Company Gas, Nicor Gas, SouthStar) and regulatory framework is accurate and concise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 405,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, which is higher than the $18 million of equity earnings (losses) recorded from that same region for the year.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the total net income attributable to ConocoPhillips from the Lower 48 region in 2021 as $4,932 million, which matches the ground truth. However, there is a critical error in the representation of the equity in earnings (losses): the ground truth states it was $(18) million (a loss of $18 million), but the LLM reports it as '$18 million of equity earnings (losses)', which inaccurately implies a positive $18 million rather than a loss. This misrepresents the sign and financial implication of the figure. Despite this, the comparison stating that net income is higher than equity earnings is still valid, as $4,932 million is indeed greater than a -$18 million result. The entity (ConocoPhillips, Lower 48 region), year (2021), and metrics (net income attributable, equity in earnings) are all correctly identified and contextually relevant. The reasoning is mostly sound but lacks clarity on the loss aspect. The answer is semantically close but has a meaningful quantitative inaccuracy in sign/direction of the equity figure, warranting a deduction in quantitative and qualitative accuracy. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 327,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "The company's total notional value of unsettled forward foreign‑exchange contracts and variable‑priced commodity contracts used to manage currency and commodity price risk was approximately $1.2 billion (the aggregate notional amount of open, unsettled forward foreign‑exchange contracts was $1,212 million, and variable‑priced commodity contracts are noted as part of its risk‑management strategy). These contracts are employed to hedge exposure to foreign‑currency fluctuations and commodity price changes, allowing the company to lock in costs for inventory and energy purchases and thereby stabilize earnings against market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total notional value of unsettled forward foreign-exchange contracts as $1,212 million (equivalent to $1.2 billion), which matches the ground truth. It accurately notes that variable-priced commodity contracts are used as part of the company's risk-management strategy, though it does not explicitly list the specific commodities (electricity, natural gas, and fuel for gas stations) mentioned in the original answer. However, this omission is minor and does not affect the core factual accuracy. 2) Quantitatively, the $1,212 million figure is reported exactly, and the rounding to $1.2 billion is appropriate and commonly accepted. There are no calculation errors. 3) The multi-hop reasoning is sound: the LLM correctly synthesizes that both instrument types are used to manage financial risks from currency and commodity price fluctuations, aligning with the company's strategy to stabilize costs and earnings. It correctly notes these are used for hedging even though derivative hedge accounting is not applied (implied by 'used to manage risk' and 'stabilize earnings'). The only slight gap is not explicitly stating that hedge accounting is not applied, but the functional use is accurately described. 4) The answer is semantically equivalent in intent and meaning, with slightly more interpretive language (e.g., 'lock in costs', 'stabilize earnings') that adds clarity without introducing inaccuracies. The response fully addresses both parts of the question: the quantitative exposure and the strategic rationale. Thus, the correctness score is 9 due to minor omission of specific commodity types and lack of explicit mention of no hedge accounting, but core facts and synthesis remain accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 473,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "Microsoft's internal development structure for Microsoft 365—particularly the integration of Office 365 Commercial, Microsoft 365 Consumer subscriptions, and Copilot for Microsoft 365 within the Productivity and Business Processes segment—drives the financial reporting updates disclosed in the FY 2024 MD&A. This is reflected in the segment metrics that track Office 365 Commercial seat growth and Microsoft 365 Consumer subscriber counts, as well as the inclusion of Microsoft 365 Basic in the updated subscriber metric, all of which directly influence the reported revenue growth and subscriber figures for Microsoft 365 in fiscal year 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies the key financial reporting update in FY 2024: the inclusion of Microsoft 365 Basic subscribers in the Microsoft 365 Consumer subscriber metric. This matches the original answer’s core claim. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the LLM correctly links internal development structure (via integration in the Productivity and Business Processes segment) to financial reporting changes. However, it slightly misattributes the organizational structure—while Microsoft 365 is reported under Productivity and Business Processes for financial purposes, the original answer specifies the 'Experiences and Devices' engineering group as the internal development unit, which the LLM omits or misaligns. This is a minor but notable deviation in entity accuracy regarding internal structure. (4) Despite this, the LLM captures the functional outcome—how internal integration influences reporting—and correctly contextualizes the impact on subscriber metrics and revenue disclosure in FY 2024. The answer is semantically close and contextually fully relevant, warranting a high score but not perfect due to the organizational structure inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 373,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "Based on the information in the document, the total number of shares counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) is calculated as follows: each PSA counts as three shares times the maximum potential payout, and the document states that as of December 31, 2023, 248 million shares were available for award under the 2019 Plan, which includes the 68 million shares assumed from the Seagen stock plan. This calculation is significant because it directly relates to the 248 million shares still available for award, demonstrating that the PSA shares (counted at 3x their maximum potential payout) are a component of the total shares reserved for future grants under the plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that each PSA counts as three shares times the maximum potential payout and notes the 248 million shares available as of December 31, 2023, which aligns with the ground truth. However, it introduces a fact not present in the original answer — the 68 million shares assumed from the Seagen stock plan — which was not mentioned in the ground truth and is extraneous. This addition may reflect information from the source document but undermines accuracy by including unverified details not in the reference answer. (2) The key numbers — 248 million shares available and the 3x share counting for PSAs — are correct and properly contextualized in terms of the plan’s share reserve. No explicit calculation (e.g., maximum PSAs possible) is requested or required, so the absence of arithmetic is not an issue. However, the inclusion of the 68 million Seagen shares introduces quantitative noise not supported by the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model connects the PSA share counting method to the total available shares and implies constraints on award issuance. However, it fails to explain the significance as clearly as the ground truth — specifically, that PSAs consume shares at a higher rate than options or TSRUs (1x), thus limiting how many such awards can be granted from the 248 million pool. This key comparative insight is missing, weakening qualitative accuracy. (4) The answer is contextually relevant and addresses the core question about share counting and significance, but lacks the full depth of the original answer’s implications for award allocation trade-offs. Hence, scores are moderate: correct on core facts but incomplete in reasoning and slightly inaccurate due to unsupported additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 496,
        "total_tokens": 1897
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 750,
    "successful_evaluations": 750,
    "failed_evaluations": 0,
    "average_correctness_score": 6.74,
    "average_quantitative_accuracy": 7.23,
    "average_qualitative_accuracy": 7.08,
    "average_contextual_relevance": 8.8,
    "score_distribution": {
      "excellent": 347,
      "good": 108,
      "fair": 146,
      "poor": 149
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750
  }
}